[
  {
    "request_id": "AM-REQ-2026-00000",
    "original_inquiry": "Urgent: Family member with ALS, exploring neural decoding or BrainGate for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8004
  },
  {
    "request_id": "AM-REQ-2026-00001",
    "original_inquiry": "Family member with ALS, exploring invasive cortical electrode or Precision Neuroscience for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6799
  },
  {
    "request_id": "AM-REQ-2026-00002",
    "original_inquiry": "Family seeking information: 海外求诊：患者intracortical array，希望评估Precision Neuroscience或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.892
  },
  {
    "request_id": "AM-REQ-2026-00003",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring ECoG or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.723
  },
  {
    "request_id": "AM-REQ-2026-00004",
    "original_inquiry": "研究者咨询：Neurologist referral: brain-computer interface candidate for Paradromics; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8391
  },
  {
    "request_id": "AM-REQ-2026-00005",
    "original_inquiry": "研究者咨询：希望了解brain-computer interface在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8469
  },
  {
    "request_id": "AM-REQ-2026-00006",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7256
  },
  {
    "request_id": "AM-REQ-2026-00007",
    "original_inquiry": "海外求诊：Patient with neural decoding seeking evaluation for Precision Neuroscience; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8273
  },
  {
    "request_id": "AM-REQ-2026-00008",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解speech decoding在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8537
  },
  {
    "request_id": "AM-REQ-2026-00009",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7239
  },
  {
    "request_id": "AM-REQ-2026-00010",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.581
  },
  {
    "request_id": "AM-REQ-2026-00011",
    "original_inquiry": "研究者咨询：Neurologist referral: invasive cortical electrode candidate for Paradromics; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.644
  },
  {
    "request_id": "AM-REQ-2026-00012",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7231
  },
  {
    "request_id": "AM-REQ-2026-00013",
    "original_inquiry": "Family seeking information: Consultation request: locked-in syndrome for Neuralink; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7757
  },
  {
    "request_id": "AM-REQ-2026-00014",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解motor neuroprosthesis在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7594
  },
  {
    "request_id": "AM-REQ-2026-00015",
    "original_inquiry": "研究者咨询：海外求诊：患者speech prosthesis，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6798
  },
  {
    "request_id": "AM-REQ-2026-00016",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5991
  },
  {
    "request_id": "AM-REQ-2026-00017",
    "original_inquiry": "研究者咨询：Urgent: neural decoding diagnosis, seeking centers offering Neuralink / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5021
  },
  {
    "request_id": "AM-REQ-2026-00018",
    "original_inquiry": "海外求诊：Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7352
  },
  {
    "request_id": "AM-REQ-2026-00019",
    "original_inquiry": "Urgent: Neurologist referral: ECoG candidate for Paradromics; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6562
  },
  {
    "request_id": "AM-REQ-2026-00020",
    "original_inquiry": "Family seeking information: 海外求诊：患者侵入式电极，希望评估Speech Neuroprosthesis或Wyss Center项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6557
  },
  {
    "request_id": "AM-REQ-2026-00021",
    "original_inquiry": "研究者咨询：Consultation request: 运动皮层解码 for BrainGate; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5102
  },
  {
    "request_id": "AM-REQ-2026-00022",
    "original_inquiry": "Family seeking information: Urgent: 脑机接口 diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.699
  },
  {
    "request_id": "AM-REQ-2026-00023",
    "original_inquiry": "Urgent: Neurologist referral: speech decoding candidate for Precision Neuroscience; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7493
  },
  {
    "request_id": "AM-REQ-2026-00024",
    "original_inquiry": "海外求诊：Family member with ALS, exploring BCI for ALS or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5782
  },
  {
    "request_id": "AM-REQ-2026-00025",
    "original_inquiry": "Family seeking information: Patient with 脑机接口 seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7844
  },
  {
    "request_id": "AM-REQ-2026-00026",
    "original_inquiry": "Referral from specialist: 海外求诊：患者脑机接口，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7645
  },
  {
    "request_id": "AM-REQ-2026-00027",
    "original_inquiry": "海外求诊：研究者咨询：希望了解locked-in syndrome在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6533
  },
  {
    "request_id": "AM-REQ-2026-00028",
    "original_inquiry": "Family seeking information: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6151
  },
  {
    "request_id": "AM-REQ-2026-00029",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8265
  },
  {
    "request_id": "AM-REQ-2026-00030",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring invasive cortical electrode or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.718
  },
  {
    "request_id": "AM-REQ-2026-00031",
    "original_inquiry": "Second opinion requested: Neurologist referral: intracortical array candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7483
  },
  {
    "request_id": "AM-REQ-2026-00032",
    "original_inquiry": "海外求诊：海外求诊：患者侵入式电极，希望评估Paradromics或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7681
  },
  {
    "request_id": "AM-REQ-2026-00033",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5424
  },
  {
    "request_id": "AM-REQ-2026-00034",
    "original_inquiry": "研究者咨询：Neurologist referral: intracortical array candidate for Neuralink; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6107
  },
  {
    "request_id": "AM-REQ-2026-00035",
    "original_inquiry": "Second opinion requested: Neurologist referral: intracortical array candidate for BrainGate; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5055
  },
  {
    "request_id": "AM-REQ-2026-00036",
    "original_inquiry": "Patient with invasive cortical electrode seeking evaluation for Paradromics; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.624
  },
  {
    "request_id": "AM-REQ-2026-00037",
    "original_inquiry": "Second opinion requested: Consultation request: neural decoding for BrainGate; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8699
  },
  {
    "request_id": "AM-REQ-2026-00038",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8445
  },
  {
    "request_id": "AM-REQ-2026-00039",
    "original_inquiry": "Consultation request: locked-in syndrome for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6126
  },
  {
    "request_id": "AM-REQ-2026-00040",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7342
  },
  {
    "request_id": "AM-REQ-2026-00041",
    "original_inquiry": "海外求诊：海外求诊：患者intracortical array，希望评估Neuralink或Wyss Center项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5648
  },
  {
    "request_id": "AM-REQ-2026-00042",
    "original_inquiry": "海外求诊：Neurologist referral: invasive cortical electrode candidate for BrainGate; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5115
  },
  {
    "request_id": "AM-REQ-2026-00043",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解ECoG在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.765
  },
  {
    "request_id": "AM-REQ-2026-00044",
    "original_inquiry": "研究者咨询：Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8146
  },
  {
    "request_id": "AM-REQ-2026-00045",
    "original_inquiry": "海外求诊：Urgent: invasive cortical electrode diagnosis, seeking centers offering Synchron Stentrode / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6055
  },
  {
    "request_id": "AM-REQ-2026-00046",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 脑机接口 or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7601
  },
  {
    "request_id": "AM-REQ-2026-00047",
    "original_inquiry": "Consultation request: 脑机接口 for Paradromics; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6882
  },
  {
    "request_id": "AM-REQ-2026-00048",
    "original_inquiry": "研究者咨询：Neurologist referral: neural decoding candidate for Synchron Stentrode; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8804
  },
  {
    "request_id": "AM-REQ-2026-00049",
    "original_inquiry": "Second opinion requested: Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Wyss Center clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6436
  },
  {
    "request_id": "AM-REQ-2026-00050",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5633
  },
  {
    "request_id": "AM-REQ-2026-00051",
    "original_inquiry": "Second opinion requested: Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7556
  },
  {
    "request_id": "AM-REQ-2026-00052",
    "original_inquiry": "Urgent: Urgent: intracortical array diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7134
  },
  {
    "request_id": "AM-REQ-2026-00053",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解invasive cortical electrode在Paradromics适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5342
  },
  {
    "request_id": "AM-REQ-2026-00054",
    "original_inquiry": "Second opinion requested: Urgent: neural decoding diagnosis, seeking centers offering Blackrock Neurotech / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5649
  },
  {
    "request_id": "AM-REQ-2026-00055",
    "original_inquiry": "Second opinion requested: Urgent: neural decoding diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5755
  },
  {
    "request_id": "AM-REQ-2026-00056",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7888
  },
  {
    "request_id": "AM-REQ-2026-00057",
    "original_inquiry": "Urgent: Neurologist referral: intracortical array candidate for Neuralink; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.706
  },
  {
    "request_id": "AM-REQ-2026-00058",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring intracortical array or Neuralink for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7129
  },
  {
    "request_id": "AM-REQ-2026-00059",
    "original_inquiry": "Family seeking information: Consultation request: speech prosthesis for Synchron Stentrode; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6525
  },
  {
    "request_id": "AM-REQ-2026-00060",
    "original_inquiry": "Family seeking information: Consultation request: speech prosthesis for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7222
  },
  {
    "request_id": "AM-REQ-2026-00061",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5276
  },
  {
    "request_id": "AM-REQ-2026-00062",
    "original_inquiry": "Second opinion requested: Urgent: brain-computer interface diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.63
  },
  {
    "request_id": "AM-REQ-2026-00063",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5786
  },
  {
    "request_id": "AM-REQ-2026-00064",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8326
  },
  {
    "request_id": "AM-REQ-2026-00065",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6071
  },
  {
    "request_id": "AM-REQ-2026-00066",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5937
  },
  {
    "request_id": "AM-REQ-2026-00067",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 侵入式电极 or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7533
  },
  {
    "request_id": "AM-REQ-2026-00068",
    "original_inquiry": "研究者咨询：Consultation request: neural decoding for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.538
  },
  {
    "request_id": "AM-REQ-2026-00069",
    "original_inquiry": "Family seeking information: 海外求诊：患者运动皮层解码，希望评估Precision Neuroscience或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.524
  },
  {
    "request_id": "AM-REQ-2026-00070",
    "original_inquiry": "Second opinion requested: Patient with motor neuroprosthesis seeking evaluation for Blackrock Neurotech; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6336
  },
  {
    "request_id": "AM-REQ-2026-00071",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5047
  },
  {
    "request_id": "AM-REQ-2026-00072",
    "original_inquiry": "Second opinion requested: Urgent: speech prosthesis diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8163
  },
  {
    "request_id": "AM-REQ-2026-00073",
    "original_inquiry": "Consultation request: 脑机接口 for Paradromics; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.893
  },
  {
    "request_id": "AM-REQ-2026-00074",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5337
  },
  {
    "request_id": "AM-REQ-2026-00075",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Blackrock Neurotech; request information on Wyss Center eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-00076",
    "original_inquiry": "Family seeking information: 海外求诊：患者neural decoding，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.639
  },
  {
    "request_id": "AM-REQ-2026-00077",
    "original_inquiry": "Referral from specialist: Consultation request: brain-computer interface for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7574
  },
  {
    "request_id": "AM-REQ-2026-00078",
    "original_inquiry": "Second opinion requested: Consultation request: brain-computer interface for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.647
  },
  {
    "request_id": "AM-REQ-2026-00079",
    "original_inquiry": "Referral from specialist: Patient with BCI for ALS seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7904
  },
  {
    "request_id": "AM-REQ-2026-00080",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring speech decoding or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6272
  },
  {
    "request_id": "AM-REQ-2026-00081",
    "original_inquiry": "海外求诊：Family member with ALS, exploring motor neuroprosthesis or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8856
  },
  {
    "request_id": "AM-REQ-2026-00082",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5839
  },
  {
    "request_id": "AM-REQ-2026-00083",
    "original_inquiry": "Referral from specialist: Urgent: BCI for ALS diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7236
  },
  {
    "request_id": "AM-REQ-2026-00084",
    "original_inquiry": "海外求诊：研究者咨询：希望了解脑机接口在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7427
  },
  {
    "request_id": "AM-REQ-2026-00085",
    "original_inquiry": "Referral from specialist: Neurologist referral: motor neuroprosthesis candidate for Speech Neuroprosthesis; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6121
  },
  {
    "request_id": "AM-REQ-2026-00086",
    "original_inquiry": "Second opinion requested: Neurologist referral: motor neuroprosthesis candidate for Paradromics; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6829
  },
  {
    "request_id": "AM-REQ-2026-00087",
    "original_inquiry": "研究者咨询：Neurologist referral: invasive cortical electrode candidate for Speech Neuroprosthesis; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7565
  },
  {
    "request_id": "AM-REQ-2026-00088",
    "original_inquiry": "Urgent: Urgent: invasive cortical electrode diagnosis, seeking centers offering Precision Neuroscience / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6863
  },
  {
    "request_id": "AM-REQ-2026-00089",
    "original_inquiry": "研究者咨询：Neurologist referral: intracortical array candidate for Blackrock Neurotech; request information on BrainGate eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.503
  },
  {
    "request_id": "AM-REQ-2026-00090",
    "original_inquiry": "Second opinion requested: Urgent: speech decoding diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7013
  },
  {
    "request_id": "AM-REQ-2026-00091",
    "original_inquiry": "Urgent: 研究者咨询：希望了解脑机接口在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5899
  },
  {
    "request_id": "AM-REQ-2026-00092",
    "original_inquiry": "海外求诊：Neurologist referral: intracortical array candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-00093",
    "original_inquiry": "研究者咨询：Urgent: BCI for ALS diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5367
  },
  {
    "request_id": "AM-REQ-2026-00094",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7859
  },
  {
    "request_id": "AM-REQ-2026-00095",
    "original_inquiry": "研究者咨询：海外求诊：患者motor neuroprosthesis，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8598
  },
  {
    "request_id": "AM-REQ-2026-00096",
    "original_inquiry": "研究者咨询：Neurologist referral: neural decoding candidate for Blackrock Neurotech; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7957
  },
  {
    "request_id": "AM-REQ-2026-00097",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8939
  },
  {
    "request_id": "AM-REQ-2026-00098",
    "original_inquiry": "Second opinion requested: 海外求诊：患者motor neuroprosthesis，希望评估BrainGate或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7434
  },
  {
    "request_id": "AM-REQ-2026-00099",
    "original_inquiry": "Referral from specialist: Consultation request: 脑机接口 for Neuralink; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6844
  },
  {
    "request_id": "AM-REQ-2026-00100",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 运动皮层解码 or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5149
  },
  {
    "request_id": "AM-REQ-2026-00101",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8197
  },
  {
    "request_id": "AM-REQ-2026-00102",
    "original_inquiry": "Urgent: Patient with brain-computer interface seeking evaluation for Precision Neuroscience; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5106
  },
  {
    "request_id": "AM-REQ-2026-00103",
    "original_inquiry": "Urgent: motor neuroprosthesis diagnosis, seeking centers offering Blackrock Neurotech / Neuralink clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.801
  },
  {
    "request_id": "AM-REQ-2026-00104",
    "original_inquiry": "研究者咨询：Consultation request: 运动皮层解码 for BrainGate; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8833
  },
  {
    "request_id": "AM-REQ-2026-00105",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5954
  },
  {
    "request_id": "AM-REQ-2026-00106",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5754
  },
  {
    "request_id": "AM-REQ-2026-00107",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解brain-computer interface在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8782
  },
  {
    "request_id": "AM-REQ-2026-00108",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5964
  },
  {
    "request_id": "AM-REQ-2026-00109",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解侵入式电极在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7409
  },
  {
    "request_id": "AM-REQ-2026-00110",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7219
  },
  {
    "request_id": "AM-REQ-2026-00111",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or Precision Neuroscience for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6604
  },
  {
    "request_id": "AM-REQ-2026-00112",
    "original_inquiry": "Second opinion requested: Patient with BCI for ALS seeking evaluation for Neuralink; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8649
  },
  {
    "request_id": "AM-REQ-2026-00113",
    "original_inquiry": "Urgent: Patient with motor neuroprosthesis seeking evaluation for BrainGate; interested in Synchron Stentrode trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7199
  },
  {
    "request_id": "AM-REQ-2026-00114",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-00115",
    "original_inquiry": "Urgent: Family member with ALS, exploring locked-in syndrome or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5818
  },
  {
    "request_id": "AM-REQ-2026-00116",
    "original_inquiry": "Family seeking information: Patient with 脑机接口 seeking evaluation for Paradromics; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8542
  },
  {
    "request_id": "AM-REQ-2026-00117",
    "original_inquiry": "Family seeking information: 海外求诊：患者脑机接口，希望评估Speech Neuroprosthesis或Wyss Center项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5913
  },
  {
    "request_id": "AM-REQ-2026-00118",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6543
  },
  {
    "request_id": "AM-REQ-2026-00119",
    "original_inquiry": "Urgent: Neurologist referral: 脑机接口 candidate for BrainGate; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7237
  },
  {
    "request_id": "AM-REQ-2026-00120",
    "original_inquiry": "Family seeking information: Neurologist referral: locked-in syndrome candidate for Wyss Center; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-00121",
    "original_inquiry": "Referral from specialist: 海外求诊：患者运动皮层解码，希望评估Speech Neuroprosthesis或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7747
  },
  {
    "request_id": "AM-REQ-2026-00122",
    "original_inquiry": "Urgent: Family member with ALS, exploring brain-computer interface or Wyss Center for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5358
  },
  {
    "request_id": "AM-REQ-2026-00123",
    "original_inquiry": "海外求诊：Consultation request: ECoG for Precision Neuroscience; interested in Wyss Center and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.797
  },
  {
    "request_id": "AM-REQ-2026-00124",
    "original_inquiry": "海外求诊：患者locked-in syndrome，希望评估Neuralink或Blackrock Neurotech项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8774
  },
  {
    "request_id": "AM-REQ-2026-00125",
    "original_inquiry": "Patient with 语音神经假体 seeking evaluation for Speech Neuroprosthesis; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7858
  },
  {
    "request_id": "AM-REQ-2026-00126",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5453
  },
  {
    "request_id": "AM-REQ-2026-00127",
    "original_inquiry": "Urgent: Urgent: speech decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5081
  },
  {
    "request_id": "AM-REQ-2026-00128",
    "original_inquiry": "Family seeking information: Patient with ECoG seeking evaluation for Paradromics; interested in BrainGate trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.591
  },
  {
    "request_id": "AM-REQ-2026-00129",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6755
  },
  {
    "request_id": "AM-REQ-2026-00130",
    "original_inquiry": "Second opinion requested: Urgent: 运动皮层解码 diagnosis, seeking centers offering Precision Neuroscience / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6878
  },
  {
    "request_id": "AM-REQ-2026-00131",
    "original_inquiry": "海外求诊：Family member with ALS, exploring motor neuroprosthesis or Wyss Center for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5853
  },
  {
    "request_id": "AM-REQ-2026-00132",
    "original_inquiry": "Urgent: 研究者咨询：希望了解侵入式电极在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.82
  },
  {
    "request_id": "AM-REQ-2026-00133",
    "original_inquiry": "研究者咨询：Consultation request: motor neuroprosthesis for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7466
  },
  {
    "request_id": "AM-REQ-2026-00134",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解neural decoding在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8463
  },
  {
    "request_id": "AM-REQ-2026-00135",
    "original_inquiry": "Urgent: motor neuroprosthesis diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5679
  },
  {
    "request_id": "AM-REQ-2026-00136",
    "original_inquiry": "Family seeking information: Neurologist referral: speech decoding candidate for Blackrock Neurotech; request information on Wyss Center eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7724
  },
  {
    "request_id": "AM-REQ-2026-00137",
    "original_inquiry": "海外求诊：Consultation request: invasive cortical electrode for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5903
  },
  {
    "request_id": "AM-REQ-2026-00138",
    "original_inquiry": "Referral from specialist: Consultation request: 脑机接口 for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7103
  },
  {
    "request_id": "AM-REQ-2026-00139",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解neural decoding在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7237
  },
  {
    "request_id": "AM-REQ-2026-00140",
    "original_inquiry": "Patient with 运动皮层解码 seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5699
  },
  {
    "request_id": "AM-REQ-2026-00141",
    "original_inquiry": "Family seeking information: Neurologist referral: 运动皮层解码 candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5124
  },
  {
    "request_id": "AM-REQ-2026-00142",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech prosthesis，希望评估BrainGate或Neuralink项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7406
  },
  {
    "request_id": "AM-REQ-2026-00143",
    "original_inquiry": "Second opinion requested: Consultation request: BCI for ALS for BrainGate; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8562
  },
  {
    "request_id": "AM-REQ-2026-00144",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7575
  },
  {
    "request_id": "AM-REQ-2026-00145",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5346
  },
  {
    "request_id": "AM-REQ-2026-00146",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8014
  },
  {
    "request_id": "AM-REQ-2026-00147",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6991
  },
  {
    "request_id": "AM-REQ-2026-00148",
    "original_inquiry": "Family member with ALS, exploring intracortical array or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6713
  },
  {
    "request_id": "AM-REQ-2026-00149",
    "original_inquiry": "Family seeking information: 海外求诊：患者语音神经假体，希望评估BrainGate或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8805
  },
  {
    "request_id": "AM-REQ-2026-00150",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Neuralink / Precision Neuroscience clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7779
  },
  {
    "request_id": "AM-REQ-2026-00151",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech prosthesis在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6277
  },
  {
    "request_id": "AM-REQ-2026-00152",
    "original_inquiry": "海外求诊：Neurologist referral: 语音神经假体 candidate for Paradromics; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5136
  },
  {
    "request_id": "AM-REQ-2026-00153",
    "original_inquiry": "Family seeking information: Urgent: brain-computer interface diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7831
  },
  {
    "request_id": "AM-REQ-2026-00154",
    "original_inquiry": "Second opinion requested: Urgent: intracortical array diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8489
  },
  {
    "request_id": "AM-REQ-2026-00155",
    "original_inquiry": "研究者咨询：Consultation request: BCI for ALS for Synchron Stentrode; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7644
  },
  {
    "request_id": "AM-REQ-2026-00156",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8903
  },
  {
    "request_id": "AM-REQ-2026-00157",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6433
  },
  {
    "request_id": "AM-REQ-2026-00158",
    "original_inquiry": "Referral from specialist: Consultation request: 语音神经假体 for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.504
  },
  {
    "request_id": "AM-REQ-2026-00159",
    "original_inquiry": "Referral from specialist: Patient with invasive cortical electrode seeking evaluation for Blackrock Neurotech; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5465
  },
  {
    "request_id": "AM-REQ-2026-00160",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解locked-in syndrome在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5825
  },
  {
    "request_id": "AM-REQ-2026-00161",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Neuralink; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5413
  },
  {
    "request_id": "AM-REQ-2026-00162",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring motor neuroprosthesis or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5466
  },
  {
    "request_id": "AM-REQ-2026-00163",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 侵入式电极 or BrainGate for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5548
  },
  {
    "request_id": "AM-REQ-2026-00164",
    "original_inquiry": "Family seeking information: Urgent: 侵入式电极 diagnosis, seeking centers offering Neuralink / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5761
  },
  {
    "request_id": "AM-REQ-2026-00165",
    "original_inquiry": "Second opinion requested: Neurologist referral: locked-in syndrome candidate for Neuralink; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7863
  },
  {
    "request_id": "AM-REQ-2026-00166",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech decoding在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7542
  },
  {
    "request_id": "AM-REQ-2026-00167",
    "original_inquiry": "Referral from specialist: Urgent: invasive cortical electrode diagnosis, seeking centers offering Speech Neuroprosthesis / Precision Neuroscience clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6719
  },
  {
    "request_id": "AM-REQ-2026-00168",
    "original_inquiry": "Urgent: Neurologist referral: brain-computer interface candidate for Paradromics; request information on Blackrock Neurotech eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8052
  },
  {
    "request_id": "AM-REQ-2026-00169",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech prosthesis，希望评估Paradromics或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6438
  },
  {
    "request_id": "AM-REQ-2026-00170",
    "original_inquiry": "海外求诊：Consultation request: invasive cortical electrode for BrainGate; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.721
  },
  {
    "request_id": "AM-REQ-2026-00171",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring locked-in syndrome or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7759
  },
  {
    "request_id": "AM-REQ-2026-00172",
    "original_inquiry": "Urgent: Neurologist referral: intracortical array candidate for Precision Neuroscience; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7209
  },
  {
    "request_id": "AM-REQ-2026-00173",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.804
  },
  {
    "request_id": "AM-REQ-2026-00174",
    "original_inquiry": "海外求诊：Neurologist referral: speech prosthesis candidate for Wyss Center; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8956
  },
  {
    "request_id": "AM-REQ-2026-00175",
    "original_inquiry": "Family seeking information: Urgent: BCI for ALS diagnosis, seeking centers offering Wyss Center / Precision Neuroscience clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5607
  },
  {
    "request_id": "AM-REQ-2026-00176",
    "original_inquiry": "Urgent: Family member with ALS, exploring 侵入式电极 or Precision Neuroscience for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6034
  },
  {
    "request_id": "AM-REQ-2026-00177",
    "original_inquiry": "Second opinion requested: Consultation request: brain-computer interface for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8886
  },
  {
    "request_id": "AM-REQ-2026-00178",
    "original_inquiry": "研究者咨询：希望了解locked-in syndrome在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8749
  },
  {
    "request_id": "AM-REQ-2026-00179",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Neuralink或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6012
  },
  {
    "request_id": "AM-REQ-2026-00180",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8746
  },
  {
    "request_id": "AM-REQ-2026-00181",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for Precision Neuroscience; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5807
  },
  {
    "request_id": "AM-REQ-2026-00182",
    "original_inquiry": "Referral from specialist: Consultation request: 脑机接口 for Paradromics; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7546
  },
  {
    "request_id": "AM-REQ-2026-00183",
    "original_inquiry": "研究者咨询：Patient with brain-computer interface seeking evaluation for Neuralink; interested in Paradromics trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5583
  },
  {
    "request_id": "AM-REQ-2026-00184",
    "original_inquiry": "Consultation request: speech prosthesis for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5972
  },
  {
    "request_id": "AM-REQ-2026-00185",
    "original_inquiry": "Urgent: Urgent: BCI for ALS diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5485
  },
  {
    "request_id": "AM-REQ-2026-00186",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解motor neuroprosthesis在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7805
  },
  {
    "request_id": "AM-REQ-2026-00187",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解locked-in syndrome在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7225
  },
  {
    "request_id": "AM-REQ-2026-00188",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解ECoG在Synchron Stentrode适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7432
  },
  {
    "request_id": "AM-REQ-2026-00189",
    "original_inquiry": "研究者咨询：Consultation request: 侵入式电极 for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.72
  },
  {
    "request_id": "AM-REQ-2026-00190",
    "original_inquiry": "Neurologist referral: locked-in syndrome candidate for Synchron Stentrode; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5882
  },
  {
    "request_id": "AM-REQ-2026-00191",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解speech decoding在Synchron Stentrode适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8782
  },
  {
    "request_id": "AM-REQ-2026-00192",
    "original_inquiry": "Second opinion requested: Patient with speech prosthesis seeking evaluation for Paradromics; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7781
  },
  {
    "request_id": "AM-REQ-2026-00193",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解ECoG在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5366
  },
  {
    "request_id": "AM-REQ-2026-00194",
    "original_inquiry": "海外求诊：Patient with 语音神经假体 seeking evaluation for Paradromics; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8794
  },
  {
    "request_id": "AM-REQ-2026-00195",
    "original_inquiry": "Urgent: locked-in syndrome diagnosis, seeking centers offering Wyss Center / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7263
  },
  {
    "request_id": "AM-REQ-2026-00196",
    "original_inquiry": "Family seeking information: Urgent: brain-computer interface diagnosis, seeking centers offering Paradromics / Precision Neuroscience clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6064
  },
  {
    "request_id": "AM-REQ-2026-00197",
    "original_inquiry": "Family seeking information: Neurologist referral: invasive cortical electrode candidate for Paradromics; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6615
  },
  {
    "request_id": "AM-REQ-2026-00198",
    "original_inquiry": "Patient with neural decoding seeking evaluation for Neuralink; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8921
  },
  {
    "request_id": "AM-REQ-2026-00199",
    "original_inquiry": "Neurologist referral: intracortical array candidate for Neuralink; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5205
  },
  {
    "request_id": "AM-REQ-2026-00200",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8009
  },
  {
    "request_id": "AM-REQ-2026-00201",
    "original_inquiry": "海外求诊：患者BCI for ALS，希望评估Speech Neuroprosthesis或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5132
  },
  {
    "request_id": "AM-REQ-2026-00202",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8866
  },
  {
    "request_id": "AM-REQ-2026-00203",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech prosthesis or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6422
  },
  {
    "request_id": "AM-REQ-2026-00204",
    "original_inquiry": "Urgent: Patient with motor neuroprosthesis seeking evaluation for BrainGate; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5199
  },
  {
    "request_id": "AM-REQ-2026-00205",
    "original_inquiry": "海外求诊：患者脑机接口，希望评估Paradromics或Neuralink项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5667
  },
  {
    "request_id": "AM-REQ-2026-00206",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring brain-computer interface or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6349
  },
  {
    "request_id": "AM-REQ-2026-00207",
    "original_inquiry": "海外求诊：患者运动皮层解码，希望评估Wyss Center或BrainGate项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6675
  },
  {
    "request_id": "AM-REQ-2026-00208",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 语音神经假体 or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6898
  },
  {
    "request_id": "AM-REQ-2026-00209",
    "original_inquiry": "海外求诊：Neurologist referral: brain-computer interface candidate for Wyss Center; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7379
  },
  {
    "request_id": "AM-REQ-2026-00210",
    "original_inquiry": "Family seeking information: 海外求诊：患者BCI for ALS，希望评估BrainGate或Blackrock Neurotech项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.896
  },
  {
    "request_id": "AM-REQ-2026-00211",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring ECoG or BrainGate for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8251
  },
  {
    "request_id": "AM-REQ-2026-00212",
    "original_inquiry": "研究者咨询：Patient with brain-computer interface seeking evaluation for BrainGate; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8295
  },
  {
    "request_id": "AM-REQ-2026-00213",
    "original_inquiry": "Consultation request: neural decoding for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8872
  },
  {
    "request_id": "AM-REQ-2026-00214",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring intracortical array or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8145
  },
  {
    "request_id": "AM-REQ-2026-00215",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5553
  },
  {
    "request_id": "AM-REQ-2026-00216",
    "original_inquiry": "Family seeking information: Neurologist referral: 脑机接口 candidate for BrainGate; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8257
  },
  {
    "request_id": "AM-REQ-2026-00217",
    "original_inquiry": "海外求诊：Neurologist referral: 侵入式电极 candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8973
  },
  {
    "request_id": "AM-REQ-2026-00218",
    "original_inquiry": "研究者咨询：Neurologist referral: neural decoding candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-00219",
    "original_inquiry": "Family seeking information: Neurologist referral: locked-in syndrome candidate for Neuralink; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8779
  },
  {
    "request_id": "AM-REQ-2026-00220",
    "original_inquiry": "Consultation request: 脑机接口 for Neuralink; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8508
  },
  {
    "request_id": "AM-REQ-2026-00221",
    "original_inquiry": "Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-00222",
    "original_inquiry": "Urgent: Family member with ALS, exploring invasive cortical electrode or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6372
  },
  {
    "request_id": "AM-REQ-2026-00223",
    "original_inquiry": "研究者咨询：Consultation request: speech decoding for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8949
  },
  {
    "request_id": "AM-REQ-2026-00224",
    "original_inquiry": "Family seeking information: Neurologist referral: 运动皮层解码 candidate for Precision Neuroscience; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7572
  },
  {
    "request_id": "AM-REQ-2026-00225",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解语音神经假体在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5375
  },
  {
    "request_id": "AM-REQ-2026-00226",
    "original_inquiry": "Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5512
  },
  {
    "request_id": "AM-REQ-2026-00227",
    "original_inquiry": "海外求诊：研究者咨询：希望了解语音神经假体在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6041
  },
  {
    "request_id": "AM-REQ-2026-00228",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5136
  },
  {
    "request_id": "AM-REQ-2026-00229",
    "original_inquiry": "Consultation request: 语音神经假体 for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6743
  },
  {
    "request_id": "AM-REQ-2026-00230",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.805
  },
  {
    "request_id": "AM-REQ-2026-00231",
    "original_inquiry": "Consultation request: BCI for ALS for Paradromics; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7216
  },
  {
    "request_id": "AM-REQ-2026-00232",
    "original_inquiry": "海外求诊：研究者咨询：希望了解运动皮层解码在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6299
  },
  {
    "request_id": "AM-REQ-2026-00233",
    "original_inquiry": "Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5579
  },
  {
    "request_id": "AM-REQ-2026-00234",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6472
  },
  {
    "request_id": "AM-REQ-2026-00235",
    "original_inquiry": "海外求诊：Neurologist referral: locked-in syndrome candidate for BrainGate; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8231
  },
  {
    "request_id": "AM-REQ-2026-00236",
    "original_inquiry": "Referral from specialist: Patient with speech prosthesis seeking evaluation for Synchron Stentrode; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8964
  },
  {
    "request_id": "AM-REQ-2026-00237",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 脑机接口 or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8198
  },
  {
    "request_id": "AM-REQ-2026-00238",
    "original_inquiry": "Urgent: Neurologist referral: motor neuroprosthesis candidate for BrainGate; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5819
  },
  {
    "request_id": "AM-REQ-2026-00239",
    "original_inquiry": "Second opinion requested: Patient with ECoG seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.622
  },
  {
    "request_id": "AM-REQ-2026-00240",
    "original_inquiry": "海外求诊：研究者咨询：希望了解运动皮层解码在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7717
  },
  {
    "request_id": "AM-REQ-2026-00241",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.754
  },
  {
    "request_id": "AM-REQ-2026-00242",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6616
  },
  {
    "request_id": "AM-REQ-2026-00243",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6565
  },
  {
    "request_id": "AM-REQ-2026-00244",
    "original_inquiry": "Consultation request: intracortical array for Neuralink; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6458
  },
  {
    "request_id": "AM-REQ-2026-00245",
    "original_inquiry": "研究者咨询：希望了解speech decoding在Precision Neuroscience适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.606
  },
  {
    "request_id": "AM-REQ-2026-00246",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7175
  },
  {
    "request_id": "AM-REQ-2026-00247",
    "original_inquiry": "海外求诊：Patient with speech prosthesis seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6018
  },
  {
    "request_id": "AM-REQ-2026-00248",
    "original_inquiry": "Referral from specialist: Urgent: speech decoding diagnosis, seeking centers offering Blackrock Neurotech / Precision Neuroscience clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-00249",
    "original_inquiry": "Referral from specialist: 海外求诊：患者ECoG，希望评估Neuralink或Synchron Stentrode项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6556
  },
  {
    "request_id": "AM-REQ-2026-00250",
    "original_inquiry": "海外求诊：研究者咨询：希望了解intracortical array在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5319
  },
  {
    "request_id": "AM-REQ-2026-00251",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7646
  },
  {
    "request_id": "AM-REQ-2026-00252",
    "original_inquiry": "Referral from specialist: Neurologist referral: ECoG candidate for Synchron Stentrode; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7323
  },
  {
    "request_id": "AM-REQ-2026-00253",
    "original_inquiry": "Urgent: Consultation request: speech decoding for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.545
  },
  {
    "request_id": "AM-REQ-2026-00254",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5704
  },
  {
    "request_id": "AM-REQ-2026-00255",
    "original_inquiry": "Referral from specialist: Patient with 运动皮层解码 seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8769
  },
  {
    "request_id": "AM-REQ-2026-00256",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7066
  },
  {
    "request_id": "AM-REQ-2026-00257",
    "original_inquiry": "Second opinion requested: Neurologist referral: ECoG candidate for Neuralink; request information on Blackrock Neurotech eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5251
  },
  {
    "request_id": "AM-REQ-2026-00258",
    "original_inquiry": "Family seeking information: Urgent: brain-computer interface diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.584
  },
  {
    "request_id": "AM-REQ-2026-00259",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5339
  },
  {
    "request_id": "AM-REQ-2026-00260",
    "original_inquiry": "Referral from specialist: 海外求诊：患者intracortical array，希望评估BrainGate或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6768
  },
  {
    "request_id": "AM-REQ-2026-00261",
    "original_inquiry": "Referral from specialist: Consultation request: motor neuroprosthesis for Blackrock Neurotech; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7127
  },
  {
    "request_id": "AM-REQ-2026-00262",
    "original_inquiry": "Urgent: 海外求诊：患者BCI for ALS，希望评估Neuralink或Precision Neuroscience项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7917
  },
  {
    "request_id": "AM-REQ-2026-00263",
    "original_inquiry": "Urgent: Neurologist referral: ECoG candidate for Blackrock Neurotech; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-00264",
    "original_inquiry": "海外求诊：Neurologist referral: speech prosthesis candidate for Synchron Stentrode; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5363
  },
  {
    "request_id": "AM-REQ-2026-00265",
    "original_inquiry": "Urgent: Consultation request: motor neuroprosthesis for Neuralink; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6964
  },
  {
    "request_id": "AM-REQ-2026-00266",
    "original_inquiry": "Family seeking information: Consultation request: ECoG for Speech Neuroprosthesis; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.539
  },
  {
    "request_id": "AM-REQ-2026-00267",
    "original_inquiry": "Urgent: Consultation request: locked-in syndrome for Blackrock Neurotech; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7832
  },
  {
    "request_id": "AM-REQ-2026-00268",
    "original_inquiry": "Family member with ALS, exploring invasive cortical electrode or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7448
  },
  {
    "request_id": "AM-REQ-2026-00269",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解invasive cortical electrode在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7957
  },
  {
    "request_id": "AM-REQ-2026-00270",
    "original_inquiry": "研究者咨询：Urgent: brain-computer interface diagnosis, seeking centers offering Neuralink / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.862
  },
  {
    "request_id": "AM-REQ-2026-00271",
    "original_inquiry": "Referral from specialist: 海外求诊：患者speech prosthesis，希望评估BrainGate或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8198
  },
  {
    "request_id": "AM-REQ-2026-00272",
    "original_inquiry": "Referral from specialist: Urgent: invasive cortical electrode diagnosis, seeking centers offering Wyss Center / Synchron Stentrode clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8585
  },
  {
    "request_id": "AM-REQ-2026-00273",
    "original_inquiry": "研究者咨询：希望了解intracortical array在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5249
  },
  {
    "request_id": "AM-REQ-2026-00274",
    "original_inquiry": "Second opinion requested: Urgent: locked-in syndrome diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6466
  },
  {
    "request_id": "AM-REQ-2026-00275",
    "original_inquiry": "海外求诊：海外求诊：患者intracortical array，希望评估Wyss Center或Synchron Stentrode项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5199
  },
  {
    "request_id": "AM-REQ-2026-00276",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome seeking evaluation for Speech Neuroprosthesis; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.72
  },
  {
    "request_id": "AM-REQ-2026-00277",
    "original_inquiry": "Urgent: Consultation request: speech decoding for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5716
  },
  {
    "request_id": "AM-REQ-2026-00278",
    "original_inquiry": "研究者咨询：海外求诊：患者BCI for ALS，希望评估Precision Neuroscience或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7265
  },
  {
    "request_id": "AM-REQ-2026-00279",
    "original_inquiry": "Second opinion requested: Consultation request: neural decoding for BrainGate; interested in Paradromics and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6846
  },
  {
    "request_id": "AM-REQ-2026-00280",
    "original_inquiry": "Second opinion requested: Patient with neural decoding seeking evaluation for Paradromics; interested in Blackrock Neurotech trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7931
  },
  {
    "request_id": "AM-REQ-2026-00281",
    "original_inquiry": "Family seeking information: Consultation request: neural decoding for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5725
  },
  {
    "request_id": "AM-REQ-2026-00282",
    "original_inquiry": "研究者咨询：希望了解侵入式电极在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6047
  },
  {
    "request_id": "AM-REQ-2026-00283",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech prosthesis，希望评估Wyss Center或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5092
  },
  {
    "request_id": "AM-REQ-2026-00284",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7626
  },
  {
    "request_id": "AM-REQ-2026-00285",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring brain-computer interface or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6967
  },
  {
    "request_id": "AM-REQ-2026-00286",
    "original_inquiry": "Urgent: 研究者咨询：希望了解brain-computer interface在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.715
  },
  {
    "request_id": "AM-REQ-2026-00287",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering Paradromics / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.863
  },
  {
    "request_id": "AM-REQ-2026-00288",
    "original_inquiry": "Urgent: 脑机接口 diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6693
  },
  {
    "request_id": "AM-REQ-2026-00289",
    "original_inquiry": "Referral from specialist: 海外求诊：患者locked-in syndrome，希望评估Synchron Stentrode或Neuralink项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7921
  },
  {
    "request_id": "AM-REQ-2026-00290",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6753
  },
  {
    "request_id": "AM-REQ-2026-00291",
    "original_inquiry": "研究者咨询：Urgent: motor neuroprosthesis diagnosis, seeking centers offering BrainGate / Paradromics clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6184
  },
  {
    "request_id": "AM-REQ-2026-00292",
    "original_inquiry": "Urgent: Patient with motor neuroprosthesis seeking evaluation for Speech Neuroprosthesis; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5513
  },
  {
    "request_id": "AM-REQ-2026-00293",
    "original_inquiry": "Referral from specialist: Patient with neural decoding seeking evaluation for Wyss Center; interested in Precision Neuroscience trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-00294",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6515
  },
  {
    "request_id": "AM-REQ-2026-00295",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7376
  },
  {
    "request_id": "AM-REQ-2026-00296",
    "original_inquiry": "Family seeking information: Consultation request: brain-computer interface for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7992
  },
  {
    "request_id": "AM-REQ-2026-00297",
    "original_inquiry": "Referral from specialist: 海外求诊：患者locked-in syndrome，希望评估Wyss Center或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5235
  },
  {
    "request_id": "AM-REQ-2026-00298",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Precision Neuroscience或Paradromics项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6045
  },
  {
    "request_id": "AM-REQ-2026-00299",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring brain-computer interface or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7083
  },
  {
    "request_id": "AM-REQ-2026-00300",
    "original_inquiry": "Urgent: 脑机接口 diagnosis, seeking centers offering Synchron Stentrode / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5052
  },
  {
    "request_id": "AM-REQ-2026-00301",
    "original_inquiry": "海外求诊：Neurologist referral: motor neuroprosthesis candidate for BrainGate; request information on Paradromics eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8068
  },
  {
    "request_id": "AM-REQ-2026-00302",
    "original_inquiry": "海外求诊：Consultation request: invasive cortical electrode for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8261
  },
  {
    "request_id": "AM-REQ-2026-00303",
    "original_inquiry": "研究者咨询：Consultation request: 侵入式电极 for Precision Neuroscience; interested in Paradromics and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.69
  },
  {
    "request_id": "AM-REQ-2026-00304",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech prosthesis在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7959
  },
  {
    "request_id": "AM-REQ-2026-00305",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring brain-computer interface or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8071
  },
  {
    "request_id": "AM-REQ-2026-00306",
    "original_inquiry": "Family member with ALS, exploring intracortical array or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6996
  },
  {
    "request_id": "AM-REQ-2026-00307",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解ECoG在Precision Neuroscience适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5303
  },
  {
    "request_id": "AM-REQ-2026-00308",
    "original_inquiry": "海外求诊：患者motor neuroprosthesis，希望评估Precision Neuroscience或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6481
  },
  {
    "request_id": "AM-REQ-2026-00309",
    "original_inquiry": "Urgent: 海外求诊：患者speech prosthesis，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6007
  },
  {
    "request_id": "AM-REQ-2026-00310",
    "original_inquiry": "海外求诊：Patient with BCI for ALS seeking evaluation for Neuralink; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5692
  },
  {
    "request_id": "AM-REQ-2026-00311",
    "original_inquiry": "Referral from specialist: 海外求诊：患者运动皮层解码，希望评估Speech Neuroprosthesis或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8319
  },
  {
    "request_id": "AM-REQ-2026-00312",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring speech decoding or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.755
  },
  {
    "request_id": "AM-REQ-2026-00313",
    "original_inquiry": "Referral from specialist: Urgent: brain-computer interface diagnosis, seeking centers offering Wyss Center / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8126
  },
  {
    "request_id": "AM-REQ-2026-00314",
    "original_inquiry": "Urgent: 研究者咨询：希望了解ECoG在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8909
  },
  {
    "request_id": "AM-REQ-2026-00315",
    "original_inquiry": "Referral from specialist: Patient with motor neuroprosthesis seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6582
  },
  {
    "request_id": "AM-REQ-2026-00316",
    "original_inquiry": "Urgent: 研究者咨询：希望了解运动皮层解码在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7165
  },
  {
    "request_id": "AM-REQ-2026-00317",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5194
  },
  {
    "request_id": "AM-REQ-2026-00318",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解neural decoding在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5079
  },
  {
    "request_id": "AM-REQ-2026-00319",
    "original_inquiry": "海外求诊：患者运动皮层解码，希望评估Wyss Center或Neuralink项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6812
  },
  {
    "request_id": "AM-REQ-2026-00320",
    "original_inquiry": "Referral from specialist: Consultation request: ECoG for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6798
  },
  {
    "request_id": "AM-REQ-2026-00321",
    "original_inquiry": "Referral from specialist: 海外求诊：患者motor neuroprosthesis，希望评估Speech Neuroprosthesis或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5193
  },
  {
    "request_id": "AM-REQ-2026-00322",
    "original_inquiry": "Second opinion requested: Consultation request: ECoG for Speech Neuroprosthesis; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-00323",
    "original_inquiry": "Referral from specialist: Consultation request: invasive cortical electrode for Paradromics; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5457
  },
  {
    "request_id": "AM-REQ-2026-00324",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8494
  },
  {
    "request_id": "AM-REQ-2026-00325",
    "original_inquiry": "Referral from specialist: 海外求诊：患者运动皮层解码，希望评估Paradromics或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6993
  },
  {
    "request_id": "AM-REQ-2026-00326",
    "original_inquiry": "海外求诊：Family member with ALS, exploring intracortical array or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7483
  },
  {
    "request_id": "AM-REQ-2026-00327",
    "original_inquiry": "海外求诊：Neurologist referral: speech decoding candidate for Synchron Stentrode; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5182
  },
  {
    "request_id": "AM-REQ-2026-00328",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5847
  },
  {
    "request_id": "AM-REQ-2026-00329",
    "original_inquiry": "Referral from specialist: Neurologist referral: intracortical array candidate for Synchron Stentrode; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6264
  },
  {
    "request_id": "AM-REQ-2026-00330",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring intracortical array or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6624
  },
  {
    "request_id": "AM-REQ-2026-00331",
    "original_inquiry": "Referral from specialist: Neurologist referral: BCI for ALS candidate for Speech Neuroprosthesis; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6304
  },
  {
    "request_id": "AM-REQ-2026-00332",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7276
  },
  {
    "request_id": "AM-REQ-2026-00333",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6095
  },
  {
    "request_id": "AM-REQ-2026-00334",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.754
  },
  {
    "request_id": "AM-REQ-2026-00335",
    "original_inquiry": "Family member with ALS, exploring BCI for ALS or Neuralink for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6959
  },
  {
    "request_id": "AM-REQ-2026-00336",
    "original_inquiry": "Urgent: Neurologist referral: locked-in syndrome candidate for Blackrock Neurotech; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8854
  },
  {
    "request_id": "AM-REQ-2026-00337",
    "original_inquiry": "Family seeking information: Consultation request: ECoG for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7963
  },
  {
    "request_id": "AM-REQ-2026-00338",
    "original_inquiry": "Family seeking information: Neurologist referral: 侵入式电极 candidate for Wyss Center; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7248
  },
  {
    "request_id": "AM-REQ-2026-00339",
    "original_inquiry": "海外求诊：Consultation request: neural decoding for BrainGate; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8275
  },
  {
    "request_id": "AM-REQ-2026-00340",
    "original_inquiry": "海外求诊：Patient with brain-computer interface seeking evaluation for Neuralink; interested in Paradromics trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8801
  },
  {
    "request_id": "AM-REQ-2026-00341",
    "original_inquiry": "Family seeking information: Patient with brain-computer interface seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6579
  },
  {
    "request_id": "AM-REQ-2026-00342",
    "original_inquiry": "Second opinion requested: Urgent: ECoG diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8754
  },
  {
    "request_id": "AM-REQ-2026-00343",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7814
  },
  {
    "request_id": "AM-REQ-2026-00344",
    "original_inquiry": "Family seeking information: 海外求诊：患者motor neuroprosthesis，希望评估Synchron Stentrode或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8834
  },
  {
    "request_id": "AM-REQ-2026-00345",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解motor neuroprosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6337
  },
  {
    "request_id": "AM-REQ-2026-00346",
    "original_inquiry": "Second opinion requested: Consultation request: speech prosthesis for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7662
  },
  {
    "request_id": "AM-REQ-2026-00347",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8817
  },
  {
    "request_id": "AM-REQ-2026-00348",
    "original_inquiry": "海外求诊：患者运动皮层解码，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6578
  },
  {
    "request_id": "AM-REQ-2026-00349",
    "original_inquiry": "Urgent: 海外求诊：患者运动皮层解码，希望评估BrainGate或Neuralink项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7142
  },
  {
    "request_id": "AM-REQ-2026-00350",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome seeking evaluation for Neuralink; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.649
  },
  {
    "request_id": "AM-REQ-2026-00351",
    "original_inquiry": "Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6049
  },
  {
    "request_id": "AM-REQ-2026-00352",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 脑机接口 or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8025
  },
  {
    "request_id": "AM-REQ-2026-00353",
    "original_inquiry": "Referral from specialist: Neurologist referral: 侵入式电极 candidate for Wyss Center; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6496
  },
  {
    "request_id": "AM-REQ-2026-00354",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解脑机接口在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.624
  },
  {
    "request_id": "AM-REQ-2026-00355",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解语音神经假体在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.878
  },
  {
    "request_id": "AM-REQ-2026-00356",
    "original_inquiry": "Family seeking information: Neurologist referral: 脑机接口 candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-00357",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8604
  },
  {
    "request_id": "AM-REQ-2026-00358",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6717
  },
  {
    "request_id": "AM-REQ-2026-00359",
    "original_inquiry": "Urgent: neural decoding diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7264
  },
  {
    "request_id": "AM-REQ-2026-00360",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech decoding在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6433
  },
  {
    "request_id": "AM-REQ-2026-00361",
    "original_inquiry": "Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6988
  },
  {
    "request_id": "AM-REQ-2026-00362",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5863
  },
  {
    "request_id": "AM-REQ-2026-00363",
    "original_inquiry": "Urgent: locked-in syndrome diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5668
  },
  {
    "request_id": "AM-REQ-2026-00364",
    "original_inquiry": "Urgent: 研究者咨询：希望了解brain-computer interface在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5862
  },
  {
    "request_id": "AM-REQ-2026-00365",
    "original_inquiry": "Second opinion requested: Patient with speech decoding seeking evaluation for BrainGate; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7113
  },
  {
    "request_id": "AM-REQ-2026-00366",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 运动皮层解码 or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6348
  },
  {
    "request_id": "AM-REQ-2026-00367",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5674
  },
  {
    "request_id": "AM-REQ-2026-00368",
    "original_inquiry": "Second opinion requested: Neurologist referral: 语音神经假体 candidate for Speech Neuroprosthesis; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7647
  },
  {
    "request_id": "AM-REQ-2026-00369",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7292
  },
  {
    "request_id": "AM-REQ-2026-00370",
    "original_inquiry": "研究者咨询：Urgent: 脑机接口 diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5532
  },
  {
    "request_id": "AM-REQ-2026-00371",
    "original_inquiry": "Urgent: Urgent: 脑机接口 diagnosis, seeking centers offering Wyss Center / Neuralink clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8651
  },
  {
    "request_id": "AM-REQ-2026-00372",
    "original_inquiry": "Second opinion requested: Patient with 运动皮层解码 seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5831
  },
  {
    "request_id": "AM-REQ-2026-00373",
    "original_inquiry": "Referral from specialist: Neurologist referral: brain-computer interface candidate for BrainGate; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8592
  },
  {
    "request_id": "AM-REQ-2026-00374",
    "original_inquiry": "Family seeking information: Consultation request: speech decoding for Synchron Stentrode; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8889
  },
  {
    "request_id": "AM-REQ-2026-00375",
    "original_inquiry": "Family member with ALS, exploring locked-in syndrome or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8261
  },
  {
    "request_id": "AM-REQ-2026-00376",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5132
  },
  {
    "request_id": "AM-REQ-2026-00377",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6806
  },
  {
    "request_id": "AM-REQ-2026-00378",
    "original_inquiry": "研究者咨询：Patient with speech prosthesis seeking evaluation for Precision Neuroscience; interested in Paradromics trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7019
  },
  {
    "request_id": "AM-REQ-2026-00379",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6722
  },
  {
    "request_id": "AM-REQ-2026-00380",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-00381",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7756
  },
  {
    "request_id": "AM-REQ-2026-00382",
    "original_inquiry": "Urgent: 海外求诊：患者运动皮层解码，希望评估Wyss Center或Precision Neuroscience项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.546
  },
  {
    "request_id": "AM-REQ-2026-00383",
    "original_inquiry": "Referral from specialist: Urgent: 侵入式电极 diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6774
  },
  {
    "request_id": "AM-REQ-2026-00384",
    "original_inquiry": "Neurologist referral: speech prosthesis candidate for Neuralink; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.778
  },
  {
    "request_id": "AM-REQ-2026-00385",
    "original_inquiry": "Referral from specialist: Neurologist referral: speech prosthesis candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8966
  },
  {
    "request_id": "AM-REQ-2026-00386",
    "original_inquiry": "Second opinion requested: Neurologist referral: motor neuroprosthesis candidate for Synchron Stentrode; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7689
  },
  {
    "request_id": "AM-REQ-2026-00387",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解locked-in syndrome在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5256
  },
  {
    "request_id": "AM-REQ-2026-00388",
    "original_inquiry": "Second opinion requested: Neurologist referral: 语音神经假体 candidate for Blackrock Neurotech; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7661
  },
  {
    "request_id": "AM-REQ-2026-00389",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解locked-in syndrome在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5828
  },
  {
    "request_id": "AM-REQ-2026-00390",
    "original_inquiry": "研究者咨询：海外求诊：患者脑机接口，希望评估Wyss Center或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5391
  },
  {
    "request_id": "AM-REQ-2026-00391",
    "original_inquiry": "海外求诊：Neurologist referral: 运动皮层解码 candidate for Synchron Stentrode; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5149
  },
  {
    "request_id": "AM-REQ-2026-00392",
    "original_inquiry": "研究者咨询：Urgent: speech decoding diagnosis, seeking centers offering Neuralink / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6205
  },
  {
    "request_id": "AM-REQ-2026-00393",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8761
  },
  {
    "request_id": "AM-REQ-2026-00394",
    "original_inquiry": "Referral from specialist: Patient with speech prosthesis seeking evaluation for Precision Neuroscience; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6802
  },
  {
    "request_id": "AM-REQ-2026-00395",
    "original_inquiry": "Urgent: Consultation request: speech decoding for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6446
  },
  {
    "request_id": "AM-REQ-2026-00396",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring speech prosthesis or BrainGate for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7039
  },
  {
    "request_id": "AM-REQ-2026-00397",
    "original_inquiry": "Second opinion requested: Consultation request: 脑机接口 for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7824
  },
  {
    "request_id": "AM-REQ-2026-00398",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring motor neuroprosthesis or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5293
  },
  {
    "request_id": "AM-REQ-2026-00399",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring speech prosthesis or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6401
  },
  {
    "request_id": "AM-REQ-2026-00400",
    "original_inquiry": "Family seeking information: Consultation request: speech prosthesis for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6098
  },
  {
    "request_id": "AM-REQ-2026-00401",
    "original_inquiry": "研究者咨询：海外求诊：患者neural decoding，希望评估Neuralink或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7551
  },
  {
    "request_id": "AM-REQ-2026-00402",
    "original_inquiry": "海外求诊：Family member with ALS, exploring speech prosthesis or Paradromics for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5098
  },
  {
    "request_id": "AM-REQ-2026-00403",
    "original_inquiry": "海外求诊：Urgent: neural decoding diagnosis, seeking centers offering Paradromics / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8779
  },
  {
    "request_id": "AM-REQ-2026-00404",
    "original_inquiry": "研究者咨询：Urgent: invasive cortical electrode diagnosis, seeking centers offering Paradromics / Precision Neuroscience clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-00405",
    "original_inquiry": "Patient with 语音神经假体 seeking evaluation for Synchron Stentrode; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6262
  },
  {
    "request_id": "AM-REQ-2026-00406",
    "original_inquiry": "Family seeking information: Urgent: BCI for ALS diagnosis, seeking centers offering Neuralink / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5009
  },
  {
    "request_id": "AM-REQ-2026-00407",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6455
  },
  {
    "request_id": "AM-REQ-2026-00408",
    "original_inquiry": "Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5924
  },
  {
    "request_id": "AM-REQ-2026-00409",
    "original_inquiry": "Patient with motor neuroprosthesis seeking evaluation for Wyss Center; interested in Synchron Stentrode trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5078
  },
  {
    "request_id": "AM-REQ-2026-00410",
    "original_inquiry": "Family seeking information: Patient with BCI for ALS seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7869
  },
  {
    "request_id": "AM-REQ-2026-00411",
    "original_inquiry": "Family seeking information: 海外求诊：患者语音神经假体，希望评估BrainGate或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5385
  },
  {
    "request_id": "AM-REQ-2026-00412",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.794
  },
  {
    "request_id": "AM-REQ-2026-00413",
    "original_inquiry": "Second opinion requested: Patient with 运动皮层解码 seeking evaluation for Paradromics; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7274
  },
  {
    "request_id": "AM-REQ-2026-00414",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估Synchron Stentrode或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.502
  },
  {
    "request_id": "AM-REQ-2026-00415",
    "original_inquiry": "Urgent: locked-in syndrome diagnosis, seeking centers offering Speech Neuroprosthesis / Paradromics clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7408
  },
  {
    "request_id": "AM-REQ-2026-00416",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解invasive cortical electrode在Synchron Stentrode适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5855
  },
  {
    "request_id": "AM-REQ-2026-00417",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解语音神经假体在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7662
  },
  {
    "request_id": "AM-REQ-2026-00418",
    "original_inquiry": "研究者咨询：Consultation request: speech decoding for Precision Neuroscience; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7262
  },
  {
    "request_id": "AM-REQ-2026-00419",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Blackrock Neurotech; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8272
  },
  {
    "request_id": "AM-REQ-2026-00420",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for Speech Neuroprosthesis; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8184
  },
  {
    "request_id": "AM-REQ-2026-00421",
    "original_inquiry": "Referral from specialist: Patient with invasive cortical electrode seeking evaluation for Neuralink; interested in Wyss Center trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-00422",
    "original_inquiry": "Second opinion requested: 海外求诊：患者locked-in syndrome，希望评估Paradromics或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8972
  },
  {
    "request_id": "AM-REQ-2026-00423",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8188
  },
  {
    "request_id": "AM-REQ-2026-00424",
    "original_inquiry": "海外求诊：海外求诊：患者locked-in syndrome，希望评估Wyss Center或Neuralink项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7312
  },
  {
    "request_id": "AM-REQ-2026-00425",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.891
  },
  {
    "request_id": "AM-REQ-2026-00426",
    "original_inquiry": "Urgent: Family member with ALS, exploring intracortical array or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7113
  },
  {
    "request_id": "AM-REQ-2026-00427",
    "original_inquiry": "Urgent: Patient with ECoG seeking evaluation for Wyss Center; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6149
  },
  {
    "request_id": "AM-REQ-2026-00428",
    "original_inquiry": "研究者咨询：Neurologist referral: ECoG candidate for Wyss Center; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7919
  },
  {
    "request_id": "AM-REQ-2026-00429",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估Precision Neuroscience或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6713
  },
  {
    "request_id": "AM-REQ-2026-00430",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解brain-computer interface在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.635
  },
  {
    "request_id": "AM-REQ-2026-00431",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring intracortical array or Speech Neuroprosthesis for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5891
  },
  {
    "request_id": "AM-REQ-2026-00432",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解脑机接口在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6245
  },
  {
    "request_id": "AM-REQ-2026-00433",
    "original_inquiry": "海外求诊：研究者咨询：希望了解brain-computer interface在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6142
  },
  {
    "request_id": "AM-REQ-2026-00434",
    "original_inquiry": "Referral from specialist: Consultation request: brain-computer interface for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5168
  },
  {
    "request_id": "AM-REQ-2026-00435",
    "original_inquiry": "海外求诊：Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Precision Neuroscience clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.87
  },
  {
    "request_id": "AM-REQ-2026-00436",
    "original_inquiry": "研究者咨询：Neurologist referral: brain-computer interface candidate for Speech Neuroprosthesis; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-00437",
    "original_inquiry": "Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5673
  },
  {
    "request_id": "AM-REQ-2026-00438",
    "original_inquiry": "Family seeking information: Urgent: neural decoding diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7581
  },
  {
    "request_id": "AM-REQ-2026-00439",
    "original_inquiry": "Urgent: Consultation request: neural decoding for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8695
  },
  {
    "request_id": "AM-REQ-2026-00440",
    "original_inquiry": "海外求诊：患者ECoG，希望评估Speech Neuroprosthesis或BrainGate项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5402
  },
  {
    "request_id": "AM-REQ-2026-00441",
    "original_inquiry": "研究者咨询：Patient with speech decoding seeking evaluation for BrainGate; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6943
  },
  {
    "request_id": "AM-REQ-2026-00442",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring motor neuroprosthesis or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6081
  },
  {
    "request_id": "AM-REQ-2026-00443",
    "original_inquiry": "Urgent: Family member with ALS, exploring ECoG or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7788
  },
  {
    "request_id": "AM-REQ-2026-00444",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解speech decoding在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5607
  },
  {
    "request_id": "AM-REQ-2026-00445",
    "original_inquiry": "海外求诊：Urgent: intracortical array diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6068
  },
  {
    "request_id": "AM-REQ-2026-00446",
    "original_inquiry": "研究者咨询：希望了解BCI for ALS在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6325
  },
  {
    "request_id": "AM-REQ-2026-00447",
    "original_inquiry": "研究者咨询：Urgent: ECoG diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8719
  },
  {
    "request_id": "AM-REQ-2026-00448",
    "original_inquiry": "研究者咨询：海外求诊：患者intracortical array，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6553
  },
  {
    "request_id": "AM-REQ-2026-00449",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6698
  },
  {
    "request_id": "AM-REQ-2026-00450",
    "original_inquiry": "海外求诊：Consultation request: BCI for ALS for BrainGate; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7045
  },
  {
    "request_id": "AM-REQ-2026-00451",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 运动皮层解码 or Speech Neuroprosthesis for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5122
  },
  {
    "request_id": "AM-REQ-2026-00452",
    "original_inquiry": "海外求诊：Family member with ALS, exploring locked-in syndrome or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8105
  },
  {
    "request_id": "AM-REQ-2026-00453",
    "original_inquiry": "研究者咨询：Consultation request: invasive cortical electrode for BrainGate; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7277
  },
  {
    "request_id": "AM-REQ-2026-00454",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring intracortical array or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5114
  },
  {
    "request_id": "AM-REQ-2026-00455",
    "original_inquiry": "海外求诊：Patient with speech prosthesis seeking evaluation for Speech Neuroprosthesis; interested in Synchron Stentrode trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5195
  },
  {
    "request_id": "AM-REQ-2026-00456",
    "original_inquiry": "Second opinion requested: Urgent: locked-in syndrome diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6943
  },
  {
    "request_id": "AM-REQ-2026-00457",
    "original_inquiry": "Family seeking information: Urgent: ECoG diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5433
  },
  {
    "request_id": "AM-REQ-2026-00458",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring BCI for ALS or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8736
  },
  {
    "request_id": "AM-REQ-2026-00459",
    "original_inquiry": "Urgent: locked-in syndrome diagnosis, seeking centers offering Speech Neuroprosthesis / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8179
  },
  {
    "request_id": "AM-REQ-2026-00460",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering Precision Neuroscience / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6095
  },
  {
    "request_id": "AM-REQ-2026-00461",
    "original_inquiry": "Urgent: Urgent: invasive cortical electrode diagnosis, seeking centers offering Speech Neuroprosthesis / Precision Neuroscience clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-00462",
    "original_inquiry": "Patient with 脑机接口 seeking evaluation for Precision Neuroscience; interested in Paradromics trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.626
  },
  {
    "request_id": "AM-REQ-2026-00463",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8007
  },
  {
    "request_id": "AM-REQ-2026-00464",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解侵入式电极在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8961
  },
  {
    "request_id": "AM-REQ-2026-00465",
    "original_inquiry": "海外求诊：研究者咨询：希望了解脑机接口在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7337
  },
  {
    "request_id": "AM-REQ-2026-00466",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7343
  },
  {
    "request_id": "AM-REQ-2026-00467",
    "original_inquiry": "Second opinion requested: Consultation request: invasive cortical electrode for BrainGate; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7405
  },
  {
    "request_id": "AM-REQ-2026-00468",
    "original_inquiry": "研究者咨询：Urgent: neural decoding diagnosis, seeking centers offering Blackrock Neurotech / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7257
  },
  {
    "request_id": "AM-REQ-2026-00469",
    "original_inquiry": "海外求诊：Urgent: 侵入式电极 diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5566
  },
  {
    "request_id": "AM-REQ-2026-00470",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring neural decoding or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8618
  },
  {
    "request_id": "AM-REQ-2026-00471",
    "original_inquiry": "研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7874
  },
  {
    "request_id": "AM-REQ-2026-00472",
    "original_inquiry": "海外求诊：Urgent: 侵入式电极 diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.893
  },
  {
    "request_id": "AM-REQ-2026-00473",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 侵入式电极 or Speech Neuroprosthesis for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5974
  },
  {
    "request_id": "AM-REQ-2026-00474",
    "original_inquiry": "Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6063
  },
  {
    "request_id": "AM-REQ-2026-00475",
    "original_inquiry": "研究者咨询：海外求诊：患者invasive cortical electrode，希望评估BrainGate或Wyss Center项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8646
  },
  {
    "request_id": "AM-REQ-2026-00476",
    "original_inquiry": "Referral from specialist: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8723
  },
  {
    "request_id": "AM-REQ-2026-00477",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解脑机接口在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7619
  },
  {
    "request_id": "AM-REQ-2026-00478",
    "original_inquiry": "Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8425
  },
  {
    "request_id": "AM-REQ-2026-00479",
    "original_inquiry": "海外求诊：Family member with ALS, exploring invasive cortical electrode or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6984
  },
  {
    "request_id": "AM-REQ-2026-00480",
    "original_inquiry": "Urgent: Neurologist referral: 运动皮层解码 candidate for Speech Neuroprosthesis; request information on Wyss Center eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5813
  },
  {
    "request_id": "AM-REQ-2026-00481",
    "original_inquiry": "Referral from specialist: Patient with 运动皮层解码 seeking evaluation for BrainGate; interested in Paradromics trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6938
  },
  {
    "request_id": "AM-REQ-2026-00482",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7654
  },
  {
    "request_id": "AM-REQ-2026-00483",
    "original_inquiry": "Consultation request: locked-in syndrome for Synchron Stentrode; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7703
  },
  {
    "request_id": "AM-REQ-2026-00484",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome seeking evaluation for Synchron Stentrode; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.712
  },
  {
    "request_id": "AM-REQ-2026-00485",
    "original_inquiry": "海外求诊：Neurologist referral: speech decoding candidate for Synchron Stentrode; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5838
  },
  {
    "request_id": "AM-REQ-2026-00486",
    "original_inquiry": "Family seeking information: Neurologist referral: 侵入式电极 candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6703
  },
  {
    "request_id": "AM-REQ-2026-00487",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring speech prosthesis or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.601
  },
  {
    "request_id": "AM-REQ-2026-00488",
    "original_inquiry": "海外求诊：Neurologist referral: motor neuroprosthesis candidate for Wyss Center; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7883
  },
  {
    "request_id": "AM-REQ-2026-00489",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5373
  },
  {
    "request_id": "AM-REQ-2026-00490",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7062
  },
  {
    "request_id": "AM-REQ-2026-00491",
    "original_inquiry": "研究者咨询：Patient with 语音神经假体 seeking evaluation for Blackrock Neurotech; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8132
  },
  {
    "request_id": "AM-REQ-2026-00492",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / BrainGate clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8971
  },
  {
    "request_id": "AM-REQ-2026-00493",
    "original_inquiry": "Second opinion requested: Urgent: BCI for ALS diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5999
  },
  {
    "request_id": "AM-REQ-2026-00494",
    "original_inquiry": "研究者咨询：Urgent: speech prosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7343
  },
  {
    "request_id": "AM-REQ-2026-00495",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 语音神经假体 or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6271
  },
  {
    "request_id": "AM-REQ-2026-00496",
    "original_inquiry": "研究者咨询：海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7529
  },
  {
    "request_id": "AM-REQ-2026-00497",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5198
  },
  {
    "request_id": "AM-REQ-2026-00498",
    "original_inquiry": "Urgent: Neurologist referral: motor neuroprosthesis candidate for BrainGate; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.735
  },
  {
    "request_id": "AM-REQ-2026-00499",
    "original_inquiry": "海外求诊：患者侵入式电极，希望评估Neuralink或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-00500",
    "original_inquiry": "Referral from specialist: Patient with BCI for ALS seeking evaluation for Wyss Center; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.729
  },
  {
    "request_id": "AM-REQ-2026-00501",
    "original_inquiry": "Family seeking information: Urgent: 脑机接口 diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6426
  },
  {
    "request_id": "AM-REQ-2026-00502",
    "original_inquiry": "海外求诊：海外求诊：患者neural decoding，希望评估Synchron Stentrode或BrainGate项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5397
  },
  {
    "request_id": "AM-REQ-2026-00503",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering Blackrock Neurotech / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5051
  },
  {
    "request_id": "AM-REQ-2026-00504",
    "original_inquiry": "Family seeking information: 海外求诊：患者脑机接口，希望评估Blackrock Neurotech或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-00505",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8173
  },
  {
    "request_id": "AM-REQ-2026-00506",
    "original_inquiry": "Family seeking information: Urgent: speech decoding diagnosis, seeking centers offering Paradromics / Neuralink clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6477
  },
  {
    "request_id": "AM-REQ-2026-00507",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring neural decoding or Speech Neuroprosthesis for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6391
  },
  {
    "request_id": "AM-REQ-2026-00508",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring ECoG or BrainGate for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7306
  },
  {
    "request_id": "AM-REQ-2026-00509",
    "original_inquiry": "Consultation request: 侵入式电极 for BrainGate; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5675
  },
  {
    "request_id": "AM-REQ-2026-00510",
    "original_inquiry": "Family member with ALS, exploring speech prosthesis or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6033
  },
  {
    "request_id": "AM-REQ-2026-00511",
    "original_inquiry": "Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6169
  },
  {
    "request_id": "AM-REQ-2026-00512",
    "original_inquiry": "海外求诊：研究者咨询：希望了解invasive cortical electrode在Synchron Stentrode适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5661
  },
  {
    "request_id": "AM-REQ-2026-00513",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解locked-in syndrome在Paradromics适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5019
  },
  {
    "request_id": "AM-REQ-2026-00514",
    "original_inquiry": "Urgent: 研究者咨询：希望了解运动皮层解码在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5821
  },
  {
    "request_id": "AM-REQ-2026-00515",
    "original_inquiry": "Referral from specialist: Neurologist referral: speech prosthesis candidate for BrainGate; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.756
  },
  {
    "request_id": "AM-REQ-2026-00516",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8642
  },
  {
    "request_id": "AM-REQ-2026-00517",
    "original_inquiry": "Urgent: 海外求诊：患者语音神经假体，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8696
  },
  {
    "request_id": "AM-REQ-2026-00518",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome seeking evaluation for Blackrock Neurotech; interested in Wyss Center trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5988
  },
  {
    "request_id": "AM-REQ-2026-00519",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5495
  },
  {
    "request_id": "AM-REQ-2026-00520",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6912
  },
  {
    "request_id": "AM-REQ-2026-00521",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8778
  },
  {
    "request_id": "AM-REQ-2026-00522",
    "original_inquiry": "Family member with ALS, exploring neural decoding or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7281
  },
  {
    "request_id": "AM-REQ-2026-00523",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 侵入式电极 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-00524",
    "original_inquiry": "Second opinion requested: Urgent: ECoG diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8955
  },
  {
    "request_id": "AM-REQ-2026-00525",
    "original_inquiry": "Urgent: Patient with BCI for ALS seeking evaluation for Paradromics; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7351
  },
  {
    "request_id": "AM-REQ-2026-00526",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8308
  },
  {
    "request_id": "AM-REQ-2026-00527",
    "original_inquiry": "Family member with ALS, exploring brain-computer interface or Speech Neuroprosthesis for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6552
  },
  {
    "request_id": "AM-REQ-2026-00528",
    "original_inquiry": "Referral from specialist: 海外求诊：患者invasive cortical electrode，希望评估Speech Neuroprosthesis或Paradromics项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6519
  },
  {
    "request_id": "AM-REQ-2026-00529",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解侵入式电极在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6253
  },
  {
    "request_id": "AM-REQ-2026-00530",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解脑机接口在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6237
  },
  {
    "request_id": "AM-REQ-2026-00531",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome seeking evaluation for Speech Neuroprosthesis; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8423
  },
  {
    "request_id": "AM-REQ-2026-00532",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7557
  },
  {
    "request_id": "AM-REQ-2026-00533",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for Paradromics; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5637
  },
  {
    "request_id": "AM-REQ-2026-00534",
    "original_inquiry": "Referral from specialist: Consultation request: speech decoding for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-00535",
    "original_inquiry": "Second opinion requested: Neurologist referral: BCI for ALS candidate for Speech Neuroprosthesis; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7707
  },
  {
    "request_id": "AM-REQ-2026-00536",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech decoding or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5593
  },
  {
    "request_id": "AM-REQ-2026-00537",
    "original_inquiry": "Referral from specialist: 海外求诊：患者locked-in syndrome，希望评估Synchron Stentrode或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5281
  },
  {
    "request_id": "AM-REQ-2026-00538",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.566
  },
  {
    "request_id": "AM-REQ-2026-00539",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 侵入式电极 or BrainGate for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8876
  },
  {
    "request_id": "AM-REQ-2026-00540",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5365
  },
  {
    "request_id": "AM-REQ-2026-00541",
    "original_inquiry": "Urgent: Urgent: 语音神经假体 diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8262
  },
  {
    "request_id": "AM-REQ-2026-00542",
    "original_inquiry": "Second opinion requested: Urgent: intracortical array diagnosis, seeking centers offering Synchron Stentrode / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5737
  },
  {
    "request_id": "AM-REQ-2026-00543",
    "original_inquiry": "Family seeking information: 海外求诊：患者运动皮层解码，希望评估Precision Neuroscience或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.826
  },
  {
    "request_id": "AM-REQ-2026-00544",
    "original_inquiry": "海外求诊：Neurologist referral: invasive cortical electrode candidate for Speech Neuroprosthesis; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8985
  },
  {
    "request_id": "AM-REQ-2026-00545",
    "original_inquiry": "Consultation request: 运动皮层解码 for Synchron Stentrode; interested in Wyss Center and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6007
  },
  {
    "request_id": "AM-REQ-2026-00546",
    "original_inquiry": "研究者咨询：Urgent: ECoG diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8185
  },
  {
    "request_id": "AM-REQ-2026-00547",
    "original_inquiry": "Urgent: Urgent: neural decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.849
  },
  {
    "request_id": "AM-REQ-2026-00548",
    "original_inquiry": "Referral from specialist: Neurologist referral: ECoG candidate for Synchron Stentrode; request information on Paradromics eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5571
  },
  {
    "request_id": "AM-REQ-2026-00549",
    "original_inquiry": "研究者咨询：Patient with invasive cortical electrode seeking evaluation for Speech Neuroprosthesis; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7233
  },
  {
    "request_id": "AM-REQ-2026-00550",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7783
  },
  {
    "request_id": "AM-REQ-2026-00551",
    "original_inquiry": "Referral from specialist: Patient with 运动皮层解码 seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6858
  },
  {
    "request_id": "AM-REQ-2026-00552",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.526
  },
  {
    "request_id": "AM-REQ-2026-00553",
    "original_inquiry": "研究者咨询：Patient with 运动皮层解码 seeking evaluation for Neuralink; interested in Precision Neuroscience trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5495
  },
  {
    "request_id": "AM-REQ-2026-00554",
    "original_inquiry": "海外求诊：研究者咨询：希望了解locked-in syndrome在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7644
  },
  {
    "request_id": "AM-REQ-2026-00555",
    "original_inquiry": "研究者咨询：希望了解invasive cortical electrode在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6393
  },
  {
    "request_id": "AM-REQ-2026-00556",
    "original_inquiry": "Urgent: 研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6972
  },
  {
    "request_id": "AM-REQ-2026-00557",
    "original_inquiry": "Family member with ALS, exploring BCI for ALS or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5774
  },
  {
    "request_id": "AM-REQ-2026-00558",
    "original_inquiry": "Referral from specialist: 海外求诊：患者invasive cortical electrode，希望评估BrainGate或Paradromics项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6675
  },
  {
    "request_id": "AM-REQ-2026-00559",
    "original_inquiry": "Urgent: 海外求诊：患者speech decoding，希望评估Speech Neuroprosthesis或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8073
  },
  {
    "request_id": "AM-REQ-2026-00560",
    "original_inquiry": "Family seeking information: Consultation request: neural decoding for Synchron Stentrode; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5777
  },
  {
    "request_id": "AM-REQ-2026-00561",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5594
  },
  {
    "request_id": "AM-REQ-2026-00562",
    "original_inquiry": "Second opinion requested: Neurologist referral: 脑机接口 candidate for Wyss Center; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5598
  },
  {
    "request_id": "AM-REQ-2026-00563",
    "original_inquiry": "Urgent: BCI for ALS diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6183
  },
  {
    "request_id": "AM-REQ-2026-00564",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Speech Neuroprosthesis; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7051
  },
  {
    "request_id": "AM-REQ-2026-00565",
    "original_inquiry": "Second opinion requested: Neurologist referral: neural decoding candidate for Speech Neuroprosthesis; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5154
  },
  {
    "request_id": "AM-REQ-2026-00566",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7686
  },
  {
    "request_id": "AM-REQ-2026-00567",
    "original_inquiry": "研究者咨询：Urgent: invasive cortical electrode diagnosis, seeking centers offering Speech Neuroprosthesis / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7816
  },
  {
    "request_id": "AM-REQ-2026-00568",
    "original_inquiry": "Urgent: Family member with ALS, exploring speech prosthesis or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.528
  },
  {
    "request_id": "AM-REQ-2026-00569",
    "original_inquiry": "Patient with intracortical array seeking evaluation for Neuralink; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6242
  },
  {
    "request_id": "AM-REQ-2026-00570",
    "original_inquiry": "Referral from specialist: Patient with intracortical array seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6038
  },
  {
    "request_id": "AM-REQ-2026-00571",
    "original_inquiry": "Urgent: Consultation request: intracortical array for Paradromics; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5474
  },
  {
    "request_id": "AM-REQ-2026-00572",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Synchron Stentrode; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6202
  },
  {
    "request_id": "AM-REQ-2026-00573",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8346
  },
  {
    "request_id": "AM-REQ-2026-00574",
    "original_inquiry": "Referral from specialist: Neurologist referral: invasive cortical electrode candidate for Precision Neuroscience; request information on Wyss Center eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6216
  },
  {
    "request_id": "AM-REQ-2026-00575",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring intracortical array or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8786
  },
  {
    "request_id": "AM-REQ-2026-00576",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解语音神经假体在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8939
  },
  {
    "request_id": "AM-REQ-2026-00577",
    "original_inquiry": "海外求诊：Family member with ALS, exploring intracortical array or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6885
  },
  {
    "request_id": "AM-REQ-2026-00578",
    "original_inquiry": "研究者咨询：Consultation request: brain-computer interface for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5604
  },
  {
    "request_id": "AM-REQ-2026-00579",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring intracortical array or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5105
  },
  {
    "request_id": "AM-REQ-2026-00580",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for Paradromics; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7655
  },
  {
    "request_id": "AM-REQ-2026-00581",
    "original_inquiry": "Second opinion requested: Consultation request: 语音神经假体 for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5872
  },
  {
    "request_id": "AM-REQ-2026-00582",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Speech Neuroprosthesis; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8048
  },
  {
    "request_id": "AM-REQ-2026-00583",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6528
  },
  {
    "request_id": "AM-REQ-2026-00584",
    "original_inquiry": "Second opinion requested: Consultation request: intracortical array for Blackrock Neurotech; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5651
  },
  {
    "request_id": "AM-REQ-2026-00585",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7068
  },
  {
    "request_id": "AM-REQ-2026-00586",
    "original_inquiry": "Urgent: Family member with ALS, exploring invasive cortical electrode or Precision Neuroscience for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8778
  },
  {
    "request_id": "AM-REQ-2026-00587",
    "original_inquiry": "Second opinion requested: 海外求诊：患者语音神经假体，希望评估Synchron Stentrode或Precision Neuroscience项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6926
  },
  {
    "request_id": "AM-REQ-2026-00588",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解intracortical array在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5333
  },
  {
    "request_id": "AM-REQ-2026-00589",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7272
  },
  {
    "request_id": "AM-REQ-2026-00590",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7514
  },
  {
    "request_id": "AM-REQ-2026-00591",
    "original_inquiry": "Urgent: Family member with ALS, exploring 侵入式电极 or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8364
  },
  {
    "request_id": "AM-REQ-2026-00592",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解neural decoding在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.519
  },
  {
    "request_id": "AM-REQ-2026-00593",
    "original_inquiry": "Urgent: 海外求诊：患者motor neuroprosthesis，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6359
  },
  {
    "request_id": "AM-REQ-2026-00594",
    "original_inquiry": "Neurologist referral: brain-computer interface candidate for Speech Neuroprosthesis; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8537
  },
  {
    "request_id": "AM-REQ-2026-00595",
    "original_inquiry": "Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5063
  },
  {
    "request_id": "AM-REQ-2026-00596",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8384
  },
  {
    "request_id": "AM-REQ-2026-00597",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5597
  },
  {
    "request_id": "AM-REQ-2026-00598",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Neuralink项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8589
  },
  {
    "request_id": "AM-REQ-2026-00599",
    "original_inquiry": "Family seeking information: Consultation request: ECoG for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.794
  },
  {
    "request_id": "AM-REQ-2026-00600",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6831
  },
  {
    "request_id": "AM-REQ-2026-00601",
    "original_inquiry": "Patient with neural decoding seeking evaluation for Paradromics; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7397
  },
  {
    "request_id": "AM-REQ-2026-00602",
    "original_inquiry": "研究者咨询：Neurologist referral: 侵入式电极 candidate for Precision Neuroscience; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7571
  },
  {
    "request_id": "AM-REQ-2026-00603",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8954
  },
  {
    "request_id": "AM-REQ-2026-00604",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech prosthesis在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5812
  },
  {
    "request_id": "AM-REQ-2026-00605",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6899
  },
  {
    "request_id": "AM-REQ-2026-00606",
    "original_inquiry": "Neurologist referral: motor neuroprosthesis candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5683
  },
  {
    "request_id": "AM-REQ-2026-00607",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解brain-computer interface在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7312
  },
  {
    "request_id": "AM-REQ-2026-00608",
    "original_inquiry": "Urgent: 研究者咨询：希望了解locked-in syndrome在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8815
  },
  {
    "request_id": "AM-REQ-2026-00609",
    "original_inquiry": "Urgent: Consultation request: 语音神经假体 for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8806
  },
  {
    "request_id": "AM-REQ-2026-00610",
    "original_inquiry": "海外求诊：Patient with motor neuroprosthesis seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8235
  },
  {
    "request_id": "AM-REQ-2026-00611",
    "original_inquiry": "Urgent: Patient with 运动皮层解码 seeking evaluation for Paradromics; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6982
  },
  {
    "request_id": "AM-REQ-2026-00612",
    "original_inquiry": "Second opinion requested: Consultation request: BCI for ALS for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7057
  },
  {
    "request_id": "AM-REQ-2026-00613",
    "original_inquiry": "Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6478
  },
  {
    "request_id": "AM-REQ-2026-00614",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解invasive cortical electrode在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-00615",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解invasive cortical electrode在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.539
  },
  {
    "request_id": "AM-REQ-2026-00616",
    "original_inquiry": "Referral from specialist: 海外求诊：患者ECoG，希望评估Wyss Center或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7949
  },
  {
    "request_id": "AM-REQ-2026-00617",
    "original_inquiry": "Family seeking information: Patient with 侵入式电极 seeking evaluation for Synchron Stentrode; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6896
  },
  {
    "request_id": "AM-REQ-2026-00618",
    "original_inquiry": "Family seeking information: Patient with motor neuroprosthesis seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6682
  },
  {
    "request_id": "AM-REQ-2026-00619",
    "original_inquiry": "Referral from specialist: Neurologist referral: intracortical array candidate for Precision Neuroscience; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6694
  },
  {
    "request_id": "AM-REQ-2026-00620",
    "original_inquiry": "研究者咨询：Urgent: ECoG diagnosis, seeking centers offering Precision Neuroscience / Wyss Center clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8119
  },
  {
    "request_id": "AM-REQ-2026-00621",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解运动皮层解码在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8952
  },
  {
    "request_id": "AM-REQ-2026-00622",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8648
  },
  {
    "request_id": "AM-REQ-2026-00623",
    "original_inquiry": "Urgent: 海外求诊：患者intracortical array，希望评估Paradromics或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5525
  },
  {
    "request_id": "AM-REQ-2026-00624",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7226
  },
  {
    "request_id": "AM-REQ-2026-00625",
    "original_inquiry": "Urgent: 研究者咨询：希望了解invasive cortical electrode在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5988
  },
  {
    "request_id": "AM-REQ-2026-00626",
    "original_inquiry": "Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7556
  },
  {
    "request_id": "AM-REQ-2026-00627",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6779
  },
  {
    "request_id": "AM-REQ-2026-00628",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5586
  },
  {
    "request_id": "AM-REQ-2026-00629",
    "original_inquiry": "Urgent: 海外求诊：患者运动皮层解码，希望评估Neuralink或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.593
  },
  {
    "request_id": "AM-REQ-2026-00630",
    "original_inquiry": "Family seeking information: Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-00631",
    "original_inquiry": "海外求诊：Consultation request: brain-computer interface for BrainGate; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8504
  },
  {
    "request_id": "AM-REQ-2026-00632",
    "original_inquiry": "Referral from specialist: Urgent: invasive cortical electrode diagnosis, seeking centers offering Paradromics / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7937
  },
  {
    "request_id": "AM-REQ-2026-00633",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5239
  },
  {
    "request_id": "AM-REQ-2026-00634",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解speech prosthesis在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7066
  },
  {
    "request_id": "AM-REQ-2026-00635",
    "original_inquiry": "Second opinion requested: Patient with invasive cortical electrode seeking evaluation for Precision Neuroscience; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6728
  },
  {
    "request_id": "AM-REQ-2026-00636",
    "original_inquiry": "Urgent: Consultation request: neural decoding for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8112
  },
  {
    "request_id": "AM-REQ-2026-00637",
    "original_inquiry": "Urgent: Consultation request: 语音神经假体 for BrainGate; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5268
  },
  {
    "request_id": "AM-REQ-2026-00638",
    "original_inquiry": "Urgent: Patient with speech prosthesis seeking evaluation for Synchron Stentrode; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5733
  },
  {
    "request_id": "AM-REQ-2026-00639",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 运动皮层解码 or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7553
  },
  {
    "request_id": "AM-REQ-2026-00640",
    "original_inquiry": "研究者咨询：希望了解ECoG在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7968
  },
  {
    "request_id": "AM-REQ-2026-00641",
    "original_inquiry": "Second opinion requested: Patient with neural decoding seeking evaluation for Blackrock Neurotech; interested in Neuralink trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.553
  },
  {
    "request_id": "AM-REQ-2026-00642",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring intracortical array or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7917
  },
  {
    "request_id": "AM-REQ-2026-00643",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6814
  },
  {
    "request_id": "AM-REQ-2026-00644",
    "original_inquiry": "海外求诊：Consultation request: speech decoding for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5185
  },
  {
    "request_id": "AM-REQ-2026-00645",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 语音神经假体 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7924
  },
  {
    "request_id": "AM-REQ-2026-00646",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6321
  },
  {
    "request_id": "AM-REQ-2026-00647",
    "original_inquiry": "Second opinion requested: Patient with ECoG seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.644
  },
  {
    "request_id": "AM-REQ-2026-00648",
    "original_inquiry": "Referral from specialist: Urgent: invasive cortical electrode diagnosis, seeking centers offering Precision Neuroscience / Wyss Center clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6631
  },
  {
    "request_id": "AM-REQ-2026-00649",
    "original_inquiry": "Second opinion requested: Consultation request: speech decoding for Paradromics; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.78
  },
  {
    "request_id": "AM-REQ-2026-00650",
    "original_inquiry": "海外求诊：Urgent: intracortical array diagnosis, seeking centers offering Wyss Center / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5992
  },
  {
    "request_id": "AM-REQ-2026-00651",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Neuralink或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5706
  },
  {
    "request_id": "AM-REQ-2026-00652",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.751
  },
  {
    "request_id": "AM-REQ-2026-00653",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7933
  },
  {
    "request_id": "AM-REQ-2026-00654",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8945
  },
  {
    "request_id": "AM-REQ-2026-00655",
    "original_inquiry": "海外求诊：Urgent: 脑机接口 diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7569
  },
  {
    "request_id": "AM-REQ-2026-00656",
    "original_inquiry": "海外求诊：Consultation request: speech prosthesis for Blackrock Neurotech; interested in Paradromics and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8378
  },
  {
    "request_id": "AM-REQ-2026-00657",
    "original_inquiry": "研究者咨询：Neurologist referral: neural decoding candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7767
  },
  {
    "request_id": "AM-REQ-2026-00658",
    "original_inquiry": "海外求诊：Family member with ALS, exploring brain-computer interface or Paradromics for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5457
  },
  {
    "request_id": "AM-REQ-2026-00659",
    "original_inquiry": "Referral from specialist: 海外求诊：患者侵入式电极，希望评估Neuralink或Wyss Center项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6135
  },
  {
    "request_id": "AM-REQ-2026-00660",
    "original_inquiry": "Urgent: Neurologist referral: 脑机接口 candidate for Neuralink; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7591
  },
  {
    "request_id": "AM-REQ-2026-00661",
    "original_inquiry": "Referral from specialist: Urgent: locked-in syndrome diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6369
  },
  {
    "request_id": "AM-REQ-2026-00662",
    "original_inquiry": "Family seeking information: Neurologist referral: 脑机接口 candidate for Speech Neuroprosthesis; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.607
  },
  {
    "request_id": "AM-REQ-2026-00663",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解neural decoding在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6604
  },
  {
    "request_id": "AM-REQ-2026-00664",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5871
  },
  {
    "request_id": "AM-REQ-2026-00665",
    "original_inquiry": "Referral from specialist: Patient with intracortical array seeking evaluation for Blackrock Neurotech; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6767
  },
  {
    "request_id": "AM-REQ-2026-00666",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解脑机接口在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5216
  },
  {
    "request_id": "AM-REQ-2026-00667",
    "original_inquiry": "Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on Wyss Center eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7981
  },
  {
    "request_id": "AM-REQ-2026-00668",
    "original_inquiry": "研究者咨询：Patient with BCI for ALS seeking evaluation for BrainGate; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8886
  },
  {
    "request_id": "AM-REQ-2026-00669",
    "original_inquiry": "Second opinion requested: 海外求诊：患者运动皮层解码，希望评估Wyss Center或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7705
  },
  {
    "request_id": "AM-REQ-2026-00670",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for Neuralink; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7405
  },
  {
    "request_id": "AM-REQ-2026-00671",
    "original_inquiry": "研究者咨询：Patient with brain-computer interface seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5269
  },
  {
    "request_id": "AM-REQ-2026-00672",
    "original_inquiry": "海外求诊：Urgent: 脑机接口 diagnosis, seeking centers offering Precision Neuroscience / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7887
  },
  {
    "request_id": "AM-REQ-2026-00673",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解intracortical array在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6241
  },
  {
    "request_id": "AM-REQ-2026-00674",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Neuralink; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7287
  },
  {
    "request_id": "AM-REQ-2026-00675",
    "original_inquiry": "Family seeking information: Consultation request: locked-in syndrome for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.544
  },
  {
    "request_id": "AM-REQ-2026-00676",
    "original_inquiry": "Urgent: Consultation request: 语音神经假体 for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5153
  },
  {
    "request_id": "AM-REQ-2026-00677",
    "original_inquiry": "Family member with ALS, exploring motor neuroprosthesis or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8941
  },
  {
    "request_id": "AM-REQ-2026-00678",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解intracortical array在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7153
  },
  {
    "request_id": "AM-REQ-2026-00679",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech prosthesis，希望评估Paradromics或Precision Neuroscience项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6657
  },
  {
    "request_id": "AM-REQ-2026-00680",
    "original_inquiry": "Patient with intracortical array seeking evaluation for Paradromics; interested in Neuralink trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.753
  },
  {
    "request_id": "AM-REQ-2026-00681",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome seeking evaluation for Synchron Stentrode; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5591
  },
  {
    "request_id": "AM-REQ-2026-00682",
    "original_inquiry": "Second opinion requested: Consultation request: ECoG for Speech Neuroprosthesis; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6276
  },
  {
    "request_id": "AM-REQ-2026-00683",
    "original_inquiry": "Urgent: 海外求诊：患者ECoG，希望评估Precision Neuroscience或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7128
  },
  {
    "request_id": "AM-REQ-2026-00684",
    "original_inquiry": "Second opinion requested: Patient with speech prosthesis seeking evaluation for Synchron Stentrode; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6886
  },
  {
    "request_id": "AM-REQ-2026-00685",
    "original_inquiry": "研究者咨询：海外求诊：患者语音神经假体，希望评估Speech Neuroprosthesis或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6385
  },
  {
    "request_id": "AM-REQ-2026-00686",
    "original_inquiry": "Second opinion requested: Patient with 运动皮层解码 seeking evaluation for Precision Neuroscience; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7392
  },
  {
    "request_id": "AM-REQ-2026-00687",
    "original_inquiry": "Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8762
  },
  {
    "request_id": "AM-REQ-2026-00688",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring brain-computer interface or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6933
  },
  {
    "request_id": "AM-REQ-2026-00689",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7979
  },
  {
    "request_id": "AM-REQ-2026-00690",
    "original_inquiry": "Family seeking information: Neurologist referral: intracortical array candidate for BrainGate; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.638
  },
  {
    "request_id": "AM-REQ-2026-00691",
    "original_inquiry": "研究者咨询：Urgent: motor neuroprosthesis diagnosis, seeking centers offering Neuralink / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5487
  },
  {
    "request_id": "AM-REQ-2026-00692",
    "original_inquiry": "Urgent: 脑机接口 diagnosis, seeking centers offering Paradromics / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7901
  },
  {
    "request_id": "AM-REQ-2026-00693",
    "original_inquiry": "Urgent: Urgent: brain-computer interface diagnosis, seeking centers offering Paradromics / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8655
  },
  {
    "request_id": "AM-REQ-2026-00694",
    "original_inquiry": "Referral from specialist: Consultation request: neural decoding for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7901
  },
  {
    "request_id": "AM-REQ-2026-00695",
    "original_inquiry": "Second opinion requested: Patient with speech prosthesis seeking evaluation for Speech Neuroprosthesis; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6424
  },
  {
    "request_id": "AM-REQ-2026-00696",
    "original_inquiry": "Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8131
  },
  {
    "request_id": "AM-REQ-2026-00697",
    "original_inquiry": "Family seeking information: Patient with speech prosthesis seeking evaluation for Precision Neuroscience; interested in Wyss Center trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8373
  },
  {
    "request_id": "AM-REQ-2026-00698",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 脑机接口 or BrainGate for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7976
  },
  {
    "request_id": "AM-REQ-2026-00699",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5815
  },
  {
    "request_id": "AM-REQ-2026-00700",
    "original_inquiry": "Family seeking information: 海外求诊：患者motor neuroprosthesis，希望评估Paradromics或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8825
  },
  {
    "request_id": "AM-REQ-2026-00701",
    "original_inquiry": "Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8105
  },
  {
    "request_id": "AM-REQ-2026-00702",
    "original_inquiry": "Second opinion requested: Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8829
  },
  {
    "request_id": "AM-REQ-2026-00703",
    "original_inquiry": "Family member with ALS, exploring ECoG or Wyss Center for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7132
  },
  {
    "request_id": "AM-REQ-2026-00704",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6221
  },
  {
    "request_id": "AM-REQ-2026-00705",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 侵入式电极 or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8656
  },
  {
    "request_id": "AM-REQ-2026-00706",
    "original_inquiry": "Urgent: Urgent: ECoG diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7133
  },
  {
    "request_id": "AM-REQ-2026-00707",
    "original_inquiry": "Family seeking information: Urgent: BCI for ALS diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-00708",
    "original_inquiry": "Family seeking information: Neurologist referral: ECoG candidate for Blackrock Neurotech; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5133
  },
  {
    "request_id": "AM-REQ-2026-00709",
    "original_inquiry": "研究者咨询：希望了解motor neuroprosthesis在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6775
  },
  {
    "request_id": "AM-REQ-2026-00710",
    "original_inquiry": "研究者咨询：希望了解语音神经假体在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.608
  },
  {
    "request_id": "AM-REQ-2026-00711",
    "original_inquiry": "海外求诊：Urgent: 语音神经假体 diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6354
  },
  {
    "request_id": "AM-REQ-2026-00712",
    "original_inquiry": "研究者咨询：Neurologist referral: intracortical array candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5864
  },
  {
    "request_id": "AM-REQ-2026-00713",
    "original_inquiry": "Patient with locked-in syndrome seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5027
  },
  {
    "request_id": "AM-REQ-2026-00714",
    "original_inquiry": "海外求诊：Consultation request: motor neuroprosthesis for Wyss Center; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7611
  },
  {
    "request_id": "AM-REQ-2026-00715",
    "original_inquiry": "Referral from specialist: Patient with speech prosthesis seeking evaluation for Wyss Center; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7345
  },
  {
    "request_id": "AM-REQ-2026-00716",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Neuralink / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6782
  },
  {
    "request_id": "AM-REQ-2026-00717",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech decoding，希望评估Synchron Stentrode或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8282
  },
  {
    "request_id": "AM-REQ-2026-00718",
    "original_inquiry": "Urgent: 研究者咨询：希望了解BCI for ALS在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.773
  },
  {
    "request_id": "AM-REQ-2026-00719",
    "original_inquiry": "Referral from specialist: 海外求诊：患者brain-computer interface，希望评估Neuralink或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8586
  },
  {
    "request_id": "AM-REQ-2026-00720",
    "original_inquiry": "Second opinion requested: Neurologist referral: ECoG candidate for Paradromics; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7077
  },
  {
    "request_id": "AM-REQ-2026-00721",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 侵入式电极 or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.821
  },
  {
    "request_id": "AM-REQ-2026-00722",
    "original_inquiry": "Neurologist referral: 侵入式电极 candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5742
  },
  {
    "request_id": "AM-REQ-2026-00723",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5468
  },
  {
    "request_id": "AM-REQ-2026-00724",
    "original_inquiry": "Second opinion requested: Consultation request: invasive cortical electrode for Wyss Center; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7181
  },
  {
    "request_id": "AM-REQ-2026-00725",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech decoding or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7616
  },
  {
    "request_id": "AM-REQ-2026-00726",
    "original_inquiry": "Neurologist referral: invasive cortical electrode candidate for Paradromics; request information on Wyss Center eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5596
  },
  {
    "request_id": "AM-REQ-2026-00727",
    "original_inquiry": "Referral from specialist: Urgent: BCI for ALS diagnosis, seeking centers offering Neuralink / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5587
  },
  {
    "request_id": "AM-REQ-2026-00728",
    "original_inquiry": "海外求诊：患者运动皮层解码，希望评估Blackrock Neurotech或Paradromics项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5741
  },
  {
    "request_id": "AM-REQ-2026-00729",
    "original_inquiry": "研究者咨询：Consultation request: intracortical array for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.866
  },
  {
    "request_id": "AM-REQ-2026-00730",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5016
  },
  {
    "request_id": "AM-REQ-2026-00731",
    "original_inquiry": "海外求诊：Patient with 运动皮层解码 seeking evaluation for Wyss Center; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5364
  },
  {
    "request_id": "AM-REQ-2026-00732",
    "original_inquiry": "Urgent: invasive cortical electrode diagnosis, seeking centers offering Synchron Stentrode / Precision Neuroscience clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5868
  },
  {
    "request_id": "AM-REQ-2026-00733",
    "original_inquiry": "研究者咨询：海外求诊：患者运动皮层解码，希望评估Neuralink或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8561
  },
  {
    "request_id": "AM-REQ-2026-00734",
    "original_inquiry": "海外求诊：Consultation request: 脑机接口 for Synchron Stentrode; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5871
  },
  {
    "request_id": "AM-REQ-2026-00735",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6813
  },
  {
    "request_id": "AM-REQ-2026-00736",
    "original_inquiry": "Second opinion requested: Patient with 脑机接口 seeking evaluation for Wyss Center; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-00737",
    "original_inquiry": "Consultation request: ECoG for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5513
  },
  {
    "request_id": "AM-REQ-2026-00738",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7278
  },
  {
    "request_id": "AM-REQ-2026-00739",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Wyss Center; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.749
  },
  {
    "request_id": "AM-REQ-2026-00740",
    "original_inquiry": "Second opinion requested: 海外求诊：患者脑机接口，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5076
  },
  {
    "request_id": "AM-REQ-2026-00741",
    "original_inquiry": "Referral from specialist: 海外求诊：患者脑机接口，希望评估Synchron Stentrode或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5558
  },
  {
    "request_id": "AM-REQ-2026-00742",
    "original_inquiry": "Family seeking information: Neurologist referral: BCI for ALS candidate for Wyss Center; request information on Neuralink eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5799
  },
  {
    "request_id": "AM-REQ-2026-00743",
    "original_inquiry": "海外求诊：Consultation request: BCI for ALS for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6764
  },
  {
    "request_id": "AM-REQ-2026-00744",
    "original_inquiry": "Urgent: Consultation request: motor neuroprosthesis for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7901
  },
  {
    "request_id": "AM-REQ-2026-00745",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring invasive cortical electrode or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7869
  },
  {
    "request_id": "AM-REQ-2026-00746",
    "original_inquiry": "Second opinion requested: Neurologist referral: BCI for ALS candidate for Neuralink; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6265
  },
  {
    "request_id": "AM-REQ-2026-00747",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6612
  },
  {
    "request_id": "AM-REQ-2026-00748",
    "original_inquiry": "海外求诊：Patient with 运动皮层解码 seeking evaluation for Paradromics; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5885
  },
  {
    "request_id": "AM-REQ-2026-00749",
    "original_inquiry": "研究者咨询：Patient with speech prosthesis seeking evaluation for Precision Neuroscience; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8965
  },
  {
    "request_id": "AM-REQ-2026-00750",
    "original_inquiry": "Urgent: Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8605
  },
  {
    "request_id": "AM-REQ-2026-00751",
    "original_inquiry": "Referral from specialist: Consultation request: motor neuroprosthesis for Wyss Center; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7992
  },
  {
    "request_id": "AM-REQ-2026-00752",
    "original_inquiry": "Family member with ALS, exploring 运动皮层解码 or Speech Neuroprosthesis for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6936
  },
  {
    "request_id": "AM-REQ-2026-00753",
    "original_inquiry": "Family seeking information: Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6072
  },
  {
    "request_id": "AM-REQ-2026-00754",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech decoding在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8629
  },
  {
    "request_id": "AM-REQ-2026-00755",
    "original_inquiry": "研究者咨询：海外求诊：患者ECoG，希望评估Neuralink或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6643
  },
  {
    "request_id": "AM-REQ-2026-00756",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解speech prosthesis在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-00757",
    "original_inquiry": "Family seeking information: Consultation request: neural decoding for Paradromics; interested in Wyss Center and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-00758",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6332
  },
  {
    "request_id": "AM-REQ-2026-00759",
    "original_inquiry": "海外求诊：海外求诊：患者intracortical array，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5243
  },
  {
    "request_id": "AM-REQ-2026-00760",
    "original_inquiry": "Family seeking information: Consultation request: intracortical array for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7436
  },
  {
    "request_id": "AM-REQ-2026-00761",
    "original_inquiry": "Neurologist referral: speech prosthesis candidate for Wyss Center; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6773
  },
  {
    "request_id": "AM-REQ-2026-00762",
    "original_inquiry": "Referral from specialist: Urgent: intracortical array diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6576
  },
  {
    "request_id": "AM-REQ-2026-00763",
    "original_inquiry": "研究者咨询：Patient with neural decoding seeking evaluation for Synchron Stentrode; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8478
  },
  {
    "request_id": "AM-REQ-2026-00764",
    "original_inquiry": "研究者咨询：Neurologist referral: brain-computer interface candidate for BrainGate; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-00765",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解运动皮层解码在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6745
  },
  {
    "request_id": "AM-REQ-2026-00766",
    "original_inquiry": "研究者咨询：希望了解侵入式电极在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5225
  },
  {
    "request_id": "AM-REQ-2026-00767",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6324
  },
  {
    "request_id": "AM-REQ-2026-00768",
    "original_inquiry": "Family seeking information: 海外求诊：患者语音神经假体，希望评估Blackrock Neurotech或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6844
  },
  {
    "request_id": "AM-REQ-2026-00769",
    "original_inquiry": "Urgent: Urgent: 脑机接口 diagnosis, seeking centers offering Wyss Center / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5775
  },
  {
    "request_id": "AM-REQ-2026-00770",
    "original_inquiry": "海外求诊：Neurologist referral: neural decoding candidate for Neuralink; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6668
  },
  {
    "request_id": "AM-REQ-2026-00771",
    "original_inquiry": "Referral from specialist: Urgent: ECoG diagnosis, seeking centers offering Synchron Stentrode / Precision Neuroscience clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.693
  },
  {
    "request_id": "AM-REQ-2026-00772",
    "original_inquiry": "Referral from specialist: Urgent: brain-computer interface diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6469
  },
  {
    "request_id": "AM-REQ-2026-00773",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6657
  },
  {
    "request_id": "AM-REQ-2026-00774",
    "original_inquiry": "Referral from specialist: Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on Wyss Center eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7917
  },
  {
    "request_id": "AM-REQ-2026-00775",
    "original_inquiry": "Second opinion requested: Consultation request: 脑机接口 for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7421
  },
  {
    "request_id": "AM-REQ-2026-00776",
    "original_inquiry": "Urgent: Patient with intracortical array seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.862
  },
  {
    "request_id": "AM-REQ-2026-00777",
    "original_inquiry": "Second opinion requested: Consultation request: speech decoding for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5476
  },
  {
    "request_id": "AM-REQ-2026-00778",
    "original_inquiry": "海外求诊：研究者咨询：希望了解motor neuroprosthesis在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8301
  },
  {
    "request_id": "AM-REQ-2026-00779",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7792
  },
  {
    "request_id": "AM-REQ-2026-00780",
    "original_inquiry": "Urgent: Consultation request: locked-in syndrome for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5042
  },
  {
    "request_id": "AM-REQ-2026-00781",
    "original_inquiry": "Urgent: Family member with ALS, exploring locked-in syndrome or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5882
  },
  {
    "request_id": "AM-REQ-2026-00782",
    "original_inquiry": "Family seeking information: Consultation request: 侵入式电极 for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8016
  },
  {
    "request_id": "AM-REQ-2026-00783",
    "original_inquiry": "Urgent: 研究者咨询：希望了解侵入式电极在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8329
  },
  {
    "request_id": "AM-REQ-2026-00784",
    "original_inquiry": "Urgent: Patient with 脑机接口 seeking evaluation for Synchron Stentrode; interested in Precision Neuroscience trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7002
  },
  {
    "request_id": "AM-REQ-2026-00785",
    "original_inquiry": "Patient with brain-computer interface seeking evaluation for Paradromics; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5397
  },
  {
    "request_id": "AM-REQ-2026-00786",
    "original_inquiry": "Urgent: brain-computer interface diagnosis, seeking centers offering Blackrock Neurotech / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.666
  },
  {
    "request_id": "AM-REQ-2026-00787",
    "original_inquiry": "Consultation request: ECoG for Wyss Center; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6386
  },
  {
    "request_id": "AM-REQ-2026-00788",
    "original_inquiry": "Family seeking information: Neurologist referral: neural decoding candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7623
  },
  {
    "request_id": "AM-REQ-2026-00789",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8951
  },
  {
    "request_id": "AM-REQ-2026-00790",
    "original_inquiry": "Second opinion requested: 海外求诊：患者侵入式电极，希望评估Speech Neuroprosthesis或Wyss Center项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6482
  },
  {
    "request_id": "AM-REQ-2026-00791",
    "original_inquiry": "Family seeking information: Consultation request: ECoG for BrainGate; interested in Paradromics and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5449
  },
  {
    "request_id": "AM-REQ-2026-00792",
    "original_inquiry": "Urgent: Consultation request: intracortical array for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7589
  },
  {
    "request_id": "AM-REQ-2026-00793",
    "original_inquiry": "Second opinion requested: Consultation request: speech decoding for Wyss Center; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7406
  },
  {
    "request_id": "AM-REQ-2026-00794",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5658
  },
  {
    "request_id": "AM-REQ-2026-00795",
    "original_inquiry": "Urgent: Consultation request: intracortical array for Speech Neuroprosthesis; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8912
  },
  {
    "request_id": "AM-REQ-2026-00796",
    "original_inquiry": "研究者咨询：Patient with speech prosthesis seeking evaluation for Neuralink; interested in Paradromics trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5698
  },
  {
    "request_id": "AM-REQ-2026-00797",
    "original_inquiry": "Referral from specialist: Urgent: BCI for ALS diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7244
  },
  {
    "request_id": "AM-REQ-2026-00798",
    "original_inquiry": "Referral from specialist: 海外求诊：患者ECoG，希望评估Paradromics或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7022
  },
  {
    "request_id": "AM-REQ-2026-00799",
    "original_inquiry": "Consultation request: ECoG for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8349
  },
  {
    "request_id": "AM-REQ-2026-00800",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解invasive cortical electrode在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8263
  },
  {
    "request_id": "AM-REQ-2026-00801",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解BCI for ALS在Synchron Stentrode适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7563
  },
  {
    "request_id": "AM-REQ-2026-00802",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech decoding or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5003
  },
  {
    "request_id": "AM-REQ-2026-00803",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8724
  },
  {
    "request_id": "AM-REQ-2026-00804",
    "original_inquiry": "研究者咨询：Consultation request: 脑机接口 for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6045
  },
  {
    "request_id": "AM-REQ-2026-00805",
    "original_inquiry": "Urgent: 海外求诊：患者intracortical array，希望评估Neuralink或Blackrock Neurotech项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-00806",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring neural decoding or BrainGate for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5605
  },
  {
    "request_id": "AM-REQ-2026-00807",
    "original_inquiry": "海外求诊：Urgent: neural decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6941
  },
  {
    "request_id": "AM-REQ-2026-00808",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6815
  },
  {
    "request_id": "AM-REQ-2026-00809",
    "original_inquiry": "Consultation request: BCI for ALS for Blackrock Neurotech; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6478
  },
  {
    "request_id": "AM-REQ-2026-00810",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解brain-computer interface在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6892
  },
  {
    "request_id": "AM-REQ-2026-00811",
    "original_inquiry": "Neurologist referral: 运动皮层解码 candidate for Speech Neuroprosthesis; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5928
  },
  {
    "request_id": "AM-REQ-2026-00812",
    "original_inquiry": "Referral from specialist: Neurologist referral: 脑机接口 candidate for Speech Neuroprosthesis; request information on BrainGate eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7237
  },
  {
    "request_id": "AM-REQ-2026-00813",
    "original_inquiry": "研究者咨询：海外求诊：患者brain-computer interface，希望评估Blackrock Neurotech或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6706
  },
  {
    "request_id": "AM-REQ-2026-00814",
    "original_inquiry": "Urgent: Neurologist referral: brain-computer interface candidate for Precision Neuroscience; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7381
  },
  {
    "request_id": "AM-REQ-2026-00815",
    "original_inquiry": "Referral from specialist: Neurologist referral: motor neuroprosthesis candidate for Synchron Stentrode; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7075
  },
  {
    "request_id": "AM-REQ-2026-00816",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring intracortical array or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5238
  },
  {
    "request_id": "AM-REQ-2026-00817",
    "original_inquiry": "Urgent: 海外求诊：患者BCI for ALS，希望评估Paradromics或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6644
  },
  {
    "request_id": "AM-REQ-2026-00818",
    "original_inquiry": "Second opinion requested: Patient with 侵入式电极 seeking evaluation for Blackrock Neurotech; interested in Synchron Stentrode trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6587
  },
  {
    "request_id": "AM-REQ-2026-00819",
    "original_inquiry": "Urgent: Urgent: neural decoding diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5528
  },
  {
    "request_id": "AM-REQ-2026-00820",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 脑机接口 or BrainGate for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8539
  },
  {
    "request_id": "AM-REQ-2026-00821",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解speech decoding在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5149
  },
  {
    "request_id": "AM-REQ-2026-00822",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.684
  },
  {
    "request_id": "AM-REQ-2026-00823",
    "original_inquiry": "Second opinion requested: Consultation request: speech decoding for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8436
  },
  {
    "request_id": "AM-REQ-2026-00824",
    "original_inquiry": "Referral from specialist: Consultation request: neural decoding for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7634
  },
  {
    "request_id": "AM-REQ-2026-00825",
    "original_inquiry": "海外求诊：Consultation request: ECoG for Synchron Stentrode; interested in BrainGate and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7922
  },
  {
    "request_id": "AM-REQ-2026-00826",
    "original_inquiry": "Second opinion requested: Urgent: 侵入式电极 diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8454
  },
  {
    "request_id": "AM-REQ-2026-00827",
    "original_inquiry": "研究者咨询：Consultation request: 侵入式电极 for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.621
  },
  {
    "request_id": "AM-REQ-2026-00828",
    "original_inquiry": "Consultation request: 侵入式电极 for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7269
  },
  {
    "request_id": "AM-REQ-2026-00829",
    "original_inquiry": "Referral from specialist: Neurologist referral: locked-in syndrome candidate for Blackrock Neurotech; request information on Neuralink eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6661
  },
  {
    "request_id": "AM-REQ-2026-00830",
    "original_inquiry": "Second opinion requested: Neurologist referral: 侵入式电极 candidate for Precision Neuroscience; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8065
  },
  {
    "request_id": "AM-REQ-2026-00831",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 运动皮层解码 or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.739
  },
  {
    "request_id": "AM-REQ-2026-00832",
    "original_inquiry": "研究者咨询：Consultation request: ECoG for BrainGate; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6519
  },
  {
    "request_id": "AM-REQ-2026-00833",
    "original_inquiry": "Urgent: Consultation request: speech prosthesis for Paradromics; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8094
  },
  {
    "request_id": "AM-REQ-2026-00834",
    "original_inquiry": "海外求诊：研究者咨询：希望了解brain-computer interface在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5825
  },
  {
    "request_id": "AM-REQ-2026-00835",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring locked-in syndrome or Neuralink for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5856
  },
  {
    "request_id": "AM-REQ-2026-00836",
    "original_inquiry": "研究者咨询：Neurologist referral: BCI for ALS candidate for Blackrock Neurotech; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6887
  },
  {
    "request_id": "AM-REQ-2026-00837",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5476
  },
  {
    "request_id": "AM-REQ-2026-00838",
    "original_inquiry": "海外求诊：Neurologist referral: 侵入式电极 candidate for BrainGate; request information on Wyss Center eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8018
  },
  {
    "request_id": "AM-REQ-2026-00839",
    "original_inquiry": "Family member with ALS, exploring speech decoding or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6057
  },
  {
    "request_id": "AM-REQ-2026-00840",
    "original_inquiry": "Referral from specialist: 海外求诊：患者locked-in syndrome，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7033
  },
  {
    "request_id": "AM-REQ-2026-00841",
    "original_inquiry": "海外求诊：Neurologist referral: 侵入式电极 candidate for Paradromics; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7265
  },
  {
    "request_id": "AM-REQ-2026-00842",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8881
  },
  {
    "request_id": "AM-REQ-2026-00843",
    "original_inquiry": "Urgent: 海外求诊：患者locked-in syndrome，希望评估Neuralink或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5649
  },
  {
    "request_id": "AM-REQ-2026-00844",
    "original_inquiry": "Urgent: 研究者咨询：希望了解intracortical array在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8558
  },
  {
    "request_id": "AM-REQ-2026-00845",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6436
  },
  {
    "request_id": "AM-REQ-2026-00846",
    "original_inquiry": "研究者咨询：希望了解locked-in syndrome在Synchron Stentrode适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6998
  },
  {
    "request_id": "AM-REQ-2026-00847",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech prosthesis在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8334
  },
  {
    "request_id": "AM-REQ-2026-00848",
    "original_inquiry": "研究者咨询：Neurologist referral: brain-computer interface candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6069
  },
  {
    "request_id": "AM-REQ-2026-00849",
    "original_inquiry": "Family member with ALS, exploring neural decoding or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5688
  },
  {
    "request_id": "AM-REQ-2026-00850",
    "original_inquiry": "海外求诊：研究者咨询：希望了解语音神经假体在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7986
  },
  {
    "request_id": "AM-REQ-2026-00851",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring motor neuroprosthesis or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.806
  },
  {
    "request_id": "AM-REQ-2026-00852",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.836
  },
  {
    "request_id": "AM-REQ-2026-00853",
    "original_inquiry": "研究者咨询：Urgent: neural decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8918
  },
  {
    "request_id": "AM-REQ-2026-00854",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6723
  },
  {
    "request_id": "AM-REQ-2026-00855",
    "original_inquiry": "海外求诊：患者neural decoding，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8931
  },
  {
    "request_id": "AM-REQ-2026-00856",
    "original_inquiry": "Family seeking information: Urgent: locked-in syndrome diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5345
  },
  {
    "request_id": "AM-REQ-2026-00857",
    "original_inquiry": "Urgent: Family member with ALS, exploring BCI for ALS or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7054
  },
  {
    "request_id": "AM-REQ-2026-00858",
    "original_inquiry": "海外求诊：研究者咨询：希望了解脑机接口在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8119
  },
  {
    "request_id": "AM-REQ-2026-00859",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring invasive cortical electrode or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8144
  },
  {
    "request_id": "AM-REQ-2026-00860",
    "original_inquiry": "Referral from specialist: Neurologist referral: speech decoding candidate for BrainGate; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7018
  },
  {
    "request_id": "AM-REQ-2026-00861",
    "original_inquiry": "Second opinion requested: Patient with ECoG seeking evaluation for Blackrock Neurotech; interested in Neuralink trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.585
  },
  {
    "request_id": "AM-REQ-2026-00862",
    "original_inquiry": "海外求诊：Urgent: 脑机接口 diagnosis, seeking centers offering Speech Neuroprosthesis / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7892
  },
  {
    "request_id": "AM-REQ-2026-00863",
    "original_inquiry": "Family seeking information: Consultation request: locked-in syndrome for Blackrock Neurotech; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7589
  },
  {
    "request_id": "AM-REQ-2026-00864",
    "original_inquiry": "Urgent: 研究者咨询：希望了解neural decoding在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5633
  },
  {
    "request_id": "AM-REQ-2026-00865",
    "original_inquiry": "研究者咨询：Neurologist referral: motor neuroprosthesis candidate for Paradromics; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8081
  },
  {
    "request_id": "AM-REQ-2026-00866",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6372
  },
  {
    "request_id": "AM-REQ-2026-00867",
    "original_inquiry": "研究者咨询：海外求诊：患者运动皮层解码，希望评估Paradromics或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5733
  },
  {
    "request_id": "AM-REQ-2026-00868",
    "original_inquiry": "Referral from specialist: Consultation request: ECoG for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7336
  },
  {
    "request_id": "AM-REQ-2026-00869",
    "original_inquiry": "Urgent: Consultation request: intracortical array for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5858
  },
  {
    "request_id": "AM-REQ-2026-00870",
    "original_inquiry": "海外求诊：Neurologist referral: 脑机接口 candidate for Wyss Center; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8686
  },
  {
    "request_id": "AM-REQ-2026-00871",
    "original_inquiry": "研究者咨询：Neurologist referral: BCI for ALS candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6338
  },
  {
    "request_id": "AM-REQ-2026-00872",
    "original_inquiry": "Neurologist referral: invasive cortical electrode candidate for Neuralink; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5477
  },
  {
    "request_id": "AM-REQ-2026-00873",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6963
  },
  {
    "request_id": "AM-REQ-2026-00874",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring locked-in syndrome or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8522
  },
  {
    "request_id": "AM-REQ-2026-00875",
    "original_inquiry": "Urgent: Consultation request: motor neuroprosthesis for Paradromics; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7413
  },
  {
    "request_id": "AM-REQ-2026-00876",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6093
  },
  {
    "request_id": "AM-REQ-2026-00877",
    "original_inquiry": "Referral from specialist: Urgent: neural decoding diagnosis, seeking centers offering BrainGate / Neuralink clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6718
  },
  {
    "request_id": "AM-REQ-2026-00878",
    "original_inquiry": "Family seeking information: Urgent: 脑机接口 diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.698
  },
  {
    "request_id": "AM-REQ-2026-00879",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6468
  },
  {
    "request_id": "AM-REQ-2026-00880",
    "original_inquiry": "研究者咨询：Urgent: intracortical array diagnosis, seeking centers offering Paradromics / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5883
  },
  {
    "request_id": "AM-REQ-2026-00881",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7813
  },
  {
    "request_id": "AM-REQ-2026-00882",
    "original_inquiry": "Urgent: Patient with 语音神经假体 seeking evaluation for Paradromics; interested in BrainGate trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5072
  },
  {
    "request_id": "AM-REQ-2026-00883",
    "original_inquiry": "Urgent: Consultation request: speech prosthesis for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6206
  },
  {
    "request_id": "AM-REQ-2026-00884",
    "original_inquiry": "Urgent: Urgent: 语音神经假体 diagnosis, seeking centers offering Neuralink / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5429
  },
  {
    "request_id": "AM-REQ-2026-00885",
    "original_inquiry": "Referral from specialist: Neurologist referral: 语音神经假体 candidate for Wyss Center; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6129
  },
  {
    "request_id": "AM-REQ-2026-00886",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解intracortical array在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6267
  },
  {
    "request_id": "AM-REQ-2026-00887",
    "original_inquiry": "Patient with locked-in syndrome seeking evaluation for Wyss Center; interested in BrainGate trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5167
  },
  {
    "request_id": "AM-REQ-2026-00888",
    "original_inquiry": "Family seeking information: Neurologist referral: 语音神经假体 candidate for BrainGate; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5574
  },
  {
    "request_id": "AM-REQ-2026-00889",
    "original_inquiry": "海外求诊：Neurologist referral: 侵入式电极 candidate for Wyss Center; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7553
  },
  {
    "request_id": "AM-REQ-2026-00890",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Precision Neuroscience; request information on Wyss Center eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6451
  },
  {
    "request_id": "AM-REQ-2026-00891",
    "original_inquiry": "Urgent: BCI for ALS diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5121
  },
  {
    "request_id": "AM-REQ-2026-00892",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解motor neuroprosthesis在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5644
  },
  {
    "request_id": "AM-REQ-2026-00893",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7758
  },
  {
    "request_id": "AM-REQ-2026-00894",
    "original_inquiry": "Urgent: Urgent: speech decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5534
  },
  {
    "request_id": "AM-REQ-2026-00895",
    "original_inquiry": "Neurologist referral: intracortical array candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-00896",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.666
  },
  {
    "request_id": "AM-REQ-2026-00897",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Paradromics项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8405
  },
  {
    "request_id": "AM-REQ-2026-00898",
    "original_inquiry": "Second opinion requested: Patient with brain-computer interface seeking evaluation for Neuralink; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8883
  },
  {
    "request_id": "AM-REQ-2026-00899",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Speech Neuroprosthesis; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6891
  },
  {
    "request_id": "AM-REQ-2026-00900",
    "original_inquiry": "研究者咨询：Patient with speech decoding seeking evaluation for Paradromics; interested in Precision Neuroscience trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7967
  },
  {
    "request_id": "AM-REQ-2026-00901",
    "original_inquiry": "研究者咨询：希望了解invasive cortical electrode在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6311
  },
  {
    "request_id": "AM-REQ-2026-00902",
    "original_inquiry": "研究者咨询：Neurologist referral: 脑机接口 candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8926
  },
  {
    "request_id": "AM-REQ-2026-00903",
    "original_inquiry": "研究者咨询：海外求诊：患者locked-in syndrome，希望评估Blackrock Neurotech或Paradromics项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5835
  },
  {
    "request_id": "AM-REQ-2026-00904",
    "original_inquiry": "Family seeking information: Urgent: 运动皮层解码 diagnosis, seeking centers offering Speech Neuroprosthesis / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6919
  },
  {
    "request_id": "AM-REQ-2026-00905",
    "original_inquiry": "Urgent: Urgent: speech decoding diagnosis, seeking centers offering Wyss Center / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6722
  },
  {
    "request_id": "AM-REQ-2026-00906",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7442
  },
  {
    "request_id": "AM-REQ-2026-00907",
    "original_inquiry": "Urgent: 海外求诊：患者intracortical array，希望评估BrainGate或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-00908",
    "original_inquiry": "Second opinion requested: Consultation request: invasive cortical electrode for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.758
  },
  {
    "request_id": "AM-REQ-2026-00909",
    "original_inquiry": "Referral from specialist: Consultation request: ECoG for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5711
  },
  {
    "request_id": "AM-REQ-2026-00910",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 侵入式电极 or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6054
  },
  {
    "request_id": "AM-REQ-2026-00911",
    "original_inquiry": "Urgent: ECoG diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7856
  },
  {
    "request_id": "AM-REQ-2026-00912",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解BCI for ALS在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6784
  },
  {
    "request_id": "AM-REQ-2026-00913",
    "original_inquiry": "Referral from specialist: Patient with speech decoding seeking evaluation for Blackrock Neurotech; interested in BrainGate trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7959
  },
  {
    "request_id": "AM-REQ-2026-00914",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 侵入式电极 or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5649
  },
  {
    "request_id": "AM-REQ-2026-00915",
    "original_inquiry": "Referral from specialist: 海外求诊：患者motor neuroprosthesis，希望评估Paradromics或Synchron Stentrode项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5604
  },
  {
    "request_id": "AM-REQ-2026-00916",
    "original_inquiry": "海外求诊：Urgent: neural decoding diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.642
  },
  {
    "request_id": "AM-REQ-2026-00917",
    "original_inquiry": "研究者咨询：Neurologist referral: speech prosthesis candidate for BrainGate; request information on Paradromics eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7522
  },
  {
    "request_id": "AM-REQ-2026-00918",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解invasive cortical electrode在Synchron Stentrode适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6364
  },
  {
    "request_id": "AM-REQ-2026-00919",
    "original_inquiry": "Second opinion requested: Neurologist referral: neural decoding candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6146
  },
  {
    "request_id": "AM-REQ-2026-00920",
    "original_inquiry": "研究者咨询：Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7467
  },
  {
    "request_id": "AM-REQ-2026-00921",
    "original_inquiry": "Family seeking information: Consultation request: 运动皮层解码 for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7357
  },
  {
    "request_id": "AM-REQ-2026-00922",
    "original_inquiry": "Urgent: BCI for ALS diagnosis, seeking centers offering Paradromics / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7402
  },
  {
    "request_id": "AM-REQ-2026-00923",
    "original_inquiry": "研究者咨询：海外求诊：患者speech prosthesis，希望评估Synchron Stentrode或Blackrock Neurotech项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8253
  },
  {
    "request_id": "AM-REQ-2026-00924",
    "original_inquiry": "Consultation request: BCI for ALS for Neuralink; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-00925",
    "original_inquiry": "Urgent: 海外求诊：患者ECoG，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5361
  },
  {
    "request_id": "AM-REQ-2026-00926",
    "original_inquiry": "Family seeking information: Consultation request: speech decoding for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8095
  },
  {
    "request_id": "AM-REQ-2026-00927",
    "original_inquiry": "Referral from specialist: 海外求诊：患者speech decoding，希望评估Synchron Stentrode或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5714
  },
  {
    "request_id": "AM-REQ-2026-00928",
    "original_inquiry": "Urgent: Urgent: 语音神经假体 diagnosis, seeking centers offering Neuralink / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8846
  },
  {
    "request_id": "AM-REQ-2026-00929",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring locked-in syndrome or Speech Neuroprosthesis for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5429
  },
  {
    "request_id": "AM-REQ-2026-00930",
    "original_inquiry": "Consultation request: 脑机接口 for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6414
  },
  {
    "request_id": "AM-REQ-2026-00931",
    "original_inquiry": "Referral from specialist: Urgent: 脑机接口 diagnosis, seeking centers offering Neuralink / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7794
  },
  {
    "request_id": "AM-REQ-2026-00932",
    "original_inquiry": "海外求诊：研究者咨询：希望了解intracortical array在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8572
  },
  {
    "request_id": "AM-REQ-2026-00933",
    "original_inquiry": "Referral from specialist: Patient with neural decoding seeking evaluation for Precision Neuroscience; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8784
  },
  {
    "request_id": "AM-REQ-2026-00934",
    "original_inquiry": "Urgent: speech prosthesis diagnosis, seeking centers offering Neuralink / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7725
  },
  {
    "request_id": "AM-REQ-2026-00935",
    "original_inquiry": "Family member with ALS, exploring 脑机接口 or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8023
  },
  {
    "request_id": "AM-REQ-2026-00936",
    "original_inquiry": "海外求诊：Urgent: speech decoding diagnosis, seeking centers offering Neuralink / Precision Neuroscience clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6336
  },
  {
    "request_id": "AM-REQ-2026-00937",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解BCI for ALS在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7737
  },
  {
    "request_id": "AM-REQ-2026-00938",
    "original_inquiry": "海外求诊：Urgent: locked-in syndrome diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8183
  },
  {
    "request_id": "AM-REQ-2026-00939",
    "original_inquiry": "研究者咨询：Patient with 运动皮层解码 seeking evaluation for Wyss Center; interested in BrainGate trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7002
  },
  {
    "request_id": "AM-REQ-2026-00940",
    "original_inquiry": "Referral from specialist: 海外求诊：患者motor neuroprosthesis，希望评估BrainGate或Neuralink项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7788
  },
  {
    "request_id": "AM-REQ-2026-00941",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5708
  },
  {
    "request_id": "AM-REQ-2026-00942",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解intracortical array在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7577
  },
  {
    "request_id": "AM-REQ-2026-00943",
    "original_inquiry": "Urgent: Patient with speech prosthesis seeking evaluation for BrainGate; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8461
  },
  {
    "request_id": "AM-REQ-2026-00944",
    "original_inquiry": "Neurologist referral: 脑机接口 candidate for Wyss Center; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6972
  },
  {
    "request_id": "AM-REQ-2026-00945",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5094
  },
  {
    "request_id": "AM-REQ-2026-00946",
    "original_inquiry": "Urgent: Patient with ECoG seeking evaluation for Synchron Stentrode; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6479
  },
  {
    "request_id": "AM-REQ-2026-00947",
    "original_inquiry": "研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7232
  },
  {
    "request_id": "AM-REQ-2026-00948",
    "original_inquiry": "Family seeking information: Neurologist referral: speech prosthesis candidate for Synchron Stentrode; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8142
  },
  {
    "request_id": "AM-REQ-2026-00949",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解BCI for ALS在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6212
  },
  {
    "request_id": "AM-REQ-2026-00950",
    "original_inquiry": "Patient with motor neuroprosthesis seeking evaluation for Speech Neuroprosthesis; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7391
  },
  {
    "request_id": "AM-REQ-2026-00951",
    "original_inquiry": "Urgent: 海外求诊：患者brain-computer interface，希望评估Neuralink或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6848
  },
  {
    "request_id": "AM-REQ-2026-00952",
    "original_inquiry": "研究者咨询：Neurologist referral: locked-in syndrome candidate for BrainGate; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-00953",
    "original_inquiry": "Family seeking information: Urgent: brain-computer interface diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6392
  },
  {
    "request_id": "AM-REQ-2026-00954",
    "original_inquiry": "Referral from specialist: Consultation request: locked-in syndrome for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8347
  },
  {
    "request_id": "AM-REQ-2026-00955",
    "original_inquiry": "Urgent: Patient with 脑机接口 seeking evaluation for BrainGate; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8489
  },
  {
    "request_id": "AM-REQ-2026-00956",
    "original_inquiry": "Referral from specialist: Neurologist referral: speech decoding candidate for Blackrock Neurotech; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6109
  },
  {
    "request_id": "AM-REQ-2026-00957",
    "original_inquiry": "Urgent: Neurologist referral: 运动皮层解码 candidate for Precision Neuroscience; request information on Blackrock Neurotech eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7755
  },
  {
    "request_id": "AM-REQ-2026-00958",
    "original_inquiry": "Second opinion requested: 海外求诊：患者脑机接口，希望评估Blackrock Neurotech或Neuralink项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7903
  },
  {
    "request_id": "AM-REQ-2026-00959",
    "original_inquiry": "Urgent: Neurologist referral: neural decoding candidate for BrainGate; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7661
  },
  {
    "request_id": "AM-REQ-2026-00960",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring neural decoding or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.866
  },
  {
    "request_id": "AM-REQ-2026-00961",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 运动皮层解码 or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5955
  },
  {
    "request_id": "AM-REQ-2026-00962",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5105
  },
  {
    "request_id": "AM-REQ-2026-00963",
    "original_inquiry": "海外求诊：海外求诊：患者locked-in syndrome，希望评估Paradromics或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7167
  },
  {
    "request_id": "AM-REQ-2026-00964",
    "original_inquiry": "海外求诊：研究者咨询：希望了解运动皮层解码在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6912
  },
  {
    "request_id": "AM-REQ-2026-00965",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6081
  },
  {
    "request_id": "AM-REQ-2026-00966",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-00967",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8267
  },
  {
    "request_id": "AM-REQ-2026-00968",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Blackrock Neurotech; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-00969",
    "original_inquiry": "Family member with ALS, exploring neural decoding or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7872
  },
  {
    "request_id": "AM-REQ-2026-00970",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5102
  },
  {
    "request_id": "AM-REQ-2026-00971",
    "original_inquiry": "研究者咨询：Neurologist referral: 语音神经假体 candidate for Paradromics; request information on Wyss Center eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7247
  },
  {
    "request_id": "AM-REQ-2026-00972",
    "original_inquiry": "海外求诊：Neurologist referral: invasive cortical electrode candidate for Neuralink; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6875
  },
  {
    "request_id": "AM-REQ-2026-00973",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6006
  },
  {
    "request_id": "AM-REQ-2026-00974",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8352
  },
  {
    "request_id": "AM-REQ-2026-00975",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6533
  },
  {
    "request_id": "AM-REQ-2026-00976",
    "original_inquiry": "Referral from specialist: Urgent: 运动皮层解码 diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6341
  },
  {
    "request_id": "AM-REQ-2026-00977",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-00978",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7186
  },
  {
    "request_id": "AM-REQ-2026-00979",
    "original_inquiry": "海外求诊：研究者咨询：希望了解invasive cortical electrode在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7319
  },
  {
    "request_id": "AM-REQ-2026-00980",
    "original_inquiry": "Second opinion requested: Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in BrainGate trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8662
  },
  {
    "request_id": "AM-REQ-2026-00981",
    "original_inquiry": "Urgent: 海外求诊：患者speech decoding，希望评估BrainGate或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6389
  },
  {
    "request_id": "AM-REQ-2026-00982",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 运动皮层解码 or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8186
  },
  {
    "request_id": "AM-REQ-2026-00983",
    "original_inquiry": "研究者咨询：希望了解neural decoding在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6448
  },
  {
    "request_id": "AM-REQ-2026-00984",
    "original_inquiry": "海外求诊：Patient with 运动皮层解码 seeking evaluation for BrainGate; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8502
  },
  {
    "request_id": "AM-REQ-2026-00985",
    "original_inquiry": "Referral from specialist: Patient with motor neuroprosthesis seeking evaluation for Blackrock Neurotech; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7447
  },
  {
    "request_id": "AM-REQ-2026-00986",
    "original_inquiry": "Second opinion requested: 海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7564
  },
  {
    "request_id": "AM-REQ-2026-00987",
    "original_inquiry": "Referral from specialist: Patient with speech decoding seeking evaluation for Blackrock Neurotech; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8796
  },
  {
    "request_id": "AM-REQ-2026-00988",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring brain-computer interface or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.742
  },
  {
    "request_id": "AM-REQ-2026-00989",
    "original_inquiry": "Second opinion requested: Consultation request: invasive cortical electrode for Neuralink; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.569
  },
  {
    "request_id": "AM-REQ-2026-00990",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8944
  },
  {
    "request_id": "AM-REQ-2026-00991",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring BCI for ALS or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7635
  },
  {
    "request_id": "AM-REQ-2026-00992",
    "original_inquiry": "Family seeking information: Consultation request: BCI for ALS for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8835
  },
  {
    "request_id": "AM-REQ-2026-00993",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 运动皮层解码 or BrainGate for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6622
  },
  {
    "request_id": "AM-REQ-2026-00994",
    "original_inquiry": "Consultation request: intracortical array for Synchron Stentrode; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7362
  },
  {
    "request_id": "AM-REQ-2026-00995",
    "original_inquiry": "Referral from specialist: Urgent: ECoG diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5045
  },
  {
    "request_id": "AM-REQ-2026-00996",
    "original_inquiry": "Referral from specialist: 海外求诊：患者intracortical array，希望评估Paradromics或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5896
  },
  {
    "request_id": "AM-REQ-2026-00997",
    "original_inquiry": "研究者咨询：海外求诊：患者脑机接口，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6184
  },
  {
    "request_id": "AM-REQ-2026-00998",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring locked-in syndrome or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6841
  },
  {
    "request_id": "AM-REQ-2026-00999",
    "original_inquiry": "Urgent: Neurologist referral: speech prosthesis candidate for Neuralink; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.755
  },
  {
    "request_id": "AM-REQ-2026-01000",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.842
  },
  {
    "request_id": "AM-REQ-2026-01001",
    "original_inquiry": "Second opinion requested: Neurologist referral: 运动皮层解码 candidate for Blackrock Neurotech; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.844
  },
  {
    "request_id": "AM-REQ-2026-01002",
    "original_inquiry": "研究者咨询：希望了解脑机接口在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8459
  },
  {
    "request_id": "AM-REQ-2026-01003",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 脑机接口 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7536
  },
  {
    "request_id": "AM-REQ-2026-01004",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8026
  },
  {
    "request_id": "AM-REQ-2026-01005",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7843
  },
  {
    "request_id": "AM-REQ-2026-01006",
    "original_inquiry": "Family seeking information: Neurologist referral: BCI for ALS candidate for BrainGate; request information on Paradromics eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5378
  },
  {
    "request_id": "AM-REQ-2026-01007",
    "original_inquiry": "Urgent: 海外求诊：患者speech prosthesis，希望评估Wyss Center或BrainGate项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7007
  },
  {
    "request_id": "AM-REQ-2026-01008",
    "original_inquiry": "Family seeking information: Patient with 侵入式电极 seeking evaluation for Paradromics; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.682
  },
  {
    "request_id": "AM-REQ-2026-01009",
    "original_inquiry": "研究者咨询：Urgent: 语音神经假体 diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6763
  },
  {
    "request_id": "AM-REQ-2026-01010",
    "original_inquiry": "海外求诊：Consultation request: 语音神经假体 for Synchron Stentrode; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.636
  },
  {
    "request_id": "AM-REQ-2026-01011",
    "original_inquiry": "Family seeking information: 海外求诊：患者脑机接口，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7581
  },
  {
    "request_id": "AM-REQ-2026-01012",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or BrainGate for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.843
  },
  {
    "request_id": "AM-REQ-2026-01013",
    "original_inquiry": "Second opinion requested: 海外求诊：患者locked-in syndrome，希望评估Speech Neuroprosthesis或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5649
  },
  {
    "request_id": "AM-REQ-2026-01014",
    "original_inquiry": "海外求诊：海外求诊：患者ECoG，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-01015",
    "original_inquiry": "Referral from specialist: Consultation request: BCI for ALS for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6323
  },
  {
    "request_id": "AM-REQ-2026-01016",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5171
  },
  {
    "request_id": "AM-REQ-2026-01017",
    "original_inquiry": "Urgent: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5157
  },
  {
    "request_id": "AM-REQ-2026-01018",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring neural decoding or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5433
  },
  {
    "request_id": "AM-REQ-2026-01019",
    "original_inquiry": "Consultation request: 侵入式电极 for Synchron Stentrode; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5161
  },
  {
    "request_id": "AM-REQ-2026-01020",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech decoding在Synchron Stentrode适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8104
  },
  {
    "request_id": "AM-REQ-2026-01021",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.675
  },
  {
    "request_id": "AM-REQ-2026-01022",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解ECoG在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7248
  },
  {
    "request_id": "AM-REQ-2026-01023",
    "original_inquiry": "Consultation request: 运动皮层解码 for Precision Neuroscience; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5305
  },
  {
    "request_id": "AM-REQ-2026-01024",
    "original_inquiry": "Urgent: Urgent: brain-computer interface diagnosis, seeking centers offering BrainGate / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6072
  },
  {
    "request_id": "AM-REQ-2026-01025",
    "original_inquiry": "Urgent: 海外求诊：患者intracortical array，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5237
  },
  {
    "request_id": "AM-REQ-2026-01026",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.652
  },
  {
    "request_id": "AM-REQ-2026-01027",
    "original_inquiry": "Second opinion requested: 海外求诊：患者locked-in syndrome，希望评估BrainGate或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7333
  },
  {
    "request_id": "AM-REQ-2026-01028",
    "original_inquiry": "研究者咨询：海外求诊：患者locked-in syndrome，希望评估Paradromics或Synchron Stentrode项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7968
  },
  {
    "request_id": "AM-REQ-2026-01029",
    "original_inquiry": "海外求诊：Neurologist referral: speech decoding candidate for Wyss Center; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7964
  },
  {
    "request_id": "AM-REQ-2026-01030",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7463
  },
  {
    "request_id": "AM-REQ-2026-01031",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6119
  },
  {
    "request_id": "AM-REQ-2026-01032",
    "original_inquiry": "Urgent: Family member with ALS, exploring speech decoding or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5373
  },
  {
    "request_id": "AM-REQ-2026-01033",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7515
  },
  {
    "request_id": "AM-REQ-2026-01034",
    "original_inquiry": "Urgent: Family member with ALS, exploring brain-computer interface or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8709
  },
  {
    "request_id": "AM-REQ-2026-01035",
    "original_inquiry": "研究者咨询：海外求诊：患者brain-computer interface，希望评估BrainGate或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8599
  },
  {
    "request_id": "AM-REQ-2026-01036",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解运动皮层解码在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5032
  },
  {
    "request_id": "AM-REQ-2026-01037",
    "original_inquiry": "研究者咨询：希望了解brain-computer interface在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6812
  },
  {
    "request_id": "AM-REQ-2026-01038",
    "original_inquiry": "Family seeking information: Neurologist referral: brain-computer interface candidate for Precision Neuroscience; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6453
  },
  {
    "request_id": "AM-REQ-2026-01039",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解invasive cortical electrode在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6958
  },
  {
    "request_id": "AM-REQ-2026-01040",
    "original_inquiry": "Urgent: 海外求诊：患者invasive cortical electrode，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7886
  },
  {
    "request_id": "AM-REQ-2026-01041",
    "original_inquiry": "海外求诊：Family member with ALS, exploring motor neuroprosthesis or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-01042",
    "original_inquiry": "Second opinion requested: Neurologist referral: motor neuroprosthesis candidate for Wyss Center; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8079
  },
  {
    "request_id": "AM-REQ-2026-01043",
    "original_inquiry": "Referral from specialist: 海外求诊：患者locked-in syndrome，希望评估Precision Neuroscience或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5499
  },
  {
    "request_id": "AM-REQ-2026-01044",
    "original_inquiry": "Second opinion requested: Urgent: locked-in syndrome diagnosis, seeking centers offering Synchron Stentrode / Neuralink clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6696
  },
  {
    "request_id": "AM-REQ-2026-01045",
    "original_inquiry": "Neurologist referral: invasive cortical electrode candidate for Paradromics; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7801
  },
  {
    "request_id": "AM-REQ-2026-01046",
    "original_inquiry": "海外求诊：Neurologist referral: speech prosthesis candidate for BrainGate; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7967
  },
  {
    "request_id": "AM-REQ-2026-01047",
    "original_inquiry": "Urgent: Consultation request: 运动皮层解码 for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5604
  },
  {
    "request_id": "AM-REQ-2026-01048",
    "original_inquiry": "Urgent: brain-computer interface diagnosis, seeking centers offering Speech Neuroprosthesis / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7977
  },
  {
    "request_id": "AM-REQ-2026-01049",
    "original_inquiry": "Urgent: 海外求诊：患者侵入式电极，希望评估Precision Neuroscience或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8833
  },
  {
    "request_id": "AM-REQ-2026-01050",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-01051",
    "original_inquiry": "Urgent: Neurologist referral: speech prosthesis candidate for Blackrock Neurotech; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8394
  },
  {
    "request_id": "AM-REQ-2026-01052",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 运动皮层解码 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7508
  },
  {
    "request_id": "AM-REQ-2026-01053",
    "original_inquiry": "海外求诊：海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7108
  },
  {
    "request_id": "AM-REQ-2026-01054",
    "original_inquiry": "Urgent: 海外求诊：患者BCI for ALS，希望评估Wyss Center或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7517
  },
  {
    "request_id": "AM-REQ-2026-01055",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring speech decoding or Paradromics for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6581
  },
  {
    "request_id": "AM-REQ-2026-01056",
    "original_inquiry": "海外求诊：Neurologist referral: 运动皮层解码 candidate for Wyss Center; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.595
  },
  {
    "request_id": "AM-REQ-2026-01057",
    "original_inquiry": "Family seeking information: Patient with 运动皮层解码 seeking evaluation for Synchron Stentrode; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5348
  },
  {
    "request_id": "AM-REQ-2026-01058",
    "original_inquiry": "Urgent: Patient with BCI for ALS seeking evaluation for Blackrock Neurotech; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6608
  },
  {
    "request_id": "AM-REQ-2026-01059",
    "original_inquiry": "Second opinion requested: Consultation request: BCI for ALS for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-01060",
    "original_inquiry": "海外求诊：Urgent: 运动皮层解码 diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.762
  },
  {
    "request_id": "AM-REQ-2026-01061",
    "original_inquiry": "研究者咨询：希望了解intracortical array在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5956
  },
  {
    "request_id": "AM-REQ-2026-01062",
    "original_inquiry": "Urgent: Urgent: 侵入式电极 diagnosis, seeking centers offering Precision Neuroscience / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8866
  },
  {
    "request_id": "AM-REQ-2026-01063",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解brain-computer interface在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6019
  },
  {
    "request_id": "AM-REQ-2026-01064",
    "original_inquiry": "海外求诊：患者invasive cortical electrode，希望评估Synchron Stentrode或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8851
  },
  {
    "request_id": "AM-REQ-2026-01065",
    "original_inquiry": "Second opinion requested: Urgent: invasive cortical electrode diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8019
  },
  {
    "request_id": "AM-REQ-2026-01066",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7619
  },
  {
    "request_id": "AM-REQ-2026-01067",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6185
  },
  {
    "request_id": "AM-REQ-2026-01068",
    "original_inquiry": "Second opinion requested: Neurologist referral: speech decoding candidate for Wyss Center; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7765
  },
  {
    "request_id": "AM-REQ-2026-01069",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 脑机接口 or Precision Neuroscience for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5569
  },
  {
    "request_id": "AM-REQ-2026-01070",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7586
  },
  {
    "request_id": "AM-REQ-2026-01071",
    "original_inquiry": "Neurologist referral: speech decoding candidate for Wyss Center; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5941
  },
  {
    "request_id": "AM-REQ-2026-01072",
    "original_inquiry": "Second opinion requested: Urgent: 语音神经假体 diagnosis, seeking centers offering Synchron Stentrode / Paradromics clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.637
  },
  {
    "request_id": "AM-REQ-2026-01073",
    "original_inquiry": "Family seeking information: Neurologist referral: motor neuroprosthesis candidate for BrainGate; request information on Neuralink eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.509
  },
  {
    "request_id": "AM-REQ-2026-01074",
    "original_inquiry": "Referral from specialist: Consultation request: intracortical array for Blackrock Neurotech; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.547
  },
  {
    "request_id": "AM-REQ-2026-01075",
    "original_inquiry": "研究者咨询：Neurologist referral: invasive cortical electrode candidate for Precision Neuroscience; request information on Wyss Center eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6066
  },
  {
    "request_id": "AM-REQ-2026-01076",
    "original_inquiry": "Urgent: 研究者咨询：希望了解语音神经假体在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.656
  },
  {
    "request_id": "AM-REQ-2026-01077",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解语音神经假体在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8542
  },
  {
    "request_id": "AM-REQ-2026-01078",
    "original_inquiry": "Second opinion requested: Neurologist referral: speech decoding candidate for Paradromics; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8002
  },
  {
    "request_id": "AM-REQ-2026-01079",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring brain-computer interface or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5171
  },
  {
    "request_id": "AM-REQ-2026-01080",
    "original_inquiry": "Family seeking information: Patient with 脑机接口 seeking evaluation for Speech Neuroprosthesis; interested in Paradromics trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6541
  },
  {
    "request_id": "AM-REQ-2026-01081",
    "original_inquiry": "研究者咨询：海外求诊：患者invasive cortical electrode，希望评估Precision Neuroscience或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8263
  },
  {
    "request_id": "AM-REQ-2026-01082",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6277
  },
  {
    "request_id": "AM-REQ-2026-01083",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring invasive cortical electrode or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7451
  },
  {
    "request_id": "AM-REQ-2026-01084",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估Paradromics或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7081
  },
  {
    "request_id": "AM-REQ-2026-01085",
    "original_inquiry": "Urgent: Consultation request: 脑机接口 for Neuralink; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7461
  },
  {
    "request_id": "AM-REQ-2026-01086",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5451
  },
  {
    "request_id": "AM-REQ-2026-01087",
    "original_inquiry": "Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.542
  },
  {
    "request_id": "AM-REQ-2026-01088",
    "original_inquiry": "研究者咨询：Consultation request: ECoG for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.607
  },
  {
    "request_id": "AM-REQ-2026-01089",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Precision Neuroscience; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8899
  },
  {
    "request_id": "AM-REQ-2026-01090",
    "original_inquiry": "研究者咨询：Neurologist referral: motor neuroprosthesis candidate for Precision Neuroscience; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6649
  },
  {
    "request_id": "AM-REQ-2026-01091",
    "original_inquiry": "研究者咨询：Consultation request: ECoG for Speech Neuroprosthesis; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8749
  },
  {
    "request_id": "AM-REQ-2026-01092",
    "original_inquiry": "Family seeking information: Consultation request: motor neuroprosthesis for Wyss Center; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7487
  },
  {
    "request_id": "AM-REQ-2026-01093",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring speech prosthesis or Precision Neuroscience for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8057
  },
  {
    "request_id": "AM-REQ-2026-01094",
    "original_inquiry": "研究者咨询：Patient with speech prosthesis seeking evaluation for Speech Neuroprosthesis; interested in Paradromics trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8283
  },
  {
    "request_id": "AM-REQ-2026-01095",
    "original_inquiry": "Referral from specialist: Patient with 语音神经假体 seeking evaluation for BrainGate; interested in Blackrock Neurotech trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5486
  },
  {
    "request_id": "AM-REQ-2026-01096",
    "original_inquiry": "Family seeking information: Consultation request: 侵入式电极 for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8178
  },
  {
    "request_id": "AM-REQ-2026-01097",
    "original_inquiry": "Urgent: Neurologist referral: brain-computer interface candidate for Paradromics; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6191
  },
  {
    "request_id": "AM-REQ-2026-01098",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech decoding在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5457
  },
  {
    "request_id": "AM-REQ-2026-01099",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5252
  },
  {
    "request_id": "AM-REQ-2026-01100",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5026
  },
  {
    "request_id": "AM-REQ-2026-01101",
    "original_inquiry": "Second opinion requested: Urgent: 语音神经假体 diagnosis, seeking centers offering Precision Neuroscience / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.564
  },
  {
    "request_id": "AM-REQ-2026-01102",
    "original_inquiry": "Urgent: Urgent: 脑机接口 diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-01103",
    "original_inquiry": "研究者咨询：Consultation request: neural decoding for Neuralink; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8975
  },
  {
    "request_id": "AM-REQ-2026-01104",
    "original_inquiry": "海外求诊：研究者咨询：希望了解语音神经假体在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7168
  },
  {
    "request_id": "AM-REQ-2026-01105",
    "original_inquiry": "Second opinion requested: Patient with motor neuroprosthesis seeking evaluation for Synchron Stentrode; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5954
  },
  {
    "request_id": "AM-REQ-2026-01106",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Blackrock Neurotech; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8471
  },
  {
    "request_id": "AM-REQ-2026-01107",
    "original_inquiry": "海外求诊：Urgent: invasive cortical electrode diagnosis, seeking centers offering Paradromics / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5975
  },
  {
    "request_id": "AM-REQ-2026-01108",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解brain-computer interface在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8487
  },
  {
    "request_id": "AM-REQ-2026-01109",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解neural decoding在Synchron Stentrode适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7177
  },
  {
    "request_id": "AM-REQ-2026-01110",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or Wyss Center for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7165
  },
  {
    "request_id": "AM-REQ-2026-01111",
    "original_inquiry": "Urgent: Neurologist referral: 语音神经假体 candidate for Blackrock Neurotech; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8256
  },
  {
    "request_id": "AM-REQ-2026-01112",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech prosthesis，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6441
  },
  {
    "request_id": "AM-REQ-2026-01113",
    "original_inquiry": "研究者咨询：Consultation request: 语音神经假体 for Speech Neuroprosthesis; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6949
  },
  {
    "request_id": "AM-REQ-2026-01114",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8475
  },
  {
    "request_id": "AM-REQ-2026-01115",
    "original_inquiry": "Referral from specialist: Patient with intracortical array seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7119
  },
  {
    "request_id": "AM-REQ-2026-01116",
    "original_inquiry": "海外求诊：研究者咨询：希望了解motor neuroprosthesis在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8113
  },
  {
    "request_id": "AM-REQ-2026-01117",
    "original_inquiry": "海外求诊：海外求诊：患者brain-computer interface，希望评估Precision Neuroscience或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5201
  },
  {
    "request_id": "AM-REQ-2026-01118",
    "original_inquiry": "Family seeking information: Urgent: speech prosthesis diagnosis, seeking centers offering Precision Neuroscience / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8425
  },
  {
    "request_id": "AM-REQ-2026-01119",
    "original_inquiry": "海外求诊：患者speech decoding，希望评估Synchron Stentrode或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5579
  },
  {
    "request_id": "AM-REQ-2026-01120",
    "original_inquiry": "Second opinion requested: Patient with motor neuroprosthesis seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8821
  },
  {
    "request_id": "AM-REQ-2026-01121",
    "original_inquiry": "Urgent: Urgent: BCI for ALS diagnosis, seeking centers offering Wyss Center / Paradromics clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5847
  },
  {
    "request_id": "AM-REQ-2026-01122",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7489
  },
  {
    "request_id": "AM-REQ-2026-01123",
    "original_inquiry": "Referral from specialist: Consultation request: ECoG for Blackrock Neurotech; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7765
  },
  {
    "request_id": "AM-REQ-2026-01124",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Neuralink; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5858
  },
  {
    "request_id": "AM-REQ-2026-01125",
    "original_inquiry": "研究者咨询：Neurologist referral: ECoG candidate for Precision Neuroscience; request information on Blackrock Neurotech eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5249
  },
  {
    "request_id": "AM-REQ-2026-01126",
    "original_inquiry": "Family member with ALS, exploring motor neuroprosthesis or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-01127",
    "original_inquiry": "研究者咨询：Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8541
  },
  {
    "request_id": "AM-REQ-2026-01128",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8977
  },
  {
    "request_id": "AM-REQ-2026-01129",
    "original_inquiry": "Second opinion requested: Urgent: 运动皮层解码 diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8358
  },
  {
    "request_id": "AM-REQ-2026-01130",
    "original_inquiry": "Urgent: invasive cortical electrode diagnosis, seeking centers offering Neuralink / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-01131",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5909
  },
  {
    "request_id": "AM-REQ-2026-01132",
    "original_inquiry": "Referral from specialist: Consultation request: intracortical array for Paradromics; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7548
  },
  {
    "request_id": "AM-REQ-2026-01133",
    "original_inquiry": "Referral from specialist: Urgent: neural decoding diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8666
  },
  {
    "request_id": "AM-REQ-2026-01134",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8652
  },
  {
    "request_id": "AM-REQ-2026-01135",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解语音神经假体在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7711
  },
  {
    "request_id": "AM-REQ-2026-01136",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6279
  },
  {
    "request_id": "AM-REQ-2026-01137",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解motor neuroprosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8953
  },
  {
    "request_id": "AM-REQ-2026-01138",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring invasive cortical electrode or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5867
  },
  {
    "request_id": "AM-REQ-2026-01139",
    "original_inquiry": "Second opinion requested: Urgent: locked-in syndrome diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8957
  },
  {
    "request_id": "AM-REQ-2026-01140",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 侵入式电极 or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6729
  },
  {
    "request_id": "AM-REQ-2026-01141",
    "original_inquiry": "Referral from specialist: 海外求诊：患者侵入式电极，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5017
  },
  {
    "request_id": "AM-REQ-2026-01142",
    "original_inquiry": "Urgent: Family member with ALS, exploring BCI for ALS or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7181
  },
  {
    "request_id": "AM-REQ-2026-01143",
    "original_inquiry": "海外求诊：海外求诊：患者locked-in syndrome，希望评估Precision Neuroscience或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7315
  },
  {
    "request_id": "AM-REQ-2026-01144",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解speech decoding在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7476
  },
  {
    "request_id": "AM-REQ-2026-01145",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解invasive cortical electrode在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8889
  },
  {
    "request_id": "AM-REQ-2026-01146",
    "original_inquiry": "Urgent: 研究者咨询：希望了解侵入式电极在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7128
  },
  {
    "request_id": "AM-REQ-2026-01147",
    "original_inquiry": "Family member with ALS, exploring BCI for ALS or BrainGate for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8691
  },
  {
    "request_id": "AM-REQ-2026-01148",
    "original_inquiry": "Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6169
  },
  {
    "request_id": "AM-REQ-2026-01149",
    "original_inquiry": "Patient with speech prosthesis seeking evaluation for Blackrock Neurotech; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5052
  },
  {
    "request_id": "AM-REQ-2026-01150",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring BCI for ALS or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5773
  },
  {
    "request_id": "AM-REQ-2026-01151",
    "original_inquiry": "Patient with invasive cortical electrode seeking evaluation for Speech Neuroprosthesis; interested in Synchron Stentrode trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7047
  },
  {
    "request_id": "AM-REQ-2026-01152",
    "original_inquiry": "海外求诊：Urgent: BCI for ALS diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-01153",
    "original_inquiry": "Referral from specialist: 海外求诊：患者speech prosthesis，希望评估Paradromics或Blackrock Neurotech项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5197
  },
  {
    "request_id": "AM-REQ-2026-01154",
    "original_inquiry": "研究者咨询：海外求诊：患者motor neuroprosthesis，希望评估Blackrock Neurotech或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5305
  },
  {
    "request_id": "AM-REQ-2026-01155",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5344
  },
  {
    "request_id": "AM-REQ-2026-01156",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Precision Neuroscience; interested in Wyss Center trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6898
  },
  {
    "request_id": "AM-REQ-2026-01157",
    "original_inquiry": "Second opinion requested: Patient with 脑机接口 seeking evaluation for BrainGate; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7842
  },
  {
    "request_id": "AM-REQ-2026-01158",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5759
  },
  {
    "request_id": "AM-REQ-2026-01159",
    "original_inquiry": "Second opinion requested: Patient with speech decoding seeking evaluation for BrainGate; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8491
  },
  {
    "request_id": "AM-REQ-2026-01160",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 语音神经假体 or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6714
  },
  {
    "request_id": "AM-REQ-2026-01161",
    "original_inquiry": "Family member with ALS, exploring invasive cortical electrode or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.837
  },
  {
    "request_id": "AM-REQ-2026-01162",
    "original_inquiry": "Family seeking information: Patient with speech decoding seeking evaluation for Paradromics; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-01163",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 语音神经假体 or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5323
  },
  {
    "request_id": "AM-REQ-2026-01164",
    "original_inquiry": "海外求诊：Urgent: ECoG diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7623
  },
  {
    "request_id": "AM-REQ-2026-01165",
    "original_inquiry": "研究者咨询：Consultation request: 脑机接口 for Neuralink; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6604
  },
  {
    "request_id": "AM-REQ-2026-01166",
    "original_inquiry": "Referral from specialist: Neurologist referral: locked-in syndrome candidate for Precision Neuroscience; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8936
  },
  {
    "request_id": "AM-REQ-2026-01167",
    "original_inquiry": "Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5993
  },
  {
    "request_id": "AM-REQ-2026-01168",
    "original_inquiry": "Referral from specialist: Neurologist referral: ECoG candidate for Neuralink; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5184
  },
  {
    "request_id": "AM-REQ-2026-01169",
    "original_inquiry": "海外求诊：Urgent: locked-in syndrome diagnosis, seeking centers offering Paradromics / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7195
  },
  {
    "request_id": "AM-REQ-2026-01170",
    "original_inquiry": "Family seeking information: Patient with 语音神经假体 seeking evaluation for Synchron Stentrode; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5153
  },
  {
    "request_id": "AM-REQ-2026-01171",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7597
  },
  {
    "request_id": "AM-REQ-2026-01172",
    "original_inquiry": "Referral from specialist: Neurologist referral: motor neuroprosthesis candidate for Paradromics; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5688
  },
  {
    "request_id": "AM-REQ-2026-01173",
    "original_inquiry": "Family seeking information: Urgent: neural decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7353
  },
  {
    "request_id": "AM-REQ-2026-01174",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech prosthesis在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8366
  },
  {
    "request_id": "AM-REQ-2026-01175",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7205
  },
  {
    "request_id": "AM-REQ-2026-01176",
    "original_inquiry": "Urgent: Neurologist referral: BCI for ALS candidate for Speech Neuroprosthesis; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5279
  },
  {
    "request_id": "AM-REQ-2026-01177",
    "original_inquiry": "Family seeking information: 海外求诊：患者BCI for ALS，希望评估BrainGate或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6642
  },
  {
    "request_id": "AM-REQ-2026-01178",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for Synchron Stentrode; interested in BrainGate trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5592
  },
  {
    "request_id": "AM-REQ-2026-01179",
    "original_inquiry": "Urgent: Urgent: speech prosthesis diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.706
  },
  {
    "request_id": "AM-REQ-2026-01180",
    "original_inquiry": "研究者咨询：海外求诊：患者BCI for ALS，希望评估Speech Neuroprosthesis或Paradromics项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-01181",
    "original_inquiry": "Second opinion requested: Neurologist referral: 语音神经假体 candidate for BrainGate; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5177
  },
  {
    "request_id": "AM-REQ-2026-01182",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7522
  },
  {
    "request_id": "AM-REQ-2026-01183",
    "original_inquiry": "Family seeking information: Consultation request: BCI for ALS for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7436
  },
  {
    "request_id": "AM-REQ-2026-01184",
    "original_inquiry": "Urgent: neural decoding diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7118
  },
  {
    "request_id": "AM-REQ-2026-01185",
    "original_inquiry": "海外求诊：研究者咨询：希望了解motor neuroprosthesis在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7881
  },
  {
    "request_id": "AM-REQ-2026-01186",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-01187",
    "original_inquiry": "Second opinion requested: 海外求诊：患者侵入式电极，希望评估BrainGate或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7883
  },
  {
    "request_id": "AM-REQ-2026-01188",
    "original_inquiry": "研究者咨询：Urgent: locked-in syndrome diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5694
  },
  {
    "request_id": "AM-REQ-2026-01189",
    "original_inquiry": "Family member with ALS, exploring ECoG or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6357
  },
  {
    "request_id": "AM-REQ-2026-01190",
    "original_inquiry": "Urgent: Neurologist referral: speech decoding candidate for Speech Neuroprosthesis; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8799
  },
  {
    "request_id": "AM-REQ-2026-01191",
    "original_inquiry": "研究者咨询：希望了解BCI for ALS在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8856
  },
  {
    "request_id": "AM-REQ-2026-01192",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7873
  },
  {
    "request_id": "AM-REQ-2026-01193",
    "original_inquiry": "研究者咨询：海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5615
  },
  {
    "request_id": "AM-REQ-2026-01194",
    "original_inquiry": "Urgent: Patient with 侵入式电极 seeking evaluation for Speech Neuroprosthesis; interested in Precision Neuroscience trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6557
  },
  {
    "request_id": "AM-REQ-2026-01195",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5674
  },
  {
    "request_id": "AM-REQ-2026-01196",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering Synchron Stentrode / Wyss Center clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.839
  },
  {
    "request_id": "AM-REQ-2026-01197",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for Neuralink; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5564
  },
  {
    "request_id": "AM-REQ-2026-01198",
    "original_inquiry": "Urgent: 研究者咨询：希望了解intracortical array在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8959
  },
  {
    "request_id": "AM-REQ-2026-01199",
    "original_inquiry": "Urgent: 海外求诊：患者locked-in syndrome，希望评估Synchron Stentrode或Blackrock Neurotech项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7547
  },
  {
    "request_id": "AM-REQ-2026-01200",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解侵入式电极在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5045
  },
  {
    "request_id": "AM-REQ-2026-01201",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解motor neuroprosthesis在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.667
  },
  {
    "request_id": "AM-REQ-2026-01202",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6066
  },
  {
    "request_id": "AM-REQ-2026-01203",
    "original_inquiry": "Referral from specialist: 海外求诊：患者motor neuroprosthesis，希望评估Synchron Stentrode或Wyss Center项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8733
  },
  {
    "request_id": "AM-REQ-2026-01204",
    "original_inquiry": "Referral from specialist: Neurologist referral: 运动皮层解码 candidate for Blackrock Neurotech; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5736
  },
  {
    "request_id": "AM-REQ-2026-01205",
    "original_inquiry": "Patient with intracortical array seeking evaluation for BrainGate; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8388
  },
  {
    "request_id": "AM-REQ-2026-01206",
    "original_inquiry": "Referral from specialist: Patient with ECoG seeking evaluation for Speech Neuroprosthesis; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5341
  },
  {
    "request_id": "AM-REQ-2026-01207",
    "original_inquiry": "Family seeking information: 海外求诊：患者ECoG，希望评估Neuralink或Blackrock Neurotech项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7861
  },
  {
    "request_id": "AM-REQ-2026-01208",
    "original_inquiry": "Consultation request: intracortical array for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5027
  },
  {
    "request_id": "AM-REQ-2026-01209",
    "original_inquiry": "Consultation request: 侵入式电极 for Synchron Stentrode; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5434
  },
  {
    "request_id": "AM-REQ-2026-01210",
    "original_inquiry": "Second opinion requested: Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7857
  },
  {
    "request_id": "AM-REQ-2026-01211",
    "original_inquiry": "Referral from specialist: 海外求诊：患者locked-in syndrome，希望评估Blackrock Neurotech或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8742
  },
  {
    "request_id": "AM-REQ-2026-01212",
    "original_inquiry": "Family member with ALS, exploring intracortical array or BrainGate for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8143
  },
  {
    "request_id": "AM-REQ-2026-01213",
    "original_inquiry": "海外求诊：Neurologist referral: 运动皮层解码 candidate for Wyss Center; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6175
  },
  {
    "request_id": "AM-REQ-2026-01214",
    "original_inquiry": "Urgent: speech prosthesis diagnosis, seeking centers offering Synchron Stentrode / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6459
  },
  {
    "request_id": "AM-REQ-2026-01215",
    "original_inquiry": "Urgent: Urgent: brain-computer interface diagnosis, seeking centers offering Precision Neuroscience / Neuralink clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7631
  },
  {
    "request_id": "AM-REQ-2026-01216",
    "original_inquiry": "研究者咨询：希望了解侵入式电极在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.878
  },
  {
    "request_id": "AM-REQ-2026-01217",
    "original_inquiry": "Urgent: speech prosthesis diagnosis, seeking centers offering Blackrock Neurotech / Neuralink clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5793
  },
  {
    "request_id": "AM-REQ-2026-01218",
    "original_inquiry": "Second opinion requested: Patient with 侵入式电极 seeking evaluation for Speech Neuroprosthesis; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7448
  },
  {
    "request_id": "AM-REQ-2026-01219",
    "original_inquiry": "Second opinion requested: 海外求诊：患者脑机接口，希望评估Wyss Center或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7861
  },
  {
    "request_id": "AM-REQ-2026-01220",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech decoding在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.531
  },
  {
    "request_id": "AM-REQ-2026-01221",
    "original_inquiry": "研究者咨询：海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Neuralink项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7205
  },
  {
    "request_id": "AM-REQ-2026-01222",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 运动皮层解码 or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5852
  },
  {
    "request_id": "AM-REQ-2026-01223",
    "original_inquiry": "Urgent: Family member with ALS, exploring BCI for ALS or Neuralink for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-01224",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解侵入式电极在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.559
  },
  {
    "request_id": "AM-REQ-2026-01225",
    "original_inquiry": "Urgent: Urgent: BCI for ALS diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7158
  },
  {
    "request_id": "AM-REQ-2026-01226",
    "original_inquiry": "海外求诊：研究者咨询：希望了解intracortical array在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8052
  },
  {
    "request_id": "AM-REQ-2026-01227",
    "original_inquiry": "Patient with 语音神经假体 seeking evaluation for Paradromics; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6193
  },
  {
    "request_id": "AM-REQ-2026-01228",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8328
  },
  {
    "request_id": "AM-REQ-2026-01229",
    "original_inquiry": "Urgent: Family member with ALS, exploring ECoG or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7489
  },
  {
    "request_id": "AM-REQ-2026-01230",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5044
  },
  {
    "request_id": "AM-REQ-2026-01231",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Wyss Center; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-01232",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6401
  },
  {
    "request_id": "AM-REQ-2026-01233",
    "original_inquiry": "研究者咨询：海外求诊：患者speech prosthesis，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.713
  },
  {
    "request_id": "AM-REQ-2026-01234",
    "original_inquiry": "Second opinion requested: Urgent: 侵入式电极 diagnosis, seeking centers offering Synchron Stentrode / BrainGate clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8773
  },
  {
    "request_id": "AM-REQ-2026-01235",
    "original_inquiry": "Family seeking information: Neurologist referral: locked-in syndrome candidate for Wyss Center; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5426
  },
  {
    "request_id": "AM-REQ-2026-01236",
    "original_inquiry": "海外求诊：海外求诊：患者intracortical array，希望评估Wyss Center或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6704
  },
  {
    "request_id": "AM-REQ-2026-01237",
    "original_inquiry": "Referral from specialist: Consultation request: brain-computer interface for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5205
  },
  {
    "request_id": "AM-REQ-2026-01238",
    "original_inquiry": "Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5167
  },
  {
    "request_id": "AM-REQ-2026-01239",
    "original_inquiry": "海外求诊：Neurologist referral: ECoG candidate for Paradromics; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5114
  },
  {
    "request_id": "AM-REQ-2026-01240",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7947
  },
  {
    "request_id": "AM-REQ-2026-01241",
    "original_inquiry": "Consultation request: speech prosthesis for Synchron Stentrode; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.874
  },
  {
    "request_id": "AM-REQ-2026-01242",
    "original_inquiry": "Family seeking information: Urgent: locked-in syndrome diagnosis, seeking centers offering Precision Neuroscience / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8052
  },
  {
    "request_id": "AM-REQ-2026-01243",
    "original_inquiry": "Referral from specialist: Patient with invasive cortical electrode seeking evaluation for Precision Neuroscience; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5637
  },
  {
    "request_id": "AM-REQ-2026-01244",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6367
  },
  {
    "request_id": "AM-REQ-2026-01245",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Paradromics; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8483
  },
  {
    "request_id": "AM-REQ-2026-01246",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8908
  },
  {
    "request_id": "AM-REQ-2026-01247",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估BrainGate或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7432
  },
  {
    "request_id": "AM-REQ-2026-01248",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8191
  },
  {
    "request_id": "AM-REQ-2026-01249",
    "original_inquiry": "Urgent: Consultation request: ECoG for Blackrock Neurotech; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7611
  },
  {
    "request_id": "AM-REQ-2026-01250",
    "original_inquiry": "Urgent: Family member with ALS, exploring 侵入式电极 or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8559
  },
  {
    "request_id": "AM-REQ-2026-01251",
    "original_inquiry": "Referral from specialist: Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.64
  },
  {
    "request_id": "AM-REQ-2026-01252",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6439
  },
  {
    "request_id": "AM-REQ-2026-01253",
    "original_inquiry": "海外求诊：Urgent: 运动皮层解码 diagnosis, seeking centers offering Wyss Center / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7056
  },
  {
    "request_id": "AM-REQ-2026-01254",
    "original_inquiry": "Referral from specialist: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Neuralink / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7421
  },
  {
    "request_id": "AM-REQ-2026-01255",
    "original_inquiry": "海外求诊：Urgent: neural decoding diagnosis, seeking centers offering Paradromics / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7194
  },
  {
    "request_id": "AM-REQ-2026-01256",
    "original_inquiry": "Urgent: 研究者咨询：希望了解neural decoding在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8937
  },
  {
    "request_id": "AM-REQ-2026-01257",
    "original_inquiry": "海外求诊：Consultation request: brain-computer interface for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6009
  },
  {
    "request_id": "AM-REQ-2026-01258",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring intracortical array or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-01259",
    "original_inquiry": "研究者咨询：Urgent: invasive cortical electrode diagnosis, seeking centers offering Synchron Stentrode / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6409
  },
  {
    "request_id": "AM-REQ-2026-01260",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5032
  },
  {
    "request_id": "AM-REQ-2026-01261",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech prosthesis or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.737
  },
  {
    "request_id": "AM-REQ-2026-01262",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech prosthesis在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7611
  },
  {
    "request_id": "AM-REQ-2026-01263",
    "original_inquiry": "Family seeking information: 海外求诊：患者ECoG，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6914
  },
  {
    "request_id": "AM-REQ-2026-01264",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解neural decoding在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6857
  },
  {
    "request_id": "AM-REQ-2026-01265",
    "original_inquiry": "Second opinion requested: 海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5848
  },
  {
    "request_id": "AM-REQ-2026-01266",
    "original_inquiry": "Family seeking information: Neurologist referral: invasive cortical electrode candidate for Paradromics; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-01267",
    "original_inquiry": "Neurologist referral: 运动皮层解码 candidate for Speech Neuroprosthesis; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7038
  },
  {
    "request_id": "AM-REQ-2026-01268",
    "original_inquiry": "Urgent: BCI for ALS diagnosis, seeking centers offering Neuralink / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6046
  },
  {
    "request_id": "AM-REQ-2026-01269",
    "original_inquiry": "Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6213
  },
  {
    "request_id": "AM-REQ-2026-01270",
    "original_inquiry": "海外求诊：Patient with speech decoding seeking evaluation for Neuralink; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.865
  },
  {
    "request_id": "AM-REQ-2026-01271",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Speech Neuroprosthesis for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5412
  },
  {
    "request_id": "AM-REQ-2026-01272",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8481
  },
  {
    "request_id": "AM-REQ-2026-01273",
    "original_inquiry": "海外求诊：Urgent: locked-in syndrome diagnosis, seeking centers offering Paradromics / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5803
  },
  {
    "request_id": "AM-REQ-2026-01274",
    "original_inquiry": "海外求诊：Consultation request: 运动皮层解码 for Paradromics; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7805
  },
  {
    "request_id": "AM-REQ-2026-01275",
    "original_inquiry": "Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7486
  },
  {
    "request_id": "AM-REQ-2026-01276",
    "original_inquiry": "海外求诊：研究者咨询：希望了解运动皮层解码在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5366
  },
  {
    "request_id": "AM-REQ-2026-01277",
    "original_inquiry": "Second opinion requested: Neurologist referral: 运动皮层解码 candidate for Precision Neuroscience; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5828
  },
  {
    "request_id": "AM-REQ-2026-01278",
    "original_inquiry": "Family member with ALS, exploring speech decoding or Neuralink for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7998
  },
  {
    "request_id": "AM-REQ-2026-01279",
    "original_inquiry": "Referral from specialist: Patient with BCI for ALS seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.664
  },
  {
    "request_id": "AM-REQ-2026-01280",
    "original_inquiry": "Urgent: Urgent: speech prosthesis diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5818
  },
  {
    "request_id": "AM-REQ-2026-01281",
    "original_inquiry": "Urgent: Neurologist referral: 脑机接口 candidate for Neuralink; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.724
  },
  {
    "request_id": "AM-REQ-2026-01282",
    "original_inquiry": "Urgent: Neurologist referral: brain-computer interface candidate for Speech Neuroprosthesis; request information on Neuralink eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5698
  },
  {
    "request_id": "AM-REQ-2026-01283",
    "original_inquiry": "Referral from specialist: Neurologist referral: neural decoding candidate for Precision Neuroscience; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6413
  },
  {
    "request_id": "AM-REQ-2026-01284",
    "original_inquiry": "研究者咨询：Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8684
  },
  {
    "request_id": "AM-REQ-2026-01285",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.609
  },
  {
    "request_id": "AM-REQ-2026-01286",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解neural decoding在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7705
  },
  {
    "request_id": "AM-REQ-2026-01287",
    "original_inquiry": "Urgent: 海外求诊：患者运动皮层解码，希望评估BrainGate或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.545
  },
  {
    "request_id": "AM-REQ-2026-01288",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6946
  },
  {
    "request_id": "AM-REQ-2026-01289",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6301
  },
  {
    "request_id": "AM-REQ-2026-01290",
    "original_inquiry": "Second opinion requested: Consultation request: 运动皮层解码 for Neuralink; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8962
  },
  {
    "request_id": "AM-REQ-2026-01291",
    "original_inquiry": "Consultation request: motor neuroprosthesis for Paradromics; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-01292",
    "original_inquiry": "Urgent: 运动皮层解码 diagnosis, seeking centers offering BrainGate / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.642
  },
  {
    "request_id": "AM-REQ-2026-01293",
    "original_inquiry": "Second opinion requested: 海外求诊：患者invasive cortical electrode，希望评估Precision Neuroscience或Paradromics项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7967
  },
  {
    "request_id": "AM-REQ-2026-01294",
    "original_inquiry": "研究者咨询：Urgent: brain-computer interface diagnosis, seeking centers offering Precision Neuroscience / Wyss Center clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5775
  },
  {
    "request_id": "AM-REQ-2026-01295",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for Precision Neuroscience; request information on BrainGate eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6044
  },
  {
    "request_id": "AM-REQ-2026-01296",
    "original_inquiry": "Urgent: Urgent: motor neuroprosthesis diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6094
  },
  {
    "request_id": "AM-REQ-2026-01297",
    "original_inquiry": "Second opinion requested: Patient with motor neuroprosthesis seeking evaluation for Neuralink; interested in Wyss Center trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8827
  },
  {
    "request_id": "AM-REQ-2026-01298",
    "original_inquiry": "Second opinion requested: Patient with BCI for ALS seeking evaluation for Synchron Stentrode; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8464
  },
  {
    "request_id": "AM-REQ-2026-01299",
    "original_inquiry": "研究者咨询：希望了解侵入式电极在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5705
  },
  {
    "request_id": "AM-REQ-2026-01300",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8651
  },
  {
    "request_id": "AM-REQ-2026-01301",
    "original_inquiry": "Referral from specialist: Urgent: speech decoding diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5661
  },
  {
    "request_id": "AM-REQ-2026-01302",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5102
  },
  {
    "request_id": "AM-REQ-2026-01303",
    "original_inquiry": "Urgent: 海外求诊：患者ECoG，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7981
  },
  {
    "request_id": "AM-REQ-2026-01304",
    "original_inquiry": "海外求诊：患者侵入式电极，希望评估BrainGate或Wyss Center项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.81
  },
  {
    "request_id": "AM-REQ-2026-01305",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring intracortical array or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8059
  },
  {
    "request_id": "AM-REQ-2026-01306",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring intracortical array or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8961
  },
  {
    "request_id": "AM-REQ-2026-01307",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8924
  },
  {
    "request_id": "AM-REQ-2026-01308",
    "original_inquiry": "研究者咨询：海外求诊：患者neural decoding，希望评估Wyss Center或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8079
  },
  {
    "request_id": "AM-REQ-2026-01309",
    "original_inquiry": "海外求诊：患者脑机接口，希望评估Blackrock Neurotech或Paradromics项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5628
  },
  {
    "request_id": "AM-REQ-2026-01310",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7414
  },
  {
    "request_id": "AM-REQ-2026-01311",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-01312",
    "original_inquiry": "Urgent: Family member with ALS, exploring ECoG or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8705
  },
  {
    "request_id": "AM-REQ-2026-01313",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-01314",
    "original_inquiry": "Family seeking information: Patient with invasive cortical electrode seeking evaluation for BrainGate; interested in Paradromics trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7717
  },
  {
    "request_id": "AM-REQ-2026-01315",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解侵入式电极在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7441
  },
  {
    "request_id": "AM-REQ-2026-01316",
    "original_inquiry": "海外求诊：海外求诊：患者运动皮层解码，希望评估Neuralink或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.868
  },
  {
    "request_id": "AM-REQ-2026-01317",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome seeking evaluation for Neuralink; interested in Blackrock Neurotech trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5229
  },
  {
    "request_id": "AM-REQ-2026-01318",
    "original_inquiry": "研究者咨询：海外求诊：患者speech prosthesis，希望评估Speech Neuroprosthesis或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5755
  },
  {
    "request_id": "AM-REQ-2026-01319",
    "original_inquiry": "Second opinion requested: 海外求诊：患者locked-in syndrome，希望评估Wyss Center或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7386
  },
  {
    "request_id": "AM-REQ-2026-01320",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 语音神经假体 or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7046
  },
  {
    "request_id": "AM-REQ-2026-01321",
    "original_inquiry": "Referral from specialist: Consultation request: 侵入式电极 for Neuralink; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.592
  },
  {
    "request_id": "AM-REQ-2026-01322",
    "original_inquiry": "海外求诊：Patient with invasive cortical electrode seeking evaluation for Wyss Center; interested in Speech Neuroprosthesis trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5587
  },
  {
    "request_id": "AM-REQ-2026-01323",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7223
  },
  {
    "request_id": "AM-REQ-2026-01324",
    "original_inquiry": "Urgent: Patient with 运动皮层解码 seeking evaluation for Neuralink; interested in Precision Neuroscience trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5672
  },
  {
    "request_id": "AM-REQ-2026-01325",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech decoding，希望评估Paradromics或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8438
  },
  {
    "request_id": "AM-REQ-2026-01326",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估Neuralink或Paradromics项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5136
  },
  {
    "request_id": "AM-REQ-2026-01327",
    "original_inquiry": "Neurologist referral: motor neuroprosthesis candidate for Blackrock Neurotech; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5848
  },
  {
    "request_id": "AM-REQ-2026-01328",
    "original_inquiry": "研究者咨询：Neurologist referral: 脑机接口 candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7519
  },
  {
    "request_id": "AM-REQ-2026-01329",
    "original_inquiry": "Urgent: Patient with 运动皮层解码 seeking evaluation for Neuralink; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5487
  },
  {
    "request_id": "AM-REQ-2026-01330",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 脑机接口 or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6139
  },
  {
    "request_id": "AM-REQ-2026-01331",
    "original_inquiry": "研究者咨询：Consultation request: brain-computer interface for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6829
  },
  {
    "request_id": "AM-REQ-2026-01332",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7349
  },
  {
    "request_id": "AM-REQ-2026-01333",
    "original_inquiry": "Urgent: neural decoding diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-01334",
    "original_inquiry": "Family member with ALS, exploring invasive cortical electrode or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5399
  },
  {
    "request_id": "AM-REQ-2026-01335",
    "original_inquiry": "Urgent: Consultation request: BCI for ALS for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5075
  },
  {
    "request_id": "AM-REQ-2026-01336",
    "original_inquiry": "Consultation request: neural decoding for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6592
  },
  {
    "request_id": "AM-REQ-2026-01337",
    "original_inquiry": "海外求诊：Family member with ALS, exploring invasive cortical electrode or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8551
  },
  {
    "request_id": "AM-REQ-2026-01338",
    "original_inquiry": "Referral from specialist: Consultation request: BCI for ALS for Synchron Stentrode; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.585
  },
  {
    "request_id": "AM-REQ-2026-01339",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-01340",
    "original_inquiry": "Family seeking information: Patient with 脑机接口 seeking evaluation for Synchron Stentrode; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6292
  },
  {
    "request_id": "AM-REQ-2026-01341",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Wyss Center或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-01342",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8531
  },
  {
    "request_id": "AM-REQ-2026-01343",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解speech decoding在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6804
  },
  {
    "request_id": "AM-REQ-2026-01344",
    "original_inquiry": "研究者咨询：Neurologist referral: invasive cortical electrode candidate for BrainGate; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7371
  },
  {
    "request_id": "AM-REQ-2026-01345",
    "original_inquiry": "海外求诊：海外求诊：患者speech decoding，希望评估Paradromics或Synchron Stentrode项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5796
  },
  {
    "request_id": "AM-REQ-2026-01346",
    "original_inquiry": "Family seeking information: Consultation request: brain-computer interface for Blackrock Neurotech; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8964
  },
  {
    "request_id": "AM-REQ-2026-01347",
    "original_inquiry": "Referral from specialist: Patient with 语音神经假体 seeking evaluation for BrainGate; interested in Wyss Center trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5804
  },
  {
    "request_id": "AM-REQ-2026-01348",
    "original_inquiry": "Consultation request: ECoG for BrainGate; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.583
  },
  {
    "request_id": "AM-REQ-2026-01349",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 脑机接口 or Precision Neuroscience for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8347
  },
  {
    "request_id": "AM-REQ-2026-01350",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.799
  },
  {
    "request_id": "AM-REQ-2026-01351",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring neural decoding or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7073
  },
  {
    "request_id": "AM-REQ-2026-01352",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech decoding在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8938
  },
  {
    "request_id": "AM-REQ-2026-01353",
    "original_inquiry": "Referral from specialist: Neurologist referral: BCI for ALS candidate for Paradromics; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7013
  },
  {
    "request_id": "AM-REQ-2026-01354",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6421
  },
  {
    "request_id": "AM-REQ-2026-01355",
    "original_inquiry": "Urgent: Consultation request: speech decoding for Paradromics; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7937
  },
  {
    "request_id": "AM-REQ-2026-01356",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5723
  },
  {
    "request_id": "AM-REQ-2026-01357",
    "original_inquiry": "Urgent: speech decoding diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6223
  },
  {
    "request_id": "AM-REQ-2026-01358",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6512
  },
  {
    "request_id": "AM-REQ-2026-01359",
    "original_inquiry": "Family seeking information: Neurologist referral: BCI for ALS candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6731
  },
  {
    "request_id": "AM-REQ-2026-01360",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解语音神经假体在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7578
  },
  {
    "request_id": "AM-REQ-2026-01361",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7296
  },
  {
    "request_id": "AM-REQ-2026-01362",
    "original_inquiry": "Urgent: Family member with ALS, exploring locked-in syndrome or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7764
  },
  {
    "request_id": "AM-REQ-2026-01363",
    "original_inquiry": "Second opinion requested: Patient with 语音神经假体 seeking evaluation for Neuralink; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5351
  },
  {
    "request_id": "AM-REQ-2026-01364",
    "original_inquiry": "研究者咨询：Neurologist referral: motor neuroprosthesis candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8683
  },
  {
    "request_id": "AM-REQ-2026-01365",
    "original_inquiry": "Second opinion requested: 海外求诊：患者语音神经假体，希望评估Precision Neuroscience或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5042
  },
  {
    "request_id": "AM-REQ-2026-01366",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Synchron Stentrode或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7582
  },
  {
    "request_id": "AM-REQ-2026-01367",
    "original_inquiry": "Second opinion requested: 海外求诊：患者invasive cortical electrode，希望评估Synchron Stentrode或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.835
  },
  {
    "request_id": "AM-REQ-2026-01368",
    "original_inquiry": "Urgent: Neurologist referral: motor neuroprosthesis candidate for Speech Neuroprosthesis; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8175
  },
  {
    "request_id": "AM-REQ-2026-01369",
    "original_inquiry": "Urgent: Family member with ALS, exploring speech prosthesis or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7031
  },
  {
    "request_id": "AM-REQ-2026-01370",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7337
  },
  {
    "request_id": "AM-REQ-2026-01371",
    "original_inquiry": "研究者咨询：希望了解motor neuroprosthesis在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7258
  },
  {
    "request_id": "AM-REQ-2026-01372",
    "original_inquiry": "Second opinion requested: Consultation request: BCI for ALS for BrainGate; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8078
  },
  {
    "request_id": "AM-REQ-2026-01373",
    "original_inquiry": "Consultation request: 语音神经假体 for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8648
  },
  {
    "request_id": "AM-REQ-2026-01374",
    "original_inquiry": "Urgent: 研究者咨询：希望了解脑机接口在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8715
  },
  {
    "request_id": "AM-REQ-2026-01375",
    "original_inquiry": "Urgent: 研究者咨询：希望了解intracortical array在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8308
  },
  {
    "request_id": "AM-REQ-2026-01376",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解ECoG在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6543
  },
  {
    "request_id": "AM-REQ-2026-01377",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解intracortical array在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6097
  },
  {
    "request_id": "AM-REQ-2026-01378",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-01379",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech decoding在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6781
  },
  {
    "request_id": "AM-REQ-2026-01380",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in Wyss Center trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5244
  },
  {
    "request_id": "AM-REQ-2026-01381",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8676
  },
  {
    "request_id": "AM-REQ-2026-01382",
    "original_inquiry": "海外求诊：Patient with neural decoding seeking evaluation for Synchron Stentrode; interested in Paradromics trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5221
  },
  {
    "request_id": "AM-REQ-2026-01383",
    "original_inquiry": "研究者咨询：海外求诊：患者neural decoding，希望评估Speech Neuroprosthesis或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5645
  },
  {
    "request_id": "AM-REQ-2026-01384",
    "original_inquiry": "Urgent: 研究者咨询：希望了解locked-in syndrome在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7977
  },
  {
    "request_id": "AM-REQ-2026-01385",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.879
  },
  {
    "request_id": "AM-REQ-2026-01386",
    "original_inquiry": "Referral from specialist: Urgent: 侵入式电极 diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7438
  },
  {
    "request_id": "AM-REQ-2026-01387",
    "original_inquiry": "Urgent: Urgent: brain-computer interface diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5882
  },
  {
    "request_id": "AM-REQ-2026-01388",
    "original_inquiry": "研究者咨询：Consultation request: ECoG for Blackrock Neurotech; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8315
  },
  {
    "request_id": "AM-REQ-2026-01389",
    "original_inquiry": "海外求诊：Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8472
  },
  {
    "request_id": "AM-REQ-2026-01390",
    "original_inquiry": "Second opinion requested: Consultation request: BCI for ALS for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6277
  },
  {
    "request_id": "AM-REQ-2026-01391",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.537
  },
  {
    "request_id": "AM-REQ-2026-01392",
    "original_inquiry": "Second opinion requested: Neurologist referral: ECoG candidate for Blackrock Neurotech; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7596
  },
  {
    "request_id": "AM-REQ-2026-01393",
    "original_inquiry": "Urgent: brain-computer interface diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-01394",
    "original_inquiry": "研究者咨询：Neurologist referral: brain-computer interface candidate for Paradromics; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6596
  },
  {
    "request_id": "AM-REQ-2026-01395",
    "original_inquiry": "Family seeking information: 海外求诊：患者脑机接口，希望评估Speech Neuroprosthesis或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5187
  },
  {
    "request_id": "AM-REQ-2026-01396",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-01397",
    "original_inquiry": "海外求诊：患者BCI for ALS，希望评估Precision Neuroscience或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7678
  },
  {
    "request_id": "AM-REQ-2026-01398",
    "original_inquiry": "Referral from specialist: Neurologist referral: 运动皮层解码 candidate for BrainGate; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7358
  },
  {
    "request_id": "AM-REQ-2026-01399",
    "original_inquiry": "Urgent: invasive cortical electrode diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7187
  },
  {
    "request_id": "AM-REQ-2026-01400",
    "original_inquiry": "Second opinion requested: Consultation request: locked-in syndrome for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5766
  },
  {
    "request_id": "AM-REQ-2026-01401",
    "original_inquiry": "Urgent: 海外求诊：患者ECoG，希望评估Paradromics或Synchron Stentrode项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5675
  },
  {
    "request_id": "AM-REQ-2026-01402",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解脑机接口在Synchron Stentrode适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5513
  },
  {
    "request_id": "AM-REQ-2026-01403",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解语音神经假体在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8871
  },
  {
    "request_id": "AM-REQ-2026-01404",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解运动皮层解码在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.528
  },
  {
    "request_id": "AM-REQ-2026-01405",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7811
  },
  {
    "request_id": "AM-REQ-2026-01406",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring intracortical array or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.557
  },
  {
    "request_id": "AM-REQ-2026-01407",
    "original_inquiry": "Referral from specialist: Consultation request: 脑机接口 for Wyss Center; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7848
  },
  {
    "request_id": "AM-REQ-2026-01408",
    "original_inquiry": "Neurologist referral: invasive cortical electrode candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7995
  },
  {
    "request_id": "AM-REQ-2026-01409",
    "original_inquiry": "研究者咨询：海外求诊：患者brain-computer interface，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.672
  },
  {
    "request_id": "AM-REQ-2026-01410",
    "original_inquiry": "Referral from specialist: Neurologist referral: neural decoding candidate for Neuralink; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5617
  },
  {
    "request_id": "AM-REQ-2026-01411",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解运动皮层解码在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8591
  },
  {
    "request_id": "AM-REQ-2026-01412",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring neural decoding or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6352
  },
  {
    "request_id": "AM-REQ-2026-01413",
    "original_inquiry": "Family member with ALS, exploring intracortical array or Wyss Center for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5856
  },
  {
    "request_id": "AM-REQ-2026-01414",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome seeking evaluation for Synchron Stentrode; interested in Wyss Center trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5269
  },
  {
    "request_id": "AM-REQ-2026-01415",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 运动皮层解码 or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7429
  },
  {
    "request_id": "AM-REQ-2026-01416",
    "original_inquiry": "研究者咨询：海外求诊：患者invasive cortical electrode，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8238
  },
  {
    "request_id": "AM-REQ-2026-01417",
    "original_inquiry": "Urgent: Family member with ALS, exploring locked-in syndrome or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7568
  },
  {
    "request_id": "AM-REQ-2026-01418",
    "original_inquiry": "Second opinion requested: Neurologist referral: locked-in syndrome candidate for Precision Neuroscience; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5641
  },
  {
    "request_id": "AM-REQ-2026-01419",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5733
  },
  {
    "request_id": "AM-REQ-2026-01420",
    "original_inquiry": "Second opinion requested: 海外求诊：患者motor neuroprosthesis，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.822
  },
  {
    "request_id": "AM-REQ-2026-01421",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6142
  },
  {
    "request_id": "AM-REQ-2026-01422",
    "original_inquiry": "Neurologist referral: 运动皮层解码 candidate for Blackrock Neurotech; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7584
  },
  {
    "request_id": "AM-REQ-2026-01423",
    "original_inquiry": "Urgent: Consultation request: locked-in syndrome for Neuralink; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5686
  },
  {
    "request_id": "AM-REQ-2026-01424",
    "original_inquiry": "海外求诊：海外求诊：患者speech prosthesis，希望评估Neuralink或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8537
  },
  {
    "request_id": "AM-REQ-2026-01425",
    "original_inquiry": "Family seeking information: Patient with invasive cortical electrode seeking evaluation for Blackrock Neurotech; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6069
  },
  {
    "request_id": "AM-REQ-2026-01426",
    "original_inquiry": "Referral from specialist: Urgent: speech decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Paradromics clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6677
  },
  {
    "request_id": "AM-REQ-2026-01427",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5942
  },
  {
    "request_id": "AM-REQ-2026-01428",
    "original_inquiry": "Referral from specialist: Consultation request: 侵入式电极 for Blackrock Neurotech; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-01429",
    "original_inquiry": "海外求诊：Patient with brain-computer interface seeking evaluation for BrainGate; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5601
  },
  {
    "request_id": "AM-REQ-2026-01430",
    "original_inquiry": "研究者咨询：希望了解locked-in syndrome在Precision Neuroscience适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5676
  },
  {
    "request_id": "AM-REQ-2026-01431",
    "original_inquiry": "研究者咨询：Urgent: speech prosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5593
  },
  {
    "request_id": "AM-REQ-2026-01432",
    "original_inquiry": "Neurologist referral: 语音神经假体 candidate for Paradromics; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7254
  },
  {
    "request_id": "AM-REQ-2026-01433",
    "original_inquiry": "Family seeking information: Consultation request: speech prosthesis for Wyss Center; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5112
  },
  {
    "request_id": "AM-REQ-2026-01434",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Neuralink / BrainGate clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.622
  },
  {
    "request_id": "AM-REQ-2026-01435",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解运动皮层解码在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8655
  },
  {
    "request_id": "AM-REQ-2026-01436",
    "original_inquiry": "研究者咨询：Urgent: locked-in syndrome diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8795
  },
  {
    "request_id": "AM-REQ-2026-01437",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Neuralink; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7785
  },
  {
    "request_id": "AM-REQ-2026-01438",
    "original_inquiry": "Referral from specialist: 海外求诊：患者neural decoding，希望评估Wyss Center或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7028
  },
  {
    "request_id": "AM-REQ-2026-01439",
    "original_inquiry": "Second opinion requested: Neurologist referral: invasive cortical electrode candidate for Precision Neuroscience; request information on Neuralink eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7473
  },
  {
    "request_id": "AM-REQ-2026-01440",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Paradromics; interested in Wyss Center trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.542
  },
  {
    "request_id": "AM-REQ-2026-01441",
    "original_inquiry": "海外求诊：Neurologist referral: ECoG candidate for Precision Neuroscience; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5174
  },
  {
    "request_id": "AM-REQ-2026-01442",
    "original_inquiry": "Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6028
  },
  {
    "request_id": "AM-REQ-2026-01443",
    "original_inquiry": "Urgent: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6602
  },
  {
    "request_id": "AM-REQ-2026-01444",
    "original_inquiry": "Consultation request: speech decoding for Synchron Stentrode; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5998
  },
  {
    "request_id": "AM-REQ-2026-01445",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech decoding，希望评估Neuralink或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7837
  },
  {
    "request_id": "AM-REQ-2026-01446",
    "original_inquiry": "Family seeking information: Neurologist referral: intracortical array candidate for BrainGate; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5547
  },
  {
    "request_id": "AM-REQ-2026-01447",
    "original_inquiry": "Referral from specialist: 海外求诊：患者speech decoding，希望评估Precision Neuroscience或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5175
  },
  {
    "request_id": "AM-REQ-2026-01448",
    "original_inquiry": "研究者咨询：希望了解运动皮层解码在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7181
  },
  {
    "request_id": "AM-REQ-2026-01449",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8867
  },
  {
    "request_id": "AM-REQ-2026-01450",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5381
  },
  {
    "request_id": "AM-REQ-2026-01451",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6522
  },
  {
    "request_id": "AM-REQ-2026-01452",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6384
  },
  {
    "request_id": "AM-REQ-2026-01453",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring BCI for ALS or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8968
  },
  {
    "request_id": "AM-REQ-2026-01454",
    "original_inquiry": "Urgent: 研究者咨询：希望了解brain-computer interface在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8973
  },
  {
    "request_id": "AM-REQ-2026-01455",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解brain-computer interface在Precision Neuroscience适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5802
  },
  {
    "request_id": "AM-REQ-2026-01456",
    "original_inquiry": "研究者咨询：希望了解ECoG在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7632
  },
  {
    "request_id": "AM-REQ-2026-01457",
    "original_inquiry": "Urgent: brain-computer interface diagnosis, seeking centers offering Blackrock Neurotech / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7917
  },
  {
    "request_id": "AM-REQ-2026-01458",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解运动皮层解码在Synchron Stentrode适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-01459",
    "original_inquiry": "海外求诊：研究者咨询：希望了解intracortical array在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7496
  },
  {
    "request_id": "AM-REQ-2026-01460",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7396
  },
  {
    "request_id": "AM-REQ-2026-01461",
    "original_inquiry": "研究者咨询：希望了解语音神经假体在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8064
  },
  {
    "request_id": "AM-REQ-2026-01462",
    "original_inquiry": "Second opinion requested: Patient with intracortical array seeking evaluation for Synchron Stentrode; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7855
  },
  {
    "request_id": "AM-REQ-2026-01463",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring ECoG or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7783
  },
  {
    "request_id": "AM-REQ-2026-01464",
    "original_inquiry": "Referral from specialist: 海外求诊：患者speech prosthesis，希望评估Synchron Stentrode或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7733
  },
  {
    "request_id": "AM-REQ-2026-01465",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring speech prosthesis or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7634
  },
  {
    "request_id": "AM-REQ-2026-01466",
    "original_inquiry": "Family seeking information: 海外求诊：患者intracortical array，希望评估Neuralink或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8242
  },
  {
    "request_id": "AM-REQ-2026-01467",
    "original_inquiry": "海外求诊：Consultation request: intracortical array for Precision Neuroscience; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6246
  },
  {
    "request_id": "AM-REQ-2026-01468",
    "original_inquiry": "Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7548
  },
  {
    "request_id": "AM-REQ-2026-01469",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8188
  },
  {
    "request_id": "AM-REQ-2026-01470",
    "original_inquiry": "Second opinion requested: Patient with 脑机接口 seeking evaluation for Synchron Stentrode; interested in BrainGate trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.616
  },
  {
    "request_id": "AM-REQ-2026-01471",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8362
  },
  {
    "request_id": "AM-REQ-2026-01472",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6462
  },
  {
    "request_id": "AM-REQ-2026-01473",
    "original_inquiry": "研究者咨询：Neurologist referral: 运动皮层解码 candidate for Synchron Stentrode; request information on Paradromics eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7688
  },
  {
    "request_id": "AM-REQ-2026-01474",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech prosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6422
  },
  {
    "request_id": "AM-REQ-2026-01475",
    "original_inquiry": "海外求诊：海外求诊：患者invasive cortical electrode，希望评估Paradromics或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6006
  },
  {
    "request_id": "AM-REQ-2026-01476",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8886
  },
  {
    "request_id": "AM-REQ-2026-01477",
    "original_inquiry": "Urgent: Consultation request: 脑机接口 for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.668
  },
  {
    "request_id": "AM-REQ-2026-01478",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8564
  },
  {
    "request_id": "AM-REQ-2026-01479",
    "original_inquiry": "海外求诊：研究者咨询：希望了解BCI for ALS在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5771
  },
  {
    "request_id": "AM-REQ-2026-01480",
    "original_inquiry": "Family seeking information: Urgent: speech decoding diagnosis, seeking centers offering Paradromics / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5049
  },
  {
    "request_id": "AM-REQ-2026-01481",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.596
  },
  {
    "request_id": "AM-REQ-2026-01482",
    "original_inquiry": "Second opinion requested: Urgent: intracortical array diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6739
  },
  {
    "request_id": "AM-REQ-2026-01483",
    "original_inquiry": "Second opinion requested: Urgent: 语音神经假体 diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5168
  },
  {
    "request_id": "AM-REQ-2026-01484",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解invasive cortical electrode在Blackrock Neurotech适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7964
  },
  {
    "request_id": "AM-REQ-2026-01485",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解locked-in syndrome在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5825
  },
  {
    "request_id": "AM-REQ-2026-01486",
    "original_inquiry": "Referral from specialist: 海外求诊：患者neural decoding，希望评估Neuralink或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8189
  },
  {
    "request_id": "AM-REQ-2026-01487",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Neuralink / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6093
  },
  {
    "request_id": "AM-REQ-2026-01488",
    "original_inquiry": "Urgent: Neurologist referral: invasive cortical electrode candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6886
  },
  {
    "request_id": "AM-REQ-2026-01489",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for BrainGate; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6665
  },
  {
    "request_id": "AM-REQ-2026-01490",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解motor neuroprosthesis在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6345
  },
  {
    "request_id": "AM-REQ-2026-01491",
    "original_inquiry": "Family seeking information: Urgent: 语音神经假体 diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7058
  },
  {
    "request_id": "AM-REQ-2026-01492",
    "original_inquiry": "Referral from specialist: 海外求诊：患者motor neuroprosthesis，希望评估Paradromics或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7231
  },
  {
    "request_id": "AM-REQ-2026-01493",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring neural decoding or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.57
  },
  {
    "request_id": "AM-REQ-2026-01494",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 脑机接口 or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.569
  },
  {
    "request_id": "AM-REQ-2026-01495",
    "original_inquiry": "Referral from specialist: Urgent: locked-in syndrome diagnosis, seeking centers offering Blackrock Neurotech / Neuralink clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7557
  },
  {
    "request_id": "AM-REQ-2026-01496",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech decoding在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6017
  },
  {
    "request_id": "AM-REQ-2026-01497",
    "original_inquiry": "海外求诊：海外求诊：患者脑机接口，希望评估Blackrock Neurotech或BrainGate项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8393
  },
  {
    "request_id": "AM-REQ-2026-01498",
    "original_inquiry": "Urgent: 海外求诊：患者BCI for ALS，希望评估Paradromics或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6763
  },
  {
    "request_id": "AM-REQ-2026-01499",
    "original_inquiry": "海外求诊：Consultation request: locked-in syndrome for BrainGate; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8142
  },
  {
    "request_id": "AM-REQ-2026-01500",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8208
  },
  {
    "request_id": "AM-REQ-2026-01501",
    "original_inquiry": "研究者咨询：Consultation request: neural decoding for Blackrock Neurotech; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5414
  },
  {
    "request_id": "AM-REQ-2026-01502",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-01503",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring locked-in syndrome or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5262
  },
  {
    "request_id": "AM-REQ-2026-01504",
    "original_inquiry": "Family seeking information: Neurologist referral: 侵入式电极 candidate for Paradromics; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6423
  },
  {
    "request_id": "AM-REQ-2026-01505",
    "original_inquiry": "Second opinion requested: Urgent: 运动皮层解码 diagnosis, seeking centers offering Speech Neuroprosthesis / Paradromics clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5324
  },
  {
    "request_id": "AM-REQ-2026-01506",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7531
  },
  {
    "request_id": "AM-REQ-2026-01507",
    "original_inquiry": "研究者咨询：海外求诊：患者brain-computer interface，希望评估Wyss Center或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7467
  },
  {
    "request_id": "AM-REQ-2026-01508",
    "original_inquiry": "海外求诊：Urgent: 运动皮层解码 diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6238
  },
  {
    "request_id": "AM-REQ-2026-01509",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解语音神经假体在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8941
  },
  {
    "request_id": "AM-REQ-2026-01510",
    "original_inquiry": "Urgent: 海外求诊：患者ECoG，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6155
  },
  {
    "request_id": "AM-REQ-2026-01511",
    "original_inquiry": "研究者咨询：Neurologist referral: neural decoding candidate for Speech Neuroprosthesis; request information on Paradromics eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7907
  },
  {
    "request_id": "AM-REQ-2026-01512",
    "original_inquiry": "海外求诊：Family member with ALS, exploring neural decoding or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5692
  },
  {
    "request_id": "AM-REQ-2026-01513",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech prosthesis在Synchron Stentrode适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8682
  },
  {
    "request_id": "AM-REQ-2026-01514",
    "original_inquiry": "Urgent: brain-computer interface diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5304
  },
  {
    "request_id": "AM-REQ-2026-01515",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6947
  },
  {
    "request_id": "AM-REQ-2026-01516",
    "original_inquiry": "研究者咨询：Neurologist referral: 脑机接口 candidate for Paradromics; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6347
  },
  {
    "request_id": "AM-REQ-2026-01517",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Paradromics; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6209
  },
  {
    "request_id": "AM-REQ-2026-01518",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring invasive cortical electrode or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8428
  },
  {
    "request_id": "AM-REQ-2026-01519",
    "original_inquiry": "Family seeking information: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Synchron Stentrode / Wyss Center clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6566
  },
  {
    "request_id": "AM-REQ-2026-01520",
    "original_inquiry": "Referral from specialist: Patient with ECoG seeking evaluation for Neuralink; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5441
  },
  {
    "request_id": "AM-REQ-2026-01521",
    "original_inquiry": "Family seeking information: Neurologist referral: invasive cortical electrode candidate for Precision Neuroscience; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6526
  },
  {
    "request_id": "AM-REQ-2026-01522",
    "original_inquiry": "Urgent: Urgent: 侵入式电极 diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7173
  },
  {
    "request_id": "AM-REQ-2026-01523",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解speech prosthesis在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6494
  },
  {
    "request_id": "AM-REQ-2026-01524",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5452
  },
  {
    "request_id": "AM-REQ-2026-01525",
    "original_inquiry": "海外求诊：海外求诊：患者BCI for ALS，希望评估Paradromics或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7258
  },
  {
    "request_id": "AM-REQ-2026-01526",
    "original_inquiry": "Family seeking information: Urgent: 运动皮层解码 diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7261
  },
  {
    "request_id": "AM-REQ-2026-01527",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8028
  },
  {
    "request_id": "AM-REQ-2026-01528",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring intracortical array or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.561
  },
  {
    "request_id": "AM-REQ-2026-01529",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8516
  },
  {
    "request_id": "AM-REQ-2026-01530",
    "original_inquiry": "Second opinion requested: Consultation request: 语音神经假体 for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6155
  },
  {
    "request_id": "AM-REQ-2026-01531",
    "original_inquiry": "Second opinion requested: Neurologist referral: 侵入式电极 candidate for Wyss Center; request information on Neuralink eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7341
  },
  {
    "request_id": "AM-REQ-2026-01532",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome seeking evaluation for BrainGate; interested in Wyss Center trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-01533",
    "original_inquiry": "Urgent: Consultation request: locked-in syndrome for Wyss Center; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8892
  },
  {
    "request_id": "AM-REQ-2026-01534",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估BrainGate或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-01535",
    "original_inquiry": "海外求诊：海外求诊：患者brain-computer interface，希望评估Blackrock Neurotech或Neuralink项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7582
  },
  {
    "request_id": "AM-REQ-2026-01536",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring intracortical array or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7679
  },
  {
    "request_id": "AM-REQ-2026-01537",
    "original_inquiry": "Referral from specialist: Neurologist referral: motor neuroprosthesis candidate for Precision Neuroscience; request information on Neuralink eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8747
  },
  {
    "request_id": "AM-REQ-2026-01538",
    "original_inquiry": "研究者咨询：Neurologist referral: BCI for ALS candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6424
  },
  {
    "request_id": "AM-REQ-2026-01539",
    "original_inquiry": "研究者咨询：Neurologist referral: 运动皮层解码 candidate for Wyss Center; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8403
  },
  {
    "request_id": "AM-REQ-2026-01540",
    "original_inquiry": "Neurologist referral: speech decoding candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.547
  },
  {
    "request_id": "AM-REQ-2026-01541",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解BCI for ALS在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6468
  },
  {
    "request_id": "AM-REQ-2026-01542",
    "original_inquiry": "Urgent: Urgent: speech prosthesis diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-01543",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7428
  },
  {
    "request_id": "AM-REQ-2026-01544",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5376
  },
  {
    "request_id": "AM-REQ-2026-01545",
    "original_inquiry": "Referral from specialist: Urgent: speech prosthesis diagnosis, seeking centers offering BrainGate / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8216
  },
  {
    "request_id": "AM-REQ-2026-01546",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech decoding在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5632
  },
  {
    "request_id": "AM-REQ-2026-01547",
    "original_inquiry": "Urgent: Consultation request: speech prosthesis for Speech Neuroprosthesis; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5693
  },
  {
    "request_id": "AM-REQ-2026-01548",
    "original_inquiry": "Referral from specialist: 海外求诊：患者BCI for ALS，希望评估Neuralink或Synchron Stentrode项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.801
  },
  {
    "request_id": "AM-REQ-2026-01549",
    "original_inquiry": "Urgent: BCI for ALS diagnosis, seeking centers offering Paradromics / Precision Neuroscience clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6376
  },
  {
    "request_id": "AM-REQ-2026-01550",
    "original_inquiry": "海外求诊：Neurologist referral: locked-in syndrome candidate for Speech Neuroprosthesis; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6249
  },
  {
    "request_id": "AM-REQ-2026-01551",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Speech Neuroprosthesis或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5693
  },
  {
    "request_id": "AM-REQ-2026-01552",
    "original_inquiry": "Family seeking information: Patient with 语音神经假体 seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7823
  },
  {
    "request_id": "AM-REQ-2026-01553",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring locked-in syndrome or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6751
  },
  {
    "request_id": "AM-REQ-2026-01554",
    "original_inquiry": "Urgent: Urgent: speech decoding diagnosis, seeking centers offering Synchron Stentrode / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8741
  },
  {
    "request_id": "AM-REQ-2026-01555",
    "original_inquiry": "Urgent: Patient with 侵入式电极 seeking evaluation for BrainGate; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5612
  },
  {
    "request_id": "AM-REQ-2026-01556",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or Speech Neuroprosthesis for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-01557",
    "original_inquiry": "海外求诊：海外求诊：患者brain-computer interface，希望评估BrainGate或Precision Neuroscience项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6715
  },
  {
    "request_id": "AM-REQ-2026-01558",
    "original_inquiry": "Neurologist referral: 脑机接口 candidate for BrainGate; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6349
  },
  {
    "request_id": "AM-REQ-2026-01559",
    "original_inquiry": "Second opinion requested: Urgent: brain-computer interface diagnosis, seeking centers offering Synchron Stentrode / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8766
  },
  {
    "request_id": "AM-REQ-2026-01560",
    "original_inquiry": "研究者咨询：海外求诊：患者intracortical array，希望评估Wyss Center或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7051
  },
  {
    "request_id": "AM-REQ-2026-01561",
    "original_inquiry": "Referral from specialist: Consultation request: intracortical array for Wyss Center; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8799
  },
  {
    "request_id": "AM-REQ-2026-01562",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-01563",
    "original_inquiry": "研究者咨询：海外求诊：患者ECoG，希望评估Precision Neuroscience或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8206
  },
  {
    "request_id": "AM-REQ-2026-01564",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8547
  },
  {
    "request_id": "AM-REQ-2026-01565",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解motor neuroprosthesis在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8424
  },
  {
    "request_id": "AM-REQ-2026-01566",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6428
  },
  {
    "request_id": "AM-REQ-2026-01567",
    "original_inquiry": "Family seeking information: Consultation request: brain-computer interface for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6277
  },
  {
    "request_id": "AM-REQ-2026-01568",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring neural decoding or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5188
  },
  {
    "request_id": "AM-REQ-2026-01569",
    "original_inquiry": "海外求诊：海外求诊：患者motor neuroprosthesis，希望评估Synchron Stentrode或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5407
  },
  {
    "request_id": "AM-REQ-2026-01570",
    "original_inquiry": "Patient with 语音神经假体 seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6563
  },
  {
    "request_id": "AM-REQ-2026-01571",
    "original_inquiry": "海外求诊：Urgent: brain-computer interface diagnosis, seeking centers offering Wyss Center / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7903
  },
  {
    "request_id": "AM-REQ-2026-01572",
    "original_inquiry": "Urgent: Consultation request: locked-in syndrome for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8952
  },
  {
    "request_id": "AM-REQ-2026-01573",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Precision Neuroscience / Paradromics clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8274
  },
  {
    "request_id": "AM-REQ-2026-01574",
    "original_inquiry": "海外求诊：研究者咨询：希望了解locked-in syndrome在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5816
  },
  {
    "request_id": "AM-REQ-2026-01575",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Paradromics trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6458
  },
  {
    "request_id": "AM-REQ-2026-01576",
    "original_inquiry": "Neurologist referral: 运动皮层解码 candidate for BrainGate; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8948
  },
  {
    "request_id": "AM-REQ-2026-01577",
    "original_inquiry": "研究者咨询：Neurologist referral: invasive cortical electrode candidate for Synchron Stentrode; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8724
  },
  {
    "request_id": "AM-REQ-2026-01578",
    "original_inquiry": "海外求诊：研究者咨询：希望了解brain-computer interface在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8849
  },
  {
    "request_id": "AM-REQ-2026-01579",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5819
  },
  {
    "request_id": "AM-REQ-2026-01580",
    "original_inquiry": "海外求诊：海外求诊：患者侵入式电极，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8576
  },
  {
    "request_id": "AM-REQ-2026-01581",
    "original_inquiry": "Urgent: Neurologist referral: locked-in syndrome candidate for Blackrock Neurotech; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7085
  },
  {
    "request_id": "AM-REQ-2026-01582",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5041
  },
  {
    "request_id": "AM-REQ-2026-01583",
    "original_inquiry": "Second opinion requested: Urgent: ECoG diagnosis, seeking centers offering Neuralink / Wyss Center clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6097
  },
  {
    "request_id": "AM-REQ-2026-01584",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6428
  },
  {
    "request_id": "AM-REQ-2026-01585",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.579
  },
  {
    "request_id": "AM-REQ-2026-01586",
    "original_inquiry": "Family seeking information: Consultation request: 脑机接口 for BrainGate; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6908
  },
  {
    "request_id": "AM-REQ-2026-01587",
    "original_inquiry": "Urgent: Neurologist referral: BCI for ALS candidate for Paradromics; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5783
  },
  {
    "request_id": "AM-REQ-2026-01588",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 语音神经假体 or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8402
  },
  {
    "request_id": "AM-REQ-2026-01589",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5791
  },
  {
    "request_id": "AM-REQ-2026-01590",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解neural decoding在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6766
  },
  {
    "request_id": "AM-REQ-2026-01591",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8698
  },
  {
    "request_id": "AM-REQ-2026-01592",
    "original_inquiry": "研究者咨询：Urgent: 语音神经假体 diagnosis, seeking centers offering Neuralink / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-01593",
    "original_inquiry": "Family seeking information: Consultation request: motor neuroprosthesis for Precision Neuroscience; interested in Paradromics and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7761
  },
  {
    "request_id": "AM-REQ-2026-01594",
    "original_inquiry": "Family member with ALS, exploring speech decoding or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8393
  },
  {
    "request_id": "AM-REQ-2026-01595",
    "original_inquiry": "Second opinion requested: Urgent: neural decoding diagnosis, seeking centers offering BrainGate / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7196
  },
  {
    "request_id": "AM-REQ-2026-01596",
    "original_inquiry": "海外求诊：研究者咨询：希望了解locked-in syndrome在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7786
  },
  {
    "request_id": "AM-REQ-2026-01597",
    "original_inquiry": "Referral from specialist: Urgent: brain-computer interface diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6955
  },
  {
    "request_id": "AM-REQ-2026-01598",
    "original_inquiry": "Neurologist referral: 运动皮层解码 candidate for Neuralink; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7077
  },
  {
    "request_id": "AM-REQ-2026-01599",
    "original_inquiry": "Consultation request: 运动皮层解码 for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.561
  },
  {
    "request_id": "AM-REQ-2026-01600",
    "original_inquiry": "Urgent: Neurologist referral: motor neuroprosthesis candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8109
  },
  {
    "request_id": "AM-REQ-2026-01601",
    "original_inquiry": "研究者咨询：Patient with 语音神经假体 seeking evaluation for Neuralink; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5662
  },
  {
    "request_id": "AM-REQ-2026-01602",
    "original_inquiry": "Urgent: Consultation request: 侵入式电极 for Wyss Center; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7316
  },
  {
    "request_id": "AM-REQ-2026-01603",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.612
  },
  {
    "request_id": "AM-REQ-2026-01604",
    "original_inquiry": "研究者咨询：Consultation request: speech prosthesis for BrainGate; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8337
  },
  {
    "request_id": "AM-REQ-2026-01605",
    "original_inquiry": "海外求诊：Family member with ALS, exploring speech decoding or Neuralink for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6459
  },
  {
    "request_id": "AM-REQ-2026-01606",
    "original_inquiry": "海外求诊：患者brain-computer interface，希望评估Neuralink或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5283
  },
  {
    "request_id": "AM-REQ-2026-01607",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6764
  },
  {
    "request_id": "AM-REQ-2026-01608",
    "original_inquiry": "研究者咨询：海外求诊：患者运动皮层解码，希望评估Blackrock Neurotech或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8526
  },
  {
    "request_id": "AM-REQ-2026-01609",
    "original_inquiry": "Family member with ALS, exploring speech decoding or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5669
  },
  {
    "request_id": "AM-REQ-2026-01610",
    "original_inquiry": "Family seeking information: Patient with 脑机接口 seeking evaluation for Blackrock Neurotech; interested in Synchron Stentrode trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5205
  },
  {
    "request_id": "AM-REQ-2026-01611",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解neural decoding在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8616
  },
  {
    "request_id": "AM-REQ-2026-01612",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解speech prosthesis在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6392
  },
  {
    "request_id": "AM-REQ-2026-01613",
    "original_inquiry": "研究者咨询：Urgent: speech prosthesis diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6201
  },
  {
    "request_id": "AM-REQ-2026-01614",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5397
  },
  {
    "request_id": "AM-REQ-2026-01615",
    "original_inquiry": "Referral from specialist: Consultation request: 脑机接口 for BrainGate; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6794
  },
  {
    "request_id": "AM-REQ-2026-01616",
    "original_inquiry": "Urgent: 海外求诊：患者脑机接口，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5316
  },
  {
    "request_id": "AM-REQ-2026-01617",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解invasive cortical electrode在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.784
  },
  {
    "request_id": "AM-REQ-2026-01618",
    "original_inquiry": "Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.528
  },
  {
    "request_id": "AM-REQ-2026-01619",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6263
  },
  {
    "request_id": "AM-REQ-2026-01620",
    "original_inquiry": "Urgent: Neurologist referral: speech prosthesis candidate for BrainGate; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7574
  },
  {
    "request_id": "AM-REQ-2026-01621",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring neural decoding or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5539
  },
  {
    "request_id": "AM-REQ-2026-01622",
    "original_inquiry": "研究者咨询：海外求诊：患者运动皮层解码，希望评估BrainGate或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6903
  },
  {
    "request_id": "AM-REQ-2026-01623",
    "original_inquiry": "海外求诊：Patient with 运动皮层解码 seeking evaluation for Precision Neuroscience; interested in Neuralink trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5153
  },
  {
    "request_id": "AM-REQ-2026-01624",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring ECoG or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7355
  },
  {
    "request_id": "AM-REQ-2026-01625",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解语音神经假体在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5842
  },
  {
    "request_id": "AM-REQ-2026-01626",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring neural decoding or BrainGate for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8237
  },
  {
    "request_id": "AM-REQ-2026-01627",
    "original_inquiry": "Urgent: Consultation request: ECoG for BrainGate; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6932
  },
  {
    "request_id": "AM-REQ-2026-01628",
    "original_inquiry": "海外求诊：Family member with ALS, exploring BCI for ALS or Speech Neuroprosthesis for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.63
  },
  {
    "request_id": "AM-REQ-2026-01629",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解brain-computer interface在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7971
  },
  {
    "request_id": "AM-REQ-2026-01630",
    "original_inquiry": "Family seeking information: Patient with intracortical array seeking evaluation for Paradromics; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5982
  },
  {
    "request_id": "AM-REQ-2026-01631",
    "original_inquiry": "海外求诊：Family member with ALS, exploring neural decoding or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7653
  },
  {
    "request_id": "AM-REQ-2026-01632",
    "original_inquiry": "Second opinion requested: Patient with intracortical array seeking evaluation for Wyss Center; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5459
  },
  {
    "request_id": "AM-REQ-2026-01633",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.788
  },
  {
    "request_id": "AM-REQ-2026-01634",
    "original_inquiry": "海外求诊：海外求诊：患者BCI for ALS，希望评估Wyss Center或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7793
  },
  {
    "request_id": "AM-REQ-2026-01635",
    "original_inquiry": "Family member with ALS, exploring 运动皮层解码 or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.627
  },
  {
    "request_id": "AM-REQ-2026-01636",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解intracortical array在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6791
  },
  {
    "request_id": "AM-REQ-2026-01637",
    "original_inquiry": "Family seeking information: 海外求诊：患者侵入式电极，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7425
  },
  {
    "request_id": "AM-REQ-2026-01638",
    "original_inquiry": "Referral from specialist: Neurologist referral: ECoG candidate for Synchron Stentrode; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6559
  },
  {
    "request_id": "AM-REQ-2026-01639",
    "original_inquiry": "Second opinion requested: Neurologist referral: speech decoding candidate for Blackrock Neurotech; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7738
  },
  {
    "request_id": "AM-REQ-2026-01640",
    "original_inquiry": "海外求诊：患者invasive cortical electrode，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8526
  },
  {
    "request_id": "AM-REQ-2026-01641",
    "original_inquiry": "Referral from specialist: Neurologist referral: 侵入式电极 candidate for Blackrock Neurotech; request information on Precision Neuroscience eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6493
  },
  {
    "request_id": "AM-REQ-2026-01642",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 运动皮层解码 or Speech Neuroprosthesis for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5667
  },
  {
    "request_id": "AM-REQ-2026-01643",
    "original_inquiry": "Second opinion requested: Urgent: neural decoding diagnosis, seeking centers offering BrainGate / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6832
  },
  {
    "request_id": "AM-REQ-2026-01644",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解intracortical array在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7907
  },
  {
    "request_id": "AM-REQ-2026-01645",
    "original_inquiry": "海外求诊：研究者咨询：希望了解语音神经假体在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6954
  },
  {
    "request_id": "AM-REQ-2026-01646",
    "original_inquiry": "Family seeking information: Neurologist referral: ECoG candidate for BrainGate; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6128
  },
  {
    "request_id": "AM-REQ-2026-01647",
    "original_inquiry": "Second opinion requested: Neurologist referral: 脑机接口 candidate for Paradromics; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5094
  },
  {
    "request_id": "AM-REQ-2026-01648",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7861
  },
  {
    "request_id": "AM-REQ-2026-01649",
    "original_inquiry": "Family seeking information: Consultation request: 运动皮层解码 for Wyss Center; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-01650",
    "original_inquiry": "海外求诊：Consultation request: 侵入式电极 for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8211
  },
  {
    "request_id": "AM-REQ-2026-01651",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Speech Neuroprosthesis; request information on Paradromics eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8062
  },
  {
    "request_id": "AM-REQ-2026-01652",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Synchron Stentrode适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6076
  },
  {
    "request_id": "AM-REQ-2026-01653",
    "original_inquiry": "研究者咨询：Neurologist referral: 脑机接口 candidate for Wyss Center; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5769
  },
  {
    "request_id": "AM-REQ-2026-01654",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解BCI for ALS在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6231
  },
  {
    "request_id": "AM-REQ-2026-01655",
    "original_inquiry": "海外求诊：海外求诊：患者运动皮层解码，希望评估Speech Neuroprosthesis或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7299
  },
  {
    "request_id": "AM-REQ-2026-01656",
    "original_inquiry": "海外求诊：Consultation request: intracortical array for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5472
  },
  {
    "request_id": "AM-REQ-2026-01657",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.761
  },
  {
    "request_id": "AM-REQ-2026-01658",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring BCI for ALS or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6241
  },
  {
    "request_id": "AM-REQ-2026-01659",
    "original_inquiry": "Urgent: Neurologist referral: locked-in syndrome candidate for Neuralink; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5932
  },
  {
    "request_id": "AM-REQ-2026-01660",
    "original_inquiry": "Urgent: Consultation request: 侵入式电极 for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5957
  },
  {
    "request_id": "AM-REQ-2026-01661",
    "original_inquiry": "Family seeking information: Urgent: speech prosthesis diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5829
  },
  {
    "request_id": "AM-REQ-2026-01662",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 运动皮层解码 or Paradromics for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6669
  },
  {
    "request_id": "AM-REQ-2026-01663",
    "original_inquiry": "Urgent: Consultation request: invasive cortical electrode for Neuralink; interested in Wyss Center and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7451
  },
  {
    "request_id": "AM-REQ-2026-01664",
    "original_inquiry": "Referral from specialist: Neurologist referral: locked-in syndrome candidate for BrainGate; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6693
  },
  {
    "request_id": "AM-REQ-2026-01665",
    "original_inquiry": "Second opinion requested: Neurologist referral: BCI for ALS candidate for BrainGate; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6287
  },
  {
    "request_id": "AM-REQ-2026-01666",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5254
  },
  {
    "request_id": "AM-REQ-2026-01667",
    "original_inquiry": "研究者咨询：Patient with speech prosthesis seeking evaluation for Wyss Center; interested in BrainGate trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.571
  },
  {
    "request_id": "AM-REQ-2026-01668",
    "original_inquiry": "Referral from specialist: Patient with speech prosthesis seeking evaluation for Speech Neuroprosthesis; interested in Precision Neuroscience trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7269
  },
  {
    "request_id": "AM-REQ-2026-01669",
    "original_inquiry": "Family seeking information: Patient with 语音神经假体 seeking evaluation for Wyss Center; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5986
  },
  {
    "request_id": "AM-REQ-2026-01670",
    "original_inquiry": "海外求诊：海外求诊：患者speech decoding，希望评估Neuralink或BrainGate项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5928
  },
  {
    "request_id": "AM-REQ-2026-01671",
    "original_inquiry": "Neurologist referral: ECoG candidate for Wyss Center; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5179
  },
  {
    "request_id": "AM-REQ-2026-01672",
    "original_inquiry": "Referral from specialist: Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Wyss Center clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6417
  },
  {
    "request_id": "AM-REQ-2026-01673",
    "original_inquiry": "海外求诊：Urgent: 语音神经假体 diagnosis, seeking centers offering Synchron Stentrode / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7074
  },
  {
    "request_id": "AM-REQ-2026-01674",
    "original_inquiry": "Urgent: Neurologist referral: intracortical array candidate for Speech Neuroprosthesis; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.81
  },
  {
    "request_id": "AM-REQ-2026-01675",
    "original_inquiry": "海外求诊：Patient with 运动皮层解码 seeking evaluation for BrainGate; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6285
  },
  {
    "request_id": "AM-REQ-2026-01676",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6816
  },
  {
    "request_id": "AM-REQ-2026-01677",
    "original_inquiry": "Second opinion requested: Urgent: 运动皮层解码 diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.572
  },
  {
    "request_id": "AM-REQ-2026-01678",
    "original_inquiry": "Urgent: Patient with invasive cortical electrode seeking evaluation for Precision Neuroscience; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7702
  },
  {
    "request_id": "AM-REQ-2026-01679",
    "original_inquiry": "研究者咨询：Urgent: 运动皮层解码 diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6378
  },
  {
    "request_id": "AM-REQ-2026-01680",
    "original_inquiry": "研究者咨询：Consultation request: neural decoding for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6105
  },
  {
    "request_id": "AM-REQ-2026-01681",
    "original_inquiry": "Urgent: Neurologist referral: speech prosthesis candidate for BrainGate; request information on Paradromics eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7414
  },
  {
    "request_id": "AM-REQ-2026-01682",
    "original_inquiry": "Urgent: 海外求诊：患者locked-in syndrome，希望评估Speech Neuroprosthesis或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6265
  },
  {
    "request_id": "AM-REQ-2026-01683",
    "original_inquiry": "研究者咨询：Neurologist referral: locked-in syndrome candidate for Wyss Center; request information on BrainGate eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6526
  },
  {
    "request_id": "AM-REQ-2026-01684",
    "original_inquiry": "Second opinion requested: Urgent: locked-in syndrome diagnosis, seeking centers offering Neuralink / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5175
  },
  {
    "request_id": "AM-REQ-2026-01685",
    "original_inquiry": "海外求诊：患者brain-computer interface，希望评估Paradromics或Wyss Center项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6017
  },
  {
    "request_id": "AM-REQ-2026-01686",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或BrainGate项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6752
  },
  {
    "request_id": "AM-REQ-2026-01687",
    "original_inquiry": "海外求诊：患者BCI for ALS，希望评估BrainGate或Blackrock Neurotech项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5492
  },
  {
    "request_id": "AM-REQ-2026-01688",
    "original_inquiry": "Family member with ALS, exploring speech prosthesis or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7628
  },
  {
    "request_id": "AM-REQ-2026-01689",
    "original_inquiry": "Referral from specialist: Urgent: brain-computer interface diagnosis, seeking centers offering Speech Neuroprosthesis / Precision Neuroscience clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7662
  },
  {
    "request_id": "AM-REQ-2026-01690",
    "original_inquiry": "海外求诊：Patient with speech prosthesis seeking evaluation for Neuralink; interested in Paradromics trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5681
  },
  {
    "request_id": "AM-REQ-2026-01691",
    "original_inquiry": "Patient with speech decoding seeking evaluation for Wyss Center; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6628
  },
  {
    "request_id": "AM-REQ-2026-01692",
    "original_inquiry": "海外求诊：研究者咨询：希望了解ECoG在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7592
  },
  {
    "request_id": "AM-REQ-2026-01693",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome seeking evaluation for Paradromics; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7325
  },
  {
    "request_id": "AM-REQ-2026-01694",
    "original_inquiry": "Urgent: Urgent: neural decoding diagnosis, seeking centers offering Paradromics / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5421
  },
  {
    "request_id": "AM-REQ-2026-01695",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.896
  },
  {
    "request_id": "AM-REQ-2026-01696",
    "original_inquiry": "海外求诊：Consultation request: brain-computer interface for BrainGate; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6477
  },
  {
    "request_id": "AM-REQ-2026-01697",
    "original_inquiry": "Patient with 脑机接口 seeking evaluation for Synchron Stentrode; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8883
  },
  {
    "request_id": "AM-REQ-2026-01698",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解brain-computer interface在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6302
  },
  {
    "request_id": "AM-REQ-2026-01699",
    "original_inquiry": "Urgent: Patient with brain-computer interface seeking evaluation for Synchron Stentrode; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6607
  },
  {
    "request_id": "AM-REQ-2026-01700",
    "original_inquiry": "海外求诊：Neurologist referral: motor neuroprosthesis candidate for Wyss Center; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-01701",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 侵入式电极 or BrainGate for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7098
  },
  {
    "request_id": "AM-REQ-2026-01702",
    "original_inquiry": "研究者咨询：Consultation request: neural decoding for Neuralink; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.524
  },
  {
    "request_id": "AM-REQ-2026-01703",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解脑机接口在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.596
  },
  {
    "request_id": "AM-REQ-2026-01704",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring invasive cortical electrode or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8224
  },
  {
    "request_id": "AM-REQ-2026-01705",
    "original_inquiry": "研究者咨询：海外求诊：患者intracortical array，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6637
  },
  {
    "request_id": "AM-REQ-2026-01706",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech prosthesis，希望评估Precision Neuroscience或Paradromics项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6785
  },
  {
    "request_id": "AM-REQ-2026-01707",
    "original_inquiry": "Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7874
  },
  {
    "request_id": "AM-REQ-2026-01708",
    "original_inquiry": "Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7269
  },
  {
    "request_id": "AM-REQ-2026-01709",
    "original_inquiry": "Urgent: invasive cortical electrode diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.724
  },
  {
    "request_id": "AM-REQ-2026-01710",
    "original_inquiry": "海外求诊：Urgent: 语音神经假体 diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-01711",
    "original_inquiry": "Family seeking information: Urgent: BCI for ALS diagnosis, seeking centers offering Neuralink / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6137
  },
  {
    "request_id": "AM-REQ-2026-01712",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8327
  },
  {
    "request_id": "AM-REQ-2026-01713",
    "original_inquiry": "研究者咨询：Neurologist referral: speech prosthesis candidate for Paradromics; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5305
  },
  {
    "request_id": "AM-REQ-2026-01714",
    "original_inquiry": "研究者咨询：Consultation request: brain-computer interface for Speech Neuroprosthesis; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.667
  },
  {
    "request_id": "AM-REQ-2026-01715",
    "original_inquiry": "Family member with ALS, exploring 运动皮层解码 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7697
  },
  {
    "request_id": "AM-REQ-2026-01716",
    "original_inquiry": "研究者咨询：希望了解ECoG在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5774
  },
  {
    "request_id": "AM-REQ-2026-01717",
    "original_inquiry": "Second opinion requested: Urgent: intracortical array diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8042
  },
  {
    "request_id": "AM-REQ-2026-01718",
    "original_inquiry": "Family seeking information: Consultation request: intracortical array for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8604
  },
  {
    "request_id": "AM-REQ-2026-01719",
    "original_inquiry": "Family seeking information: Urgent: invasive cortical electrode diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7726
  },
  {
    "request_id": "AM-REQ-2026-01720",
    "original_inquiry": "Family seeking information: Urgent: locked-in syndrome diagnosis, seeking centers offering Speech Neuroprosthesis / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7849
  },
  {
    "request_id": "AM-REQ-2026-01721",
    "original_inquiry": "海外求诊：海外求诊：患者语音神经假体，希望评估Neuralink或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.652
  },
  {
    "request_id": "AM-REQ-2026-01722",
    "original_inquiry": "Urgent: Urgent: 侵入式电极 diagnosis, seeking centers offering BrainGate / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5373
  },
  {
    "request_id": "AM-REQ-2026-01723",
    "original_inquiry": "研究者咨询：Patient with intracortical array seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7591
  },
  {
    "request_id": "AM-REQ-2026-01724",
    "original_inquiry": "Urgent: 研究者咨询：希望了解locked-in syndrome在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7417
  },
  {
    "request_id": "AM-REQ-2026-01725",
    "original_inquiry": "Neurologist referral: brain-computer interface candidate for Blackrock Neurotech; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7148
  },
  {
    "request_id": "AM-REQ-2026-01726",
    "original_inquiry": "Consultation request: BCI for ALS for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-01727",
    "original_inquiry": "Consultation request: neural decoding for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6993
  },
  {
    "request_id": "AM-REQ-2026-01728",
    "original_inquiry": "Family seeking information: Neurologist referral: speech decoding candidate for Paradromics; request information on Synchron Stentrode eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5672
  },
  {
    "request_id": "AM-REQ-2026-01729",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring intracortical array or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5096
  },
  {
    "request_id": "AM-REQ-2026-01730",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring locked-in syndrome or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7733
  },
  {
    "request_id": "AM-REQ-2026-01731",
    "original_inquiry": "Referral from specialist: Neurologist referral: invasive cortical electrode candidate for Neuralink; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8099
  },
  {
    "request_id": "AM-REQ-2026-01732",
    "original_inquiry": "海外求诊：Consultation request: 侵入式电极 for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7738
  },
  {
    "request_id": "AM-REQ-2026-01733",
    "original_inquiry": "Urgent: 研究者咨询：希望了解运动皮层解码在Precision Neuroscience适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8871
  },
  {
    "request_id": "AM-REQ-2026-01734",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech decoding在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7934
  },
  {
    "request_id": "AM-REQ-2026-01735",
    "original_inquiry": "Referral from specialist: Patient with ECoG seeking evaluation for BrainGate; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7446
  },
  {
    "request_id": "AM-REQ-2026-01736",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7852
  },
  {
    "request_id": "AM-REQ-2026-01737",
    "original_inquiry": "Urgent: Neurologist referral: neural decoding candidate for Wyss Center; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7571
  },
  {
    "request_id": "AM-REQ-2026-01738",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8988
  },
  {
    "request_id": "AM-REQ-2026-01739",
    "original_inquiry": "Family seeking information: Urgent: speech prosthesis diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5465
  },
  {
    "request_id": "AM-REQ-2026-01740",
    "original_inquiry": "研究者咨询：Patient with motor neuroprosthesis seeking evaluation for Neuralink; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7267
  },
  {
    "request_id": "AM-REQ-2026-01741",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 运动皮层解码 or Wyss Center for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6519
  },
  {
    "request_id": "AM-REQ-2026-01742",
    "original_inquiry": "Referral from specialist: Patient with 脑机接口 seeking evaluation for Wyss Center; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7047
  },
  {
    "request_id": "AM-REQ-2026-01743",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-01744",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Paradromics; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5067
  },
  {
    "request_id": "AM-REQ-2026-01745",
    "original_inquiry": "研究者咨询：Consultation request: 语音神经假体 for Paradromics; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6164
  },
  {
    "request_id": "AM-REQ-2026-01746",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7993
  },
  {
    "request_id": "AM-REQ-2026-01747",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解intracortical array在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.658
  },
  {
    "request_id": "AM-REQ-2026-01748",
    "original_inquiry": "Neurologist referral: speech decoding candidate for Paradromics; request information on BrainGate eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8901
  },
  {
    "request_id": "AM-REQ-2026-01749",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech prosthesis在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8785
  },
  {
    "request_id": "AM-REQ-2026-01750",
    "original_inquiry": "Referral from specialist: Patient with 侵入式电极 seeking evaluation for Synchron Stentrode; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7697
  },
  {
    "request_id": "AM-REQ-2026-01751",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 运动皮层解码 or BrainGate for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.877
  },
  {
    "request_id": "AM-REQ-2026-01752",
    "original_inquiry": "Referral from specialist: Neurologist referral: intracortical array candidate for Synchron Stentrode; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7743
  },
  {
    "request_id": "AM-REQ-2026-01753",
    "original_inquiry": "Urgent: Consultation request: neural decoding for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8476
  },
  {
    "request_id": "AM-REQ-2026-01754",
    "original_inquiry": "研究者咨询：海外求诊：患者brain-computer interface，希望评估Speech Neuroprosthesis或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5942
  },
  {
    "request_id": "AM-REQ-2026-01755",
    "original_inquiry": "Second opinion requested: Neurologist referral: intracortical array candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5516
  },
  {
    "request_id": "AM-REQ-2026-01756",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6317
  },
  {
    "request_id": "AM-REQ-2026-01757",
    "original_inquiry": "Referral from specialist: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.861
  },
  {
    "request_id": "AM-REQ-2026-01758",
    "original_inquiry": "Urgent: 研究者咨询：希望了解BCI for ALS在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7436
  },
  {
    "request_id": "AM-REQ-2026-01759",
    "original_inquiry": "Referral from specialist: Urgent: locked-in syndrome diagnosis, seeking centers offering Speech Neuroprosthesis / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8879
  },
  {
    "request_id": "AM-REQ-2026-01760",
    "original_inquiry": "研究者咨询：Neurologist referral: speech prosthesis candidate for BrainGate; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7975
  },
  {
    "request_id": "AM-REQ-2026-01761",
    "original_inquiry": "Family seeking information: Consultation request: 脑机接口 for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7023
  },
  {
    "request_id": "AM-REQ-2026-01762",
    "original_inquiry": "研究者咨询：海外求诊：患者speech decoding，希望评估Wyss Center或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6834
  },
  {
    "request_id": "AM-REQ-2026-01763",
    "original_inquiry": "海外求诊：Consultation request: speech decoding for Synchron Stentrode; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5494
  },
  {
    "request_id": "AM-REQ-2026-01764",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech prosthesis，希望评估Wyss Center或BrainGate项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5057
  },
  {
    "request_id": "AM-REQ-2026-01765",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7206
  },
  {
    "request_id": "AM-REQ-2026-01766",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解ECoG在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7499
  },
  {
    "request_id": "AM-REQ-2026-01767",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring locked-in syndrome or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8153
  },
  {
    "request_id": "AM-REQ-2026-01768",
    "original_inquiry": "Family seeking information: Urgent: 运动皮层解码 diagnosis, seeking centers offering Blackrock Neurotech / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5526
  },
  {
    "request_id": "AM-REQ-2026-01769",
    "original_inquiry": "Urgent: Consultation request: 运动皮层解码 for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.874
  },
  {
    "request_id": "AM-REQ-2026-01770",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6604
  },
  {
    "request_id": "AM-REQ-2026-01771",
    "original_inquiry": "Family seeking information: Urgent: 语音神经假体 diagnosis, seeking centers offering Speech Neuroprosthesis / Blackrock Neurotech clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.858
  },
  {
    "request_id": "AM-REQ-2026-01772",
    "original_inquiry": "Urgent: Patient with intracortical array seeking evaluation for Synchron Stentrode; interested in Wyss Center trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7924
  },
  {
    "request_id": "AM-REQ-2026-01773",
    "original_inquiry": "Referral from specialist: Consultation request: speech decoding for Blackrock Neurotech; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-01774",
    "original_inquiry": "Urgent: 海外求诊：患者语音神经假体，希望评估Wyss Center或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7811
  },
  {
    "request_id": "AM-REQ-2026-01775",
    "original_inquiry": "Neurologist referral: 侵入式电极 candidate for Synchron Stentrode; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6485
  },
  {
    "request_id": "AM-REQ-2026-01776",
    "original_inquiry": "Urgent: Urgent: 语音神经假体 diagnosis, seeking centers offering Speech Neuroprosthesis / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6281
  },
  {
    "request_id": "AM-REQ-2026-01777",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解侵入式电极在BrainGate适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.688
  },
  {
    "request_id": "AM-REQ-2026-01778",
    "original_inquiry": "海外求诊：海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6984
  },
  {
    "request_id": "AM-REQ-2026-01779",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for BrainGate; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6474
  },
  {
    "request_id": "AM-REQ-2026-01780",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8572
  },
  {
    "request_id": "AM-REQ-2026-01781",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 脑机接口 or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8287
  },
  {
    "request_id": "AM-REQ-2026-01782",
    "original_inquiry": "Second opinion requested: Neurologist referral: 脑机接口 candidate for Paradromics; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8424
  },
  {
    "request_id": "AM-REQ-2026-01783",
    "original_inquiry": "Urgent: speech prosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5768
  },
  {
    "request_id": "AM-REQ-2026-01784",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解motor neuroprosthesis在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8981
  },
  {
    "request_id": "AM-REQ-2026-01785",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech prosthesis在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7429
  },
  {
    "request_id": "AM-REQ-2026-01786",
    "original_inquiry": "Urgent: Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8848
  },
  {
    "request_id": "AM-REQ-2026-01787",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解运动皮层解码在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8088
  },
  {
    "request_id": "AM-REQ-2026-01788",
    "original_inquiry": "研究者咨询：Patient with invasive cortical electrode seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-01789",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解motor neuroprosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8079
  },
  {
    "request_id": "AM-REQ-2026-01790",
    "original_inquiry": "海外求诊：海外求诊：患者侵入式电极，希望评估Precision Neuroscience或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.784
  },
  {
    "request_id": "AM-REQ-2026-01791",
    "original_inquiry": "Neurologist referral: 运动皮层解码 candidate for BrainGate; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7585
  },
  {
    "request_id": "AM-REQ-2026-01792",
    "original_inquiry": "海外求诊：Neurologist referral: BCI for ALS candidate for Speech Neuroprosthesis; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6147
  },
  {
    "request_id": "AM-REQ-2026-01793",
    "original_inquiry": "Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5277
  },
  {
    "request_id": "AM-REQ-2026-01794",
    "original_inquiry": "Neurologist referral: speech prosthesis candidate for Paradromics; request information on Neuralink eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8693
  },
  {
    "request_id": "AM-REQ-2026-01795",
    "original_inquiry": "海外求诊：研究者咨询：希望了解invasive cortical electrode在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6545
  },
  {
    "request_id": "AM-REQ-2026-01796",
    "original_inquiry": "海外求诊：海外求诊：患者motor neuroprosthesis，希望评估Precision Neuroscience或Paradromics项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6813
  },
  {
    "request_id": "AM-REQ-2026-01797",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Wyss Center或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7536
  },
  {
    "request_id": "AM-REQ-2026-01798",
    "original_inquiry": "研究者咨询：Neurologist referral: speech prosthesis candidate for Wyss Center; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6314
  },
  {
    "request_id": "AM-REQ-2026-01799",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 运动皮层解码 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5463
  },
  {
    "request_id": "AM-REQ-2026-01800",
    "original_inquiry": "研究者咨询：希望了解BCI for ALS在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6558
  },
  {
    "request_id": "AM-REQ-2026-01801",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 侵入式电极 or Speech Neuroprosthesis for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-01802",
    "original_inquiry": "Referral from specialist: Neurologist referral: 语音神经假体 candidate for Speech Neuroprosthesis; request information on Wyss Center eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7585
  },
  {
    "request_id": "AM-REQ-2026-01803",
    "original_inquiry": "Urgent: Family member with ALS, exploring 运动皮层解码 or Neuralink for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5349
  },
  {
    "request_id": "AM-REQ-2026-01804",
    "original_inquiry": "Second opinion requested: Consultation request: BCI for ALS for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5075
  },
  {
    "request_id": "AM-REQ-2026-01805",
    "original_inquiry": "海外求诊：患者语音神经假体，希望评估Synchron Stentrode或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-01806",
    "original_inquiry": "Second opinion requested: Neurologist referral: neural decoding candidate for Blackrock Neurotech; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5486
  },
  {
    "request_id": "AM-REQ-2026-01807",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Wyss Center或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7915
  },
  {
    "request_id": "AM-REQ-2026-01808",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7166
  },
  {
    "request_id": "AM-REQ-2026-01809",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring BCI for ALS or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8141
  },
  {
    "request_id": "AM-REQ-2026-01810",
    "original_inquiry": "Family seeking information: Neurologist referral: intracortical array candidate for BrainGate; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.712
  },
  {
    "request_id": "AM-REQ-2026-01811",
    "original_inquiry": "Urgent: Consultation request: locked-in syndrome for Blackrock Neurotech; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-01812",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring speech decoding or Speech Neuroprosthesis for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5846
  },
  {
    "request_id": "AM-REQ-2026-01813",
    "original_inquiry": "Referral from specialist: Urgent: brain-computer interface diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7039
  },
  {
    "request_id": "AM-REQ-2026-01814",
    "original_inquiry": "Second opinion requested: Consultation request: ECoG for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6142
  },
  {
    "request_id": "AM-REQ-2026-01815",
    "original_inquiry": "海外求诊：患者motor neuroprosthesis，希望评估Wyss Center或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5658
  },
  {
    "request_id": "AM-REQ-2026-01816",
    "original_inquiry": "研究者咨询：Urgent: 运动皮层解码 diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6493
  },
  {
    "request_id": "AM-REQ-2026-01817",
    "original_inquiry": "Second opinion requested: Consultation request: locked-in syndrome for Neuralink; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5948
  },
  {
    "request_id": "AM-REQ-2026-01818",
    "original_inquiry": "Referral from specialist: 海外求诊：患者脑机接口，希望评估BrainGate或Blackrock Neurotech项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6871
  },
  {
    "request_id": "AM-REQ-2026-01819",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5377
  },
  {
    "request_id": "AM-REQ-2026-01820",
    "original_inquiry": "研究者咨询：希望了解脑机接口在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8654
  },
  {
    "request_id": "AM-REQ-2026-01821",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 侵入式电极 or BrainGate for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5497
  },
  {
    "request_id": "AM-REQ-2026-01822",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7265
  },
  {
    "request_id": "AM-REQ-2026-01823",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5245
  },
  {
    "request_id": "AM-REQ-2026-01824",
    "original_inquiry": "海外求诊：Patient with 脑机接口 seeking evaluation for Neuralink; interested in Synchron Stentrode trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8264
  },
  {
    "request_id": "AM-REQ-2026-01825",
    "original_inquiry": "Referral from specialist: Consultation request: brain-computer interface for Blackrock Neurotech; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8029
  },
  {
    "request_id": "AM-REQ-2026-01826",
    "original_inquiry": "Referral from specialist: Urgent: ECoG diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6593
  },
  {
    "request_id": "AM-REQ-2026-01827",
    "original_inquiry": "Second opinion requested: Neurologist referral: speech prosthesis candidate for Blackrock Neurotech; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5889
  },
  {
    "request_id": "AM-REQ-2026-01828",
    "original_inquiry": "海外求诊：海外求诊：患者locked-in syndrome，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8319
  },
  {
    "request_id": "AM-REQ-2026-01829",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6738
  },
  {
    "request_id": "AM-REQ-2026-01830",
    "original_inquiry": "Urgent: 海外求诊：患者speech decoding，希望评估Neuralink或Wyss Center项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7765
  },
  {
    "request_id": "AM-REQ-2026-01831",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5631
  },
  {
    "request_id": "AM-REQ-2026-01832",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring ECoG or Precision Neuroscience for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6974
  },
  {
    "request_id": "AM-REQ-2026-01833",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解BCI for ALS在Neuralink适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8392
  },
  {
    "request_id": "AM-REQ-2026-01834",
    "original_inquiry": "Family seeking information: Urgent: intracortical array diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.824
  },
  {
    "request_id": "AM-REQ-2026-01835",
    "original_inquiry": "Second opinion requested: Urgent: intracortical array diagnosis, seeking centers offering Wyss Center / Paradromics clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7325
  },
  {
    "request_id": "AM-REQ-2026-01836",
    "original_inquiry": "研究者咨询：Consultation request: 脑机接口 for Precision Neuroscience; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8697
  },
  {
    "request_id": "AM-REQ-2026-01837",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring invasive cortical electrode or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6151
  },
  {
    "request_id": "AM-REQ-2026-01838",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6067
  },
  {
    "request_id": "AM-REQ-2026-01839",
    "original_inquiry": "Referral from specialist: 海外求诊：患者brain-computer interface，希望评估BrainGate或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8693
  },
  {
    "request_id": "AM-REQ-2026-01840",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5546
  },
  {
    "request_id": "AM-REQ-2026-01841",
    "original_inquiry": "Referral from specialist: Urgent: ECoG diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.794
  },
  {
    "request_id": "AM-REQ-2026-01842",
    "original_inquiry": "海外求诊：Urgent: 脑机接口 diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5569
  },
  {
    "request_id": "AM-REQ-2026-01843",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring BCI for ALS or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8935
  },
  {
    "request_id": "AM-REQ-2026-01844",
    "original_inquiry": "Urgent: Neurologist referral: 脑机接口 candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8526
  },
  {
    "request_id": "AM-REQ-2026-01845",
    "original_inquiry": "Family seeking information: Urgent: brain-computer interface diagnosis, seeking centers offering Wyss Center / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5554
  },
  {
    "request_id": "AM-REQ-2026-01846",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7759
  },
  {
    "request_id": "AM-REQ-2026-01847",
    "original_inquiry": "研究者咨询：希望了解locked-in syndrome在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7402
  },
  {
    "request_id": "AM-REQ-2026-01848",
    "original_inquiry": "Referral from specialist: Patient with neural decoding seeking evaluation for Blackrock Neurotech; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-01849",
    "original_inquiry": "Referral from specialist: Patient with 侵入式电极 seeking evaluation for Wyss Center; interested in Neuralink trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6906
  },
  {
    "request_id": "AM-REQ-2026-01850",
    "original_inquiry": "Neurologist referral: motor neuroprosthesis candidate for Precision Neuroscience; request information on BrainGate eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5605
  },
  {
    "request_id": "AM-REQ-2026-01851",
    "original_inquiry": "Urgent: Family member with ALS, exploring intracortical array or Paradromics for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8051
  },
  {
    "request_id": "AM-REQ-2026-01852",
    "original_inquiry": "Second opinion requested: Patient with 语音神经假体 seeking evaluation for Paradromics; interested in Blackrock Neurotech trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8474
  },
  {
    "request_id": "AM-REQ-2026-01853",
    "original_inquiry": "海外求诊：Neurologist referral: speech decoding candidate for Wyss Center; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6231
  },
  {
    "request_id": "AM-REQ-2026-01854",
    "original_inquiry": "Referral from specialist: Neurologist referral: 语音神经假体 candidate for Neuralink; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6325
  },
  {
    "request_id": "AM-REQ-2026-01855",
    "original_inquiry": "海外求诊：Urgent: intracortical array diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5466
  },
  {
    "request_id": "AM-REQ-2026-01856",
    "original_inquiry": "Patient with speech prosthesis seeking evaluation for Wyss Center; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5915
  },
  {
    "request_id": "AM-REQ-2026-01857",
    "original_inquiry": "Family seeking information: Neurologist referral: 运动皮层解码 candidate for Paradromics; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.812
  },
  {
    "request_id": "AM-REQ-2026-01858",
    "original_inquiry": "海外求诊：Consultation request: brain-computer interface for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6005
  },
  {
    "request_id": "AM-REQ-2026-01859",
    "original_inquiry": "研究者咨询：海外求诊：患者neural decoding，希望评估Neuralink或Paradromics项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7491
  },
  {
    "request_id": "AM-REQ-2026-01860",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 语音神经假体 or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-01861",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6612
  },
  {
    "request_id": "AM-REQ-2026-01862",
    "original_inquiry": "研究者咨询：Urgent: invasive cortical electrode diagnosis, seeking centers offering Blackrock Neurotech / Neuralink clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5097
  },
  {
    "request_id": "AM-REQ-2026-01863",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7485
  },
  {
    "request_id": "AM-REQ-2026-01864",
    "original_inquiry": "Second opinion requested: Neurologist referral: 运动皮层解码 candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6239
  },
  {
    "request_id": "AM-REQ-2026-01865",
    "original_inquiry": "海外求诊：患者brain-computer interface，希望评估Blackrock Neurotech或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5071
  },
  {
    "request_id": "AM-REQ-2026-01866",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8985
  },
  {
    "request_id": "AM-REQ-2026-01867",
    "original_inquiry": "Urgent: Consultation request: motor neuroprosthesis for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7841
  },
  {
    "request_id": "AM-REQ-2026-01868",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解invasive cortical electrode在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7714
  },
  {
    "request_id": "AM-REQ-2026-01869",
    "original_inquiry": "研究者咨询：希望了解运动皮层解码在Precision Neuroscience适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8236
  },
  {
    "request_id": "AM-REQ-2026-01870",
    "original_inquiry": "Urgent: Patient with speech decoding seeking evaluation for Speech Neuroprosthesis; interested in Wyss Center trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7124
  },
  {
    "request_id": "AM-REQ-2026-01871",
    "original_inquiry": "海外求诊：患者neural decoding，希望评估Neuralink或Wyss Center项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8822
  },
  {
    "request_id": "AM-REQ-2026-01872",
    "original_inquiry": "研究者咨询：Urgent: brain-computer interface diagnosis, seeking centers offering Paradromics / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6492
  },
  {
    "request_id": "AM-REQ-2026-01873",
    "original_inquiry": "Family seeking information: 海外求诊：患者motor neuroprosthesis，希望评估Paradromics或BrainGate项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8171
  },
  {
    "request_id": "AM-REQ-2026-01874",
    "original_inquiry": "Second opinion requested: Neurologist referral: 脑机接口 candidate for Neuralink; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7554
  },
  {
    "request_id": "AM-REQ-2026-01875",
    "original_inquiry": "Urgent: motor neuroprosthesis diagnosis, seeking centers offering Paradromics / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8393
  },
  {
    "request_id": "AM-REQ-2026-01876",
    "original_inquiry": "Second opinion requested: Urgent: 语音神经假体 diagnosis, seeking centers offering BrainGate / Paradromics clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6141
  },
  {
    "request_id": "AM-REQ-2026-01877",
    "original_inquiry": "Referral from specialist: Patient with 侵入式电极 seeking evaluation for BrainGate; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8695
  },
  {
    "request_id": "AM-REQ-2026-01878",
    "original_inquiry": "海外求诊：Family member with ALS, exploring BCI for ALS or Neuralink for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5931
  },
  {
    "request_id": "AM-REQ-2026-01879",
    "original_inquiry": "研究者咨询：海外求诊：患者invasive cortical electrode，希望评估Wyss Center或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.723
  },
  {
    "request_id": "AM-REQ-2026-01880",
    "original_inquiry": "Urgent: Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in Wyss Center trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6332
  },
  {
    "request_id": "AM-REQ-2026-01881",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5803
  },
  {
    "request_id": "AM-REQ-2026-01882",
    "original_inquiry": "Referral from specialist: Neurologist referral: speech prosthesis candidate for Wyss Center; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6249
  },
  {
    "request_id": "AM-REQ-2026-01883",
    "original_inquiry": "Second opinion requested: 海外求诊：患者motor neuroprosthesis，希望评估Wyss Center或Paradromics项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7638
  },
  {
    "request_id": "AM-REQ-2026-01884",
    "original_inquiry": "Family seeking information: Consultation request: motor neuroprosthesis for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5228
  },
  {
    "request_id": "AM-REQ-2026-01885",
    "original_inquiry": "Second opinion requested: Consultation request: locked-in syndrome for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7417
  },
  {
    "request_id": "AM-REQ-2026-01886",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解语音神经假体在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6934
  },
  {
    "request_id": "AM-REQ-2026-01887",
    "original_inquiry": "Second opinion requested: Urgent: locked-in syndrome diagnosis, seeking centers offering Wyss Center / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5687
  },
  {
    "request_id": "AM-REQ-2026-01888",
    "original_inquiry": "Referral from specialist: Neurologist referral: 侵入式电极 candidate for Precision Neuroscience; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5485
  },
  {
    "request_id": "AM-REQ-2026-01889",
    "original_inquiry": "Family seeking information: Consultation request: locked-in syndrome for Blackrock Neurotech; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5527
  },
  {
    "request_id": "AM-REQ-2026-01890",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8794
  },
  {
    "request_id": "AM-REQ-2026-01891",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解motor neuroprosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7129
  },
  {
    "request_id": "AM-REQ-2026-01892",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring invasive cortical electrode or Speech Neuroprosthesis for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8349
  },
  {
    "request_id": "AM-REQ-2026-01893",
    "original_inquiry": "Family seeking information: Urgent: speech decoding diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.715
  },
  {
    "request_id": "AM-REQ-2026-01894",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6965
  },
  {
    "request_id": "AM-REQ-2026-01895",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解motor neuroprosthesis在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7333
  },
  {
    "request_id": "AM-REQ-2026-01896",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech decoding在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6722
  },
  {
    "request_id": "AM-REQ-2026-01897",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解ECoG在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8953
  },
  {
    "request_id": "AM-REQ-2026-01898",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech prosthesis在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7082
  },
  {
    "request_id": "AM-REQ-2026-01899",
    "original_inquiry": "Consultation request: invasive cortical electrode for BrainGate; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8527
  },
  {
    "request_id": "AM-REQ-2026-01900",
    "original_inquiry": "海外求诊：研究者咨询：希望了解speech prosthesis在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6349
  },
  {
    "request_id": "AM-REQ-2026-01901",
    "original_inquiry": "研究者咨询：Neurologist referral: invasive cortical electrode candidate for BrainGate; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8602
  },
  {
    "request_id": "AM-REQ-2026-01902",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Neuralink; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8295
  },
  {
    "request_id": "AM-REQ-2026-01903",
    "original_inquiry": "Referral from specialist: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Wyss Center / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8774
  },
  {
    "request_id": "AM-REQ-2026-01904",
    "original_inquiry": "Referral from specialist: Urgent: speech prosthesis diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.887
  },
  {
    "request_id": "AM-REQ-2026-01905",
    "original_inquiry": "Second opinion requested: Patient with speech prosthesis seeking evaluation for Blackrock Neurotech; interested in Precision Neuroscience trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6049
  },
  {
    "request_id": "AM-REQ-2026-01906",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-01907",
    "original_inquiry": "研究者咨询：Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5973
  },
  {
    "request_id": "AM-REQ-2026-01908",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8238
  },
  {
    "request_id": "AM-REQ-2026-01909",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Paradromics; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8989
  },
  {
    "request_id": "AM-REQ-2026-01910",
    "original_inquiry": "海外求诊：患者neural decoding，希望评估BrainGate或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8695
  },
  {
    "request_id": "AM-REQ-2026-01911",
    "original_inquiry": "海外求诊：海外求诊：患者speech decoding，希望评估Neuralink或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8854
  },
  {
    "request_id": "AM-REQ-2026-01912",
    "original_inquiry": "Urgent: Consultation request: invasive cortical electrode for BrainGate; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8513
  },
  {
    "request_id": "AM-REQ-2026-01913",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring locked-in syndrome or Wyss Center for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6538
  },
  {
    "request_id": "AM-REQ-2026-01914",
    "original_inquiry": "研究者咨询：Urgent: neural decoding diagnosis, seeking centers offering Precision Neuroscience / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8368
  },
  {
    "request_id": "AM-REQ-2026-01915",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7328
  },
  {
    "request_id": "AM-REQ-2026-01916",
    "original_inquiry": "Second opinion requested: Patient with speech decoding seeking evaluation for Wyss Center; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8273
  },
  {
    "request_id": "AM-REQ-2026-01917",
    "original_inquiry": "Neurologist referral: brain-computer interface candidate for Wyss Center; request information on BrainGate eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.583
  },
  {
    "request_id": "AM-REQ-2026-01918",
    "original_inquiry": "Second opinion requested: Urgent: speech decoding diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7343
  },
  {
    "request_id": "AM-REQ-2026-01919",
    "original_inquiry": "Consultation request: BCI for ALS for Blackrock Neurotech; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6066
  },
  {
    "request_id": "AM-REQ-2026-01920",
    "original_inquiry": "研究者咨询：海外求诊：患者运动皮层解码，希望评估Blackrock Neurotech或Neuralink项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5407
  },
  {
    "request_id": "AM-REQ-2026-01921",
    "original_inquiry": "Urgent: Urgent: intracortical array diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5604
  },
  {
    "request_id": "AM-REQ-2026-01922",
    "original_inquiry": "Urgent: Neurologist referral: 脑机接口 candidate for BrainGate; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7957
  },
  {
    "request_id": "AM-REQ-2026-01923",
    "original_inquiry": "Neurologist referral: invasive cortical electrode candidate for Speech Neuroprosthesis; request information on Neuralink eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6883
  },
  {
    "request_id": "AM-REQ-2026-01924",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5557
  },
  {
    "request_id": "AM-REQ-2026-01925",
    "original_inquiry": "Referral from specialist: Urgent: brain-computer interface diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8169
  },
  {
    "request_id": "AM-REQ-2026-01926",
    "original_inquiry": "Urgent: 海外求诊：患者运动皮层解码，希望评估Precision Neuroscience或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5535
  },
  {
    "request_id": "AM-REQ-2026-01927",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 脑机接口 or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8974
  },
  {
    "request_id": "AM-REQ-2026-01928",
    "original_inquiry": "Urgent: 语音神经假体 diagnosis, seeking centers offering BrainGate / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6698
  },
  {
    "request_id": "AM-REQ-2026-01929",
    "original_inquiry": "Patient with BCI for ALS seeking evaluation for Neuralink; interested in Wyss Center trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8273
  },
  {
    "request_id": "AM-REQ-2026-01930",
    "original_inquiry": "研究者咨询：Neurologist referral: neural decoding candidate for Synchron Stentrode; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6416
  },
  {
    "request_id": "AM-REQ-2026-01931",
    "original_inquiry": "Neurologist referral: 语音神经假体 candidate for Precision Neuroscience; request information on BrainGate eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7791
  },
  {
    "request_id": "AM-REQ-2026-01932",
    "original_inquiry": "Urgent: brain-computer interface diagnosis, seeking centers offering Blackrock Neurotech / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.724
  },
  {
    "request_id": "AM-REQ-2026-01933",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5387
  },
  {
    "request_id": "AM-REQ-2026-01934",
    "original_inquiry": "Second opinion requested: 海外求诊：患者speech prosthesis，希望评估Paradromics或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7356
  },
  {
    "request_id": "AM-REQ-2026-01935",
    "original_inquiry": "研究者咨询：Urgent: speech decoding diagnosis, seeking centers offering Neuralink / Synchron Stentrode clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7738
  },
  {
    "request_id": "AM-REQ-2026-01936",
    "original_inquiry": "Second opinion requested: 海外求诊：患者运动皮层解码，希望评估Synchron Stentrode或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8758
  },
  {
    "request_id": "AM-REQ-2026-01937",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5383
  },
  {
    "request_id": "AM-REQ-2026-01938",
    "original_inquiry": "Second opinion requested: Patient with speech prosthesis seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8038
  },
  {
    "request_id": "AM-REQ-2026-01939",
    "original_inquiry": "Patient with locked-in syndrome seeking evaluation for Wyss Center; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8866
  },
  {
    "request_id": "AM-REQ-2026-01940",
    "original_inquiry": "Urgent: Family member with ALS, exploring brain-computer interface or BrainGate for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6034
  },
  {
    "request_id": "AM-REQ-2026-01941",
    "original_inquiry": "Urgent: Consultation request: neural decoding for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6247
  },
  {
    "request_id": "AM-REQ-2026-01942",
    "original_inquiry": "Second opinion requested: Consultation request: 侵入式电极 for Blackrock Neurotech; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6999
  },
  {
    "request_id": "AM-REQ-2026-01943",
    "original_inquiry": "Urgent: Urgent: invasive cortical electrode diagnosis, seeking centers offering BrainGate / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-01944",
    "original_inquiry": "海外求诊：Urgent: 运动皮层解码 diagnosis, seeking centers offering Neuralink / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8478
  },
  {
    "request_id": "AM-REQ-2026-01945",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring invasive cortical electrode or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-01946",
    "original_inquiry": "Family seeking information: Patient with ECoG seeking evaluation for Neuralink; interested in BrainGate trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-01947",
    "original_inquiry": "Urgent: 海外求诊：患者motor neuroprosthesis，希望评估BrainGate或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6405
  },
  {
    "request_id": "AM-REQ-2026-01948",
    "original_inquiry": "海外求诊：Patient with 脑机接口 seeking evaluation for Synchron Stentrode; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.562
  },
  {
    "request_id": "AM-REQ-2026-01949",
    "original_inquiry": "Urgent: Family member with ALS, exploring ECoG or Wyss Center for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5211
  },
  {
    "request_id": "AM-REQ-2026-01950",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring BCI for ALS or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.534
  },
  {
    "request_id": "AM-REQ-2026-01951",
    "original_inquiry": "Family seeking information: Consultation request: brain-computer interface for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6647
  },
  {
    "request_id": "AM-REQ-2026-01952",
    "original_inquiry": "Family seeking information: Consultation request: 语音神经假体 for BrainGate; interested in Paradromics and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6208
  },
  {
    "request_id": "AM-REQ-2026-01953",
    "original_inquiry": "Second opinion requested: 海外求诊：患者motor neuroprosthesis，希望评估Neuralink或BrainGate项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6817
  },
  {
    "request_id": "AM-REQ-2026-01954",
    "original_inquiry": "研究者咨询：Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.612
  },
  {
    "request_id": "AM-REQ-2026-01955",
    "original_inquiry": "Second opinion requested: Neurologist referral: neural decoding candidate for Wyss Center; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8749
  },
  {
    "request_id": "AM-REQ-2026-01956",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6271
  },
  {
    "request_id": "AM-REQ-2026-01957",
    "original_inquiry": "Consultation request: invasive cortical electrode for Blackrock Neurotech; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5677
  },
  {
    "request_id": "AM-REQ-2026-01958",
    "original_inquiry": "Second opinion requested: Consultation request: 脑机接口 for Wyss Center; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7151
  },
  {
    "request_id": "AM-REQ-2026-01959",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech decoding在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5147
  },
  {
    "request_id": "AM-REQ-2026-01960",
    "original_inquiry": "Urgent: Consultation request: BCI for ALS for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8145
  },
  {
    "request_id": "AM-REQ-2026-01961",
    "original_inquiry": "Referral from specialist: Neurologist referral: BCI for ALS candidate for Paradromics; request information on Wyss Center eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5948
  },
  {
    "request_id": "AM-REQ-2026-01962",
    "original_inquiry": "Second opinion requested: Neurologist referral: 侵入式电极 candidate for Speech Neuroprosthesis; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6059
  },
  {
    "request_id": "AM-REQ-2026-01963",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for BrainGate; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5225
  },
  {
    "request_id": "AM-REQ-2026-01964",
    "original_inquiry": "研究者咨询：Urgent: invasive cortical electrode diagnosis, seeking centers offering Precision Neuroscience / BrainGate clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7294
  },
  {
    "request_id": "AM-REQ-2026-01965",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech decoding在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5845
  },
  {
    "request_id": "AM-REQ-2026-01966",
    "original_inquiry": "Family seeking information: Patient with motor neuroprosthesis seeking evaluation for Blackrock Neurotech; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7061
  },
  {
    "request_id": "AM-REQ-2026-01967",
    "original_inquiry": "研究者咨询：海外求诊：患者speech prosthesis，希望评估Neuralink或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6249
  },
  {
    "request_id": "AM-REQ-2026-01968",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5275
  },
  {
    "request_id": "AM-REQ-2026-01969",
    "original_inquiry": "Second opinion requested: Neurologist referral: motor neuroprosthesis candidate for Wyss Center; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5179
  },
  {
    "request_id": "AM-REQ-2026-01970",
    "original_inquiry": "研究者咨询：Urgent: ECoG diagnosis, seeking centers offering BrainGate / Speech Neuroprosthesis clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8115
  },
  {
    "request_id": "AM-REQ-2026-01971",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring speech prosthesis or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7872
  },
  {
    "request_id": "AM-REQ-2026-01972",
    "original_inquiry": "海外求诊：海外求诊：患者brain-computer interface，希望评估Wyss Center或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8445
  },
  {
    "request_id": "AM-REQ-2026-01973",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 运动皮层解码 or Blackrock Neurotech for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-01974",
    "original_inquiry": "研究者咨询：Patient with intracortical array seeking evaluation for Paradromics; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5192
  },
  {
    "request_id": "AM-REQ-2026-01975",
    "original_inquiry": "研究者咨询：希望了解brain-computer interface在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5075
  },
  {
    "request_id": "AM-REQ-2026-01976",
    "original_inquiry": "Family member with ALS, exploring 侵入式电极 or Wyss Center for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8274
  },
  {
    "request_id": "AM-REQ-2026-01977",
    "original_inquiry": "Family seeking information: Patient with BCI for ALS seeking evaluation for Paradromics; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5109
  },
  {
    "request_id": "AM-REQ-2026-01978",
    "original_inquiry": "海外求诊：Patient with brain-computer interface seeking evaluation for Blackrock Neurotech; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.87
  },
  {
    "request_id": "AM-REQ-2026-01979",
    "original_inquiry": "研究者咨询：Patient with motor neuroprosthesis seeking evaluation for Neuralink; interested in BrainGate trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8433
  },
  {
    "request_id": "AM-REQ-2026-01980",
    "original_inquiry": "Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6891
  },
  {
    "request_id": "AM-REQ-2026-01981",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解neural decoding在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8382
  },
  {
    "request_id": "AM-REQ-2026-01982",
    "original_inquiry": "研究者咨询：Urgent: BCI for ALS diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.734
  },
  {
    "request_id": "AM-REQ-2026-01983",
    "original_inquiry": "Urgent: 海外求诊：患者invasive cortical electrode，希望评估Synchron Stentrode或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8714
  },
  {
    "request_id": "AM-REQ-2026-01984",
    "original_inquiry": "Urgent: Patient with invasive cortical electrode seeking evaluation for Blackrock Neurotech; interested in Neuralink trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7279
  },
  {
    "request_id": "AM-REQ-2026-01985",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解侵入式电极在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6182
  },
  {
    "request_id": "AM-REQ-2026-01986",
    "original_inquiry": "Urgent: Neurologist referral: locked-in syndrome candidate for Wyss Center; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7734
  },
  {
    "request_id": "AM-REQ-2026-01987",
    "original_inquiry": "Consultation request: 脑机接口 for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5763
  },
  {
    "request_id": "AM-REQ-2026-01988",
    "original_inquiry": "Consultation request: locked-in syndrome for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8046
  },
  {
    "request_id": "AM-REQ-2026-01989",
    "original_inquiry": "Second opinion requested: Consultation request: speech decoding for Neuralink; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7227
  },
  {
    "request_id": "AM-REQ-2026-01990",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Wyss Center / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8837
  },
  {
    "request_id": "AM-REQ-2026-01991",
    "original_inquiry": "Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6054
  },
  {
    "request_id": "AM-REQ-2026-01992",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 侵入式电极 or Synchron Stentrode for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5592
  },
  {
    "request_id": "AM-REQ-2026-01993",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5972
  },
  {
    "request_id": "AM-REQ-2026-01994",
    "original_inquiry": "Urgent: 海外求诊：患者locked-in syndrome，希望评估Synchron Stentrode或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7529
  },
  {
    "request_id": "AM-REQ-2026-01995",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8122
  },
  {
    "request_id": "AM-REQ-2026-01996",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 语音神经假体 or Speech Neuroprosthesis for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.549
  },
  {
    "request_id": "AM-REQ-2026-01997",
    "original_inquiry": "Consultation request: 运动皮层解码 for Speech Neuroprosthesis; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7685
  },
  {
    "request_id": "AM-REQ-2026-01998",
    "original_inquiry": "Urgent: Consultation request: ECoG for Paradromics; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6417
  },
  {
    "request_id": "AM-REQ-2026-01999",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7055
  },
  {
    "request_id": "AM-REQ-2026-02000",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6436
  },
  {
    "request_id": "AM-REQ-2026-02001",
    "original_inquiry": "Referral from specialist: Urgent: neural decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5686
  },
  {
    "request_id": "AM-REQ-2026-02002",
    "original_inquiry": "Urgent: Neurologist referral: intracortical array candidate for Precision Neuroscience; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8903
  },
  {
    "request_id": "AM-REQ-2026-02003",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Wyss Center / Paradromics clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.602
  },
  {
    "request_id": "AM-REQ-2026-02004",
    "original_inquiry": "Second opinion requested: Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5144
  },
  {
    "request_id": "AM-REQ-2026-02005",
    "original_inquiry": "Urgent: Consultation request: speech decoding for Synchron Stentrode; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8876
  },
  {
    "request_id": "AM-REQ-2026-02006",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6338
  },
  {
    "request_id": "AM-REQ-2026-02007",
    "original_inquiry": "Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8796
  },
  {
    "request_id": "AM-REQ-2026-02008",
    "original_inquiry": "研究者咨询：Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5706
  },
  {
    "request_id": "AM-REQ-2026-02009",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring neural decoding or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8067
  },
  {
    "request_id": "AM-REQ-2026-02010",
    "original_inquiry": "海外求诊：Consultation request: invasive cortical electrode for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7645
  },
  {
    "request_id": "AM-REQ-2026-02011",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5223
  },
  {
    "request_id": "AM-REQ-2026-02012",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5079
  },
  {
    "request_id": "AM-REQ-2026-02013",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring motor neuroprosthesis or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6903
  },
  {
    "request_id": "AM-REQ-2026-02014",
    "original_inquiry": "Family seeking information: 海外求诊：患者speech prosthesis，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6053
  },
  {
    "request_id": "AM-REQ-2026-02015",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 运动皮层解码 or Paradromics for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7278
  },
  {
    "request_id": "AM-REQ-2026-02016",
    "original_inquiry": "Urgent: Family member with ALS, exploring 运动皮层解码 or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7238
  },
  {
    "request_id": "AM-REQ-2026-02017",
    "original_inquiry": "海外求诊：Consultation request: locked-in syndrome for Wyss Center; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8066
  },
  {
    "request_id": "AM-REQ-2026-02018",
    "original_inquiry": "Referral from specialist: Neurologist referral: motor neuroprosthesis candidate for Wyss Center; request information on Neuralink eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6869
  },
  {
    "request_id": "AM-REQ-2026-02019",
    "original_inquiry": "Second opinion requested: Consultation request: intracortical array for Blackrock Neurotech; interested in Synchron Stentrode and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8179
  },
  {
    "request_id": "AM-REQ-2026-02020",
    "original_inquiry": "Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5635
  },
  {
    "request_id": "AM-REQ-2026-02021",
    "original_inquiry": "研究者咨询：Urgent: BCI for ALS diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7421
  },
  {
    "request_id": "AM-REQ-2026-02022",
    "original_inquiry": "Urgent: Consultation request: neural decoding for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5024
  },
  {
    "request_id": "AM-REQ-2026-02023",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6629
  },
  {
    "request_id": "AM-REQ-2026-02024",
    "original_inquiry": "Referral from specialist: Neurologist referral: invasive cortical electrode candidate for Synchron Stentrode; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7004
  },
  {
    "request_id": "AM-REQ-2026-02025",
    "original_inquiry": "海外求诊：Urgent: invasive cortical electrode diagnosis, seeking centers offering Synchron Stentrode / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5976
  },
  {
    "request_id": "AM-REQ-2026-02026",
    "original_inquiry": "Second opinion requested: Consultation request: locked-in syndrome for Precision Neuroscience; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.846
  },
  {
    "request_id": "AM-REQ-2026-02027",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解脑机接口在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8063
  },
  {
    "request_id": "AM-REQ-2026-02028",
    "original_inquiry": "Urgent: Urgent: speech prosthesis diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7041
  },
  {
    "request_id": "AM-REQ-2026-02029",
    "original_inquiry": "海外求诊：Patient with motor neuroprosthesis seeking evaluation for Speech Neuroprosthesis; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6759
  },
  {
    "request_id": "AM-REQ-2026-02030",
    "original_inquiry": "Second opinion requested: Patient with speech prosthesis seeking evaluation for Blackrock Neurotech; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6492
  },
  {
    "request_id": "AM-REQ-2026-02031",
    "original_inquiry": "Referral from specialist: Patient with 语音神经假体 seeking evaluation for BrainGate; interested in Precision Neuroscience trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8801
  },
  {
    "request_id": "AM-REQ-2026-02032",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5726
  },
  {
    "request_id": "AM-REQ-2026-02033",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for Speech Neuroprosthesis; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8216
  },
  {
    "request_id": "AM-REQ-2026-02034",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8028
  },
  {
    "request_id": "AM-REQ-2026-02035",
    "original_inquiry": "Referral from specialist: Patient with 脑机接口 seeking evaluation for Blackrock Neurotech; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7456
  },
  {
    "request_id": "AM-REQ-2026-02036",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring BCI for ALS or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8591
  },
  {
    "request_id": "AM-REQ-2026-02037",
    "original_inquiry": "Second opinion requested: Patient with 语音神经假体 seeking evaluation for BrainGate; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7092
  },
  {
    "request_id": "AM-REQ-2026-02038",
    "original_inquiry": "海外求诊：患者intracortical array，希望评估Wyss Center或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8475
  },
  {
    "request_id": "AM-REQ-2026-02039",
    "original_inquiry": "海外求诊：患者speech decoding，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7047
  },
  {
    "request_id": "AM-REQ-2026-02040",
    "original_inquiry": "Second opinion requested: Consultation request: ECoG for Wyss Center; interested in Synchron Stentrode and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8538
  },
  {
    "request_id": "AM-REQ-2026-02041",
    "original_inquiry": "Family seeking information: Urgent: BCI for ALS diagnosis, seeking centers offering Paradromics / Neuralink clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5698
  },
  {
    "request_id": "AM-REQ-2026-02042",
    "original_inquiry": "研究者咨询：Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8699
  },
  {
    "request_id": "AM-REQ-2026-02043",
    "original_inquiry": "Second opinion requested: 海外求诊：患者neural decoding，希望评估Wyss Center或Speech Neuroprosthesis项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5761
  },
  {
    "request_id": "AM-REQ-2026-02044",
    "original_inquiry": "Family seeking information: Urgent: motor neuroprosthesis diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6232
  },
  {
    "request_id": "AM-REQ-2026-02045",
    "original_inquiry": "Referral from specialist: 海外求诊：患者intracortical array，希望评估Blackrock Neurotech或BrainGate项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5343
  },
  {
    "request_id": "AM-REQ-2026-02046",
    "original_inquiry": "Referral from specialist: 海外求诊：患者intracortical array，希望评估Precision Neuroscience或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-02047",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解speech decoding在BrainGate适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8156
  },
  {
    "request_id": "AM-REQ-2026-02048",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5859
  },
  {
    "request_id": "AM-REQ-2026-02049",
    "original_inquiry": "Referral from specialist: Consultation request: ECoG for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7185
  },
  {
    "request_id": "AM-REQ-2026-02050",
    "original_inquiry": "Patient with 侵入式电极 seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.764
  },
  {
    "request_id": "AM-REQ-2026-02051",
    "original_inquiry": "海外求诊：Family member with ALS, exploring neural decoding or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5727
  },
  {
    "request_id": "AM-REQ-2026-02052",
    "original_inquiry": "海外求诊：Consultation request: 侵入式电极 for Wyss Center; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8462
  },
  {
    "request_id": "AM-REQ-2026-02053",
    "original_inquiry": "Referral from specialist: Neurologist referral: 侵入式电极 candidate for Blackrock Neurotech; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5509
  },
  {
    "request_id": "AM-REQ-2026-02054",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring invasive cortical electrode or Wyss Center for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7587
  },
  {
    "request_id": "AM-REQ-2026-02055",
    "original_inquiry": "Urgent: Consultation request: speech prosthesis for Paradromics; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6622
  },
  {
    "request_id": "AM-REQ-2026-02056",
    "original_inquiry": "海外求诊：Family member with ALS, exploring ECoG or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5906
  },
  {
    "request_id": "AM-REQ-2026-02057",
    "original_inquiry": "海外求诊：Consultation request: 侵入式电极 for Neuralink; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8565
  },
  {
    "request_id": "AM-REQ-2026-02058",
    "original_inquiry": "Referral from specialist: Patient with ECoG seeking evaluation for BrainGate; interested in Precision Neuroscience trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7502
  },
  {
    "request_id": "AM-REQ-2026-02059",
    "original_inquiry": "Family seeking information: Consultation request: 运动皮层解码 for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7143
  },
  {
    "request_id": "AM-REQ-2026-02060",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8508
  },
  {
    "request_id": "AM-REQ-2026-02061",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7122
  },
  {
    "request_id": "AM-REQ-2026-02062",
    "original_inquiry": "研究者咨询：海外求诊：患者运动皮层解码，希望评估BrainGate或Wyss Center项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8246
  },
  {
    "request_id": "AM-REQ-2026-02063",
    "original_inquiry": "Neurologist referral: 脑机接口 candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8027
  },
  {
    "request_id": "AM-REQ-2026-02064",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解locked-in syndrome在Precision Neuroscience适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8495
  },
  {
    "request_id": "AM-REQ-2026-02065",
    "original_inquiry": "Referral from specialist: Urgent: invasive cortical electrode diagnosis, seeking centers offering Paradromics / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8355
  },
  {
    "request_id": "AM-REQ-2026-02066",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 运动皮层解码 or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-02067",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring 脑机接口 or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.731
  },
  {
    "request_id": "AM-REQ-2026-02068",
    "original_inquiry": "研究者咨询：Consultation request: 脑机接口 for BrainGate; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8148
  },
  {
    "request_id": "AM-REQ-2026-02069",
    "original_inquiry": "Urgent: Neurologist referral: speech decoding candidate for Precision Neuroscience; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.814
  },
  {
    "request_id": "AM-REQ-2026-02070",
    "original_inquiry": "Family seeking information: Consultation request: neural decoding for Neuralink; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5039
  },
  {
    "request_id": "AM-REQ-2026-02071",
    "original_inquiry": "Neurologist referral: intracortical array candidate for BrainGate; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5486
  },
  {
    "request_id": "AM-REQ-2026-02072",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解neural decoding在BrainGate适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.69
  },
  {
    "request_id": "AM-REQ-2026-02073",
    "original_inquiry": "研究者咨询：希望了解ECoG在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8825
  },
  {
    "request_id": "AM-REQ-2026-02074",
    "original_inquiry": "Referral from specialist: Neurologist referral: neural decoding candidate for BrainGate; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6224
  },
  {
    "request_id": "AM-REQ-2026-02075",
    "original_inquiry": "Second opinion requested: 海外求诊：患者BCI for ALS，希望评估Neuralink或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-02076",
    "original_inquiry": "Urgent: Family member with ALS, exploring 语音神经假体 or Neuralink for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6609
  },
  {
    "request_id": "AM-REQ-2026-02077",
    "original_inquiry": "海外求诊：Patient with speech prosthesis seeking evaluation for BrainGate; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6234
  },
  {
    "request_id": "AM-REQ-2026-02078",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6517
  },
  {
    "request_id": "AM-REQ-2026-02079",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring speech prosthesis or Paradromics for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8861
  },
  {
    "request_id": "AM-REQ-2026-02080",
    "original_inquiry": "研究者咨询：Urgent: 语音神经假体 diagnosis, seeking centers offering Wyss Center / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6798
  },
  {
    "request_id": "AM-REQ-2026-02081",
    "original_inquiry": "Family seeking information: Neurologist referral: 脑机接口 candidate for Paradromics; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5955
  },
  {
    "request_id": "AM-REQ-2026-02082",
    "original_inquiry": "Urgent: Consultation request: neural decoding for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7873
  },
  {
    "request_id": "AM-REQ-2026-02083",
    "original_inquiry": "Referral from specialist: Patient with invasive cortical electrode seeking evaluation for Neuralink; interested in Paradromics trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8132
  },
  {
    "request_id": "AM-REQ-2026-02084",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for Synchron Stentrode; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.586
  },
  {
    "request_id": "AM-REQ-2026-02085",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解locked-in syndrome在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-02086",
    "original_inquiry": "研究者咨询：希望了解ECoG在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-02087",
    "original_inquiry": "Family seeking information: Urgent: ECoG diagnosis, seeking centers offering Synchron Stentrode / Paradromics clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6008
  },
  {
    "request_id": "AM-REQ-2026-02088",
    "original_inquiry": "Urgent: 研究者咨询：希望了解BCI for ALS在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8012
  },
  {
    "request_id": "AM-REQ-2026-02089",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8832
  },
  {
    "request_id": "AM-REQ-2026-02090",
    "original_inquiry": "Family member with ALS, exploring locked-in syndrome or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6731
  },
  {
    "request_id": "AM-REQ-2026-02091",
    "original_inquiry": "Referral from specialist: 海外求诊：患者brain-computer interface，希望评估Blackrock Neurotech或Neuralink项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7137
  },
  {
    "request_id": "AM-REQ-2026-02092",
    "original_inquiry": "研究者咨询：Patient with motor neuroprosthesis seeking evaluation for Wyss Center; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8403
  },
  {
    "request_id": "AM-REQ-2026-02093",
    "original_inquiry": "研究者咨询：Neurologist referral: 语音神经假体 candidate for Wyss Center; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7515
  },
  {
    "request_id": "AM-REQ-2026-02094",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech decoding在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8178
  },
  {
    "request_id": "AM-REQ-2026-02095",
    "original_inquiry": "Neurologist referral: motor neuroprosthesis candidate for Synchron Stentrode; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8249
  },
  {
    "request_id": "AM-REQ-2026-02096",
    "original_inquiry": "Urgent: 海外求诊：患者intracortical array，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5354
  },
  {
    "request_id": "AM-REQ-2026-02097",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6027
  },
  {
    "request_id": "AM-REQ-2026-02098",
    "original_inquiry": "海外求诊：研究者咨询：希望了解语音神经假体在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6261
  },
  {
    "request_id": "AM-REQ-2026-02099",
    "original_inquiry": "海外求诊：研究者咨询：希望了解neural decoding在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7141
  },
  {
    "request_id": "AM-REQ-2026-02100",
    "original_inquiry": "Second opinion requested: Patient with 语音神经假体 seeking evaluation for Neuralink; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6157
  },
  {
    "request_id": "AM-REQ-2026-02101",
    "original_inquiry": "Family member with ALS, exploring motor neuroprosthesis or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8105
  },
  {
    "request_id": "AM-REQ-2026-02102",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解speech decoding在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7321
  },
  {
    "request_id": "AM-REQ-2026-02103",
    "original_inquiry": "Consultation request: invasive cortical electrode for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5701
  },
  {
    "request_id": "AM-REQ-2026-02104",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for BrainGate; request information on Neuralink eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-02105",
    "original_inquiry": "海外求诊：研究者咨询：希望了解运动皮层解码在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7803
  },
  {
    "request_id": "AM-REQ-2026-02106",
    "original_inquiry": "海外求诊：Urgent: speech decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8456
  },
  {
    "request_id": "AM-REQ-2026-02107",
    "original_inquiry": "研究者咨询：希望了解语音神经假体在Paradromics适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7481
  },
  {
    "request_id": "AM-REQ-2026-02108",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解brain-computer interface在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5906
  },
  {
    "request_id": "AM-REQ-2026-02109",
    "original_inquiry": "海外求诊：海外求诊：患者speech prosthesis，希望评估Wyss Center或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7882
  },
  {
    "request_id": "AM-REQ-2026-02110",
    "original_inquiry": "海外求诊：Consultation request: invasive cortical electrode for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5457
  },
  {
    "request_id": "AM-REQ-2026-02111",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6155
  },
  {
    "request_id": "AM-REQ-2026-02112",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5807
  },
  {
    "request_id": "AM-REQ-2026-02113",
    "original_inquiry": "Second opinion requested: Consultation request: 脑机接口 for BrainGate; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6105
  },
  {
    "request_id": "AM-REQ-2026-02114",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring motor neuroprosthesis or Speech Neuroprosthesis for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7432
  },
  {
    "request_id": "AM-REQ-2026-02115",
    "original_inquiry": "研究者咨询：希望了解neural decoding在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8937
  },
  {
    "request_id": "AM-REQ-2026-02116",
    "original_inquiry": "Urgent: 研究者咨询：希望了解invasive cortical electrode在Wyss Center适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.814
  },
  {
    "request_id": "AM-REQ-2026-02117",
    "original_inquiry": "Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6654
  },
  {
    "request_id": "AM-REQ-2026-02118",
    "original_inquiry": "Referral from specialist: Consultation request: 脑机接口 for Paradromics; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6679
  },
  {
    "request_id": "AM-REQ-2026-02119",
    "original_inquiry": "海外求诊：Patient with speech decoding seeking evaluation for Paradromics; interested in Speech Neuroprosthesis trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7004
  },
  {
    "request_id": "AM-REQ-2026-02120",
    "original_inquiry": "Referral from specialist: Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8495
  },
  {
    "request_id": "AM-REQ-2026-02121",
    "original_inquiry": "Referral from specialist: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Paradromics / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8979
  },
  {
    "request_id": "AM-REQ-2026-02122",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring brain-computer interface or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5937
  },
  {
    "request_id": "AM-REQ-2026-02123",
    "original_inquiry": "Urgent: Patient with 语音神经假体 seeking evaluation for Speech Neuroprosthesis; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7993
  },
  {
    "request_id": "AM-REQ-2026-02124",
    "original_inquiry": "Second opinion requested: Patient with motor neuroprosthesis seeking evaluation for Synchron Stentrode; interested in Paradromics trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.83
  },
  {
    "request_id": "AM-REQ-2026-02125",
    "original_inquiry": "Referral from specialist: Patient with 运动皮层解码 seeking evaluation for Synchron Stentrode; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7245
  },
  {
    "request_id": "AM-REQ-2026-02126",
    "original_inquiry": "海外求诊：患者运动皮层解码，希望评估Synchron Stentrode或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8646
  },
  {
    "request_id": "AM-REQ-2026-02127",
    "original_inquiry": "海外求诊：Neurologist referral: speech prosthesis candidate for Blackrock Neurotech; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8647
  },
  {
    "request_id": "AM-REQ-2026-02128",
    "original_inquiry": "Urgent: motor neuroprosthesis diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6625
  },
  {
    "request_id": "AM-REQ-2026-02129",
    "original_inquiry": "Urgent: Neurologist referral: BCI for ALS candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8919
  },
  {
    "request_id": "AM-REQ-2026-02130",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7392
  },
  {
    "request_id": "AM-REQ-2026-02131",
    "original_inquiry": "研究者咨询：Urgent: brain-computer interface diagnosis, seeking centers offering Precision Neuroscience / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7843
  },
  {
    "request_id": "AM-REQ-2026-02132",
    "original_inquiry": "Family seeking information: Consultation request: brain-computer interface for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-02133",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech prosthesis or Wyss Center for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8417
  },
  {
    "request_id": "AM-REQ-2026-02134",
    "original_inquiry": "Urgent: 侵入式电极 diagnosis, seeking centers offering Paradromics / BrainGate clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7978
  },
  {
    "request_id": "AM-REQ-2026-02135",
    "original_inquiry": "Urgent: Neurologist referral: neural decoding candidate for Synchron Stentrode; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6129
  },
  {
    "request_id": "AM-REQ-2026-02136",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解ECoG在Synchron Stentrode适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5831
  },
  {
    "request_id": "AM-REQ-2026-02137",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6411
  },
  {
    "request_id": "AM-REQ-2026-02138",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7999
  },
  {
    "request_id": "AM-REQ-2026-02139",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Speech Neuroprosthesis / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8809
  },
  {
    "request_id": "AM-REQ-2026-02140",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解intracortical array在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.642
  },
  {
    "request_id": "AM-REQ-2026-02141",
    "original_inquiry": "Family seeking information: Urgent: invasive cortical electrode diagnosis, seeking centers offering Precision Neuroscience / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6861
  },
  {
    "request_id": "AM-REQ-2026-02142",
    "original_inquiry": "Urgent: 研究者咨询：希望了解motor neuroprosthesis在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.88
  },
  {
    "request_id": "AM-REQ-2026-02143",
    "original_inquiry": "Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8266
  },
  {
    "request_id": "AM-REQ-2026-02144",
    "original_inquiry": "Referral from specialist: Neurologist referral: 脑机接口 candidate for Neuralink; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7241
  },
  {
    "request_id": "AM-REQ-2026-02145",
    "original_inquiry": "Neurologist referral: intracortical array candidate for Neuralink; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.777
  },
  {
    "request_id": "AM-REQ-2026-02146",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8929
  },
  {
    "request_id": "AM-REQ-2026-02147",
    "original_inquiry": "Patient with neural decoding seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6254
  },
  {
    "request_id": "AM-REQ-2026-02148",
    "original_inquiry": "海外求诊：Neurologist referral: ECoG candidate for Blackrock Neurotech; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.834
  },
  {
    "request_id": "AM-REQ-2026-02149",
    "original_inquiry": "Second opinion requested: Urgent: speech prosthesis diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6669
  },
  {
    "request_id": "AM-REQ-2026-02150",
    "original_inquiry": "Family seeking information: 海外求诊：患者intracortical array，希望评估Precision Neuroscience或BrainGate项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5715
  },
  {
    "request_id": "AM-REQ-2026-02151",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Wyss Center; interested in Speech Neuroprosthesis trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8364
  },
  {
    "request_id": "AM-REQ-2026-02152",
    "original_inquiry": "Urgent: Consultation request: motor neuroprosthesis for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5938
  },
  {
    "request_id": "AM-REQ-2026-02153",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7283
  },
  {
    "request_id": "AM-REQ-2026-02154",
    "original_inquiry": "Consultation request: neural decoding for Blackrock Neurotech; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8924
  },
  {
    "request_id": "AM-REQ-2026-02155",
    "original_inquiry": "研究者咨询：海外求诊：患者brain-computer interface，希望评估Precision Neuroscience或Neuralink项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7426
  },
  {
    "request_id": "AM-REQ-2026-02156",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6172
  },
  {
    "request_id": "AM-REQ-2026-02157",
    "original_inquiry": "Urgent: 海外求诊：患者BCI for ALS，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5961
  },
  {
    "request_id": "AM-REQ-2026-02158",
    "original_inquiry": "研究者咨询：Urgent: ECoG diagnosis, seeking centers offering Paradromics / Wyss Center clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.524
  },
  {
    "request_id": "AM-REQ-2026-02159",
    "original_inquiry": "Urgent: Consultation request: intracortical array for BrainGate; interested in Paradromics and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7667
  },
  {
    "request_id": "AM-REQ-2026-02160",
    "original_inquiry": "研究者咨询：海外求诊：患者invasive cortical electrode，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8321
  },
  {
    "request_id": "AM-REQ-2026-02161",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解locked-in syndrome在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.746
  },
  {
    "request_id": "AM-REQ-2026-02162",
    "original_inquiry": "Family member with ALS, exploring invasive cortical electrode or Synchron Stentrode for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5834
  },
  {
    "request_id": "AM-REQ-2026-02163",
    "original_inquiry": "Urgent: Consultation request: 侵入式电极 for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5884
  },
  {
    "request_id": "AM-REQ-2026-02164",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解ECoG在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6772
  },
  {
    "request_id": "AM-REQ-2026-02165",
    "original_inquiry": "Family seeking information: Neurologist referral: locked-in syndrome candidate for Speech Neuroprosthesis; request information on Wyss Center eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6947
  },
  {
    "request_id": "AM-REQ-2026-02166",
    "original_inquiry": "海外求诊：Consultation request: intracortical array for BrainGate; interested in Neuralink and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5436
  },
  {
    "request_id": "AM-REQ-2026-02167",
    "original_inquiry": "Referral from specialist: Neurologist referral: ECoG candidate for Synchron Stentrode; request information on Paradromics eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8661
  },
  {
    "request_id": "AM-REQ-2026-02168",
    "original_inquiry": "海外求诊：研究者咨询：希望了解脑机接口在Precision Neuroscience适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6402
  },
  {
    "request_id": "AM-REQ-2026-02169",
    "original_inquiry": "Family seeking information: 海外求诊：患者invasive cortical electrode，希望评估Wyss Center或Neuralink项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8302
  },
  {
    "request_id": "AM-REQ-2026-02170",
    "original_inquiry": "Neurologist referral: speech prosthesis candidate for Blackrock Neurotech; request information on BrainGate eligibility.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7016
  },
  {
    "request_id": "AM-REQ-2026-02171",
    "original_inquiry": "Family seeking information: 海外求诊：患者语音神经假体，希望评估Precision Neuroscience或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7
  },
  {
    "request_id": "AM-REQ-2026-02172",
    "original_inquiry": "Second opinion requested: Neurologist referral: invasive cortical electrode candidate for Paradromics; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5996
  },
  {
    "request_id": "AM-REQ-2026-02173",
    "original_inquiry": "Consultation request: BCI for ALS for Paradromics; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-02174",
    "original_inquiry": "研究者咨询：海外求诊：患者BCI for ALS，希望评估Synchron Stentrode或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7606
  },
  {
    "request_id": "AM-REQ-2026-02175",
    "original_inquiry": "Neurologist referral: locked-in syndrome candidate for Synchron Stentrode; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.899
  },
  {
    "request_id": "AM-REQ-2026-02176",
    "original_inquiry": "Urgent: Family member with ALS, exploring locked-in syndrome or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5485
  },
  {
    "request_id": "AM-REQ-2026-02177",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5539
  },
  {
    "request_id": "AM-REQ-2026-02178",
    "original_inquiry": "海外求诊：Consultation request: BCI for ALS for Paradromics; interested in Precision Neuroscience and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6204
  },
  {
    "request_id": "AM-REQ-2026-02179",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7664
  },
  {
    "request_id": "AM-REQ-2026-02180",
    "original_inquiry": "研究者咨询：Neurologist referral: 侵入式电极 candidate for Synchron Stentrode; request information on Speech Neuroprosthesis eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-02181",
    "original_inquiry": "Second opinion requested: Patient with 语音神经假体 seeking evaluation for Neuralink; interested in BrainGate trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8686
  },
  {
    "request_id": "AM-REQ-2026-02182",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8534
  },
  {
    "request_id": "AM-REQ-2026-02183",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解脑机接口在Paradromics适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.792
  },
  {
    "request_id": "AM-REQ-2026-02184",
    "original_inquiry": "海外求诊：患者语音神经假体，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5402
  },
  {
    "request_id": "AM-REQ-2026-02185",
    "original_inquiry": "Second opinion requested: Consultation request: ECoG for Precision Neuroscience; interested in Paradromics and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-02186",
    "original_inquiry": "Referral from specialist: Consultation request: neural decoding for Blackrock Neurotech; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-02187",
    "original_inquiry": "研究者咨询：Urgent: ECoG diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.577
  },
  {
    "request_id": "AM-REQ-2026-02188",
    "original_inquiry": "研究者咨询：Neurologist referral: ECoG candidate for Synchron Stentrode; request information on Speech Neuroprosthesis eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7086
  },
  {
    "request_id": "AM-REQ-2026-02189",
    "original_inquiry": "Second opinion requested: Patient with 脑机接口 seeking evaluation for Paradromics; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5187
  },
  {
    "request_id": "AM-REQ-2026-02190",
    "original_inquiry": "Family member with ALS, exploring motor neuroprosthesis or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6223
  },
  {
    "request_id": "AM-REQ-2026-02191",
    "original_inquiry": "Family seeking information: Urgent: 语音神经假体 diagnosis, seeking centers offering Synchron Stentrode / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5656
  },
  {
    "request_id": "AM-REQ-2026-02192",
    "original_inquiry": "海外求诊：Patient with 运动皮层解码 seeking evaluation for Synchron Stentrode; interested in Precision Neuroscience trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7331
  },
  {
    "request_id": "AM-REQ-2026-02193",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解invasive cortical electrode在Paradromics适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6375
  },
  {
    "request_id": "AM-REQ-2026-02194",
    "original_inquiry": "Second opinion requested: Consultation request: neural decoding for Paradromics; interested in Blackrock Neurotech and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8543
  },
  {
    "request_id": "AM-REQ-2026-02195",
    "original_inquiry": "海外求诊：Consultation request: locked-in syndrome for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7557
  },
  {
    "request_id": "AM-REQ-2026-02196",
    "original_inquiry": "Urgent: Patient with neural decoding seeking evaluation for Blackrock Neurotech; interested in Wyss Center trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.591
  },
  {
    "request_id": "AM-REQ-2026-02197",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7974
  },
  {
    "request_id": "AM-REQ-2026-02198",
    "original_inquiry": "Urgent: Urgent: locked-in syndrome diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5778
  },
  {
    "request_id": "AM-REQ-2026-02199",
    "original_inquiry": "Family seeking information: Urgent: locked-in syndrome diagnosis, seeking centers offering Neuralink / Blackrock Neurotech clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6656
  },
  {
    "request_id": "AM-REQ-2026-02200",
    "original_inquiry": "Referral from specialist: 海外求诊：患者运动皮层解码，希望评估Neuralink或Wyss Center项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5319
  },
  {
    "request_id": "AM-REQ-2026-02201",
    "original_inquiry": "海外求诊：Urgent: 侵入式电极 diagnosis, seeking centers offering Neuralink / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5935
  },
  {
    "request_id": "AM-REQ-2026-02202",
    "original_inquiry": "Family seeking information: 海外求诊：患者侵入式电极，希望评估BrainGate或Synchron Stentrode项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-02203",
    "original_inquiry": "海外求诊：患者invasive cortical electrode，希望评估Speech Neuroprosthesis或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5942
  },
  {
    "request_id": "AM-REQ-2026-02204",
    "original_inquiry": "Urgent: Family member with ALS, exploring invasive cortical electrode or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8477
  },
  {
    "request_id": "AM-REQ-2026-02205",
    "original_inquiry": "研究者咨询：Neurologist referral: motor neuroprosthesis candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7308
  },
  {
    "request_id": "AM-REQ-2026-02206",
    "original_inquiry": "海外求诊：Urgent: 语音神经假体 diagnosis, seeking centers offering Precision Neuroscience / Synchron Stentrode clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7619
  },
  {
    "request_id": "AM-REQ-2026-02207",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring speech decoding or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7027
  },
  {
    "request_id": "AM-REQ-2026-02208",
    "original_inquiry": "Urgent: Consultation request: 运动皮层解码 for Synchron Stentrode; interested in Speech Neuroprosthesis and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6088
  },
  {
    "request_id": "AM-REQ-2026-02209",
    "original_inquiry": "Second opinion requested: Consultation request: ECoG for BrainGate; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8947
  },
  {
    "request_id": "AM-REQ-2026-02210",
    "original_inquiry": "海外求诊：患者ECoG，希望评估Paradromics或Wyss Center项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7679
  },
  {
    "request_id": "AM-REQ-2026-02211",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring intracortical array or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6217
  },
  {
    "request_id": "AM-REQ-2026-02212",
    "original_inquiry": "Family seeking information: Patient with BCI for ALS seeking evaluation for Speech Neuroprosthesis; interested in Blackrock Neurotech trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5011
  },
  {
    "request_id": "AM-REQ-2026-02213",
    "original_inquiry": "海外求诊：Consultation request: 运动皮层解码 for Precision Neuroscience; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6086
  },
  {
    "request_id": "AM-REQ-2026-02214",
    "original_inquiry": "海外求诊：Neurologist referral: 运动皮层解码 candidate for Wyss Center; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8726
  },
  {
    "request_id": "AM-REQ-2026-02215",
    "original_inquiry": "Referral from specialist: Urgent: 语音神经假体 diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-02216",
    "original_inquiry": "Referral from specialist: Urgent: ECoG diagnosis, seeking centers offering Precision Neuroscience / Synchron Stentrode clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.554
  },
  {
    "request_id": "AM-REQ-2026-02217",
    "original_inquiry": "Family member with ALS, exploring 语音神经假体 or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7694
  },
  {
    "request_id": "AM-REQ-2026-02218",
    "original_inquiry": "Family seeking information: Urgent: intracortical array diagnosis, seeking centers offering Neuralink / BrainGate clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8672
  },
  {
    "request_id": "AM-REQ-2026-02219",
    "original_inquiry": "海外求诊：研究者咨询：希望了解neural decoding在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5928
  },
  {
    "request_id": "AM-REQ-2026-02220",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8165
  },
  {
    "request_id": "AM-REQ-2026-02221",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.552
  },
  {
    "request_id": "AM-REQ-2026-02222",
    "original_inquiry": "研究者咨询：希望了解motor neuroprosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6104
  },
  {
    "request_id": "AM-REQ-2026-02223",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring ECoG or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5228
  },
  {
    "request_id": "AM-REQ-2026-02224",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8479
  },
  {
    "request_id": "AM-REQ-2026-02225",
    "original_inquiry": "海外求诊：Consultation request: intracortical array for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5263
  },
  {
    "request_id": "AM-REQ-2026-02226",
    "original_inquiry": "Urgent: Family member with ALS, exploring 侵入式电极 or Paradromics for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5462
  },
  {
    "request_id": "AM-REQ-2026-02227",
    "original_inquiry": "Urgent: Consultation request: motor neuroprosthesis for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8032
  },
  {
    "request_id": "AM-REQ-2026-02228",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6169
  },
  {
    "request_id": "AM-REQ-2026-02229",
    "original_inquiry": "海外求诊：Consultation request: invasive cortical electrode for Synchron Stentrode; interested in Paradromics and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7177
  },
  {
    "request_id": "AM-REQ-2026-02230",
    "original_inquiry": "Referral from specialist: Urgent: speech decoding diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6773
  },
  {
    "request_id": "AM-REQ-2026-02231",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5377
  },
  {
    "request_id": "AM-REQ-2026-02232",
    "original_inquiry": "Referral from specialist: 海外求诊：患者ECoG，希望评估Wyss Center或Blackrock Neurotech项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6352
  },
  {
    "request_id": "AM-REQ-2026-02233",
    "original_inquiry": "研究者咨询：Consultation request: 语音神经假体 for Wyss Center; interested in Precision Neuroscience and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5761
  },
  {
    "request_id": "AM-REQ-2026-02234",
    "original_inquiry": "Second opinion requested: Urgent: invasive cortical electrode diagnosis, seeking centers offering BrainGate / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6983
  },
  {
    "request_id": "AM-REQ-2026-02235",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8226
  },
  {
    "request_id": "AM-REQ-2026-02236",
    "original_inquiry": "海外求诊：Family member with ALS, exploring motor neuroprosthesis or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7303
  },
  {
    "request_id": "AM-REQ-2026-02237",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6888
  },
  {
    "request_id": "AM-REQ-2026-02238",
    "original_inquiry": "Consultation request: neural decoding for Synchron Stentrode; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7556
  },
  {
    "request_id": "AM-REQ-2026-02239",
    "original_inquiry": "Urgent: Patient with intracortical array seeking evaluation for Neuralink; interested in BrainGate trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7473
  },
  {
    "request_id": "AM-REQ-2026-02240",
    "original_inquiry": "Referral from specialist: Urgent: invasive cortical electrode diagnosis, seeking centers offering Blackrock Neurotech / Precision Neuroscience clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5094
  },
  {
    "request_id": "AM-REQ-2026-02241",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8468
  },
  {
    "request_id": "AM-REQ-2026-02242",
    "original_inquiry": "Family seeking information: 海外求诊：患者ECoG，希望评估Precision Neuroscience或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7946
  },
  {
    "request_id": "AM-REQ-2026-02243",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking motor neuroprosthesis or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5338
  },
  {
    "request_id": "AM-REQ-2026-02244",
    "original_inquiry": "Family seeking information: Neurologist referral: neural decoding candidate for Blackrock Neurotech; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5178
  },
  {
    "request_id": "AM-REQ-2026-02245",
    "original_inquiry": "Neurologist referral: 语音神经假体 candidate for BrainGate; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.699
  },
  {
    "request_id": "AM-REQ-2026-02246",
    "original_inquiry": "Second opinion requested: 海外求诊：患者语音神经假体，希望评估Precision Neuroscience或Synchron Stentrode项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5357
  },
  {
    "request_id": "AM-REQ-2026-02247",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for BrainGate; request information on Paradromics eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7607
  },
  {
    "request_id": "AM-REQ-2026-02248",
    "original_inquiry": "Urgent: Consultation request: BCI for ALS for Blackrock Neurotech; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5583
  },
  {
    "request_id": "AM-REQ-2026-02249",
    "original_inquiry": "Urgent: Urgent: motor neuroprosthesis diagnosis, seeking centers offering BrainGate / Synchron Stentrode clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-02250",
    "original_inquiry": "Second opinion requested: Neurologist referral: locked-in syndrome candidate for Synchron Stentrode; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6375
  },
  {
    "request_id": "AM-REQ-2026-02251",
    "original_inquiry": "Family member with ALS, exploring locked-in syndrome or Paradromics for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.503
  },
  {
    "request_id": "AM-REQ-2026-02252",
    "original_inquiry": "Family seeking information: Consultation request: 语音神经假体 for Neuralink; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7677
  },
  {
    "request_id": "AM-REQ-2026-02253",
    "original_inquiry": "Referral from specialist: Consultation request: speech decoding for Speech Neuroprosthesis; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.718
  },
  {
    "request_id": "AM-REQ-2026-02254",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7565
  },
  {
    "request_id": "AM-REQ-2026-02255",
    "original_inquiry": "Urgent: Neurologist referral: motor neuroprosthesis candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7651
  },
  {
    "request_id": "AM-REQ-2026-02256",
    "original_inquiry": "Urgent: Consultation request: invasive cortical electrode for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6099
  },
  {
    "request_id": "AM-REQ-2026-02257",
    "original_inquiry": "Patient with 侵入式电极 seeking evaluation for Paradromics; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5074
  },
  {
    "request_id": "AM-REQ-2026-02258",
    "original_inquiry": "海外求诊：Neurologist referral: 运动皮层解码 candidate for Speech Neuroprosthesis; request information on Synchron Stentrode eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7756
  },
  {
    "request_id": "AM-REQ-2026-02259",
    "original_inquiry": "Urgent: speech decoding diagnosis, seeking centers offering Speech Neuroprosthesis / Precision Neuroscience clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7001
  },
  {
    "request_id": "AM-REQ-2026-02260",
    "original_inquiry": "Referral from specialist: Urgent: 运动皮层解码 diagnosis, seeking centers offering Synchron Stentrode / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8055
  },
  {
    "request_id": "AM-REQ-2026-02261",
    "original_inquiry": "Referral from specialist: Patient with invasive cortical electrode seeking evaluation for Blackrock Neurotech; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5737
  },
  {
    "request_id": "AM-REQ-2026-02262",
    "original_inquiry": "Urgent: Urgent: ECoG diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5919
  },
  {
    "request_id": "AM-REQ-2026-02263",
    "original_inquiry": "研究者咨询：Patient with speech decoding seeking evaluation for Paradromics; interested in Precision Neuroscience trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8681
  },
  {
    "request_id": "AM-REQ-2026-02264",
    "original_inquiry": "海外求诊：Urgent: invasive cortical electrode diagnosis, seeking centers offering BrainGate / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8697
  },
  {
    "request_id": "AM-REQ-2026-02265",
    "original_inquiry": "研究者咨询：Urgent: 脑机接口 diagnosis, seeking centers offering BrainGate / Paradromics clinical programs.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6434
  },
  {
    "request_id": "AM-REQ-2026-02266",
    "original_inquiry": "Referral from specialist: Neurologist referral: 语音神经假体 candidate for BrainGate; request information on Blackrock Neurotech eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5868
  },
  {
    "request_id": "AM-REQ-2026-02267",
    "original_inquiry": "海外求诊：研究者咨询：希望了解脑机接口在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5404
  },
  {
    "request_id": "AM-REQ-2026-02268",
    "original_inquiry": "Consultation request: 脑机接口 for Speech Neuroprosthesis; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8967
  },
  {
    "request_id": "AM-REQ-2026-02269",
    "original_inquiry": "Family seeking information: Patient with speech decoding seeking evaluation for Wyss Center; interested in Precision Neuroscience trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7494
  },
  {
    "request_id": "AM-REQ-2026-02270",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解intracortical array在Paradromics适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5973
  },
  {
    "request_id": "AM-REQ-2026-02271",
    "original_inquiry": "Second opinion requested: Patient with 运动皮层解码 seeking evaluation for Synchron Stentrode; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8047
  },
  {
    "request_id": "AM-REQ-2026-02272",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking locked-in syndrome or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8802
  },
  {
    "request_id": "AM-REQ-2026-02273",
    "original_inquiry": "Urgent: invasive cortical electrode diagnosis, seeking centers offering Synchron Stentrode / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7508
  },
  {
    "request_id": "AM-REQ-2026-02274",
    "original_inquiry": "海外求诊：Patient with 侵入式电极 seeking evaluation for Paradromics; interested in Precision Neuroscience trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7046
  },
  {
    "request_id": "AM-REQ-2026-02275",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring neural decoding or Paradromics for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7532
  },
  {
    "request_id": "AM-REQ-2026-02276",
    "original_inquiry": "海外求诊：研究者咨询：希望了解ECoG在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6034
  },
  {
    "request_id": "AM-REQ-2026-02277",
    "original_inquiry": "海外求诊：Patient with intracortical array seeking evaluation for Wyss Center; interested in Paradromics trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7843
  },
  {
    "request_id": "AM-REQ-2026-02278",
    "original_inquiry": "海外求诊：Family member with ALS, exploring BCI for ALS or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6399
  },
  {
    "request_id": "AM-REQ-2026-02279",
    "original_inquiry": "海外求诊：Urgent: speech decoding diagnosis, seeking centers offering Neuralink / Wyss Center clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8217
  },
  {
    "request_id": "AM-REQ-2026-02280",
    "original_inquiry": "Referral from specialist: 海外求诊：患者ECoG，希望评估Wyss Center或Paradromics项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8024
  },
  {
    "request_id": "AM-REQ-2026-02281",
    "original_inquiry": "Urgent: Neurologist referral: brain-computer interface candidate for Wyss Center; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.52
  },
  {
    "request_id": "AM-REQ-2026-02282",
    "original_inquiry": "Urgent: 研究者咨询：希望了解brain-computer interface在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5959
  },
  {
    "request_id": "AM-REQ-2026-02283",
    "original_inquiry": "海外求诊：Consultation request: speech decoding for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.558
  },
  {
    "request_id": "AM-REQ-2026-02284",
    "original_inquiry": "Family seeking information: Consultation request: ECoG for BrainGate; interested in Precision Neuroscience and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8133
  },
  {
    "request_id": "AM-REQ-2026-02285",
    "original_inquiry": "研究者咨询：Consultation request: 语音神经假体 for Paradromics; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8396
  },
  {
    "request_id": "AM-REQ-2026-02286",
    "original_inquiry": "Referral from specialist: Patient with motor neuroprosthesis seeking evaluation for Neuralink; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7192
  },
  {
    "request_id": "AM-REQ-2026-02287",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5345
  },
  {
    "request_id": "AM-REQ-2026-02288",
    "original_inquiry": "Family seeking information: Patient with 侵入式电极 seeking evaluation for Precision Neuroscience; interested in Paradromics trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-02289",
    "original_inquiry": "Urgent: 研究者咨询：希望了解neural decoding在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6979
  },
  {
    "request_id": "AM-REQ-2026-02290",
    "original_inquiry": "Urgent: Urgent: 运动皮层解码 diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6535
  },
  {
    "request_id": "AM-REQ-2026-02291",
    "original_inquiry": "Referral from specialist: Neurologist referral: BCI for ALS candidate for Wyss Center; request information on Paradromics eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6208
  },
  {
    "request_id": "AM-REQ-2026-02292",
    "original_inquiry": "Urgent: Neurologist referral: 侵入式电极 candidate for BrainGate; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5189
  },
  {
    "request_id": "AM-REQ-2026-02293",
    "original_inquiry": "Urgent: 海外求诊：患者neural decoding，希望评估Neuralink或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.549
  },
  {
    "request_id": "AM-REQ-2026-02294",
    "original_inquiry": "Urgent: Family member with ALS, exploring 侵入式电极 or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.787
  },
  {
    "request_id": "AM-REQ-2026-02295",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解neural decoding在Synchron Stentrode适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7811
  },
  {
    "request_id": "AM-REQ-2026-02296",
    "original_inquiry": "Family seeking information: Patient with 脑机接口 seeking evaluation for Wyss Center; interested in Neuralink trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5584
  },
  {
    "request_id": "AM-REQ-2026-02297",
    "original_inquiry": "Urgent: 海外求诊：患者neural decoding，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8968
  },
  {
    "request_id": "AM-REQ-2026-02298",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8967
  },
  {
    "request_id": "AM-REQ-2026-02299",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5444
  },
  {
    "request_id": "AM-REQ-2026-02300",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring ECoG or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8433
  },
  {
    "request_id": "AM-REQ-2026-02301",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5302
  },
  {
    "request_id": "AM-REQ-2026-02302",
    "original_inquiry": "海外求诊：Neurologist referral: intracortical array candidate for BrainGate; request information on Wyss Center eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8658
  },
  {
    "request_id": "AM-REQ-2026-02303",
    "original_inquiry": "Second opinion requested: Patient with speech decoding seeking evaluation for Blackrock Neurotech; interested in BrainGate trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7114
  },
  {
    "request_id": "AM-REQ-2026-02304",
    "original_inquiry": "Neurologist referral: 侵入式电极 candidate for Speech Neuroprosthesis; request information on Blackrock Neurotech eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7932
  },
  {
    "request_id": "AM-REQ-2026-02305",
    "original_inquiry": "Family seeking information: Urgent: ECoG diagnosis, seeking centers offering Blackrock Neurotech / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8257
  },
  {
    "request_id": "AM-REQ-2026-02306",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Paradromics for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7145
  },
  {
    "request_id": "AM-REQ-2026-02307",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解locked-in syndrome在Speech Neuroprosthesis适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8383
  },
  {
    "request_id": "AM-REQ-2026-02308",
    "original_inquiry": "Family seeking information: Patient with 运动皮层解码 seeking evaluation for Neuralink; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5216
  },
  {
    "request_id": "AM-REQ-2026-02309",
    "original_inquiry": "研究者咨询：Neurologist referral: intracortical array candidate for Speech Neuroprosthesis; request information on Blackrock Neurotech eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-02310",
    "original_inquiry": "Referral from specialist: Neurologist referral: 语音神经假体 candidate for Blackrock Neurotech; request information on Paradromics eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7425
  },
  {
    "request_id": "AM-REQ-2026-02311",
    "original_inquiry": "Second opinion requested: Urgent: speech decoding diagnosis, seeking centers offering BrainGate / Paradromics clinical programs. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7319
  },
  {
    "request_id": "AM-REQ-2026-02312",
    "original_inquiry": "海外求诊：Neurologist referral: 侵入式电极 candidate for Paradromics; request information on Synchron Stentrode eligibility. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8586
  },
  {
    "request_id": "AM-REQ-2026-02313",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8684
  },
  {
    "request_id": "AM-REQ-2026-02314",
    "original_inquiry": "Referral from specialist: 研究者咨询：希望了解侵入式电极在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8542
  },
  {
    "request_id": "AM-REQ-2026-02315",
    "original_inquiry": "Urgent: Consultation request: BCI for ALS for Paradromics; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8271
  },
  {
    "request_id": "AM-REQ-2026-02316",
    "original_inquiry": "海外求诊：Patient with speech decoding seeking evaluation for Paradromics; interested in Wyss Center trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5813
  },
  {
    "request_id": "AM-REQ-2026-02317",
    "original_inquiry": "海外求诊：患者侵入式电极，希望评估Synchron Stentrode或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5711
  },
  {
    "request_id": "AM-REQ-2026-02318",
    "original_inquiry": "Second opinion requested: Patient with brain-computer interface seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6862
  },
  {
    "request_id": "AM-REQ-2026-02319",
    "original_inquiry": "Second opinion requested: 海外求诊：患者invasive cortical electrode，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5378
  },
  {
    "request_id": "AM-REQ-2026-02320",
    "original_inquiry": "Referral from specialist: Urgent: BCI for ALS diagnosis, seeking centers offering Speech Neuroprosthesis / Wyss Center clinical programs. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6491
  },
  {
    "request_id": "AM-REQ-2026-02321",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8751
  },
  {
    "request_id": "AM-REQ-2026-02322",
    "original_inquiry": "Urgent: Family member with ALS, exploring BCI for ALS or BrainGate for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6543
  },
  {
    "request_id": "AM-REQ-2026-02323",
    "original_inquiry": "Family seeking information: Urgent: speech prosthesis diagnosis, seeking centers offering Blackrock Neurotech / Wyss Center clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6846
  },
  {
    "request_id": "AM-REQ-2026-02324",
    "original_inquiry": "研究者咨询：希望了解运动皮层解码在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.666
  },
  {
    "request_id": "AM-REQ-2026-02325",
    "original_inquiry": "Referral from specialist: Patient with speech prosthesis seeking evaluation for Paradromics; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7746
  },
  {
    "request_id": "AM-REQ-2026-02326",
    "original_inquiry": "海外求诊：Urgent: brain-computer interface diagnosis, seeking centers offering Synchron Stentrode / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7673
  },
  {
    "request_id": "AM-REQ-2026-02327",
    "original_inquiry": "Family member with ALS, exploring 脑机接口 or Wyss Center for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6141
  },
  {
    "request_id": "AM-REQ-2026-02328",
    "original_inquiry": "海外求诊：Neurologist referral: BCI for ALS candidate for Blackrock Neurotech; request information on BrainGate eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5858
  },
  {
    "request_id": "AM-REQ-2026-02329",
    "original_inquiry": "Consultation request: 运动皮层解码 for Synchron Stentrode; interested in Precision Neuroscience and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5142
  },
  {
    "request_id": "AM-REQ-2026-02330",
    "original_inquiry": "Second opinion requested: Consultation request: 运动皮层解码 for Blackrock Neurotech; interested in Paradromics and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6637
  },
  {
    "request_id": "AM-REQ-2026-02331",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5398
  },
  {
    "request_id": "AM-REQ-2026-02332",
    "original_inquiry": "Second opinion requested: Neurologist referral: brain-computer interface candidate for BrainGate; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5714
  },
  {
    "request_id": "AM-REQ-2026-02333",
    "original_inquiry": "研究者咨询：Consultation request: BCI for ALS for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7164
  },
  {
    "request_id": "AM-REQ-2026-02334",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring invasive cortical electrode or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8715
  },
  {
    "request_id": "AM-REQ-2026-02335",
    "original_inquiry": "Second opinion requested: Neurologist referral: 侵入式电极 candidate for Speech Neuroprosthesis; request information on Neuralink eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7836
  },
  {
    "request_id": "AM-REQ-2026-02336",
    "original_inquiry": "研究者咨询：Consultation request: ECoG for Speech Neuroprosthesis; interested in Neuralink and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5637
  },
  {
    "request_id": "AM-REQ-2026-02337",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for Speech Neuroprosthesis; interested in Wyss Center and similar neuroprosthesis options.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7324
  },
  {
    "request_id": "AM-REQ-2026-02338",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5665
  },
  {
    "request_id": "AM-REQ-2026-02339",
    "original_inquiry": "Second opinion requested: Patient with 运动皮层解码 seeking evaluation for Precision Neuroscience; interested in Speech Neuroprosthesis trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7208
  },
  {
    "request_id": "AM-REQ-2026-02340",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8838
  },
  {
    "request_id": "AM-REQ-2026-02341",
    "original_inquiry": "Family member with ALS, exploring BCI for ALS or Blackrock Neurotech for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8167
  },
  {
    "request_id": "AM-REQ-2026-02342",
    "original_inquiry": "海外求诊：Patient with neural decoding seeking evaluation for Neuralink; interested in Synchron Stentrode trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.841
  },
  {
    "request_id": "AM-REQ-2026-02343",
    "original_inquiry": "Second opinion requested: Neurologist referral: speech prosthesis candidate for Synchron Stentrode; request information on Wyss Center eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5857
  },
  {
    "request_id": "AM-REQ-2026-02344",
    "original_inquiry": "Patient with locked-in syndrome seeking evaluation for Precision Neuroscience; interested in Synchron Stentrode trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7421
  },
  {
    "request_id": "AM-REQ-2026-02345",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring locked-in syndrome or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6926
  },
  {
    "request_id": "AM-REQ-2026-02346",
    "original_inquiry": "Second opinion requested: Neurologist referral: neural decoding candidate for Wyss Center; request information on Neuralink eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.801
  },
  {
    "request_id": "AM-REQ-2026-02347",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking ECoG or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6103
  },
  {
    "request_id": "AM-REQ-2026-02348",
    "original_inquiry": "Referral from specialist: Urgent: speech decoding diagnosis, seeking centers offering Wyss Center / Speech Neuroprosthesis clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7711
  },
  {
    "request_id": "AM-REQ-2026-02349",
    "original_inquiry": "研究者咨询：Patient with BCI for ALS seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8349
  },
  {
    "request_id": "AM-REQ-2026-02350",
    "original_inquiry": "Referral from specialist: Urgent: intracortical array diagnosis, seeking centers offering Wyss Center / Synchron Stentrode clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.787
  },
  {
    "request_id": "AM-REQ-2026-02351",
    "original_inquiry": "Referral from specialist: 海外求诊：患者brain-computer interface，希望评估BrainGate或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7145
  },
  {
    "request_id": "AM-REQ-2026-02352",
    "original_inquiry": "Urgent: Family member with ALS, exploring 脑机接口 or Blackrock Neurotech for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8923
  },
  {
    "request_id": "AM-REQ-2026-02353",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解brain-computer interface在BrainGate适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5641
  },
  {
    "request_id": "AM-REQ-2026-02354",
    "original_inquiry": "研究者咨询：Patient with speech prosthesis seeking evaluation for Wyss Center; interested in Synchron Stentrode trials. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7486
  },
  {
    "request_id": "AM-REQ-2026-02355",
    "original_inquiry": "Urgent: Neurologist referral: 语音神经假体 candidate for Blackrock Neurotech; request information on Speech Neuroprosthesis eligibility.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7
  },
  {
    "request_id": "AM-REQ-2026-02356",
    "original_inquiry": "Urgent: 海外求诊：患者脑机接口，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8516
  },
  {
    "request_id": "AM-REQ-2026-02357",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring 运动皮层解码 or Synchron Stentrode for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7182
  },
  {
    "request_id": "AM-REQ-2026-02358",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8814
  },
  {
    "request_id": "AM-REQ-2026-02359",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6728
  },
  {
    "request_id": "AM-REQ-2026-02360",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解invasive cortical electrode在Synchron Stentrode适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8144
  },
  {
    "request_id": "AM-REQ-2026-02361",
    "original_inquiry": "Referral from specialist: Patient with speech prosthesis seeking evaluation for Blackrock Neurotech; interested in Precision Neuroscience trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7239
  },
  {
    "request_id": "AM-REQ-2026-02362",
    "original_inquiry": "Urgent: Consultation request: 侵入式电极 for Neuralink; interested in BrainGate and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7276
  },
  {
    "request_id": "AM-REQ-2026-02363",
    "original_inquiry": "Second opinion requested: Urgent: motor neuroprosthesis diagnosis, seeking centers offering Precision Neuroscience / Neuralink clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.803
  },
  {
    "request_id": "AM-REQ-2026-02364",
    "original_inquiry": "Referral from specialist: Consultation request: invasive cortical electrode for Speech Neuroprosthesis; interested in Paradromics and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6396
  },
  {
    "request_id": "AM-REQ-2026-02365",
    "original_inquiry": "海外求诊：Family member with ALS, exploring BCI for ALS or BrainGate for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7291
  },
  {
    "request_id": "AM-REQ-2026-02366",
    "original_inquiry": "Family seeking information: Urgent: intracortical array diagnosis, seeking centers offering Paradromics / Speech Neuroprosthesis clinical programs. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5759
  },
  {
    "request_id": "AM-REQ-2026-02367",
    "original_inquiry": "Referral from specialist: Neurologist referral: locked-in syndrome candidate for Wyss Center; request information on BrainGate eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8233
  },
  {
    "request_id": "AM-REQ-2026-02368",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Neuralink for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7831
  },
  {
    "request_id": "AM-REQ-2026-02369",
    "original_inquiry": "Family seeking information: 海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5945
  },
  {
    "request_id": "AM-REQ-2026-02370",
    "original_inquiry": "Consultation request: 运动皮层解码 for Precision Neuroscience; interested in Blackrock Neurotech and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8734
  },
  {
    "request_id": "AM-REQ-2026-02371",
    "original_inquiry": "海外求诊：Patient with motor neuroprosthesis seeking evaluation for Synchron Stentrode; interested in Blackrock Neurotech trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8371
  },
  {
    "request_id": "AM-REQ-2026-02372",
    "original_inquiry": "Family seeking information: Urgent: speech decoding diagnosis, seeking centers offering BrainGate / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6054
  },
  {
    "request_id": "AM-REQ-2026-02373",
    "original_inquiry": "Family seeking information: Urgent: neural decoding diagnosis, seeking centers offering Neuralink / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6286
  },
  {
    "request_id": "AM-REQ-2026-02374",
    "original_inquiry": "Urgent: 研究者咨询：希望了解BCI for ALS在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7458
  },
  {
    "request_id": "AM-REQ-2026-02375",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解语音神经假体在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5366
  },
  {
    "request_id": "AM-REQ-2026-02376",
    "original_inquiry": "Urgent: 海外求诊：患者脑机接口，希望评估Synchron Stentrode或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6725
  },
  {
    "request_id": "AM-REQ-2026-02377",
    "original_inquiry": "Second opinion requested: Urgent: speech decoding diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7209
  },
  {
    "request_id": "AM-REQ-2026-02378",
    "original_inquiry": "Patient with 脑机接口 seeking evaluation for Speech Neuroprosthesis; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8523
  },
  {
    "request_id": "AM-REQ-2026-02379",
    "original_inquiry": "Referral from specialist: Urgent: ECoG diagnosis, seeking centers offering Synchron Stentrode / BrainGate clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6414
  },
  {
    "request_id": "AM-REQ-2026-02380",
    "original_inquiry": "海外求诊：研究者咨询：希望了解motor neuroprosthesis在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8357
  },
  {
    "request_id": "AM-REQ-2026-02381",
    "original_inquiry": "研究者咨询：Urgent: 脑机接口 diagnosis, seeking centers offering Precision Neuroscience / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8372
  },
  {
    "request_id": "AM-REQ-2026-02382",
    "original_inquiry": "Urgent: motor neuroprosthesis diagnosis, seeking centers offering Speech Neuroprosthesis / Paradromics clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5147
  },
  {
    "request_id": "AM-REQ-2026-02383",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring speech prosthesis or Speech Neuroprosthesis for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8505
  },
  {
    "request_id": "AM-REQ-2026-02384",
    "original_inquiry": "海外求诊：Urgent: locked-in syndrome diagnosis, seeking centers offering Precision Neuroscience / Speech Neuroprosthesis clinical programs.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7634
  },
  {
    "request_id": "AM-REQ-2026-02385",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解neural decoding在Precision Neuroscience适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5722
  },
  {
    "request_id": "AM-REQ-2026-02386",
    "original_inquiry": "海外求诊：Consultation request: 侵入式电极 for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-02387",
    "original_inquiry": "海外求诊：海外求诊：患者motor neuroprosthesis，希望评估Neuralink或BrainGate项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-02388",
    "original_inquiry": "Second opinion requested: Neurologist referral: speech prosthesis candidate for Blackrock Neurotech; request information on Neuralink eligibility.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.649
  },
  {
    "request_id": "AM-REQ-2026-02389",
    "original_inquiry": "Urgent: 研究者咨询：希望了解脑机接口在Neuralink适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8324
  },
  {
    "request_id": "AM-REQ-2026-02390",
    "original_inquiry": "海外求诊：Family member with ALS, exploring invasive cortical electrode or Precision Neuroscience for communication restoration.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5033
  },
  {
    "request_id": "AM-REQ-2026-02391",
    "original_inquiry": "Referral from specialist: Consultation request: 运动皮层解码 for BrainGate; interested in Wyss Center and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8175
  },
  {
    "request_id": "AM-REQ-2026-02392",
    "original_inquiry": "海外求诊：Patient with speech prosthesis seeking evaluation for Synchron Stentrode; interested in Neuralink trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7867
  },
  {
    "request_id": "AM-REQ-2026-02393",
    "original_inquiry": "Referral from specialist: Neurologist referral: BCI for ALS candidate for Neuralink; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7417
  },
  {
    "request_id": "AM-REQ-2026-02394",
    "original_inquiry": "Urgent: 语音神经假体 diagnosis, seeking centers offering Neuralink / Wyss Center clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6448
  },
  {
    "request_id": "AM-REQ-2026-02395",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6177
  },
  {
    "request_id": "AM-REQ-2026-02396",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Precision Neuroscience; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7611
  },
  {
    "request_id": "AM-REQ-2026-02397",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8281
  },
  {
    "request_id": "AM-REQ-2026-02398",
    "original_inquiry": "Urgent: Urgent: ECoG diagnosis, seeking centers offering Blackrock Neurotech / Paradromics clinical programs.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8687
  },
  {
    "request_id": "AM-REQ-2026-02399",
    "original_inquiry": "Referral from specialist: Patient with 语音神经假体 seeking evaluation for Synchron Stentrode; interested in Wyss Center trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5935
  },
  {
    "request_id": "AM-REQ-2026-02400",
    "original_inquiry": "海外求诊：Consultation request: speech prosthesis for Blackrock Neurotech; interested in Synchron Stentrode and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7335
  },
  {
    "request_id": "AM-REQ-2026-02401",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring BCI for ALS or Neuralink for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5209
  },
  {
    "request_id": "AM-REQ-2026-02402",
    "original_inquiry": "海外求诊：患者neural decoding，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-02403",
    "original_inquiry": "Urgent: 研究者咨询：希望了解speech prosthesis在Paradromics适应症中的临床试验进展与入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7358
  },
  {
    "request_id": "AM-REQ-2026-02404",
    "original_inquiry": "Neurologist referral: BCI for ALS candidate for Precision Neuroscience; request information on Blackrock Neurotech eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.53
  },
  {
    "request_id": "AM-REQ-2026-02405",
    "original_inquiry": "Urgent: 海外求诊：患者locked-in syndrome，希望评估Neuralink或Synchron Stentrode项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6979
  },
  {
    "request_id": "AM-REQ-2026-02406",
    "original_inquiry": "海外求诊：海外求诊：患者speech prosthesis，希望评估Synchron Stentrode或Speech Neuroprosthesis项目参与资格。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8188
  },
  {
    "request_id": "AM-REQ-2026-02407",
    "original_inquiry": "Consultation request: motor neuroprosthesis for Precision Neuroscience; interested in Neuralink and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7934
  },
  {
    "request_id": "AM-REQ-2026-02408",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6122
  },
  {
    "request_id": "AM-REQ-2026-02409",
    "original_inquiry": "海外求诊：Neurologist referral: 脑机接口 candidate for Neuralink; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5549
  },
  {
    "request_id": "AM-REQ-2026-02410",
    "original_inquiry": "研究者咨询：海外求诊：患者invasive cortical electrode，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6433
  },
  {
    "request_id": "AM-REQ-2026-02411",
    "original_inquiry": "Second opinion requested: 海外求诊：患者brain-computer interface，希望评估BrainGate或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8524
  },
  {
    "request_id": "AM-REQ-2026-02412",
    "original_inquiry": "Referral from specialist: Consultation request: 语音神经假体 for Synchron Stentrode; interested in Wyss Center and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6434
  },
  {
    "request_id": "AM-REQ-2026-02413",
    "original_inquiry": "研究者咨询：Patient with ECoG seeking evaluation for Wyss Center; interested in Paradromics trials.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6969
  },
  {
    "request_id": "AM-REQ-2026-02414",
    "original_inquiry": "Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7587
  },
  {
    "request_id": "AM-REQ-2026-02415",
    "original_inquiry": "Consultation request: 脑机接口 for Synchron Stentrode; interested in Neuralink and similar neuroprosthesis options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7738
  },
  {
    "request_id": "AM-REQ-2026-02416",
    "original_inquiry": "Referral from specialist: Neurologist referral: motor neuroprosthesis candidate for Precision Neuroscience; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6159
  },
  {
    "request_id": "AM-REQ-2026-02417",
    "original_inquiry": "Second opinion requested: 研究者咨询：希望了解speech decoding在Paradromics适应症中的临床试验进展与入组标准。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5211
  },
  {
    "request_id": "AM-REQ-2026-02418",
    "original_inquiry": "海外求诊：海外求诊：患者locked-in syndrome，希望评估Blackrock Neurotech或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8343
  },
  {
    "request_id": "AM-REQ-2026-02419",
    "original_inquiry": "Referral from specialist: Neurologist referral: intracortical array candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8175
  },
  {
    "request_id": "AM-REQ-2026-02420",
    "original_inquiry": "Family member with ALS, exploring speech decoding or Speech Neuroprosthesis for communication restoration.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5305
  },
  {
    "request_id": "AM-REQ-2026-02421",
    "original_inquiry": "Patient with 语音神经假体 seeking evaluation for Paradromics; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8536
  },
  {
    "request_id": "AM-REQ-2026-02422",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6525
  },
  {
    "request_id": "AM-REQ-2026-02423",
    "original_inquiry": "Family seeking information: Patient with locked-in syndrome; family seeking 脑机接口 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8504
  },
  {
    "request_id": "AM-REQ-2026-02424",
    "original_inquiry": "Urgent: Neurologist referral: intracortical array candidate for Blackrock Neurotech; request information on Precision Neuroscience eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8744
  },
  {
    "request_id": "AM-REQ-2026-02425",
    "original_inquiry": "Family member with ALS, exploring locked-in syndrome or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6374
  },
  {
    "request_id": "AM-REQ-2026-02426",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking intracortical array or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7173
  },
  {
    "request_id": "AM-REQ-2026-02427",
    "original_inquiry": "海外求诊：海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Wyss Center项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7454
  },
  {
    "request_id": "AM-REQ-2026-02428",
    "original_inquiry": "研究者咨询：Urgent: brain-computer interface diagnosis, seeking centers offering BrainGate / Neuralink clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6674
  },
  {
    "request_id": "AM-REQ-2026-02429",
    "original_inquiry": "海外求诊：Urgent: motor neuroprosthesis diagnosis, seeking centers offering Blackrock Neurotech / Precision Neuroscience clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8285
  },
  {
    "request_id": "AM-REQ-2026-02430",
    "original_inquiry": "Family seeking information: Family member with ALS, exploring 脑机接口 or BrainGate for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8677
  },
  {
    "request_id": "AM-REQ-2026-02431",
    "original_inquiry": "海外求诊：Patient with BCI for ALS seeking evaluation for Speech Neuroprosthesis; interested in BrainGate trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7129
  },
  {
    "request_id": "AM-REQ-2026-02432",
    "original_inquiry": "海外求诊：患者neural decoding，希望评估Blackrock Neurotech或Paradromics项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7428
  },
  {
    "request_id": "AM-REQ-2026-02433",
    "original_inquiry": "Second opinion requested: Neurologist referral: motor neuroprosthesis candidate for Neuralink; request information on Speech Neuroprosthesis eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7976
  },
  {
    "request_id": "AM-REQ-2026-02434",
    "original_inquiry": "研究者咨询：Urgent: 侵入式电极 diagnosis, seeking centers offering Wyss Center / Blackrock Neurotech clinical programs.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6299
  },
  {
    "request_id": "AM-REQ-2026-02435",
    "original_inquiry": "Patient with brain-computer interface seeking evaluation for Paradromics; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-02436",
    "original_inquiry": "Second opinion requested: Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Paradromics trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5954
  },
  {
    "request_id": "AM-REQ-2026-02437",
    "original_inquiry": "Urgent: Consultation request: intracortical array for Blackrock Neurotech; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6882
  },
  {
    "request_id": "AM-REQ-2026-02438",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 运动皮层解码 or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8929
  },
  {
    "request_id": "AM-REQ-2026-02439",
    "original_inquiry": "海外求诊：Neurologist referral: BCI for ALS candidate for Wyss Center; request information on Synchron Stentrode eligibility.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6665
  },
  {
    "request_id": "AM-REQ-2026-02440",
    "original_inquiry": "海外求诊：Family member with ALS, exploring speech prosthesis or Precision Neuroscience for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6484
  },
  {
    "request_id": "AM-REQ-2026-02441",
    "original_inquiry": "Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5434
  },
  {
    "request_id": "AM-REQ-2026-02442",
    "original_inquiry": "Referral from specialist: Neurologist referral: BCI for ALS candidate for Wyss Center; request information on Blackrock Neurotech eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5417
  },
  {
    "request_id": "AM-REQ-2026-02443",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6211
  },
  {
    "request_id": "AM-REQ-2026-02444",
    "original_inquiry": "海外求诊：海外求诊：患者运动皮层解码，希望评估Wyss Center或Speech Neuroprosthesis项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8093
  },
  {
    "request_id": "AM-REQ-2026-02445",
    "original_inquiry": "海外求诊：Family member with ALS, exploring brain-computer interface or Precision Neuroscience for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7043
  },
  {
    "request_id": "AM-REQ-2026-02446",
    "original_inquiry": "Family member with ALS, exploring 脑机接口 or Paradromics for communication restoration.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.602
  },
  {
    "request_id": "AM-REQ-2026-02447",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 语音神经假体 or Neuralink for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7698
  },
  {
    "request_id": "AM-REQ-2026-02448",
    "original_inquiry": "海外求诊：患者locked-in syndrome，希望评估Neuralink或Speech Neuroprosthesis项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.738
  },
  {
    "request_id": "AM-REQ-2026-02449",
    "original_inquiry": "研究者咨询：希望了解运动皮层解码在Wyss Center适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5263
  },
  {
    "request_id": "AM-REQ-2026-02450",
    "original_inquiry": "Urgent: Patient with locked-in syndrome; family seeking invasive cortical electrode or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5966
  },
  {
    "request_id": "AM-REQ-2026-02451",
    "original_inquiry": "Referral from specialist: Consultation request: speech prosthesis for Precision Neuroscience; interested in Wyss Center and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7702
  },
  {
    "request_id": "AM-REQ-2026-02452",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解speech prosthesis在Wyss Center适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-02453",
    "original_inquiry": "海外求诊：Consultation request: 语音神经假体 for Wyss Center; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8897
  },
  {
    "request_id": "AM-REQ-2026-02454",
    "original_inquiry": "Urgent: 海外求诊：患者locked-in syndrome，希望评估Speech Neuroprosthesis或Blackrock Neurotech项目参与资格。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8596
  },
  {
    "request_id": "AM-REQ-2026-02455",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.573
  },
  {
    "request_id": "AM-REQ-2026-02456",
    "original_inquiry": "Urgent: 海外求诊：患者speech prosthesis，希望评估Blackrock Neurotech或Paradromics项目参与资格。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7414
  },
  {
    "request_id": "AM-REQ-2026-02457",
    "original_inquiry": "研究者咨询：Urgent: BCI for ALS diagnosis, seeking centers offering Wyss Center / BrainGate clinical programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5577
  },
  {
    "request_id": "AM-REQ-2026-02458",
    "original_inquiry": "Second opinion requested: 海外求诊：患者neural decoding，希望评估Synchron Stentrode或Precision Neuroscience项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5577
  },
  {
    "request_id": "AM-REQ-2026-02459",
    "original_inquiry": "Second opinion requested: Neurologist referral: neural decoding candidate for Wyss Center; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7531
  },
  {
    "request_id": "AM-REQ-2026-02460",
    "original_inquiry": "海外求诊：研究者咨询：希望了解motor neuroprosthesis在Neuralink适应症中的临床试验进展与入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6803
  },
  {
    "request_id": "AM-REQ-2026-02461",
    "original_inquiry": "Referral from specialist: Patient with locked-in syndrome; family seeking speech decoding or Speech Neuroprosthesis pathways.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8123
  },
  {
    "request_id": "AM-REQ-2026-02462",
    "original_inquiry": "Urgent: Neurologist referral: 运动皮层解码 candidate for Paradromics; request information on Neuralink eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7758
  },
  {
    "request_id": "AM-REQ-2026-02463",
    "original_inquiry": "Family seeking information: 研究者咨询：希望了解侵入式电极在Blackrock Neurotech适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7397
  },
  {
    "request_id": "AM-REQ-2026-02464",
    "original_inquiry": "Family seeking information: Consultation request: speech prosthesis for Paradromics; interested in Speech Neuroprosthesis and similar neuroprosthesis options.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8902
  },
  {
    "request_id": "AM-REQ-2026-02465",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring invasive cortical electrode or Neuralink for communication restoration. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7946
  },
  {
    "request_id": "AM-REQ-2026-02466",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking speech prosthesis or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.503
  },
  {
    "request_id": "AM-REQ-2026-02467",
    "original_inquiry": "海外求诊：Family member with ALS, exploring 语音神经假体 or Wyss Center for communication restoration. Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6102
  },
  {
    "request_id": "AM-REQ-2026-02468",
    "original_inquiry": "研究者咨询：海外求诊：患者侵入式电极，希望评估Speech Neuroprosthesis或Neuralink项目参与资格。 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-02469",
    "original_inquiry": "Neurologist referral: neural decoding candidate for Synchron Stentrode; request information on Paradromics eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8934
  },
  {
    "request_id": "AM-REQ-2026-02470",
    "original_inquiry": "研究者咨询：Patient with motor neuroprosthesis seeking evaluation for Blackrock Neurotech; interested in Synchron Stentrode trials.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6702
  },
  {
    "request_id": "AM-REQ-2026-02471",
    "original_inquiry": "研究者咨询：Neurologist referral: 运动皮层解码 candidate for Speech Neuroprosthesis; request information on Precision Neuroscience eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8649
  },
  {
    "request_id": "AM-REQ-2026-02472",
    "original_inquiry": "海外求诊：患者speech prosthesis，希望评估BrainGate或Paradromics项目参与资格。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8644
  },
  {
    "request_id": "AM-REQ-2026-02473",
    "original_inquiry": "海外求诊：Urgent: speech decoding diagnosis, seeking centers offering Precision Neuroscience / Synchron Stentrode clinical programs. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7007
  },
  {
    "request_id": "AM-REQ-2026-02474",
    "original_inquiry": "Second opinion requested: Patient with intracortical array seeking evaluation for Wyss Center; interested in Speech Neuroprosthesis trials. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5188
  },
  {
    "request_id": "AM-REQ-2026-02475",
    "original_inquiry": "研究者咨询：Patient with locked-in syndrome; family seeking 语音神经假体 or Speech Neuroprosthesis pathways. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6529
  },
  {
    "request_id": "AM-REQ-2026-02476",
    "original_inquiry": "Urgent: 研究者咨询：希望了解脑机接口在Blackrock Neurotech适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6669
  },
  {
    "request_id": "AM-REQ-2026-02477",
    "original_inquiry": "Patient with speech decoding seeking evaluation for Synchron Stentrode; interested in Neuralink trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8944
  },
  {
    "request_id": "AM-REQ-2026-02478",
    "original_inquiry": "研究者咨询：Family member with ALS, exploring neural decoding or Blackrock Neurotech for communication restoration. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7075
  },
  {
    "request_id": "AM-REQ-2026-02479",
    "original_inquiry": "Urgent: Consultation request: 运动皮层解码 for Wyss Center; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7907
  },
  {
    "request_id": "AM-REQ-2026-02480",
    "original_inquiry": "Urgent: 海外求诊：患者BCI for ALS，希望评估Blackrock Neurotech或BrainGate项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7151
  },
  {
    "request_id": "AM-REQ-2026-02481",
    "original_inquiry": "Referral from specialist: Patient with 运动皮层解码 seeking evaluation for Neuralink; interested in BrainGate trials. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7235
  },
  {
    "request_id": "AM-REQ-2026-02482",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking neural decoding or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-02483",
    "original_inquiry": "Family seeking information: 海外求诊：患者侵入式电极，希望评估Neuralink或Blackrock Neurotech项目参与资格。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5585
  },
  {
    "request_id": "AM-REQ-2026-02484",
    "original_inquiry": "Second opinion requested: Urgent: brain-computer interface diagnosis, seeking centers offering Wyss Center / Paradromics clinical programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.891
  },
  {
    "request_id": "AM-REQ-2026-02485",
    "original_inquiry": "Referral from specialist: Patient with brain-computer interface seeking evaluation for Neuralink; interested in Wyss Center trials. Please advise on next steps.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5277
  },
  {
    "request_id": "AM-REQ-2026-02486",
    "original_inquiry": "Second opinion requested: Patient with locked-in syndrome; family seeking 侵入式电极 or Speech Neuroprosthesis pathways.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8478
  },
  {
    "request_id": "AM-REQ-2026-02487",
    "original_inquiry": "海外求诊：患者neural decoding，希望评估Neuralink或Precision Neuroscience项目参与资格。 Please advise on next steps.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8617
  },
  {
    "request_id": "AM-REQ-2026-02488",
    "original_inquiry": "Patient with locked-in syndrome; family seeking BCI for ALS or Speech Neuroprosthesis pathways. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6404
  },
  {
    "request_id": "AM-REQ-2026-02489",
    "original_inquiry": "海外求诊：Patient with invasive cortical electrode seeking evaluation for Precision Neuroscience; interested in Neuralink trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5061
  },
  {
    "request_id": "AM-REQ-2026-02490",
    "original_inquiry": "Second opinion requested: Consultation request: speech prosthesis for BrainGate; interested in Speech Neuroprosthesis and similar neuroprosthesis options. Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5643
  },
  {
    "request_id": "AM-REQ-2026-02491",
    "original_inquiry": "Referral from specialist: Family member with ALS, exploring 侵入式电极 or Neuralink for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5809
  },
  {
    "request_id": "AM-REQ-2026-02492",
    "original_inquiry": "研究者咨询：研究者咨询：希望了解intracortical array在Neuralink适应症中的临床试验进展与入组标准。 Please advise on next steps.",
    "standard_mapping": "BCI clinical trial; ALS or locked-in syndrome",
    "asset_category": "BCI",
    "l1_entropy_target": 0.8991
  },
  {
    "request_id": "AM-REQ-2026-02493",
    "original_inquiry": "Family seeking information: Patient with brain-computer interface seeking evaluation for Synchron Stentrode; interested in Blackrock Neurotech trials.",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.7404
  },
  {
    "request_id": "AM-REQ-2026-02494",
    "original_inquiry": "Second opinion requested: Neurologist referral: intracortical array candidate for Precision Neuroscience; request information on BrainGate eligibility. Please advise on next steps.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-02495",
    "original_inquiry": "海外求诊：Patient with locked-in syndrome; family seeking brain-computer interface or Speech Neuroprosthesis pathways. 希望了解入组标准与中心列表。",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.6767
  },
  {
    "request_id": "AM-REQ-2026-02496",
    "original_inquiry": "Urgent: 研究者咨询：希望了解侵入式电极在Wyss Center适应症中的临床试验进展与入组标准。",
    "standard_mapping": "Invasive neural interface; speech neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5186
  },
  {
    "request_id": "AM-REQ-2026-02497",
    "original_inquiry": "Second opinion requested: Family member with ALS, exploring motor neuroprosthesis or Wyss Center for communication restoration. 希望了解入组标准与中心列表。",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5411
  },
  {
    "request_id": "AM-REQ-2026-02498",
    "original_inquiry": "Family seeking information: Patient with 语音神经假体 seeking evaluation for Neuralink; interested in Precision Neuroscience trials.",
    "standard_mapping": "Cortical electrode array; motor neuroprosthesis",
    "asset_category": "BCI",
    "l1_entropy_target": 0.5456
  },
  {
    "request_id": "AM-REQ-2026-02499",
    "original_inquiry": "Consultation request: BCI for ALS for Blackrock Neurotech; interested in BrainGate and similar neuroprosthesis options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Brain-computer interface (BCI) for motor/speech restoration",
    "asset_category": "BCI",
    "l1_entropy_target": 0.747
  },
  {
    "request_id": "AM-REQ-2026-02500",
    "original_inquiry": "研究者咨询：Child with spinal muscular atrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-02501",
    "original_inquiry": "海外求诊：海外求药：SMA基因治疗患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8164
  },
  {
    "request_id": "AM-REQ-2026-02502",
    "original_inquiry": "Second opinion requested: Researcher inquiry: SMA delivery and Lyfgenia outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7646
  },
  {
    "request_id": "AM-REQ-2026-02503",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6015
  },
  {
    "request_id": "AM-REQ-2026-02504",
    "original_inquiry": "研究者咨询：Urgent consultation: DMD diagnosis, seeking exon skipping / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8923
  },
  {
    "request_id": "AM-REQ-2026-02505",
    "original_inquiry": "研究者咨询：Researcher inquiry: sickle cell disease delivery and CRISPR-Cas9 outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6173
  },
  {
    "request_id": "AM-REQ-2026-02506",
    "original_inquiry": "Second opinion requested: Patient with spinal muscular atrophy; requesting information on CRISPR-Cas9 and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7668
  },
  {
    "request_id": "AM-REQ-2026-02507",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5736
  },
  {
    "request_id": "AM-REQ-2026-02508",
    "original_inquiry": "海外求诊：Researcher inquiry: sickle cell disease delivery and Casgevy outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5862
  },
  {
    "request_id": "AM-REQ-2026-02509",
    "original_inquiry": "Referral from specialist: 海外求药：gene therapy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7752
  },
  {
    "request_id": "AM-REQ-2026-02510",
    "original_inquiry": "海外求诊：Patient with spinal muscular atrophy; requesting information on Casgevy and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.806
  },
  {
    "request_id": "AM-REQ-2026-02511",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6507
  },
  {
    "request_id": "AM-REQ-2026-02512",
    "original_inquiry": "Urgent: Patient with SMA; requesting information on CRISPR-Cas9 and ELEVIDYS access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5447
  },
  {
    "request_id": "AM-REQ-2026-02513",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6434
  },
  {
    "request_id": "AM-REQ-2026-02514",
    "original_inquiry": "Urgent: 海外求药：SMA基因治疗患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6326
  },
  {
    "request_id": "AM-REQ-2026-02515",
    "original_inquiry": "研究者咨询：Child with CRISPR疗法; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6846
  },
  {
    "request_id": "AM-REQ-2026-02516",
    "original_inquiry": "Family seeking information: 海外求药：Duchenne muscular dystrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5748
  },
  {
    "request_id": "AM-REQ-2026-02517",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5097
  },
  {
    "request_id": "AM-REQ-2026-02518",
    "original_inquiry": "Referral from specialist: Child with Duchenne muscular dystrophy; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7827
  },
  {
    "request_id": "AM-REQ-2026-02519",
    "original_inquiry": "Patient with 杜氏肌营养不良; requesting information on gene replacement therapy and ELEVIDYS access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5969
  },
  {
    "request_id": "AM-REQ-2026-02520",
    "original_inquiry": "研究者咨询：Child with CRISPR疗法; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7863
  },
  {
    "request_id": "AM-REQ-2026-02521",
    "original_inquiry": "Family seeking information: Child with SMA; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6938
  },
  {
    "request_id": "AM-REQ-2026-02522",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊beta-thalassemia，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6347
  },
  {
    "request_id": "AM-REQ-2026-02523",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5814
  },
  {
    "request_id": "AM-REQ-2026-02524",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5633
  },
  {
    "request_id": "AM-REQ-2026-02525",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.823
  },
  {
    "request_id": "AM-REQ-2026-02526",
    "original_inquiry": "Referral from specialist: Child with SMA; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7464
  },
  {
    "request_id": "AM-REQ-2026-02527",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8481
  },
  {
    "request_id": "AM-REQ-2026-02528",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6357
  },
  {
    "request_id": "AM-REQ-2026-02529",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8079
  },
  {
    "request_id": "AM-REQ-2026-02530",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.528
  },
  {
    "request_id": "AM-REQ-2026-02531",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.896
  },
  {
    "request_id": "AM-REQ-2026-02532",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 镰状细胞贫血 delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.802
  },
  {
    "request_id": "AM-REQ-2026-02533",
    "original_inquiry": "研究者咨询：Researcher inquiry: CRISPR疗法 delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5749
  },
  {
    "request_id": "AM-REQ-2026-02534",
    "original_inquiry": "研究者咨询：Geneticist referral: SMA基因治疗 confirmed; exploring AAV9 and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6033
  },
  {
    "request_id": "AM-REQ-2026-02535",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking exon skipping / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7111
  },
  {
    "request_id": "AM-REQ-2026-02536",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8833
  },
  {
    "request_id": "AM-REQ-2026-02537",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5433
  },
  {
    "request_id": "AM-REQ-2026-02538",
    "original_inquiry": "家长咨询：患儿确诊SMA，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7766
  },
  {
    "request_id": "AM-REQ-2026-02539",
    "original_inquiry": "研究者咨询：Child with Duchenne muscular dystrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5784
  },
  {
    "request_id": "AM-REQ-2026-02540",
    "original_inquiry": "Geneticist referral: beta-thalassemia confirmed; exploring Lyfgenia and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8049
  },
  {
    "request_id": "AM-REQ-2026-02541",
    "original_inquiry": "海外求诊：Geneticist referral: SMA confirmed; exploring gene replacement therapy and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6687
  },
  {
    "request_id": "AM-REQ-2026-02542",
    "original_inquiry": "海外求诊：海外求药：DMD患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5543
  },
  {
    "request_id": "AM-REQ-2026-02543",
    "original_inquiry": "海外求诊：Geneticist referral: SMA基因治疗 confirmed; exploring SRP-9001 and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7227
  },
  {
    "request_id": "AM-REQ-2026-02544",
    "original_inquiry": "研究者咨询：Child with beta-thalassemia; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.61
  },
  {
    "request_id": "AM-REQ-2026-02545",
    "original_inquiry": "海外求诊：Geneticist referral: 杜氏肌营养不良 confirmed; exploring Zolgensma and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5084
  },
  {
    "request_id": "AM-REQ-2026-02546",
    "original_inquiry": "家长咨询：患儿确诊SMA基因治疗，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5499
  },
  {
    "request_id": "AM-REQ-2026-02547",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6993
  },
  {
    "request_id": "AM-REQ-2026-02548",
    "original_inquiry": "Urgent: Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8334
  },
  {
    "request_id": "AM-REQ-2026-02549",
    "original_inquiry": "Referral from specialist: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring Zolgensma and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5597
  },
  {
    "request_id": "AM-REQ-2026-02550",
    "original_inquiry": "Child with beta-thalassemia; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.608
  },
  {
    "request_id": "AM-REQ-2026-02551",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7354
  },
  {
    "request_id": "AM-REQ-2026-02552",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊杜氏肌营养不良，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8074
  },
  {
    "request_id": "AM-REQ-2026-02553",
    "original_inquiry": "Geneticist referral: spinal muscular atrophy confirmed; exploring Zolgensma and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6255
  },
  {
    "request_id": "AM-REQ-2026-02554",
    "original_inquiry": "Family seeking information: Patient with SMA基因治疗; requesting information on exon skipping and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.727
  },
  {
    "request_id": "AM-REQ-2026-02555",
    "original_inquiry": "海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7883
  },
  {
    "request_id": "AM-REQ-2026-02556",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊beta-thalassemia，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6739
  },
  {
    "request_id": "AM-REQ-2026-02557",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8681
  },
  {
    "request_id": "AM-REQ-2026-02558",
    "original_inquiry": "研究者咨询：Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6988
  },
  {
    "request_id": "AM-REQ-2026-02559",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6021
  },
  {
    "request_id": "AM-REQ-2026-02560",
    "original_inquiry": "Second opinion requested: 海外求药：DMD患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7304
  },
  {
    "request_id": "AM-REQ-2026-02561",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8757
  },
  {
    "request_id": "AM-REQ-2026-02562",
    "original_inquiry": "研究者咨询：Patient with gene therapy; requesting information on ELEVIDYS and Casgevy access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.729
  },
  {
    "request_id": "AM-REQ-2026-02563",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7661
  },
  {
    "request_id": "AM-REQ-2026-02564",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊DMD，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6558
  },
  {
    "request_id": "AM-REQ-2026-02565",
    "original_inquiry": "Patient with sickle cell disease; requesting information on Lyfgenia and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7105
  },
  {
    "request_id": "AM-REQ-2026-02566",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8946
  },
  {
    "request_id": "AM-REQ-2026-02567",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA基因治疗 delivery and Lyfgenia outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7215
  },
  {
    "request_id": "AM-REQ-2026-02568",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊AAV vector，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7373
  },
  {
    "request_id": "AM-REQ-2026-02569",
    "original_inquiry": "研究者咨询：Researcher inquiry: 镰状细胞贫血 delivery and AAV9 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7571
  },
  {
    "request_id": "AM-REQ-2026-02570",
    "original_inquiry": "Urgent: Urgent consultation: SMA基因治疗 diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.626
  },
  {
    "request_id": "AM-REQ-2026-02571",
    "original_inquiry": "Second opinion requested: Patient with DMD; requesting information on CRISPR-Cas9 and Lyfgenia access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7583
  },
  {
    "request_id": "AM-REQ-2026-02572",
    "original_inquiry": "Urgent: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring SRP-9001 and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8947
  },
  {
    "request_id": "AM-REQ-2026-02573",
    "original_inquiry": "Second opinion requested: Patient with Duchenne muscular dystrophy; requesting information on Lyfgenia and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8632
  },
  {
    "request_id": "AM-REQ-2026-02574",
    "original_inquiry": "Child with beta-thalassemia; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7993
  },
  {
    "request_id": "AM-REQ-2026-02575",
    "original_inquiry": "海外求诊：Patient with DMD; requesting information on ELEVIDYS and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7195
  },
  {
    "request_id": "AM-REQ-2026-02576",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5958
  },
  {
    "request_id": "AM-REQ-2026-02577",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6811
  },
  {
    "request_id": "AM-REQ-2026-02578",
    "original_inquiry": "Family seeking information: 海外求药：SMA患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.737
  },
  {
    "request_id": "AM-REQ-2026-02579",
    "original_inquiry": "Referral from specialist: Patient with Duchenne muscular dystrophy; requesting information on exon skipping and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7459
  },
  {
    "request_id": "AM-REQ-2026-02580",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8968
  },
  {
    "request_id": "AM-REQ-2026-02581",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6012
  },
  {
    "request_id": "AM-REQ-2026-02582",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8839
  },
  {
    "request_id": "AM-REQ-2026-02583",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7463
  },
  {
    "request_id": "AM-REQ-2026-02584",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and Zolgensma outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6417
  },
  {
    "request_id": "AM-REQ-2026-02585",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊beta-thalassemia，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6495
  },
  {
    "request_id": "AM-REQ-2026-02586",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7986
  },
  {
    "request_id": "AM-REQ-2026-02587",
    "original_inquiry": "Urgent: Child with sickle cell disease; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5279
  },
  {
    "request_id": "AM-REQ-2026-02588",
    "original_inquiry": "Referral from specialist: Geneticist referral: DMD confirmed; exploring gene replacement therapy and SRP-9001 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5456
  },
  {
    "request_id": "AM-REQ-2026-02589",
    "original_inquiry": "研究者咨询：Geneticist referral: DMD confirmed; exploring ELEVIDYS and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7998
  },
  {
    "request_id": "AM-REQ-2026-02590",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7269
  },
  {
    "request_id": "AM-REQ-2026-02591",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6398
  },
  {
    "request_id": "AM-REQ-2026-02592",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5658
  },
  {
    "request_id": "AM-REQ-2026-02593",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7794
  },
  {
    "request_id": "AM-REQ-2026-02594",
    "original_inquiry": "Researcher inquiry: 杜氏肌营养不良 delivery and Casgevy outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6528
  },
  {
    "request_id": "AM-REQ-2026-02595",
    "original_inquiry": "Second opinion requested: Geneticist referral: gene therapy confirmed; exploring SRP-9001 and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5906
  },
  {
    "request_id": "AM-REQ-2026-02596",
    "original_inquiry": "海外求诊：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6322
  },
  {
    "request_id": "AM-REQ-2026-02597",
    "original_inquiry": "海外求诊：Patient with SMA基因治疗; requesting information on Casgevy and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6317
  },
  {
    "request_id": "AM-REQ-2026-02598",
    "original_inquiry": "海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7023
  },
  {
    "request_id": "AM-REQ-2026-02599",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5679
  },
  {
    "request_id": "AM-REQ-2026-02600",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6349
  },
  {
    "request_id": "AM-REQ-2026-02601",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and ELEVIDYS outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8276
  },
  {
    "request_id": "AM-REQ-2026-02602",
    "original_inquiry": "Second opinion requested: Child with 杜氏肌营养不良; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8304
  },
  {
    "request_id": "AM-REQ-2026-02603",
    "original_inquiry": "海外求药：beta-thalassemia患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6368
  },
  {
    "request_id": "AM-REQ-2026-02604",
    "original_inquiry": "Urgent: 海外求药：SMA患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6865
  },
  {
    "request_id": "AM-REQ-2026-02605",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6407
  },
  {
    "request_id": "AM-REQ-2026-02606",
    "original_inquiry": "研究者咨询：海外求药：AAV vector患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7983
  },
  {
    "request_id": "AM-REQ-2026-02607",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8568
  },
  {
    "request_id": "AM-REQ-2026-02608",
    "original_inquiry": "Urgent: Researcher inquiry: SMA delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6888
  },
  {
    "request_id": "AM-REQ-2026-02609",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5363
  },
  {
    "request_id": "AM-REQ-2026-02610",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6013
  },
  {
    "request_id": "AM-REQ-2026-02611",
    "original_inquiry": "海外求诊：Researcher inquiry: Duchenne muscular dystrophy delivery and ELEVIDYS outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5182
  },
  {
    "request_id": "AM-REQ-2026-02612",
    "original_inquiry": "Second opinion requested: Child with spinal muscular atrophy; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7242
  },
  {
    "request_id": "AM-REQ-2026-02613",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊AAV vector，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6048
  },
  {
    "request_id": "AM-REQ-2026-02614",
    "original_inquiry": "Child with 杜氏肌营养不良; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5309
  },
  {
    "request_id": "AM-REQ-2026-02615",
    "original_inquiry": "Referral from specialist: Patient with CRISPR疗法; requesting information on Lyfgenia and AAV9 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7225
  },
  {
    "request_id": "AM-REQ-2026-02616",
    "original_inquiry": "海外求诊：海外求药：spinal muscular atrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.524
  },
  {
    "request_id": "AM-REQ-2026-02617",
    "original_inquiry": "Urgent consultation: AAV vector diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8012
  },
  {
    "request_id": "AM-REQ-2026-02618",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 杜氏肌营养不良 delivery and gene replacement therapy outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7819
  },
  {
    "request_id": "AM-REQ-2026-02619",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on exon skipping and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8819
  },
  {
    "request_id": "AM-REQ-2026-02620",
    "original_inquiry": "研究者咨询：Patient with AAV vector; requesting information on gene replacement therapy and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7391
  },
  {
    "request_id": "AM-REQ-2026-02621",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and ELEVIDYS outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5766
  },
  {
    "request_id": "AM-REQ-2026-02622",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on Casgevy and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8032
  },
  {
    "request_id": "AM-REQ-2026-02623",
    "original_inquiry": "Referral from specialist: Urgent consultation: CRISPR疗法 diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6559
  },
  {
    "request_id": "AM-REQ-2026-02624",
    "original_inquiry": "Urgent: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring AAV9 and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7698
  },
  {
    "request_id": "AM-REQ-2026-02625",
    "original_inquiry": "Urgent: Child with SMA基因治疗; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-02626",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5839
  },
  {
    "request_id": "AM-REQ-2026-02627",
    "original_inquiry": "海外求诊：海外求药：SMA基因治疗患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7315
  },
  {
    "request_id": "AM-REQ-2026-02628",
    "original_inquiry": "Referral from specialist: Urgent consultation: gene therapy diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8749
  },
  {
    "request_id": "AM-REQ-2026-02629",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊CRISPR疗法，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6146
  },
  {
    "request_id": "AM-REQ-2026-02630",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊sickle cell disease，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.575
  },
  {
    "request_id": "AM-REQ-2026-02631",
    "original_inquiry": "研究者咨询：Child with DMD; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5761
  },
  {
    "request_id": "AM-REQ-2026-02632",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊gene therapy，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7537
  },
  {
    "request_id": "AM-REQ-2026-02633",
    "original_inquiry": "Family seeking information: Child with SMA基因治疗; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5187
  },
  {
    "request_id": "AM-REQ-2026-02634",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.666
  },
  {
    "request_id": "AM-REQ-2026-02635",
    "original_inquiry": "Second opinion requested: Geneticist referral: AAV vector confirmed; exploring Casgevy and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7955
  },
  {
    "request_id": "AM-REQ-2026-02636",
    "original_inquiry": "Researcher inquiry: SMA delivery and gene replacement therapy outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7921
  },
  {
    "request_id": "AM-REQ-2026-02637",
    "original_inquiry": "家长咨询：患儿确诊spinal muscular atrophy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7816
  },
  {
    "request_id": "AM-REQ-2026-02638",
    "original_inquiry": "Child with 杜氏肌营养不良; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5504
  },
  {
    "request_id": "AM-REQ-2026-02639",
    "original_inquiry": "Referral from specialist: Patient with CRISPR疗法; requesting information on gene replacement therapy and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6016
  },
  {
    "request_id": "AM-REQ-2026-02640",
    "original_inquiry": "Geneticist referral: 杜氏肌营养不良 confirmed; exploring gene replacement therapy and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5923
  },
  {
    "request_id": "AM-REQ-2026-02641",
    "original_inquiry": "海外求诊：Researcher inquiry: CRISPR疗法 delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6981
  },
  {
    "request_id": "AM-REQ-2026-02642",
    "original_inquiry": "Referral from specialist: Patient with 镰状细胞贫血; requesting information on AAV9 and Casgevy access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-02643",
    "original_inquiry": "Referral from specialist: Researcher inquiry: AAV vector delivery and AAV9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5739
  },
  {
    "request_id": "AM-REQ-2026-02644",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking AAV9 / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.773
  },
  {
    "request_id": "AM-REQ-2026-02645",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8533
  },
  {
    "request_id": "AM-REQ-2026-02646",
    "original_inquiry": "Second opinion requested: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5396
  },
  {
    "request_id": "AM-REQ-2026-02647",
    "original_inquiry": "Referral from specialist: 海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.592
  },
  {
    "request_id": "AM-REQ-2026-02648",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8303
  },
  {
    "request_id": "AM-REQ-2026-02649",
    "original_inquiry": "Family seeking information: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring AAV9 and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8217
  },
  {
    "request_id": "AM-REQ-2026-02650",
    "original_inquiry": "Referral from specialist: Urgent consultation: spinal muscular atrophy diagnosis, seeking Lyfgenia / SRP-9001 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7296
  },
  {
    "request_id": "AM-REQ-2026-02651",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring Lyfgenia and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6826
  },
  {
    "request_id": "AM-REQ-2026-02652",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7769
  },
  {
    "request_id": "AM-REQ-2026-02653",
    "original_inquiry": "Referral from specialist: Patient with CRISPR疗法; requesting information on CRISPR-Cas9 and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8705
  },
  {
    "request_id": "AM-REQ-2026-02654",
    "original_inquiry": "Second opinion requested: Child with DMD; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8198
  },
  {
    "request_id": "AM-REQ-2026-02655",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊AAV vector，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7517
  },
  {
    "request_id": "AM-REQ-2026-02656",
    "original_inquiry": "Family seeking information: 海外求药：CRISPR疗法患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8147
  },
  {
    "request_id": "AM-REQ-2026-02657",
    "original_inquiry": "Referral from specialist: Patient with spinal muscular atrophy; requesting information on SRP-9001 and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8596
  },
  {
    "request_id": "AM-REQ-2026-02658",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA confirmed; exploring Lyfgenia and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7477
  },
  {
    "request_id": "AM-REQ-2026-02659",
    "original_inquiry": "Child with SMA; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8745
  },
  {
    "request_id": "AM-REQ-2026-02660",
    "original_inquiry": "家长咨询：患儿确诊Duchenne muscular dystrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8248
  },
  {
    "request_id": "AM-REQ-2026-02661",
    "original_inquiry": "海外求诊：Geneticist referral: sickle cell disease confirmed; exploring Lyfgenia and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8857
  },
  {
    "request_id": "AM-REQ-2026-02662",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6706
  },
  {
    "request_id": "AM-REQ-2026-02663",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊DMD，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7811
  },
  {
    "request_id": "AM-REQ-2026-02664",
    "original_inquiry": "海外求药：DMD患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8719
  },
  {
    "request_id": "AM-REQ-2026-02665",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA基因治疗 delivery and gene replacement therapy outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5945
  },
  {
    "request_id": "AM-REQ-2026-02666",
    "original_inquiry": "Second opinion requested: Patient with 镰状细胞贫血; requesting information on CRISPR-Cas9 and SRP-9001 access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8095
  },
  {
    "request_id": "AM-REQ-2026-02667",
    "original_inquiry": "Referral from specialist: Urgent consultation: spinal muscular atrophy diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7528
  },
  {
    "request_id": "AM-REQ-2026-02668",
    "original_inquiry": "Family seeking information: Child with DMD; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7443
  },
  {
    "request_id": "AM-REQ-2026-02669",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-02670",
    "original_inquiry": "Second opinion requested: Child with SMA; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5068
  },
  {
    "request_id": "AM-REQ-2026-02671",
    "original_inquiry": "Family seeking information: Patient with AAV vector; requesting information on gene replacement therapy and Lyfgenia access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7993
  },
  {
    "request_id": "AM-REQ-2026-02672",
    "original_inquiry": "Second opinion requested: 海外求药：spinal muscular atrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6384
  },
  {
    "request_id": "AM-REQ-2026-02673",
    "original_inquiry": "海外求诊：Urgent consultation: sickle cell disease diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6355
  },
  {
    "request_id": "AM-REQ-2026-02674",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊gene therapy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6106
  },
  {
    "request_id": "AM-REQ-2026-02675",
    "original_inquiry": "Referral from specialist: 海外求药：镰状细胞贫血患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.538
  },
  {
    "request_id": "AM-REQ-2026-02676",
    "original_inquiry": "Urgent: Geneticist referral: SMA confirmed; exploring Lyfgenia and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6395
  },
  {
    "request_id": "AM-REQ-2026-02677",
    "original_inquiry": "Urgent: 海外求药：杜氏肌营养不良患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7506
  },
  {
    "request_id": "AM-REQ-2026-02678",
    "original_inquiry": "研究者咨询：Child with CRISPR疗法; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7971
  },
  {
    "request_id": "AM-REQ-2026-02679",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Duchenne muscular dystrophy delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5652
  },
  {
    "request_id": "AM-REQ-2026-02680",
    "original_inquiry": "海外求诊：Urgent consultation: AAV vector diagnosis, seeking gene replacement therapy / Zolgensma availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6445
  },
  {
    "request_id": "AM-REQ-2026-02681",
    "original_inquiry": "家长咨询：患儿确诊sickle cell disease，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6345
  },
  {
    "request_id": "AM-REQ-2026-02682",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7176
  },
  {
    "request_id": "AM-REQ-2026-02683",
    "original_inquiry": "Referral from specialist: Patient with DMD; requesting information on SRP-9001 and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5293
  },
  {
    "request_id": "AM-REQ-2026-02684",
    "original_inquiry": "Geneticist referral: 镰状细胞贫血 confirmed; exploring Lyfgenia and SRP-9001 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5338
  },
  {
    "request_id": "AM-REQ-2026-02685",
    "original_inquiry": "Referral from specialist: Child with sickle cell disease; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.501
  },
  {
    "request_id": "AM-REQ-2026-02686",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; requesting information on Zolgensma and AAV9 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7138
  },
  {
    "request_id": "AM-REQ-2026-02687",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring Zolgensma and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.778
  },
  {
    "request_id": "AM-REQ-2026-02688",
    "original_inquiry": "Referral from specialist: Urgent consultation: sickle cell disease diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8783
  },
  {
    "request_id": "AM-REQ-2026-02689",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking Lyfgenia / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5291
  },
  {
    "request_id": "AM-REQ-2026-02690",
    "original_inquiry": "Urgent: Urgent consultation: AAV vector diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7289
  },
  {
    "request_id": "AM-REQ-2026-02691",
    "original_inquiry": "Family seeking information: 海外求药：SMA患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7807
  },
  {
    "request_id": "AM-REQ-2026-02692",
    "original_inquiry": "Family seeking information: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking AAV9 / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5871
  },
  {
    "request_id": "AM-REQ-2026-02693",
    "original_inquiry": "Child with spinal muscular atrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-02694",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.805
  },
  {
    "request_id": "AM-REQ-2026-02695",
    "original_inquiry": "Family seeking information: Child with sickle cell disease; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6152
  },
  {
    "request_id": "AM-REQ-2026-02696",
    "original_inquiry": "Child with CRISPR疗法; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.9
  },
  {
    "request_id": "AM-REQ-2026-02697",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and exon skipping outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7403
  },
  {
    "request_id": "AM-REQ-2026-02698",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊DMD，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.558
  },
  {
    "request_id": "AM-REQ-2026-02699",
    "original_inquiry": "Urgent: Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5801
  },
  {
    "request_id": "AM-REQ-2026-02700",
    "original_inquiry": "Family seeking information: Patient with spinal muscular atrophy; requesting information on SRP-9001 and AAV9 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6285
  },
  {
    "request_id": "AM-REQ-2026-02701",
    "original_inquiry": "Referral from specialist: Patient with DMD; requesting information on Lyfgenia and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8809
  },
  {
    "request_id": "AM-REQ-2026-02702",
    "original_inquiry": "Second opinion requested: 海外求药：gene therapy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8609
  },
  {
    "request_id": "AM-REQ-2026-02703",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.552
  },
  {
    "request_id": "AM-REQ-2026-02704",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on exon skipping and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8011
  },
  {
    "request_id": "AM-REQ-2026-02705",
    "original_inquiry": "Child with 杜氏肌营养不良; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7429
  },
  {
    "request_id": "AM-REQ-2026-02706",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7193
  },
  {
    "request_id": "AM-REQ-2026-02707",
    "original_inquiry": "Referral from specialist: 海外求药：Duchenne muscular dystrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5978
  },
  {
    "request_id": "AM-REQ-2026-02708",
    "original_inquiry": "研究者咨询：Geneticist referral: spinal muscular atrophy confirmed; exploring ELEVIDYS and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8667
  },
  {
    "request_id": "AM-REQ-2026-02709",
    "original_inquiry": "海外求诊：Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5575
  },
  {
    "request_id": "AM-REQ-2026-02710",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring exon skipping and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7673
  },
  {
    "request_id": "AM-REQ-2026-02711",
    "original_inquiry": "Patient with beta-thalassemia; requesting information on ELEVIDYS and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8031
  },
  {
    "request_id": "AM-REQ-2026-02712",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6668
  },
  {
    "request_id": "AM-REQ-2026-02713",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5126
  },
  {
    "request_id": "AM-REQ-2026-02714",
    "original_inquiry": "海外求药：SMA患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6227
  },
  {
    "request_id": "AM-REQ-2026-02715",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊镰状细胞贫血，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7579
  },
  {
    "request_id": "AM-REQ-2026-02716",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7689
  },
  {
    "request_id": "AM-REQ-2026-02717",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5287
  },
  {
    "request_id": "AM-REQ-2026-02718",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7748
  },
  {
    "request_id": "AM-REQ-2026-02719",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊AAV vector，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6981
  },
  {
    "request_id": "AM-REQ-2026-02720",
    "original_inquiry": "Child with 镰状细胞贫血; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5534
  },
  {
    "request_id": "AM-REQ-2026-02721",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6107
  },
  {
    "request_id": "AM-REQ-2026-02722",
    "original_inquiry": "Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking ELEVIDYS / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7521
  },
  {
    "request_id": "AM-REQ-2026-02723",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and Zolgensma outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6554
  },
  {
    "request_id": "AM-REQ-2026-02724",
    "original_inquiry": "研究者咨询：Researcher inquiry: SMA基因治疗 delivery and Casgevy outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.868
  },
  {
    "request_id": "AM-REQ-2026-02725",
    "original_inquiry": "海外求诊：Child with SMA; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5478
  },
  {
    "request_id": "AM-REQ-2026-02726",
    "original_inquiry": "海外求诊：海外求药：gene therapy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-02727",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6983
  },
  {
    "request_id": "AM-REQ-2026-02728",
    "original_inquiry": "海外求诊：海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.556
  },
  {
    "request_id": "AM-REQ-2026-02729",
    "original_inquiry": "Patient with gene therapy; requesting information on Casgevy and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8217
  },
  {
    "request_id": "AM-REQ-2026-02730",
    "original_inquiry": "Family seeking information: 海外求药：Duchenne muscular dystrophy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.632
  },
  {
    "request_id": "AM-REQ-2026-02731",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6853
  },
  {
    "request_id": "AM-REQ-2026-02732",
    "original_inquiry": "Referral from specialist: Urgent consultation: CRISPR疗法 diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.85
  },
  {
    "request_id": "AM-REQ-2026-02733",
    "original_inquiry": "研究者咨询：Researcher inquiry: DMD delivery and SRP-9001 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6597
  },
  {
    "request_id": "AM-REQ-2026-02734",
    "original_inquiry": "Urgent: 海外求药：镰状细胞贫血患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8142
  },
  {
    "request_id": "AM-REQ-2026-02735",
    "original_inquiry": "Child with beta-thalassemia; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5618
  },
  {
    "request_id": "AM-REQ-2026-02736",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5971
  },
  {
    "request_id": "AM-REQ-2026-02737",
    "original_inquiry": "研究者咨询：Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and Zolgensma trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6339
  },
  {
    "request_id": "AM-REQ-2026-02738",
    "original_inquiry": "Patient with SMA; requesting information on ELEVIDYS and AAV9 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8754
  },
  {
    "request_id": "AM-REQ-2026-02739",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6733
  },
  {
    "request_id": "AM-REQ-2026-02740",
    "original_inquiry": "Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.603
  },
  {
    "request_id": "AM-REQ-2026-02741",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8388
  },
  {
    "request_id": "AM-REQ-2026-02742",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6295
  },
  {
    "request_id": "AM-REQ-2026-02743",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7201
  },
  {
    "request_id": "AM-REQ-2026-02744",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring AAV9 and Zolgensma trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6674
  },
  {
    "request_id": "AM-REQ-2026-02745",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8835
  },
  {
    "request_id": "AM-REQ-2026-02746",
    "original_inquiry": "Referral from specialist: Child with 镰状细胞贫血; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7223
  },
  {
    "request_id": "AM-REQ-2026-02747",
    "original_inquiry": "Child with AAV vector; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8569
  },
  {
    "request_id": "AM-REQ-2026-02748",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5276
  },
  {
    "request_id": "AM-REQ-2026-02749",
    "original_inquiry": "海外求诊：Researcher inquiry: SMA基因治疗 delivery and exon skipping outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7774
  },
  {
    "request_id": "AM-REQ-2026-02750",
    "original_inquiry": "Urgent: Researcher inquiry: gene therapy delivery and Zolgensma outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.703
  },
  {
    "request_id": "AM-REQ-2026-02751",
    "original_inquiry": "Second opinion requested: Patient with CRISPR疗法; requesting information on AAV9 and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7716
  },
  {
    "request_id": "AM-REQ-2026-02752",
    "original_inquiry": "Urgent: Child with SMA; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8801
  },
  {
    "request_id": "AM-REQ-2026-02753",
    "original_inquiry": "家长咨询：患儿确诊CRISPR疗法，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8972
  },
  {
    "request_id": "AM-REQ-2026-02754",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊gene therapy，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6624
  },
  {
    "request_id": "AM-REQ-2026-02755",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8224
  },
  {
    "request_id": "AM-REQ-2026-02756",
    "original_inquiry": "海外求诊：Urgent consultation: SMA diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6939
  },
  {
    "request_id": "AM-REQ-2026-02757",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and AAV9 outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6339
  },
  {
    "request_id": "AM-REQ-2026-02758",
    "original_inquiry": "Patient with 杜氏肌营养不良; requesting information on Lyfgenia and SRP-9001 access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5082
  },
  {
    "request_id": "AM-REQ-2026-02759",
    "original_inquiry": "Urgent: Urgent consultation: AAV vector diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8564
  },
  {
    "request_id": "AM-REQ-2026-02760",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7817
  },
  {
    "request_id": "AM-REQ-2026-02761",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7086
  },
  {
    "request_id": "AM-REQ-2026-02762",
    "original_inquiry": "Urgent: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring ELEVIDYS and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8261
  },
  {
    "request_id": "AM-REQ-2026-02763",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and SRP-9001 outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.62
  },
  {
    "request_id": "AM-REQ-2026-02764",
    "original_inquiry": "海外求诊：Patient with 镰状细胞贫血; requesting information on exon skipping and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5015
  },
  {
    "request_id": "AM-REQ-2026-02765",
    "original_inquiry": "Family seeking information: Geneticist referral: spinal muscular atrophy confirmed; exploring Casgevy and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8582
  },
  {
    "request_id": "AM-REQ-2026-02766",
    "original_inquiry": "Referral from specialist: Patient with spinal muscular atrophy; requesting information on Casgevy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6792
  },
  {
    "request_id": "AM-REQ-2026-02767",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7489
  },
  {
    "request_id": "AM-REQ-2026-02768",
    "original_inquiry": "Family seeking information: Child with 镰状细胞贫血; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8701
  },
  {
    "request_id": "AM-REQ-2026-02769",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊SMA基因治疗，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7577
  },
  {
    "request_id": "AM-REQ-2026-02770",
    "original_inquiry": "研究者咨询：Geneticist referral: 杜氏肌营养不良 confirmed; exploring Lyfgenia and AAV9 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7543
  },
  {
    "request_id": "AM-REQ-2026-02771",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking exon skipping / Zolgensma availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-02772",
    "original_inquiry": "研究者咨询：Child with SMA; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6047
  },
  {
    "request_id": "AM-REQ-2026-02773",
    "original_inquiry": "Family seeking information: Patient with SMA基因治疗; requesting information on CRISPR-Cas9 and Zolgensma access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8929
  },
  {
    "request_id": "AM-REQ-2026-02774",
    "original_inquiry": "研究者咨询：Researcher inquiry: 镰状细胞贫血 delivery and SRP-9001 outcomes in AAV9; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8839
  },
  {
    "request_id": "AM-REQ-2026-02775",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Casgevy outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5852
  },
  {
    "request_id": "AM-REQ-2026-02776",
    "original_inquiry": "研究者咨询：Urgent consultation: CRISPR疗法 diagnosis, seeking AAV9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6707
  },
  {
    "request_id": "AM-REQ-2026-02777",
    "original_inquiry": "Second opinion requested: Patient with gene therapy; requesting information on exon skipping and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5882
  },
  {
    "request_id": "AM-REQ-2026-02778",
    "original_inquiry": "Family seeking information: Researcher inquiry: DMD delivery and SRP-9001 outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6692
  },
  {
    "request_id": "AM-REQ-2026-02779",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.62
  },
  {
    "request_id": "AM-REQ-2026-02780",
    "original_inquiry": "研究者咨询：Patient with Duchenne muscular dystrophy; requesting information on AAV9 and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.822
  },
  {
    "request_id": "AM-REQ-2026-02781",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6016
  },
  {
    "request_id": "AM-REQ-2026-02782",
    "original_inquiry": "海外求药：sickle cell disease患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8415
  },
  {
    "request_id": "AM-REQ-2026-02783",
    "original_inquiry": "Geneticist referral: beta-thalassemia confirmed; exploring Zolgensma and SRP-9001 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7107
  },
  {
    "request_id": "AM-REQ-2026-02784",
    "original_inquiry": "海外求诊：Researcher inquiry: gene therapy delivery and Casgevy outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6427
  },
  {
    "request_id": "AM-REQ-2026-02785",
    "original_inquiry": "海外求诊：Patient with AAV vector; requesting information on CRISPR-Cas9 and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8519
  },
  {
    "request_id": "AM-REQ-2026-02786",
    "original_inquiry": "Urgent: Researcher inquiry: DMD delivery and AAV9 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8104
  },
  {
    "request_id": "AM-REQ-2026-02787",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊CRISPR疗法，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7044
  },
  {
    "request_id": "AM-REQ-2026-02788",
    "original_inquiry": "Urgent: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring exon skipping and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.709
  },
  {
    "request_id": "AM-REQ-2026-02789",
    "original_inquiry": "Family seeking information: Patient with beta-thalassemia; requesting information on gene replacement therapy and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8699
  },
  {
    "request_id": "AM-REQ-2026-02790",
    "original_inquiry": "Referral from specialist: Child with SMA基因治疗; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7883
  },
  {
    "request_id": "AM-REQ-2026-02791",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8788
  },
  {
    "request_id": "AM-REQ-2026-02792",
    "original_inquiry": "Urgent: Geneticist referral: SMA基因治疗 confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5589
  },
  {
    "request_id": "AM-REQ-2026-02793",
    "original_inquiry": "Referral from specialist: Child with beta-thalassemia; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-02794",
    "original_inquiry": "Urgent: Child with spinal muscular atrophy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7035
  },
  {
    "request_id": "AM-REQ-2026-02795",
    "original_inquiry": "海外求诊：Child with sickle cell disease; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7526
  },
  {
    "request_id": "AM-REQ-2026-02796",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5535
  },
  {
    "request_id": "AM-REQ-2026-02797",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5966
  },
  {
    "request_id": "AM-REQ-2026-02798",
    "original_inquiry": "Urgent: 海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7972
  },
  {
    "request_id": "AM-REQ-2026-02799",
    "original_inquiry": "Referral from specialist: Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7878
  },
  {
    "request_id": "AM-REQ-2026-02800",
    "original_inquiry": "Family seeking information: Geneticist referral: 镰状细胞贫血 confirmed; exploring ELEVIDYS and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8282
  },
  {
    "request_id": "AM-REQ-2026-02801",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.62
  },
  {
    "request_id": "AM-REQ-2026-02802",
    "original_inquiry": "Child with AAV vector; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8551
  },
  {
    "request_id": "AM-REQ-2026-02803",
    "original_inquiry": "研究者咨询：Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6649
  },
  {
    "request_id": "AM-REQ-2026-02804",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on Casgevy and AAV9 access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5423
  },
  {
    "request_id": "AM-REQ-2026-02805",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8015
  },
  {
    "request_id": "AM-REQ-2026-02806",
    "original_inquiry": "家长咨询：患儿确诊gene therapy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8308
  },
  {
    "request_id": "AM-REQ-2026-02807",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8424
  },
  {
    "request_id": "AM-REQ-2026-02808",
    "original_inquiry": "海外求诊：Researcher inquiry: gene therapy delivery and Lyfgenia outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8799
  },
  {
    "request_id": "AM-REQ-2026-02809",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and gene replacement therapy outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6132
  },
  {
    "request_id": "AM-REQ-2026-02810",
    "original_inquiry": "Urgent: Urgent consultation: gene therapy diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8642
  },
  {
    "request_id": "AM-REQ-2026-02811",
    "original_inquiry": "海外求诊：海外求药：CRISPR疗法患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5591
  },
  {
    "request_id": "AM-REQ-2026-02812",
    "original_inquiry": "Second opinion requested: Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8608
  },
  {
    "request_id": "AM-REQ-2026-02813",
    "original_inquiry": "Urgent: Urgent consultation: 镰状细胞贫血 diagnosis, seeking exon skipping / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8464
  },
  {
    "request_id": "AM-REQ-2026-02814",
    "original_inquiry": "Urgent: Geneticist referral: DMD confirmed; exploring Zolgensma and Lyfgenia trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5247
  },
  {
    "request_id": "AM-REQ-2026-02815",
    "original_inquiry": "Urgent: Urgent consultation: CRISPR疗法 diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7076
  },
  {
    "request_id": "AM-REQ-2026-02816",
    "original_inquiry": "Referral from specialist: Geneticist referral: beta-thalassemia confirmed; exploring ELEVIDYS and SRP-9001 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5697
  },
  {
    "request_id": "AM-REQ-2026-02817",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and Zolgensma outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6672
  },
  {
    "request_id": "AM-REQ-2026-02818",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊AAV vector，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7297
  },
  {
    "request_id": "AM-REQ-2026-02819",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.665
  },
  {
    "request_id": "AM-REQ-2026-02820",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring CRISPR-Cas9 and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8298
  },
  {
    "request_id": "AM-REQ-2026-02821",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7766
  },
  {
    "request_id": "AM-REQ-2026-02822",
    "original_inquiry": "研究者咨询：Patient with spinal muscular atrophy; requesting information on Zolgensma and Casgevy access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7572
  },
  {
    "request_id": "AM-REQ-2026-02823",
    "original_inquiry": "研究者咨询：Urgent consultation: gene therapy diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5678
  },
  {
    "request_id": "AM-REQ-2026-02824",
    "original_inquiry": "Family seeking information: Child with gene therapy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8101
  },
  {
    "request_id": "AM-REQ-2026-02825",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊gene therapy，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8409
  },
  {
    "request_id": "AM-REQ-2026-02826",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.678
  },
  {
    "request_id": "AM-REQ-2026-02827",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊beta-thalassemia，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8683
  },
  {
    "request_id": "AM-REQ-2026-02828",
    "original_inquiry": "Referral from specialist: Patient with SMA; requesting information on gene replacement therapy and SRP-9001 access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8645
  },
  {
    "request_id": "AM-REQ-2026-02829",
    "original_inquiry": "Family seeking information: 海外求药：SMA患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6676
  },
  {
    "request_id": "AM-REQ-2026-02830",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊CRISPR疗法，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5395
  },
  {
    "request_id": "AM-REQ-2026-02831",
    "original_inquiry": "Referral from specialist: Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5997
  },
  {
    "request_id": "AM-REQ-2026-02832",
    "original_inquiry": "研究者咨询：Child with AAV vector; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8012
  },
  {
    "request_id": "AM-REQ-2026-02833",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on Zolgensma and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.733
  },
  {
    "request_id": "AM-REQ-2026-02834",
    "original_inquiry": "研究者咨询：海外求药：SMA患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8275
  },
  {
    "request_id": "AM-REQ-2026-02835",
    "original_inquiry": "Urgent: Patient with spinal muscular atrophy; requesting information on exon skipping and ELEVIDYS access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6668
  },
  {
    "request_id": "AM-REQ-2026-02836",
    "original_inquiry": "Urgent: Urgent consultation: CRISPR疗法 diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5274
  },
  {
    "request_id": "AM-REQ-2026-02837",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6313
  },
  {
    "request_id": "AM-REQ-2026-02838",
    "original_inquiry": "Family seeking information: Urgent consultation: beta-thalassemia diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6684
  },
  {
    "request_id": "AM-REQ-2026-02839",
    "original_inquiry": "研究者咨询：Urgent consultation: DMD diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6824
  },
  {
    "request_id": "AM-REQ-2026-02840",
    "original_inquiry": "Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Zolgensma / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5472
  },
  {
    "request_id": "AM-REQ-2026-02841",
    "original_inquiry": "海外求诊：海外求药：杜氏肌营养不良患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8633
  },
  {
    "request_id": "AM-REQ-2026-02842",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring AAV9 and Casgevy trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7515
  },
  {
    "request_id": "AM-REQ-2026-02843",
    "original_inquiry": "Researcher inquiry: spinal muscular atrophy delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.84
  },
  {
    "request_id": "AM-REQ-2026-02844",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7679
  },
  {
    "request_id": "AM-REQ-2026-02845",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊AAV vector，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7797
  },
  {
    "request_id": "AM-REQ-2026-02846",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6011
  },
  {
    "request_id": "AM-REQ-2026-02847",
    "original_inquiry": "海外求诊：Child with CRISPR疗法; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6171
  },
  {
    "request_id": "AM-REQ-2026-02848",
    "original_inquiry": "Child with spinal muscular atrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.632
  },
  {
    "request_id": "AM-REQ-2026-02849",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.701
  },
  {
    "request_id": "AM-REQ-2026-02850",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8521
  },
  {
    "request_id": "AM-REQ-2026-02851",
    "original_inquiry": "Second opinion requested: Patient with spinal muscular atrophy; requesting information on Zolgensma and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7354
  },
  {
    "request_id": "AM-REQ-2026-02852",
    "original_inquiry": "研究者咨询：海外求药：Duchenne muscular dystrophy患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8935
  },
  {
    "request_id": "AM-REQ-2026-02853",
    "original_inquiry": "Family seeking information: Child with SMA基因治疗; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7928
  },
  {
    "request_id": "AM-REQ-2026-02854",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA，寻求Lyfgenia或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8992
  },
  {
    "request_id": "AM-REQ-2026-02855",
    "original_inquiry": "Second opinion requested: Geneticist referral: 杜氏肌营养不良 confirmed; exploring CRISPR-Cas9 and Lyfgenia trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8008
  },
  {
    "request_id": "AM-REQ-2026-02856",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 镰状细胞贫血 delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.858
  },
  {
    "request_id": "AM-REQ-2026-02857",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and Lyfgenia outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.687
  },
  {
    "request_id": "AM-REQ-2026-02858",
    "original_inquiry": "Family seeking information: Geneticist referral: 镰状细胞贫血 confirmed; exploring gene replacement therapy and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6787
  },
  {
    "request_id": "AM-REQ-2026-02859",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊sickle cell disease，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7082
  },
  {
    "request_id": "AM-REQ-2026-02860",
    "original_inquiry": "Second opinion requested: Child with beta-thalassemia; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8146
  },
  {
    "request_id": "AM-REQ-2026-02861",
    "original_inquiry": "Family seeking information: Researcher inquiry: 镰状细胞贫血 delivery and exon skipping outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6961
  },
  {
    "request_id": "AM-REQ-2026-02862",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5182
  },
  {
    "request_id": "AM-REQ-2026-02863",
    "original_inquiry": "Geneticist referral: SMA基因治疗 confirmed; exploring Lyfgenia and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8536
  },
  {
    "request_id": "AM-REQ-2026-02864",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8101
  },
  {
    "request_id": "AM-REQ-2026-02865",
    "original_inquiry": "Child with spinal muscular atrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7239
  },
  {
    "request_id": "AM-REQ-2026-02866",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5776
  },
  {
    "request_id": "AM-REQ-2026-02867",
    "original_inquiry": "Geneticist referral: spinal muscular atrophy confirmed; exploring Casgevy and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6567
  },
  {
    "request_id": "AM-REQ-2026-02868",
    "original_inquiry": "Referral from specialist: Geneticist referral: DMD confirmed; exploring Lyfgenia and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7199
  },
  {
    "request_id": "AM-REQ-2026-02869",
    "original_inquiry": "Referral from specialist: Child with DMD; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5115
  },
  {
    "request_id": "AM-REQ-2026-02870",
    "original_inquiry": "Geneticist referral: beta-thalassemia confirmed; exploring Lyfgenia and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5318
  },
  {
    "request_id": "AM-REQ-2026-02871",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.708
  },
  {
    "request_id": "AM-REQ-2026-02872",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-02873",
    "original_inquiry": "Referral from specialist: Patient with AAV vector; requesting information on gene replacement therapy and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7224
  },
  {
    "request_id": "AM-REQ-2026-02874",
    "original_inquiry": "海外求诊：Geneticist referral: 镰状细胞贫血 confirmed; exploring CRISPR-Cas9 and SRP-9001 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5006
  },
  {
    "request_id": "AM-REQ-2026-02875",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 杜氏肌营养不良 delivery and Lyfgenia outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7574
  },
  {
    "request_id": "AM-REQ-2026-02876",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊镰状细胞贫血，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.574
  },
  {
    "request_id": "AM-REQ-2026-02877",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6116
  },
  {
    "request_id": "AM-REQ-2026-02878",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on Zolgensma and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8395
  },
  {
    "request_id": "AM-REQ-2026-02879",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7259
  },
  {
    "request_id": "AM-REQ-2026-02880",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊gene therapy，寻求Zolgensma或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5208
  },
  {
    "request_id": "AM-REQ-2026-02881",
    "original_inquiry": "Urgent: Urgent consultation: spinal muscular atrophy diagnosis, seeking Zolgensma / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7413
  },
  {
    "request_id": "AM-REQ-2026-02882",
    "original_inquiry": "Referral from specialist: Child with gene therapy; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8933
  },
  {
    "request_id": "AM-REQ-2026-02883",
    "original_inquiry": "Second opinion requested: Geneticist referral: SMA confirmed; exploring Lyfgenia and AAV9 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7515
  },
  {
    "request_id": "AM-REQ-2026-02884",
    "original_inquiry": "研究者咨询：海外求药：CRISPR疗法患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5739
  },
  {
    "request_id": "AM-REQ-2026-02885",
    "original_inquiry": "研究者咨询：Urgent consultation: 镰状细胞贫血 diagnosis, seeking Casgevy / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5953
  },
  {
    "request_id": "AM-REQ-2026-02886",
    "original_inquiry": "Urgent: Patient with SMA基因治疗; requesting information on ELEVIDYS and Lyfgenia access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-02887",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on Casgevy and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8277
  },
  {
    "request_id": "AM-REQ-2026-02888",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring gene replacement therapy and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8451
  },
  {
    "request_id": "AM-REQ-2026-02889",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊sickle cell disease，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6296
  },
  {
    "request_id": "AM-REQ-2026-02890",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5432
  },
  {
    "request_id": "AM-REQ-2026-02891",
    "original_inquiry": "Referral from specialist: Researcher inquiry: gene therapy delivery and ELEVIDYS outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5164
  },
  {
    "request_id": "AM-REQ-2026-02892",
    "original_inquiry": "Urgent: Patient with Duchenne muscular dystrophy; requesting information on Lyfgenia and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6005
  },
  {
    "request_id": "AM-REQ-2026-02893",
    "original_inquiry": "Second opinion requested: Geneticist referral: beta-thalassemia confirmed; exploring gene replacement therapy and Zolgensma trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5923
  },
  {
    "request_id": "AM-REQ-2026-02894",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8192
  },
  {
    "request_id": "AM-REQ-2026-02895",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA基因治疗 diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6225
  },
  {
    "request_id": "AM-REQ-2026-02896",
    "original_inquiry": "Urgent: Geneticist referral: DMD confirmed; exploring SRP-9001 and Lyfgenia trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6036
  },
  {
    "request_id": "AM-REQ-2026-02897",
    "original_inquiry": "Referral from specialist: Urgent consultation: CRISPR疗法 diagnosis, seeking exon skipping / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6569
  },
  {
    "request_id": "AM-REQ-2026-02898",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6393
  },
  {
    "request_id": "AM-REQ-2026-02899",
    "original_inquiry": "Urgent: Urgent consultation: CRISPR疗法 diagnosis, seeking gene replacement therapy / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6178
  },
  {
    "request_id": "AM-REQ-2026-02900",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and Casgevy outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6085
  },
  {
    "request_id": "AM-REQ-2026-02901",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5002
  },
  {
    "request_id": "AM-REQ-2026-02902",
    "original_inquiry": "Referral from specialist: Geneticist referral: DMD confirmed; exploring ELEVIDYS and AAV9 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8404
  },
  {
    "request_id": "AM-REQ-2026-02903",
    "original_inquiry": "Urgent: Urgent consultation: SMA diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6233
  },
  {
    "request_id": "AM-REQ-2026-02904",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6039
  },
  {
    "request_id": "AM-REQ-2026-02905",
    "original_inquiry": "Urgent: Urgent consultation: sickle cell disease diagnosis, seeking AAV9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7569
  },
  {
    "request_id": "AM-REQ-2026-02906",
    "original_inquiry": "Geneticist referral: Duchenne muscular dystrophy confirmed; exploring gene replacement therapy and SRP-9001 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.824
  },
  {
    "request_id": "AM-REQ-2026-02907",
    "original_inquiry": "Family seeking information: 海外求药：CRISPR疗法患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5245
  },
  {
    "request_id": "AM-REQ-2026-02908",
    "original_inquiry": "Family seeking information: Geneticist referral: CRISPR疗法 confirmed; exploring CRISPR-Cas9 and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6611
  },
  {
    "request_id": "AM-REQ-2026-02909",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and Casgevy outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6877
  },
  {
    "request_id": "AM-REQ-2026-02910",
    "original_inquiry": "Second opinion requested: Urgent consultation: gene therapy diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7237
  },
  {
    "request_id": "AM-REQ-2026-02911",
    "original_inquiry": "研究者咨询：Child with CRISPR疗法; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7518
  },
  {
    "request_id": "AM-REQ-2026-02912",
    "original_inquiry": "Second opinion requested: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Lyfgenia and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-02913",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6507
  },
  {
    "request_id": "AM-REQ-2026-02914",
    "original_inquiry": "Urgent: Child with sickle cell disease; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5441
  },
  {
    "request_id": "AM-REQ-2026-02915",
    "original_inquiry": "海外求诊：Geneticist referral: DMD confirmed; exploring Zolgensma and Casgevy trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6724
  },
  {
    "request_id": "AM-REQ-2026-02916",
    "original_inquiry": "Referral from specialist: Child with gene therapy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7452
  },
  {
    "request_id": "AM-REQ-2026-02917",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6012
  },
  {
    "request_id": "AM-REQ-2026-02918",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7148
  },
  {
    "request_id": "AM-REQ-2026-02919",
    "original_inquiry": "Second opinion requested: Geneticist referral: spinal muscular atrophy confirmed; exploring CRISPR-Cas9 and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8056
  },
  {
    "request_id": "AM-REQ-2026-02920",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊CRISPR疗法，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5708
  },
  {
    "request_id": "AM-REQ-2026-02921",
    "original_inquiry": "研究者咨询：海外求药：gene therapy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.878
  },
  {
    "request_id": "AM-REQ-2026-02922",
    "original_inquiry": "研究者咨询：海外求药：beta-thalassemia患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8811
  },
  {
    "request_id": "AM-REQ-2026-02923",
    "original_inquiry": "Family seeking information: Urgent consultation: beta-thalassemia diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.595
  },
  {
    "request_id": "AM-REQ-2026-02924",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊beta-thalassemia，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6836
  },
  {
    "request_id": "AM-REQ-2026-02925",
    "original_inquiry": "Second opinion requested: Researcher inquiry: gene therapy delivery and Zolgensma outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-02926",
    "original_inquiry": "Referral from specialist: Child with DMD; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6937
  },
  {
    "request_id": "AM-REQ-2026-02927",
    "original_inquiry": "海外求诊：Researcher inquiry: SMA delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.585
  },
  {
    "request_id": "AM-REQ-2026-02928",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and gene replacement therapy outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7803
  },
  {
    "request_id": "AM-REQ-2026-02929",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7814
  },
  {
    "request_id": "AM-REQ-2026-02930",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8706
  },
  {
    "request_id": "AM-REQ-2026-02931",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5532
  },
  {
    "request_id": "AM-REQ-2026-02932",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6834
  },
  {
    "request_id": "AM-REQ-2026-02933",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring gene replacement therapy and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8539
  },
  {
    "request_id": "AM-REQ-2026-02934",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6758
  },
  {
    "request_id": "AM-REQ-2026-02935",
    "original_inquiry": "Urgent: Child with 镰状细胞贫血; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7388
  },
  {
    "request_id": "AM-REQ-2026-02936",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊spinal muscular atrophy，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8572
  },
  {
    "request_id": "AM-REQ-2026-02937",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.511
  },
  {
    "request_id": "AM-REQ-2026-02938",
    "original_inquiry": "Referral from specialist: Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5754
  },
  {
    "request_id": "AM-REQ-2026-02939",
    "original_inquiry": "Urgent: Urgent consultation: AAV vector diagnosis, seeking AAV9 / Zolgensma availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.547
  },
  {
    "request_id": "AM-REQ-2026-02940",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊镰状细胞贫血，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8035
  },
  {
    "request_id": "AM-REQ-2026-02941",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6682
  },
  {
    "request_id": "AM-REQ-2026-02942",
    "original_inquiry": "Child with DMD; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5548
  },
  {
    "request_id": "AM-REQ-2026-02943",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on Zolgensma and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5043
  },
  {
    "request_id": "AM-REQ-2026-02944",
    "original_inquiry": "Referral from specialist: 海外求药：spinal muscular atrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6871
  },
  {
    "request_id": "AM-REQ-2026-02945",
    "original_inquiry": "Family seeking information: 海外求药：DMD患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8942
  },
  {
    "request_id": "AM-REQ-2026-02946",
    "original_inquiry": "Second opinion requested: Child with DMD; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5697
  },
  {
    "request_id": "AM-REQ-2026-02947",
    "original_inquiry": "Referral from specialist: Researcher inquiry: beta-thalassemia delivery and Zolgensma outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6053
  },
  {
    "request_id": "AM-REQ-2026-02948",
    "original_inquiry": "Second opinion requested: Researcher inquiry: SMA delivery and gene replacement therapy outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8612
  },
  {
    "request_id": "AM-REQ-2026-02949",
    "original_inquiry": "Second opinion requested: 海外求药：beta-thalassemia患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6079
  },
  {
    "request_id": "AM-REQ-2026-02950",
    "original_inquiry": "Urgent: 海外求药：AAV vector患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7115
  },
  {
    "request_id": "AM-REQ-2026-02951",
    "original_inquiry": "Family seeking information: Patient with gene therapy; requesting information on ELEVIDYS and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5591
  },
  {
    "request_id": "AM-REQ-2026-02952",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊CRISPR疗法，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.551
  },
  {
    "request_id": "AM-REQ-2026-02953",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and Zolgensma outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5867
  },
  {
    "request_id": "AM-REQ-2026-02954",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊DMD，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5885
  },
  {
    "request_id": "AM-REQ-2026-02955",
    "original_inquiry": "Urgent: Researcher inquiry: CRISPR疗法 delivery and Zolgensma outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5547
  },
  {
    "request_id": "AM-REQ-2026-02956",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊DMD，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7788
  },
  {
    "request_id": "AM-REQ-2026-02957",
    "original_inquiry": "研究者咨询：Patient with 杜氏肌营养不良; requesting information on SRP-9001 and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7632
  },
  {
    "request_id": "AM-REQ-2026-02958",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7017
  },
  {
    "request_id": "AM-REQ-2026-02959",
    "original_inquiry": "Child with 镰状细胞贫血; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7164
  },
  {
    "request_id": "AM-REQ-2026-02960",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5278
  },
  {
    "request_id": "AM-REQ-2026-02961",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on Casgevy and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5427
  },
  {
    "request_id": "AM-REQ-2026-02962",
    "original_inquiry": "Referral from specialist: Researcher inquiry: DMD delivery and AAV9 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6787
  },
  {
    "request_id": "AM-REQ-2026-02963",
    "original_inquiry": "海外求诊：Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6286
  },
  {
    "request_id": "AM-REQ-2026-02964",
    "original_inquiry": "研究者咨询：Patient with DMD; requesting information on SRP-9001 and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7104
  },
  {
    "request_id": "AM-REQ-2026-02965",
    "original_inquiry": "Family seeking information: Geneticist referral: 镰状细胞贫血 confirmed; exploring ELEVIDYS and AAV9 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6429
  },
  {
    "request_id": "AM-REQ-2026-02966",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on ELEVIDYS and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8856
  },
  {
    "request_id": "AM-REQ-2026-02967",
    "original_inquiry": "海外求诊：Patient with beta-thalassemia; requesting information on CRISPR-Cas9 and Lyfgenia access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7998
  },
  {
    "request_id": "AM-REQ-2026-02968",
    "original_inquiry": "海外求诊：Researcher inquiry: CRISPR疗法 delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7458
  },
  {
    "request_id": "AM-REQ-2026-02969",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6029
  },
  {
    "request_id": "AM-REQ-2026-02970",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6541
  },
  {
    "request_id": "AM-REQ-2026-02971",
    "original_inquiry": "Referral from specialist: Patient with spinal muscular atrophy; requesting information on gene replacement therapy and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8425
  },
  {
    "request_id": "AM-REQ-2026-02972",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6497
  },
  {
    "request_id": "AM-REQ-2026-02973",
    "original_inquiry": "Second opinion requested: Geneticist referral: DMD confirmed; exploring CRISPR-Cas9 and Lyfgenia trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6932
  },
  {
    "request_id": "AM-REQ-2026-02974",
    "original_inquiry": "海外求诊：Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5629
  },
  {
    "request_id": "AM-REQ-2026-02975",
    "original_inquiry": "Referral from specialist: 海外求药：SMA基因治疗患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8857
  },
  {
    "request_id": "AM-REQ-2026-02976",
    "original_inquiry": "海外求诊：Geneticist referral: sickle cell disease confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5559
  },
  {
    "request_id": "AM-REQ-2026-02977",
    "original_inquiry": "Referral from specialist: Geneticist referral: spinal muscular atrophy confirmed; exploring exon skipping and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5067
  },
  {
    "request_id": "AM-REQ-2026-02978",
    "original_inquiry": "Child with 镰状细胞贫血; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8223
  },
  {
    "request_id": "AM-REQ-2026-02979",
    "original_inquiry": "海外求诊：Child with beta-thalassemia; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8566
  },
  {
    "request_id": "AM-REQ-2026-02980",
    "original_inquiry": "Second opinion requested: Researcher inquiry: sickle cell disease delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8508
  },
  {
    "request_id": "AM-REQ-2026-02981",
    "original_inquiry": "Second opinion requested: Geneticist referral: CRISPR疗法 confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6579
  },
  {
    "request_id": "AM-REQ-2026-02982",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5433
  },
  {
    "request_id": "AM-REQ-2026-02983",
    "original_inquiry": "Geneticist referral: 镰状细胞贫血 confirmed; exploring ELEVIDYS and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6427
  },
  {
    "request_id": "AM-REQ-2026-02984",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊beta-thalassemia，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-02985",
    "original_inquiry": "海外求诊：Researcher inquiry: AAV vector delivery and SRP-9001 outcomes in AAV9; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.594
  },
  {
    "request_id": "AM-REQ-2026-02986",
    "original_inquiry": "Second opinion requested: Urgent consultation: DMD diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8533
  },
  {
    "request_id": "AM-REQ-2026-02987",
    "original_inquiry": "Second opinion requested: Patient with Duchenne muscular dystrophy; requesting information on ELEVIDYS and SRP-9001 access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8587
  },
  {
    "request_id": "AM-REQ-2026-02988",
    "original_inquiry": "Referral from specialist: Patient with SMA基因治疗; requesting information on ELEVIDYS and Lyfgenia access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7589
  },
  {
    "request_id": "AM-REQ-2026-02989",
    "original_inquiry": "Referral from specialist: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6776
  },
  {
    "request_id": "AM-REQ-2026-02990",
    "original_inquiry": "海外求诊：Child with AAV vector; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5187
  },
  {
    "request_id": "AM-REQ-2026-02991",
    "original_inquiry": "研究者咨询：海外求药：AAV vector患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5069
  },
  {
    "request_id": "AM-REQ-2026-02992",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring gene replacement therapy and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8627
  },
  {
    "request_id": "AM-REQ-2026-02993",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5489
  },
  {
    "request_id": "AM-REQ-2026-02994",
    "original_inquiry": "Child with SMA基因治疗; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8234
  },
  {
    "request_id": "AM-REQ-2026-02995",
    "original_inquiry": "Urgent consultation: beta-thalassemia diagnosis, seeking AAV9 / Casgevy availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.774
  },
  {
    "request_id": "AM-REQ-2026-02996",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6539
  },
  {
    "request_id": "AM-REQ-2026-02997",
    "original_inquiry": "Urgent: Researcher inquiry: CRISPR疗法 delivery and SRP-9001 outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8926
  },
  {
    "request_id": "AM-REQ-2026-02998",
    "original_inquiry": "海外求诊：Patient with DMD; requesting information on Casgevy and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6731
  },
  {
    "request_id": "AM-REQ-2026-02999",
    "original_inquiry": "Family seeking information: Patient with Duchenne muscular dystrophy; requesting information on Casgevy and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7503
  },
  {
    "request_id": "AM-REQ-2026-03000",
    "original_inquiry": "海外求诊：Geneticist referral: gene therapy confirmed; exploring Zolgensma and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.516
  },
  {
    "request_id": "AM-REQ-2026-03001",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5385
  },
  {
    "request_id": "AM-REQ-2026-03002",
    "original_inquiry": "Second opinion requested: Patient with 镰状细胞贫血; requesting information on ELEVIDYS and SRP-9001 access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-03003",
    "original_inquiry": "Family seeking information: Child with DMD; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7023
  },
  {
    "request_id": "AM-REQ-2026-03004",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5783
  },
  {
    "request_id": "AM-REQ-2026-03005",
    "original_inquiry": "Family seeking information: Geneticist referral: sickle cell disease confirmed; exploring ELEVIDYS and Lyfgenia trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6772
  },
  {
    "request_id": "AM-REQ-2026-03006",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.773
  },
  {
    "request_id": "AM-REQ-2026-03007",
    "original_inquiry": "Urgent: 海外求药：Duchenne muscular dystrophy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8977
  },
  {
    "request_id": "AM-REQ-2026-03008",
    "original_inquiry": "Urgent: 海外求药：spinal muscular atrophy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6816
  },
  {
    "request_id": "AM-REQ-2026-03009",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring Casgevy and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6934
  },
  {
    "request_id": "AM-REQ-2026-03010",
    "original_inquiry": "Second opinion requested: Geneticist referral: gene therapy confirmed; exploring SRP-9001 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5301
  },
  {
    "request_id": "AM-REQ-2026-03011",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊杜氏肌营养不良，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7321
  },
  {
    "request_id": "AM-REQ-2026-03012",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA delivery and ELEVIDYS outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8618
  },
  {
    "request_id": "AM-REQ-2026-03013",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and SRP-9001 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8909
  },
  {
    "request_id": "AM-REQ-2026-03014",
    "original_inquiry": "海外求诊：Child with SMA; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8817
  },
  {
    "request_id": "AM-REQ-2026-03015",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8565
  },
  {
    "request_id": "AM-REQ-2026-03016",
    "original_inquiry": "Geneticist referral: beta-thalassemia confirmed; exploring ELEVIDYS and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6848
  },
  {
    "request_id": "AM-REQ-2026-03017",
    "original_inquiry": "家长咨询：患儿确诊AAV vector，寻求AAV9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7386
  },
  {
    "request_id": "AM-REQ-2026-03018",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7599
  },
  {
    "request_id": "AM-REQ-2026-03019",
    "original_inquiry": "Urgent: Patient with SMA; requesting information on Lyfgenia and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8295
  },
  {
    "request_id": "AM-REQ-2026-03020",
    "original_inquiry": "Urgent: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6431
  },
  {
    "request_id": "AM-REQ-2026-03021",
    "original_inquiry": "Patient with DMD; requesting information on AAV9 and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7733
  },
  {
    "request_id": "AM-REQ-2026-03022",
    "original_inquiry": "Urgent: Child with sickle cell disease; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7478
  },
  {
    "request_id": "AM-REQ-2026-03023",
    "original_inquiry": "海外求诊：Child with SMA基因治疗; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7376
  },
  {
    "request_id": "AM-REQ-2026-03024",
    "original_inquiry": "Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6844
  },
  {
    "request_id": "AM-REQ-2026-03025",
    "original_inquiry": "海外求药：镰状细胞贫血患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.529
  },
  {
    "request_id": "AM-REQ-2026-03026",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6162
  },
  {
    "request_id": "AM-REQ-2026-03027",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊spinal muscular atrophy，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5009
  },
  {
    "request_id": "AM-REQ-2026-03028",
    "original_inquiry": "Researcher inquiry: SMA基因治疗 delivery and AAV9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7607
  },
  {
    "request_id": "AM-REQ-2026-03029",
    "original_inquiry": "Urgent: Researcher inquiry: spinal muscular atrophy delivery and ELEVIDYS outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5698
  },
  {
    "request_id": "AM-REQ-2026-03030",
    "original_inquiry": "Second opinion requested: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring exon skipping and SRP-9001 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5064
  },
  {
    "request_id": "AM-REQ-2026-03031",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7148
  },
  {
    "request_id": "AM-REQ-2026-03032",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊镰状细胞贫血，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6966
  },
  {
    "request_id": "AM-REQ-2026-03033",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊AAV vector，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5495
  },
  {
    "request_id": "AM-REQ-2026-03034",
    "original_inquiry": "Family seeking information: 海外求药：spinal muscular atrophy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6792
  },
  {
    "request_id": "AM-REQ-2026-03035",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.87
  },
  {
    "request_id": "AM-REQ-2026-03036",
    "original_inquiry": "Family seeking information: Researcher inquiry: 镰状细胞贫血 delivery and SRP-9001 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7285
  },
  {
    "request_id": "AM-REQ-2026-03037",
    "original_inquiry": "Urgent: Geneticist referral: sickle cell disease confirmed; exploring gene replacement therapy and ELEVIDYS trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8942
  },
  {
    "request_id": "AM-REQ-2026-03038",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5391
  },
  {
    "request_id": "AM-REQ-2026-03039",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6505
  },
  {
    "request_id": "AM-REQ-2026-03040",
    "original_inquiry": "Second opinion requested: Geneticist referral: AAV vector confirmed; exploring exon skipping and Casgevy trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7772
  },
  {
    "request_id": "AM-REQ-2026-03041",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on exon skipping and ELEVIDYS access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8703
  },
  {
    "request_id": "AM-REQ-2026-03042",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-03043",
    "original_inquiry": "Urgent consultation: SMA基因治疗 diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7429
  },
  {
    "request_id": "AM-REQ-2026-03044",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7908
  },
  {
    "request_id": "AM-REQ-2026-03045",
    "original_inquiry": "Urgent: 海外求药：杜氏肌营养不良患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5971
  },
  {
    "request_id": "AM-REQ-2026-03046",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA confirmed; exploring Casgevy and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6814
  },
  {
    "request_id": "AM-REQ-2026-03047",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on Casgevy and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6865
  },
  {
    "request_id": "AM-REQ-2026-03048",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring CRISPR-Cas9 and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.707
  },
  {
    "request_id": "AM-REQ-2026-03049",
    "original_inquiry": "Urgent: Urgent consultation: DMD diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6799
  },
  {
    "request_id": "AM-REQ-2026-03050",
    "original_inquiry": "研究者咨询：Child with gene therapy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7725
  },
  {
    "request_id": "AM-REQ-2026-03051",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and SRP-9001 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6482
  },
  {
    "request_id": "AM-REQ-2026-03052",
    "original_inquiry": "Urgent: Patient with spinal muscular atrophy; requesting information on SRP-9001 and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5292
  },
  {
    "request_id": "AM-REQ-2026-03053",
    "original_inquiry": "Urgent: Geneticist referral: CRISPR疗法 confirmed; exploring exon skipping and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5085
  },
  {
    "request_id": "AM-REQ-2026-03054",
    "original_inquiry": "Urgent: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6385
  },
  {
    "request_id": "AM-REQ-2026-03055",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5386
  },
  {
    "request_id": "AM-REQ-2026-03056",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6604
  },
  {
    "request_id": "AM-REQ-2026-03057",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8662
  },
  {
    "request_id": "AM-REQ-2026-03058",
    "original_inquiry": "Urgent: Patient with 杜氏肌营养不良; requesting information on Zolgensma and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7838
  },
  {
    "request_id": "AM-REQ-2026-03059",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6404
  },
  {
    "request_id": "AM-REQ-2026-03060",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5845
  },
  {
    "request_id": "AM-REQ-2026-03061",
    "original_inquiry": "海外求诊：Researcher inquiry: gene therapy delivery and Zolgensma outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8456
  },
  {
    "request_id": "AM-REQ-2026-03062",
    "original_inquiry": "Urgent: Researcher inquiry: DMD delivery and ELEVIDYS outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5911
  },
  {
    "request_id": "AM-REQ-2026-03063",
    "original_inquiry": "家长咨询：患儿确诊AAV vector，寻求Zolgensma或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-03064",
    "original_inquiry": "Family seeking information: Patient with spinal muscular atrophy; requesting information on SRP-9001 and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6778
  },
  {
    "request_id": "AM-REQ-2026-03065",
    "original_inquiry": "Urgent: Geneticist referral: AAV vector confirmed; exploring AAV9 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7952
  },
  {
    "request_id": "AM-REQ-2026-03066",
    "original_inquiry": "Urgent: Patient with SMA; requesting information on gene replacement therapy and Casgevy access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7606
  },
  {
    "request_id": "AM-REQ-2026-03067",
    "original_inquiry": "研究者咨询：Researcher inquiry: sickle cell disease delivery and gene replacement therapy outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5534
  },
  {
    "request_id": "AM-REQ-2026-03068",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-03069",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.791
  },
  {
    "request_id": "AM-REQ-2026-03070",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊镰状细胞贫血，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5242
  },
  {
    "request_id": "AM-REQ-2026-03071",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊DMD，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8614
  },
  {
    "request_id": "AM-REQ-2026-03072",
    "original_inquiry": "Urgent: 海外求药：SMA患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6329
  },
  {
    "request_id": "AM-REQ-2026-03073",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊spinal muscular atrophy，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8911
  },
  {
    "request_id": "AM-REQ-2026-03074",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6098
  },
  {
    "request_id": "AM-REQ-2026-03075",
    "original_inquiry": "Urgent consultation: 杜氏肌营养不良 diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5675
  },
  {
    "request_id": "AM-REQ-2026-03076",
    "original_inquiry": "研究者咨询：Child with DMD; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7576
  },
  {
    "request_id": "AM-REQ-2026-03077",
    "original_inquiry": "海外求诊：海外求药：SMA基因治疗患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5921
  },
  {
    "request_id": "AM-REQ-2026-03078",
    "original_inquiry": "Urgent: Researcher inquiry: sickle cell disease delivery and AAV9 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8483
  },
  {
    "request_id": "AM-REQ-2026-03079",
    "original_inquiry": "Referral from specialist: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7837
  },
  {
    "request_id": "AM-REQ-2026-03080",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5316
  },
  {
    "request_id": "AM-REQ-2026-03081",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.52
  },
  {
    "request_id": "AM-REQ-2026-03082",
    "original_inquiry": "Geneticist referral: CRISPR疗法 confirmed; exploring gene replacement therapy and Zolgensma trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8927
  },
  {
    "request_id": "AM-REQ-2026-03083",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊杜氏肌营养不良，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5896
  },
  {
    "request_id": "AM-REQ-2026-03084",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊sickle cell disease，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8985
  },
  {
    "request_id": "AM-REQ-2026-03085",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5221
  },
  {
    "request_id": "AM-REQ-2026-03086",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking gene replacement therapy / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5774
  },
  {
    "request_id": "AM-REQ-2026-03087",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6205
  },
  {
    "request_id": "AM-REQ-2026-03088",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6614
  },
  {
    "request_id": "AM-REQ-2026-03089",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊beta-thalassemia，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7
  },
  {
    "request_id": "AM-REQ-2026-03090",
    "original_inquiry": "Urgent: Geneticist referral: DMD confirmed; exploring Casgevy and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7651
  },
  {
    "request_id": "AM-REQ-2026-03091",
    "original_inquiry": "Urgent: Urgent consultation: beta-thalassemia diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5736
  },
  {
    "request_id": "AM-REQ-2026-03092",
    "original_inquiry": "Urgent: 海外求药：镰状细胞贫血患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-03093",
    "original_inquiry": "Second opinion requested: Patient with Duchenne muscular dystrophy; requesting information on AAV9 and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8954
  },
  {
    "request_id": "AM-REQ-2026-03094",
    "original_inquiry": "Second opinion requested: Geneticist referral: CRISPR疗法 confirmed; exploring gene replacement therapy and Zolgensma trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7561
  },
  {
    "request_id": "AM-REQ-2026-03095",
    "original_inquiry": "Referral from specialist: 海外求药：SMA基因治疗患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8392
  },
  {
    "request_id": "AM-REQ-2026-03096",
    "original_inquiry": "海外求诊：Urgent consultation: SMA基因治疗 diagnosis, seeking Lyfgenia / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5352
  },
  {
    "request_id": "AM-REQ-2026-03097",
    "original_inquiry": "Child with CRISPR疗法; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5651
  },
  {
    "request_id": "AM-REQ-2026-03098",
    "original_inquiry": "研究者咨询：Child with DMD; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8202
  },
  {
    "request_id": "AM-REQ-2026-03099",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8338
  },
  {
    "request_id": "AM-REQ-2026-03100",
    "original_inquiry": "Child with spinal muscular atrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5311
  },
  {
    "request_id": "AM-REQ-2026-03101",
    "original_inquiry": "Second opinion requested: Urgent consultation: DMD diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5846
  },
  {
    "request_id": "AM-REQ-2026-03102",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8468
  },
  {
    "request_id": "AM-REQ-2026-03103",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8077
  },
  {
    "request_id": "AM-REQ-2026-03104",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6605
  },
  {
    "request_id": "AM-REQ-2026-03105",
    "original_inquiry": "Second opinion requested: Researcher inquiry: AAV vector delivery and Zolgensma outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8453
  },
  {
    "request_id": "AM-REQ-2026-03106",
    "original_inquiry": "研究者咨询：Urgent consultation: gene therapy diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6803
  },
  {
    "request_id": "AM-REQ-2026-03107",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on Lyfgenia and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6284
  },
  {
    "request_id": "AM-REQ-2026-03108",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7087
  },
  {
    "request_id": "AM-REQ-2026-03109",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊sickle cell disease，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6773
  },
  {
    "request_id": "AM-REQ-2026-03110",
    "original_inquiry": "Second opinion requested: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Zolgensma and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.712
  },
  {
    "request_id": "AM-REQ-2026-03111",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on ELEVIDYS and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.69
  },
  {
    "request_id": "AM-REQ-2026-03112",
    "original_inquiry": "海外求诊：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8168
  },
  {
    "request_id": "AM-REQ-2026-03113",
    "original_inquiry": "海外求诊：Patient with CRISPR疗法; requesting information on SRP-9001 and AAV9 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6993
  },
  {
    "request_id": "AM-REQ-2026-03114",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7022
  },
  {
    "request_id": "AM-REQ-2026-03115",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6112
  },
  {
    "request_id": "AM-REQ-2026-03116",
    "original_inquiry": "Second opinion requested: Patient with beta-thalassemia; requesting information on CRISPR-Cas9 and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7439
  },
  {
    "request_id": "AM-REQ-2026-03117",
    "original_inquiry": "Urgent: Researcher inquiry: 杜氏肌营养不良 delivery and ELEVIDYS outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7654
  },
  {
    "request_id": "AM-REQ-2026-03118",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-03119",
    "original_inquiry": "Family seeking information: Geneticist referral: spinal muscular atrophy confirmed; exploring exon skipping and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6978
  },
  {
    "request_id": "AM-REQ-2026-03120",
    "original_inquiry": "Second opinion requested: Patient with 镰状细胞贫血; requesting information on Casgevy and Zolgensma access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8559
  },
  {
    "request_id": "AM-REQ-2026-03121",
    "original_inquiry": "海外求诊：海外求药：sickle cell disease患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5602
  },
  {
    "request_id": "AM-REQ-2026-03122",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊CRISPR疗法，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.642
  },
  {
    "request_id": "AM-REQ-2026-03123",
    "original_inquiry": "Child with SMA基因治疗; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7057
  },
  {
    "request_id": "AM-REQ-2026-03124",
    "original_inquiry": "海外求诊：Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-03125",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and Zolgensma outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6342
  },
  {
    "request_id": "AM-REQ-2026-03126",
    "original_inquiry": "海外求诊：Child with AAV vector; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8873
  },
  {
    "request_id": "AM-REQ-2026-03127",
    "original_inquiry": "海外求诊：Geneticist referral: SMA基因治疗 confirmed; exploring ELEVIDYS and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6682
  },
  {
    "request_id": "AM-REQ-2026-03128",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.726
  },
  {
    "request_id": "AM-REQ-2026-03129",
    "original_inquiry": "研究者咨询：Child with SMA基因治疗; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6017
  },
  {
    "request_id": "AM-REQ-2026-03130",
    "original_inquiry": "Referral from specialist: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5542
  },
  {
    "request_id": "AM-REQ-2026-03131",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5186
  },
  {
    "request_id": "AM-REQ-2026-03132",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and exon skipping outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7699
  },
  {
    "request_id": "AM-REQ-2026-03133",
    "original_inquiry": "海外求诊：Child with AAV vector; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.724
  },
  {
    "request_id": "AM-REQ-2026-03134",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring Zolgensma and ELEVIDYS trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7669
  },
  {
    "request_id": "AM-REQ-2026-03135",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5948
  },
  {
    "request_id": "AM-REQ-2026-03136",
    "original_inquiry": "Second opinion requested: Urgent consultation: DMD diagnosis, seeking Lyfgenia / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5987
  },
  {
    "request_id": "AM-REQ-2026-03137",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7196
  },
  {
    "request_id": "AM-REQ-2026-03138",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5807
  },
  {
    "request_id": "AM-REQ-2026-03139",
    "original_inquiry": "Second opinion requested: 海外求药：gene therapy患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7965
  },
  {
    "request_id": "AM-REQ-2026-03140",
    "original_inquiry": "Urgent: 海外求药：gene therapy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8544
  },
  {
    "request_id": "AM-REQ-2026-03141",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.581
  },
  {
    "request_id": "AM-REQ-2026-03142",
    "original_inquiry": "研究者咨询：Patient with beta-thalassemia; requesting information on Casgevy and ELEVIDYS access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6067
  },
  {
    "request_id": "AM-REQ-2026-03143",
    "original_inquiry": "Referral from specialist: Researcher inquiry: gene therapy delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5296
  },
  {
    "request_id": "AM-REQ-2026-03144",
    "original_inquiry": "Family seeking information: Researcher inquiry: sickle cell disease delivery and Casgevy outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7335
  },
  {
    "request_id": "AM-REQ-2026-03145",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5243
  },
  {
    "request_id": "AM-REQ-2026-03146",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊CRISPR疗法，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.704
  },
  {
    "request_id": "AM-REQ-2026-03147",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7874
  },
  {
    "request_id": "AM-REQ-2026-03148",
    "original_inquiry": "海外求诊：Child with AAV vector; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7699
  },
  {
    "request_id": "AM-REQ-2026-03149",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8676
  },
  {
    "request_id": "AM-REQ-2026-03150",
    "original_inquiry": "研究者咨询：Urgent consultation: spinal muscular atrophy diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5405
  },
  {
    "request_id": "AM-REQ-2026-03151",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.701
  },
  {
    "request_id": "AM-REQ-2026-03152",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7881
  },
  {
    "request_id": "AM-REQ-2026-03153",
    "original_inquiry": "Urgent consultation: SMA基因治疗 diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8307
  },
  {
    "request_id": "AM-REQ-2026-03154",
    "original_inquiry": "海外求药：sickle cell disease患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7786
  },
  {
    "request_id": "AM-REQ-2026-03155",
    "original_inquiry": "Second opinion requested: 海外求药：beta-thalassemia患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-03156",
    "original_inquiry": "海外求药：DMD患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8143
  },
  {
    "request_id": "AM-REQ-2026-03157",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8271
  },
  {
    "request_id": "AM-REQ-2026-03158",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5514
  },
  {
    "request_id": "AM-REQ-2026-03159",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊beta-thalassemia，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6568
  },
  {
    "request_id": "AM-REQ-2026-03160",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6065
  },
  {
    "request_id": "AM-REQ-2026-03161",
    "original_inquiry": "Family seeking information: Patient with gene therapy; requesting information on Lyfgenia and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7043
  },
  {
    "request_id": "AM-REQ-2026-03162",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8903
  },
  {
    "request_id": "AM-REQ-2026-03163",
    "original_inquiry": "Family seeking information: Patient with 镰状细胞贫血; requesting information on Zolgensma and Casgevy access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8548
  },
  {
    "request_id": "AM-REQ-2026-03164",
    "original_inquiry": "Family seeking information: Patient with spinal muscular atrophy; requesting information on SRP-9001 and Casgevy access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6904
  },
  {
    "request_id": "AM-REQ-2026-03165",
    "original_inquiry": "研究者咨询：Geneticist referral: AAV vector confirmed; exploring Casgevy and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6278
  },
  {
    "request_id": "AM-REQ-2026-03166",
    "original_inquiry": "Urgent: Researcher inquiry: gene therapy delivery and Lyfgenia outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5135
  },
  {
    "request_id": "AM-REQ-2026-03167",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and ELEVIDYS outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.534
  },
  {
    "request_id": "AM-REQ-2026-03168",
    "original_inquiry": "研究者咨询：Child with 镰状细胞贫血; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8624
  },
  {
    "request_id": "AM-REQ-2026-03169",
    "original_inquiry": "Child with beta-thalassemia; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.697
  },
  {
    "request_id": "AM-REQ-2026-03170",
    "original_inquiry": "Researcher inquiry: SMA delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7919
  },
  {
    "request_id": "AM-REQ-2026-03171",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Casgevy / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8621
  },
  {
    "request_id": "AM-REQ-2026-03172",
    "original_inquiry": "Urgent: Child with gene therapy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-03173",
    "original_inquiry": "研究者咨询：海外求药：SMA基因治疗患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6454
  },
  {
    "request_id": "AM-REQ-2026-03174",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊杜氏肌营养不良，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8147
  },
  {
    "request_id": "AM-REQ-2026-03175",
    "original_inquiry": "Referral from specialist: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking SRP-9001 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7091
  },
  {
    "request_id": "AM-REQ-2026-03176",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5447
  },
  {
    "request_id": "AM-REQ-2026-03177",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on CRISPR-Cas9 and Lyfgenia access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6837
  },
  {
    "request_id": "AM-REQ-2026-03178",
    "original_inquiry": "Family seeking information: Researcher inquiry: 杜氏肌营养不良 delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5966
  },
  {
    "request_id": "AM-REQ-2026-03179",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7005
  },
  {
    "request_id": "AM-REQ-2026-03180",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8675
  },
  {
    "request_id": "AM-REQ-2026-03181",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊杜氏肌营养不良，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6383
  },
  {
    "request_id": "AM-REQ-2026-03182",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring Lyfgenia and SRP-9001 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6114
  },
  {
    "request_id": "AM-REQ-2026-03183",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊镰状细胞贫血，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6176
  },
  {
    "request_id": "AM-REQ-2026-03184",
    "original_inquiry": "研究者咨询：Researcher inquiry: spinal muscular atrophy delivery and ELEVIDYS outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-03185",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA基因治疗 diagnosis, seeking SRP-9001 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8605
  },
  {
    "request_id": "AM-REQ-2026-03186",
    "original_inquiry": "Urgent: Urgent consultation: sickle cell disease diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5878
  },
  {
    "request_id": "AM-REQ-2026-03187",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8979
  },
  {
    "request_id": "AM-REQ-2026-03188",
    "original_inquiry": "Referral from specialist: Geneticist referral: beta-thalassemia confirmed; exploring SRP-9001 and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8402
  },
  {
    "request_id": "AM-REQ-2026-03189",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊CRISPR疗法，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7001
  },
  {
    "request_id": "AM-REQ-2026-03190",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8233
  },
  {
    "request_id": "AM-REQ-2026-03191",
    "original_inquiry": "Second opinion requested: Urgent consultation: DMD diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5589
  },
  {
    "request_id": "AM-REQ-2026-03192",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7452
  },
  {
    "request_id": "AM-REQ-2026-03193",
    "original_inquiry": "Second opinion requested: Geneticist referral: SMA confirmed; exploring CRISPR-Cas9 and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7015
  },
  {
    "request_id": "AM-REQ-2026-03194",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-03195",
    "original_inquiry": "Family seeking information: Researcher inquiry: DMD delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7781
  },
  {
    "request_id": "AM-REQ-2026-03196",
    "original_inquiry": "Referral from specialist: 海外求药：SMA基因治疗患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6824
  },
  {
    "request_id": "AM-REQ-2026-03197",
    "original_inquiry": "研究者咨询：Geneticist referral: 杜氏肌营养不良 confirmed; exploring Lyfgenia and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5678
  },
  {
    "request_id": "AM-REQ-2026-03198",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.837
  },
  {
    "request_id": "AM-REQ-2026-03199",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5693
  },
  {
    "request_id": "AM-REQ-2026-03200",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.635
  },
  {
    "request_id": "AM-REQ-2026-03201",
    "original_inquiry": "海外求诊：海外求药：SMA基因治疗患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7251
  },
  {
    "request_id": "AM-REQ-2026-03202",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊DMD，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7133
  },
  {
    "request_id": "AM-REQ-2026-03203",
    "original_inquiry": "海外求诊：海外求药：AAV vector患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6352
  },
  {
    "request_id": "AM-REQ-2026-03204",
    "original_inquiry": "Second opinion requested: Child with AAV vector; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6159
  },
  {
    "request_id": "AM-REQ-2026-03205",
    "original_inquiry": "研究者咨询：Geneticist referral: AAV vector confirmed; exploring Lyfgenia and Casgevy trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6223
  },
  {
    "request_id": "AM-REQ-2026-03206",
    "original_inquiry": "Referral from specialist: Urgent consultation: beta-thalassemia diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.893
  },
  {
    "request_id": "AM-REQ-2026-03207",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7015
  },
  {
    "request_id": "AM-REQ-2026-03208",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5359
  },
  {
    "request_id": "AM-REQ-2026-03209",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7353
  },
  {
    "request_id": "AM-REQ-2026-03210",
    "original_inquiry": "Family seeking information: Patient with Duchenne muscular dystrophy; requesting information on Casgevy and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.533
  },
  {
    "request_id": "AM-REQ-2026-03211",
    "original_inquiry": "Urgent: Child with SMA; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6552
  },
  {
    "request_id": "AM-REQ-2026-03212",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA基因治疗 diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5801
  },
  {
    "request_id": "AM-REQ-2026-03213",
    "original_inquiry": "研究者咨询：Patient with SMA; requesting information on AAV9 and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5833
  },
  {
    "request_id": "AM-REQ-2026-03214",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊CRISPR疗法，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5928
  },
  {
    "request_id": "AM-REQ-2026-03215",
    "original_inquiry": "研究者咨询：Researcher inquiry: gene therapy delivery and SRP-9001 outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8498
  },
  {
    "request_id": "AM-REQ-2026-03216",
    "original_inquiry": "海外求诊：海外求药：gene therapy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8701
  },
  {
    "request_id": "AM-REQ-2026-03217",
    "original_inquiry": "Referral from specialist: Child with 杜氏肌营养不良; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.529
  },
  {
    "request_id": "AM-REQ-2026-03218",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7616
  },
  {
    "request_id": "AM-REQ-2026-03219",
    "original_inquiry": "Urgent: Child with 杜氏肌营养不良; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6118
  },
  {
    "request_id": "AM-REQ-2026-03220",
    "original_inquiry": "Urgent: Researcher inquiry: DMD delivery and gene replacement therapy outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7318
  },
  {
    "request_id": "AM-REQ-2026-03221",
    "original_inquiry": "Child with DMD; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7254
  },
  {
    "request_id": "AM-REQ-2026-03222",
    "original_inquiry": "Urgent: Researcher inquiry: sickle cell disease delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6304
  },
  {
    "request_id": "AM-REQ-2026-03223",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-03224",
    "original_inquiry": "海外求诊：海外求药：Duchenne muscular dystrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7105
  },
  {
    "request_id": "AM-REQ-2026-03225",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7763
  },
  {
    "request_id": "AM-REQ-2026-03226",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5046
  },
  {
    "request_id": "AM-REQ-2026-03227",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7608
  },
  {
    "request_id": "AM-REQ-2026-03228",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.655
  },
  {
    "request_id": "AM-REQ-2026-03229",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊SMA，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5747
  },
  {
    "request_id": "AM-REQ-2026-03230",
    "original_inquiry": "Family seeking information: Geneticist referral: DMD confirmed; exploring CRISPR-Cas9 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6906
  },
  {
    "request_id": "AM-REQ-2026-03231",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring SRP-9001 and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6421
  },
  {
    "request_id": "AM-REQ-2026-03232",
    "original_inquiry": "Child with DMD; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8405
  },
  {
    "request_id": "AM-REQ-2026-03233",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8262
  },
  {
    "request_id": "AM-REQ-2026-03234",
    "original_inquiry": "Second opinion requested: Geneticist referral: CRISPR疗法 confirmed; exploring exon skipping and Lyfgenia trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8874
  },
  {
    "request_id": "AM-REQ-2026-03235",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5264
  },
  {
    "request_id": "AM-REQ-2026-03236",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8372
  },
  {
    "request_id": "AM-REQ-2026-03237",
    "original_inquiry": "家长咨询：患儿确诊sickle cell disease，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7626
  },
  {
    "request_id": "AM-REQ-2026-03238",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on Casgevy and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6273
  },
  {
    "request_id": "AM-REQ-2026-03239",
    "original_inquiry": "海外求药：SMA患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8704
  },
  {
    "request_id": "AM-REQ-2026-03240",
    "original_inquiry": "Patient with SMA基因治疗; requesting information on exon skipping and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-03241",
    "original_inquiry": "Family seeking information: Patient with gene therapy; requesting information on Casgevy and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8512
  },
  {
    "request_id": "AM-REQ-2026-03242",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5685
  },
  {
    "request_id": "AM-REQ-2026-03243",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8639
  },
  {
    "request_id": "AM-REQ-2026-03244",
    "original_inquiry": "Researcher inquiry: 镰状细胞贫血 delivery and ELEVIDYS outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-03245",
    "original_inquiry": "海外求诊：Geneticist referral: sickle cell disease confirmed; exploring exon skipping and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8423
  },
  {
    "request_id": "AM-REQ-2026-03246",
    "original_inquiry": "Second opinion requested: Researcher inquiry: AAV vector delivery and exon skipping outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8393
  },
  {
    "request_id": "AM-REQ-2026-03247",
    "original_inquiry": "Geneticist referral: spinal muscular atrophy confirmed; exploring AAV9 and Casgevy trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6002
  },
  {
    "request_id": "AM-REQ-2026-03248",
    "original_inquiry": "研究者咨询：Geneticist referral: AAV vector confirmed; exploring Casgevy and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5383
  },
  {
    "request_id": "AM-REQ-2026-03249",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7593
  },
  {
    "request_id": "AM-REQ-2026-03250",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-03251",
    "original_inquiry": "Child with sickle cell disease; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8658
  },
  {
    "request_id": "AM-REQ-2026-03252",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-03253",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8267
  },
  {
    "request_id": "AM-REQ-2026-03254",
    "original_inquiry": "研究者咨询：Patient with DMD; requesting information on Casgevy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.719
  },
  {
    "request_id": "AM-REQ-2026-03255",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊CRISPR疗法，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8706
  },
  {
    "request_id": "AM-REQ-2026-03256",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊sickle cell disease，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7781
  },
  {
    "request_id": "AM-REQ-2026-03257",
    "original_inquiry": "研究者咨询：Geneticist referral: 镰状细胞贫血 confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8917
  },
  {
    "request_id": "AM-REQ-2026-03258",
    "original_inquiry": "Urgent: Geneticist referral: AAV vector confirmed; exploring Casgevy and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6504
  },
  {
    "request_id": "AM-REQ-2026-03259",
    "original_inquiry": "海外求诊：海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6665
  },
  {
    "request_id": "AM-REQ-2026-03260",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊SMA，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6766
  },
  {
    "request_id": "AM-REQ-2026-03261",
    "original_inquiry": "研究者咨询：Geneticist referral: AAV vector confirmed; exploring Casgevy and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5434
  },
  {
    "request_id": "AM-REQ-2026-03262",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on Lyfgenia and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7044
  },
  {
    "request_id": "AM-REQ-2026-03263",
    "original_inquiry": "Family seeking information: Geneticist referral: sickle cell disease confirmed; exploring AAV9 and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5385
  },
  {
    "request_id": "AM-REQ-2026-03264",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.856
  },
  {
    "request_id": "AM-REQ-2026-03265",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6203
  },
  {
    "request_id": "AM-REQ-2026-03266",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5954
  },
  {
    "request_id": "AM-REQ-2026-03267",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; requesting information on Zolgensma and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6913
  },
  {
    "request_id": "AM-REQ-2026-03268",
    "original_inquiry": "海外求诊：Child with DMD; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7487
  },
  {
    "request_id": "AM-REQ-2026-03269",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8588
  },
  {
    "request_id": "AM-REQ-2026-03270",
    "original_inquiry": "Second opinion requested: Geneticist referral: beta-thalassemia confirmed; exploring Lyfgenia and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7797
  },
  {
    "request_id": "AM-REQ-2026-03271",
    "original_inquiry": "Family seeking information: Child with DMD; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7628
  },
  {
    "request_id": "AM-REQ-2026-03272",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6326
  },
  {
    "request_id": "AM-REQ-2026-03273",
    "original_inquiry": "研究者咨询：Patient with 镰状细胞贫血; requesting information on Casgevy and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7198
  },
  {
    "request_id": "AM-REQ-2026-03274",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊杜氏肌营养不良，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5118
  },
  {
    "request_id": "AM-REQ-2026-03275",
    "original_inquiry": "Second opinion requested: Patient with CRISPR疗法; requesting information on ELEVIDYS and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5611
  },
  {
    "request_id": "AM-REQ-2026-03276",
    "original_inquiry": "Urgent: Urgent consultation: DMD diagnosis, seeking SRP-9001 / AAV9 availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5772
  },
  {
    "request_id": "AM-REQ-2026-03277",
    "original_inquiry": "Second opinion requested: Urgent consultation: beta-thalassemia diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7118
  },
  {
    "request_id": "AM-REQ-2026-03278",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8037
  },
  {
    "request_id": "AM-REQ-2026-03279",
    "original_inquiry": "Urgent consultation: sickle cell disease diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6
  },
  {
    "request_id": "AM-REQ-2026-03280",
    "original_inquiry": "Child with SMA; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5075
  },
  {
    "request_id": "AM-REQ-2026-03281",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6595
  },
  {
    "request_id": "AM-REQ-2026-03282",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5791
  },
  {
    "request_id": "AM-REQ-2026-03283",
    "original_inquiry": "海外求诊：海外求药：spinal muscular atrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5027
  },
  {
    "request_id": "AM-REQ-2026-03284",
    "original_inquiry": "Family seeking information: 海外求药：SMA患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.808
  },
  {
    "request_id": "AM-REQ-2026-03285",
    "original_inquiry": "Referral from specialist: Urgent consultation: DMD diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.686
  },
  {
    "request_id": "AM-REQ-2026-03286",
    "original_inquiry": "Family seeking information: Researcher inquiry: gene therapy delivery and SRP-9001 outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6977
  },
  {
    "request_id": "AM-REQ-2026-03287",
    "original_inquiry": "Second opinion requested: Geneticist referral: CRISPR疗法 confirmed; exploring CRISPR-Cas9 and Casgevy trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5506
  },
  {
    "request_id": "AM-REQ-2026-03288",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Casgevy outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5369
  },
  {
    "request_id": "AM-REQ-2026-03289",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5893
  },
  {
    "request_id": "AM-REQ-2026-03290",
    "original_inquiry": "海外求药：AAV vector患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5814
  },
  {
    "request_id": "AM-REQ-2026-03291",
    "original_inquiry": "Referral from specialist: Child with gene therapy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7748
  },
  {
    "request_id": "AM-REQ-2026-03292",
    "original_inquiry": "海外求诊：海外求药：gene therapy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6802
  },
  {
    "request_id": "AM-REQ-2026-03293",
    "original_inquiry": "Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-03294",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA基因治疗 diagnosis, seeking AAV9 / Casgevy availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5271
  },
  {
    "request_id": "AM-REQ-2026-03295",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA基因治疗 delivery and Casgevy outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6352
  },
  {
    "request_id": "AM-REQ-2026-03296",
    "original_inquiry": "海外求诊：Researcher inquiry: SMA delivery and Casgevy outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7998
  },
  {
    "request_id": "AM-REQ-2026-03297",
    "original_inquiry": "Geneticist referral: spinal muscular atrophy confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5254
  },
  {
    "request_id": "AM-REQ-2026-03298",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8112
  },
  {
    "request_id": "AM-REQ-2026-03299",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8893
  },
  {
    "request_id": "AM-REQ-2026-03300",
    "original_inquiry": "Urgent: Urgent consultation: SMA diagnosis, seeking Lyfgenia / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7146
  },
  {
    "request_id": "AM-REQ-2026-03301",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊CRISPR疗法，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7562
  },
  {
    "request_id": "AM-REQ-2026-03302",
    "original_inquiry": "家长咨询：患儿确诊Duchenne muscular dystrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6649
  },
  {
    "request_id": "AM-REQ-2026-03303",
    "original_inquiry": "研究者咨询：Geneticist referral: gene therapy confirmed; exploring AAV9 and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.859
  },
  {
    "request_id": "AM-REQ-2026-03304",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring AAV9 and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6177
  },
  {
    "request_id": "AM-REQ-2026-03305",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊杜氏肌营养不良，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5056
  },
  {
    "request_id": "AM-REQ-2026-03306",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring Casgevy and Lyfgenia trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5609
  },
  {
    "request_id": "AM-REQ-2026-03307",
    "original_inquiry": "海外求诊：海外求药：CRISPR疗法患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6906
  },
  {
    "request_id": "AM-REQ-2026-03308",
    "original_inquiry": "研究者咨询：海外求药：Duchenne muscular dystrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5047
  },
  {
    "request_id": "AM-REQ-2026-03309",
    "original_inquiry": "海外求诊：Child with 杜氏肌营养不良; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8154
  },
  {
    "request_id": "AM-REQ-2026-03310",
    "original_inquiry": "Second opinion requested: 海外求药：spinal muscular atrophy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8685
  },
  {
    "request_id": "AM-REQ-2026-03311",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and AAV9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-03312",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8481
  },
  {
    "request_id": "AM-REQ-2026-03313",
    "original_inquiry": "研究者咨询：Researcher inquiry: SMA基因治疗 delivery and gene replacement therapy outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8411
  },
  {
    "request_id": "AM-REQ-2026-03314",
    "original_inquiry": "Child with AAV vector; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6548
  },
  {
    "request_id": "AM-REQ-2026-03315",
    "original_inquiry": "研究者咨询：Researcher inquiry: AAV vector delivery and ELEVIDYS outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6406
  },
  {
    "request_id": "AM-REQ-2026-03316",
    "original_inquiry": "Urgent: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7395
  },
  {
    "request_id": "AM-REQ-2026-03317",
    "original_inquiry": "Urgent: Patient with Duchenne muscular dystrophy; requesting information on Casgevy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5082
  },
  {
    "request_id": "AM-REQ-2026-03318",
    "original_inquiry": "Urgent: Urgent consultation: CRISPR疗法 diagnosis, seeking SRP-9001 / AAV9 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7029
  },
  {
    "request_id": "AM-REQ-2026-03319",
    "original_inquiry": "Referral from specialist: Child with AAV vector; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8644
  },
  {
    "request_id": "AM-REQ-2026-03320",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7927
  },
  {
    "request_id": "AM-REQ-2026-03321",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA基因治疗 delivery and Lyfgenia outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.78
  },
  {
    "request_id": "AM-REQ-2026-03322",
    "original_inquiry": "Child with beta-thalassemia; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.802
  },
  {
    "request_id": "AM-REQ-2026-03323",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA基因治疗，寻求Zolgensma或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8704
  },
  {
    "request_id": "AM-REQ-2026-03324",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7866
  },
  {
    "request_id": "AM-REQ-2026-03325",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7289
  },
  {
    "request_id": "AM-REQ-2026-03326",
    "original_inquiry": "Urgent: 海外求药：DMD患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5356
  },
  {
    "request_id": "AM-REQ-2026-03327",
    "original_inquiry": "Family seeking information: Child with DMD; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6031
  },
  {
    "request_id": "AM-REQ-2026-03328",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊beta-thalassemia，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5705
  },
  {
    "request_id": "AM-REQ-2026-03329",
    "original_inquiry": "Geneticist referral: CRISPR疗法 confirmed; exploring AAV9 and Casgevy trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6033
  },
  {
    "request_id": "AM-REQ-2026-03330",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊spinal muscular atrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6882
  },
  {
    "request_id": "AM-REQ-2026-03331",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and gene replacement therapy outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6923
  },
  {
    "request_id": "AM-REQ-2026-03332",
    "original_inquiry": "海外求诊：Urgent consultation: 镰状细胞贫血 diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5612
  },
  {
    "request_id": "AM-REQ-2026-03333",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6009
  },
  {
    "request_id": "AM-REQ-2026-03334",
    "original_inquiry": "Family seeking information: 海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7054
  },
  {
    "request_id": "AM-REQ-2026-03335",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7548
  },
  {
    "request_id": "AM-REQ-2026-03336",
    "original_inquiry": "Referral from specialist: Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / Casgevy availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-03337",
    "original_inquiry": "Urgent: Urgent consultation: beta-thalassemia diagnosis, seeking SRP-9001 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5466
  },
  {
    "request_id": "AM-REQ-2026-03338",
    "original_inquiry": "海外求诊：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking ELEVIDYS / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5249
  },
  {
    "request_id": "AM-REQ-2026-03339",
    "original_inquiry": "Second opinion requested: Geneticist referral: DMD confirmed; exploring gene replacement therapy and Lyfgenia trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5267
  },
  {
    "request_id": "AM-REQ-2026-03340",
    "original_inquiry": "Second opinion requested: Patient with SMA; requesting information on SRP-9001 and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5797
  },
  {
    "request_id": "AM-REQ-2026-03341",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊gene therapy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8961
  },
  {
    "request_id": "AM-REQ-2026-03342",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊sickle cell disease，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7401
  },
  {
    "request_id": "AM-REQ-2026-03343",
    "original_inquiry": "Urgent: Researcher inquiry: sickle cell disease delivery and Zolgensma outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8372
  },
  {
    "request_id": "AM-REQ-2026-03344",
    "original_inquiry": "Second opinion requested: Child with gene therapy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5229
  },
  {
    "request_id": "AM-REQ-2026-03345",
    "original_inquiry": "Family seeking information: 海外求药：Duchenne muscular dystrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.854
  },
  {
    "request_id": "AM-REQ-2026-03346",
    "original_inquiry": "海外求诊：Researcher inquiry: CRISPR疗法 delivery and gene replacement therapy outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8596
  },
  {
    "request_id": "AM-REQ-2026-03347",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5264
  },
  {
    "request_id": "AM-REQ-2026-03348",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5669
  },
  {
    "request_id": "AM-REQ-2026-03349",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA基因治疗 diagnosis, seeking exon skipping / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7517
  },
  {
    "request_id": "AM-REQ-2026-03350",
    "original_inquiry": "Urgent: Patient with SMA基因治疗; requesting information on Lyfgenia and Casgevy access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8827
  },
  {
    "request_id": "AM-REQ-2026-03351",
    "original_inquiry": "Patient with SMA基因治疗; requesting information on gene replacement therapy and Zolgensma access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5859
  },
  {
    "request_id": "AM-REQ-2026-03352",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5086
  },
  {
    "request_id": "AM-REQ-2026-03353",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7623
  },
  {
    "request_id": "AM-REQ-2026-03354",
    "original_inquiry": "研究者咨询：Patient with beta-thalassemia; requesting information on Lyfgenia and Zolgensma access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5027
  },
  {
    "request_id": "AM-REQ-2026-03355",
    "original_inquiry": "研究者咨询：Urgent consultation: gene therapy diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5566
  },
  {
    "request_id": "AM-REQ-2026-03356",
    "original_inquiry": "研究者咨询：Geneticist referral: SMA基因治疗 confirmed; exploring gene replacement therapy and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8916
  },
  {
    "request_id": "AM-REQ-2026-03357",
    "original_inquiry": "海外求诊：Child with Duchenne muscular dystrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8993
  },
  {
    "request_id": "AM-REQ-2026-03358",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7148
  },
  {
    "request_id": "AM-REQ-2026-03359",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring gene replacement therapy and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7514
  },
  {
    "request_id": "AM-REQ-2026-03360",
    "original_inquiry": "Referral from specialist: Patient with 镰状细胞贫血; requesting information on exon skipping and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7288
  },
  {
    "request_id": "AM-REQ-2026-03361",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and SRP-9001 outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8067
  },
  {
    "request_id": "AM-REQ-2026-03362",
    "original_inquiry": "家长咨询：患儿确诊SMA基因治疗，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8213
  },
  {
    "request_id": "AM-REQ-2026-03363",
    "original_inquiry": "Second opinion requested: Child with SMA; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5981
  },
  {
    "request_id": "AM-REQ-2026-03364",
    "original_inquiry": "Urgent: Child with gene therapy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7524
  },
  {
    "request_id": "AM-REQ-2026-03365",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊spinal muscular atrophy，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7763
  },
  {
    "request_id": "AM-REQ-2026-03366",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on AAV9 and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7809
  },
  {
    "request_id": "AM-REQ-2026-03367",
    "original_inquiry": "海外求诊：Geneticist referral: sickle cell disease confirmed; exploring ELEVIDYS and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.625
  },
  {
    "request_id": "AM-REQ-2026-03368",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and gene replacement therapy outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5851
  },
  {
    "request_id": "AM-REQ-2026-03369",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5084
  },
  {
    "request_id": "AM-REQ-2026-03370",
    "original_inquiry": "Child with 杜氏肌营养不良; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7442
  },
  {
    "request_id": "AM-REQ-2026-03371",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-03372",
    "original_inquiry": "Second opinion requested: 海外求药：AAV vector患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6726
  },
  {
    "request_id": "AM-REQ-2026-03373",
    "original_inquiry": "海外求诊：海外求药：beta-thalassemia患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6535
  },
  {
    "request_id": "AM-REQ-2026-03374",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5557
  },
  {
    "request_id": "AM-REQ-2026-03375",
    "original_inquiry": "Referral from specialist: Patient with gene therapy; requesting information on Casgevy and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6111
  },
  {
    "request_id": "AM-REQ-2026-03376",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8349
  },
  {
    "request_id": "AM-REQ-2026-03377",
    "original_inquiry": "Geneticist referral: SMA confirmed; exploring exon skipping and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6275
  },
  {
    "request_id": "AM-REQ-2026-03378",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊镰状细胞贫血，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6824
  },
  {
    "request_id": "AM-REQ-2026-03379",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7322
  },
  {
    "request_id": "AM-REQ-2026-03380",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-03381",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and Casgevy outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5225
  },
  {
    "request_id": "AM-REQ-2026-03382",
    "original_inquiry": "海外求药：杜氏肌营养不良患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7734
  },
  {
    "request_id": "AM-REQ-2026-03383",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and SRP-9001 outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-03384",
    "original_inquiry": "Second opinion requested: Patient with Duchenne muscular dystrophy; requesting information on Lyfgenia and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-03385",
    "original_inquiry": "Referral from specialist: 海外求药：SMA基因治疗患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8485
  },
  {
    "request_id": "AM-REQ-2026-03386",
    "original_inquiry": "海外求诊：Urgent consultation: AAV vector diagnosis, seeking Casgevy / AAV9 availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.57
  },
  {
    "request_id": "AM-REQ-2026-03387",
    "original_inquiry": "Family seeking information: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7613
  },
  {
    "request_id": "AM-REQ-2026-03388",
    "original_inquiry": "Urgent: Child with spinal muscular atrophy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8023
  },
  {
    "request_id": "AM-REQ-2026-03389",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking ELEVIDYS / Zolgensma availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8732
  },
  {
    "request_id": "AM-REQ-2026-03390",
    "original_inquiry": "海外求诊：Urgent consultation: CRISPR疗法 diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-03391",
    "original_inquiry": "研究者咨询：Patient with beta-thalassemia; requesting information on gene replacement therapy and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6726
  },
  {
    "request_id": "AM-REQ-2026-03392",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6314
  },
  {
    "request_id": "AM-REQ-2026-03393",
    "original_inquiry": "Second opinion requested: Patient with gene therapy; requesting information on Casgevy and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5128
  },
  {
    "request_id": "AM-REQ-2026-03394",
    "original_inquiry": "Family seeking information: Urgent consultation: AAV vector diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5229
  },
  {
    "request_id": "AM-REQ-2026-03395",
    "original_inquiry": "Referral from specialist: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring Casgevy and ELEVIDYS trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7368
  },
  {
    "request_id": "AM-REQ-2026-03396",
    "original_inquiry": "Referral from specialist: Urgent consultation: spinal muscular atrophy diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7836
  },
  {
    "request_id": "AM-REQ-2026-03397",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8258
  },
  {
    "request_id": "AM-REQ-2026-03398",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on Casgevy and AAV9 access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8317
  },
  {
    "request_id": "AM-REQ-2026-03399",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8691
  },
  {
    "request_id": "AM-REQ-2026-03400",
    "original_inquiry": "Family seeking information: 海外求药：DMD患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5655
  },
  {
    "request_id": "AM-REQ-2026-03401",
    "original_inquiry": "Second opinion requested: Patient with SMA; requesting information on Casgevy and Zolgensma access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.834
  },
  {
    "request_id": "AM-REQ-2026-03402",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊DMD，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8629
  },
  {
    "request_id": "AM-REQ-2026-03403",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6806
  },
  {
    "request_id": "AM-REQ-2026-03404",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7516
  },
  {
    "request_id": "AM-REQ-2026-03405",
    "original_inquiry": "研究者咨询：Geneticist referral: 杜氏肌营养不良 confirmed; exploring SRP-9001 and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6891
  },
  {
    "request_id": "AM-REQ-2026-03406",
    "original_inquiry": "Urgent: Geneticist referral: spinal muscular atrophy confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7932
  },
  {
    "request_id": "AM-REQ-2026-03407",
    "original_inquiry": "研究者咨询：Researcher inquiry: SMA基因治疗 delivery and CRISPR-Cas9 outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6096
  },
  {
    "request_id": "AM-REQ-2026-03408",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5031
  },
  {
    "request_id": "AM-REQ-2026-03409",
    "original_inquiry": "Geneticist referral: 杜氏肌营养不良 confirmed; exploring exon skipping and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8716
  },
  {
    "request_id": "AM-REQ-2026-03410",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8864
  },
  {
    "request_id": "AM-REQ-2026-03411",
    "original_inquiry": "Second opinion requested: Patient with beta-thalassemia; requesting information on SRP-9001 and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6713
  },
  {
    "request_id": "AM-REQ-2026-03412",
    "original_inquiry": "Referral from specialist: 海外求药：SMA患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8632
  },
  {
    "request_id": "AM-REQ-2026-03413",
    "original_inquiry": "研究者咨询：Geneticist referral: 杜氏肌营养不良 confirmed; exploring Zolgensma and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5465
  },
  {
    "request_id": "AM-REQ-2026-03414",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring exon skipping and Zolgensma trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6744
  },
  {
    "request_id": "AM-REQ-2026-03415",
    "original_inquiry": "Referral from specialist: Patient with spinal muscular atrophy; requesting information on exon skipping and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6927
  },
  {
    "request_id": "AM-REQ-2026-03416",
    "original_inquiry": "Second opinion requested: Patient with 杜氏肌营养不良; requesting information on exon skipping and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8101
  },
  {
    "request_id": "AM-REQ-2026-03417",
    "original_inquiry": "Referral from specialist: Urgent consultation: DMD diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8636
  },
  {
    "request_id": "AM-REQ-2026-03418",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊sickle cell disease，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5753
  },
  {
    "request_id": "AM-REQ-2026-03419",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring AAV9 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8691
  },
  {
    "request_id": "AM-REQ-2026-03420",
    "original_inquiry": "Referral from specialist: Patient with DMD; requesting information on Casgevy and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8512
  },
  {
    "request_id": "AM-REQ-2026-03421",
    "original_inquiry": "Family seeking information: 海外求药：gene therapy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6371
  },
  {
    "request_id": "AM-REQ-2026-03422",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6924
  },
  {
    "request_id": "AM-REQ-2026-03423",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8972
  },
  {
    "request_id": "AM-REQ-2026-03424",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5541
  },
  {
    "request_id": "AM-REQ-2026-03425",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and Casgevy outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8879
  },
  {
    "request_id": "AM-REQ-2026-03426",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8003
  },
  {
    "request_id": "AM-REQ-2026-03427",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and SRP-9001 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6518
  },
  {
    "request_id": "AM-REQ-2026-03428",
    "original_inquiry": "海外求诊：Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6223
  },
  {
    "request_id": "AM-REQ-2026-03429",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8494
  },
  {
    "request_id": "AM-REQ-2026-03430",
    "original_inquiry": "Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7125
  },
  {
    "request_id": "AM-REQ-2026-03431",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7659
  },
  {
    "request_id": "AM-REQ-2026-03432",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7594
  },
  {
    "request_id": "AM-REQ-2026-03433",
    "original_inquiry": "研究者咨询：Child with 镰状细胞贫血; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5225
  },
  {
    "request_id": "AM-REQ-2026-03434",
    "original_inquiry": "Referral from specialist: Child with 镰状细胞贫血; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7817
  },
  {
    "request_id": "AM-REQ-2026-03435",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5494
  },
  {
    "request_id": "AM-REQ-2026-03436",
    "original_inquiry": "海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5892
  },
  {
    "request_id": "AM-REQ-2026-03437",
    "original_inquiry": "Referral from specialist: Geneticist referral: 镰状细胞贫血 confirmed; exploring Lyfgenia and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6867
  },
  {
    "request_id": "AM-REQ-2026-03438",
    "original_inquiry": "研究者咨询：Child with 镰状细胞贫血; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5796
  },
  {
    "request_id": "AM-REQ-2026-03439",
    "original_inquiry": "研究者咨询：Urgent consultation: DMD diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5219
  },
  {
    "request_id": "AM-REQ-2026-03440",
    "original_inquiry": "研究者咨询：Patient with SMA; requesting information on gene replacement therapy and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5925
  },
  {
    "request_id": "AM-REQ-2026-03441",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊SMA基因治疗，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8309
  },
  {
    "request_id": "AM-REQ-2026-03442",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7203
  },
  {
    "request_id": "AM-REQ-2026-03443",
    "original_inquiry": "Urgent: Researcher inquiry: Duchenne muscular dystrophy delivery and SRP-9001 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5768
  },
  {
    "request_id": "AM-REQ-2026-03444",
    "original_inquiry": "海外求药：DMD患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8576
  },
  {
    "request_id": "AM-REQ-2026-03445",
    "original_inquiry": "海外求诊：Child with SMA基因治疗; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5857
  },
  {
    "request_id": "AM-REQ-2026-03446",
    "original_inquiry": "海外求诊：Geneticist referral: gene therapy confirmed; exploring gene replacement therapy and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.673
  },
  {
    "request_id": "AM-REQ-2026-03447",
    "original_inquiry": "Second opinion requested: 海外求药：Duchenne muscular dystrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-03448",
    "original_inquiry": "Referral from specialist: Researcher inquiry: DMD delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5073
  },
  {
    "request_id": "AM-REQ-2026-03449",
    "original_inquiry": "Urgent: Geneticist referral: AAV vector confirmed; exploring ELEVIDYS and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6228
  },
  {
    "request_id": "AM-REQ-2026-03450",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊SMA，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7211
  },
  {
    "request_id": "AM-REQ-2026-03451",
    "original_inquiry": "海外求诊：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Zolgensma / AAV9 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7014
  },
  {
    "request_id": "AM-REQ-2026-03452",
    "original_inquiry": "家长咨询：患儿确诊SMA，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5141
  },
  {
    "request_id": "AM-REQ-2026-03453",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6945
  },
  {
    "request_id": "AM-REQ-2026-03454",
    "original_inquiry": "Urgent: Urgent consultation: spinal muscular atrophy diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.55
  },
  {
    "request_id": "AM-REQ-2026-03455",
    "original_inquiry": "研究者咨询：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7462
  },
  {
    "request_id": "AM-REQ-2026-03456",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on exon skipping and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.669
  },
  {
    "request_id": "AM-REQ-2026-03457",
    "original_inquiry": "Urgent: Researcher inquiry: beta-thalassemia delivery and SRP-9001 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.674
  },
  {
    "request_id": "AM-REQ-2026-03458",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊beta-thalassemia，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8795
  },
  {
    "request_id": "AM-REQ-2026-03459",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊DMD，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5673
  },
  {
    "request_id": "AM-REQ-2026-03460",
    "original_inquiry": "Child with Duchenne muscular dystrophy; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8774
  },
  {
    "request_id": "AM-REQ-2026-03461",
    "original_inquiry": "Child with DMD; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6613
  },
  {
    "request_id": "AM-REQ-2026-03462",
    "original_inquiry": "Urgent: Researcher inquiry: gene therapy delivery and AAV9 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.535
  },
  {
    "request_id": "AM-REQ-2026-03463",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7936
  },
  {
    "request_id": "AM-REQ-2026-03464",
    "original_inquiry": "Geneticist referral: 杜氏肌营养不良 confirmed; exploring AAV9 and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5823
  },
  {
    "request_id": "AM-REQ-2026-03465",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 镰状细胞贫血 delivery and Lyfgenia outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5437
  },
  {
    "request_id": "AM-REQ-2026-03466",
    "original_inquiry": "Urgent consultation: gene therapy diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5121
  },
  {
    "request_id": "AM-REQ-2026-03467",
    "original_inquiry": "Referral from specialist: Child with 杜氏肌营养不良; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6734
  },
  {
    "request_id": "AM-REQ-2026-03468",
    "original_inquiry": "Urgent: Child with sickle cell disease; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6419
  },
  {
    "request_id": "AM-REQ-2026-03469",
    "original_inquiry": "海外求诊：Child with SMA基因治疗; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6203
  },
  {
    "request_id": "AM-REQ-2026-03470",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊sickle cell disease，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7604
  },
  {
    "request_id": "AM-REQ-2026-03471",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7171
  },
  {
    "request_id": "AM-REQ-2026-03472",
    "original_inquiry": "海外求诊：Researcher inquiry: AAV vector delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8351
  },
  {
    "request_id": "AM-REQ-2026-03473",
    "original_inquiry": "研究者咨询：Patient with 杜氏肌营养不良; requesting information on ELEVIDYS and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.659
  },
  {
    "request_id": "AM-REQ-2026-03474",
    "original_inquiry": "Referral from specialist: 海外求药：gene therapy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7621
  },
  {
    "request_id": "AM-REQ-2026-03475",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5166
  },
  {
    "request_id": "AM-REQ-2026-03476",
    "original_inquiry": "海外求诊：Urgent consultation: SMA基因治疗 diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8683
  },
  {
    "request_id": "AM-REQ-2026-03477",
    "original_inquiry": "Urgent: Geneticist referral: AAV vector confirmed; exploring Casgevy and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7739
  },
  {
    "request_id": "AM-REQ-2026-03478",
    "original_inquiry": "Family seeking information: Patient with 杜氏肌营养不良; requesting information on Zolgensma and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8819
  },
  {
    "request_id": "AM-REQ-2026-03479",
    "original_inquiry": "Referral from specialist: Patient with 杜氏肌营养不良; requesting information on Casgevy and AAV9 access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6605
  },
  {
    "request_id": "AM-REQ-2026-03480",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.761
  },
  {
    "request_id": "AM-REQ-2026-03481",
    "original_inquiry": "Child with SMA; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-03482",
    "original_inquiry": "Urgent: Child with 杜氏肌营养不良; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5001
  },
  {
    "request_id": "AM-REQ-2026-03483",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-03484",
    "original_inquiry": "海外求诊：Child with SMA基因治疗; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6216
  },
  {
    "request_id": "AM-REQ-2026-03485",
    "original_inquiry": "Urgent consultation: CRISPR疗法 diagnosis, seeking AAV9 / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.512
  },
  {
    "request_id": "AM-REQ-2026-03486",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA基因治疗 confirmed; exploring gene replacement therapy and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8676
  },
  {
    "request_id": "AM-REQ-2026-03487",
    "original_inquiry": "研究者咨询：Child with DMD; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-03488",
    "original_inquiry": "Second opinion requested: Researcher inquiry: gene therapy delivery and Zolgensma outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7575
  },
  {
    "request_id": "AM-REQ-2026-03489",
    "original_inquiry": "研究者咨询：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Casgevy / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5778
  },
  {
    "request_id": "AM-REQ-2026-03490",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6575
  },
  {
    "request_id": "AM-REQ-2026-03491",
    "original_inquiry": "Child with 杜氏肌营养不良; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8834
  },
  {
    "request_id": "AM-REQ-2026-03492",
    "original_inquiry": "研究者咨询：海外求药：gene therapy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-03493",
    "original_inquiry": "研究者咨询：Patient with AAV vector; requesting information on ELEVIDYS and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5817
  },
  {
    "request_id": "AM-REQ-2026-03494",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8304
  },
  {
    "request_id": "AM-REQ-2026-03495",
    "original_inquiry": "Urgent: 海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8259
  },
  {
    "request_id": "AM-REQ-2026-03496",
    "original_inquiry": "Urgent: Urgent consultation: gene therapy diagnosis, seeking ELEVIDYS / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8272
  },
  {
    "request_id": "AM-REQ-2026-03497",
    "original_inquiry": "海外求诊：海外求药：spinal muscular atrophy患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5528
  },
  {
    "request_id": "AM-REQ-2026-03498",
    "original_inquiry": "Patient with CRISPR疗法; requesting information on Zolgensma and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.708
  },
  {
    "request_id": "AM-REQ-2026-03499",
    "original_inquiry": "Patient with 杜氏肌营养不良; requesting information on SRP-9001 and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8287
  },
  {
    "request_id": "AM-REQ-2026-03500",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊CRISPR疗法，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8412
  },
  {
    "request_id": "AM-REQ-2026-03501",
    "original_inquiry": "Family seeking information: Child with gene therapy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6591
  },
  {
    "request_id": "AM-REQ-2026-03502",
    "original_inquiry": "Family seeking information: Child with DMD; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6432
  },
  {
    "request_id": "AM-REQ-2026-03503",
    "original_inquiry": "研究者咨询：Child with Duchenne muscular dystrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8693
  },
  {
    "request_id": "AM-REQ-2026-03504",
    "original_inquiry": "Second opinion requested: 海外求药：DMD患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.613
  },
  {
    "request_id": "AM-REQ-2026-03505",
    "original_inquiry": "研究者咨询：Patient with gene therapy; requesting information on ELEVIDYS and Zolgensma access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8401
  },
  {
    "request_id": "AM-REQ-2026-03506",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring ELEVIDYS and SRP-9001 trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6758
  },
  {
    "request_id": "AM-REQ-2026-03507",
    "original_inquiry": "Urgent: Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6172
  },
  {
    "request_id": "AM-REQ-2026-03508",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7498
  },
  {
    "request_id": "AM-REQ-2026-03509",
    "original_inquiry": "Urgent: Geneticist referral: SMA基因治疗 confirmed; exploring AAV9 and SRP-9001 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6243
  },
  {
    "request_id": "AM-REQ-2026-03510",
    "original_inquiry": "Family seeking information: Child with gene therapy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7161
  },
  {
    "request_id": "AM-REQ-2026-03511",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.785
  },
  {
    "request_id": "AM-REQ-2026-03512",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and Lyfgenia outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7264
  },
  {
    "request_id": "AM-REQ-2026-03513",
    "original_inquiry": "Researcher inquiry: DMD delivery and gene replacement therapy outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8759
  },
  {
    "request_id": "AM-REQ-2026-03514",
    "original_inquiry": "海外求诊：Geneticist referral: Duchenne muscular dystrophy confirmed; exploring CRISPR-Cas9 and Zolgensma trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8903
  },
  {
    "request_id": "AM-REQ-2026-03515",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 杜氏肌营养不良 delivery and Casgevy outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5698
  },
  {
    "request_id": "AM-REQ-2026-03516",
    "original_inquiry": "海外求诊：Child with SMA; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.893
  },
  {
    "request_id": "AM-REQ-2026-03517",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊杜氏肌营养不良，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6499
  },
  {
    "request_id": "AM-REQ-2026-03518",
    "original_inquiry": "Second opinion requested: 海外求药：SMA患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6185
  },
  {
    "request_id": "AM-REQ-2026-03519",
    "original_inquiry": "研究者咨询：Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-03520",
    "original_inquiry": "研究者咨询：Urgent consultation: beta-thalassemia diagnosis, seeking Zolgensma / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7942
  },
  {
    "request_id": "AM-REQ-2026-03521",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5534
  },
  {
    "request_id": "AM-REQ-2026-03522",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊spinal muscular atrophy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6528
  },
  {
    "request_id": "AM-REQ-2026-03523",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5964
  },
  {
    "request_id": "AM-REQ-2026-03524",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.72
  },
  {
    "request_id": "AM-REQ-2026-03525",
    "original_inquiry": "Second opinion requested: Geneticist referral: gene therapy confirmed; exploring SRP-9001 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5614
  },
  {
    "request_id": "AM-REQ-2026-03526",
    "original_inquiry": "研究者咨询：海外求药：DMD患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-03527",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8972
  },
  {
    "request_id": "AM-REQ-2026-03528",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.637
  },
  {
    "request_id": "AM-REQ-2026-03529",
    "original_inquiry": "Second opinion requested: Researcher inquiry: CRISPR疗法 delivery and exon skipping outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5277
  },
  {
    "request_id": "AM-REQ-2026-03530",
    "original_inquiry": "研究者咨询：Patient with spinal muscular atrophy; requesting information on ELEVIDYS and Casgevy access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8004
  },
  {
    "request_id": "AM-REQ-2026-03531",
    "original_inquiry": "Child with SMA基因治疗; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5527
  },
  {
    "request_id": "AM-REQ-2026-03532",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6891
  },
  {
    "request_id": "AM-REQ-2026-03533",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring AAV9 and ELEVIDYS trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.599
  },
  {
    "request_id": "AM-REQ-2026-03534",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊beta-thalassemia，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.714
  },
  {
    "request_id": "AM-REQ-2026-03535",
    "original_inquiry": "Researcher inquiry: CRISPR疗法 delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5385
  },
  {
    "request_id": "AM-REQ-2026-03536",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊镰状细胞贫血，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5886
  },
  {
    "request_id": "AM-REQ-2026-03537",
    "original_inquiry": "海外求诊：Child with DMD; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7935
  },
  {
    "request_id": "AM-REQ-2026-03538",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊CRISPR疗法，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8268
  },
  {
    "request_id": "AM-REQ-2026-03539",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5473
  },
  {
    "request_id": "AM-REQ-2026-03540",
    "original_inquiry": "Referral from specialist: Researcher inquiry: beta-thalassemia delivery and exon skipping outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8836
  },
  {
    "request_id": "AM-REQ-2026-03541",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring CRISPR-Cas9 and Lyfgenia trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5286
  },
  {
    "request_id": "AM-REQ-2026-03542",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-03543",
    "original_inquiry": "Geneticist referral: beta-thalassemia confirmed; exploring SRP-9001 and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6361
  },
  {
    "request_id": "AM-REQ-2026-03544",
    "original_inquiry": "Patient with Duchenne muscular dystrophy; requesting information on ELEVIDYS and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5434
  },
  {
    "request_id": "AM-REQ-2026-03545",
    "original_inquiry": "Researcher inquiry: gene therapy delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6471
  },
  {
    "request_id": "AM-REQ-2026-03546",
    "original_inquiry": "Urgent consultation: DMD diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5791
  },
  {
    "request_id": "AM-REQ-2026-03547",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and Zolgensma outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6019
  },
  {
    "request_id": "AM-REQ-2026-03548",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on AAV9 and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6556
  },
  {
    "request_id": "AM-REQ-2026-03549",
    "original_inquiry": "Urgent: Child with 杜氏肌营养不良; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.781
  },
  {
    "request_id": "AM-REQ-2026-03550",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6442
  },
  {
    "request_id": "AM-REQ-2026-03551",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and exon skipping outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8778
  },
  {
    "request_id": "AM-REQ-2026-03552",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8604
  },
  {
    "request_id": "AM-REQ-2026-03553",
    "original_inquiry": "海外求药：beta-thalassemia患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7232
  },
  {
    "request_id": "AM-REQ-2026-03554",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.62
  },
  {
    "request_id": "AM-REQ-2026-03555",
    "original_inquiry": "Second opinion requested: Geneticist referral: 镰状细胞贫血 confirmed; exploring Lyfgenia and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7293
  },
  {
    "request_id": "AM-REQ-2026-03556",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊gene therapy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7428
  },
  {
    "request_id": "AM-REQ-2026-03557",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.612
  },
  {
    "request_id": "AM-REQ-2026-03558",
    "original_inquiry": "Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-03559",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5351
  },
  {
    "request_id": "AM-REQ-2026-03560",
    "original_inquiry": "Referral from specialist: Researcher inquiry: gene therapy delivery and Casgevy outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8695
  },
  {
    "request_id": "AM-REQ-2026-03561",
    "original_inquiry": "Urgent consultation: spinal muscular atrophy diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6649
  },
  {
    "request_id": "AM-REQ-2026-03562",
    "original_inquiry": "Urgent: Child with SMA; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6908
  },
  {
    "request_id": "AM-REQ-2026-03563",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6244
  },
  {
    "request_id": "AM-REQ-2026-03564",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5202
  },
  {
    "request_id": "AM-REQ-2026-03565",
    "original_inquiry": "Second opinion requested: Geneticist referral: beta-thalassemia confirmed; exploring CRISPR-Cas9 and Casgevy trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5089
  },
  {
    "request_id": "AM-REQ-2026-03566",
    "original_inquiry": "Second opinion requested: Urgent consultation: sickle cell disease diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5897
  },
  {
    "request_id": "AM-REQ-2026-03567",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8325
  },
  {
    "request_id": "AM-REQ-2026-03568",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-03569",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6692
  },
  {
    "request_id": "AM-REQ-2026-03570",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊DMD，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5593
  },
  {
    "request_id": "AM-REQ-2026-03571",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5389
  },
  {
    "request_id": "AM-REQ-2026-03572",
    "original_inquiry": "Urgent: Researcher inquiry: Duchenne muscular dystrophy delivery and AAV9 outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7388
  },
  {
    "request_id": "AM-REQ-2026-03573",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA基因治疗 diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.506
  },
  {
    "request_id": "AM-REQ-2026-03574",
    "original_inquiry": "海外求诊：Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6785
  },
  {
    "request_id": "AM-REQ-2026-03575",
    "original_inquiry": "Family seeking information: 海外求药：SMA基因治疗患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-03576",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on AAV9 and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7129
  },
  {
    "request_id": "AM-REQ-2026-03577",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8712
  },
  {
    "request_id": "AM-REQ-2026-03578",
    "original_inquiry": "研究者咨询：Geneticist referral: 镰状细胞贫血 confirmed; exploring exon skipping and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8941
  },
  {
    "request_id": "AM-REQ-2026-03579",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8257
  },
  {
    "request_id": "AM-REQ-2026-03580",
    "original_inquiry": "海外求诊：Geneticist referral: Duchenne muscular dystrophy confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5215
  },
  {
    "request_id": "AM-REQ-2026-03581",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊DMD，寻求Zolgensma或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5265
  },
  {
    "request_id": "AM-REQ-2026-03582",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA基因治疗 confirmed; exploring SRP-9001 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7561
  },
  {
    "request_id": "AM-REQ-2026-03583",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on SRP-9001 and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.746
  },
  {
    "request_id": "AM-REQ-2026-03584",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8034
  },
  {
    "request_id": "AM-REQ-2026-03585",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6109
  },
  {
    "request_id": "AM-REQ-2026-03586",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA delivery and exon skipping outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.89
  },
  {
    "request_id": "AM-REQ-2026-03587",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.579
  },
  {
    "request_id": "AM-REQ-2026-03588",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring Zolgensma and SRP-9001 trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.634
  },
  {
    "request_id": "AM-REQ-2026-03589",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5139
  },
  {
    "request_id": "AM-REQ-2026-03590",
    "original_inquiry": "研究者咨询：Researcher inquiry: sickle cell disease delivery and SRP-9001 outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7203
  },
  {
    "request_id": "AM-REQ-2026-03591",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊spinal muscular atrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.573
  },
  {
    "request_id": "AM-REQ-2026-03592",
    "original_inquiry": "Urgent consultation: DMD diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8045
  },
  {
    "request_id": "AM-REQ-2026-03593",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6938
  },
  {
    "request_id": "AM-REQ-2026-03594",
    "original_inquiry": "Researcher inquiry: SMA基因治疗 delivery and Casgevy outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8343
  },
  {
    "request_id": "AM-REQ-2026-03595",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊DMD，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.834
  },
  {
    "request_id": "AM-REQ-2026-03596",
    "original_inquiry": "Urgent: 海外求药：SMA基因治疗患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5972
  },
  {
    "request_id": "AM-REQ-2026-03597",
    "original_inquiry": "Family seeking information: Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8714
  },
  {
    "request_id": "AM-REQ-2026-03598",
    "original_inquiry": "海外求诊：Researcher inquiry: Duchenne muscular dystrophy delivery and Zolgensma outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8843
  },
  {
    "request_id": "AM-REQ-2026-03599",
    "original_inquiry": "研究者咨询：Geneticist referral: spinal muscular atrophy confirmed; exploring CRISPR-Cas9 and ELEVIDYS trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6372
  },
  {
    "request_id": "AM-REQ-2026-03600",
    "original_inquiry": "Urgent: Patient with beta-thalassemia; requesting information on SRP-9001 and AAV9 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7624
  },
  {
    "request_id": "AM-REQ-2026-03601",
    "original_inquiry": "Second opinion requested: Geneticist referral: spinal muscular atrophy confirmed; exploring Lyfgenia and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6379
  },
  {
    "request_id": "AM-REQ-2026-03602",
    "original_inquiry": "Referral from specialist: Child with beta-thalassemia; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7937
  },
  {
    "request_id": "AM-REQ-2026-03603",
    "original_inquiry": "家长咨询：患儿确诊AAV vector，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5074
  },
  {
    "request_id": "AM-REQ-2026-03604",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5382
  },
  {
    "request_id": "AM-REQ-2026-03605",
    "original_inquiry": "海外求诊：海外求药：AAV vector患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8083
  },
  {
    "request_id": "AM-REQ-2026-03606",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6069
  },
  {
    "request_id": "AM-REQ-2026-03607",
    "original_inquiry": "Family seeking information: Child with SMA基因治疗; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7522
  },
  {
    "request_id": "AM-REQ-2026-03608",
    "original_inquiry": "Referral from specialist: Patient with 杜氏肌营养不良; requesting information on gene replacement therapy and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7622
  },
  {
    "request_id": "AM-REQ-2026-03609",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5198
  },
  {
    "request_id": "AM-REQ-2026-03610",
    "original_inquiry": "Urgent: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6162
  },
  {
    "request_id": "AM-REQ-2026-03611",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7785
  },
  {
    "request_id": "AM-REQ-2026-03612",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊镰状细胞贫血，寻求Zolgensma或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6905
  },
  {
    "request_id": "AM-REQ-2026-03613",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7272
  },
  {
    "request_id": "AM-REQ-2026-03614",
    "original_inquiry": "海外求诊：Child with DMD; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8859
  },
  {
    "request_id": "AM-REQ-2026-03615",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7568
  },
  {
    "request_id": "AM-REQ-2026-03616",
    "original_inquiry": "海外求诊：Geneticist referral: SMA confirmed; exploring Lyfgenia and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8185
  },
  {
    "request_id": "AM-REQ-2026-03617",
    "original_inquiry": "研究者咨询：Urgent consultation: gene therapy diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5539
  },
  {
    "request_id": "AM-REQ-2026-03618",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7596
  },
  {
    "request_id": "AM-REQ-2026-03619",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7633
  },
  {
    "request_id": "AM-REQ-2026-03620",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking ELEVIDYS / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.835
  },
  {
    "request_id": "AM-REQ-2026-03621",
    "original_inquiry": "Referral from specialist: Researcher inquiry: CRISPR疗法 delivery and CRISPR-Cas9 outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7509
  },
  {
    "request_id": "AM-REQ-2026-03622",
    "original_inquiry": "Urgent: Child with gene therapy; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6482
  },
  {
    "request_id": "AM-REQ-2026-03623",
    "original_inquiry": "Urgent consultation: CRISPR疗法 diagnosis, seeking Casgevy / Lyfgenia availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8011
  },
  {
    "request_id": "AM-REQ-2026-03624",
    "original_inquiry": "Second opinion requested: Researcher inquiry: beta-thalassemia delivery and gene replacement therapy outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.869
  },
  {
    "request_id": "AM-REQ-2026-03625",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8665
  },
  {
    "request_id": "AM-REQ-2026-03626",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊beta-thalassemia，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8879
  },
  {
    "request_id": "AM-REQ-2026-03627",
    "original_inquiry": "Child with beta-thalassemia; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5872
  },
  {
    "request_id": "AM-REQ-2026-03628",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7724
  },
  {
    "request_id": "AM-REQ-2026-03629",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on SRP-9001 and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7003
  },
  {
    "request_id": "AM-REQ-2026-03630",
    "original_inquiry": "Family seeking information: Patient with gene therapy; requesting information on CRISPR-Cas9 and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6695
  },
  {
    "request_id": "AM-REQ-2026-03631",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊杜氏肌营养不良，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5921
  },
  {
    "request_id": "AM-REQ-2026-03632",
    "original_inquiry": "Urgent: Geneticist referral: SMA基因治疗 confirmed; exploring AAV9 and ELEVIDYS trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8693
  },
  {
    "request_id": "AM-REQ-2026-03633",
    "original_inquiry": "Referral from specialist: Urgent consultation: 镰状细胞贫血 diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8554
  },
  {
    "request_id": "AM-REQ-2026-03634",
    "original_inquiry": "Urgent: Researcher inquiry: 镰状细胞贫血 delivery and Casgevy outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7071
  },
  {
    "request_id": "AM-REQ-2026-03635",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6905
  },
  {
    "request_id": "AM-REQ-2026-03636",
    "original_inquiry": "海外求药：spinal muscular atrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8471
  },
  {
    "request_id": "AM-REQ-2026-03637",
    "original_inquiry": "Family seeking information: Child with SMA; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5244
  },
  {
    "request_id": "AM-REQ-2026-03638",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6135
  },
  {
    "request_id": "AM-REQ-2026-03639",
    "original_inquiry": "Family seeking information: 海外求药：beta-thalassemia患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8587
  },
  {
    "request_id": "AM-REQ-2026-03640",
    "original_inquiry": "Urgent: Geneticist referral: CRISPR疗法 confirmed; exploring SRP-9001 and Casgevy trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6774
  },
  {
    "request_id": "AM-REQ-2026-03641",
    "original_inquiry": "Referral from specialist: Geneticist referral: CRISPR疗法 confirmed; exploring gene replacement therapy and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6614
  },
  {
    "request_id": "AM-REQ-2026-03642",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6932
  },
  {
    "request_id": "AM-REQ-2026-03643",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on SRP-9001 and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6024
  },
  {
    "request_id": "AM-REQ-2026-03644",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7396
  },
  {
    "request_id": "AM-REQ-2026-03645",
    "original_inquiry": "Second opinion requested: Patient with 杜氏肌营养不良; requesting information on Zolgensma and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5704
  },
  {
    "request_id": "AM-REQ-2026-03646",
    "original_inquiry": "家长咨询：患儿确诊spinal muscular atrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7642
  },
  {
    "request_id": "AM-REQ-2026-03647",
    "original_inquiry": "研究者咨询：海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.624
  },
  {
    "request_id": "AM-REQ-2026-03648",
    "original_inquiry": "Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5986
  },
  {
    "request_id": "AM-REQ-2026-03649",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5981
  },
  {
    "request_id": "AM-REQ-2026-03650",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5654
  },
  {
    "request_id": "AM-REQ-2026-03651",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7343
  },
  {
    "request_id": "AM-REQ-2026-03652",
    "original_inquiry": "Family seeking information: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Zolgensma and Lyfgenia trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-03653",
    "original_inquiry": "Second opinion requested: Patient with Duchenne muscular dystrophy; requesting information on ELEVIDYS and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-03654",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-03655",
    "original_inquiry": "Second opinion requested: Child with Duchenne muscular dystrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6594
  },
  {
    "request_id": "AM-REQ-2026-03656",
    "original_inquiry": "海外求诊：Urgent consultation: beta-thalassemia diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7923
  },
  {
    "request_id": "AM-REQ-2026-03657",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5646
  },
  {
    "request_id": "AM-REQ-2026-03658",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8153
  },
  {
    "request_id": "AM-REQ-2026-03659",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.783
  },
  {
    "request_id": "AM-REQ-2026-03660",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on ELEVIDYS and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7578
  },
  {
    "request_id": "AM-REQ-2026-03661",
    "original_inquiry": "Second opinion requested: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.66
  },
  {
    "request_id": "AM-REQ-2026-03662",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5077
  },
  {
    "request_id": "AM-REQ-2026-03663",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5545
  },
  {
    "request_id": "AM-REQ-2026-03664",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊AAV vector，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.672
  },
  {
    "request_id": "AM-REQ-2026-03665",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7268
  },
  {
    "request_id": "AM-REQ-2026-03666",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5152
  },
  {
    "request_id": "AM-REQ-2026-03667",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5343
  },
  {
    "request_id": "AM-REQ-2026-03668",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7294
  },
  {
    "request_id": "AM-REQ-2026-03669",
    "original_inquiry": "海外求诊：海外求药：镰状细胞贫血患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6815
  },
  {
    "request_id": "AM-REQ-2026-03670",
    "original_inquiry": "海外求诊：Geneticist referral: spinal muscular atrophy confirmed; exploring Zolgensma and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7952
  },
  {
    "request_id": "AM-REQ-2026-03671",
    "original_inquiry": "Referral from specialist: Researcher inquiry: DMD delivery and CRISPR-Cas9 outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.611
  },
  {
    "request_id": "AM-REQ-2026-03672",
    "original_inquiry": "Urgent: Child with 镰状细胞贫血; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5291
  },
  {
    "request_id": "AM-REQ-2026-03673",
    "original_inquiry": "研究者咨询：Child with DMD; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8393
  },
  {
    "request_id": "AM-REQ-2026-03674",
    "original_inquiry": "Researcher inquiry: DMD delivery and AAV9 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6631
  },
  {
    "request_id": "AM-REQ-2026-03675",
    "original_inquiry": "Referral from specialist: Urgent consultation: spinal muscular atrophy diagnosis, seeking Zolgensma / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5068
  },
  {
    "request_id": "AM-REQ-2026-03676",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8944
  },
  {
    "request_id": "AM-REQ-2026-03677",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8579
  },
  {
    "request_id": "AM-REQ-2026-03678",
    "original_inquiry": "Second opinion requested: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring SRP-9001 and Zolgensma trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7369
  },
  {
    "request_id": "AM-REQ-2026-03679",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6872
  },
  {
    "request_id": "AM-REQ-2026-03680",
    "original_inquiry": "Second opinion requested: 海外求药：sickle cell disease患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7305
  },
  {
    "request_id": "AM-REQ-2026-03681",
    "original_inquiry": "Urgent: Child with sickle cell disease; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5188
  },
  {
    "request_id": "AM-REQ-2026-03682",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6419
  },
  {
    "request_id": "AM-REQ-2026-03683",
    "original_inquiry": "Referral from specialist: Geneticist referral: DMD confirmed; exploring ELEVIDYS and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7405
  },
  {
    "request_id": "AM-REQ-2026-03684",
    "original_inquiry": "研究者咨询：海外求药：Duchenne muscular dystrophy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5364
  },
  {
    "request_id": "AM-REQ-2026-03685",
    "original_inquiry": "海外求药：镰状细胞贫血患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.754
  },
  {
    "request_id": "AM-REQ-2026-03686",
    "original_inquiry": "Urgent: Urgent consultation: beta-thalassemia diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8351
  },
  {
    "request_id": "AM-REQ-2026-03687",
    "original_inquiry": "研究者咨询：Geneticist referral: 杜氏肌营养不良 confirmed; exploring SRP-9001 and Casgevy trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6955
  },
  {
    "request_id": "AM-REQ-2026-03688",
    "original_inquiry": "研究者咨询：Geneticist referral: CRISPR疗法 confirmed; exploring AAV9 and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5899
  },
  {
    "request_id": "AM-REQ-2026-03689",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on ELEVIDYS and Casgevy access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.858
  },
  {
    "request_id": "AM-REQ-2026-03690",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5465
  },
  {
    "request_id": "AM-REQ-2026-03691",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and AAV9 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8344
  },
  {
    "request_id": "AM-REQ-2026-03692",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-03693",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8416
  },
  {
    "request_id": "AM-REQ-2026-03694",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8128
  },
  {
    "request_id": "AM-REQ-2026-03695",
    "original_inquiry": "Family seeking information: Geneticist referral: AAV vector confirmed; exploring exon skipping and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5104
  },
  {
    "request_id": "AM-REQ-2026-03696",
    "original_inquiry": "Child with beta-thalassemia; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.541
  },
  {
    "request_id": "AM-REQ-2026-03697",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7191
  },
  {
    "request_id": "AM-REQ-2026-03698",
    "original_inquiry": "Referral from specialist: 海外求药：CRISPR疗法患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5137
  },
  {
    "request_id": "AM-REQ-2026-03699",
    "original_inquiry": "研究者咨询：海外求药：镰状细胞贫血患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5758
  },
  {
    "request_id": "AM-REQ-2026-03700",
    "original_inquiry": "Family seeking information: Researcher inquiry: gene therapy delivery and ELEVIDYS outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6515
  },
  {
    "request_id": "AM-REQ-2026-03701",
    "original_inquiry": "研究者咨询：Patient with 杜氏肌营养不良; requesting information on exon skipping and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5433
  },
  {
    "request_id": "AM-REQ-2026-03702",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8871
  },
  {
    "request_id": "AM-REQ-2026-03703",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring ELEVIDYS and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7944
  },
  {
    "request_id": "AM-REQ-2026-03704",
    "original_inquiry": "Second opinion requested: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Lyfgenia and AAV9 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7812
  },
  {
    "request_id": "AM-REQ-2026-03705",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊CRISPR疗法，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.747
  },
  {
    "request_id": "AM-REQ-2026-03706",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on Zolgensma and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5204
  },
  {
    "request_id": "AM-REQ-2026-03707",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8536
  },
  {
    "request_id": "AM-REQ-2026-03708",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA基因治疗 delivery and SRP-9001 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-03709",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and Casgevy outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5713
  },
  {
    "request_id": "AM-REQ-2026-03710",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA基因治疗 diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8738
  },
  {
    "request_id": "AM-REQ-2026-03711",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA基因治疗 delivery and Zolgensma outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5158
  },
  {
    "request_id": "AM-REQ-2026-03712",
    "original_inquiry": "海外求诊：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7582
  },
  {
    "request_id": "AM-REQ-2026-03713",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊AAV vector，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8415
  },
  {
    "request_id": "AM-REQ-2026-03714",
    "original_inquiry": "海外求药：spinal muscular atrophy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8165
  },
  {
    "request_id": "AM-REQ-2026-03715",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6113
  },
  {
    "request_id": "AM-REQ-2026-03716",
    "original_inquiry": "Patient with 杜氏肌营养不良; requesting information on SRP-9001 and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7196
  },
  {
    "request_id": "AM-REQ-2026-03717",
    "original_inquiry": "Second opinion requested: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring CRISPR-Cas9 and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6447
  },
  {
    "request_id": "AM-REQ-2026-03718",
    "original_inquiry": "研究者咨询：Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8153
  },
  {
    "request_id": "AM-REQ-2026-03719",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6274
  },
  {
    "request_id": "AM-REQ-2026-03720",
    "original_inquiry": "海外求诊：海外求药：Duchenne muscular dystrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5646
  },
  {
    "request_id": "AM-REQ-2026-03721",
    "original_inquiry": "Child with Duchenne muscular dystrophy; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7445
  },
  {
    "request_id": "AM-REQ-2026-03722",
    "original_inquiry": "Second opinion requested: 海外求药：SMA患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8179
  },
  {
    "request_id": "AM-REQ-2026-03723",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊sickle cell disease，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8578
  },
  {
    "request_id": "AM-REQ-2026-03724",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring ELEVIDYS and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6948
  },
  {
    "request_id": "AM-REQ-2026-03725",
    "original_inquiry": "海外求诊：Child with Duchenne muscular dystrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6691
  },
  {
    "request_id": "AM-REQ-2026-03726",
    "original_inquiry": "研究者咨询：Researcher inquiry: beta-thalassemia delivery and SRP-9001 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7928
  },
  {
    "request_id": "AM-REQ-2026-03727",
    "original_inquiry": "Urgent: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7846
  },
  {
    "request_id": "AM-REQ-2026-03728",
    "original_inquiry": "研究者咨询：Geneticist referral: DMD confirmed; exploring exon skipping and Zolgensma trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5447
  },
  {
    "request_id": "AM-REQ-2026-03729",
    "original_inquiry": "海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6109
  },
  {
    "request_id": "AM-REQ-2026-03730",
    "original_inquiry": "Second opinion requested: Researcher inquiry: spinal muscular atrophy delivery and exon skipping outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5217
  },
  {
    "request_id": "AM-REQ-2026-03731",
    "original_inquiry": "Referral from specialist: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7522
  },
  {
    "request_id": "AM-REQ-2026-03732",
    "original_inquiry": "研究者咨询：海外求药：SMA患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6178
  },
  {
    "request_id": "AM-REQ-2026-03733",
    "original_inquiry": "Urgent: Child with CRISPR疗法; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8862
  },
  {
    "request_id": "AM-REQ-2026-03734",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking exon skipping / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8087
  },
  {
    "request_id": "AM-REQ-2026-03735",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6783
  },
  {
    "request_id": "AM-REQ-2026-03736",
    "original_inquiry": "Researcher inquiry: gene therapy delivery and Lyfgenia outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6584
  },
  {
    "request_id": "AM-REQ-2026-03737",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6619
  },
  {
    "request_id": "AM-REQ-2026-03738",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7764
  },
  {
    "request_id": "AM-REQ-2026-03739",
    "original_inquiry": "研究者咨询：Geneticist referral: beta-thalassemia confirmed; exploring gene replacement therapy and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5982
  },
  {
    "request_id": "AM-REQ-2026-03740",
    "original_inquiry": "研究者咨询：Researcher inquiry: DMD delivery and exon skipping outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-03741",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊AAV vector，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8206
  },
  {
    "request_id": "AM-REQ-2026-03742",
    "original_inquiry": "研究者咨询：Geneticist referral: gene therapy confirmed; exploring Casgevy and Lyfgenia trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5129
  },
  {
    "request_id": "AM-REQ-2026-03743",
    "original_inquiry": "Second opinion requested: Child with spinal muscular atrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5813
  },
  {
    "request_id": "AM-REQ-2026-03744",
    "original_inquiry": "Geneticist referral: AAV vector confirmed; exploring CRISPR-Cas9 and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.753
  },
  {
    "request_id": "AM-REQ-2026-03745",
    "original_inquiry": "Urgent consultation: sickle cell disease diagnosis, seeking AAV9 / Zolgensma availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8327
  },
  {
    "request_id": "AM-REQ-2026-03746",
    "original_inquiry": "Referral from specialist: Urgent consultation: CRISPR疗法 diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8418
  },
  {
    "request_id": "AM-REQ-2026-03747",
    "original_inquiry": "Family seeking information: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8267
  },
  {
    "request_id": "AM-REQ-2026-03748",
    "original_inquiry": "海外求诊：Urgent consultation: SMA基因治疗 diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6352
  },
  {
    "request_id": "AM-REQ-2026-03749",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊sickle cell disease，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.56
  },
  {
    "request_id": "AM-REQ-2026-03750",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6564
  },
  {
    "request_id": "AM-REQ-2026-03751",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring Casgevy and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.826
  },
  {
    "request_id": "AM-REQ-2026-03752",
    "original_inquiry": "Second opinion requested: Geneticist referral: AAV vector confirmed; exploring ELEVIDYS and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5476
  },
  {
    "request_id": "AM-REQ-2026-03753",
    "original_inquiry": "海外求药：SMA基因治疗患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5139
  },
  {
    "request_id": "AM-REQ-2026-03754",
    "original_inquiry": "家长咨询：患儿确诊DMD，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-03755",
    "original_inquiry": "Referral from specialist: Child with spinal muscular atrophy; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6591
  },
  {
    "request_id": "AM-REQ-2026-03756",
    "original_inquiry": "Second opinion requested: Researcher inquiry: CRISPR疗法 delivery and exon skipping outcomes in Casgevy; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8571
  },
  {
    "request_id": "AM-REQ-2026-03757",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and Lyfgenia outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8637
  },
  {
    "request_id": "AM-REQ-2026-03758",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊CRISPR疗法，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7158
  },
  {
    "request_id": "AM-REQ-2026-03759",
    "original_inquiry": "海外求诊：Researcher inquiry: Duchenne muscular dystrophy delivery and exon skipping outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8352
  },
  {
    "request_id": "AM-REQ-2026-03760",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7944
  },
  {
    "request_id": "AM-REQ-2026-03761",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.731
  },
  {
    "request_id": "AM-REQ-2026-03762",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5605
  },
  {
    "request_id": "AM-REQ-2026-03763",
    "original_inquiry": "Urgent: Child with SMA; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6273
  },
  {
    "request_id": "AM-REQ-2026-03764",
    "original_inquiry": "海外求药：AAV vector患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7958
  },
  {
    "request_id": "AM-REQ-2026-03765",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Duchenne muscular dystrophy delivery and AAV9 outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7034
  },
  {
    "request_id": "AM-REQ-2026-03766",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5714
  },
  {
    "request_id": "AM-REQ-2026-03767",
    "original_inquiry": "Family seeking information: Patient with AAV vector; requesting information on AAV9 and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-03768",
    "original_inquiry": "海外求诊：海外求药：gene therapy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5176
  },
  {
    "request_id": "AM-REQ-2026-03769",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊杜氏肌营养不良，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6872
  },
  {
    "request_id": "AM-REQ-2026-03770",
    "original_inquiry": "Family seeking information: Geneticist referral: sickle cell disease confirmed; exploring AAV9 and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6172
  },
  {
    "request_id": "AM-REQ-2026-03771",
    "original_inquiry": "研究者咨询：Patient with CRISPR疗法; requesting information on AAV9 and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7534
  },
  {
    "request_id": "AM-REQ-2026-03772",
    "original_inquiry": "海外求诊：Researcher inquiry: 杜氏肌营养不良 delivery and AAV9 outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8226
  },
  {
    "request_id": "AM-REQ-2026-03773",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5849
  },
  {
    "request_id": "AM-REQ-2026-03774",
    "original_inquiry": "研究者咨询：Researcher inquiry: CRISPR疗法 delivery and CRISPR-Cas9 outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5324
  },
  {
    "request_id": "AM-REQ-2026-03775",
    "original_inquiry": "海外求诊：Geneticist referral: AAV vector confirmed; exploring ELEVIDYS and AAV9 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8609
  },
  {
    "request_id": "AM-REQ-2026-03776",
    "original_inquiry": "Family seeking information: Geneticist referral: beta-thalassemia confirmed; exploring Lyfgenia and Casgevy trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5396
  },
  {
    "request_id": "AM-REQ-2026-03777",
    "original_inquiry": "Referral from specialist: Geneticist referral: beta-thalassemia confirmed; exploring Zolgensma and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-03778",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring exon skipping and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6724
  },
  {
    "request_id": "AM-REQ-2026-03779",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8977
  },
  {
    "request_id": "AM-REQ-2026-03780",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-03781",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5448
  },
  {
    "request_id": "AM-REQ-2026-03782",
    "original_inquiry": "Second opinion requested: Patient with beta-thalassemia; requesting information on Lyfgenia and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5359
  },
  {
    "request_id": "AM-REQ-2026-03783",
    "original_inquiry": "Urgent: Researcher inquiry: AAV vector delivery and Lyfgenia outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6624
  },
  {
    "request_id": "AM-REQ-2026-03784",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and Casgevy outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8961
  },
  {
    "request_id": "AM-REQ-2026-03785",
    "original_inquiry": "Urgent: Child with SMA; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8684
  },
  {
    "request_id": "AM-REQ-2026-03786",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring ELEVIDYS and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6132
  },
  {
    "request_id": "AM-REQ-2026-03787",
    "original_inquiry": "研究者咨询：Child with CRISPR疗法; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6301
  },
  {
    "request_id": "AM-REQ-2026-03788",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5291
  },
  {
    "request_id": "AM-REQ-2026-03789",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7692
  },
  {
    "request_id": "AM-REQ-2026-03790",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊DMD，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8925
  },
  {
    "request_id": "AM-REQ-2026-03791",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7692
  },
  {
    "request_id": "AM-REQ-2026-03792",
    "original_inquiry": "Urgent: Patient with sickle cell disease; requesting information on AAV9 and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6419
  },
  {
    "request_id": "AM-REQ-2026-03793",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8896
  },
  {
    "request_id": "AM-REQ-2026-03794",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7428
  },
  {
    "request_id": "AM-REQ-2026-03795",
    "original_inquiry": "研究者咨询：Child with SMA基因治疗; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7689
  },
  {
    "request_id": "AM-REQ-2026-03796",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-03797",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7268
  },
  {
    "request_id": "AM-REQ-2026-03798",
    "original_inquiry": "Urgent: Child with CRISPR疗法; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5926
  },
  {
    "request_id": "AM-REQ-2026-03799",
    "original_inquiry": "海外求诊：Researcher inquiry: 杜氏肌营养不良 delivery and AAV9 outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6074
  },
  {
    "request_id": "AM-REQ-2026-03800",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7832
  },
  {
    "request_id": "AM-REQ-2026-03801",
    "original_inquiry": "Urgent: 海外求药：杜氏肌营养不良患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.79
  },
  {
    "request_id": "AM-REQ-2026-03802",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8533
  },
  {
    "request_id": "AM-REQ-2026-03803",
    "original_inquiry": "Urgent: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Casgevy / Zolgensma availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6001
  },
  {
    "request_id": "AM-REQ-2026-03804",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6303
  },
  {
    "request_id": "AM-REQ-2026-03805",
    "original_inquiry": "Urgent: Geneticist referral: 杜氏肌营养不良 confirmed; exploring AAV9 and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7381
  },
  {
    "request_id": "AM-REQ-2026-03806",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5463
  },
  {
    "request_id": "AM-REQ-2026-03807",
    "original_inquiry": "研究者咨询：海外求药：gene therapy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6199
  },
  {
    "request_id": "AM-REQ-2026-03808",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA基因治疗，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7511
  },
  {
    "request_id": "AM-REQ-2026-03809",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6329
  },
  {
    "request_id": "AM-REQ-2026-03810",
    "original_inquiry": "海外求诊：海外求药：gene therapy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5753
  },
  {
    "request_id": "AM-REQ-2026-03811",
    "original_inquiry": "Family seeking information: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5188
  },
  {
    "request_id": "AM-REQ-2026-03812",
    "original_inquiry": "研究者咨询：Child with sickle cell disease; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8941
  },
  {
    "request_id": "AM-REQ-2026-03813",
    "original_inquiry": "Second opinion requested: Child with beta-thalassemia; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6934
  },
  {
    "request_id": "AM-REQ-2026-03814",
    "original_inquiry": "Second opinion requested: Geneticist referral: sickle cell disease confirmed; exploring ELEVIDYS and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.61
  },
  {
    "request_id": "AM-REQ-2026-03815",
    "original_inquiry": "Urgent: Urgent consultation: AAV vector diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7014
  },
  {
    "request_id": "AM-REQ-2026-03816",
    "original_inquiry": "家长咨询：患儿确诊spinal muscular atrophy，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7916
  },
  {
    "request_id": "AM-REQ-2026-03817",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊DMD，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.653
  },
  {
    "request_id": "AM-REQ-2026-03818",
    "original_inquiry": "Second opinion requested: Geneticist referral: AAV vector confirmed; exploring CRISPR-Cas9 and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6901
  },
  {
    "request_id": "AM-REQ-2026-03819",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7786
  },
  {
    "request_id": "AM-REQ-2026-03820",
    "original_inquiry": "Geneticist referral: spinal muscular atrophy confirmed; exploring gene replacement therapy and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8119
  },
  {
    "request_id": "AM-REQ-2026-03821",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊镰状细胞贫血，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8082
  },
  {
    "request_id": "AM-REQ-2026-03822",
    "original_inquiry": "Second opinion requested: Child with DMD; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.575
  },
  {
    "request_id": "AM-REQ-2026-03823",
    "original_inquiry": "Family seeking information: Urgent consultation: beta-thalassemia diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6642
  },
  {
    "request_id": "AM-REQ-2026-03824",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5598
  },
  {
    "request_id": "AM-REQ-2026-03825",
    "original_inquiry": "Referral from specialist: Child with SMA基因治疗; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6135
  },
  {
    "request_id": "AM-REQ-2026-03826",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.844
  },
  {
    "request_id": "AM-REQ-2026-03827",
    "original_inquiry": "海外求诊：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5937
  },
  {
    "request_id": "AM-REQ-2026-03828",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on Casgevy and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6872
  },
  {
    "request_id": "AM-REQ-2026-03829",
    "original_inquiry": "Second opinion requested: Child with Duchenne muscular dystrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5024
  },
  {
    "request_id": "AM-REQ-2026-03830",
    "original_inquiry": "Second opinion requested: Child with SMA; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7701
  },
  {
    "request_id": "AM-REQ-2026-03831",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊sickle cell disease，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6059
  },
  {
    "request_id": "AM-REQ-2026-03832",
    "original_inquiry": "Patient with spinal muscular atrophy; requesting information on Casgevy and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7983
  },
  {
    "request_id": "AM-REQ-2026-03833",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-03834",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊DMD，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7741
  },
  {
    "request_id": "AM-REQ-2026-03835",
    "original_inquiry": "研究者咨询：海外求药：杜氏肌营养不良患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5331
  },
  {
    "request_id": "AM-REQ-2026-03836",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on ELEVIDYS and Casgevy access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8726
  },
  {
    "request_id": "AM-REQ-2026-03837",
    "original_inquiry": "Family seeking information: Geneticist referral: DMD confirmed; exploring CRISPR-Cas9 and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8625
  },
  {
    "request_id": "AM-REQ-2026-03838",
    "original_inquiry": "Family seeking information: 海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7805
  },
  {
    "request_id": "AM-REQ-2026-03839",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7627
  },
  {
    "request_id": "AM-REQ-2026-03840",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8615
  },
  {
    "request_id": "AM-REQ-2026-03841",
    "original_inquiry": "海外求药：spinal muscular atrophy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5111
  },
  {
    "request_id": "AM-REQ-2026-03842",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8637
  },
  {
    "request_id": "AM-REQ-2026-03843",
    "original_inquiry": "Urgent: Child with sickle cell disease; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8459
  },
  {
    "request_id": "AM-REQ-2026-03844",
    "original_inquiry": "海外求诊：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7161
  },
  {
    "request_id": "AM-REQ-2026-03845",
    "original_inquiry": "Referral from specialist: Urgent consultation: 镰状细胞贫血 diagnosis, seeking Casgevy / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8917
  },
  {
    "request_id": "AM-REQ-2026-03846",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊SMA基因治疗，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5154
  },
  {
    "request_id": "AM-REQ-2026-03847",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring AAV9 and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5493
  },
  {
    "request_id": "AM-REQ-2026-03848",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6915
  },
  {
    "request_id": "AM-REQ-2026-03849",
    "original_inquiry": "研究者咨询：Patient with DMD; requesting information on Lyfgenia and Casgevy access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5554
  },
  {
    "request_id": "AM-REQ-2026-03850",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7434
  },
  {
    "request_id": "AM-REQ-2026-03851",
    "original_inquiry": "研究者咨询：Child with spinal muscular atrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7995
  },
  {
    "request_id": "AM-REQ-2026-03852",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8108
  },
  {
    "request_id": "AM-REQ-2026-03853",
    "original_inquiry": "Second opinion requested: Geneticist referral: 镰状细胞贫血 confirmed; exploring Zolgensma and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.841
  },
  {
    "request_id": "AM-REQ-2026-03854",
    "original_inquiry": "Urgent: Geneticist referral: sickle cell disease confirmed; exploring ELEVIDYS and AAV9 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6735
  },
  {
    "request_id": "AM-REQ-2026-03855",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8303
  },
  {
    "request_id": "AM-REQ-2026-03856",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8316
  },
  {
    "request_id": "AM-REQ-2026-03857",
    "original_inquiry": "Urgent: Urgent consultation: AAV vector diagnosis, seeking Zolgensma / AAV9 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7731
  },
  {
    "request_id": "AM-REQ-2026-03858",
    "original_inquiry": "海外求诊：Child with SMA; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7456
  },
  {
    "request_id": "AM-REQ-2026-03859",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊镰状细胞贫血，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7282
  },
  {
    "request_id": "AM-REQ-2026-03860",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7563
  },
  {
    "request_id": "AM-REQ-2026-03861",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊DMD，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7447
  },
  {
    "request_id": "AM-REQ-2026-03862",
    "original_inquiry": "Family seeking information: 海外求药：sickle cell disease患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7461
  },
  {
    "request_id": "AM-REQ-2026-03863",
    "original_inquiry": "Referral from specialist: Child with spinal muscular atrophy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8831
  },
  {
    "request_id": "AM-REQ-2026-03864",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5844
  },
  {
    "request_id": "AM-REQ-2026-03865",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊杜氏肌营养不良，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8735
  },
  {
    "request_id": "AM-REQ-2026-03866",
    "original_inquiry": "Family seeking information: Child with CRISPR疗法; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5182
  },
  {
    "request_id": "AM-REQ-2026-03867",
    "original_inquiry": "Researcher inquiry: spinal muscular atrophy delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7022
  },
  {
    "request_id": "AM-REQ-2026-03868",
    "original_inquiry": "Referral from specialist: Child with gene therapy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6609
  },
  {
    "request_id": "AM-REQ-2026-03869",
    "original_inquiry": "海外求诊：Researcher inquiry: spinal muscular atrophy delivery and Casgevy outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7696
  },
  {
    "request_id": "AM-REQ-2026-03870",
    "original_inquiry": "Second opinion requested: Patient with AAV vector; requesting information on SRP-9001 and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7577
  },
  {
    "request_id": "AM-REQ-2026-03871",
    "original_inquiry": "Second opinion requested: Child with spinal muscular atrophy; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5084
  },
  {
    "request_id": "AM-REQ-2026-03872",
    "original_inquiry": "Family seeking information: Researcher inquiry: beta-thalassemia delivery and exon skipping outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6133
  },
  {
    "request_id": "AM-REQ-2026-03873",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊gene therapy，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8736
  },
  {
    "request_id": "AM-REQ-2026-03874",
    "original_inquiry": "研究者咨询：Urgent consultation: spinal muscular atrophy diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5372
  },
  {
    "request_id": "AM-REQ-2026-03875",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7813
  },
  {
    "request_id": "AM-REQ-2026-03876",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊DMD，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5889
  },
  {
    "request_id": "AM-REQ-2026-03877",
    "original_inquiry": "研究者咨询：Researcher inquiry: CRISPR疗法 delivery and CRISPR-Cas9 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5868
  },
  {
    "request_id": "AM-REQ-2026-03878",
    "original_inquiry": "海外求诊：Child with spinal muscular atrophy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.657
  },
  {
    "request_id": "AM-REQ-2026-03879",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6493
  },
  {
    "request_id": "AM-REQ-2026-03880",
    "original_inquiry": "海外求诊：Researcher inquiry: gene therapy delivery and Casgevy outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7228
  },
  {
    "request_id": "AM-REQ-2026-03881",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-03882",
    "original_inquiry": "研究者咨询：Patient with SMA; requesting information on Lyfgenia and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6721
  },
  {
    "request_id": "AM-REQ-2026-03883",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8784
  },
  {
    "request_id": "AM-REQ-2026-03884",
    "original_inquiry": "Second opinion requested: Researcher inquiry: SMA基因治疗 delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6753
  },
  {
    "request_id": "AM-REQ-2026-03885",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8627
  },
  {
    "request_id": "AM-REQ-2026-03886",
    "original_inquiry": "Family seeking information: Researcher inquiry: 杜氏肌营养不良 delivery and Casgevy outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.735
  },
  {
    "request_id": "AM-REQ-2026-03887",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and AAV9 outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6747
  },
  {
    "request_id": "AM-REQ-2026-03888",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6982
  },
  {
    "request_id": "AM-REQ-2026-03889",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking Lyfgenia / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-03890",
    "original_inquiry": "Second opinion requested: 海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5914
  },
  {
    "request_id": "AM-REQ-2026-03891",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.654
  },
  {
    "request_id": "AM-REQ-2026-03892",
    "original_inquiry": "Referral from specialist: Urgent consultation: DMD diagnosis, seeking Lyfgenia / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8934
  },
  {
    "request_id": "AM-REQ-2026-03893",
    "original_inquiry": "Family seeking information: Geneticist referral: beta-thalassemia confirmed; exploring exon skipping and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5877
  },
  {
    "request_id": "AM-REQ-2026-03894",
    "original_inquiry": "海外求诊：Geneticist referral: 杜氏肌营养不良 confirmed; exploring Lyfgenia and Zolgensma trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5183
  },
  {
    "request_id": "AM-REQ-2026-03895",
    "original_inquiry": "Urgent consultation: 杜氏肌营养不良 diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8388
  },
  {
    "request_id": "AM-REQ-2026-03896",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5988
  },
  {
    "request_id": "AM-REQ-2026-03897",
    "original_inquiry": "Referral from specialist: Researcher inquiry: CRISPR疗法 delivery and Zolgensma outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6387
  },
  {
    "request_id": "AM-REQ-2026-03898",
    "original_inquiry": "研究者咨询：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5452
  },
  {
    "request_id": "AM-REQ-2026-03899",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7407
  },
  {
    "request_id": "AM-REQ-2026-03900",
    "original_inquiry": "海外求诊：Researcher inquiry: SMA基因治疗 delivery and AAV9 outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5976
  },
  {
    "request_id": "AM-REQ-2026-03901",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and Lyfgenia outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8679
  },
  {
    "request_id": "AM-REQ-2026-03902",
    "original_inquiry": "Second opinion requested: Patient with gene therapy; requesting information on gene replacement therapy and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8492
  },
  {
    "request_id": "AM-REQ-2026-03903",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5114
  },
  {
    "request_id": "AM-REQ-2026-03904",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊gene therapy，寻求Zolgensma或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8916
  },
  {
    "request_id": "AM-REQ-2026-03905",
    "original_inquiry": "Child with AAV vector; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5998
  },
  {
    "request_id": "AM-REQ-2026-03906",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-03907",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA基因治疗 delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5111
  },
  {
    "request_id": "AM-REQ-2026-03908",
    "original_inquiry": "研究者咨询：Researcher inquiry: Duchenne muscular dystrophy delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6925
  },
  {
    "request_id": "AM-REQ-2026-03909",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on ELEVIDYS and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8568
  },
  {
    "request_id": "AM-REQ-2026-03910",
    "original_inquiry": "Urgent consultation: gene therapy diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5912
  },
  {
    "request_id": "AM-REQ-2026-03911",
    "original_inquiry": "海外求诊：Geneticist referral: SMA confirmed; exploring Lyfgenia and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7919
  },
  {
    "request_id": "AM-REQ-2026-03912",
    "original_inquiry": "研究者咨询：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.726
  },
  {
    "request_id": "AM-REQ-2026-03913",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6065
  },
  {
    "request_id": "AM-REQ-2026-03914",
    "original_inquiry": "Second opinion requested: Patient with gene therapy; requesting information on Zolgensma and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5067
  },
  {
    "request_id": "AM-REQ-2026-03915",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA基因治疗，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5614
  },
  {
    "request_id": "AM-REQ-2026-03916",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on SRP-9001 and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5227
  },
  {
    "request_id": "AM-REQ-2026-03917",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.743
  },
  {
    "request_id": "AM-REQ-2026-03918",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA基因治疗，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5777
  },
  {
    "request_id": "AM-REQ-2026-03919",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.591
  },
  {
    "request_id": "AM-REQ-2026-03920",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊AAV vector，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7589
  },
  {
    "request_id": "AM-REQ-2026-03921",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7219
  },
  {
    "request_id": "AM-REQ-2026-03922",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7959
  },
  {
    "request_id": "AM-REQ-2026-03923",
    "original_inquiry": "海外求诊：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7996
  },
  {
    "request_id": "AM-REQ-2026-03924",
    "original_inquiry": "Family seeking information: Geneticist referral: spinal muscular atrophy confirmed; exploring ELEVIDYS and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7951
  },
  {
    "request_id": "AM-REQ-2026-03925",
    "original_inquiry": "Urgent: Patient with spinal muscular atrophy; requesting information on ELEVIDYS and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.554
  },
  {
    "request_id": "AM-REQ-2026-03926",
    "original_inquiry": "Second opinion requested: Child with SMA; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5516
  },
  {
    "request_id": "AM-REQ-2026-03927",
    "original_inquiry": "Second opinion requested: Patient with Duchenne muscular dystrophy; requesting information on Zolgensma and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8835
  },
  {
    "request_id": "AM-REQ-2026-03928",
    "original_inquiry": "研究者咨询：Researcher inquiry: SMA delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5707
  },
  {
    "request_id": "AM-REQ-2026-03929",
    "original_inquiry": "Second opinion requested: Geneticist referral: spinal muscular atrophy confirmed; exploring ELEVIDYS and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6641
  },
  {
    "request_id": "AM-REQ-2026-03930",
    "original_inquiry": "Referral from specialist: Geneticist referral: CRISPR疗法 confirmed; exploring ELEVIDYS and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8413
  },
  {
    "request_id": "AM-REQ-2026-03931",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring exon skipping and Zolgensma trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7877
  },
  {
    "request_id": "AM-REQ-2026-03932",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-03933",
    "original_inquiry": "Family seeking information: Child with 杜氏肌营养不良; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5781
  },
  {
    "request_id": "AM-REQ-2026-03934",
    "original_inquiry": "Urgent: Child with beta-thalassemia; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7567
  },
  {
    "request_id": "AM-REQ-2026-03935",
    "original_inquiry": "Family seeking information: Geneticist referral: 杜氏肌营养不良 confirmed; exploring exon skipping and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7499
  },
  {
    "request_id": "AM-REQ-2026-03936",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7026
  },
  {
    "request_id": "AM-REQ-2026-03937",
    "original_inquiry": "Family seeking information: 海外求药：SMA基因治疗患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5368
  },
  {
    "request_id": "AM-REQ-2026-03938",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA基因治疗，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7237
  },
  {
    "request_id": "AM-REQ-2026-03939",
    "original_inquiry": "Referral from specialist: Patient with Duchenne muscular dystrophy; requesting information on AAV9 and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6655
  },
  {
    "request_id": "AM-REQ-2026-03940",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring gene replacement therapy and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-03941",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on Lyfgenia and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5559
  },
  {
    "request_id": "AM-REQ-2026-03942",
    "original_inquiry": "研究者咨询：Geneticist referral: DMD confirmed; exploring exon skipping and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7279
  },
  {
    "request_id": "AM-REQ-2026-03943",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊sickle cell disease，寻求Lyfgenia或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8695
  },
  {
    "request_id": "AM-REQ-2026-03944",
    "original_inquiry": "Family seeking information: Patient with beta-thalassemia; requesting information on ELEVIDYS and SRP-9001 access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7371
  },
  {
    "request_id": "AM-REQ-2026-03945",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6166
  },
  {
    "request_id": "AM-REQ-2026-03946",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6616
  },
  {
    "request_id": "AM-REQ-2026-03947",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.647
  },
  {
    "request_id": "AM-REQ-2026-03948",
    "original_inquiry": "海外求药：gene therapy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5759
  },
  {
    "request_id": "AM-REQ-2026-03949",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.761
  },
  {
    "request_id": "AM-REQ-2026-03950",
    "original_inquiry": "Second opinion requested: Child with 镰状细胞贫血; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6464
  },
  {
    "request_id": "AM-REQ-2026-03951",
    "original_inquiry": "Referral from specialist: Urgent consultation: spinal muscular atrophy diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5665
  },
  {
    "request_id": "AM-REQ-2026-03952",
    "original_inquiry": "Family seeking information: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7911
  },
  {
    "request_id": "AM-REQ-2026-03953",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6358
  },
  {
    "request_id": "AM-REQ-2026-03954",
    "original_inquiry": "Referral from specialist: Urgent consultation: sickle cell disease diagnosis, seeking Casgevy / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.831
  },
  {
    "request_id": "AM-REQ-2026-03955",
    "original_inquiry": "家长咨询：患儿确诊SMA基因治疗，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7161
  },
  {
    "request_id": "AM-REQ-2026-03956",
    "original_inquiry": "研究者咨询：Patient with 杜氏肌营养不良; requesting information on SRP-9001 and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7228
  },
  {
    "request_id": "AM-REQ-2026-03957",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6175
  },
  {
    "request_id": "AM-REQ-2026-03958",
    "original_inquiry": "Second opinion requested: Urgent consultation: spinal muscular atrophy diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6015
  },
  {
    "request_id": "AM-REQ-2026-03959",
    "original_inquiry": "Family seeking information: Geneticist referral: sickle cell disease confirmed; exploring gene replacement therapy and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8898
  },
  {
    "request_id": "AM-REQ-2026-03960",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7262
  },
  {
    "request_id": "AM-REQ-2026-03961",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6317
  },
  {
    "request_id": "AM-REQ-2026-03962",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6098
  },
  {
    "request_id": "AM-REQ-2026-03963",
    "original_inquiry": "研究者咨询：Geneticist referral: spinal muscular atrophy confirmed; exploring Casgevy and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6117
  },
  {
    "request_id": "AM-REQ-2026-03964",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA基因治疗 diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5021
  },
  {
    "request_id": "AM-REQ-2026-03965",
    "original_inquiry": "Family seeking information: Patient with Duchenne muscular dystrophy; requesting information on gene replacement therapy and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.614
  },
  {
    "request_id": "AM-REQ-2026-03966",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊beta-thalassemia，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7566
  },
  {
    "request_id": "AM-REQ-2026-03967",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-03968",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on ELEVIDYS and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7133
  },
  {
    "request_id": "AM-REQ-2026-03969",
    "original_inquiry": "研究者咨询：海外求药：杜氏肌营养不良患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7282
  },
  {
    "request_id": "AM-REQ-2026-03970",
    "original_inquiry": "海外求药：spinal muscular atrophy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7616
  },
  {
    "request_id": "AM-REQ-2026-03971",
    "original_inquiry": "Referral from specialist: Child with SMA; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7329
  },
  {
    "request_id": "AM-REQ-2026-03972",
    "original_inquiry": "海外求诊：Patient with beta-thalassemia; requesting information on gene replacement therapy and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6395
  },
  {
    "request_id": "AM-REQ-2026-03973",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring Lyfgenia and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-03974",
    "original_inquiry": "Urgent: Geneticist referral: SMA基因治疗 confirmed; exploring SRP-9001 and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6156
  },
  {
    "request_id": "AM-REQ-2026-03975",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6629
  },
  {
    "request_id": "AM-REQ-2026-03976",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and Zolgensma outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-03977",
    "original_inquiry": "Second opinion requested: Patient with SMA; requesting information on AAV9 and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5573
  },
  {
    "request_id": "AM-REQ-2026-03978",
    "original_inquiry": "Referral from specialist: Urgent consultation: AAV vector diagnosis, seeking Lyfgenia / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6588
  },
  {
    "request_id": "AM-REQ-2026-03979",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7331
  },
  {
    "request_id": "AM-REQ-2026-03980",
    "original_inquiry": "Referral from specialist: 海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.635
  },
  {
    "request_id": "AM-REQ-2026-03981",
    "original_inquiry": "Researcher inquiry: CRISPR疗法 delivery and Casgevy outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7132
  },
  {
    "request_id": "AM-REQ-2026-03982",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊SMA，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-03983",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊杜氏肌营养不良，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8098
  },
  {
    "request_id": "AM-REQ-2026-03984",
    "original_inquiry": "Referral from specialist: Patient with 杜氏肌营养不良; requesting information on exon skipping and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5606
  },
  {
    "request_id": "AM-REQ-2026-03985",
    "original_inquiry": "Second opinion requested: Patient with CRISPR疗法; requesting information on gene replacement therapy and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5448
  },
  {
    "request_id": "AM-REQ-2026-03986",
    "original_inquiry": "海外求诊：海外求药：beta-thalassemia患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6849
  },
  {
    "request_id": "AM-REQ-2026-03987",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on exon skipping and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7272
  },
  {
    "request_id": "AM-REQ-2026-03988",
    "original_inquiry": "研究者咨询：Urgent consultation: gene therapy diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8983
  },
  {
    "request_id": "AM-REQ-2026-03989",
    "original_inquiry": "Family seeking information: Geneticist referral: spinal muscular atrophy confirmed; exploring SRP-9001 and AAV9 trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5188
  },
  {
    "request_id": "AM-REQ-2026-03990",
    "original_inquiry": "Urgent: Urgent consultation: spinal muscular atrophy diagnosis, seeking exon skipping / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5838
  },
  {
    "request_id": "AM-REQ-2026-03991",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8203
  },
  {
    "request_id": "AM-REQ-2026-03992",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on AAV9 and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8306
  },
  {
    "request_id": "AM-REQ-2026-03993",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5781
  },
  {
    "request_id": "AM-REQ-2026-03994",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊镰状细胞贫血，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5882
  },
  {
    "request_id": "AM-REQ-2026-03995",
    "original_inquiry": "Urgent: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Casgevy and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6466
  },
  {
    "request_id": "AM-REQ-2026-03996",
    "original_inquiry": "家长咨询：患儿确诊SMA基因治疗，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6634
  },
  {
    "request_id": "AM-REQ-2026-03997",
    "original_inquiry": "研究者咨询：Geneticist referral: gene therapy confirmed; exploring Lyfgenia and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.583
  },
  {
    "request_id": "AM-REQ-2026-03998",
    "original_inquiry": "Researcher inquiry: 镰状细胞贫血 delivery and ELEVIDYS outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8609
  },
  {
    "request_id": "AM-REQ-2026-03999",
    "original_inquiry": "Urgent: Researcher inquiry: Duchenne muscular dystrophy delivery and SRP-9001 outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6327
  },
  {
    "request_id": "AM-REQ-2026-04000",
    "original_inquiry": "Urgent: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6242
  },
  {
    "request_id": "AM-REQ-2026-04001",
    "original_inquiry": "Urgent: Geneticist referral: AAV vector confirmed; exploring CRISPR-Cas9 and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7111
  },
  {
    "request_id": "AM-REQ-2026-04002",
    "original_inquiry": "Second opinion requested: Geneticist referral: CRISPR疗法 confirmed; exploring AAV9 and Casgevy trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6482
  },
  {
    "request_id": "AM-REQ-2026-04003",
    "original_inquiry": "研究者咨询：Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / Zolgensma availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6441
  },
  {
    "request_id": "AM-REQ-2026-04004",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and Zolgensma outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8398
  },
  {
    "request_id": "AM-REQ-2026-04005",
    "original_inquiry": "研究者咨询：Urgent consultation: sickle cell disease diagnosis, seeking exon skipping / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6157
  },
  {
    "request_id": "AM-REQ-2026-04006",
    "original_inquiry": "海外求诊：Child with SMA; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5072
  },
  {
    "request_id": "AM-REQ-2026-04007",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8329
  },
  {
    "request_id": "AM-REQ-2026-04008",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on Zolgensma and Casgevy access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6092
  },
  {
    "request_id": "AM-REQ-2026-04009",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5854
  },
  {
    "request_id": "AM-REQ-2026-04010",
    "original_inquiry": "研究者咨询：Child with beta-thalassemia; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5945
  },
  {
    "request_id": "AM-REQ-2026-04011",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on Lyfgenia and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8132
  },
  {
    "request_id": "AM-REQ-2026-04012",
    "original_inquiry": "Researcher inquiry: gene therapy delivery and Lyfgenia outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.863
  },
  {
    "request_id": "AM-REQ-2026-04013",
    "original_inquiry": "研究者咨询：Child with CRISPR疗法; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-04014",
    "original_inquiry": "Urgent: Geneticist referral: sickle cell disease confirmed; exploring exon skipping and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5482
  },
  {
    "request_id": "AM-REQ-2026-04015",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7964
  },
  {
    "request_id": "AM-REQ-2026-04016",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6588
  },
  {
    "request_id": "AM-REQ-2026-04017",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring CRISPR-Cas9 and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8137
  },
  {
    "request_id": "AM-REQ-2026-04018",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8859
  },
  {
    "request_id": "AM-REQ-2026-04019",
    "original_inquiry": "Second opinion requested: Patient with beta-thalassemia; requesting information on SRP-9001 and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6444
  },
  {
    "request_id": "AM-REQ-2026-04020",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6366
  },
  {
    "request_id": "AM-REQ-2026-04021",
    "original_inquiry": "Family seeking information: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6007
  },
  {
    "request_id": "AM-REQ-2026-04022",
    "original_inquiry": "海外求诊：Urgent consultation: DMD diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-04023",
    "original_inquiry": "海外求诊：Patient with AAV vector; requesting information on exon skipping and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8572
  },
  {
    "request_id": "AM-REQ-2026-04024",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring exon skipping and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.671
  },
  {
    "request_id": "AM-REQ-2026-04025",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6399
  },
  {
    "request_id": "AM-REQ-2026-04026",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and exon skipping outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8214
  },
  {
    "request_id": "AM-REQ-2026-04027",
    "original_inquiry": "Family seeking information: Researcher inquiry: AAV vector delivery and SRP-9001 outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8333
  },
  {
    "request_id": "AM-REQ-2026-04028",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊sickle cell disease，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8254
  },
  {
    "request_id": "AM-REQ-2026-04029",
    "original_inquiry": "海外求诊：Researcher inquiry: CRISPR疗法 delivery and exon skipping outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5458
  },
  {
    "request_id": "AM-REQ-2026-04030",
    "original_inquiry": "Second opinion requested: 海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5894
  },
  {
    "request_id": "AM-REQ-2026-04031",
    "original_inquiry": "Urgent: Researcher inquiry: SMA delivery and Zolgensma outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8083
  },
  {
    "request_id": "AM-REQ-2026-04032",
    "original_inquiry": "Urgent: Researcher inquiry: AAV vector delivery and ELEVIDYS outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-04033",
    "original_inquiry": "研究者咨询：海外求药：SMA患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7858
  },
  {
    "request_id": "AM-REQ-2026-04034",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5514
  },
  {
    "request_id": "AM-REQ-2026-04035",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8527
  },
  {
    "request_id": "AM-REQ-2026-04036",
    "original_inquiry": "Referral from specialist: Patient with DMD; requesting information on gene replacement therapy and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8767
  },
  {
    "request_id": "AM-REQ-2026-04037",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA基因治疗 diagnosis, seeking SRP-9001 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7936
  },
  {
    "request_id": "AM-REQ-2026-04038",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5366
  },
  {
    "request_id": "AM-REQ-2026-04039",
    "original_inquiry": "Family seeking information: Researcher inquiry: 镰状细胞贫血 delivery and Zolgensma outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8784
  },
  {
    "request_id": "AM-REQ-2026-04040",
    "original_inquiry": "Child with gene therapy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5425
  },
  {
    "request_id": "AM-REQ-2026-04041",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7678
  },
  {
    "request_id": "AM-REQ-2026-04042",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and CRISPR-Cas9 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6482
  },
  {
    "request_id": "AM-REQ-2026-04043",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.775
  },
  {
    "request_id": "AM-REQ-2026-04044",
    "original_inquiry": "Referral from specialist: Urgent consultation: AAV vector diagnosis, seeking ELEVIDYS / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-04045",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and Casgevy outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5677
  },
  {
    "request_id": "AM-REQ-2026-04046",
    "original_inquiry": "家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.86
  },
  {
    "request_id": "AM-REQ-2026-04047",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8458
  },
  {
    "request_id": "AM-REQ-2026-04048",
    "original_inquiry": "研究者咨询：Geneticist referral: sickle cell disease confirmed; exploring Lyfgenia and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7784
  },
  {
    "request_id": "AM-REQ-2026-04049",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8198
  },
  {
    "request_id": "AM-REQ-2026-04050",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring exon skipping and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8249
  },
  {
    "request_id": "AM-REQ-2026-04051",
    "original_inquiry": "Family seeking information: Child with SMA; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6953
  },
  {
    "request_id": "AM-REQ-2026-04052",
    "original_inquiry": "Referral from specialist: Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5893
  },
  {
    "request_id": "AM-REQ-2026-04053",
    "original_inquiry": "Second opinion requested: 海外求药：spinal muscular atrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5649
  },
  {
    "request_id": "AM-REQ-2026-04054",
    "original_inquiry": "Family seeking information: Urgent consultation: sickle cell disease diagnosis, seeking exon skipping / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8807
  },
  {
    "request_id": "AM-REQ-2026-04055",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8855
  },
  {
    "request_id": "AM-REQ-2026-04056",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.66
  },
  {
    "request_id": "AM-REQ-2026-04057",
    "original_inquiry": "Urgent: Patient with SMA基因治疗; requesting information on gene replacement therapy and Zolgensma access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7494
  },
  {
    "request_id": "AM-REQ-2026-04058",
    "original_inquiry": "研究者咨询：Geneticist referral: spinal muscular atrophy confirmed; exploring Zolgensma and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5899
  },
  {
    "request_id": "AM-REQ-2026-04059",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7555
  },
  {
    "request_id": "AM-REQ-2026-04060",
    "original_inquiry": "Second opinion requested: 海外求药：spinal muscular atrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.806
  },
  {
    "request_id": "AM-REQ-2026-04061",
    "original_inquiry": "海外求诊：Patient with Duchenne muscular dystrophy; requesting information on CRISPR-Cas9 and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7868
  },
  {
    "request_id": "AM-REQ-2026-04062",
    "original_inquiry": "Second opinion requested: Urgent consultation: DMD diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8541
  },
  {
    "request_id": "AM-REQ-2026-04063",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊杜氏肌营养不良，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7271
  },
  {
    "request_id": "AM-REQ-2026-04064",
    "original_inquiry": "Family seeking information: Child with beta-thalassemia; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.841
  },
  {
    "request_id": "AM-REQ-2026-04065",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8877
  },
  {
    "request_id": "AM-REQ-2026-04066",
    "original_inquiry": "海外求诊：Researcher inquiry: CRISPR疗法 delivery and Lyfgenia outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5444
  },
  {
    "request_id": "AM-REQ-2026-04067",
    "original_inquiry": "Family seeking information: Urgent consultation: sickle cell disease diagnosis, seeking ELEVIDYS / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-04068",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on gene replacement therapy and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7486
  },
  {
    "request_id": "AM-REQ-2026-04069",
    "original_inquiry": "研究者咨询：Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and Lyfgenia trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5677
  },
  {
    "request_id": "AM-REQ-2026-04070",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring gene replacement therapy and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5847
  },
  {
    "request_id": "AM-REQ-2026-04071",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7055
  },
  {
    "request_id": "AM-REQ-2026-04072",
    "original_inquiry": "研究者咨询：Researcher inquiry: CRISPR疗法 delivery and Zolgensma outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6243
  },
  {
    "request_id": "AM-REQ-2026-04073",
    "original_inquiry": "海外求药：杜氏肌营养不良患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6104
  },
  {
    "request_id": "AM-REQ-2026-04074",
    "original_inquiry": "Second opinion requested: Researcher inquiry: Duchenne muscular dystrophy delivery and exon skipping outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6729
  },
  {
    "request_id": "AM-REQ-2026-04075",
    "original_inquiry": "Second opinion requested: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking gene replacement therapy / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6523
  },
  {
    "request_id": "AM-REQ-2026-04076",
    "original_inquiry": "海外求诊：海外求药：镰状细胞贫血患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8604
  },
  {
    "request_id": "AM-REQ-2026-04077",
    "original_inquiry": "海外求诊：Urgent consultation: AAV vector diagnosis, seeking Zolgensma / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8384
  },
  {
    "request_id": "AM-REQ-2026-04078",
    "original_inquiry": "Family seeking information: Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.657
  },
  {
    "request_id": "AM-REQ-2026-04079",
    "original_inquiry": "Researcher inquiry: gene therapy delivery and Zolgensma outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-04080",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7402
  },
  {
    "request_id": "AM-REQ-2026-04081",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8565
  },
  {
    "request_id": "AM-REQ-2026-04082",
    "original_inquiry": "Referral from specialist: Researcher inquiry: sickle cell disease delivery and Zolgensma outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5847
  },
  {
    "request_id": "AM-REQ-2026-04083",
    "original_inquiry": "海外求诊：海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6493
  },
  {
    "request_id": "AM-REQ-2026-04084",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊DMD，寻求SRP-9001或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7544
  },
  {
    "request_id": "AM-REQ-2026-04085",
    "original_inquiry": "研究者咨询：Researcher inquiry: 杜氏肌营养不良 delivery and exon skipping outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6645
  },
  {
    "request_id": "AM-REQ-2026-04086",
    "original_inquiry": "Urgent: 海外求药：AAV vector患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7786
  },
  {
    "request_id": "AM-REQ-2026-04087",
    "original_inquiry": "Referral from specialist: 海外求药：SMA基因治疗患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7779
  },
  {
    "request_id": "AM-REQ-2026-04088",
    "original_inquiry": "海外求诊：Researcher inquiry: DMD delivery and AAV9 outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8567
  },
  {
    "request_id": "AM-REQ-2026-04089",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on CRISPR-Cas9 and Zolgensma access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7654
  },
  {
    "request_id": "AM-REQ-2026-04090",
    "original_inquiry": "Patient with gene therapy; requesting information on Lyfgenia and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7354
  },
  {
    "request_id": "AM-REQ-2026-04091",
    "original_inquiry": "研究者咨询：海外求药：gene therapy患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.59
  },
  {
    "request_id": "AM-REQ-2026-04092",
    "original_inquiry": "Family seeking information: Patient with SMA基因治疗; requesting information on Casgevy and ELEVIDYS access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5839
  },
  {
    "request_id": "AM-REQ-2026-04093",
    "original_inquiry": "Family seeking information: Urgent consultation: gene therapy diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6748
  },
  {
    "request_id": "AM-REQ-2026-04094",
    "original_inquiry": "研究者咨询：Researcher inquiry: spinal muscular atrophy delivery and ELEVIDYS outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5295
  },
  {
    "request_id": "AM-REQ-2026-04095",
    "original_inquiry": "Second opinion requested: Geneticist referral: gene therapy confirmed; exploring exon skipping and SRP-9001 trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-04096",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5591
  },
  {
    "request_id": "AM-REQ-2026-04097",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8139
  },
  {
    "request_id": "AM-REQ-2026-04098",
    "original_inquiry": "Second opinion requested: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8737
  },
  {
    "request_id": "AM-REQ-2026-04099",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring AAV9 and Lyfgenia trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8567
  },
  {
    "request_id": "AM-REQ-2026-04100",
    "original_inquiry": "Urgent: Child with SMA基因治疗; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.826
  },
  {
    "request_id": "AM-REQ-2026-04101",
    "original_inquiry": "Family seeking information: Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-04102",
    "original_inquiry": "研究者咨询：海外求药：beta-thalassemia患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6707
  },
  {
    "request_id": "AM-REQ-2026-04103",
    "original_inquiry": "Patient with beta-thalassemia; requesting information on SRP-9001 and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.644
  },
  {
    "request_id": "AM-REQ-2026-04104",
    "original_inquiry": "研究者咨询：Child with 杜氏肌营养不良; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.604
  },
  {
    "request_id": "AM-REQ-2026-04105",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring exon skipping and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8575
  },
  {
    "request_id": "AM-REQ-2026-04106",
    "original_inquiry": "研究者咨询：Urgent consultation: 镰状细胞贫血 diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8258
  },
  {
    "request_id": "AM-REQ-2026-04107",
    "original_inquiry": "Urgent: Patient with AAV vector; requesting information on AAV9 and Zolgensma access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-04108",
    "original_inquiry": "Family seeking information: Geneticist referral: 镰状细胞贫血 confirmed; exploring exon skipping and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8569
  },
  {
    "request_id": "AM-REQ-2026-04109",
    "original_inquiry": "Referral from specialist: Geneticist referral: spinal muscular atrophy confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7899
  },
  {
    "request_id": "AM-REQ-2026-04110",
    "original_inquiry": "Referral from specialist: Urgent consultation: AAV vector diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5526
  },
  {
    "request_id": "AM-REQ-2026-04111",
    "original_inquiry": "研究者咨询：Urgent consultation: 镰状细胞贫血 diagnosis, seeking gene replacement therapy / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8141
  },
  {
    "request_id": "AM-REQ-2026-04112",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊镰状细胞贫血，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7305
  },
  {
    "request_id": "AM-REQ-2026-04113",
    "original_inquiry": "Second opinion requested: Child with spinal muscular atrophy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5374
  },
  {
    "request_id": "AM-REQ-2026-04114",
    "original_inquiry": "Patient with spinal muscular atrophy; requesting information on ELEVIDYS and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6679
  },
  {
    "request_id": "AM-REQ-2026-04115",
    "original_inquiry": "Family seeking information: Patient with AAV vector; requesting information on gene replacement therapy and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7063
  },
  {
    "request_id": "AM-REQ-2026-04116",
    "original_inquiry": "Family seeking information: Patient with spinal muscular atrophy; requesting information on ELEVIDYS and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5213
  },
  {
    "request_id": "AM-REQ-2026-04117",
    "original_inquiry": "Second opinion requested: 海外求药：beta-thalassemia患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7504
  },
  {
    "request_id": "AM-REQ-2026-04118",
    "original_inquiry": "Second opinion requested: Geneticist referral: gene therapy confirmed; exploring Casgevy and AAV9 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7801
  },
  {
    "request_id": "AM-REQ-2026-04119",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking Lyfgenia / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7251
  },
  {
    "request_id": "AM-REQ-2026-04120",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8384
  },
  {
    "request_id": "AM-REQ-2026-04121",
    "original_inquiry": "Family seeking information: Urgent consultation: AAV vector diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.638
  },
  {
    "request_id": "AM-REQ-2026-04122",
    "original_inquiry": "Second opinion requested: Patient with SMA基因治疗; requesting information on ELEVIDYS and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6554
  },
  {
    "request_id": "AM-REQ-2026-04123",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.676
  },
  {
    "request_id": "AM-REQ-2026-04124",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring Zolgensma and SRP-9001 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7506
  },
  {
    "request_id": "AM-REQ-2026-04125",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-04126",
    "original_inquiry": "家长咨询：患儿确诊SMA，寻求AAV9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6645
  },
  {
    "request_id": "AM-REQ-2026-04127",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8079
  },
  {
    "request_id": "AM-REQ-2026-04128",
    "original_inquiry": "海外求药：sickle cell disease患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7129
  },
  {
    "request_id": "AM-REQ-2026-04129",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring Casgevy and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5163
  },
  {
    "request_id": "AM-REQ-2026-04130",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring exon skipping and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6811
  },
  {
    "request_id": "AM-REQ-2026-04131",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA基因治疗 delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6674
  },
  {
    "request_id": "AM-REQ-2026-04132",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on AAV9 and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5365
  },
  {
    "request_id": "AM-REQ-2026-04133",
    "original_inquiry": "海外求诊：Researcher inquiry: AAV vector delivery and AAV9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8613
  },
  {
    "request_id": "AM-REQ-2026-04134",
    "original_inquiry": "Second opinion requested: Researcher inquiry: sickle cell disease delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8406
  },
  {
    "request_id": "AM-REQ-2026-04135",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8959
  },
  {
    "request_id": "AM-REQ-2026-04136",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-04137",
    "original_inquiry": "Family seeking information: Patient with spinal muscular atrophy; requesting information on ELEVIDYS and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.86
  },
  {
    "request_id": "AM-REQ-2026-04138",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5733
  },
  {
    "request_id": "AM-REQ-2026-04139",
    "original_inquiry": "海外求诊：Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6106
  },
  {
    "request_id": "AM-REQ-2026-04140",
    "original_inquiry": "Second opinion requested: Urgent consultation: CRISPR疗法 diagnosis, seeking Casgevy / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8439
  },
  {
    "request_id": "AM-REQ-2026-04141",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6102
  },
  {
    "request_id": "AM-REQ-2026-04142",
    "original_inquiry": "研究者咨询：Geneticist referral: gene therapy confirmed; exploring CRISPR-Cas9 and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8874
  },
  {
    "request_id": "AM-REQ-2026-04143",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.826
  },
  {
    "request_id": "AM-REQ-2026-04144",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.795
  },
  {
    "request_id": "AM-REQ-2026-04145",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8302
  },
  {
    "request_id": "AM-REQ-2026-04146",
    "original_inquiry": "Second opinion requested: Urgent consultation: spinal muscular atrophy diagnosis, seeking Casgevy / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6242
  },
  {
    "request_id": "AM-REQ-2026-04147",
    "original_inquiry": "海外求诊：Researcher inquiry: AAV vector delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-04148",
    "original_inquiry": "Referral from specialist: 海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7215
  },
  {
    "request_id": "AM-REQ-2026-04149",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊杜氏肌营养不良，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5657
  },
  {
    "request_id": "AM-REQ-2026-04150",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7893
  },
  {
    "request_id": "AM-REQ-2026-04151",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊gene therapy，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7092
  },
  {
    "request_id": "AM-REQ-2026-04152",
    "original_inquiry": "Urgent consultation: AAV vector diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5293
  },
  {
    "request_id": "AM-REQ-2026-04153",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and SRP-9001 outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.805
  },
  {
    "request_id": "AM-REQ-2026-04154",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking exon skipping / SRP-9001 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.64
  },
  {
    "request_id": "AM-REQ-2026-04155",
    "original_inquiry": "Referral from specialist: 海外求药：DMD患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7282
  },
  {
    "request_id": "AM-REQ-2026-04156",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA基因治疗 diagnosis, seeking Casgevy / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8522
  },
  {
    "request_id": "AM-REQ-2026-04157",
    "original_inquiry": "Urgent: 海外求药：AAV vector患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7831
  },
  {
    "request_id": "AM-REQ-2026-04158",
    "original_inquiry": "Urgent: Child with SMA; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8044
  },
  {
    "request_id": "AM-REQ-2026-04159",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6457
  },
  {
    "request_id": "AM-REQ-2026-04160",
    "original_inquiry": "Family seeking information: Urgent consultation: gene therapy diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7708
  },
  {
    "request_id": "AM-REQ-2026-04161",
    "original_inquiry": "Geneticist referral: 镰状细胞贫血 confirmed; exploring CRISPR-Cas9 and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.757
  },
  {
    "request_id": "AM-REQ-2026-04162",
    "original_inquiry": "Second opinion requested: Researcher inquiry: SMA基因治疗 delivery and Zolgensma outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8673
  },
  {
    "request_id": "AM-REQ-2026-04163",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA confirmed; exploring gene replacement therapy and Lyfgenia trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8907
  },
  {
    "request_id": "AM-REQ-2026-04164",
    "original_inquiry": "Urgent: 海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8837
  },
  {
    "request_id": "AM-REQ-2026-04165",
    "original_inquiry": "海外求诊：Child with CRISPR疗法; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8846
  },
  {
    "request_id": "AM-REQ-2026-04166",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on Lyfgenia and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7024
  },
  {
    "request_id": "AM-REQ-2026-04167",
    "original_inquiry": "Urgent: Child with DMD; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6015
  },
  {
    "request_id": "AM-REQ-2026-04168",
    "original_inquiry": "Referral from specialist: Patient with gene therapy; requesting information on ELEVIDYS and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7427
  },
  {
    "request_id": "AM-REQ-2026-04169",
    "original_inquiry": "研究者咨询：Researcher inquiry: gene therapy delivery and gene replacement therapy outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8352
  },
  {
    "request_id": "AM-REQ-2026-04170",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊spinal muscular atrophy，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6175
  },
  {
    "request_id": "AM-REQ-2026-04171",
    "original_inquiry": "Referral from specialist: 海外求药：AAV vector患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7015
  },
  {
    "request_id": "AM-REQ-2026-04172",
    "original_inquiry": "Second opinion requested: Child with DMD; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5269
  },
  {
    "request_id": "AM-REQ-2026-04173",
    "original_inquiry": "Referral from specialist: Patient with DMD; requesting information on CRISPR-Cas9 and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7256
  },
  {
    "request_id": "AM-REQ-2026-04174",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.666
  },
  {
    "request_id": "AM-REQ-2026-04175",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊CRISPR疗法，寻求ELEVIDYS或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8037
  },
  {
    "request_id": "AM-REQ-2026-04176",
    "original_inquiry": "Researcher inquiry: gene therapy delivery and Casgevy outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.704
  },
  {
    "request_id": "AM-REQ-2026-04177",
    "original_inquiry": "海外求药：sickle cell disease患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8375
  },
  {
    "request_id": "AM-REQ-2026-04178",
    "original_inquiry": "Second opinion requested: Urgent consultation: spinal muscular atrophy diagnosis, seeking Casgevy / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6381
  },
  {
    "request_id": "AM-REQ-2026-04179",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7337
  },
  {
    "request_id": "AM-REQ-2026-04180",
    "original_inquiry": "家长咨询：患儿确诊SMA，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7002
  },
  {
    "request_id": "AM-REQ-2026-04181",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and Lyfgenia trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5788
  },
  {
    "request_id": "AM-REQ-2026-04182",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6003
  },
  {
    "request_id": "AM-REQ-2026-04183",
    "original_inquiry": "Patient with SMA; requesting information on Zolgensma and Casgevy access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5596
  },
  {
    "request_id": "AM-REQ-2026-04184",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6339
  },
  {
    "request_id": "AM-REQ-2026-04185",
    "original_inquiry": "海外求诊：Researcher inquiry: AAV vector delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7022
  },
  {
    "request_id": "AM-REQ-2026-04186",
    "original_inquiry": "Urgent: 海外求药：Duchenne muscular dystrophy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.835
  },
  {
    "request_id": "AM-REQ-2026-04187",
    "original_inquiry": "海外求诊：Urgent consultation: SMA基因治疗 diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7362
  },
  {
    "request_id": "AM-REQ-2026-04188",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6286
  },
  {
    "request_id": "AM-REQ-2026-04189",
    "original_inquiry": "研究者咨询：Geneticist referral: beta-thalassemia confirmed; exploring CRISPR-Cas9 and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8478
  },
  {
    "request_id": "AM-REQ-2026-04190",
    "original_inquiry": "Patient with beta-thalassemia; requesting information on exon skipping and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7607
  },
  {
    "request_id": "AM-REQ-2026-04191",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; requesting information on AAV9 and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7107
  },
  {
    "request_id": "AM-REQ-2026-04192",
    "original_inquiry": "Second opinion requested: Urgent consultation: CRISPR疗法 diagnosis, seeking gene replacement therapy / Lyfgenia availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.511
  },
  {
    "request_id": "AM-REQ-2026-04193",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and Zolgensma outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8345
  },
  {
    "request_id": "AM-REQ-2026-04194",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8724
  },
  {
    "request_id": "AM-REQ-2026-04195",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊镰状细胞贫血，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6943
  },
  {
    "request_id": "AM-REQ-2026-04196",
    "original_inquiry": "海外求诊：Researcher inquiry: spinal muscular atrophy delivery and exon skipping outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.708
  },
  {
    "request_id": "AM-REQ-2026-04197",
    "original_inquiry": "海外求诊：海外求药：spinal muscular atrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.809
  },
  {
    "request_id": "AM-REQ-2026-04198",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.738
  },
  {
    "request_id": "AM-REQ-2026-04199",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and Zolgensma outcomes in AAV9; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5305
  },
  {
    "request_id": "AM-REQ-2026-04200",
    "original_inquiry": "Second opinion requested: Patient with spinal muscular atrophy; requesting information on Casgevy and Zolgensma access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-04201",
    "original_inquiry": "Referral from specialist: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Lyfgenia / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.87
  },
  {
    "request_id": "AM-REQ-2026-04202",
    "original_inquiry": "Family seeking information: Patient with DMD; requesting information on SRP-9001 and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8
  },
  {
    "request_id": "AM-REQ-2026-04203",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8674
  },
  {
    "request_id": "AM-REQ-2026-04204",
    "original_inquiry": "Second opinion requested: Child with spinal muscular atrophy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-04205",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊CRISPR疗法，寻求SRP-9001或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8293
  },
  {
    "request_id": "AM-REQ-2026-04206",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA delivery and gene replacement therapy outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5979
  },
  {
    "request_id": "AM-REQ-2026-04207",
    "original_inquiry": "Family seeking information: Child with CRISPR疗法; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8148
  },
  {
    "request_id": "AM-REQ-2026-04208",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求Lyfgenia或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5678
  },
  {
    "request_id": "AM-REQ-2026-04209",
    "original_inquiry": "研究者咨询：Researcher inquiry: sickle cell disease delivery and ELEVIDYS outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6445
  },
  {
    "request_id": "AM-REQ-2026-04210",
    "original_inquiry": "海外求药：CRISPR疗法患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7139
  },
  {
    "request_id": "AM-REQ-2026-04211",
    "original_inquiry": "Referral from specialist: Researcher inquiry: DMD delivery and AAV9 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5755
  },
  {
    "request_id": "AM-REQ-2026-04212",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊DMD，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.616
  },
  {
    "request_id": "AM-REQ-2026-04213",
    "original_inquiry": "Urgent: Urgent consultation: DMD diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7812
  },
  {
    "request_id": "AM-REQ-2026-04214",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6961
  },
  {
    "request_id": "AM-REQ-2026-04215",
    "original_inquiry": "研究者咨询：Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.883
  },
  {
    "request_id": "AM-REQ-2026-04216",
    "original_inquiry": "海外求诊：Researcher inquiry: sickle cell disease delivery and AAV9 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6424
  },
  {
    "request_id": "AM-REQ-2026-04217",
    "original_inquiry": "Urgent: Researcher inquiry: sickle cell disease delivery and ELEVIDYS outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.531
  },
  {
    "request_id": "AM-REQ-2026-04218",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊gene therapy，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5684
  },
  {
    "request_id": "AM-REQ-2026-04219",
    "original_inquiry": "Urgent: 海外求药：镰状细胞贫血患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6977
  },
  {
    "request_id": "AM-REQ-2026-04220",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 镰状细胞贫血 delivery and Zolgensma outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.657
  },
  {
    "request_id": "AM-REQ-2026-04221",
    "original_inquiry": "Family seeking information: 海外求药：gene therapy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7903
  },
  {
    "request_id": "AM-REQ-2026-04222",
    "original_inquiry": "Referral from specialist: Urgent consultation: beta-thalassemia diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6429
  },
  {
    "request_id": "AM-REQ-2026-04223",
    "original_inquiry": "Urgent consultation: SMA基因治疗 diagnosis, seeking exon skipping / SRP-9001 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8461
  },
  {
    "request_id": "AM-REQ-2026-04224",
    "original_inquiry": "研究者咨询：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Casgevy / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5966
  },
  {
    "request_id": "AM-REQ-2026-04225",
    "original_inquiry": "Urgent: Child with beta-thalassemia; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7991
  },
  {
    "request_id": "AM-REQ-2026-04226",
    "original_inquiry": "研究者咨询：Patient with beta-thalassemia; requesting information on ELEVIDYS and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5856
  },
  {
    "request_id": "AM-REQ-2026-04227",
    "original_inquiry": "海外求药：镰状细胞贫血患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8212
  },
  {
    "request_id": "AM-REQ-2026-04228",
    "original_inquiry": "海外求诊：海外求药：beta-thalassemia患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5013
  },
  {
    "request_id": "AM-REQ-2026-04229",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5332
  },
  {
    "request_id": "AM-REQ-2026-04230",
    "original_inquiry": "Referral from specialist: 海外求药：杜氏肌营养不良患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6805
  },
  {
    "request_id": "AM-REQ-2026-04231",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5594
  },
  {
    "request_id": "AM-REQ-2026-04232",
    "original_inquiry": "Urgent consultation: 镰状细胞贫血 diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7115
  },
  {
    "request_id": "AM-REQ-2026-04233",
    "original_inquiry": "Family seeking information: Urgent consultation: AAV vector diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7094
  },
  {
    "request_id": "AM-REQ-2026-04234",
    "original_inquiry": "Second opinion requested: Patient with DMD; requesting information on CRISPR-Cas9 and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7425
  },
  {
    "request_id": "AM-REQ-2026-04235",
    "original_inquiry": "Referral from specialist: Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-04236",
    "original_inquiry": "Geneticist referral: spinal muscular atrophy confirmed; exploring exon skipping and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6116
  },
  {
    "request_id": "AM-REQ-2026-04237",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on Lyfgenia and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8245
  },
  {
    "request_id": "AM-REQ-2026-04238",
    "original_inquiry": "Urgent: Patient with Duchenne muscular dystrophy; requesting information on exon skipping and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6354
  },
  {
    "request_id": "AM-REQ-2026-04239",
    "original_inquiry": "Second opinion requested: Geneticist referral: spinal muscular atrophy confirmed; exploring AAV9 and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5647
  },
  {
    "request_id": "AM-REQ-2026-04240",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on gene replacement therapy and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7307
  },
  {
    "request_id": "AM-REQ-2026-04241",
    "original_inquiry": "海外求诊：Researcher inquiry: sickle cell disease delivery and gene replacement therapy outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8308
  },
  {
    "request_id": "AM-REQ-2026-04242",
    "original_inquiry": "Family seeking information: Geneticist referral: beta-thalassemia confirmed; exploring CRISPR-Cas9 and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5171
  },
  {
    "request_id": "AM-REQ-2026-04243",
    "original_inquiry": "海外求药：AAV vector患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6827
  },
  {
    "request_id": "AM-REQ-2026-04244",
    "original_inquiry": "Second opinion requested: Urgent consultation: beta-thalassemia diagnosis, seeking AAV9 / SRP-9001 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8317
  },
  {
    "request_id": "AM-REQ-2026-04245",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊AAV vector，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6361
  },
  {
    "request_id": "AM-REQ-2026-04246",
    "original_inquiry": "Referral from specialist: Researcher inquiry: CRISPR疗法 delivery and Casgevy outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5594
  },
  {
    "request_id": "AM-REQ-2026-04247",
    "original_inquiry": "研究者咨询：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8329
  },
  {
    "request_id": "AM-REQ-2026-04248",
    "original_inquiry": "Urgent: Researcher inquiry: 杜氏肌营养不良 delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8697
  },
  {
    "request_id": "AM-REQ-2026-04249",
    "original_inquiry": "海外求诊：Geneticist referral: DMD confirmed; exploring Casgevy and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6517
  },
  {
    "request_id": "AM-REQ-2026-04250",
    "original_inquiry": "Referral from specialist: Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7125
  },
  {
    "request_id": "AM-REQ-2026-04251",
    "original_inquiry": "Referral from specialist: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7396
  },
  {
    "request_id": "AM-REQ-2026-04252",
    "original_inquiry": "海外求诊：Geneticist referral: 杜氏肌营养不良 confirmed; exploring CRISPR-Cas9 and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6024
  },
  {
    "request_id": "AM-REQ-2026-04253",
    "original_inquiry": "海外求诊：Geneticist referral: gene therapy confirmed; exploring CRISPR-Cas9 and SRP-9001 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7618
  },
  {
    "request_id": "AM-REQ-2026-04254",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6021
  },
  {
    "request_id": "AM-REQ-2026-04255",
    "original_inquiry": "Referral from specialist: Urgent consultation: 镰状细胞贫血 diagnosis, seeking exon skipping / SRP-9001 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.597
  },
  {
    "request_id": "AM-REQ-2026-04256",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊CRISPR疗法，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6231
  },
  {
    "request_id": "AM-REQ-2026-04257",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.879
  },
  {
    "request_id": "AM-REQ-2026-04258",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6732
  },
  {
    "request_id": "AM-REQ-2026-04259",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring SRP-9001 and AAV9 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7441
  },
  {
    "request_id": "AM-REQ-2026-04260",
    "original_inquiry": "研究者咨询：Urgent consultation: 镰状细胞贫血 diagnosis, seeking Casgevy / AAV9 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7455
  },
  {
    "request_id": "AM-REQ-2026-04261",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on Zolgensma and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6386
  },
  {
    "request_id": "AM-REQ-2026-04262",
    "original_inquiry": "Second opinion requested: 海外求药：CRISPR疗法患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5411
  },
  {
    "request_id": "AM-REQ-2026-04263",
    "original_inquiry": "研究者咨询：Patient with CRISPR疗法; requesting information on Lyfgenia and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6594
  },
  {
    "request_id": "AM-REQ-2026-04264",
    "original_inquiry": "Referral from specialist: 海外求药：Duchenne muscular dystrophy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6935
  },
  {
    "request_id": "AM-REQ-2026-04265",
    "original_inquiry": "Referral from specialist: Urgent consultation: DMD diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6601
  },
  {
    "request_id": "AM-REQ-2026-04266",
    "original_inquiry": "Second opinion requested: Researcher inquiry: sickle cell disease delivery and Zolgensma outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5019
  },
  {
    "request_id": "AM-REQ-2026-04267",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊sickle cell disease，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-04268",
    "original_inquiry": "Family seeking information: Geneticist referral: DMD confirmed; exploring Lyfgenia and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5569
  },
  {
    "request_id": "AM-REQ-2026-04269",
    "original_inquiry": "海外求药：CRISPR疗法患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7378
  },
  {
    "request_id": "AM-REQ-2026-04270",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊beta-thalassemia，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8387
  },
  {
    "request_id": "AM-REQ-2026-04271",
    "original_inquiry": "Second opinion requested: Geneticist referral: spinal muscular atrophy confirmed; exploring Casgevy and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7181
  },
  {
    "request_id": "AM-REQ-2026-04272",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8191
  },
  {
    "request_id": "AM-REQ-2026-04273",
    "original_inquiry": "Referral from specialist: Patient with 杜氏肌营养不良; requesting information on ELEVIDYS and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5732
  },
  {
    "request_id": "AM-REQ-2026-04274",
    "original_inquiry": "研究者咨询：Child with beta-thalassemia; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8505
  },
  {
    "request_id": "AM-REQ-2026-04275",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on SRP-9001 and Lyfgenia access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7973
  },
  {
    "request_id": "AM-REQ-2026-04276",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7172
  },
  {
    "request_id": "AM-REQ-2026-04277",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6163
  },
  {
    "request_id": "AM-REQ-2026-04278",
    "original_inquiry": "研究者咨询：Child with 镰状细胞贫血; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.609
  },
  {
    "request_id": "AM-REQ-2026-04279",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊CRISPR疗法，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6575
  },
  {
    "request_id": "AM-REQ-2026-04280",
    "original_inquiry": "Second opinion requested: Patient with spinal muscular atrophy; requesting information on ELEVIDYS and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7009
  },
  {
    "request_id": "AM-REQ-2026-04281",
    "original_inquiry": "研究者咨询：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking AAV9 / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-04282",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking exon skipping / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8595
  },
  {
    "request_id": "AM-REQ-2026-04283",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7076
  },
  {
    "request_id": "AM-REQ-2026-04284",
    "original_inquiry": "Researcher inquiry: beta-thalassemia delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5411
  },
  {
    "request_id": "AM-REQ-2026-04285",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊beta-thalassemia，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5586
  },
  {
    "request_id": "AM-REQ-2026-04286",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊spinal muscular atrophy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.781
  },
  {
    "request_id": "AM-REQ-2026-04287",
    "original_inquiry": "Second opinion requested: Researcher inquiry: beta-thalassemia delivery and Zolgensma outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6015
  },
  {
    "request_id": "AM-REQ-2026-04288",
    "original_inquiry": "Patient with DMD; requesting information on exon skipping and Lyfgenia access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5838
  },
  {
    "request_id": "AM-REQ-2026-04289",
    "original_inquiry": "Patient with Duchenne muscular dystrophy; requesting information on Casgevy and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6729
  },
  {
    "request_id": "AM-REQ-2026-04290",
    "original_inquiry": "Patient with spinal muscular atrophy; requesting information on Casgevy and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5834
  },
  {
    "request_id": "AM-REQ-2026-04291",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7796
  },
  {
    "request_id": "AM-REQ-2026-04292",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5267
  },
  {
    "request_id": "AM-REQ-2026-04293",
    "original_inquiry": "Referral from specialist: 海外求药：SMA基因治疗患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8157
  },
  {
    "request_id": "AM-REQ-2026-04294",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking SRP-9001 / AAV9 availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7945
  },
  {
    "request_id": "AM-REQ-2026-04295",
    "original_inquiry": "海外求诊：Patient with spinal muscular atrophy; requesting information on Lyfgenia and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6614
  },
  {
    "request_id": "AM-REQ-2026-04296",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5081
  },
  {
    "request_id": "AM-REQ-2026-04297",
    "original_inquiry": "Referral from specialist: Urgent consultation: sickle cell disease diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7103
  },
  {
    "request_id": "AM-REQ-2026-04298",
    "original_inquiry": "海外求诊：Child with DMD; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6816
  },
  {
    "request_id": "AM-REQ-2026-04299",
    "original_inquiry": "研究者咨询：Geneticist referral: gene therapy confirmed; exploring gene replacement therapy and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7289
  },
  {
    "request_id": "AM-REQ-2026-04300",
    "original_inquiry": "Referral from specialist: 海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-04301",
    "original_inquiry": "海外求诊：Geneticist referral: sickle cell disease confirmed; exploring Zolgensma and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7886
  },
  {
    "request_id": "AM-REQ-2026-04302",
    "original_inquiry": "Second opinion requested: 海外求药：SMA患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8984
  },
  {
    "request_id": "AM-REQ-2026-04303",
    "original_inquiry": "Urgent: Geneticist referral: CRISPR疗法 confirmed; exploring Zolgensma and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6816
  },
  {
    "request_id": "AM-REQ-2026-04304",
    "original_inquiry": "Urgent: 海外求药：beta-thalassemia患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7793
  },
  {
    "request_id": "AM-REQ-2026-04305",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7824
  },
  {
    "request_id": "AM-REQ-2026-04306",
    "original_inquiry": "Child with 杜氏肌营养不良; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5785
  },
  {
    "request_id": "AM-REQ-2026-04307",
    "original_inquiry": "海外求诊：海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6728
  },
  {
    "request_id": "AM-REQ-2026-04308",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7062
  },
  {
    "request_id": "AM-REQ-2026-04309",
    "original_inquiry": "海外求诊：Urgent consultation: AAV vector diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7423
  },
  {
    "request_id": "AM-REQ-2026-04310",
    "original_inquiry": "研究者咨询：Patient with gene therapy; requesting information on Casgevy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8864
  },
  {
    "request_id": "AM-REQ-2026-04311",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5004
  },
  {
    "request_id": "AM-REQ-2026-04312",
    "original_inquiry": "Urgent: Patient with sickle cell disease; requesting information on Casgevy and AAV9 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8741
  },
  {
    "request_id": "AM-REQ-2026-04313",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7479
  },
  {
    "request_id": "AM-REQ-2026-04314",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8728
  },
  {
    "request_id": "AM-REQ-2026-04315",
    "original_inquiry": "Referral from specialist: Researcher inquiry: sickle cell disease delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8189
  },
  {
    "request_id": "AM-REQ-2026-04316",
    "original_inquiry": "研究者咨询：Urgent consultation: AAV vector diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5599
  },
  {
    "request_id": "AM-REQ-2026-04317",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5188
  },
  {
    "request_id": "AM-REQ-2026-04318",
    "original_inquiry": "研究者咨询：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5693
  },
  {
    "request_id": "AM-REQ-2026-04319",
    "original_inquiry": "Referral from specialist: Patient with CRISPR疗法; requesting information on gene replacement therapy and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6065
  },
  {
    "request_id": "AM-REQ-2026-04320",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking Casgevy / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-04321",
    "original_inquiry": "海外求诊：Urgent consultation: 杜氏肌营养不良 diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.872
  },
  {
    "request_id": "AM-REQ-2026-04322",
    "original_inquiry": "Referral from specialist: Urgent consultation: gene therapy diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8842
  },
  {
    "request_id": "AM-REQ-2026-04323",
    "original_inquiry": "Urgent: 海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7947
  },
  {
    "request_id": "AM-REQ-2026-04324",
    "original_inquiry": "Referral from specialist: Child with 镰状细胞贫血; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6758
  },
  {
    "request_id": "AM-REQ-2026-04325",
    "original_inquiry": "Patient with sickle cell disease; requesting information on gene replacement therapy and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6773
  },
  {
    "request_id": "AM-REQ-2026-04326",
    "original_inquiry": "研究者咨询：Researcher inquiry: 杜氏肌营养不良 delivery and gene replacement therapy outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5373
  },
  {
    "request_id": "AM-REQ-2026-04327",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊DMD，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6405
  },
  {
    "request_id": "AM-REQ-2026-04328",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA基因治疗 diagnosis, seeking Zolgensma / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8718
  },
  {
    "request_id": "AM-REQ-2026-04329",
    "original_inquiry": "研究者咨询：Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.898
  },
  {
    "request_id": "AM-REQ-2026-04330",
    "original_inquiry": "Family seeking information: Geneticist referral: sickle cell disease confirmed; exploring gene replacement therapy and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6121
  },
  {
    "request_id": "AM-REQ-2026-04331",
    "original_inquiry": "研究者咨询：海外求药：AAV vector患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8049
  },
  {
    "request_id": "AM-REQ-2026-04332",
    "original_inquiry": "研究者咨询：海外求药：Duchenne muscular dystrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.665
  },
  {
    "request_id": "AM-REQ-2026-04333",
    "original_inquiry": "海外求诊：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-04334",
    "original_inquiry": "Urgent: Geneticist referral: CRISPR疗法 confirmed; exploring Lyfgenia and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-04335",
    "original_inquiry": "Referral from specialist: Child with Duchenne muscular dystrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.542
  },
  {
    "request_id": "AM-REQ-2026-04336",
    "original_inquiry": "Urgent consultation: DMD diagnosis, seeking SRP-9001 / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7928
  },
  {
    "request_id": "AM-REQ-2026-04337",
    "original_inquiry": "Urgent: 海外求药：杜氏肌营养不良患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7705
  },
  {
    "request_id": "AM-REQ-2026-04338",
    "original_inquiry": "Urgent consultation: DMD diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6867
  },
  {
    "request_id": "AM-REQ-2026-04339",
    "original_inquiry": "Second opinion requested: Geneticist referral: SMA基因治疗 confirmed; exploring exon skipping and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6483
  },
  {
    "request_id": "AM-REQ-2026-04340",
    "original_inquiry": "海外求诊：Urgent consultation: spinal muscular atrophy diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5405
  },
  {
    "request_id": "AM-REQ-2026-04341",
    "original_inquiry": "海外求诊：Patient with CRISPR疗法; requesting information on AAV9 and Lyfgenia access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8986
  },
  {
    "request_id": "AM-REQ-2026-04342",
    "original_inquiry": "Researcher inquiry: beta-thalassemia delivery and gene replacement therapy outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7113
  },
  {
    "request_id": "AM-REQ-2026-04343",
    "original_inquiry": "Referral from specialist: Patient with gene therapy; requesting information on Lyfgenia and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8635
  },
  {
    "request_id": "AM-REQ-2026-04344",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.641
  },
  {
    "request_id": "AM-REQ-2026-04345",
    "original_inquiry": "Researcher inquiry: 杜氏肌营养不良 delivery and SRP-9001 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7196
  },
  {
    "request_id": "AM-REQ-2026-04346",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6957
  },
  {
    "request_id": "AM-REQ-2026-04347",
    "original_inquiry": "Researcher inquiry: CRISPR疗法 delivery and SRP-9001 outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5392
  },
  {
    "request_id": "AM-REQ-2026-04348",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7776
  },
  {
    "request_id": "AM-REQ-2026-04349",
    "original_inquiry": "Family seeking information: Urgent consultation: gene therapy diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7874
  },
  {
    "request_id": "AM-REQ-2026-04350",
    "original_inquiry": "Second opinion requested: 海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6554
  },
  {
    "request_id": "AM-REQ-2026-04351",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5205
  },
  {
    "request_id": "AM-REQ-2026-04352",
    "original_inquiry": "Family seeking information: Urgent consultation: 镰状细胞贫血 diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5036
  },
  {
    "request_id": "AM-REQ-2026-04353",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7896
  },
  {
    "request_id": "AM-REQ-2026-04354",
    "original_inquiry": "研究者咨询：Child with DMD; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8587
  },
  {
    "request_id": "AM-REQ-2026-04355",
    "original_inquiry": "研究者咨询：Child with AAV vector; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7853
  },
  {
    "request_id": "AM-REQ-2026-04356",
    "original_inquiry": "Second opinion requested: Patient with spinal muscular atrophy; requesting information on gene replacement therapy and Lyfgenia access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5805
  },
  {
    "request_id": "AM-REQ-2026-04357",
    "original_inquiry": "Family seeking information: 海外求药：SMA基因治疗患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5426
  },
  {
    "request_id": "AM-REQ-2026-04358",
    "original_inquiry": "Referral from specialist: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking exon skipping / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5509
  },
  {
    "request_id": "AM-REQ-2026-04359",
    "original_inquiry": "研究者咨询：Child with Duchenne muscular dystrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5478
  },
  {
    "request_id": "AM-REQ-2026-04360",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7044
  },
  {
    "request_id": "AM-REQ-2026-04361",
    "original_inquiry": "Urgent: Child with SMA基因治疗; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5546
  },
  {
    "request_id": "AM-REQ-2026-04362",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and ELEVIDYS outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5626
  },
  {
    "request_id": "AM-REQ-2026-04363",
    "original_inquiry": "海外求诊：Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8398
  },
  {
    "request_id": "AM-REQ-2026-04364",
    "original_inquiry": "Referral from specialist: Patient with SMA; requesting information on SRP-9001 and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-04365",
    "original_inquiry": "Urgent: Researcher inquiry: SMA基因治疗 delivery and Casgevy outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6281
  },
  {
    "request_id": "AM-REQ-2026-04366",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking exon skipping / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5862
  },
  {
    "request_id": "AM-REQ-2026-04367",
    "original_inquiry": "Referral from specialist: Urgent consultation: DMD diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8548
  },
  {
    "request_id": "AM-REQ-2026-04368",
    "original_inquiry": "海外求诊：Urgent consultation: SMA基因治疗 diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5067
  },
  {
    "request_id": "AM-REQ-2026-04369",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊gene therapy，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6541
  },
  {
    "request_id": "AM-REQ-2026-04370",
    "original_inquiry": "海外求诊：Geneticist referral: SMA confirmed; exploring Zolgensma and AAV9 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8761
  },
  {
    "request_id": "AM-REQ-2026-04371",
    "original_inquiry": "Urgent: Urgent consultation: sickle cell disease diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5888
  },
  {
    "request_id": "AM-REQ-2026-04372",
    "original_inquiry": "海外求药：SMA患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7073
  },
  {
    "request_id": "AM-REQ-2026-04373",
    "original_inquiry": "海外求诊：Urgent consultation: DMD diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6994
  },
  {
    "request_id": "AM-REQ-2026-04374",
    "original_inquiry": "研究者咨询：Patient with DMD; requesting information on exon skipping and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6833
  },
  {
    "request_id": "AM-REQ-2026-04375",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5855
  },
  {
    "request_id": "AM-REQ-2026-04376",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on Casgevy and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6369
  },
  {
    "request_id": "AM-REQ-2026-04377",
    "original_inquiry": "Urgent: 海外求药：Duchenne muscular dystrophy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8399
  },
  {
    "request_id": "AM-REQ-2026-04378",
    "original_inquiry": "家长咨询：患儿确诊CRISPR疗法，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8116
  },
  {
    "request_id": "AM-REQ-2026-04379",
    "original_inquiry": "Second opinion requested: Researcher inquiry: SMA基因治疗 delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6482
  },
  {
    "request_id": "AM-REQ-2026-04380",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.511
  },
  {
    "request_id": "AM-REQ-2026-04381",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊AAV vector，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5516
  },
  {
    "request_id": "AM-REQ-2026-04382",
    "original_inquiry": "Referral from specialist: Geneticist referral: 镰状细胞贫血 confirmed; exploring AAV9 and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8074
  },
  {
    "request_id": "AM-REQ-2026-04383",
    "original_inquiry": "Referral from specialist: Urgent consultation: 镰状细胞贫血 diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5697
  },
  {
    "request_id": "AM-REQ-2026-04384",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6024
  },
  {
    "request_id": "AM-REQ-2026-04385",
    "original_inquiry": "Family seeking information: Patient with 镰状细胞贫血; requesting information on AAV9 and Zolgensma access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8599
  },
  {
    "request_id": "AM-REQ-2026-04386",
    "original_inquiry": "海外求诊：Child with spinal muscular atrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5067
  },
  {
    "request_id": "AM-REQ-2026-04387",
    "original_inquiry": "Family seeking information: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking AAV9 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8983
  },
  {
    "request_id": "AM-REQ-2026-04388",
    "original_inquiry": "Referral from specialist: Patient with Duchenne muscular dystrophy; requesting information on Casgevy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8603
  },
  {
    "request_id": "AM-REQ-2026-04389",
    "original_inquiry": "Second opinion requested: Urgent consultation: sickle cell disease diagnosis, seeking Zolgensma / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5488
  },
  {
    "request_id": "AM-REQ-2026-04390",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5831
  },
  {
    "request_id": "AM-REQ-2026-04391",
    "original_inquiry": "Referral from specialist: 海外求药：AAV vector患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8704
  },
  {
    "request_id": "AM-REQ-2026-04392",
    "original_inquiry": "Urgent consultation: 镰状细胞贫血 diagnosis, seeking Casgevy / Zolgensma availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8612
  },
  {
    "request_id": "AM-REQ-2026-04393",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊DMD，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5253
  },
  {
    "request_id": "AM-REQ-2026-04394",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6227
  },
  {
    "request_id": "AM-REQ-2026-04395",
    "original_inquiry": "Second opinion requested: Researcher inquiry: beta-thalassemia delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7493
  },
  {
    "request_id": "AM-REQ-2026-04396",
    "original_inquiry": "Second opinion requested: 海外求药：gene therapy患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.822
  },
  {
    "request_id": "AM-REQ-2026-04397",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求gene replacement therapy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8648
  },
  {
    "request_id": "AM-REQ-2026-04398",
    "original_inquiry": "研究者咨询：Child with spinal muscular atrophy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7598
  },
  {
    "request_id": "AM-REQ-2026-04399",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6753
  },
  {
    "request_id": "AM-REQ-2026-04400",
    "original_inquiry": "家长咨询：患儿确诊sickle cell disease，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5662
  },
  {
    "request_id": "AM-REQ-2026-04401",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring exon skipping and SRP-9001 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8814
  },
  {
    "request_id": "AM-REQ-2026-04402",
    "original_inquiry": "海外求药：DMD患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.888
  },
  {
    "request_id": "AM-REQ-2026-04403",
    "original_inquiry": "家长咨询：患儿确诊SMA，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8496
  },
  {
    "request_id": "AM-REQ-2026-04404",
    "original_inquiry": "海外求药：AAV vector患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5056
  },
  {
    "request_id": "AM-REQ-2026-04405",
    "original_inquiry": "Urgent consultation: spinal muscular atrophy diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5104
  },
  {
    "request_id": "AM-REQ-2026-04406",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6004
  },
  {
    "request_id": "AM-REQ-2026-04407",
    "original_inquiry": "研究者咨询：Child with spinal muscular atrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8267
  },
  {
    "request_id": "AM-REQ-2026-04408",
    "original_inquiry": "Referral from specialist: Patient with AAV vector; requesting information on AAV9 and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-04409",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8212
  },
  {
    "request_id": "AM-REQ-2026-04410",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8214
  },
  {
    "request_id": "AM-REQ-2026-04411",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊spinal muscular atrophy，寻求Lyfgenia或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5715
  },
  {
    "request_id": "AM-REQ-2026-04412",
    "original_inquiry": "Urgent: Urgent consultation: AAV vector diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8954
  },
  {
    "request_id": "AM-REQ-2026-04413",
    "original_inquiry": "Family seeking information: 海外求药：SMA基因治疗患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5739
  },
  {
    "request_id": "AM-REQ-2026-04414",
    "original_inquiry": "Second opinion requested: Child with CRISPR疗法; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-04415",
    "original_inquiry": "研究者咨询：Researcher inquiry: DMD delivery and SRP-9001 outcomes in AAV9; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6774
  },
  {
    "request_id": "AM-REQ-2026-04416",
    "original_inquiry": "Patient with AAV vector; requesting information on AAV9 and Casgevy access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7369
  },
  {
    "request_id": "AM-REQ-2026-04417",
    "original_inquiry": "Geneticist referral: gene therapy confirmed; exploring gene replacement therapy and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6605
  },
  {
    "request_id": "AM-REQ-2026-04418",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.689
  },
  {
    "request_id": "AM-REQ-2026-04419",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5089
  },
  {
    "request_id": "AM-REQ-2026-04420",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊beta-thalassemia，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-04421",
    "original_inquiry": "Urgent: 海外求药：DMD患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6346
  },
  {
    "request_id": "AM-REQ-2026-04422",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on exon skipping and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5435
  },
  {
    "request_id": "AM-REQ-2026-04423",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊SMA，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-04424",
    "original_inquiry": "Second opinion requested: Geneticist referral: 镰状细胞贫血 confirmed; exploring Lyfgenia and AAV9 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5494
  },
  {
    "request_id": "AM-REQ-2026-04425",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊DMD，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5337
  },
  {
    "request_id": "AM-REQ-2026-04426",
    "original_inquiry": "Family seeking information: 海外求药：Duchenne muscular dystrophy患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8216
  },
  {
    "request_id": "AM-REQ-2026-04427",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7601
  },
  {
    "request_id": "AM-REQ-2026-04428",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6881
  },
  {
    "request_id": "AM-REQ-2026-04429",
    "original_inquiry": "Urgent: Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in AAV9; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6114
  },
  {
    "request_id": "AM-REQ-2026-04430",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6646
  },
  {
    "request_id": "AM-REQ-2026-04431",
    "original_inquiry": "Geneticist referral: SMA基因治疗 confirmed; exploring Casgevy and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5166
  },
  {
    "request_id": "AM-REQ-2026-04432",
    "original_inquiry": "Family seeking information: 海外求药：杜氏肌营养不良患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.843
  },
  {
    "request_id": "AM-REQ-2026-04433",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊spinal muscular atrophy，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5639
  },
  {
    "request_id": "AM-REQ-2026-04434",
    "original_inquiry": "Referral from specialist: Urgent consultation: sickle cell disease diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5484
  },
  {
    "request_id": "AM-REQ-2026-04435",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6121
  },
  {
    "request_id": "AM-REQ-2026-04436",
    "original_inquiry": "Second opinion requested: Urgent consultation: sickle cell disease diagnosis, seeking Zolgensma / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8511
  },
  {
    "request_id": "AM-REQ-2026-04437",
    "original_inquiry": "Referral from specialist: Geneticist referral: SMA基因治疗 confirmed; exploring exon skipping and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7243
  },
  {
    "request_id": "AM-REQ-2026-04438",
    "original_inquiry": "研究者咨询：海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7822
  },
  {
    "request_id": "AM-REQ-2026-04439",
    "original_inquiry": "Urgent: Child with beta-thalassemia; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6922
  },
  {
    "request_id": "AM-REQ-2026-04440",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.712
  },
  {
    "request_id": "AM-REQ-2026-04441",
    "original_inquiry": "Urgent: Geneticist referral: AAV vector confirmed; exploring ELEVIDYS and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-04442",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊sickle cell disease，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8475
  },
  {
    "request_id": "AM-REQ-2026-04443",
    "original_inquiry": "研究者咨询：Geneticist referral: sickle cell disease confirmed; exploring SRP-9001 and Casgevy trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-04444",
    "original_inquiry": "海外求诊：Researcher inquiry: gene therapy delivery and exon skipping outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7409
  },
  {
    "request_id": "AM-REQ-2026-04445",
    "original_inquiry": "Urgent consultation: SMA基因治疗 diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8792
  },
  {
    "request_id": "AM-REQ-2026-04446",
    "original_inquiry": "Family seeking information: Urgent consultation: sickle cell disease diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7078
  },
  {
    "request_id": "AM-REQ-2026-04447",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; requesting information on Zolgensma and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7715
  },
  {
    "request_id": "AM-REQ-2026-04448",
    "original_inquiry": "海外求诊：Patient with CRISPR疗法; requesting information on Zolgensma and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8735
  },
  {
    "request_id": "AM-REQ-2026-04449",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5879
  },
  {
    "request_id": "AM-REQ-2026-04450",
    "original_inquiry": "研究者咨询：Researcher inquiry: Duchenne muscular dystrophy delivery and gene replacement therapy outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6553
  },
  {
    "request_id": "AM-REQ-2026-04451",
    "original_inquiry": "Geneticist referral: SMA confirmed; exploring SRP-9001 and Zolgensma trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7464
  },
  {
    "request_id": "AM-REQ-2026-04452",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Lyfgenia and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7555
  },
  {
    "request_id": "AM-REQ-2026-04453",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8564
  },
  {
    "request_id": "AM-REQ-2026-04454",
    "original_inquiry": "海外求诊：Urgent consultation: SMA diagnosis, seeking Lyfgenia / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8582
  },
  {
    "request_id": "AM-REQ-2026-04455",
    "original_inquiry": "Family seeking information: Geneticist referral: AAV vector confirmed; exploring ELEVIDYS and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6142
  },
  {
    "request_id": "AM-REQ-2026-04456",
    "original_inquiry": "Second opinion requested: 海外求药：SMA患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6158
  },
  {
    "request_id": "AM-REQ-2026-04457",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊sickle cell disease，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.632
  },
  {
    "request_id": "AM-REQ-2026-04458",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊spinal muscular atrophy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5219
  },
  {
    "request_id": "AM-REQ-2026-04459",
    "original_inquiry": "Referral from specialist: Patient with Duchenne muscular dystrophy; requesting information on ELEVIDYS and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.783
  },
  {
    "request_id": "AM-REQ-2026-04460",
    "original_inquiry": "Family seeking information: Patient with 镰状细胞贫血; requesting information on ELEVIDYS and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8649
  },
  {
    "request_id": "AM-REQ-2026-04461",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA基因治疗，寻求Zolgensma或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6488
  },
  {
    "request_id": "AM-REQ-2026-04462",
    "original_inquiry": "Second opinion requested: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring exon skipping and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8877
  },
  {
    "request_id": "AM-REQ-2026-04463",
    "original_inquiry": "Referral from specialist: 海外求药：spinal muscular atrophy患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8253
  },
  {
    "request_id": "AM-REQ-2026-04464",
    "original_inquiry": "Referral from specialist: Urgent consultation: beta-thalassemia diagnosis, seeking AAV9 / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5533
  },
  {
    "request_id": "AM-REQ-2026-04465",
    "original_inquiry": "Patient with gene therapy; requesting information on Casgevy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6198
  },
  {
    "request_id": "AM-REQ-2026-04466",
    "original_inquiry": "Referral from specialist: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking SRP-9001 / Casgevy availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6089
  },
  {
    "request_id": "AM-REQ-2026-04467",
    "original_inquiry": "Patient with sickle cell disease; requesting information on gene replacement therapy and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5222
  },
  {
    "request_id": "AM-REQ-2026-04468",
    "original_inquiry": "研究者咨询：海外求药：SMA基因治疗患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6432
  },
  {
    "request_id": "AM-REQ-2026-04469",
    "original_inquiry": "Second opinion requested: Researcher inquiry: CRISPR疗法 delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5128
  },
  {
    "request_id": "AM-REQ-2026-04470",
    "original_inquiry": "Family seeking information: Researcher inquiry: gene therapy delivery and exon skipping outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8069
  },
  {
    "request_id": "AM-REQ-2026-04471",
    "original_inquiry": "Urgent: Researcher inquiry: DMD delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7631
  },
  {
    "request_id": "AM-REQ-2026-04472",
    "original_inquiry": "Patient with Duchenne muscular dystrophy; requesting information on gene replacement therapy and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5575
  },
  {
    "request_id": "AM-REQ-2026-04473",
    "original_inquiry": "Urgent: 海外求药：AAV vector患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6408
  },
  {
    "request_id": "AM-REQ-2026-04474",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊gene therapy，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6123
  },
  {
    "request_id": "AM-REQ-2026-04475",
    "original_inquiry": "Family seeking information: Patient with 杜氏肌营养不良; requesting information on Zolgensma and Lyfgenia access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7476
  },
  {
    "request_id": "AM-REQ-2026-04476",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊杜氏肌营养不良，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7585
  },
  {
    "request_id": "AM-REQ-2026-04477",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊杜氏肌营养不良，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5118
  },
  {
    "request_id": "AM-REQ-2026-04478",
    "original_inquiry": "Family seeking information: Urgent consultation: beta-thalassemia diagnosis, seeking exon skipping / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5062
  },
  {
    "request_id": "AM-REQ-2026-04479",
    "original_inquiry": "Family seeking information: Child with Duchenne muscular dystrophy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7997
  },
  {
    "request_id": "AM-REQ-2026-04480",
    "original_inquiry": "Child with gene therapy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.737
  },
  {
    "request_id": "AM-REQ-2026-04481",
    "original_inquiry": "海外求诊：海外求药：杜氏肌营养不良患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6363
  },
  {
    "request_id": "AM-REQ-2026-04482",
    "original_inquiry": "Urgent consultation: CRISPR疗法 diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6239
  },
  {
    "request_id": "AM-REQ-2026-04483",
    "original_inquiry": "Family seeking information: Geneticist referral: beta-thalassemia confirmed; exploring gene replacement therapy and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7846
  },
  {
    "request_id": "AM-REQ-2026-04484",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8069
  },
  {
    "request_id": "AM-REQ-2026-04485",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5527
  },
  {
    "request_id": "AM-REQ-2026-04486",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring SRP-9001 and AAV9 trials.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8082
  },
  {
    "request_id": "AM-REQ-2026-04487",
    "original_inquiry": "研究者咨询：Patient with 镰状细胞贫血; requesting information on exon skipping and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6541
  },
  {
    "request_id": "AM-REQ-2026-04488",
    "original_inquiry": "Second opinion requested: 海外求药：CRISPR疗法患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8425
  },
  {
    "request_id": "AM-REQ-2026-04489",
    "original_inquiry": "Family seeking information: Researcher inquiry: gene therapy delivery and Zolgensma outcomes in SRP-9001; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6022
  },
  {
    "request_id": "AM-REQ-2026-04490",
    "original_inquiry": "Family seeking information: Researcher inquiry: beta-thalassemia delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8455
  },
  {
    "request_id": "AM-REQ-2026-04491",
    "original_inquiry": "Child with Duchenne muscular dystrophy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8951
  },
  {
    "request_id": "AM-REQ-2026-04492",
    "original_inquiry": "Referral from specialist: 海外求药：Duchenne muscular dystrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5073
  },
  {
    "request_id": "AM-REQ-2026-04493",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA基因治疗 diagnosis, seeking Casgevy / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5862
  },
  {
    "request_id": "AM-REQ-2026-04494",
    "original_inquiry": "研究者咨询：Patient with SMA; requesting information on AAV9 and ELEVIDYS access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.881
  },
  {
    "request_id": "AM-REQ-2026-04495",
    "original_inquiry": "研究者咨询：Geneticist referral: beta-thalassemia confirmed; exploring Casgevy and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.812
  },
  {
    "request_id": "AM-REQ-2026-04496",
    "original_inquiry": "Urgent: Researcher inquiry: AAV vector delivery and exon skipping outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5318
  },
  {
    "request_id": "AM-REQ-2026-04497",
    "original_inquiry": "Second opinion requested: 海外求药：beta-thalassemia患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8389
  },
  {
    "request_id": "AM-REQ-2026-04498",
    "original_inquiry": "研究者咨询：Patient with Duchenne muscular dystrophy; requesting information on CRISPR-Cas9 and Zolgensma access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7837
  },
  {
    "request_id": "AM-REQ-2026-04499",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊sickle cell disease，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6712
  },
  {
    "request_id": "AM-REQ-2026-04500",
    "original_inquiry": "研究者咨询：Urgent consultation: beta-thalassemia diagnosis, seeking Zolgensma / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5788
  },
  {
    "request_id": "AM-REQ-2026-04501",
    "original_inquiry": "Urgent: Geneticist referral: beta-thalassemia confirmed; exploring exon skipping and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8266
  },
  {
    "request_id": "AM-REQ-2026-04502",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6088
  },
  {
    "request_id": "AM-REQ-2026-04503",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA基因治疗 delivery and gene replacement therapy outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5156
  },
  {
    "request_id": "AM-REQ-2026-04504",
    "original_inquiry": "家长咨询：患儿确诊DMD，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6995
  },
  {
    "request_id": "AM-REQ-2026-04505",
    "original_inquiry": "Urgent: 海外求药：sickle cell disease患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5908
  },
  {
    "request_id": "AM-REQ-2026-04506",
    "original_inquiry": "研究者咨询：Urgent consultation: sickle cell disease diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8943
  },
  {
    "request_id": "AM-REQ-2026-04507",
    "original_inquiry": "Urgent: 海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7956
  },
  {
    "request_id": "AM-REQ-2026-04508",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7881
  },
  {
    "request_id": "AM-REQ-2026-04509",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6297
  },
  {
    "request_id": "AM-REQ-2026-04510",
    "original_inquiry": "Referral from specialist: Geneticist referral: sickle cell disease confirmed; exploring ELEVIDYS and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.875
  },
  {
    "request_id": "AM-REQ-2026-04511",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking Casgevy / AAV9 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8824
  },
  {
    "request_id": "AM-REQ-2026-04512",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking Lyfgenia / ELEVIDYS availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7523
  },
  {
    "request_id": "AM-REQ-2026-04513",
    "original_inquiry": "Urgent: Urgent consultation: DMD diagnosis, seeking SRP-9001 / Casgevy availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7334
  },
  {
    "request_id": "AM-REQ-2026-04514",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊beta-thalassemia，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.736
  },
  {
    "request_id": "AM-REQ-2026-04515",
    "original_inquiry": "Second opinion requested: Urgent consultation: AAV vector diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.812
  },
  {
    "request_id": "AM-REQ-2026-04516",
    "original_inquiry": "Patient with AAV vector; requesting information on SRP-9001 and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-04517",
    "original_inquiry": "Second opinion requested: Geneticist referral: sickle cell disease confirmed; exploring Lyfgenia and ELEVIDYS trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6798
  },
  {
    "request_id": "AM-REQ-2026-04518",
    "original_inquiry": "研究者咨询：Child with Duchenne muscular dystrophy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7033
  },
  {
    "request_id": "AM-REQ-2026-04519",
    "original_inquiry": "Referral from specialist: Geneticist referral: 镰状细胞贫血 confirmed; exploring CRISPR-Cas9 and Lyfgenia trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7987
  },
  {
    "request_id": "AM-REQ-2026-04520",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7219
  },
  {
    "request_id": "AM-REQ-2026-04521",
    "original_inquiry": "Urgent: Geneticist referral: 镰状细胞贫血 confirmed; exploring Casgevy and SRP-9001 trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8419
  },
  {
    "request_id": "AM-REQ-2026-04522",
    "original_inquiry": "Urgent: Child with AAV vector; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5309
  },
  {
    "request_id": "AM-REQ-2026-04523",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊AAV vector，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8088
  },
  {
    "request_id": "AM-REQ-2026-04524",
    "original_inquiry": "Urgent: Patient with AAV vector; requesting information on AAV9 and Lyfgenia access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.785
  },
  {
    "request_id": "AM-REQ-2026-04525",
    "original_inquiry": "Urgent consultation: 镰状细胞贫血 diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7758
  },
  {
    "request_id": "AM-REQ-2026-04526",
    "original_inquiry": "海外求诊：Urgent consultation: 镰状细胞贫血 diagnosis, seeking CRISPR-Cas9 / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6851
  },
  {
    "request_id": "AM-REQ-2026-04527",
    "original_inquiry": "Referral from specialist: Geneticist referral: CRISPR疗法 confirmed; exploring Zolgensma and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5467
  },
  {
    "request_id": "AM-REQ-2026-04528",
    "original_inquiry": "海外求诊：海外求药：gene therapy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5517
  },
  {
    "request_id": "AM-REQ-2026-04529",
    "original_inquiry": "Geneticist referral: SMA基因治疗 confirmed; exploring Zolgensma and AAV9 trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.611
  },
  {
    "request_id": "AM-REQ-2026-04530",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求exon skipping或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5572
  },
  {
    "request_id": "AM-REQ-2026-04531",
    "original_inquiry": "Second opinion requested: Urgent consultation: sickle cell disease diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8646
  },
  {
    "request_id": "AM-REQ-2026-04532",
    "original_inquiry": "Urgent consultation: beta-thalassemia diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8222
  },
  {
    "request_id": "AM-REQ-2026-04533",
    "original_inquiry": "Urgent: Researcher inquiry: SMA基因治疗 delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-04534",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7187
  },
  {
    "request_id": "AM-REQ-2026-04535",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8099
  },
  {
    "request_id": "AM-REQ-2026-04536",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊DMD，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8534
  },
  {
    "request_id": "AM-REQ-2026-04537",
    "original_inquiry": "Urgent: Child with spinal muscular atrophy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7656
  },
  {
    "request_id": "AM-REQ-2026-04538",
    "original_inquiry": "Family seeking information: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring Lyfgenia and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-04539",
    "original_inquiry": "Referral from specialist: 海外求药：gene therapy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8746
  },
  {
    "request_id": "AM-REQ-2026-04540",
    "original_inquiry": "Referral from specialist: Urgent consultation: SMA diagnosis, seeking ELEVIDYS / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6561
  },
  {
    "request_id": "AM-REQ-2026-04541",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and gene replacement therapy outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6398
  },
  {
    "request_id": "AM-REQ-2026-04542",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8061
  },
  {
    "request_id": "AM-REQ-2026-04543",
    "original_inquiry": "Referral from specialist: 海外求药：spinal muscular atrophy患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6883
  },
  {
    "request_id": "AM-REQ-2026-04544",
    "original_inquiry": "Second opinion requested: Patient with DMD; requesting information on SRP-9001 and Casgevy access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6354
  },
  {
    "request_id": "AM-REQ-2026-04545",
    "original_inquiry": "Geneticist referral: 杜氏肌营养不良 confirmed; exploring SRP-9001 and Casgevy trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6332
  },
  {
    "request_id": "AM-REQ-2026-04546",
    "original_inquiry": "研究者咨询：Urgent consultation: AAV vector diagnosis, seeking Casgevy / SRP-9001 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8595
  },
  {
    "request_id": "AM-REQ-2026-04547",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring Zolgensma and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.723
  },
  {
    "request_id": "AM-REQ-2026-04548",
    "original_inquiry": "研究者咨询：Patient with SMA基因治疗; requesting information on gene replacement therapy and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7383
  },
  {
    "request_id": "AM-REQ-2026-04549",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求Zolgensma或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5515
  },
  {
    "request_id": "AM-REQ-2026-04550",
    "original_inquiry": "Second opinion requested: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8498
  },
  {
    "request_id": "AM-REQ-2026-04551",
    "original_inquiry": "Urgent: 海外求药：spinal muscular atrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-04552",
    "original_inquiry": "Referral from specialist: Patient with 镰状细胞贫血; requesting information on gene replacement therapy and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-04553",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking SRP-9001 / AAV9 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6334
  },
  {
    "request_id": "AM-REQ-2026-04554",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊DMD，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6521
  },
  {
    "request_id": "AM-REQ-2026-04555",
    "original_inquiry": "Family seeking information: Patient with gene therapy; requesting information on Casgevy and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6215
  },
  {
    "request_id": "AM-REQ-2026-04556",
    "original_inquiry": "家长咨询：患儿确诊beta-thalassemia，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7894
  },
  {
    "request_id": "AM-REQ-2026-04557",
    "original_inquiry": "Urgent: Child with CRISPR疗法; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7815
  },
  {
    "request_id": "AM-REQ-2026-04558",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.677
  },
  {
    "request_id": "AM-REQ-2026-04559",
    "original_inquiry": "Geneticist referral: SMA基因治疗 confirmed; exploring SRP-9001 and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8281
  },
  {
    "request_id": "AM-REQ-2026-04560",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 杜氏肌营养不良 delivery and exon skipping outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5604
  },
  {
    "request_id": "AM-REQ-2026-04561",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8989
  },
  {
    "request_id": "AM-REQ-2026-04562",
    "original_inquiry": "Referral from specialist: Patient with SMA基因治疗; requesting information on ELEVIDYS and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5745
  },
  {
    "request_id": "AM-REQ-2026-04563",
    "original_inquiry": "Referral from specialist: Urgent consultation: DMD diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.885
  },
  {
    "request_id": "AM-REQ-2026-04564",
    "original_inquiry": "研究者咨询：Researcher inquiry: beta-thalassemia delivery and exon skipping outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6431
  },
  {
    "request_id": "AM-REQ-2026-04565",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7504
  },
  {
    "request_id": "AM-REQ-2026-04566",
    "original_inquiry": "Urgent: Urgent consultation: CRISPR疗法 diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8228
  },
  {
    "request_id": "AM-REQ-2026-04567",
    "original_inquiry": "Researcher inquiry: gene therapy delivery and Casgevy outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7263
  },
  {
    "request_id": "AM-REQ-2026-04568",
    "original_inquiry": "Family seeking information: 海外求药：CRISPR疗法患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5376
  },
  {
    "request_id": "AM-REQ-2026-04569",
    "original_inquiry": "Second opinion requested: 海外求药：CRISPR疗法患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.726
  },
  {
    "request_id": "AM-REQ-2026-04570",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7426
  },
  {
    "request_id": "AM-REQ-2026-04571",
    "original_inquiry": "Urgent: Geneticist referral: gene therapy confirmed; exploring exon skipping and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6607
  },
  {
    "request_id": "AM-REQ-2026-04572",
    "original_inquiry": "家长咨询：患儿确诊DMD，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6246
  },
  {
    "request_id": "AM-REQ-2026-04573",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊sickle cell disease，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5442
  },
  {
    "request_id": "AM-REQ-2026-04574",
    "original_inquiry": "Geneticist referral: 镰状细胞贫血 confirmed; exploring exon skipping and Lyfgenia trials.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8988
  },
  {
    "request_id": "AM-REQ-2026-04575",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7076
  },
  {
    "request_id": "AM-REQ-2026-04576",
    "original_inquiry": "Second opinion requested: Urgent consultation: CRISPR疗法 diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5829
  },
  {
    "request_id": "AM-REQ-2026-04577",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6174
  },
  {
    "request_id": "AM-REQ-2026-04578",
    "original_inquiry": "研究者咨询：Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6607
  },
  {
    "request_id": "AM-REQ-2026-04579",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5071
  },
  {
    "request_id": "AM-REQ-2026-04580",
    "original_inquiry": "Family seeking information: Urgent consultation: spinal muscular atrophy diagnosis, seeking Lyfgenia / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.862
  },
  {
    "request_id": "AM-REQ-2026-04581",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA delivery and ELEVIDYS outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6269
  },
  {
    "request_id": "AM-REQ-2026-04582",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6315
  },
  {
    "request_id": "AM-REQ-2026-04583",
    "original_inquiry": "Urgent consultation: beta-thalassemia diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6125
  },
  {
    "request_id": "AM-REQ-2026-04584",
    "original_inquiry": "Second opinion requested: Child with AAV vector; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6186
  },
  {
    "request_id": "AM-REQ-2026-04585",
    "original_inquiry": "Second opinion requested: Patient with SMA基因治疗; requesting information on CRISPR-Cas9 and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5788
  },
  {
    "request_id": "AM-REQ-2026-04586",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and ELEVIDYS outcomes in SRP-9001; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7596
  },
  {
    "request_id": "AM-REQ-2026-04587",
    "original_inquiry": "Referral from specialist: Child with Duchenne muscular dystrophy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5204
  },
  {
    "request_id": "AM-REQ-2026-04588",
    "original_inquiry": "Patient with sickle cell disease; requesting information on SRP-9001 and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8799
  },
  {
    "request_id": "AM-REQ-2026-04589",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.546
  },
  {
    "request_id": "AM-REQ-2026-04590",
    "original_inquiry": "海外求诊：Geneticist referral: sickle cell disease confirmed; exploring exon skipping and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7962
  },
  {
    "request_id": "AM-REQ-2026-04591",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; requesting information on CRISPR-Cas9 and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8567
  },
  {
    "request_id": "AM-REQ-2026-04592",
    "original_inquiry": "海外求诊：Patient with CRISPR疗法; requesting information on exon skipping and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8352
  },
  {
    "request_id": "AM-REQ-2026-04593",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊杜氏肌营养不良，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6644
  },
  {
    "request_id": "AM-REQ-2026-04594",
    "original_inquiry": "Family seeking information: Researcher inquiry: sickle cell disease delivery and gene replacement therapy outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5133
  },
  {
    "request_id": "AM-REQ-2026-04595",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊gene therapy，寻求Casgevy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6048
  },
  {
    "request_id": "AM-REQ-2026-04596",
    "original_inquiry": "研究者咨询：Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8051
  },
  {
    "request_id": "AM-REQ-2026-04597",
    "original_inquiry": "海外求诊：Patient with SMA; requesting information on Casgevy and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5201
  },
  {
    "request_id": "AM-REQ-2026-04598",
    "original_inquiry": "研究者咨询：Geneticist referral: CRISPR疗法 confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5475
  },
  {
    "request_id": "AM-REQ-2026-04599",
    "original_inquiry": "海外求诊：Researcher inquiry: SMA基因治疗 delivery and AAV9 outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7305
  },
  {
    "request_id": "AM-REQ-2026-04600",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊SMA基因治疗，寻求Zolgensma或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6551
  },
  {
    "request_id": "AM-REQ-2026-04601",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊spinal muscular atrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5933
  },
  {
    "request_id": "AM-REQ-2026-04602",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and exon skipping outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7272
  },
  {
    "request_id": "AM-REQ-2026-04603",
    "original_inquiry": "Referral from specialist: 海外求药：gene therapy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8379
  },
  {
    "request_id": "AM-REQ-2026-04604",
    "original_inquiry": "家长咨询：患儿确诊gene therapy，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5012
  },
  {
    "request_id": "AM-REQ-2026-04605",
    "original_inquiry": "Referral from specialist: Geneticist referral: DMD confirmed; exploring Casgevy and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7927
  },
  {
    "request_id": "AM-REQ-2026-04606",
    "original_inquiry": "家长咨询：患儿确诊镰状细胞贫血，寻求Casgevy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.688
  },
  {
    "request_id": "AM-REQ-2026-04607",
    "original_inquiry": "Referral from specialist: Patient with spinal muscular atrophy; requesting information on ELEVIDYS and Zolgensma access programs.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5502
  },
  {
    "request_id": "AM-REQ-2026-04608",
    "original_inquiry": "Child with 镰状细胞贫血; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8262
  },
  {
    "request_id": "AM-REQ-2026-04609",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊AAV vector，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-04610",
    "original_inquiry": "海外求诊：Researcher inquiry: SMA delivery and AAV9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8722
  },
  {
    "request_id": "AM-REQ-2026-04611",
    "original_inquiry": "Referral from specialist: Child with spinal muscular atrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.523
  },
  {
    "request_id": "AM-REQ-2026-04612",
    "original_inquiry": "研究者咨询：海外求药：杜氏肌营养不良患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6581
  },
  {
    "request_id": "AM-REQ-2026-04613",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊AAV vector，寻求AAV9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6331
  },
  {
    "request_id": "AM-REQ-2026-04614",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 镰状细胞贫血 delivery and AAV9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7656
  },
  {
    "request_id": "AM-REQ-2026-04615",
    "original_inquiry": "海外求诊：Geneticist referral: CRISPR疗法 confirmed; exploring exon skipping and Lyfgenia trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5132
  },
  {
    "request_id": "AM-REQ-2026-04616",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5152
  },
  {
    "request_id": "AM-REQ-2026-04617",
    "original_inquiry": "Patient with beta-thalassemia; requesting information on exon skipping and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5675
  },
  {
    "request_id": "AM-REQ-2026-04618",
    "original_inquiry": "海外求诊：海外求药：CRISPR疗法患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.694
  },
  {
    "request_id": "AM-REQ-2026-04619",
    "original_inquiry": "Urgent: Geneticist referral: SMA基因治疗 confirmed; exploring Lyfgenia and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6663
  },
  {
    "request_id": "AM-REQ-2026-04620",
    "original_inquiry": "Second opinion requested: Urgent consultation: spinal muscular atrophy diagnosis, seeking Lyfgenia / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7573
  },
  {
    "request_id": "AM-REQ-2026-04621",
    "original_inquiry": "Referral from specialist: Researcher inquiry: DMD delivery and SRP-9001 outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.714
  },
  {
    "request_id": "AM-REQ-2026-04622",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.594
  },
  {
    "request_id": "AM-REQ-2026-04623",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8114
  },
  {
    "request_id": "AM-REQ-2026-04624",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊CRISPR疗法，寻求Casgevy或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8435
  },
  {
    "request_id": "AM-REQ-2026-04625",
    "original_inquiry": "Family seeking information: Urgent consultation: CRISPR疗法 diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-04626",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-04627",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring Lyfgenia and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7812
  },
  {
    "request_id": "AM-REQ-2026-04628",
    "original_inquiry": "Second opinion requested: Urgent consultation: gene therapy diagnosis, seeking exon skipping / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8857
  },
  {
    "request_id": "AM-REQ-2026-04629",
    "original_inquiry": "Urgent: Urgent consultation: DMD diagnosis, seeking exon skipping / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7168
  },
  {
    "request_id": "AM-REQ-2026-04630",
    "original_inquiry": "Urgent: Urgent consultation: 镰状细胞贫血 diagnosis, seeking ELEVIDYS / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7072
  },
  {
    "request_id": "AM-REQ-2026-04631",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8371
  },
  {
    "request_id": "AM-REQ-2026-04632",
    "original_inquiry": "研究者咨询：Patient with beta-thalassemia; requesting information on Lyfgenia and Zolgensma access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6702
  },
  {
    "request_id": "AM-REQ-2026-04633",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring ELEVIDYS and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6289
  },
  {
    "request_id": "AM-REQ-2026-04634",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊sickle cell disease，寻求Lyfgenia或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.793
  },
  {
    "request_id": "AM-REQ-2026-04635",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8422
  },
  {
    "request_id": "AM-REQ-2026-04636",
    "original_inquiry": "Referral from specialist: Urgent consultation: AAV vector diagnosis, seeking SRP-9001 / Lyfgenia availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.749
  },
  {
    "request_id": "AM-REQ-2026-04637",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊镰状细胞贫血，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6768
  },
  {
    "request_id": "AM-REQ-2026-04638",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7462
  },
  {
    "request_id": "AM-REQ-2026-04639",
    "original_inquiry": "Child with SMA; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6359
  },
  {
    "request_id": "AM-REQ-2026-04640",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5318
  },
  {
    "request_id": "AM-REQ-2026-04641",
    "original_inquiry": "Second opinion requested: Child with 镰状细胞贫血; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6575
  },
  {
    "request_id": "AM-REQ-2026-04642",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on exon skipping and ELEVIDYS access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-04643",
    "original_inquiry": "Patient with spinal muscular atrophy; requesting information on CRISPR-Cas9 and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8604
  },
  {
    "request_id": "AM-REQ-2026-04644",
    "original_inquiry": "海外求诊：Child with 杜氏肌营养不良; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-04645",
    "original_inquiry": "研究者咨询：Urgent consultation: spinal muscular atrophy diagnosis, seeking Lyfgenia / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8207
  },
  {
    "request_id": "AM-REQ-2026-04646",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-04647",
    "original_inquiry": "研究者咨询：海外求药：AAV vector患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8672
  },
  {
    "request_id": "AM-REQ-2026-04648",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.849
  },
  {
    "request_id": "AM-REQ-2026-04649",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6303
  },
  {
    "request_id": "AM-REQ-2026-04650",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA基因治疗，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5834
  },
  {
    "request_id": "AM-REQ-2026-04651",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA基因治疗 diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5145
  },
  {
    "request_id": "AM-REQ-2026-04652",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊SMA基因治疗，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8461
  },
  {
    "request_id": "AM-REQ-2026-04653",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5996
  },
  {
    "request_id": "AM-REQ-2026-04654",
    "original_inquiry": "Referral from specialist: Patient with beta-thalassemia; requesting information on SRP-9001 and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7782
  },
  {
    "request_id": "AM-REQ-2026-04655",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and AAV9 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6765
  },
  {
    "request_id": "AM-REQ-2026-04656",
    "original_inquiry": "Urgent: Child with spinal muscular atrophy; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6298
  },
  {
    "request_id": "AM-REQ-2026-04657",
    "original_inquiry": "Family seeking information: Child with SMA基因治疗; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8306
  },
  {
    "request_id": "AM-REQ-2026-04658",
    "original_inquiry": "Family seeking information: 海外求药：CRISPR疗法患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8169
  },
  {
    "request_id": "AM-REQ-2026-04659",
    "original_inquiry": "Referral from specialist: Researcher inquiry: gene therapy delivery and AAV9 outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6206
  },
  {
    "request_id": "AM-REQ-2026-04660",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6574
  },
  {
    "request_id": "AM-REQ-2026-04661",
    "original_inquiry": "Patient with AAV vector; requesting information on CRISPR-Cas9 and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6169
  },
  {
    "request_id": "AM-REQ-2026-04662",
    "original_inquiry": "海外求诊：Patient with spinal muscular atrophy; requesting information on Lyfgenia and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5638
  },
  {
    "request_id": "AM-REQ-2026-04663",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5412
  },
  {
    "request_id": "AM-REQ-2026-04664",
    "original_inquiry": "Family seeking information: Geneticist referral: beta-thalassemia confirmed; exploring CRISPR-Cas9 and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8915
  },
  {
    "request_id": "AM-REQ-2026-04665",
    "original_inquiry": "Child with sickle cell disease; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5637
  },
  {
    "request_id": "AM-REQ-2026-04666",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊gene therapy，寻求AAV9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-04667",
    "original_inquiry": "Researcher inquiry: AAV vector delivery and Zolgensma outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8362
  },
  {
    "request_id": "AM-REQ-2026-04668",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6087
  },
  {
    "request_id": "AM-REQ-2026-04669",
    "original_inquiry": "海外求诊：Geneticist referral: AAV vector confirmed; exploring AAV9 and SRP-9001 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7334
  },
  {
    "request_id": "AM-REQ-2026-04670",
    "original_inquiry": "研究者咨询：Patient with spinal muscular atrophy; requesting information on ELEVIDYS and AAV9 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7405
  },
  {
    "request_id": "AM-REQ-2026-04671",
    "original_inquiry": "海外求诊：Child with gene therapy; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7271
  },
  {
    "request_id": "AM-REQ-2026-04672",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring ELEVIDYS and AAV9 trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5707
  },
  {
    "request_id": "AM-REQ-2026-04673",
    "original_inquiry": "研究者咨询：海外求药：sickle cell disease患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5614
  },
  {
    "request_id": "AM-REQ-2026-04674",
    "original_inquiry": "Referral from specialist: Urgent consultation: gene therapy diagnosis, seeking CRISPR-Cas9 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8089
  },
  {
    "request_id": "AM-REQ-2026-04675",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7699
  },
  {
    "request_id": "AM-REQ-2026-04676",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8472
  },
  {
    "request_id": "AM-REQ-2026-04677",
    "original_inquiry": "Urgent: 海外求药：beta-thalassemia患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6365
  },
  {
    "request_id": "AM-REQ-2026-04678",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6433
  },
  {
    "request_id": "AM-REQ-2026-04679",
    "original_inquiry": "研究者咨询：Child with sickle cell disease; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6855
  },
  {
    "request_id": "AM-REQ-2026-04680",
    "original_inquiry": "Referral from specialist: Child with 镰状细胞贫血; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8021
  },
  {
    "request_id": "AM-REQ-2026-04681",
    "original_inquiry": "Second opinion requested: Researcher inquiry: DMD delivery and CRISPR-Cas9 outcomes in Lyfgenia; trial design interest. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5775
  },
  {
    "request_id": "AM-REQ-2026-04682",
    "original_inquiry": "Urgent: 海外求药：镰状细胞贫血患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6199
  },
  {
    "request_id": "AM-REQ-2026-04683",
    "original_inquiry": "Second opinion requested: Urgent consultation: sickle cell disease diagnosis, seeking Lyfgenia / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7005
  },
  {
    "request_id": "AM-REQ-2026-04684",
    "original_inquiry": "Referral from specialist: 海外求药：镰状细胞贫血患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6469
  },
  {
    "request_id": "AM-REQ-2026-04685",
    "original_inquiry": "Second opinion requested: 海外求药：DMD患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-04686",
    "original_inquiry": "研究者咨询：Researcher inquiry: beta-thalassemia delivery and AAV9 outcomes in Zolgensma; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8974
  },
  {
    "request_id": "AM-REQ-2026-04687",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊SMA基因治疗，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7912
  },
  {
    "request_id": "AM-REQ-2026-04688",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA diagnosis, seeking gene replacement therapy / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8102
  },
  {
    "request_id": "AM-REQ-2026-04689",
    "original_inquiry": "Family seeking information: Child with Duchenne muscular dystrophy; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6631
  },
  {
    "request_id": "AM-REQ-2026-04690",
    "original_inquiry": "海外求诊：Geneticist referral: Duchenne muscular dystrophy confirmed; exploring ELEVIDYS and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7707
  },
  {
    "request_id": "AM-REQ-2026-04691",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-04692",
    "original_inquiry": "海外求诊：Researcher inquiry: Duchenne muscular dystrophy delivery and exon skipping outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6119
  },
  {
    "request_id": "AM-REQ-2026-04693",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6796
  },
  {
    "request_id": "AM-REQ-2026-04694",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and SRP-9001 outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5402
  },
  {
    "request_id": "AM-REQ-2026-04695",
    "original_inquiry": "海外求诊：海外求药：杜氏肌营养不良患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5343
  },
  {
    "request_id": "AM-REQ-2026-04696",
    "original_inquiry": "Urgent: Patient with SMA基因治疗; requesting information on ELEVIDYS and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5595
  },
  {
    "request_id": "AM-REQ-2026-04697",
    "original_inquiry": "Second opinion requested: Child with Duchenne muscular dystrophy; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6053
  },
  {
    "request_id": "AM-REQ-2026-04698",
    "original_inquiry": "Urgent: Child with gene therapy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8087
  },
  {
    "request_id": "AM-REQ-2026-04699",
    "original_inquiry": "Second opinion requested: Researcher inquiry: SMA基因治疗 delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5518
  },
  {
    "request_id": "AM-REQ-2026-04700",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5397
  },
  {
    "request_id": "AM-REQ-2026-04701",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8482
  },
  {
    "request_id": "AM-REQ-2026-04702",
    "original_inquiry": "家长咨询：患儿确诊杜氏肌营养不良，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7387
  },
  {
    "request_id": "AM-REQ-2026-04703",
    "original_inquiry": "研究者咨询：Researcher inquiry: DMD delivery and Casgevy outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5288
  },
  {
    "request_id": "AM-REQ-2026-04704",
    "original_inquiry": "Urgent: 海外求药：gene therapy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8309
  },
  {
    "request_id": "AM-REQ-2026-04705",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6741
  },
  {
    "request_id": "AM-REQ-2026-04706",
    "original_inquiry": "Second opinion requested: Urgent consultation: CRISPR疗法 diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7392
  },
  {
    "request_id": "AM-REQ-2026-04707",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊beta-thalassemia，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8279
  },
  {
    "request_id": "AM-REQ-2026-04708",
    "original_inquiry": "Referral from specialist: 海外求药：DMD患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-04709",
    "original_inquiry": "Referral from specialist: Researcher inquiry: gene therapy delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8157
  },
  {
    "request_id": "AM-REQ-2026-04710",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7021
  },
  {
    "request_id": "AM-REQ-2026-04711",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5123
  },
  {
    "request_id": "AM-REQ-2026-04712",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5862
  },
  {
    "request_id": "AM-REQ-2026-04713",
    "original_inquiry": "Second opinion requested: Urgent consultation: beta-thalassemia diagnosis, seeking AAV9 / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6695
  },
  {
    "request_id": "AM-REQ-2026-04714",
    "original_inquiry": "Second opinion requested: Geneticist referral: 杜氏肌营养不良 confirmed; exploring SRP-9001 and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7838
  },
  {
    "request_id": "AM-REQ-2026-04715",
    "original_inquiry": "Second opinion requested: Patient with CRISPR疗法; requesting information on Casgevy and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8016
  },
  {
    "request_id": "AM-REQ-2026-04716",
    "original_inquiry": "Second opinion requested: Researcher inquiry: CRISPR疗法 delivery and exon skipping outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7493
  },
  {
    "request_id": "AM-REQ-2026-04717",
    "original_inquiry": "Urgent: 海外求药：gene therapy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.867
  },
  {
    "request_id": "AM-REQ-2026-04718",
    "original_inquiry": "Researcher inquiry: Duchenne muscular dystrophy delivery and gene replacement therapy outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6002
  },
  {
    "request_id": "AM-REQ-2026-04719",
    "original_inquiry": "海外求诊：Child with SMA基因治疗; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6001
  },
  {
    "request_id": "AM-REQ-2026-04720",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8026
  },
  {
    "request_id": "AM-REQ-2026-04721",
    "original_inquiry": "海外求诊：Urgent consultation: CRISPR疗法 diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7307
  },
  {
    "request_id": "AM-REQ-2026-04722",
    "original_inquiry": "Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6966
  },
  {
    "request_id": "AM-REQ-2026-04723",
    "original_inquiry": "Researcher inquiry: 杜氏肌营养不良 delivery and AAV9 outcomes in Zolgensma; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5926
  },
  {
    "request_id": "AM-REQ-2026-04724",
    "original_inquiry": "研究者咨询：Patient with SMA; requesting information on exon skipping and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6478
  },
  {
    "request_id": "AM-REQ-2026-04725",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7493
  },
  {
    "request_id": "AM-REQ-2026-04726",
    "original_inquiry": "Family seeking information: Child with beta-thalassemia; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7198
  },
  {
    "request_id": "AM-REQ-2026-04727",
    "original_inquiry": "Researcher inquiry: beta-thalassemia delivery and exon skipping outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5709
  },
  {
    "request_id": "AM-REQ-2026-04728",
    "original_inquiry": "海外求诊：Child with CRISPR疗法; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5215
  },
  {
    "request_id": "AM-REQ-2026-04729",
    "original_inquiry": "Family seeking information: 海外求药：CRISPR疗法患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7437
  },
  {
    "request_id": "AM-REQ-2026-04730",
    "original_inquiry": "Second opinion requested: Urgent consultation: beta-thalassemia diagnosis, seeking ELEVIDYS / AAV9 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6752
  },
  {
    "request_id": "AM-REQ-2026-04731",
    "original_inquiry": "研究者咨询：海外求药：gene therapy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5388
  },
  {
    "request_id": "AM-REQ-2026-04732",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6448
  },
  {
    "request_id": "AM-REQ-2026-04733",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求Zolgensma或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5413
  },
  {
    "request_id": "AM-REQ-2026-04734",
    "original_inquiry": "Second opinion requested: Urgent consultation: beta-thalassemia diagnosis, seeking exon skipping / Lyfgenia availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5386
  },
  {
    "request_id": "AM-REQ-2026-04735",
    "original_inquiry": "Referral from specialist: Patient with gene therapy; requesting information on exon skipping and SRP-9001 access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7804
  },
  {
    "request_id": "AM-REQ-2026-04736",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊AAV vector，寻求Lyfgenia或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5596
  },
  {
    "request_id": "AM-REQ-2026-04737",
    "original_inquiry": "海外求药：镰状细胞贫血患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5977
  },
  {
    "request_id": "AM-REQ-2026-04738",
    "original_inquiry": "Urgent: Geneticist referral: sickle cell disease confirmed; exploring Casgevy and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5498
  },
  {
    "request_id": "AM-REQ-2026-04739",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8798
  },
  {
    "request_id": "AM-REQ-2026-04740",
    "original_inquiry": "Referral from specialist: 海外求药：镰状细胞贫血患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6246
  },
  {
    "request_id": "AM-REQ-2026-04741",
    "original_inquiry": "研究者咨询：Patient with 镰状细胞贫血; requesting information on Zolgensma and ELEVIDYS access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7739
  },
  {
    "request_id": "AM-REQ-2026-04742",
    "original_inquiry": "Urgent: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Zolgensma / AAV9 availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8838
  },
  {
    "request_id": "AM-REQ-2026-04743",
    "original_inquiry": "海外求诊：Urgent consultation: CRISPR疗法 diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5765
  },
  {
    "request_id": "AM-REQ-2026-04744",
    "original_inquiry": "Referral from specialist: Child with 杜氏肌营养不良; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7522
  },
  {
    "request_id": "AM-REQ-2026-04745",
    "original_inquiry": "Urgent: Urgent consultation: DMD diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8449
  },
  {
    "request_id": "AM-REQ-2026-04746",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5439
  },
  {
    "request_id": "AM-REQ-2026-04747",
    "original_inquiry": "Urgent: Researcher inquiry: DMD delivery and CRISPR-Cas9 outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8077
  },
  {
    "request_id": "AM-REQ-2026-04748",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊镰状细胞贫血，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6721
  },
  {
    "request_id": "AM-REQ-2026-04749",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7865
  },
  {
    "request_id": "AM-REQ-2026-04750",
    "original_inquiry": "Second opinion requested: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking AAV9 / SRP-9001 availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7731
  },
  {
    "request_id": "AM-REQ-2026-04751",
    "original_inquiry": "Patient with Duchenne muscular dystrophy; requesting information on AAV9 and Zolgensma access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8965
  },
  {
    "request_id": "AM-REQ-2026-04752",
    "original_inquiry": "Second opinion requested: Urgent consultation: SMA基因治疗 diagnosis, seeking Lyfgenia / Casgevy availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.849
  },
  {
    "request_id": "AM-REQ-2026-04753",
    "original_inquiry": "Urgent: 海外求药：杜氏肌营养不良患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.52
  },
  {
    "request_id": "AM-REQ-2026-04754",
    "original_inquiry": "海外求药：镰状细胞贫血患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5454
  },
  {
    "request_id": "AM-REQ-2026-04755",
    "original_inquiry": "Referral from specialist: Patient with SMA基因治疗; requesting information on Casgevy and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6076
  },
  {
    "request_id": "AM-REQ-2026-04756",
    "original_inquiry": "海外求诊：Researcher inquiry: beta-thalassemia delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6195
  },
  {
    "request_id": "AM-REQ-2026-04757",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.812
  },
  {
    "request_id": "AM-REQ-2026-04758",
    "original_inquiry": "Second opinion requested: Patient with beta-thalassemia; requesting information on AAV9 and Lyfgenia access programs.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5581
  },
  {
    "request_id": "AM-REQ-2026-04759",
    "original_inquiry": "研究者咨询：海外求药：镰状细胞贫血患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-04760",
    "original_inquiry": "Urgent: Geneticist referral: CRISPR疗法 confirmed; exploring ELEVIDYS and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6916
  },
  {
    "request_id": "AM-REQ-2026-04761",
    "original_inquiry": "Family seeking information: 家长咨询：患儿确诊AAV vector，寻求Lyfgenia或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5735
  },
  {
    "request_id": "AM-REQ-2026-04762",
    "original_inquiry": "海外求诊：海外求药：Duchenne muscular dystrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6878
  },
  {
    "request_id": "AM-REQ-2026-04763",
    "original_inquiry": "Family seeking information: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking Zolgensma / SRP-9001 availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8395
  },
  {
    "request_id": "AM-REQ-2026-04764",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7916
  },
  {
    "request_id": "AM-REQ-2026-04765",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.878
  },
  {
    "request_id": "AM-REQ-2026-04766",
    "original_inquiry": "研究者咨询：Geneticist referral: SMA confirmed; exploring AAV9 and Lyfgenia trials.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5287
  },
  {
    "request_id": "AM-REQ-2026-04767",
    "original_inquiry": "海外求诊：Geneticist referral: SMA基因治疗 confirmed; exploring Zolgensma and Lyfgenia trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6888
  },
  {
    "request_id": "AM-REQ-2026-04768",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-04769",
    "original_inquiry": "Urgent: Child with spinal muscular atrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8265
  },
  {
    "request_id": "AM-REQ-2026-04770",
    "original_inquiry": "Family seeking information: Patient with SMA; requesting information on Zolgensma and SRP-9001 access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.862
  },
  {
    "request_id": "AM-REQ-2026-04771",
    "original_inquiry": "Urgent: Patient with Duchenne muscular dystrophy; requesting information on Zolgensma and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7002
  },
  {
    "request_id": "AM-REQ-2026-04772",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊spinal muscular atrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5453
  },
  {
    "request_id": "AM-REQ-2026-04773",
    "original_inquiry": "Urgent: 海外求药：杜氏肌营养不良患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7002
  },
  {
    "request_id": "AM-REQ-2026-04774",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6376
  },
  {
    "request_id": "AM-REQ-2026-04775",
    "original_inquiry": "Referral from specialist: Child with AAV vector; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5937
  },
  {
    "request_id": "AM-REQ-2026-04776",
    "original_inquiry": "Referral from specialist: Urgent consultation: AAV vector diagnosis, seeking Zolgensma / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8546
  },
  {
    "request_id": "AM-REQ-2026-04777",
    "original_inquiry": "海外求诊：Child with 镰状细胞贫血; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8257
  },
  {
    "request_id": "AM-REQ-2026-04778",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7668
  },
  {
    "request_id": "AM-REQ-2026-04779",
    "original_inquiry": "Second opinion requested: Geneticist referral: SMA基因治疗 confirmed; exploring gene replacement therapy and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8338
  },
  {
    "request_id": "AM-REQ-2026-04780",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5346
  },
  {
    "request_id": "AM-REQ-2026-04781",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7707
  },
  {
    "request_id": "AM-REQ-2026-04782",
    "original_inquiry": "家长咨询：患儿确诊SMA，寻求Lyfgenia或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6046
  },
  {
    "request_id": "AM-REQ-2026-04783",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.576
  },
  {
    "request_id": "AM-REQ-2026-04784",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring Zolgensma and ELEVIDYS trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7505
  },
  {
    "request_id": "AM-REQ-2026-04785",
    "original_inquiry": "海外求诊：Patient with CRISPR疗法; requesting information on Casgevy and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7935
  },
  {
    "request_id": "AM-REQ-2026-04786",
    "original_inquiry": "Family seeking information: Child with sickle cell disease; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8343
  },
  {
    "request_id": "AM-REQ-2026-04787",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7779
  },
  {
    "request_id": "AM-REQ-2026-04788",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6972
  },
  {
    "request_id": "AM-REQ-2026-04789",
    "original_inquiry": "Referral from specialist: Patient with gene therapy; requesting information on exon skipping and Lyfgenia access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8062
  },
  {
    "request_id": "AM-REQ-2026-04790",
    "original_inquiry": "Urgent consultation: 杜氏肌营养不良 diagnosis, seeking gene replacement therapy / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-04791",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking gene replacement therapy / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.591
  },
  {
    "request_id": "AM-REQ-2026-04792",
    "original_inquiry": "Family seeking information: Child with spinal muscular atrophy; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.774
  },
  {
    "request_id": "AM-REQ-2026-04793",
    "original_inquiry": "家长咨询：患儿确诊DMD，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8108
  },
  {
    "request_id": "AM-REQ-2026-04794",
    "original_inquiry": "Family seeking information: 海外求药：镰状细胞贫血患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5751
  },
  {
    "request_id": "AM-REQ-2026-04795",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊gene therapy，寻求exon skipping或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7205
  },
  {
    "request_id": "AM-REQ-2026-04796",
    "original_inquiry": "Referral from specialist: Child with CRISPR疗法; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5366
  },
  {
    "request_id": "AM-REQ-2026-04797",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求AAV9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.787
  },
  {
    "request_id": "AM-REQ-2026-04798",
    "original_inquiry": "研究者咨询：Researcher inquiry: SMA delivery and gene replacement therapy outcomes in Lyfgenia; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5501
  },
  {
    "request_id": "AM-REQ-2026-04799",
    "original_inquiry": "Urgent: Patient with sickle cell disease; requesting information on AAV9 and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5016
  },
  {
    "request_id": "AM-REQ-2026-04800",
    "original_inquiry": "海外求诊：海外求药：sickle cell disease患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5745
  },
  {
    "request_id": "AM-REQ-2026-04801",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊spinal muscular atrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-04802",
    "original_inquiry": "Second opinion requested: 海外求药：SMA基因治疗患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5635
  },
  {
    "request_id": "AM-REQ-2026-04803",
    "original_inquiry": "研究者咨询：Researcher inquiry: Duchenne muscular dystrophy delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5593
  },
  {
    "request_id": "AM-REQ-2026-04804",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8648
  },
  {
    "request_id": "AM-REQ-2026-04805",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-04806",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7297
  },
  {
    "request_id": "AM-REQ-2026-04807",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊镰状细胞贫血，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7051
  },
  {
    "request_id": "AM-REQ-2026-04808",
    "original_inquiry": "研究者咨询：Urgent consultation: SMA diagnosis, seeking SRP-9001 / AAV9 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8664
  },
  {
    "request_id": "AM-REQ-2026-04809",
    "original_inquiry": "研究者咨询：Geneticist referral: spinal muscular atrophy confirmed; exploring SRP-9001 and AAV9 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6687
  },
  {
    "request_id": "AM-REQ-2026-04810",
    "original_inquiry": "Second opinion requested: Researcher inquiry: sickle cell disease delivery and exon skipping outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5065
  },
  {
    "request_id": "AM-REQ-2026-04811",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA基因治疗 delivery and AAV9 outcomes in Zolgensma; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6693
  },
  {
    "request_id": "AM-REQ-2026-04812",
    "original_inquiry": "海外求诊：Patient with 杜氏肌营养不良; requesting information on Lyfgenia and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8051
  },
  {
    "request_id": "AM-REQ-2026-04813",
    "original_inquiry": "Urgent: Geneticist referral: beta-thalassemia confirmed; exploring ELEVIDYS and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7306
  },
  {
    "request_id": "AM-REQ-2026-04814",
    "original_inquiry": "Referral from specialist: Urgent consultation: 镰状细胞贫血 diagnosis, seeking SRP-9001 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7719
  },
  {
    "request_id": "AM-REQ-2026-04815",
    "original_inquiry": "海外求诊：Urgent consultation: CRISPR疗法 diagnosis, seeking Casgevy / Zolgensma availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6611
  },
  {
    "request_id": "AM-REQ-2026-04816",
    "original_inquiry": "Referral from specialist: Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking ELEVIDYS / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6513
  },
  {
    "request_id": "AM-REQ-2026-04817",
    "original_inquiry": "Patient with SMA基因治疗; requesting information on SRP-9001 and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6375
  },
  {
    "request_id": "AM-REQ-2026-04818",
    "original_inquiry": "Referral from specialist: Child with 镰状细胞贫血; family seeking SRP-9001 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5996
  },
  {
    "request_id": "AM-REQ-2026-04819",
    "original_inquiry": "Urgent consultation: gene therapy diagnosis, seeking exon skipping / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5473
  },
  {
    "request_id": "AM-REQ-2026-04820",
    "original_inquiry": "Referral from specialist: 海外求药：spinal muscular atrophy患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7133
  },
  {
    "request_id": "AM-REQ-2026-04821",
    "original_inquiry": "Referral from specialist: Urgent consultation: AAV vector diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.579
  },
  {
    "request_id": "AM-REQ-2026-04822",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5369
  },
  {
    "request_id": "AM-REQ-2026-04823",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊Duchenne muscular dystrophy，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8835
  },
  {
    "request_id": "AM-REQ-2026-04824",
    "original_inquiry": "Researcher inquiry: sickle cell disease delivery and AAV9 outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8617
  },
  {
    "request_id": "AM-REQ-2026-04825",
    "original_inquiry": "海外求诊：Geneticist referral: AAV vector confirmed; exploring SRP-9001 and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7999
  },
  {
    "request_id": "AM-REQ-2026-04826",
    "original_inquiry": "Geneticist referral: Duchenne muscular dystrophy confirmed; exploring AAV9 and Lyfgenia trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5068
  },
  {
    "request_id": "AM-REQ-2026-04827",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊sickle cell disease，寻求ELEVIDYS或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8033
  },
  {
    "request_id": "AM-REQ-2026-04828",
    "original_inquiry": "Referral from specialist: Urgent consultation: gene therapy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6109
  },
  {
    "request_id": "AM-REQ-2026-04829",
    "original_inquiry": "Researcher inquiry: spinal muscular atrophy delivery and Zolgensma outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-04830",
    "original_inquiry": "Family seeking information: Researcher inquiry: beta-thalassemia delivery and AAV9 outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5963
  },
  {
    "request_id": "AM-REQ-2026-04831",
    "original_inquiry": "Geneticist referral: DMD confirmed; exploring gene replacement therapy and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6047
  },
  {
    "request_id": "AM-REQ-2026-04832",
    "original_inquiry": "Referral from specialist: Geneticist referral: 杜氏肌营养不良 confirmed; exploring Zolgensma and ELEVIDYS trials. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5453
  },
  {
    "request_id": "AM-REQ-2026-04833",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8245
  },
  {
    "request_id": "AM-REQ-2026-04834",
    "original_inquiry": "研究者咨询：海外求药：DMD患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8836
  },
  {
    "request_id": "AM-REQ-2026-04835",
    "original_inquiry": "Referral from specialist: Geneticist referral: beta-thalassemia confirmed; exploring ELEVIDYS and Casgevy trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5717
  },
  {
    "request_id": "AM-REQ-2026-04836",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5311
  },
  {
    "request_id": "AM-REQ-2026-04837",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7729
  },
  {
    "request_id": "AM-REQ-2026-04838",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6313
  },
  {
    "request_id": "AM-REQ-2026-04839",
    "original_inquiry": "Family seeking information: Researcher inquiry: Duchenne muscular dystrophy delivery and Zolgensma outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5161
  },
  {
    "request_id": "AM-REQ-2026-04840",
    "original_inquiry": "Referral from specialist: Patient with 杜氏肌营养不良; requesting information on Lyfgenia and Casgevy access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7036
  },
  {
    "request_id": "AM-REQ-2026-04841",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; requesting information on gene replacement therapy and ELEVIDYS access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7737
  },
  {
    "request_id": "AM-REQ-2026-04842",
    "original_inquiry": "Urgent: 海外求药：DMD患者，希望了解exon skipping、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5743
  },
  {
    "request_id": "AM-REQ-2026-04843",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and Lyfgenia outcomes in ELEVIDYS; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.845
  },
  {
    "request_id": "AM-REQ-2026-04844",
    "original_inquiry": "研究者咨询：Geneticist referral: Duchenne muscular dystrophy confirmed; exploring AAV9 and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5818
  },
  {
    "request_id": "AM-REQ-2026-04845",
    "original_inquiry": "Urgent consultation: SMA diagnosis, seeking ELEVIDYS / SRP-9001 availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6024
  },
  {
    "request_id": "AM-REQ-2026-04846",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8684
  },
  {
    "request_id": "AM-REQ-2026-04847",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6282
  },
  {
    "request_id": "AM-REQ-2026-04848",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6062
  },
  {
    "request_id": "AM-REQ-2026-04849",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 镰状细胞贫血 delivery and gene replacement therapy outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6906
  },
  {
    "request_id": "AM-REQ-2026-04850",
    "original_inquiry": "Second opinion requested: Researcher inquiry: beta-thalassemia delivery and gene replacement therapy outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5345
  },
  {
    "request_id": "AM-REQ-2026-04851",
    "original_inquiry": "Urgent: Urgent consultation: CRISPR疗法 diagnosis, seeking exon skipping / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7434
  },
  {
    "request_id": "AM-REQ-2026-04852",
    "original_inquiry": "研究者咨询：Patient with DMD; requesting information on Zolgensma and Lyfgenia access programs.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8187
  },
  {
    "request_id": "AM-REQ-2026-04853",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7891
  },
  {
    "request_id": "AM-REQ-2026-04854",
    "original_inquiry": "Second opinion requested: 海外求药：CRISPR疗法患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7352
  },
  {
    "request_id": "AM-REQ-2026-04855",
    "original_inquiry": "研究者咨询：Researcher inquiry: gene therapy delivery and Casgevy outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8642
  },
  {
    "request_id": "AM-REQ-2026-04856",
    "original_inquiry": "海外求诊：Patient with 镰状细胞贫血; requesting information on SRP-9001 and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8992
  },
  {
    "request_id": "AM-REQ-2026-04857",
    "original_inquiry": "Patient with 镰状细胞贫血; requesting information on CRISPR-Cas9 and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8947
  },
  {
    "request_id": "AM-REQ-2026-04858",
    "original_inquiry": "海外求诊：Urgent consultation: gene therapy diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6922
  },
  {
    "request_id": "AM-REQ-2026-04859",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-04860",
    "original_inquiry": "Referral from specialist: Patient with CRISPR疗法; requesting information on gene replacement therapy and Casgevy access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5696
  },
  {
    "request_id": "AM-REQ-2026-04861",
    "original_inquiry": "Referral from specialist: Urgent consultation: 镰状细胞贫血 diagnosis, seeking Casgevy / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5303
  },
  {
    "request_id": "AM-REQ-2026-04862",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊spinal muscular atrophy，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-04863",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊gene therapy，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6612
  },
  {
    "request_id": "AM-REQ-2026-04864",
    "original_inquiry": "Urgent: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7363
  },
  {
    "request_id": "AM-REQ-2026-04865",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 镰状细胞贫血 delivery and exon skipping outcomes in Casgevy; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-04866",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6633
  },
  {
    "request_id": "AM-REQ-2026-04867",
    "original_inquiry": "研究者咨询：Researcher inquiry: SMA delivery and gene replacement therapy outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8033
  },
  {
    "request_id": "AM-REQ-2026-04868",
    "original_inquiry": "海外求诊：Urgent consultation: 镰状细胞贫血 diagnosis, seeking CRISPR-Cas9 / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7075
  },
  {
    "request_id": "AM-REQ-2026-04869",
    "original_inquiry": "Geneticist referral: 杜氏肌营养不良 confirmed; exploring Casgevy and AAV9 trials. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5769
  },
  {
    "request_id": "AM-REQ-2026-04870",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6129
  },
  {
    "request_id": "AM-REQ-2026-04871",
    "original_inquiry": "Second opinion requested: Geneticist referral: Duchenne muscular dystrophy confirmed; exploring exon skipping and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.636
  },
  {
    "request_id": "AM-REQ-2026-04872",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5281
  },
  {
    "request_id": "AM-REQ-2026-04873",
    "original_inquiry": "Family seeking information: Child with AAV vector; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.56
  },
  {
    "request_id": "AM-REQ-2026-04874",
    "original_inquiry": "研究者咨询：Child with 镰状细胞贫血; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7477
  },
  {
    "request_id": "AM-REQ-2026-04875",
    "original_inquiry": "Family seeking information: Researcher inquiry: SMA delivery and exon skipping outcomes in Casgevy; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.751
  },
  {
    "request_id": "AM-REQ-2026-04876",
    "original_inquiry": "海外求诊：Urgent consultation: 镰状细胞贫血 diagnosis, seeking Casgevy / Zolgensma availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5357
  },
  {
    "request_id": "AM-REQ-2026-04877",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5892
  },
  {
    "request_id": "AM-REQ-2026-04878",
    "original_inquiry": "Family seeking information: Researcher inquiry: 镰状细胞贫血 delivery and Zolgensma outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5737
  },
  {
    "request_id": "AM-REQ-2026-04879",
    "original_inquiry": "Referral from specialist: Patient with beta-thalassemia; requesting information on Casgevy and Zolgensma access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8564
  },
  {
    "request_id": "AM-REQ-2026-04880",
    "original_inquiry": "海外求诊：Researcher inquiry: Duchenne muscular dystrophy delivery and AAV9 outcomes in SRP-9001; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.555
  },
  {
    "request_id": "AM-REQ-2026-04881",
    "original_inquiry": "研究者咨询：Patient with SMA; requesting information on Lyfgenia and Casgevy access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5535
  },
  {
    "request_id": "AM-REQ-2026-04882",
    "original_inquiry": "Patient with 镰状细胞贫血; requesting information on gene replacement therapy and Zolgensma access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5177
  },
  {
    "request_id": "AM-REQ-2026-04883",
    "original_inquiry": "海外求诊：Geneticist referral: 镰状细胞贫血 confirmed; exploring AAV9 and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.681
  },
  {
    "request_id": "AM-REQ-2026-04884",
    "original_inquiry": "海外求药：beta-thalassemia患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7964
  },
  {
    "request_id": "AM-REQ-2026-04885",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7395
  },
  {
    "request_id": "AM-REQ-2026-04886",
    "original_inquiry": "Family seeking information: Geneticist referral: CRISPR疗法 confirmed; exploring SRP-9001 and Casgevy trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.897
  },
  {
    "request_id": "AM-REQ-2026-04887",
    "original_inquiry": "Family seeking information: Urgent consultation: gene therapy diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6255
  },
  {
    "request_id": "AM-REQ-2026-04888",
    "original_inquiry": "研究者咨询：海外求药：SMA患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.782
  },
  {
    "request_id": "AM-REQ-2026-04889",
    "original_inquiry": "Family seeking information: Geneticist referral: SMA confirmed; exploring ELEVIDYS and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6057
  },
  {
    "request_id": "AM-REQ-2026-04890",
    "original_inquiry": "Second opinion requested: Child with CRISPR疗法; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6218
  },
  {
    "request_id": "AM-REQ-2026-04891",
    "original_inquiry": "海外求诊：Patient with CRISPR疗法; requesting information on SRP-9001 and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8658
  },
  {
    "request_id": "AM-REQ-2026-04892",
    "original_inquiry": "Researcher inquiry: beta-thalassemia delivery and ELEVIDYS outcomes in Casgevy; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7779
  },
  {
    "request_id": "AM-REQ-2026-04893",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8114
  },
  {
    "request_id": "AM-REQ-2026-04894",
    "original_inquiry": "Second opinion requested: Child with sickle cell disease; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8244
  },
  {
    "request_id": "AM-REQ-2026-04895",
    "original_inquiry": "Second opinion requested: Researcher inquiry: sickle cell disease delivery and ELEVIDYS outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6305
  },
  {
    "request_id": "AM-REQ-2026-04896",
    "original_inquiry": "Referral from specialist: Patient with 镰状细胞贫血; requesting information on ELEVIDYS and Casgevy access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5115
  },
  {
    "request_id": "AM-REQ-2026-04897",
    "original_inquiry": "Family seeking information: Patient with CRISPR疗法; requesting information on exon skipping and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8384
  },
  {
    "request_id": "AM-REQ-2026-04898",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8245
  },
  {
    "request_id": "AM-REQ-2026-04899",
    "original_inquiry": "Urgent: Patient with sickle cell disease; requesting information on Lyfgenia and AAV9 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6188
  },
  {
    "request_id": "AM-REQ-2026-04900",
    "original_inquiry": "Urgent: Urgent consultation: SMA基因治疗 diagnosis, seeking gene replacement therapy / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-04901",
    "original_inquiry": "研究者咨询：Patient with gene therapy; requesting information on Zolgensma and AAV9 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5298
  },
  {
    "request_id": "AM-REQ-2026-04902",
    "original_inquiry": "Urgent: 家长咨询：患儿确诊spinal muscular atrophy，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5436
  },
  {
    "request_id": "AM-REQ-2026-04903",
    "original_inquiry": "Urgent: Geneticist referral: beta-thalassemia confirmed; exploring SRP-9001 and ELEVIDYS trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8733
  },
  {
    "request_id": "AM-REQ-2026-04904",
    "original_inquiry": "Urgent: Urgent consultation: spinal muscular atrophy diagnosis, seeking AAV9 / Casgevy availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.807
  },
  {
    "request_id": "AM-REQ-2026-04905",
    "original_inquiry": "Child with Duchenne muscular dystrophy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6508
  },
  {
    "request_id": "AM-REQ-2026-04906",
    "original_inquiry": "Referral from specialist: Urgent consultation: beta-thalassemia diagnosis, seeking AAV9 / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6893
  },
  {
    "request_id": "AM-REQ-2026-04907",
    "original_inquiry": "海外求诊：Child with CRISPR疗法; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7685
  },
  {
    "request_id": "AM-REQ-2026-04908",
    "original_inquiry": "Referral from specialist: 海外求药：AAV vector患者，希望了解Lyfgenia、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8883
  },
  {
    "request_id": "AM-REQ-2026-04909",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊AAV vector，寻求AAV9或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5778
  },
  {
    "request_id": "AM-REQ-2026-04910",
    "original_inquiry": "Referral from specialist: Child with DMD; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6656
  },
  {
    "request_id": "AM-REQ-2026-04911",
    "original_inquiry": "海外求诊：Patient with 杜氏肌营养不良; requesting information on CRISPR-Cas9 and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-04912",
    "original_inquiry": "Second opinion requested: Child with 杜氏肌营养不良; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5592
  },
  {
    "request_id": "AM-REQ-2026-04913",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5603
  },
  {
    "request_id": "AM-REQ-2026-04914",
    "original_inquiry": "海外求诊：Child with beta-thalassemia; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6831
  },
  {
    "request_id": "AM-REQ-2026-04915",
    "original_inquiry": "Referral from specialist: Researcher inquiry: AAV vector delivery and ELEVIDYS outcomes in Casgevy; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-04916",
    "original_inquiry": "海外求诊：海外求药：beta-thalassemia患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8622
  },
  {
    "request_id": "AM-REQ-2026-04917",
    "original_inquiry": "Urgent: Child with gene therapy; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5642
  },
  {
    "request_id": "AM-REQ-2026-04918",
    "original_inquiry": "海外求药：SMA基因治疗患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5077
  },
  {
    "request_id": "AM-REQ-2026-04919",
    "original_inquiry": "Urgent: Researcher inquiry: gene therapy delivery and exon skipping outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5204
  },
  {
    "request_id": "AM-REQ-2026-04920",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊SMA基因治疗，寻求gene replacement therapy或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7638
  },
  {
    "request_id": "AM-REQ-2026-04921",
    "original_inquiry": "海外求诊：Researcher inquiry: 镰状细胞贫血 delivery and Zolgensma outcomes in Lyfgenia; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6889
  },
  {
    "request_id": "AM-REQ-2026-04922",
    "original_inquiry": "Referral from specialist: 家长咨询：患儿确诊beta-thalassemia，寻求Casgevy或Zolgensma相关中心及入组标准。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7956
  },
  {
    "request_id": "AM-REQ-2026-04923",
    "original_inquiry": "Geneticist referral: AAV vector confirmed; exploring exon skipping and Zolgensma trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6042
  },
  {
    "request_id": "AM-REQ-2026-04924",
    "original_inquiry": "研究者咨询：Researcher inquiry: AAV vector delivery and AAV9 outcomes in ELEVIDYS; trial design interest. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7058
  },
  {
    "request_id": "AM-REQ-2026-04925",
    "original_inquiry": "海外求诊：Urgent consultation: AAV vector diagnosis, seeking ELEVIDYS / Lyfgenia availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7063
  },
  {
    "request_id": "AM-REQ-2026-04926",
    "original_inquiry": "Referral from specialist: Geneticist referral: sickle cell disease confirmed; exploring Casgevy and SRP-9001 trials.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6291
  },
  {
    "request_id": "AM-REQ-2026-04927",
    "original_inquiry": "Second opinion requested: Researcher inquiry: sickle cell disease delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8861
  },
  {
    "request_id": "AM-REQ-2026-04928",
    "original_inquiry": "Child with DMD; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.84
  },
  {
    "request_id": "AM-REQ-2026-04929",
    "original_inquiry": "Urgent consultation: DMD diagnosis, seeking CRISPR-Cas9 / Casgevy availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8631
  },
  {
    "request_id": "AM-REQ-2026-04930",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊beta-thalassemia，寻求Zolgensma或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6912
  },
  {
    "request_id": "AM-REQ-2026-04931",
    "original_inquiry": "Urgent: 海外求药：Duchenne muscular dystrophy患者，希望了解ELEVIDYS、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7375
  },
  {
    "request_id": "AM-REQ-2026-04932",
    "original_inquiry": "研究者咨询：Urgent consultation: 镰状细胞贫血 diagnosis, seeking exon skipping / Lyfgenia availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6484
  },
  {
    "request_id": "AM-REQ-2026-04933",
    "original_inquiry": "Second opinion requested: Child with 杜氏肌营养不良; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7737
  },
  {
    "request_id": "AM-REQ-2026-04934",
    "original_inquiry": "Second opinion requested: Child with SMA基因治疗; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5124
  },
  {
    "request_id": "AM-REQ-2026-04935",
    "original_inquiry": "Family seeking information: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8469
  },
  {
    "request_id": "AM-REQ-2026-04936",
    "original_inquiry": "Family seeking information: Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / Casgevy availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7621
  },
  {
    "request_id": "AM-REQ-2026-04937",
    "original_inquiry": "Researcher inquiry: CRISPR疗法 delivery and SRP-9001 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8666
  },
  {
    "request_id": "AM-REQ-2026-04938",
    "original_inquiry": "研究者咨询：Researcher inquiry: 镰状细胞贫血 delivery and AAV9 outcomes in ELEVIDYS; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7703
  },
  {
    "request_id": "AM-REQ-2026-04939",
    "original_inquiry": "Researcher inquiry: 镰状细胞贫血 delivery and CRISPR-Cas9 outcomes in Zolgensma; trial design interest. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7631
  },
  {
    "request_id": "AM-REQ-2026-04940",
    "original_inquiry": "Urgent: Researcher inquiry: AAV vector delivery and gene replacement therapy outcomes in SRP-9001; trial design interest.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5452
  },
  {
    "request_id": "AM-REQ-2026-04941",
    "original_inquiry": "研究者咨询：Urgent consultation: gene therapy diagnosis, seeking exon skipping / SRP-9001 availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7477
  },
  {
    "request_id": "AM-REQ-2026-04942",
    "original_inquiry": "Family seeking information: 海外求药：beta-thalassemia患者，希望了解Casgevy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8619
  },
  {
    "request_id": "AM-REQ-2026-04943",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6353
  },
  {
    "request_id": "AM-REQ-2026-04944",
    "original_inquiry": "Second opinion requested: Patient with SMA; requesting information on AAV9 and SRP-9001 access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8108
  },
  {
    "request_id": "AM-REQ-2026-04945",
    "original_inquiry": "Family seeking information: Geneticist referral: 杜氏肌营养不良 confirmed; exploring AAV9 and Zolgensma trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.845
  },
  {
    "request_id": "AM-REQ-2026-04946",
    "original_inquiry": "Urgent: Researcher inquiry: CRISPR疗法 delivery and Zolgensma outcomes in Casgevy; trial design interest.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-04947",
    "original_inquiry": "Urgent: Patient with 镰状细胞贫血; requesting information on gene replacement therapy and Lyfgenia access programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6423
  },
  {
    "request_id": "AM-REQ-2026-04948",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7624
  },
  {
    "request_id": "AM-REQ-2026-04949",
    "original_inquiry": "Urgent: Patient with gene therapy; requesting information on Zolgensma and ELEVIDYS access programs.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5647
  },
  {
    "request_id": "AM-REQ-2026-04950",
    "original_inquiry": "海外求诊：Child with CRISPR疗法; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8434
  },
  {
    "request_id": "AM-REQ-2026-04951",
    "original_inquiry": "Referral from specialist: Geneticist referral: CRISPR疗法 confirmed; exploring gene replacement therapy and SRP-9001 trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6659
  },
  {
    "request_id": "AM-REQ-2026-04952",
    "original_inquiry": "Family seeking information: Child with CRISPR疗法; family seeking Zolgensma (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7793
  },
  {
    "request_id": "AM-REQ-2026-04953",
    "original_inquiry": "Referral from specialist: Researcher inquiry: sickle cell disease delivery and CRISPR-Cas9 outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6381
  },
  {
    "request_id": "AM-REQ-2026-04954",
    "original_inquiry": "Family seeking information: 海外求药：AAV vector患者，希望了解Zolgensma、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.814
  },
  {
    "request_id": "AM-REQ-2026-04955",
    "original_inquiry": "Family seeking information: Urgent consultation: AAV vector diagnosis, seeking Casgevy / ELEVIDYS availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8639
  },
  {
    "request_id": "AM-REQ-2026-04956",
    "original_inquiry": "Second opinion requested: 家长咨询：患儿确诊sickle cell disease，寻求SRP-9001或Zolgensma相关中心及入组标准。 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7108
  },
  {
    "request_id": "AM-REQ-2026-04957",
    "original_inquiry": "研究者咨询：Geneticist referral: 镰状细胞贫血 confirmed; exploring Zolgensma and Lyfgenia trials. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8108
  },
  {
    "request_id": "AM-REQ-2026-04958",
    "original_inquiry": "研究者咨询：Patient with 杜氏肌营养不良; requesting information on ELEVIDYS and Lyfgenia access programs. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6959
  },
  {
    "request_id": "AM-REQ-2026-04959",
    "original_inquiry": "Family seeking information: Urgent consultation: sickle cell disease diagnosis, seeking exon skipping / SRP-9001 availability and eligibility. 希望了解入组标准与中心列表。",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5313
  },
  {
    "request_id": "AM-REQ-2026-04960",
    "original_inquiry": "研究者咨询：Patient with 镰状细胞贫血; requesting information on gene replacement therapy and SRP-9001 access programs. Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6427
  },
  {
    "request_id": "AM-REQ-2026-04961",
    "original_inquiry": "Family seeking information: Urgent consultation: DMD diagnosis, seeking Lyfgenia / ELEVIDYS availability and eligibility. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7332
  },
  {
    "request_id": "AM-REQ-2026-04962",
    "original_inquiry": "Family seeking information: 海外求药：DMD患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8211
  },
  {
    "request_id": "AM-REQ-2026-04963",
    "original_inquiry": "Referral from specialist: 海外求药：AAV vector患者，希望了解CRISPR-Cas9、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7826
  },
  {
    "request_id": "AM-REQ-2026-04964",
    "original_inquiry": "Referral from specialist: Child with Duchenne muscular dystrophy; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7533
  },
  {
    "request_id": "AM-REQ-2026-04965",
    "original_inquiry": "Referral from specialist: Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / AAV9 availability and eligibility.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6598
  },
  {
    "request_id": "AM-REQ-2026-04966",
    "original_inquiry": "研究者咨询：家长咨询：患儿确诊镰状细胞贫血，寻求CRISPR-Cas9或Zolgensma相关中心及入组标准。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7848
  },
  {
    "request_id": "AM-REQ-2026-04967",
    "original_inquiry": "Referral from specialist: Researcher inquiry: CRISPR疗法 delivery and SRP-9001 outcomes in AAV9; trial design interest.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5905
  },
  {
    "request_id": "AM-REQ-2026-04968",
    "original_inquiry": "Geneticist referral: sickle cell disease confirmed; exploring Lyfgenia and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6443
  },
  {
    "request_id": "AM-REQ-2026-04969",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.599
  },
  {
    "request_id": "AM-REQ-2026-04970",
    "original_inquiry": "研究者咨询：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5541
  },
  {
    "request_id": "AM-REQ-2026-04971",
    "original_inquiry": "Second opinion requested: 海外求药：杜氏肌营养不良患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7487
  },
  {
    "request_id": "AM-REQ-2026-04972",
    "original_inquiry": "Urgent consultation: Duchenne muscular dystrophy diagnosis, seeking CRISPR-Cas9 / ELEVIDYS availability and eligibility. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6152
  },
  {
    "request_id": "AM-REQ-2026-04973",
    "original_inquiry": "Family seeking information: Urgent consultation: SMA diagnosis, seeking SRP-9001 / Zolgensma availability and eligibility. Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7588
  },
  {
    "request_id": "AM-REQ-2026-04974",
    "original_inquiry": "Family seeking information: Patient with Duchenne muscular dystrophy; requesting information on CRISPR-Cas9 and SRP-9001 access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-04975",
    "original_inquiry": "研究者咨询：海外求药：spinal muscular atrophy患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5363
  },
  {
    "request_id": "AM-REQ-2026-04976",
    "original_inquiry": "Family seeking information: Child with SMA基因治疗; family seeking AAV9 (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5045
  },
  {
    "request_id": "AM-REQ-2026-04977",
    "original_inquiry": "海外求诊：Researcher inquiry: DMD delivery and gene replacement therapy outcomes in ELEVIDYS; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5385
  },
  {
    "request_id": "AM-REQ-2026-04978",
    "original_inquiry": "Referral from specialist: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6637
  },
  {
    "request_id": "AM-REQ-2026-04979",
    "original_inquiry": "海外求诊：海外求药：SMA患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 Please advise on next steps.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6357
  },
  {
    "request_id": "AM-REQ-2026-04980",
    "original_inquiry": "研究者咨询：Child with beta-thalassemia; family seeking ELEVIDYS (ELEVIDYS) or other approved gene therapy options.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6014
  },
  {
    "request_id": "AM-REQ-2026-04981",
    "original_inquiry": "Family seeking information: Urgent consultation: 杜氏肌营养不良 diagnosis, seeking Lyfgenia / Casgevy availability and eligibility.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6286
  },
  {
    "request_id": "AM-REQ-2026-04982",
    "original_inquiry": "Referral from specialist: 海外求药：SMA患者，希望了解gene replacement therapy、Casgevy或Zolgensma的用药与临床试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7118
  },
  {
    "request_id": "AM-REQ-2026-04983",
    "original_inquiry": "Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5922
  },
  {
    "request_id": "AM-REQ-2026-04984",
    "original_inquiry": "Family seeking information: Geneticist referral: gene therapy confirmed; exploring AAV9 and SRP-9001 trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8183
  },
  {
    "request_id": "AM-REQ-2026-04985",
    "original_inquiry": "研究者咨询：海外求药：杜氏肌营养不良患者，希望了解AAV9、Casgevy或Zolgensma的用药与临床试验。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5344
  },
  {
    "request_id": "AM-REQ-2026-04986",
    "original_inquiry": "Urgent: Child with SMA; family seeking Lyfgenia (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8874
  },
  {
    "request_id": "AM-REQ-2026-04987",
    "original_inquiry": "Referral from specialist: Child with SMA基因治疗; family seeking gene replacement therapy (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8288
  },
  {
    "request_id": "AM-REQ-2026-04988",
    "original_inquiry": "Second opinion requested: Urgent consultation: sickle cell disease diagnosis, seeking SRP-9001 / Casgevy availability and eligibility.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8523
  },
  {
    "request_id": "AM-REQ-2026-04989",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.819
  },
  {
    "request_id": "AM-REQ-2026-04990",
    "original_inquiry": "海外求诊：家长咨询：患儿确诊Duchenne muscular dystrophy，寻求exon skipping或Zolgensma相关中心及入组标准。 Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8215
  },
  {
    "request_id": "AM-REQ-2026-04991",
    "original_inquiry": "Urgent: Child with CRISPR疗法; family seeking exon skipping (ELEVIDYS) or other approved gene therapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8213
  },
  {
    "request_id": "AM-REQ-2026-04992",
    "original_inquiry": "研究者咨询：Patient with DMD; requesting information on Lyfgenia and ELEVIDYS access programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8837
  },
  {
    "request_id": "AM-REQ-2026-04993",
    "original_inquiry": "研究者咨询：Researcher inquiry: beta-thalassemia delivery and SRP-9001 outcomes in AAV9; trial design interest. Would like to discuss eligibility and timeline.",
    "standard_mapping": "AAV vector gene therapy; neuromuscular or hemoglobinopathy",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8577
  },
  {
    "request_id": "AM-REQ-2026-04994",
    "original_inquiry": "Second opinion requested: Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.8768
  },
  {
    "request_id": "AM-REQ-2026-04995",
    "original_inquiry": "海外求诊：海外求药：Duchenne muscular dystrophy患者，希望了解SRP-9001、Casgevy或Zolgensma的用药与临床试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene therapy; AAV-based or CRISPR-based; DMD/SMA/sickle cell",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.6302
  },
  {
    "request_id": "AM-REQ-2026-04996",
    "original_inquiry": "Referral from specialist: Researcher inquiry: SMA基因治疗 delivery and gene replacement therapy outcomes in Lyfgenia; trial design interest.",
    "standard_mapping": "CRISPR-Cas9 therapy; sickle cell or thalassemia",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7903
  },
  {
    "request_id": "AM-REQ-2026-04997",
    "original_inquiry": "研究者咨询：Child with AAV vector; family seeking Casgevy (ELEVIDYS) or other approved gene therapy options. Please advise on next steps.",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7759
  },
  {
    "request_id": "AM-REQ-2026-04998",
    "original_inquiry": "Urgent: Child with AAV vector; family seeking CRISPR-Cas9 (ELEVIDYS) or other approved gene therapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.5574
  },
  {
    "request_id": "AM-REQ-2026-04999",
    "original_inquiry": "海外求诊：Patient with sickle cell disease; interested in Casgevy or Lyfgenia and long-term follow-up. 希望了解入组标准与中心列表。",
    "standard_mapping": "Gene replacement or gene editing; rare disease",
    "asset_category": "Gene_Therapy",
    "l1_entropy_target": 0.7456
  },
  {
    "request_id": "AM-REQ-2026-05000",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8414
  },
  {
    "request_id": "AM-REQ-2026-05001",
    "original_inquiry": "Urgent: Neurologist: regenerative medicine patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5517
  },
  {
    "request_id": "AM-REQ-2026-05002",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5145
  },
  {
    "request_id": "AM-REQ-2026-05003",
    "original_inquiry": "Referral from specialist: 海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-05004",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8461
  },
  {
    "request_id": "AM-REQ-2026-05005",
    "original_inquiry": "海外求诊：Family seeking iPSC-derived neuron therapy for dopaminergic neuron; request centers with cardiomyocyte programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6712
  },
  {
    "request_id": "AM-REQ-2026-05006",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 类器官移植 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8056
  },
  {
    "request_id": "AM-REQ-2026-05007",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7337
  },
  {
    "request_id": "AM-REQ-2026-05008",
    "original_inquiry": "Urgent: 海外求诊：干细胞分化患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8625
  },
  {
    "request_id": "AM-REQ-2026-05009",
    "original_inquiry": "海外求诊：Patient with advanced clinical trial; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5557
  },
  {
    "request_id": "AM-REQ-2026-05010",
    "original_inquiry": "Second opinion requested: Neurologist: 帕金森 patient, exploring dopaminergic neuron and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7189
  },
  {
    "request_id": "AM-REQ-2026-05011",
    "original_inquiry": "海外求诊：Neurologist: 多能干细胞 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.596
  },
  {
    "request_id": "AM-REQ-2026-05012",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5473
  },
  {
    "request_id": "AM-REQ-2026-05013",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7662
  },
  {
    "request_id": "AM-REQ-2026-05014",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5207
  },
  {
    "request_id": "AM-REQ-2026-05015",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking cell replacement or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7677
  },
  {
    "request_id": "AM-REQ-2026-05016",
    "original_inquiry": "Referral from specialist: Researcher inquiry: clinical trial manufacturing and iPSC transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8721
  },
  {
    "request_id": "AM-REQ-2026-05017",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5933
  },
  {
    "request_id": "AM-REQ-2026-05018",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8922
  },
  {
    "request_id": "AM-REQ-2026-05019",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7872
  },
  {
    "request_id": "AM-REQ-2026-05020",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6807
  },
  {
    "request_id": "AM-REQ-2026-05021",
    "original_inquiry": "海外求诊：Cardiologist referral: 心肌修复 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6923
  },
  {
    "request_id": "AM-REQ-2026-05022",
    "original_inquiry": "Family seeking information: Family seeking 多能干细胞 therapy for cell replacement; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5375
  },
  {
    "request_id": "AM-REQ-2026-05023",
    "original_inquiry": "Referral from specialist: 海外求诊：帕金森患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.766
  },
  {
    "request_id": "AM-REQ-2026-05024",
    "original_inquiry": "Urgent: 海外求诊：多能干细胞患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.854
  },
  {
    "request_id": "AM-REQ-2026-05025",
    "original_inquiry": "研究者咨询：Researcher inquiry: 帕金森 manufacturing and organoid transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7041
  },
  {
    "request_id": "AM-REQ-2026-05026",
    "original_inquiry": "Family seeking information: Patient with advanced cell therapy; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5164
  },
  {
    "request_id": "AM-REQ-2026-05027",
    "original_inquiry": "Urgent: Patient with advanced 类器官移植; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-05028",
    "original_inquiry": "Second opinion requested: Patient with advanced iPSC-derived neuron; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5538
  },
  {
    "request_id": "AM-REQ-2026-05029",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8963
  },
  {
    "request_id": "AM-REQ-2026-05030",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8775
  },
  {
    "request_id": "AM-REQ-2026-05031",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5355
  },
  {
    "request_id": "AM-REQ-2026-05032",
    "original_inquiry": "Second opinion requested: Neurologist: 心肌修复 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8027
  },
  {
    "request_id": "AM-REQ-2026-05033",
    "original_inquiry": "研究者咨询：Neurologist: 类器官移植 patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5392
  },
  {
    "request_id": "AM-REQ-2026-05034",
    "original_inquiry": "患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7522
  },
  {
    "request_id": "AM-REQ-2026-05035",
    "original_inquiry": "Urgent: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6711
  },
  {
    "request_id": "AM-REQ-2026-05036",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6227
  },
  {
    "request_id": "AM-REQ-2026-05037",
    "original_inquiry": "Second opinion requested: Consultation: 心肌修复 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7251
  },
  {
    "request_id": "AM-REQ-2026-05038",
    "original_inquiry": "Second opinion requested: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8426
  },
  {
    "request_id": "AM-REQ-2026-05039",
    "original_inquiry": "Family seeking information: 海外求诊：regenerative medicine患者，希望评估iPSC或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7209
  },
  {
    "request_id": "AM-REQ-2026-05040",
    "original_inquiry": "海外求诊：Cardiologist referral: 帕金森 with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5561
  },
  {
    "request_id": "AM-REQ-2026-05041",
    "original_inquiry": "海外求诊：Consultation: 类器官移植 with spinal cord injury; interested in heart failure or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.764
  },
  {
    "request_id": "AM-REQ-2026-05042",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6642
  },
  {
    "request_id": "AM-REQ-2026-05043",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7395
  },
  {
    "request_id": "AM-REQ-2026-05044",
    "original_inquiry": "海外求诊：Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7167
  },
  {
    "request_id": "AM-REQ-2026-05045",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6954
  },
  {
    "request_id": "AM-REQ-2026-05046",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for spinal cord injury; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.739
  },
  {
    "request_id": "AM-REQ-2026-05047",
    "original_inquiry": "海外求诊：海外求诊：clinical trial患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8496
  },
  {
    "request_id": "AM-REQ-2026-05048",
    "original_inquiry": "海外求诊：Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8928
  },
  {
    "request_id": "AM-REQ-2026-05049",
    "original_inquiry": "Family seeking information: Cardiologist referral: regenerative medicine with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8215
  },
  {
    "request_id": "AM-REQ-2026-05050",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.794
  },
  {
    "request_id": "AM-REQ-2026-05051",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6207
  },
  {
    "request_id": "AM-REQ-2026-05052",
    "original_inquiry": "研究者咨询：海外求诊：帕金森患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7147
  },
  {
    "request_id": "AM-REQ-2026-05053",
    "original_inquiry": "Second opinion requested: Researcher inquiry: cell therapy manufacturing and organoid transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8592
  },
  {
    "request_id": "AM-REQ-2026-05054",
    "original_inquiry": "研究者咨询：Family seeking clinical trial therapy for Parkinson; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7876
  },
  {
    "request_id": "AM-REQ-2026-05055",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8571
  },
  {
    "request_id": "AM-REQ-2026-05056",
    "original_inquiry": "Urgent: 海外求诊：cell therapy患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8086
  },
  {
    "request_id": "AM-REQ-2026-05057",
    "original_inquiry": "海外求诊：海外求诊：类器官移植患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6111
  },
  {
    "request_id": "AM-REQ-2026-05058",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6571
  },
  {
    "request_id": "AM-REQ-2026-05059",
    "original_inquiry": "Urgent: Neurologist: clinical trial patient, exploring heart failure and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8785
  },
  {
    "request_id": "AM-REQ-2026-05060",
    "original_inquiry": "研究者咨询：Neurologist: regenerative medicine patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5381
  },
  {
    "request_id": "AM-REQ-2026-05061",
    "original_inquiry": "Urgent: Neurologist: 干细胞分化 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6291
  },
  {
    "request_id": "AM-REQ-2026-05062",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估spinal cord injury或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8713
  },
  {
    "request_id": "AM-REQ-2026-05063",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7623
  },
  {
    "request_id": "AM-REQ-2026-05064",
    "original_inquiry": "Cardiologist referral: clinical trial with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5847
  },
  {
    "request_id": "AM-REQ-2026-05065",
    "original_inquiry": "Second opinion requested: Patient with advanced 心肌修复; seeking cell replacement or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8975
  },
  {
    "request_id": "AM-REQ-2026-05066",
    "original_inquiry": "海外求诊：Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7948
  },
  {
    "request_id": "AM-REQ-2026-05067",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 帕金森 manufacturing and organoid transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.733
  },
  {
    "request_id": "AM-REQ-2026-05068",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for Parkinson; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8589
  },
  {
    "request_id": "AM-REQ-2026-05069",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5056
  },
  {
    "request_id": "AM-REQ-2026-05070",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7752
  },
  {
    "request_id": "AM-REQ-2026-05071",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.581
  },
  {
    "request_id": "AM-REQ-2026-05072",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8179
  },
  {
    "request_id": "AM-REQ-2026-05073",
    "original_inquiry": "研究者咨询：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in spinal cord injury or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8681
  },
  {
    "request_id": "AM-REQ-2026-05074",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring heart failure and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7404
  },
  {
    "request_id": "AM-REQ-2026-05075",
    "original_inquiry": "Urgent: Consultation: 帕金森 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7105
  },
  {
    "request_id": "AM-REQ-2026-05076",
    "original_inquiry": "Family seeking information: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8816
  },
  {
    "request_id": "AM-REQ-2026-05077",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in spinal cord injury or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6208
  },
  {
    "request_id": "AM-REQ-2026-05078",
    "original_inquiry": "Family seeking information: Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8828
  },
  {
    "request_id": "AM-REQ-2026-05079",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6324
  },
  {
    "request_id": "AM-REQ-2026-05080",
    "original_inquiry": "海外求诊：Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6371
  },
  {
    "request_id": "AM-REQ-2026-05081",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 类器官移植 manufacturing and Parkinson transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5585
  },
  {
    "request_id": "AM-REQ-2026-05082",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in Parkinson or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7775
  },
  {
    "request_id": "AM-REQ-2026-05083",
    "original_inquiry": "Patient with advanced cell therapy; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.894
  },
  {
    "request_id": "AM-REQ-2026-05084",
    "original_inquiry": "Second opinion requested: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6863
  },
  {
    "request_id": "AM-REQ-2026-05085",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7018
  },
  {
    "request_id": "AM-REQ-2026-05086",
    "original_inquiry": "Urgent: Researcher inquiry: 帕金森 manufacturing and dopaminergic neuron transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7886
  },
  {
    "request_id": "AM-REQ-2026-05087",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 多能干细胞 manufacturing and iPSC transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7267
  },
  {
    "request_id": "AM-REQ-2026-05088",
    "original_inquiry": "研究者咨询：海外求诊：多能干细胞患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6467
  },
  {
    "request_id": "AM-REQ-2026-05089",
    "original_inquiry": "研究者咨询：海外求诊：帕金森患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7263
  },
  {
    "request_id": "AM-REQ-2026-05090",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 干细胞分化 manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6191
  },
  {
    "request_id": "AM-REQ-2026-05091",
    "original_inquiry": "研究者咨询：Neurologist: clinical trial patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5253
  },
  {
    "request_id": "AM-REQ-2026-05092",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5835
  },
  {
    "request_id": "AM-REQ-2026-05093",
    "original_inquiry": "Referral from specialist: Patient with advanced clinical trial; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7996
  },
  {
    "request_id": "AM-REQ-2026-05094",
    "original_inquiry": "Urgent: Family seeking clinical trial therapy for Parkinson; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5603
  },
  {
    "request_id": "AM-REQ-2026-05095",
    "original_inquiry": "研究者咨询：Researcher inquiry: cell therapy manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6459
  },
  {
    "request_id": "AM-REQ-2026-05096",
    "original_inquiry": "研究者咨询：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5996
  },
  {
    "request_id": "AM-REQ-2026-05097",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7219
  },
  {
    "request_id": "AM-REQ-2026-05098",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6662
  },
  {
    "request_id": "AM-REQ-2026-05099",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8097
  },
  {
    "request_id": "AM-REQ-2026-05100",
    "original_inquiry": "Neurologist: iPSC-derived neuron patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7304
  },
  {
    "request_id": "AM-REQ-2026-05101",
    "original_inquiry": "研究者咨询：Researcher inquiry: 心肌修复 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7449
  },
  {
    "request_id": "AM-REQ-2026-05102",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8326
  },
  {
    "request_id": "AM-REQ-2026-05103",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8263
  },
  {
    "request_id": "AM-REQ-2026-05104",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 帕金森 manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8262
  },
  {
    "request_id": "AM-REQ-2026-05105",
    "original_inquiry": "海外求诊：Patient with advanced 干细胞分化; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5745
  },
  {
    "request_id": "AM-REQ-2026-05106",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-05107",
    "original_inquiry": "海外求诊：Neurologist: 类器官移植 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.623
  },
  {
    "request_id": "AM-REQ-2026-05108",
    "original_inquiry": "Referral from specialist: Cardiologist referral: regenerative medicine with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5654
  },
  {
    "request_id": "AM-REQ-2026-05109",
    "original_inquiry": "Second opinion requested: Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5474
  },
  {
    "request_id": "AM-REQ-2026-05110",
    "original_inquiry": "Family seeking information: Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8428
  },
  {
    "request_id": "AM-REQ-2026-05111",
    "original_inquiry": "海外求诊：Researcher inquiry: 多能干细胞 manufacturing and induced pluripotent stem cell transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8099
  },
  {
    "request_id": "AM-REQ-2026-05112",
    "original_inquiry": "Family seeking information: 海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5484
  },
  {
    "request_id": "AM-REQ-2026-05113",
    "original_inquiry": "Family seeking information: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6092
  },
  {
    "request_id": "AM-REQ-2026-05114",
    "original_inquiry": "Referral from specialist: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.503
  },
  {
    "request_id": "AM-REQ-2026-05115",
    "original_inquiry": "研究者咨询：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7292
  },
  {
    "request_id": "AM-REQ-2026-05116",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5772
  },
  {
    "request_id": "AM-REQ-2026-05117",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5436
  },
  {
    "request_id": "AM-REQ-2026-05118",
    "original_inquiry": "Neurologist: 心肌修复 patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6823
  },
  {
    "request_id": "AM-REQ-2026-05119",
    "original_inquiry": "海外求诊：Researcher inquiry: 干细胞分化 manufacturing and iPSC transplantation for organoid; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.605
  },
  {
    "request_id": "AM-REQ-2026-05120",
    "original_inquiry": "Urgent: Cardiologist referral: cell therapy with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5844
  },
  {
    "request_id": "AM-REQ-2026-05121",
    "original_inquiry": "Referral from specialist: Neurologist: cell therapy patient, exploring heart failure and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.58
  },
  {
    "request_id": "AM-REQ-2026-05122",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8299
  },
  {
    "request_id": "AM-REQ-2026-05123",
    "original_inquiry": "Neurologist: 心肌修复 patient, exploring dopaminergic neuron and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7017
  },
  {
    "request_id": "AM-REQ-2026-05124",
    "original_inquiry": "Patient with advanced clinical trial; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7537
  },
  {
    "request_id": "AM-REQ-2026-05125",
    "original_inquiry": "海外求诊：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8778
  },
  {
    "request_id": "AM-REQ-2026-05126",
    "original_inquiry": "Second opinion requested: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5652
  },
  {
    "request_id": "AM-REQ-2026-05127",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5742
  },
  {
    "request_id": "AM-REQ-2026-05128",
    "original_inquiry": "Second opinion requested: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6201
  },
  {
    "request_id": "AM-REQ-2026-05129",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8848
  },
  {
    "request_id": "AM-REQ-2026-05130",
    "original_inquiry": "Family seeking information: Researcher inquiry: cell therapy manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.805
  },
  {
    "request_id": "AM-REQ-2026-05131",
    "original_inquiry": "Referral from specialist: Neurologist: iPSC-derived neuron patient, exploring cell replacement and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6262
  },
  {
    "request_id": "AM-REQ-2026-05132",
    "original_inquiry": "海外求诊：海外求诊：clinical trial患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.743
  },
  {
    "request_id": "AM-REQ-2026-05133",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 多能干细胞 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7485
  },
  {
    "request_id": "AM-REQ-2026-05134",
    "original_inquiry": "海外求诊：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7482
  },
  {
    "request_id": "AM-REQ-2026-05135",
    "original_inquiry": "Referral from specialist: Neurologist: 帕金森 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8746
  },
  {
    "request_id": "AM-REQ-2026-05136",
    "original_inquiry": "海外求诊：Family seeking 帕金森 therapy for spinal cord injury; request centers with iPSC programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.891
  },
  {
    "request_id": "AM-REQ-2026-05137",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.762
  },
  {
    "request_id": "AM-REQ-2026-05138",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5452
  },
  {
    "request_id": "AM-REQ-2026-05139",
    "original_inquiry": "研究者咨询：Researcher inquiry: clinical trial manufacturing and spinal cord injury transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8018
  },
  {
    "request_id": "AM-REQ-2026-05140",
    "original_inquiry": "Cardiologist referral: clinical trial with reduced EF; interested in cell replacement or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7368
  },
  {
    "request_id": "AM-REQ-2026-05141",
    "original_inquiry": "Family seeking regenerative medicine therapy for organoid; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5427
  },
  {
    "request_id": "AM-REQ-2026-05142",
    "original_inquiry": "Referral from specialist: Cardiologist referral: cell therapy with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5835
  },
  {
    "request_id": "AM-REQ-2026-05143",
    "original_inquiry": "Urgent: Consultation: clinical trial with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6134
  },
  {
    "request_id": "AM-REQ-2026-05144",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5928
  },
  {
    "request_id": "AM-REQ-2026-05145",
    "original_inquiry": "Second opinion requested: Patient with advanced iPSC-derived neuron; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-05146",
    "original_inquiry": "Second opinion requested: Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8423
  },
  {
    "request_id": "AM-REQ-2026-05147",
    "original_inquiry": "Consultation: clinical trial with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6872
  },
  {
    "request_id": "AM-REQ-2026-05148",
    "original_inquiry": "Second opinion requested: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6066
  },
  {
    "request_id": "AM-REQ-2026-05149",
    "original_inquiry": "研究者咨询：Researcher inquiry: cell therapy manufacturing and heart failure transplantation for iPSC; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8316
  },
  {
    "request_id": "AM-REQ-2026-05150",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8015
  },
  {
    "request_id": "AM-REQ-2026-05151",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 类器官移植 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6237
  },
  {
    "request_id": "AM-REQ-2026-05152",
    "original_inquiry": "患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8614
  },
  {
    "request_id": "AM-REQ-2026-05153",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.842
  },
  {
    "request_id": "AM-REQ-2026-05154",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-05155",
    "original_inquiry": "Second opinion requested: Patient with advanced cell therapy; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5011
  },
  {
    "request_id": "AM-REQ-2026-05156",
    "original_inquiry": "Family seeking information: Researcher inquiry: cell therapy manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8431
  },
  {
    "request_id": "AM-REQ-2026-05157",
    "original_inquiry": "Second opinion requested: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5975
  },
  {
    "request_id": "AM-REQ-2026-05158",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for heart failure; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5264
  },
  {
    "request_id": "AM-REQ-2026-05159",
    "original_inquiry": "Urgent: Family seeking cell therapy therapy for cell replacement; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5889
  },
  {
    "request_id": "AM-REQ-2026-05160",
    "original_inquiry": "Neurologist: cell therapy patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7369
  },
  {
    "request_id": "AM-REQ-2026-05161",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5048
  },
  {
    "request_id": "AM-REQ-2026-05162",
    "original_inquiry": "Family seeking information: 海外求诊：clinical trial患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8281
  },
  {
    "request_id": "AM-REQ-2026-05163",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6254
  },
  {
    "request_id": "AM-REQ-2026-05164",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for Parkinson; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-05165",
    "original_inquiry": "研究者咨询：海外求诊：类器官移植患者，希望评估spinal cord injury或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7665
  },
  {
    "request_id": "AM-REQ-2026-05166",
    "original_inquiry": "Urgent: 海外求诊：多能干细胞患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5046
  },
  {
    "request_id": "AM-REQ-2026-05167",
    "original_inquiry": "Patient with advanced 干细胞分化; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.716
  },
  {
    "request_id": "AM-REQ-2026-05168",
    "original_inquiry": "海外求诊：Cardiologist referral: 多能干细胞 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6217
  },
  {
    "request_id": "AM-REQ-2026-05169",
    "original_inquiry": "Referral from specialist: Family seeking 多能干细胞 therapy for Parkinson; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7826
  },
  {
    "request_id": "AM-REQ-2026-05170",
    "original_inquiry": "Family seeking information: Patient with advanced 干细胞分化; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6147
  },
  {
    "request_id": "AM-REQ-2026-05171",
    "original_inquiry": "研究者咨询：Family seeking clinical trial therapy for cell replacement; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7948
  },
  {
    "request_id": "AM-REQ-2026-05172",
    "original_inquiry": "Urgent: Researcher inquiry: 类器官移植 manufacturing and cardiomyocyte transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8888
  },
  {
    "request_id": "AM-REQ-2026-05173",
    "original_inquiry": "Referral from specialist: Family seeking clinical trial therapy for cell replacement; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5822
  },
  {
    "request_id": "AM-REQ-2026-05174",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.653
  },
  {
    "request_id": "AM-REQ-2026-05175",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5414
  },
  {
    "request_id": "AM-REQ-2026-05176",
    "original_inquiry": "Urgent: Patient with advanced regenerative medicine; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5598
  },
  {
    "request_id": "AM-REQ-2026-05177",
    "original_inquiry": "海外求诊：Consultation: clinical trial with spinal cord injury; interested in spinal cord injury or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8644
  },
  {
    "request_id": "AM-REQ-2026-05178",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for cardiomyocyte; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5614
  },
  {
    "request_id": "AM-REQ-2026-05179",
    "original_inquiry": "Referral from specialist: Family seeking 干细胞分化 therapy for cell replacement; request centers with iPSC programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.571
  },
  {
    "request_id": "AM-REQ-2026-05180",
    "original_inquiry": "研究者咨询：Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5289
  },
  {
    "request_id": "AM-REQ-2026-05181",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8985
  },
  {
    "request_id": "AM-REQ-2026-05182",
    "original_inquiry": "Urgent: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5536
  },
  {
    "request_id": "AM-REQ-2026-05183",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8322
  },
  {
    "request_id": "AM-REQ-2026-05184",
    "original_inquiry": "Family seeking information: Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5002
  },
  {
    "request_id": "AM-REQ-2026-05185",
    "original_inquiry": "Cardiologist referral: regenerative medicine with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7214
  },
  {
    "request_id": "AM-REQ-2026-05186",
    "original_inquiry": "Urgent: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5424
  },
  {
    "request_id": "AM-REQ-2026-05187",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 多能干细胞 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8094
  },
  {
    "request_id": "AM-REQ-2026-05188",
    "original_inquiry": "海外求诊：Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5858
  },
  {
    "request_id": "AM-REQ-2026-05189",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and cardiomyocyte transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8876
  },
  {
    "request_id": "AM-REQ-2026-05190",
    "original_inquiry": "Second opinion requested: Consultation: iPSC-derived neuron with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8204
  },
  {
    "request_id": "AM-REQ-2026-05191",
    "original_inquiry": "Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.581
  },
  {
    "request_id": "AM-REQ-2026-05192",
    "original_inquiry": "Consultation: regenerative medicine with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6905
  },
  {
    "request_id": "AM-REQ-2026-05193",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8498
  },
  {
    "request_id": "AM-REQ-2026-05194",
    "original_inquiry": "研究者咨询：海外求诊：iPSC-derived neuron患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.607
  },
  {
    "request_id": "AM-REQ-2026-05195",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.583
  },
  {
    "request_id": "AM-REQ-2026-05196",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估organoid或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7732
  },
  {
    "request_id": "AM-REQ-2026-05197",
    "original_inquiry": "海外求诊：Patient with advanced regenerative medicine; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6517
  },
  {
    "request_id": "AM-REQ-2026-05198",
    "original_inquiry": "Family seeking information: Researcher inquiry: clinical trial manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8242
  },
  {
    "request_id": "AM-REQ-2026-05199",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5144
  },
  {
    "request_id": "AM-REQ-2026-05200",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7966
  },
  {
    "request_id": "AM-REQ-2026-05201",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7223
  },
  {
    "request_id": "AM-REQ-2026-05202",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6234
  },
  {
    "request_id": "AM-REQ-2026-05203",
    "original_inquiry": "Family seeking information: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.751
  },
  {
    "request_id": "AM-REQ-2026-05204",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and Parkinson transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7024
  },
  {
    "request_id": "AM-REQ-2026-05205",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6265
  },
  {
    "request_id": "AM-REQ-2026-05206",
    "original_inquiry": "海外求诊：Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7877
  },
  {
    "request_id": "AM-REQ-2026-05207",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.664
  },
  {
    "request_id": "AM-REQ-2026-05208",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and organoid transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8453
  },
  {
    "request_id": "AM-REQ-2026-05209",
    "original_inquiry": "患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6136
  },
  {
    "request_id": "AM-REQ-2026-05210",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5695
  },
  {
    "request_id": "AM-REQ-2026-05211",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7366
  },
  {
    "request_id": "AM-REQ-2026-05212",
    "original_inquiry": "Urgent: Researcher inquiry: regenerative medicine manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7425
  },
  {
    "request_id": "AM-REQ-2026-05213",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8613
  },
  {
    "request_id": "AM-REQ-2026-05214",
    "original_inquiry": "Referral from specialist: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8379
  },
  {
    "request_id": "AM-REQ-2026-05215",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.708
  },
  {
    "request_id": "AM-REQ-2026-05216",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8282
  },
  {
    "request_id": "AM-REQ-2026-05217",
    "original_inquiry": "Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6521
  },
  {
    "request_id": "AM-REQ-2026-05218",
    "original_inquiry": "Cardiologist referral: regenerative medicine with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7387
  },
  {
    "request_id": "AM-REQ-2026-05219",
    "original_inquiry": "Family seeking information: 海外求诊：regenerative medicine患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8794
  },
  {
    "request_id": "AM-REQ-2026-05220",
    "original_inquiry": "Family seeking information: Consultation: 类器官移植 with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8759
  },
  {
    "request_id": "AM-REQ-2026-05221",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5696
  },
  {
    "request_id": "AM-REQ-2026-05222",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8823
  },
  {
    "request_id": "AM-REQ-2026-05223",
    "original_inquiry": "海外求诊：海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.539
  },
  {
    "request_id": "AM-REQ-2026-05224",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5929
  },
  {
    "request_id": "AM-REQ-2026-05225",
    "original_inquiry": "Urgent: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7903
  },
  {
    "request_id": "AM-REQ-2026-05226",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-05227",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.796
  },
  {
    "request_id": "AM-REQ-2026-05228",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7142
  },
  {
    "request_id": "AM-REQ-2026-05229",
    "original_inquiry": "研究者咨询：Consultation: 心肌修复 with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8173
  },
  {
    "request_id": "AM-REQ-2026-05230",
    "original_inquiry": "Family seeking information: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7789
  },
  {
    "request_id": "AM-REQ-2026-05231",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6578
  },
  {
    "request_id": "AM-REQ-2026-05232",
    "original_inquiry": "Family seeking information: Consultation: 多能干细胞 with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6971
  },
  {
    "request_id": "AM-REQ-2026-05233",
    "original_inquiry": "Referral from specialist: Patient with advanced 心肌修复; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7341
  },
  {
    "request_id": "AM-REQ-2026-05234",
    "original_inquiry": "Neurologist: 类器官移植 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.82
  },
  {
    "request_id": "AM-REQ-2026-05235",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6092
  },
  {
    "request_id": "AM-REQ-2026-05236",
    "original_inquiry": "Referral from specialist: Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5295
  },
  {
    "request_id": "AM-REQ-2026-05237",
    "original_inquiry": "Referral from specialist: 海外求诊：干细胞分化患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.773
  },
  {
    "request_id": "AM-REQ-2026-05238",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8869
  },
  {
    "request_id": "AM-REQ-2026-05239",
    "original_inquiry": "Family seeking information: Family seeking 心肌修复 therapy for iPSC; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8776
  },
  {
    "request_id": "AM-REQ-2026-05240",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 帕金森 with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5254
  },
  {
    "request_id": "AM-REQ-2026-05241",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and heart failure transplantation for iPSC; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-05242",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5993
  },
  {
    "request_id": "AM-REQ-2026-05243",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5286
  },
  {
    "request_id": "AM-REQ-2026-05244",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8063
  },
  {
    "request_id": "AM-REQ-2026-05245",
    "original_inquiry": "Second opinion requested: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7571
  },
  {
    "request_id": "AM-REQ-2026-05246",
    "original_inquiry": "Second opinion requested: Neurologist: clinical trial patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-05247",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8827
  },
  {
    "request_id": "AM-REQ-2026-05248",
    "original_inquiry": "Family seeking information: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5044
  },
  {
    "request_id": "AM-REQ-2026-05249",
    "original_inquiry": "患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8472
  },
  {
    "request_id": "AM-REQ-2026-05250",
    "original_inquiry": "海外求诊：Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7826
  },
  {
    "request_id": "AM-REQ-2026-05251",
    "original_inquiry": "海外求诊：Patient with advanced 干细胞分化; seeking cell replacement or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7152
  },
  {
    "request_id": "AM-REQ-2026-05252",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8218
  },
  {
    "request_id": "AM-REQ-2026-05253",
    "original_inquiry": "海外求诊：Patient with advanced iPSC-derived neuron; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5341
  },
  {
    "request_id": "AM-REQ-2026-05254",
    "original_inquiry": "Referral from specialist: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.546
  },
  {
    "request_id": "AM-REQ-2026-05255",
    "original_inquiry": "Family seeking iPSC-derived neuron therapy for heart failure; request centers with cardiomyocyte programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8311
  },
  {
    "request_id": "AM-REQ-2026-05256",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.565
  },
  {
    "request_id": "AM-REQ-2026-05257",
    "original_inquiry": "Family seeking information: Researcher inquiry: 心肌修复 manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-05258",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and iPSC transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.868
  },
  {
    "request_id": "AM-REQ-2026-05259",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in spinal cord injury or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8511
  },
  {
    "request_id": "AM-REQ-2026-05260",
    "original_inquiry": "海外求诊：Researcher inquiry: 类器官移植 manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7523
  },
  {
    "request_id": "AM-REQ-2026-05261",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6801
  },
  {
    "request_id": "AM-REQ-2026-05262",
    "original_inquiry": "Urgent: Cardiologist referral: 心肌修复 with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6979
  },
  {
    "request_id": "AM-REQ-2026-05263",
    "original_inquiry": "研究者咨询：Neurologist: 类器官移植 patient, exploring heart failure and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5694
  },
  {
    "request_id": "AM-REQ-2026-05264",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6513
  },
  {
    "request_id": "AM-REQ-2026-05265",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7256
  },
  {
    "request_id": "AM-REQ-2026-05266",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and spinal cord injury transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5116
  },
  {
    "request_id": "AM-REQ-2026-05267",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7873
  },
  {
    "request_id": "AM-REQ-2026-05268",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for induced pluripotent stem cell; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.769
  },
  {
    "request_id": "AM-REQ-2026-05269",
    "original_inquiry": "研究者咨询：Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8437
  },
  {
    "request_id": "AM-REQ-2026-05270",
    "original_inquiry": "海外求诊：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5789
  },
  {
    "request_id": "AM-REQ-2026-05271",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6874
  },
  {
    "request_id": "AM-REQ-2026-05272",
    "original_inquiry": "Family seeking information: Family seeking iPSC-derived neuron therapy for heart failure; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5551
  },
  {
    "request_id": "AM-REQ-2026-05273",
    "original_inquiry": "Consultation: 多能干细胞 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.61
  },
  {
    "request_id": "AM-REQ-2026-05274",
    "original_inquiry": "海外求诊：Consultation: clinical trial with spinal cord injury; interested in heart failure or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.638
  },
  {
    "request_id": "AM-REQ-2026-05275",
    "original_inquiry": "Family seeking 干细胞分化 therapy for dopaminergic neuron; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7344
  },
  {
    "request_id": "AM-REQ-2026-05276",
    "original_inquiry": "Urgent: Neurologist: clinical trial patient, exploring cardiomyocyte and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7336
  },
  {
    "request_id": "AM-REQ-2026-05277",
    "original_inquiry": "Cardiologist referral: regenerative medicine with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.653
  },
  {
    "request_id": "AM-REQ-2026-05278",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 帕金森 manufacturing and organoid transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8765
  },
  {
    "request_id": "AM-REQ-2026-05279",
    "original_inquiry": "Referral from specialist: Consultation: 帕金森 with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7665
  },
  {
    "request_id": "AM-REQ-2026-05280",
    "original_inquiry": "Urgent: Researcher inquiry: regenerative medicine manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8475
  },
  {
    "request_id": "AM-REQ-2026-05281",
    "original_inquiry": "Urgent: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.717
  },
  {
    "request_id": "AM-REQ-2026-05282",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.618
  },
  {
    "request_id": "AM-REQ-2026-05283",
    "original_inquiry": "研究者咨询：Neurologist: 干细胞分化 patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.619
  },
  {
    "request_id": "AM-REQ-2026-05284",
    "original_inquiry": "研究者咨询：海外求诊：多能干细胞患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6759
  },
  {
    "request_id": "AM-REQ-2026-05285",
    "original_inquiry": "Urgent: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5071
  },
  {
    "request_id": "AM-REQ-2026-05286",
    "original_inquiry": "海外求诊：Family seeking clinical trial therapy for dopaminergic neuron; request centers with cardiomyocyte programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.603
  },
  {
    "request_id": "AM-REQ-2026-05287",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.871
  },
  {
    "request_id": "AM-REQ-2026-05288",
    "original_inquiry": "Neurologist: 多能干细胞 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5739
  },
  {
    "request_id": "AM-REQ-2026-05289",
    "original_inquiry": "Referral from specialist: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8314
  },
  {
    "request_id": "AM-REQ-2026-05290",
    "original_inquiry": "Urgent: Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8788
  },
  {
    "request_id": "AM-REQ-2026-05291",
    "original_inquiry": "Consultation: 多能干细胞 with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6622
  },
  {
    "request_id": "AM-REQ-2026-05292",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6618
  },
  {
    "request_id": "AM-REQ-2026-05293",
    "original_inquiry": "海外求诊：Cardiologist referral: 多能干细胞 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7935
  },
  {
    "request_id": "AM-REQ-2026-05294",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7578
  },
  {
    "request_id": "AM-REQ-2026-05295",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring spinal cord injury and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5953
  },
  {
    "request_id": "AM-REQ-2026-05296",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and Parkinson transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5605
  },
  {
    "request_id": "AM-REQ-2026-05297",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 干细胞分化 manufacturing and organoid transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6655
  },
  {
    "request_id": "AM-REQ-2026-05298",
    "original_inquiry": "Referral from specialist: Family seeking iPSC-derived neuron therapy for spinal cord injury; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7347
  },
  {
    "request_id": "AM-REQ-2026-05299",
    "original_inquiry": "Second opinion requested: 海外求诊：clinical trial患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5479
  },
  {
    "request_id": "AM-REQ-2026-05300",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8451
  },
  {
    "request_id": "AM-REQ-2026-05301",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.612
  },
  {
    "request_id": "AM-REQ-2026-05302",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7992
  },
  {
    "request_id": "AM-REQ-2026-05303",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.685
  },
  {
    "request_id": "AM-REQ-2026-05304",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5263
  },
  {
    "request_id": "AM-REQ-2026-05305",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6978
  },
  {
    "request_id": "AM-REQ-2026-05306",
    "original_inquiry": "研究者咨询：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8059
  },
  {
    "request_id": "AM-REQ-2026-05307",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5668
  },
  {
    "request_id": "AM-REQ-2026-05308",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7309
  },
  {
    "request_id": "AM-REQ-2026-05309",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6798
  },
  {
    "request_id": "AM-REQ-2026-05310",
    "original_inquiry": "Referral from specialist: Patient with advanced 心肌修复; seeking organoid or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5877
  },
  {
    "request_id": "AM-REQ-2026-05311",
    "original_inquiry": "Second opinion requested: Family seeking regenerative medicine therapy for Parkinson; request centers with cardiomyocyte programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8107
  },
  {
    "request_id": "AM-REQ-2026-05312",
    "original_inquiry": "Family seeking information: 海外求诊：干细胞分化患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8511
  },
  {
    "request_id": "AM-REQ-2026-05313",
    "original_inquiry": "研究者咨询：Patient with advanced 心肌修复; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5255
  },
  {
    "request_id": "AM-REQ-2026-05314",
    "original_inquiry": "Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.798
  },
  {
    "request_id": "AM-REQ-2026-05315",
    "original_inquiry": "Family seeking 帕金森 therapy for dopaminergic neuron; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6121
  },
  {
    "request_id": "AM-REQ-2026-05316",
    "original_inquiry": "海外求诊：Patient with advanced 干细胞分化; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6152
  },
  {
    "request_id": "AM-REQ-2026-05317",
    "original_inquiry": "海外求诊：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6977
  },
  {
    "request_id": "AM-REQ-2026-05318",
    "original_inquiry": "Second opinion requested: Researcher inquiry: clinical trial manufacturing and cardiomyocyte transplantation for organoid; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8303
  },
  {
    "request_id": "AM-REQ-2026-05319",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring cardiomyocyte and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6424
  },
  {
    "request_id": "AM-REQ-2026-05320",
    "original_inquiry": "海外求诊：海外求诊：iPSC-derived neuron患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7784
  },
  {
    "request_id": "AM-REQ-2026-05321",
    "original_inquiry": "Second opinion requested: Researcher inquiry: iPSC-derived neuron manufacturing and heart failure transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6807
  },
  {
    "request_id": "AM-REQ-2026-05322",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估spinal cord injury或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6277
  },
  {
    "request_id": "AM-REQ-2026-05323",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6275
  },
  {
    "request_id": "AM-REQ-2026-05324",
    "original_inquiry": "海外求诊：Consultation: 类器官移植 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5468
  },
  {
    "request_id": "AM-REQ-2026-05325",
    "original_inquiry": "Urgent: Patient with advanced iPSC-derived neuron; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6585
  },
  {
    "request_id": "AM-REQ-2026-05326",
    "original_inquiry": "海外求诊：Family seeking clinical trial therapy for Parkinson; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7975
  },
  {
    "request_id": "AM-REQ-2026-05327",
    "original_inquiry": "Second opinion requested: Neurologist: 干细胞分化 patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8534
  },
  {
    "request_id": "AM-REQ-2026-05328",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.659
  },
  {
    "request_id": "AM-REQ-2026-05329",
    "original_inquiry": "Patient with advanced 类器官移植; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.527
  },
  {
    "request_id": "AM-REQ-2026-05330",
    "original_inquiry": "海外求诊：Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8249
  },
  {
    "request_id": "AM-REQ-2026-05331",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6803
  },
  {
    "request_id": "AM-REQ-2026-05332",
    "original_inquiry": "Family seeking information: Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7771
  },
  {
    "request_id": "AM-REQ-2026-05333",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5298
  },
  {
    "request_id": "AM-REQ-2026-05334",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7675
  },
  {
    "request_id": "AM-REQ-2026-05335",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7749
  },
  {
    "request_id": "AM-REQ-2026-05336",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6193
  },
  {
    "request_id": "AM-REQ-2026-05337",
    "original_inquiry": "Urgent: 海外求诊：iPSC-derived neuron患者，希望评估iPSC或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7412
  },
  {
    "request_id": "AM-REQ-2026-05338",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8047
  },
  {
    "request_id": "AM-REQ-2026-05339",
    "original_inquiry": "研究者咨询：Patient with advanced clinical trial; seeking organoid or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5101
  },
  {
    "request_id": "AM-REQ-2026-05340",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6285
  },
  {
    "request_id": "AM-REQ-2026-05341",
    "original_inquiry": "Second opinion requested: Family seeking 多能干细胞 therapy for heart failure; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7236
  },
  {
    "request_id": "AM-REQ-2026-05342",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8504
  },
  {
    "request_id": "AM-REQ-2026-05343",
    "original_inquiry": "Referral from specialist: Family seeking iPSC-derived neuron therapy for Parkinson; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8963
  },
  {
    "request_id": "AM-REQ-2026-05344",
    "original_inquiry": "海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5363
  },
  {
    "request_id": "AM-REQ-2026-05345",
    "original_inquiry": "海外求诊：心肌修复患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5418
  },
  {
    "request_id": "AM-REQ-2026-05346",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 干细胞分化 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5863
  },
  {
    "request_id": "AM-REQ-2026-05347",
    "original_inquiry": "Urgent: Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6705
  },
  {
    "request_id": "AM-REQ-2026-05348",
    "original_inquiry": "Referral from specialist: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8312
  },
  {
    "request_id": "AM-REQ-2026-05349",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6589
  },
  {
    "request_id": "AM-REQ-2026-05350",
    "original_inquiry": "海外求诊：Researcher inquiry: 帕金森 manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8783
  },
  {
    "request_id": "AM-REQ-2026-05351",
    "original_inquiry": "研究者咨询：Neurologist: clinical trial patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5069
  },
  {
    "request_id": "AM-REQ-2026-05352",
    "original_inquiry": "Second opinion requested: Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7156
  },
  {
    "request_id": "AM-REQ-2026-05353",
    "original_inquiry": "Second opinion requested: Family seeking iPSC-derived neuron therapy for spinal cord injury; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6687
  },
  {
    "request_id": "AM-REQ-2026-05354",
    "original_inquiry": "Family seeking information: Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6566
  },
  {
    "request_id": "AM-REQ-2026-05355",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5544
  },
  {
    "request_id": "AM-REQ-2026-05356",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7884
  },
  {
    "request_id": "AM-REQ-2026-05357",
    "original_inquiry": "研究者咨询：Neurologist: 心肌修复 patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5293
  },
  {
    "request_id": "AM-REQ-2026-05358",
    "original_inquiry": "Urgent: Patient with advanced 类器官移植; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7011
  },
  {
    "request_id": "AM-REQ-2026-05359",
    "original_inquiry": "Urgent: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.673
  },
  {
    "request_id": "AM-REQ-2026-05360",
    "original_inquiry": "Second opinion requested: Patient with advanced 帕金森; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5041
  },
  {
    "request_id": "AM-REQ-2026-05361",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for heart failure; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5098
  },
  {
    "request_id": "AM-REQ-2026-05362",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8752
  },
  {
    "request_id": "AM-REQ-2026-05363",
    "original_inquiry": "研究者咨询：海外求诊：类器官移植患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8899
  },
  {
    "request_id": "AM-REQ-2026-05364",
    "original_inquiry": "Family seeking information: Cardiologist referral: 帕金森 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6814
  },
  {
    "request_id": "AM-REQ-2026-05365",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7507
  },
  {
    "request_id": "AM-REQ-2026-05366",
    "original_inquiry": "Family seeking information: Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-05367",
    "original_inquiry": "Family seeking 多能干细胞 therapy for Parkinson; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6064
  },
  {
    "request_id": "AM-REQ-2026-05368",
    "original_inquiry": "Second opinion requested: Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5175
  },
  {
    "request_id": "AM-REQ-2026-05369",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for dopaminergic neuron; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8809
  },
  {
    "request_id": "AM-REQ-2026-05370",
    "original_inquiry": "Second opinion requested: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5411
  },
  {
    "request_id": "AM-REQ-2026-05371",
    "original_inquiry": "研究者咨询：Cardiologist referral: 心肌修复 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7601
  },
  {
    "request_id": "AM-REQ-2026-05372",
    "original_inquiry": "海外求诊：海外求诊：干细胞分化患者，希望评估iPSC或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5575
  },
  {
    "request_id": "AM-REQ-2026-05373",
    "original_inquiry": "Family seeking information: 海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8963
  },
  {
    "request_id": "AM-REQ-2026-05374",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.81
  },
  {
    "request_id": "AM-REQ-2026-05375",
    "original_inquiry": "海外求诊：Neurologist: 帕金森 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8018
  },
  {
    "request_id": "AM-REQ-2026-05376",
    "original_inquiry": "Family seeking 多能干细胞 therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6366
  },
  {
    "request_id": "AM-REQ-2026-05377",
    "original_inquiry": "患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6897
  },
  {
    "request_id": "AM-REQ-2026-05378",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8734
  },
  {
    "request_id": "AM-REQ-2026-05379",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6252
  },
  {
    "request_id": "AM-REQ-2026-05380",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8189
  },
  {
    "request_id": "AM-REQ-2026-05381",
    "original_inquiry": "研究者咨询：Researcher inquiry: clinical trial manufacturing and cardiomyocyte transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7939
  },
  {
    "request_id": "AM-REQ-2026-05382",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for Parkinson; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7468
  },
  {
    "request_id": "AM-REQ-2026-05383",
    "original_inquiry": "Family seeking information: Patient with advanced 帕金森; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8714
  },
  {
    "request_id": "AM-REQ-2026-05384",
    "original_inquiry": "海外求诊：Patient with advanced regenerative medicine; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7296
  },
  {
    "request_id": "AM-REQ-2026-05385",
    "original_inquiry": "Second opinion requested: Family seeking 心肌修复 therapy for Parkinson; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7255
  },
  {
    "request_id": "AM-REQ-2026-05386",
    "original_inquiry": "Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6413
  },
  {
    "request_id": "AM-REQ-2026-05387",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8082
  },
  {
    "request_id": "AM-REQ-2026-05388",
    "original_inquiry": "海外求诊：Cardiologist referral: clinical trial with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8633
  },
  {
    "request_id": "AM-REQ-2026-05389",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6597
  },
  {
    "request_id": "AM-REQ-2026-05390",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 干细胞分化 with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8104
  },
  {
    "request_id": "AM-REQ-2026-05391",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8114
  },
  {
    "request_id": "AM-REQ-2026-05392",
    "original_inquiry": "研究者咨询：海外求诊：iPSC-derived neuron患者，希望评估cell replacement或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6314
  },
  {
    "request_id": "AM-REQ-2026-05393",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for cell replacement; request centers with iPSC programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7079
  },
  {
    "request_id": "AM-REQ-2026-05394",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5764
  },
  {
    "request_id": "AM-REQ-2026-05395",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5084
  },
  {
    "request_id": "AM-REQ-2026-05396",
    "original_inquiry": "海外求诊：Cardiologist referral: cell therapy with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8849
  },
  {
    "request_id": "AM-REQ-2026-05397",
    "original_inquiry": "Urgent: Consultation: 类器官移植 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-05398",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7175
  },
  {
    "request_id": "AM-REQ-2026-05399",
    "original_inquiry": "Family seeking information: Consultation: 多能干细胞 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8264
  },
  {
    "request_id": "AM-REQ-2026-05400",
    "original_inquiry": "Family seeking information: Consultation: 类器官移植 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8133
  },
  {
    "request_id": "AM-REQ-2026-05401",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8222
  },
  {
    "request_id": "AM-REQ-2026-05402",
    "original_inquiry": "Neurologist: cell therapy patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5673
  },
  {
    "request_id": "AM-REQ-2026-05403",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5576
  },
  {
    "request_id": "AM-REQ-2026-05404",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6576
  },
  {
    "request_id": "AM-REQ-2026-05405",
    "original_inquiry": "Urgent: 海外求诊：类器官移植患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5651
  },
  {
    "request_id": "AM-REQ-2026-05406",
    "original_inquiry": "Family seeking information: Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7753
  },
  {
    "request_id": "AM-REQ-2026-05407",
    "original_inquiry": "Urgent: Patient with advanced 类器官移植; seeking spinal cord injury or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7752
  },
  {
    "request_id": "AM-REQ-2026-05408",
    "original_inquiry": "研究者咨询：患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5078
  },
  {
    "request_id": "AM-REQ-2026-05409",
    "original_inquiry": "Urgent: Neurologist: cell therapy patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7633
  },
  {
    "request_id": "AM-REQ-2026-05410",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.731
  },
  {
    "request_id": "AM-REQ-2026-05411",
    "original_inquiry": "Second opinion requested: Family seeking 心肌修复 therapy for Parkinson; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8276
  },
  {
    "request_id": "AM-REQ-2026-05412",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5107
  },
  {
    "request_id": "AM-REQ-2026-05413",
    "original_inquiry": "Cardiologist referral: 类器官移植 with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5583
  },
  {
    "request_id": "AM-REQ-2026-05414",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7368
  },
  {
    "request_id": "AM-REQ-2026-05415",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6043
  },
  {
    "request_id": "AM-REQ-2026-05416",
    "original_inquiry": "Second opinion requested: Consultation: 多能干细胞 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8819
  },
  {
    "request_id": "AM-REQ-2026-05417",
    "original_inquiry": "研究者咨询：Family seeking 类器官移植 therapy for iPSC; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5235
  },
  {
    "request_id": "AM-REQ-2026-05418",
    "original_inquiry": "Referral from specialist: 海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.598
  },
  {
    "request_id": "AM-REQ-2026-05419",
    "original_inquiry": "Family seeking regenerative medicine therapy for cell replacement; request centers with dopaminergic neuron programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8219
  },
  {
    "request_id": "AM-REQ-2026-05420",
    "original_inquiry": "Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6292
  },
  {
    "request_id": "AM-REQ-2026-05421",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8097
  },
  {
    "request_id": "AM-REQ-2026-05422",
    "original_inquiry": "海外求诊：iPSC-derived neuron患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6232
  },
  {
    "request_id": "AM-REQ-2026-05423",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for heart failure; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5376
  },
  {
    "request_id": "AM-REQ-2026-05424",
    "original_inquiry": "Family seeking information: Consultation: iPSC-derived neuron with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8465
  },
  {
    "request_id": "AM-REQ-2026-05425",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8888
  },
  {
    "request_id": "AM-REQ-2026-05426",
    "original_inquiry": "海外求诊：Researcher inquiry: regenerative medicine manufacturing and Parkinson transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8176
  },
  {
    "request_id": "AM-REQ-2026-05427",
    "original_inquiry": "Family seeking information: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7071
  },
  {
    "request_id": "AM-REQ-2026-05428",
    "original_inquiry": "Urgent: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6158
  },
  {
    "request_id": "AM-REQ-2026-05429",
    "original_inquiry": "研究者咨询：Family seeking 类器官移植 therapy for organoid; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8051
  },
  {
    "request_id": "AM-REQ-2026-05430",
    "original_inquiry": "研究者咨询：患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8271
  },
  {
    "request_id": "AM-REQ-2026-05431",
    "original_inquiry": "研究者咨询：Family seeking cell therapy therapy for cardiomyocyte; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.623
  },
  {
    "request_id": "AM-REQ-2026-05432",
    "original_inquiry": "Second opinion requested: 海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8627
  },
  {
    "request_id": "AM-REQ-2026-05433",
    "original_inquiry": "海外求诊：Family seeking iPSC-derived neuron therapy for iPSC; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8627
  },
  {
    "request_id": "AM-REQ-2026-05434",
    "original_inquiry": "Urgent: Family seeking 心肌修复 therapy for Parkinson; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5362
  },
  {
    "request_id": "AM-REQ-2026-05435",
    "original_inquiry": "Family seeking information: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-05436",
    "original_inquiry": "Urgent: Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7249
  },
  {
    "request_id": "AM-REQ-2026-05437",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8171
  },
  {
    "request_id": "AM-REQ-2026-05438",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7554
  },
  {
    "request_id": "AM-REQ-2026-05439",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring spinal cord injury and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5657
  },
  {
    "request_id": "AM-REQ-2026-05440",
    "original_inquiry": "研究者咨询：Family seeking 多能干细胞 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7738
  },
  {
    "request_id": "AM-REQ-2026-05441",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.534
  },
  {
    "request_id": "AM-REQ-2026-05442",
    "original_inquiry": "研究者咨询：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7899
  },
  {
    "request_id": "AM-REQ-2026-05443",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8693
  },
  {
    "request_id": "AM-REQ-2026-05444",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and cell replacement transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6891
  },
  {
    "request_id": "AM-REQ-2026-05445",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 干细胞分化 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-05446",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8306
  },
  {
    "request_id": "AM-REQ-2026-05447",
    "original_inquiry": "Referral from specialist: Family seeking 帕金森 therapy for iPSC; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6925
  },
  {
    "request_id": "AM-REQ-2026-05448",
    "original_inquiry": "Urgent: Cardiologist referral: regenerative medicine with reduced EF; interested in spinal cord injury or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8104
  },
  {
    "request_id": "AM-REQ-2026-05449",
    "original_inquiry": "海外求诊：Consultation: 心肌修复 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8176
  },
  {
    "request_id": "AM-REQ-2026-05450",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5128
  },
  {
    "request_id": "AM-REQ-2026-05451",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8926
  },
  {
    "request_id": "AM-REQ-2026-05452",
    "original_inquiry": "Urgent: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5538
  },
  {
    "request_id": "AM-REQ-2026-05453",
    "original_inquiry": "Urgent: Cardiologist referral: 心肌修复 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6915
  },
  {
    "request_id": "AM-REQ-2026-05454",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8455
  },
  {
    "request_id": "AM-REQ-2026-05455",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5184
  },
  {
    "request_id": "AM-REQ-2026-05456",
    "original_inquiry": "Referral from specialist: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.709
  },
  {
    "request_id": "AM-REQ-2026-05457",
    "original_inquiry": "Second opinion requested: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7183
  },
  {
    "request_id": "AM-REQ-2026-05458",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.712
  },
  {
    "request_id": "AM-REQ-2026-05459",
    "original_inquiry": "海外求诊：Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6153
  },
  {
    "request_id": "AM-REQ-2026-05460",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6035
  },
  {
    "request_id": "AM-REQ-2026-05461",
    "original_inquiry": "海外求诊：iPSC-derived neuron患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8038
  },
  {
    "request_id": "AM-REQ-2026-05462",
    "original_inquiry": "Neurologist: clinical trial patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7814
  },
  {
    "request_id": "AM-REQ-2026-05463",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for spinal cord injury; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8185
  },
  {
    "request_id": "AM-REQ-2026-05464",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7176
  },
  {
    "request_id": "AM-REQ-2026-05465",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7703
  },
  {
    "request_id": "AM-REQ-2026-05466",
    "original_inquiry": "海外求诊：iPSC-derived neuron患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7233
  },
  {
    "request_id": "AM-REQ-2026-05467",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7543
  },
  {
    "request_id": "AM-REQ-2026-05468",
    "original_inquiry": "Referral from specialist: Family seeking 类器官移植 therapy for spinal cord injury; request centers with iPSC programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6126
  },
  {
    "request_id": "AM-REQ-2026-05469",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7606
  },
  {
    "request_id": "AM-REQ-2026-05470",
    "original_inquiry": "Family seeking 帕金森 therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7744
  },
  {
    "request_id": "AM-REQ-2026-05471",
    "original_inquiry": "Urgent: Consultation: regenerative medicine with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7517
  },
  {
    "request_id": "AM-REQ-2026-05472",
    "original_inquiry": "海外求诊：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8016
  },
  {
    "request_id": "AM-REQ-2026-05473",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5602
  },
  {
    "request_id": "AM-REQ-2026-05474",
    "original_inquiry": "Neurologist: 类器官移植 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8267
  },
  {
    "request_id": "AM-REQ-2026-05475",
    "original_inquiry": "Family seeking information: Cardiologist referral: regenerative medicine with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7336
  },
  {
    "request_id": "AM-REQ-2026-05476",
    "original_inquiry": "Second opinion requested: Family seeking 心肌修复 therapy for spinal cord injury; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8625
  },
  {
    "request_id": "AM-REQ-2026-05477",
    "original_inquiry": "Family seeking information: Researcher inquiry: 类器官移植 manufacturing and cell replacement transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5023
  },
  {
    "request_id": "AM-REQ-2026-05478",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7115
  },
  {
    "request_id": "AM-REQ-2026-05479",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7274
  },
  {
    "request_id": "AM-REQ-2026-05480",
    "original_inquiry": "Family seeking information: Consultation: 帕金森 with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5166
  },
  {
    "request_id": "AM-REQ-2026-05481",
    "original_inquiry": "Referral from specialist: Cardiologist referral: cell therapy with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6994
  },
  {
    "request_id": "AM-REQ-2026-05482",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7881
  },
  {
    "request_id": "AM-REQ-2026-05483",
    "original_inquiry": "Family seeking information: Researcher inquiry: cell therapy manufacturing and organoid transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8312
  },
  {
    "request_id": "AM-REQ-2026-05484",
    "original_inquiry": "Urgent: Neurologist: 干细胞分化 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8865
  },
  {
    "request_id": "AM-REQ-2026-05485",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7061
  },
  {
    "request_id": "AM-REQ-2026-05486",
    "original_inquiry": "Second opinion requested: Consultation: 干细胞分化 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6499
  },
  {
    "request_id": "AM-REQ-2026-05487",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7647
  },
  {
    "request_id": "AM-REQ-2026-05488",
    "original_inquiry": "Referral from specialist: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7659
  },
  {
    "request_id": "AM-REQ-2026-05489",
    "original_inquiry": "Neurologist: iPSC-derived neuron patient, exploring heart failure and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8977
  },
  {
    "request_id": "AM-REQ-2026-05490",
    "original_inquiry": "Referral from specialist: Neurologist: clinical trial patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8085
  },
  {
    "request_id": "AM-REQ-2026-05491",
    "original_inquiry": "Family seeking cell therapy therapy for spinal cord injury; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5801
  },
  {
    "request_id": "AM-REQ-2026-05492",
    "original_inquiry": "Urgent: Cardiologist referral: 心肌修复 with reduced EF; interested in iPSC or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5531
  },
  {
    "request_id": "AM-REQ-2026-05493",
    "original_inquiry": "Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7799
  },
  {
    "request_id": "AM-REQ-2026-05494",
    "original_inquiry": "研究者咨询：Neurologist: 类器官移植 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5099
  },
  {
    "request_id": "AM-REQ-2026-05495",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8159
  },
  {
    "request_id": "AM-REQ-2026-05496",
    "original_inquiry": "Referral from specialist: 海外求诊：干细胞分化患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6005
  },
  {
    "request_id": "AM-REQ-2026-05497",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5306
  },
  {
    "request_id": "AM-REQ-2026-05498",
    "original_inquiry": "Referral from specialist: 海外求诊：clinical trial患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8045
  },
  {
    "request_id": "AM-REQ-2026-05499",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.573
  },
  {
    "request_id": "AM-REQ-2026-05500",
    "original_inquiry": "研究者咨询：Consultation: regenerative medicine with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6651
  },
  {
    "request_id": "AM-REQ-2026-05501",
    "original_inquiry": "Family seeking information: Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for iPSC; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7378
  },
  {
    "request_id": "AM-REQ-2026-05502",
    "original_inquiry": "海外求诊：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8149
  },
  {
    "request_id": "AM-REQ-2026-05503",
    "original_inquiry": "研究者咨询：Patient with advanced cell therapy; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5737
  },
  {
    "request_id": "AM-REQ-2026-05504",
    "original_inquiry": "Neurologist: 类器官移植 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5838
  },
  {
    "request_id": "AM-REQ-2026-05505",
    "original_inquiry": "海外求诊：海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.73
  },
  {
    "request_id": "AM-REQ-2026-05506",
    "original_inquiry": "Second opinion requested: Consultation: 心肌修复 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6512
  },
  {
    "request_id": "AM-REQ-2026-05507",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8327
  },
  {
    "request_id": "AM-REQ-2026-05508",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6882
  },
  {
    "request_id": "AM-REQ-2026-05509",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.86
  },
  {
    "request_id": "AM-REQ-2026-05510",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6263
  },
  {
    "request_id": "AM-REQ-2026-05511",
    "original_inquiry": "Referral from specialist: Consultation: 类器官移植 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7157
  },
  {
    "request_id": "AM-REQ-2026-05512",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7483
  },
  {
    "request_id": "AM-REQ-2026-05513",
    "original_inquiry": "海外求诊：Researcher inquiry: 帕金森 manufacturing and dopaminergic neuron transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5914
  },
  {
    "request_id": "AM-REQ-2026-05514",
    "original_inquiry": "海外求诊：Family seeking 心肌修复 therapy for iPSC; request centers with organoid programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5389
  },
  {
    "request_id": "AM-REQ-2026-05515",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5009
  },
  {
    "request_id": "AM-REQ-2026-05516",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring heart failure and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5616
  },
  {
    "request_id": "AM-REQ-2026-05517",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6643
  },
  {
    "request_id": "AM-REQ-2026-05518",
    "original_inquiry": "海外求诊：Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6945
  },
  {
    "request_id": "AM-REQ-2026-05519",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for dopaminergic neuron; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6581
  },
  {
    "request_id": "AM-REQ-2026-05520",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7296
  },
  {
    "request_id": "AM-REQ-2026-05521",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7907
  },
  {
    "request_id": "AM-REQ-2026-05522",
    "original_inquiry": "Family seeking information: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5327
  },
  {
    "request_id": "AM-REQ-2026-05523",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5356
  },
  {
    "request_id": "AM-REQ-2026-05524",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8836
  },
  {
    "request_id": "AM-REQ-2026-05525",
    "original_inquiry": "Urgent: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8386
  },
  {
    "request_id": "AM-REQ-2026-05526",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6156
  },
  {
    "request_id": "AM-REQ-2026-05527",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7533
  },
  {
    "request_id": "AM-REQ-2026-05528",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7175
  },
  {
    "request_id": "AM-REQ-2026-05529",
    "original_inquiry": "Urgent: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6145
  },
  {
    "request_id": "AM-REQ-2026-05530",
    "original_inquiry": "海外求诊：Consultation: clinical trial with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7396
  },
  {
    "request_id": "AM-REQ-2026-05531",
    "original_inquiry": "海外求诊：Researcher inquiry: 帕金森 manufacturing and iPSC transplantation for organoid; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6688
  },
  {
    "request_id": "AM-REQ-2026-05532",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6312
  },
  {
    "request_id": "AM-REQ-2026-05533",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for iPSC; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7762
  },
  {
    "request_id": "AM-REQ-2026-05534",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6184
  },
  {
    "request_id": "AM-REQ-2026-05535",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6936
  },
  {
    "request_id": "AM-REQ-2026-05536",
    "original_inquiry": "海外求诊：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8014
  },
  {
    "request_id": "AM-REQ-2026-05537",
    "original_inquiry": "海外求诊：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6295
  },
  {
    "request_id": "AM-REQ-2026-05538",
    "original_inquiry": "Second opinion requested: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5173
  },
  {
    "request_id": "AM-REQ-2026-05539",
    "original_inquiry": "海外求诊：Family seeking iPSC-derived neuron therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6803
  },
  {
    "request_id": "AM-REQ-2026-05540",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-05541",
    "original_inquiry": "海外求诊：海外求诊：心肌修复患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5112
  },
  {
    "request_id": "AM-REQ-2026-05542",
    "original_inquiry": "Urgent: Researcher inquiry: iPSC-derived neuron manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5336
  },
  {
    "request_id": "AM-REQ-2026-05543",
    "original_inquiry": "Family seeking information: Family seeking 心肌修复 therapy for cell replacement; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6819
  },
  {
    "request_id": "AM-REQ-2026-05544",
    "original_inquiry": "海外求诊：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8972
  },
  {
    "request_id": "AM-REQ-2026-05545",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5008
  },
  {
    "request_id": "AM-REQ-2026-05546",
    "original_inquiry": "Patient with advanced cell therapy; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5504
  },
  {
    "request_id": "AM-REQ-2026-05547",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7278
  },
  {
    "request_id": "AM-REQ-2026-05548",
    "original_inquiry": "Patient with advanced 类器官移植; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5014
  },
  {
    "request_id": "AM-REQ-2026-05549",
    "original_inquiry": "Family seeking information: Consultation: 类器官移植 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7048
  },
  {
    "request_id": "AM-REQ-2026-05550",
    "original_inquiry": "Referral from specialist: 海外求诊：类器官移植患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7976
  },
  {
    "request_id": "AM-REQ-2026-05551",
    "original_inquiry": "海外求诊：Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.735
  },
  {
    "request_id": "AM-REQ-2026-05552",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and cardiomyocyte transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5442
  },
  {
    "request_id": "AM-REQ-2026-05553",
    "original_inquiry": "Urgent: Family seeking cell therapy therapy for Parkinson; request centers with iPSC programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8858
  },
  {
    "request_id": "AM-REQ-2026-05554",
    "original_inquiry": "海外求诊：Patient with advanced iPSC-derived neuron; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.578
  },
  {
    "request_id": "AM-REQ-2026-05555",
    "original_inquiry": "海外求诊：Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8271
  },
  {
    "request_id": "AM-REQ-2026-05556",
    "original_inquiry": "Second opinion requested: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5753
  },
  {
    "request_id": "AM-REQ-2026-05557",
    "original_inquiry": "Family seeking information: Family seeking 多能干细胞 therapy for heart failure; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7005
  },
  {
    "request_id": "AM-REQ-2026-05558",
    "original_inquiry": "研究者咨询：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-05559",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8554
  },
  {
    "request_id": "AM-REQ-2026-05560",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5935
  },
  {
    "request_id": "AM-REQ-2026-05561",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5194
  },
  {
    "request_id": "AM-REQ-2026-05562",
    "original_inquiry": "Second opinion requested: Consultation: cell therapy with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6568
  },
  {
    "request_id": "AM-REQ-2026-05563",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking cell replacement or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5357
  },
  {
    "request_id": "AM-REQ-2026-05564",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5112
  },
  {
    "request_id": "AM-REQ-2026-05565",
    "original_inquiry": "Urgent: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5912
  },
  {
    "request_id": "AM-REQ-2026-05566",
    "original_inquiry": "Referral from specialist: Patient with advanced 干细胞分化; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7254
  },
  {
    "request_id": "AM-REQ-2026-05567",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6143
  },
  {
    "request_id": "AM-REQ-2026-05568",
    "original_inquiry": "海外求诊：干细胞分化患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8484
  },
  {
    "request_id": "AM-REQ-2026-05569",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring cell replacement and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6111
  },
  {
    "request_id": "AM-REQ-2026-05570",
    "original_inquiry": "Urgent: Family seeking iPSC-derived neuron therapy for dopaminergic neuron; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5923
  },
  {
    "request_id": "AM-REQ-2026-05571",
    "original_inquiry": "Second opinion requested: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6274
  },
  {
    "request_id": "AM-REQ-2026-05572",
    "original_inquiry": "Family seeking information: 海外求诊：cell therapy患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5742
  },
  {
    "request_id": "AM-REQ-2026-05573",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5853
  },
  {
    "request_id": "AM-REQ-2026-05574",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5259
  },
  {
    "request_id": "AM-REQ-2026-05575",
    "original_inquiry": "Referral from specialist: Neurologist: clinical trial patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6237
  },
  {
    "request_id": "AM-REQ-2026-05576",
    "original_inquiry": "Second opinion requested: Cardiologist referral: regenerative medicine with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8372
  },
  {
    "request_id": "AM-REQ-2026-05577",
    "original_inquiry": "Second opinion requested: Family seeking regenerative medicine therapy for dopaminergic neuron; request centers with cardiomyocyte programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-05578",
    "original_inquiry": "Referral from specialist: 海外求诊：多能干细胞患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6544
  },
  {
    "request_id": "AM-REQ-2026-05579",
    "original_inquiry": "Family seeking information: Cardiologist referral: clinical trial with reduced EF; interested in cell replacement or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7199
  },
  {
    "request_id": "AM-REQ-2026-05580",
    "original_inquiry": "Urgent: Neurologist: cell therapy patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.505
  },
  {
    "request_id": "AM-REQ-2026-05581",
    "original_inquiry": "Family seeking information: Consultation: 心肌修复 with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6695
  },
  {
    "request_id": "AM-REQ-2026-05582",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5218
  },
  {
    "request_id": "AM-REQ-2026-05583",
    "original_inquiry": "研究者咨询：海外求诊：regenerative medicine患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8136
  },
  {
    "request_id": "AM-REQ-2026-05584",
    "original_inquiry": "Family seeking information: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5092
  },
  {
    "request_id": "AM-REQ-2026-05585",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5088
  },
  {
    "request_id": "AM-REQ-2026-05586",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8115
  },
  {
    "request_id": "AM-REQ-2026-05587",
    "original_inquiry": "Urgent: Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6411
  },
  {
    "request_id": "AM-REQ-2026-05588",
    "original_inquiry": "Urgent: Patient with advanced iPSC-derived neuron; seeking organoid or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.637
  },
  {
    "request_id": "AM-REQ-2026-05589",
    "original_inquiry": "Second opinion requested: Patient with advanced 类器官移植; seeking spinal cord injury or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5175
  },
  {
    "request_id": "AM-REQ-2026-05590",
    "original_inquiry": "Urgent: Patient with advanced 心肌修复; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5958
  },
  {
    "request_id": "AM-REQ-2026-05591",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for cardiomyocyte; request centers with iPSC programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5676
  },
  {
    "request_id": "AM-REQ-2026-05592",
    "original_inquiry": "Second opinion requested: Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.526
  },
  {
    "request_id": "AM-REQ-2026-05593",
    "original_inquiry": "Second opinion requested: Neurologist: cell therapy patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8614
  },
  {
    "request_id": "AM-REQ-2026-05594",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8692
  },
  {
    "request_id": "AM-REQ-2026-05595",
    "original_inquiry": "Referral from specialist: Family seeking 多能干细胞 therapy for organoid; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7934
  },
  {
    "request_id": "AM-REQ-2026-05596",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 帕金森 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8838
  },
  {
    "request_id": "AM-REQ-2026-05597",
    "original_inquiry": "Family seeking information: Family seeking 干细胞分化 therapy for Parkinson; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-05598",
    "original_inquiry": "Second opinion requested: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8879
  },
  {
    "request_id": "AM-REQ-2026-05599",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7586
  },
  {
    "request_id": "AM-REQ-2026-05600",
    "original_inquiry": "海外求诊：Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.844
  },
  {
    "request_id": "AM-REQ-2026-05601",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6333
  },
  {
    "request_id": "AM-REQ-2026-05602",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6139
  },
  {
    "request_id": "AM-REQ-2026-05603",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7439
  },
  {
    "request_id": "AM-REQ-2026-05604",
    "original_inquiry": "Referral from specialist: Neurologist: 帕金森 patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5628
  },
  {
    "request_id": "AM-REQ-2026-05605",
    "original_inquiry": "Family seeking information: Cardiologist referral: regenerative medicine with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5348
  },
  {
    "request_id": "AM-REQ-2026-05606",
    "original_inquiry": "Referral from specialist: Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6856
  },
  {
    "request_id": "AM-REQ-2026-05607",
    "original_inquiry": "患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7086
  },
  {
    "request_id": "AM-REQ-2026-05608",
    "original_inquiry": "Referral from specialist: Family seeking iPSC-derived neuron therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8769
  },
  {
    "request_id": "AM-REQ-2026-05609",
    "original_inquiry": "Second opinion requested: Consultation: 帕金森 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8785
  },
  {
    "request_id": "AM-REQ-2026-05610",
    "original_inquiry": "研究者咨询：Cardiologist referral: 心肌修复 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7995
  },
  {
    "request_id": "AM-REQ-2026-05611",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-05612",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 帕金森 manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7053
  },
  {
    "request_id": "AM-REQ-2026-05613",
    "original_inquiry": "Researcher inquiry: clinical trial manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6925
  },
  {
    "request_id": "AM-REQ-2026-05614",
    "original_inquiry": "Family seeking information: Family seeking cell therapy therapy for Parkinson; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5328
  },
  {
    "request_id": "AM-REQ-2026-05615",
    "original_inquiry": "Referral from specialist: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6662
  },
  {
    "request_id": "AM-REQ-2026-05616",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8903
  },
  {
    "request_id": "AM-REQ-2026-05617",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.691
  },
  {
    "request_id": "AM-REQ-2026-05618",
    "original_inquiry": "Family seeking information: Researcher inquiry: cell therapy manufacturing and Parkinson transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.503
  },
  {
    "request_id": "AM-REQ-2026-05619",
    "original_inquiry": "Family seeking information: 海外求诊：干细胞分化患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8342
  },
  {
    "request_id": "AM-REQ-2026-05620",
    "original_inquiry": "研究者咨询：Neurologist: 干细胞分化 patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7216
  },
  {
    "request_id": "AM-REQ-2026-05621",
    "original_inquiry": "Second opinion requested: 海外求诊：iPSC-derived neuron患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5645
  },
  {
    "request_id": "AM-REQ-2026-05622",
    "original_inquiry": "Second opinion requested: Family seeking 多能干细胞 therapy for heart failure; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6629
  },
  {
    "request_id": "AM-REQ-2026-05623",
    "original_inquiry": "研究者咨询：海外求诊：regenerative medicine患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8296
  },
  {
    "request_id": "AM-REQ-2026-05624",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5215
  },
  {
    "request_id": "AM-REQ-2026-05625",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6308
  },
  {
    "request_id": "AM-REQ-2026-05626",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5885
  },
  {
    "request_id": "AM-REQ-2026-05627",
    "original_inquiry": "Family seeking information: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7333
  },
  {
    "request_id": "AM-REQ-2026-05628",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-05629",
    "original_inquiry": "Urgent: Consultation: 类器官移植 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8557
  },
  {
    "request_id": "AM-REQ-2026-05630",
    "original_inquiry": "Second opinion requested: Researcher inquiry: clinical trial manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5638
  },
  {
    "request_id": "AM-REQ-2026-05631",
    "original_inquiry": "Second opinion requested: 海外求诊：心肌修复患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6476
  },
  {
    "request_id": "AM-REQ-2026-05632",
    "original_inquiry": "海外求诊：海外求诊：干细胞分化患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5362
  },
  {
    "request_id": "AM-REQ-2026-05633",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5948
  },
  {
    "request_id": "AM-REQ-2026-05634",
    "original_inquiry": "Family seeking information: Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7455
  },
  {
    "request_id": "AM-REQ-2026-05635",
    "original_inquiry": "Referral from specialist: 海外求诊：帕金森患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7431
  },
  {
    "request_id": "AM-REQ-2026-05636",
    "original_inquiry": "海外求诊：Family seeking 类器官移植 therapy for organoid; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8374
  },
  {
    "request_id": "AM-REQ-2026-05637",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5239
  },
  {
    "request_id": "AM-REQ-2026-05638",
    "original_inquiry": "研究者咨询：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5837
  },
  {
    "request_id": "AM-REQ-2026-05639",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7794
  },
  {
    "request_id": "AM-REQ-2026-05640",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.699
  },
  {
    "request_id": "AM-REQ-2026-05641",
    "original_inquiry": "海外求诊：Researcher inquiry: 干细胞分化 manufacturing and spinal cord injury transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5156
  },
  {
    "request_id": "AM-REQ-2026-05642",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7871
  },
  {
    "request_id": "AM-REQ-2026-05643",
    "original_inquiry": "Consultation: 干细胞分化 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-05644",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7769
  },
  {
    "request_id": "AM-REQ-2026-05645",
    "original_inquiry": "Referral from specialist: Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.832
  },
  {
    "request_id": "AM-REQ-2026-05646",
    "original_inquiry": "Referral from specialist: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7474
  },
  {
    "request_id": "AM-REQ-2026-05647",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-05648",
    "original_inquiry": "Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5694
  },
  {
    "request_id": "AM-REQ-2026-05649",
    "original_inquiry": "Family seeking information: 海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7531
  },
  {
    "request_id": "AM-REQ-2026-05650",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 多能干细胞 with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7587
  },
  {
    "request_id": "AM-REQ-2026-05651",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5646
  },
  {
    "request_id": "AM-REQ-2026-05652",
    "original_inquiry": "Referral from specialist: Neurologist: 帕金森 patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7871
  },
  {
    "request_id": "AM-REQ-2026-05653",
    "original_inquiry": "Family seeking information: 海外求诊：clinical trial患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6778
  },
  {
    "request_id": "AM-REQ-2026-05654",
    "original_inquiry": "Family seeking information: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8386
  },
  {
    "request_id": "AM-REQ-2026-05655",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.596
  },
  {
    "request_id": "AM-REQ-2026-05656",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8118
  },
  {
    "request_id": "AM-REQ-2026-05657",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.786
  },
  {
    "request_id": "AM-REQ-2026-05658",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5692
  },
  {
    "request_id": "AM-REQ-2026-05659",
    "original_inquiry": "Cardiologist referral: 心肌修复 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.814
  },
  {
    "request_id": "AM-REQ-2026-05660",
    "original_inquiry": "Family seeking information: Family seeking 类器官移植 therapy for organoid; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5342
  },
  {
    "request_id": "AM-REQ-2026-05661",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in heart failure or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5
  },
  {
    "request_id": "AM-REQ-2026-05662",
    "original_inquiry": "Referral from specialist: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8391
  },
  {
    "request_id": "AM-REQ-2026-05663",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.558
  },
  {
    "request_id": "AM-REQ-2026-05664",
    "original_inquiry": "Urgent: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5079
  },
  {
    "request_id": "AM-REQ-2026-05665",
    "original_inquiry": "Referral from specialist: Consultation: 帕金森 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6832
  },
  {
    "request_id": "AM-REQ-2026-05666",
    "original_inquiry": "海外求诊：Consultation: cell therapy with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6516
  },
  {
    "request_id": "AM-REQ-2026-05667",
    "original_inquiry": "Urgent: Consultation: cell therapy with spinal cord injury; interested in heart failure or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7507
  },
  {
    "request_id": "AM-REQ-2026-05668",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8466
  },
  {
    "request_id": "AM-REQ-2026-05669",
    "original_inquiry": "海外求诊：Family seeking clinical trial therapy for induced pluripotent stem cell; request centers with organoid programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7068
  },
  {
    "request_id": "AM-REQ-2026-05670",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6719
  },
  {
    "request_id": "AM-REQ-2026-05671",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6632
  },
  {
    "request_id": "AM-REQ-2026-05672",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8722
  },
  {
    "request_id": "AM-REQ-2026-05673",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for induced pluripotent stem cell; request centers with organoid programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8905
  },
  {
    "request_id": "AM-REQ-2026-05674",
    "original_inquiry": "Family seeking information: Consultation: 多能干细胞 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7685
  },
  {
    "request_id": "AM-REQ-2026-05675",
    "original_inquiry": "Cardiologist referral: 心肌修复 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7968
  },
  {
    "request_id": "AM-REQ-2026-05676",
    "original_inquiry": "海外求诊：Researcher inquiry: 类器官移植 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6153
  },
  {
    "request_id": "AM-REQ-2026-05677",
    "original_inquiry": "研究者咨询：Neurologist: regenerative medicine patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.729
  },
  {
    "request_id": "AM-REQ-2026-05678",
    "original_inquiry": "Urgent: 海外求诊：iPSC-derived neuron患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5757
  },
  {
    "request_id": "AM-REQ-2026-05679",
    "original_inquiry": "研究者咨询：Consultation: 类器官移植 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5309
  },
  {
    "request_id": "AM-REQ-2026-05680",
    "original_inquiry": "Family seeking iPSC-derived neuron therapy for heart failure; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7337
  },
  {
    "request_id": "AM-REQ-2026-05681",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7524
  },
  {
    "request_id": "AM-REQ-2026-05682",
    "original_inquiry": "Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5073
  },
  {
    "request_id": "AM-REQ-2026-05683",
    "original_inquiry": "研究者咨询：Researcher inquiry: 多能干细胞 manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6588
  },
  {
    "request_id": "AM-REQ-2026-05684",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5734
  },
  {
    "request_id": "AM-REQ-2026-05685",
    "original_inquiry": "Urgent: Family seeking 多能干细胞 therapy for cell replacement; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5836
  },
  {
    "request_id": "AM-REQ-2026-05686",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and organoid transplantation for iPSC; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.779
  },
  {
    "request_id": "AM-REQ-2026-05687",
    "original_inquiry": "Referral from specialist: 海外求诊：regenerative medicine患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-05688",
    "original_inquiry": "海外求诊：Family seeking 类器官移植 therapy for heart failure; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7836
  },
  {
    "request_id": "AM-REQ-2026-05689",
    "original_inquiry": "Family seeking information: 海外求诊：干细胞分化患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8195
  },
  {
    "request_id": "AM-REQ-2026-05690",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8069
  },
  {
    "request_id": "AM-REQ-2026-05691",
    "original_inquiry": "海外求诊：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6358
  },
  {
    "request_id": "AM-REQ-2026-05692",
    "original_inquiry": "海外求诊：海外求诊：iPSC-derived neuron患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.719
  },
  {
    "request_id": "AM-REQ-2026-05693",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6819
  },
  {
    "request_id": "AM-REQ-2026-05694",
    "original_inquiry": "Family seeking information: Family seeking regenerative medicine therapy for cardiomyocyte; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8181
  },
  {
    "request_id": "AM-REQ-2026-05695",
    "original_inquiry": "Second opinion requested: Researcher inquiry: iPSC-derived neuron manufacturing and cell replacement transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7646
  },
  {
    "request_id": "AM-REQ-2026-05696",
    "original_inquiry": "Family seeking information: Neurologist: iPSC-derived neuron patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5439
  },
  {
    "request_id": "AM-REQ-2026-05697",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6084
  },
  {
    "request_id": "AM-REQ-2026-05698",
    "original_inquiry": "Second opinion requested: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8126
  },
  {
    "request_id": "AM-REQ-2026-05699",
    "original_inquiry": "Family seeking information: Patient with advanced clinical trial; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8035
  },
  {
    "request_id": "AM-REQ-2026-05700",
    "original_inquiry": "研究者咨询：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6312
  },
  {
    "request_id": "AM-REQ-2026-05701",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5959
  },
  {
    "request_id": "AM-REQ-2026-05702",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking spinal cord injury or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5971
  },
  {
    "request_id": "AM-REQ-2026-05703",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for dopaminergic neuron; request centers with organoid programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5573
  },
  {
    "request_id": "AM-REQ-2026-05704",
    "original_inquiry": "海外求诊：Consultation: cell therapy with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6268
  },
  {
    "request_id": "AM-REQ-2026-05705",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and cell replacement transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8146
  },
  {
    "request_id": "AM-REQ-2026-05706",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5199
  },
  {
    "request_id": "AM-REQ-2026-05707",
    "original_inquiry": "Second opinion requested: Patient with advanced 干细胞分化; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7253
  },
  {
    "request_id": "AM-REQ-2026-05708",
    "original_inquiry": "海外求诊：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5439
  },
  {
    "request_id": "AM-REQ-2026-05709",
    "original_inquiry": "Family seeking information: Patient with advanced 心肌修复; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7574
  },
  {
    "request_id": "AM-REQ-2026-05710",
    "original_inquiry": "Family seeking information: Researcher inquiry: 多能干细胞 manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.584
  },
  {
    "request_id": "AM-REQ-2026-05711",
    "original_inquiry": "Family seeking information: Cardiologist referral: 类器官移植 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6435
  },
  {
    "request_id": "AM-REQ-2026-05712",
    "original_inquiry": "Referral from specialist: Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5215
  },
  {
    "request_id": "AM-REQ-2026-05713",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7075
  },
  {
    "request_id": "AM-REQ-2026-05714",
    "original_inquiry": "研究者咨询：Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7921
  },
  {
    "request_id": "AM-REQ-2026-05715",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8934
  },
  {
    "request_id": "AM-REQ-2026-05716",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6722
  },
  {
    "request_id": "AM-REQ-2026-05717",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8951
  },
  {
    "request_id": "AM-REQ-2026-05718",
    "original_inquiry": "Referral from specialist: 海外求诊：clinical trial患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5589
  },
  {
    "request_id": "AM-REQ-2026-05719",
    "original_inquiry": "研究者咨询：Family seeking 帕金森 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8442
  },
  {
    "request_id": "AM-REQ-2026-05720",
    "original_inquiry": "研究者咨询：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6231
  },
  {
    "request_id": "AM-REQ-2026-05721",
    "original_inquiry": "Referral from specialist: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6399
  },
  {
    "request_id": "AM-REQ-2026-05722",
    "original_inquiry": "Family seeking information: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6677
  },
  {
    "request_id": "AM-REQ-2026-05723",
    "original_inquiry": "Referral from specialist: Researcher inquiry: clinical trial manufacturing and organoid transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7875
  },
  {
    "request_id": "AM-REQ-2026-05724",
    "original_inquiry": "Family seeking information: Cardiologist referral: 帕金森 with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.562
  },
  {
    "request_id": "AM-REQ-2026-05725",
    "original_inquiry": "Second opinion requested: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5214
  },
  {
    "request_id": "AM-REQ-2026-05726",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8555
  },
  {
    "request_id": "AM-REQ-2026-05727",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for cell replacement; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6607
  },
  {
    "request_id": "AM-REQ-2026-05728",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6436
  },
  {
    "request_id": "AM-REQ-2026-05729",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6354
  },
  {
    "request_id": "AM-REQ-2026-05730",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8093
  },
  {
    "request_id": "AM-REQ-2026-05731",
    "original_inquiry": "海外求诊：Cardiologist referral: cell therapy with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8933
  },
  {
    "request_id": "AM-REQ-2026-05732",
    "original_inquiry": "Second opinion requested: 海外求诊：cell therapy患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.525
  },
  {
    "request_id": "AM-REQ-2026-05733",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5689
  },
  {
    "request_id": "AM-REQ-2026-05734",
    "original_inquiry": "患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6342
  },
  {
    "request_id": "AM-REQ-2026-05735",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7414
  },
  {
    "request_id": "AM-REQ-2026-05736",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 干细胞分化 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7742
  },
  {
    "request_id": "AM-REQ-2026-05737",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6448
  },
  {
    "request_id": "AM-REQ-2026-05738",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7881
  },
  {
    "request_id": "AM-REQ-2026-05739",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6529
  },
  {
    "request_id": "AM-REQ-2026-05740",
    "original_inquiry": "患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7413
  },
  {
    "request_id": "AM-REQ-2026-05741",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5278
  },
  {
    "request_id": "AM-REQ-2026-05742",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and spinal cord injury transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6159
  },
  {
    "request_id": "AM-REQ-2026-05743",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5717
  },
  {
    "request_id": "AM-REQ-2026-05744",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8668
  },
  {
    "request_id": "AM-REQ-2026-05745",
    "original_inquiry": "Second opinion requested: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.804
  },
  {
    "request_id": "AM-REQ-2026-05746",
    "original_inquiry": "Second opinion requested: 海外求诊：帕金森患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5336
  },
  {
    "request_id": "AM-REQ-2026-05747",
    "original_inquiry": "Family seeking information: Neurologist: 类器官移植 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.65
  },
  {
    "request_id": "AM-REQ-2026-05748",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5022
  },
  {
    "request_id": "AM-REQ-2026-05749",
    "original_inquiry": "Referral from specialist: Consultation: 心肌修复 with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6087
  },
  {
    "request_id": "AM-REQ-2026-05750",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5896
  },
  {
    "request_id": "AM-REQ-2026-05751",
    "original_inquiry": "Urgent: Family seeking 心肌修复 therapy for cell replacement; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5933
  },
  {
    "request_id": "AM-REQ-2026-05752",
    "original_inquiry": "Second opinion requested: Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6257
  },
  {
    "request_id": "AM-REQ-2026-05753",
    "original_inquiry": "Second opinion requested: 海外求诊：clinical trial患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7339
  },
  {
    "request_id": "AM-REQ-2026-05754",
    "original_inquiry": "Urgent: Patient with advanced 干细胞分化; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8677
  },
  {
    "request_id": "AM-REQ-2026-05755",
    "original_inquiry": "研究者咨询：Cardiologist referral: 干细胞分化 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5572
  },
  {
    "request_id": "AM-REQ-2026-05756",
    "original_inquiry": "Family seeking information: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.623
  },
  {
    "request_id": "AM-REQ-2026-05757",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for dopaminergic neuron; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.57
  },
  {
    "request_id": "AM-REQ-2026-05758",
    "original_inquiry": "Second opinion requested: Consultation: 类器官移植 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7135
  },
  {
    "request_id": "AM-REQ-2026-05759",
    "original_inquiry": "Urgent: 海外求诊：类器官移植患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8426
  },
  {
    "request_id": "AM-REQ-2026-05760",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5651
  },
  {
    "request_id": "AM-REQ-2026-05761",
    "original_inquiry": "Urgent: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6733
  },
  {
    "request_id": "AM-REQ-2026-05762",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6302
  },
  {
    "request_id": "AM-REQ-2026-05763",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8041
  },
  {
    "request_id": "AM-REQ-2026-05764",
    "original_inquiry": "海外求诊：Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6624
  },
  {
    "request_id": "AM-REQ-2026-05765",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7377
  },
  {
    "request_id": "AM-REQ-2026-05766",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5574
  },
  {
    "request_id": "AM-REQ-2026-05767",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5513
  },
  {
    "request_id": "AM-REQ-2026-05768",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.668
  },
  {
    "request_id": "AM-REQ-2026-05769",
    "original_inquiry": "研究者咨询：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7075
  },
  {
    "request_id": "AM-REQ-2026-05770",
    "original_inquiry": "Second opinion requested: Researcher inquiry: cell therapy manufacturing and dopaminergic neuron transplantation for iPSC; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6826
  },
  {
    "request_id": "AM-REQ-2026-05771",
    "original_inquiry": "Family seeking clinical trial therapy for dopaminergic neuron; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8853
  },
  {
    "request_id": "AM-REQ-2026-05772",
    "original_inquiry": "患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7503
  },
  {
    "request_id": "AM-REQ-2026-05773",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking spinal cord injury or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8522
  },
  {
    "request_id": "AM-REQ-2026-05774",
    "original_inquiry": "Second opinion requested: Patient with advanced 帕金森; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5498
  },
  {
    "request_id": "AM-REQ-2026-05775",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7158
  },
  {
    "request_id": "AM-REQ-2026-05776",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for Parkinson; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6075
  },
  {
    "request_id": "AM-REQ-2026-05777",
    "original_inquiry": "Family seeking information: Researcher inquiry: 干细胞分化 manufacturing and organoid transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8006
  },
  {
    "request_id": "AM-REQ-2026-05778",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.569
  },
  {
    "request_id": "AM-REQ-2026-05779",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 心肌修复 manufacturing and iPSC transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8121
  },
  {
    "request_id": "AM-REQ-2026-05780",
    "original_inquiry": "海外求诊：Cardiologist referral: 帕金森 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7422
  },
  {
    "request_id": "AM-REQ-2026-05781",
    "original_inquiry": "患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7745
  },
  {
    "request_id": "AM-REQ-2026-05782",
    "original_inquiry": "Researcher inquiry: clinical trial manufacturing and iPSC transplantation for organoid; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.51
  },
  {
    "request_id": "AM-REQ-2026-05783",
    "original_inquiry": "Family seeking cell therapy therapy for dopaminergic neuron; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7676
  },
  {
    "request_id": "AM-REQ-2026-05784",
    "original_inquiry": "研究者咨询：海外求诊：cell therapy患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7969
  },
  {
    "request_id": "AM-REQ-2026-05785",
    "original_inquiry": "海外求诊：Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.821
  },
  {
    "request_id": "AM-REQ-2026-05786",
    "original_inquiry": "Urgent: Family seeking 多能干细胞 therapy for cardiomyocyte; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7791
  },
  {
    "request_id": "AM-REQ-2026-05787",
    "original_inquiry": "Family seeking information: Family seeking clinical trial therapy for iPSC; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8822
  },
  {
    "request_id": "AM-REQ-2026-05788",
    "original_inquiry": "Family seeking clinical trial therapy for spinal cord injury; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7247
  },
  {
    "request_id": "AM-REQ-2026-05789",
    "original_inquiry": "研究者咨询：Neurologist: 干细胞分化 patient, exploring cardiomyocyte and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5887
  },
  {
    "request_id": "AM-REQ-2026-05790",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5269
  },
  {
    "request_id": "AM-REQ-2026-05791",
    "original_inquiry": "Second opinion requested: Family seeking 类器官移植 therapy for induced pluripotent stem cell; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7008
  },
  {
    "request_id": "AM-REQ-2026-05792",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6222
  },
  {
    "request_id": "AM-REQ-2026-05793",
    "original_inquiry": "Urgent: 海外求诊：iPSC-derived neuron患者，希望评估organoid或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8146
  },
  {
    "request_id": "AM-REQ-2026-05794",
    "original_inquiry": "Urgent: Neurologist: iPSC-derived neuron patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7537
  },
  {
    "request_id": "AM-REQ-2026-05795",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and heart failure transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7469
  },
  {
    "request_id": "AM-REQ-2026-05796",
    "original_inquiry": "Family seeking information: Family seeking cell therapy therapy for cell replacement; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.668
  },
  {
    "request_id": "AM-REQ-2026-05797",
    "original_inquiry": "海外求诊：Cardiologist referral: clinical trial with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8323
  },
  {
    "request_id": "AM-REQ-2026-05798",
    "original_inquiry": "研究者咨询：Neurologist: iPSC-derived neuron patient, exploring dopaminergic neuron and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6312
  },
  {
    "request_id": "AM-REQ-2026-05799",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 类器官移植 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6353
  },
  {
    "request_id": "AM-REQ-2026-05800",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5578
  },
  {
    "request_id": "AM-REQ-2026-05801",
    "original_inquiry": "Family seeking information: Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6064
  },
  {
    "request_id": "AM-REQ-2026-05802",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-05803",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.773
  },
  {
    "request_id": "AM-REQ-2026-05804",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8789
  },
  {
    "request_id": "AM-REQ-2026-05805",
    "original_inquiry": "Urgent: Family seeking cell therapy therapy for induced pluripotent stem cell; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8401
  },
  {
    "request_id": "AM-REQ-2026-05806",
    "original_inquiry": "Second opinion requested: Consultation: 干细胞分化 with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6529
  },
  {
    "request_id": "AM-REQ-2026-05807",
    "original_inquiry": "海外求诊：Family seeking regenerative medicine therapy for Parkinson; request centers with cardiomyocyte programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.825
  },
  {
    "request_id": "AM-REQ-2026-05808",
    "original_inquiry": "海外求诊：clinical trial患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7798
  },
  {
    "request_id": "AM-REQ-2026-05809",
    "original_inquiry": "海外求诊：Cardiologist referral: clinical trial with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8366
  },
  {
    "request_id": "AM-REQ-2026-05810",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for Parkinson; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8102
  },
  {
    "request_id": "AM-REQ-2026-05811",
    "original_inquiry": "Urgent: Cardiologist referral: cell therapy with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5449
  },
  {
    "request_id": "AM-REQ-2026-05812",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8588
  },
  {
    "request_id": "AM-REQ-2026-05813",
    "original_inquiry": "研究者咨询：Researcher inquiry: 帕金森 manufacturing and induced pluripotent stem cell transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6199
  },
  {
    "request_id": "AM-REQ-2026-05814",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8036
  },
  {
    "request_id": "AM-REQ-2026-05815",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6002
  },
  {
    "request_id": "AM-REQ-2026-05816",
    "original_inquiry": "研究者咨询：海外求诊：帕金森患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6963
  },
  {
    "request_id": "AM-REQ-2026-05817",
    "original_inquiry": "Second opinion requested: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5281
  },
  {
    "request_id": "AM-REQ-2026-05818",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for cell replacement; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5969
  },
  {
    "request_id": "AM-REQ-2026-05819",
    "original_inquiry": "Second opinion requested: Family seeking 多能干细胞 therapy for heart failure; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6618
  },
  {
    "request_id": "AM-REQ-2026-05820",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8147
  },
  {
    "request_id": "AM-REQ-2026-05821",
    "original_inquiry": "Urgent: Researcher inquiry: 类器官移植 manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8164
  },
  {
    "request_id": "AM-REQ-2026-05822",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5363
  },
  {
    "request_id": "AM-REQ-2026-05823",
    "original_inquiry": "Family seeking 帕金森 therapy for heart failure; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8228
  },
  {
    "request_id": "AM-REQ-2026-05824",
    "original_inquiry": "海外求诊：Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7595
  },
  {
    "request_id": "AM-REQ-2026-05825",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.708
  },
  {
    "request_id": "AM-REQ-2026-05826",
    "original_inquiry": "海外求诊：多能干细胞患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5185
  },
  {
    "request_id": "AM-REQ-2026-05827",
    "original_inquiry": "Referral from specialist: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8697
  },
  {
    "request_id": "AM-REQ-2026-05828",
    "original_inquiry": "Family seeking information: Consultation: 多能干细胞 with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8702
  },
  {
    "request_id": "AM-REQ-2026-05829",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5964
  },
  {
    "request_id": "AM-REQ-2026-05830",
    "original_inquiry": "Consultation: 帕金森 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5294
  },
  {
    "request_id": "AM-REQ-2026-05831",
    "original_inquiry": "Patient with advanced cell therapy; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7774
  },
  {
    "request_id": "AM-REQ-2026-05832",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6308
  },
  {
    "request_id": "AM-REQ-2026-05833",
    "original_inquiry": "海外求诊：Family seeking 心肌修复 therapy for cell replacement; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.673
  },
  {
    "request_id": "AM-REQ-2026-05834",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8129
  },
  {
    "request_id": "AM-REQ-2026-05835",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7448
  },
  {
    "request_id": "AM-REQ-2026-05836",
    "original_inquiry": "研究者咨询：Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6958
  },
  {
    "request_id": "AM-REQ-2026-05837",
    "original_inquiry": "Urgent: Patient with advanced 心肌修复; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6446
  },
  {
    "request_id": "AM-REQ-2026-05838",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6338
  },
  {
    "request_id": "AM-REQ-2026-05839",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6432
  },
  {
    "request_id": "AM-REQ-2026-05840",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5526
  },
  {
    "request_id": "AM-REQ-2026-05841",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5403
  },
  {
    "request_id": "AM-REQ-2026-05842",
    "original_inquiry": "Second opinion requested: Neurologist: 干细胞分化 patient, exploring dopaminergic neuron and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8573
  },
  {
    "request_id": "AM-REQ-2026-05843",
    "original_inquiry": "Family seeking information: Family seeking cell therapy therapy for iPSC; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5829
  },
  {
    "request_id": "AM-REQ-2026-05844",
    "original_inquiry": "Urgent: 海外求诊：regenerative medicine患者，希望评估cell replacement或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5167
  },
  {
    "request_id": "AM-REQ-2026-05845",
    "original_inquiry": "海外求诊：Patient with advanced 干细胞分化; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8949
  },
  {
    "request_id": "AM-REQ-2026-05846",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5772
  },
  {
    "request_id": "AM-REQ-2026-05847",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.665
  },
  {
    "request_id": "AM-REQ-2026-05848",
    "original_inquiry": "研究者咨询：Neurologist: 心肌修复 patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7957
  },
  {
    "request_id": "AM-REQ-2026-05849",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5037
  },
  {
    "request_id": "AM-REQ-2026-05850",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5267
  },
  {
    "request_id": "AM-REQ-2026-05851",
    "original_inquiry": "Second opinion requested: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7324
  },
  {
    "request_id": "AM-REQ-2026-05852",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5555
  },
  {
    "request_id": "AM-REQ-2026-05853",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and heart failure transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6852
  },
  {
    "request_id": "AM-REQ-2026-05854",
    "original_inquiry": "Urgent: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7316
  },
  {
    "request_id": "AM-REQ-2026-05855",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5535
  },
  {
    "request_id": "AM-REQ-2026-05856",
    "original_inquiry": "Urgent: Researcher inquiry: cell therapy manufacturing and cardiomyocyte transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7069
  },
  {
    "request_id": "AM-REQ-2026-05857",
    "original_inquiry": "研究者咨询：海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8753
  },
  {
    "request_id": "AM-REQ-2026-05858",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6681
  },
  {
    "request_id": "AM-REQ-2026-05859",
    "original_inquiry": "Neurologist: cell therapy patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5179
  },
  {
    "request_id": "AM-REQ-2026-05860",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 帕金森 manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5158
  },
  {
    "request_id": "AM-REQ-2026-05861",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5315
  },
  {
    "request_id": "AM-REQ-2026-05862",
    "original_inquiry": "Family seeking information: Researcher inquiry: 帕金森 manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6469
  },
  {
    "request_id": "AM-REQ-2026-05863",
    "original_inquiry": "Consultation: regenerative medicine with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7402
  },
  {
    "request_id": "AM-REQ-2026-05864",
    "original_inquiry": "Urgent: Cardiologist referral: cell therapy with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5264
  },
  {
    "request_id": "AM-REQ-2026-05865",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for induced pluripotent stem cell; request centers with organoid programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.809
  },
  {
    "request_id": "AM-REQ-2026-05866",
    "original_inquiry": "Researcher inquiry: cell therapy manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7864
  },
  {
    "request_id": "AM-REQ-2026-05867",
    "original_inquiry": "Family seeking information: Consultation: 帕金森 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6741
  },
  {
    "request_id": "AM-REQ-2026-05868",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for organoid; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5828
  },
  {
    "request_id": "AM-REQ-2026-05869",
    "original_inquiry": "海外求诊：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.638
  },
  {
    "request_id": "AM-REQ-2026-05870",
    "original_inquiry": "Referral from specialist: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-05871",
    "original_inquiry": "海外求诊：海外求诊：帕金森患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7495
  },
  {
    "request_id": "AM-REQ-2026-05872",
    "original_inquiry": "Family seeking 帕金森 therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-05873",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7791
  },
  {
    "request_id": "AM-REQ-2026-05874",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-05875",
    "original_inquiry": "研究者咨询：Family seeking cell therapy therapy for iPSC; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5704
  },
  {
    "request_id": "AM-REQ-2026-05876",
    "original_inquiry": "Urgent: Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.734
  },
  {
    "request_id": "AM-REQ-2026-05877",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5852
  },
  {
    "request_id": "AM-REQ-2026-05878",
    "original_inquiry": "Referral from specialist: Family seeking clinical trial therapy for cell replacement; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5476
  },
  {
    "request_id": "AM-REQ-2026-05879",
    "original_inquiry": "海外求诊：多能干细胞患者，希望评估cell replacement或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6012
  },
  {
    "request_id": "AM-REQ-2026-05880",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring cell replacement and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5502
  },
  {
    "request_id": "AM-REQ-2026-05881",
    "original_inquiry": "研究者咨询：海外求诊：帕金森患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6881
  },
  {
    "request_id": "AM-REQ-2026-05882",
    "original_inquiry": "Family seeking information: Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8426
  },
  {
    "request_id": "AM-REQ-2026-05883",
    "original_inquiry": "Family seeking information: Family seeking 心肌修复 therapy for cardiomyocyte; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8919
  },
  {
    "request_id": "AM-REQ-2026-05884",
    "original_inquiry": "Patient with advanced 干细胞分化; seeking organoid or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7365
  },
  {
    "request_id": "AM-REQ-2026-05885",
    "original_inquiry": "Referral from specialist: Consultation: 多能干细胞 with spinal cord injury; interested in heart failure or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6908
  },
  {
    "request_id": "AM-REQ-2026-05886",
    "original_inquiry": "Family seeking information: Consultation: cell therapy with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8635
  },
  {
    "request_id": "AM-REQ-2026-05887",
    "original_inquiry": "研究者咨询：Consultation: 多能干细胞 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6072
  },
  {
    "request_id": "AM-REQ-2026-05888",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6028
  },
  {
    "request_id": "AM-REQ-2026-05889",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5585
  },
  {
    "request_id": "AM-REQ-2026-05890",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 多能干细胞 with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7425
  },
  {
    "request_id": "AM-REQ-2026-05891",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 帕金森 manufacturing and iPSC transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8217
  },
  {
    "request_id": "AM-REQ-2026-05892",
    "original_inquiry": "Urgent: Neurologist: 干细胞分化 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5972
  },
  {
    "request_id": "AM-REQ-2026-05893",
    "original_inquiry": "Urgent: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-05894",
    "original_inquiry": "Second opinion requested: Cardiologist referral: clinical trial with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6768
  },
  {
    "request_id": "AM-REQ-2026-05895",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估cell replacement或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.582
  },
  {
    "request_id": "AM-REQ-2026-05896",
    "original_inquiry": "Second opinion requested: Consultation: 干细胞分化 with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.613
  },
  {
    "request_id": "AM-REQ-2026-05897",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8029
  },
  {
    "request_id": "AM-REQ-2026-05898",
    "original_inquiry": "海外求诊：Consultation: cell therapy with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7856
  },
  {
    "request_id": "AM-REQ-2026-05899",
    "original_inquiry": "Family seeking information: Consultation: 帕金森 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6852
  },
  {
    "request_id": "AM-REQ-2026-05900",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7261
  },
  {
    "request_id": "AM-REQ-2026-05901",
    "original_inquiry": "研究者咨询：Family seeking 多能干细胞 therapy for cardiomyocyte; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5215
  },
  {
    "request_id": "AM-REQ-2026-05902",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8458
  },
  {
    "request_id": "AM-REQ-2026-05903",
    "original_inquiry": "Referral from specialist: Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6688
  },
  {
    "request_id": "AM-REQ-2026-05904",
    "original_inquiry": "Second opinion requested: Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-05905",
    "original_inquiry": "Patient with advanced 帕金森; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7915
  },
  {
    "request_id": "AM-REQ-2026-05906",
    "original_inquiry": "Cardiologist referral: clinical trial with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7192
  },
  {
    "request_id": "AM-REQ-2026-05907",
    "original_inquiry": "海外求诊：Researcher inquiry: clinical trial manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5796
  },
  {
    "request_id": "AM-REQ-2026-05908",
    "original_inquiry": "Referral from specialist: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7704
  },
  {
    "request_id": "AM-REQ-2026-05909",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for heart failure; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.656
  },
  {
    "request_id": "AM-REQ-2026-05910",
    "original_inquiry": "Urgent: Researcher inquiry: 类器官移植 manufacturing and iPSC transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5302
  },
  {
    "request_id": "AM-REQ-2026-05911",
    "original_inquiry": "海外求诊：Neurologist: 心肌修复 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5731
  },
  {
    "request_id": "AM-REQ-2026-05912",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.647
  },
  {
    "request_id": "AM-REQ-2026-05913",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8444
  },
  {
    "request_id": "AM-REQ-2026-05914",
    "original_inquiry": "Family seeking information: 海外求诊：干细胞分化患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.834
  },
  {
    "request_id": "AM-REQ-2026-05915",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估iPSC或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5685
  },
  {
    "request_id": "AM-REQ-2026-05916",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6293
  },
  {
    "request_id": "AM-REQ-2026-05917",
    "original_inquiry": "Referral from specialist: 海外求诊：clinical trial患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7374
  },
  {
    "request_id": "AM-REQ-2026-05918",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6177
  },
  {
    "request_id": "AM-REQ-2026-05919",
    "original_inquiry": "Family seeking information: Cardiologist referral: clinical trial with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.828
  },
  {
    "request_id": "AM-REQ-2026-05920",
    "original_inquiry": "Urgent: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8382
  },
  {
    "request_id": "AM-REQ-2026-05921",
    "original_inquiry": "Referral from specialist: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5102
  },
  {
    "request_id": "AM-REQ-2026-05922",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6571
  },
  {
    "request_id": "AM-REQ-2026-05923",
    "original_inquiry": "Consultation: 心肌修复 with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5484
  },
  {
    "request_id": "AM-REQ-2026-05924",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7093
  },
  {
    "request_id": "AM-REQ-2026-05925",
    "original_inquiry": "Family seeking information: Researcher inquiry: 多能干细胞 manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8265
  },
  {
    "request_id": "AM-REQ-2026-05926",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 帕金森 manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5128
  },
  {
    "request_id": "AM-REQ-2026-05927",
    "original_inquiry": "Second opinion requested: Patient with advanced regenerative medicine; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8391
  },
  {
    "request_id": "AM-REQ-2026-05928",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7437
  },
  {
    "request_id": "AM-REQ-2026-05929",
    "original_inquiry": "Referral from specialist: Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7043
  },
  {
    "request_id": "AM-REQ-2026-05930",
    "original_inquiry": "Second opinion requested: Patient with advanced regenerative medicine; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5347
  },
  {
    "request_id": "AM-REQ-2026-05931",
    "original_inquiry": "Family seeking information: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8928
  },
  {
    "request_id": "AM-REQ-2026-05932",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5024
  },
  {
    "request_id": "AM-REQ-2026-05933",
    "original_inquiry": "Referral from specialist: Neurologist: iPSC-derived neuron patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-05934",
    "original_inquiry": "Urgent: 海外求诊：类器官移植患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6679
  },
  {
    "request_id": "AM-REQ-2026-05935",
    "original_inquiry": "海外求诊：Researcher inquiry: 类器官移植 manufacturing and cell replacement transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6565
  },
  {
    "request_id": "AM-REQ-2026-05936",
    "original_inquiry": "Referral from specialist: Family seeking 心肌修复 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8499
  },
  {
    "request_id": "AM-REQ-2026-05937",
    "original_inquiry": "Referral from specialist: Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7116
  },
  {
    "request_id": "AM-REQ-2026-05938",
    "original_inquiry": "研究者咨询：Consultation: 类器官移植 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7266
  },
  {
    "request_id": "AM-REQ-2026-05939",
    "original_inquiry": "海外求诊：Neurologist: iPSC-derived neuron patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6591
  },
  {
    "request_id": "AM-REQ-2026-05940",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7328
  },
  {
    "request_id": "AM-REQ-2026-05941",
    "original_inquiry": "Urgent: 海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8503
  },
  {
    "request_id": "AM-REQ-2026-05942",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7215
  },
  {
    "request_id": "AM-REQ-2026-05943",
    "original_inquiry": "患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7628
  },
  {
    "request_id": "AM-REQ-2026-05944",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8755
  },
  {
    "request_id": "AM-REQ-2026-05945",
    "original_inquiry": "Urgent: Cardiologist referral: 心肌修复 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.556
  },
  {
    "request_id": "AM-REQ-2026-05946",
    "original_inquiry": "Referral from specialist: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8501
  },
  {
    "request_id": "AM-REQ-2026-05947",
    "original_inquiry": "Second opinion requested: Neurologist: 干细胞分化 patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.577
  },
  {
    "request_id": "AM-REQ-2026-05948",
    "original_inquiry": "Second opinion requested: Patient with advanced 帕金森; seeking cell replacement or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7366
  },
  {
    "request_id": "AM-REQ-2026-05949",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5915
  },
  {
    "request_id": "AM-REQ-2026-05950",
    "original_inquiry": "Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5427
  },
  {
    "request_id": "AM-REQ-2026-05951",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.559
  },
  {
    "request_id": "AM-REQ-2026-05952",
    "original_inquiry": "Researcher inquiry: clinical trial manufacturing and dopaminergic neuron transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6433
  },
  {
    "request_id": "AM-REQ-2026-05953",
    "original_inquiry": "Family seeking 帕金森 therapy for cell replacement; request centers with iPSC programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6645
  },
  {
    "request_id": "AM-REQ-2026-05954",
    "original_inquiry": "Consultation: 干细胞分化 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7357
  },
  {
    "request_id": "AM-REQ-2026-05955",
    "original_inquiry": "Urgent: 海外求诊：帕金森患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-05956",
    "original_inquiry": "Referral from specialist: Consultation: 类器官移植 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8134
  },
  {
    "request_id": "AM-REQ-2026-05957",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8705
  },
  {
    "request_id": "AM-REQ-2026-05958",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6235
  },
  {
    "request_id": "AM-REQ-2026-05959",
    "original_inquiry": "Referral from specialist: 海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6957
  },
  {
    "request_id": "AM-REQ-2026-05960",
    "original_inquiry": "Family seeking information: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6805
  },
  {
    "request_id": "AM-REQ-2026-05961",
    "original_inquiry": "研究者咨询：Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8378
  },
  {
    "request_id": "AM-REQ-2026-05962",
    "original_inquiry": "Second opinion requested: 海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8089
  },
  {
    "request_id": "AM-REQ-2026-05963",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5304
  },
  {
    "request_id": "AM-REQ-2026-05964",
    "original_inquiry": "Second opinion requested: Researcher inquiry: regenerative medicine manufacturing and organoid transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8594
  },
  {
    "request_id": "AM-REQ-2026-05965",
    "original_inquiry": "研究者咨询：海外求诊：类器官移植患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6006
  },
  {
    "request_id": "AM-REQ-2026-05966",
    "original_inquiry": "Family seeking 类器官移植 therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5917
  },
  {
    "request_id": "AM-REQ-2026-05967",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8749
  },
  {
    "request_id": "AM-REQ-2026-05968",
    "original_inquiry": "研究者咨询：Neurologist: iPSC-derived neuron patient, exploring cardiomyocyte and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-05969",
    "original_inquiry": "Urgent: Patient with advanced 类器官移植; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7019
  },
  {
    "request_id": "AM-REQ-2026-05970",
    "original_inquiry": "Researcher inquiry: regenerative medicine manufacturing and spinal cord injury transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5289
  },
  {
    "request_id": "AM-REQ-2026-05971",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in heart failure or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5988
  },
  {
    "request_id": "AM-REQ-2026-05972",
    "original_inquiry": "Second opinion requested: Family seeking cell therapy therapy for spinal cord injury; request centers with iPSC programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7828
  },
  {
    "request_id": "AM-REQ-2026-05973",
    "original_inquiry": "Family seeking information: 海外求诊：iPSC-derived neuron患者，希望评估cell replacement或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5681
  },
  {
    "request_id": "AM-REQ-2026-05974",
    "original_inquiry": "研究者咨询：Family seeking 帕金森 therapy for induced pluripotent stem cell; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7103
  },
  {
    "request_id": "AM-REQ-2026-05975",
    "original_inquiry": "Urgent: 海外求诊：clinical trial患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6584
  },
  {
    "request_id": "AM-REQ-2026-05976",
    "original_inquiry": "Urgent: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8058
  },
  {
    "request_id": "AM-REQ-2026-05977",
    "original_inquiry": "Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8844
  },
  {
    "request_id": "AM-REQ-2026-05978",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 心肌修复 manufacturing and organoid transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6448
  },
  {
    "request_id": "AM-REQ-2026-05979",
    "original_inquiry": "Family seeking information: 海外求诊：心肌修复患者，希望评估spinal cord injury或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7228
  },
  {
    "request_id": "AM-REQ-2026-05980",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and heart failure transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5782
  },
  {
    "request_id": "AM-REQ-2026-05981",
    "original_inquiry": "Family seeking information: Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6087
  },
  {
    "request_id": "AM-REQ-2026-05982",
    "original_inquiry": "研究者咨询：Patient with advanced iPSC-derived neuron; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5058
  },
  {
    "request_id": "AM-REQ-2026-05983",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.533
  },
  {
    "request_id": "AM-REQ-2026-05984",
    "original_inquiry": "海外求诊：Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6764
  },
  {
    "request_id": "AM-REQ-2026-05985",
    "original_inquiry": "Urgent: Researcher inquiry: 帕金森 manufacturing and organoid transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5492
  },
  {
    "request_id": "AM-REQ-2026-05986",
    "original_inquiry": "研究者咨询：海外求诊：帕金森患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7943
  },
  {
    "request_id": "AM-REQ-2026-05987",
    "original_inquiry": "Urgent: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8362
  },
  {
    "request_id": "AM-REQ-2026-05988",
    "original_inquiry": "研究者咨询：Neurologist: 干细胞分化 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6404
  },
  {
    "request_id": "AM-REQ-2026-05989",
    "original_inquiry": "Family seeking information: Researcher inquiry: 多能干细胞 manufacturing and dopaminergic neuron transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7659
  },
  {
    "request_id": "AM-REQ-2026-05990",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5451
  },
  {
    "request_id": "AM-REQ-2026-05991",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and Parkinson transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.825
  },
  {
    "request_id": "AM-REQ-2026-05992",
    "original_inquiry": "Urgent: Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8004
  },
  {
    "request_id": "AM-REQ-2026-05993",
    "original_inquiry": "Family seeking information: Family seeking clinical trial therapy for cell replacement; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5326
  },
  {
    "request_id": "AM-REQ-2026-05994",
    "original_inquiry": "Urgent: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7377
  },
  {
    "request_id": "AM-REQ-2026-05995",
    "original_inquiry": "Family seeking information: 海外求诊：干细胞分化患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8683
  },
  {
    "request_id": "AM-REQ-2026-05996",
    "original_inquiry": "研究者咨询：Cardiologist referral: 心肌修复 with reduced EF; interested in organoid or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7395
  },
  {
    "request_id": "AM-REQ-2026-05997",
    "original_inquiry": "Referral from specialist: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6302
  },
  {
    "request_id": "AM-REQ-2026-05998",
    "original_inquiry": "Researcher inquiry: 心肌修复 manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6381
  },
  {
    "request_id": "AM-REQ-2026-05999",
    "original_inquiry": "研究者咨询：患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8956
  },
  {
    "request_id": "AM-REQ-2026-06000",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7882
  },
  {
    "request_id": "AM-REQ-2026-06001",
    "original_inquiry": "Cardiologist referral: 帕金森 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6501
  },
  {
    "request_id": "AM-REQ-2026-06002",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8024
  },
  {
    "request_id": "AM-REQ-2026-06003",
    "original_inquiry": "Urgent: Consultation: regenerative medicine with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5358
  },
  {
    "request_id": "AM-REQ-2026-06004",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in Parkinson or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.588
  },
  {
    "request_id": "AM-REQ-2026-06005",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7427
  },
  {
    "request_id": "AM-REQ-2026-06006",
    "original_inquiry": "海外求诊：Patient with advanced regenerative medicine; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6371
  },
  {
    "request_id": "AM-REQ-2026-06007",
    "original_inquiry": "Second opinion requested: Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8403
  },
  {
    "request_id": "AM-REQ-2026-06008",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6219
  },
  {
    "request_id": "AM-REQ-2026-06009",
    "original_inquiry": "Referral from specialist: Neurologist: 帕金森 patient, exploring heart failure and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8859
  },
  {
    "request_id": "AM-REQ-2026-06010",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 帕金森 manufacturing and induced pluripotent stem cell transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7862
  },
  {
    "request_id": "AM-REQ-2026-06011",
    "original_inquiry": "Family seeking information: Researcher inquiry: 类器官移植 manufacturing and heart failure transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5766
  },
  {
    "request_id": "AM-REQ-2026-06012",
    "original_inquiry": "Urgent: Patient with advanced 干细胞分化; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.838
  },
  {
    "request_id": "AM-REQ-2026-06013",
    "original_inquiry": "海外求诊：Neurologist: regenerative medicine patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6497
  },
  {
    "request_id": "AM-REQ-2026-06014",
    "original_inquiry": "患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6443
  },
  {
    "request_id": "AM-REQ-2026-06015",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8935
  },
  {
    "request_id": "AM-REQ-2026-06016",
    "original_inquiry": "Urgent: Neurologist: regenerative medicine patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6922
  },
  {
    "request_id": "AM-REQ-2026-06017",
    "original_inquiry": "Urgent: Consultation: cell therapy with spinal cord injury; interested in Parkinson or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7395
  },
  {
    "request_id": "AM-REQ-2026-06018",
    "original_inquiry": "Family seeking iPSC-derived neuron therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8931
  },
  {
    "request_id": "AM-REQ-2026-06019",
    "original_inquiry": "Second opinion requested: Neurologist: cell therapy patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.528
  },
  {
    "request_id": "AM-REQ-2026-06020",
    "original_inquiry": "Family seeking information: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7482
  },
  {
    "request_id": "AM-REQ-2026-06021",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5774
  },
  {
    "request_id": "AM-REQ-2026-06022",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5586
  },
  {
    "request_id": "AM-REQ-2026-06023",
    "original_inquiry": "研究者咨询：Patient with advanced 类器官移植; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7206
  },
  {
    "request_id": "AM-REQ-2026-06024",
    "original_inquiry": "Second opinion requested: Family seeking cell therapy therapy for heart failure; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.56
  },
  {
    "request_id": "AM-REQ-2026-06025",
    "original_inquiry": "患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6626
  },
  {
    "request_id": "AM-REQ-2026-06026",
    "original_inquiry": "Referral from specialist: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for organoid; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7383
  },
  {
    "request_id": "AM-REQ-2026-06027",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8969
  },
  {
    "request_id": "AM-REQ-2026-06028",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6869
  },
  {
    "request_id": "AM-REQ-2026-06029",
    "original_inquiry": "Family seeking information: Researcher inquiry: iPSC-derived neuron manufacturing and iPSC transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5261
  },
  {
    "request_id": "AM-REQ-2026-06030",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking organoid or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6937
  },
  {
    "request_id": "AM-REQ-2026-06031",
    "original_inquiry": "Urgent: 海外求诊：帕金森患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.765
  },
  {
    "request_id": "AM-REQ-2026-06032",
    "original_inquiry": "研究者咨询：Patient with advanced 类器官移植; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6988
  },
  {
    "request_id": "AM-REQ-2026-06033",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and induced pluripotent stem cell transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.555
  },
  {
    "request_id": "AM-REQ-2026-06034",
    "original_inquiry": "Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6465
  },
  {
    "request_id": "AM-REQ-2026-06035",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7815
  },
  {
    "request_id": "AM-REQ-2026-06036",
    "original_inquiry": "海外求诊：Patient with advanced 类器官移植; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8851
  },
  {
    "request_id": "AM-REQ-2026-06037",
    "original_inquiry": "Family seeking information: Family seeking 帕金森 therapy for Parkinson; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5119
  },
  {
    "request_id": "AM-REQ-2026-06038",
    "original_inquiry": "研究者咨询：Patient with advanced regenerative medicine; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.823
  },
  {
    "request_id": "AM-REQ-2026-06039",
    "original_inquiry": "Urgent: 海外求诊：类器官移植患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8969
  },
  {
    "request_id": "AM-REQ-2026-06040",
    "original_inquiry": "研究者咨询：Cardiologist referral: 干细胞分化 with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8073
  },
  {
    "request_id": "AM-REQ-2026-06041",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.633
  },
  {
    "request_id": "AM-REQ-2026-06042",
    "original_inquiry": "Urgent: Family seeking iPSC-derived neuron therapy for cardiomyocyte; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-06043",
    "original_inquiry": "Referral from specialist: Consultation: 类器官移植 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-06044",
    "original_inquiry": "Family seeking information: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6863
  },
  {
    "request_id": "AM-REQ-2026-06045",
    "original_inquiry": "Urgent: 海外求诊：iPSC-derived neuron患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6461
  },
  {
    "request_id": "AM-REQ-2026-06046",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 多能干细胞 manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7588
  },
  {
    "request_id": "AM-REQ-2026-06047",
    "original_inquiry": "海外求诊：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5157
  },
  {
    "request_id": "AM-REQ-2026-06048",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-06049",
    "original_inquiry": "Cardiologist referral: 帕金森 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.82
  },
  {
    "request_id": "AM-REQ-2026-06050",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5467
  },
  {
    "request_id": "AM-REQ-2026-06051",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5367
  },
  {
    "request_id": "AM-REQ-2026-06052",
    "original_inquiry": "Family seeking 多能干细胞 therapy for dopaminergic neuron; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6202
  },
  {
    "request_id": "AM-REQ-2026-06053",
    "original_inquiry": "Urgent: Family seeking 多能干细胞 therapy for organoid; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5631
  },
  {
    "request_id": "AM-REQ-2026-06054",
    "original_inquiry": "海外求诊：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6017
  },
  {
    "request_id": "AM-REQ-2026-06055",
    "original_inquiry": "海外求诊：干细胞分化患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.885
  },
  {
    "request_id": "AM-REQ-2026-06056",
    "original_inquiry": "研究者咨询：Consultation: 多能干细胞 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6615
  },
  {
    "request_id": "AM-REQ-2026-06057",
    "original_inquiry": "Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7842
  },
  {
    "request_id": "AM-REQ-2026-06058",
    "original_inquiry": "Family seeking information: 海外求诊：多能干细胞患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5221
  },
  {
    "request_id": "AM-REQ-2026-06059",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5599
  },
  {
    "request_id": "AM-REQ-2026-06060",
    "original_inquiry": "研究者咨询：Researcher inquiry: cell therapy manufacturing and heart failure transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5414
  },
  {
    "request_id": "AM-REQ-2026-06061",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for heart failure; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5242
  },
  {
    "request_id": "AM-REQ-2026-06062",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for organoid; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6432
  },
  {
    "request_id": "AM-REQ-2026-06063",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8851
  },
  {
    "request_id": "AM-REQ-2026-06064",
    "original_inquiry": "Family seeking information: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5566
  },
  {
    "request_id": "AM-REQ-2026-06065",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8441
  },
  {
    "request_id": "AM-REQ-2026-06066",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.643
  },
  {
    "request_id": "AM-REQ-2026-06067",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6923
  },
  {
    "request_id": "AM-REQ-2026-06068",
    "original_inquiry": "Family seeking information: Family seeking iPSC-derived neuron therapy for Parkinson; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6004
  },
  {
    "request_id": "AM-REQ-2026-06069",
    "original_inquiry": "患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7042
  },
  {
    "request_id": "AM-REQ-2026-06070",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6562
  },
  {
    "request_id": "AM-REQ-2026-06071",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.643
  },
  {
    "request_id": "AM-REQ-2026-06072",
    "original_inquiry": "Urgent: Consultation: cell therapy with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.781
  },
  {
    "request_id": "AM-REQ-2026-06073",
    "original_inquiry": "海外求诊：Family seeking clinical trial therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7024
  },
  {
    "request_id": "AM-REQ-2026-06074",
    "original_inquiry": "研究者咨询：Neurologist: regenerative medicine patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6755
  },
  {
    "request_id": "AM-REQ-2026-06075",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8036
  },
  {
    "request_id": "AM-REQ-2026-06076",
    "original_inquiry": "Family seeking information: Consultation: regenerative medicine with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7578
  },
  {
    "request_id": "AM-REQ-2026-06077",
    "original_inquiry": "Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.716
  },
  {
    "request_id": "AM-REQ-2026-06078",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5747
  },
  {
    "request_id": "AM-REQ-2026-06079",
    "original_inquiry": "研究者咨询：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6945
  },
  {
    "request_id": "AM-REQ-2026-06080",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5963
  },
  {
    "request_id": "AM-REQ-2026-06081",
    "original_inquiry": "海外求诊：Researcher inquiry: 多能干细胞 manufacturing and organoid transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8614
  },
  {
    "request_id": "AM-REQ-2026-06082",
    "original_inquiry": "Patient with advanced clinical trial; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6824
  },
  {
    "request_id": "AM-REQ-2026-06083",
    "original_inquiry": "Referral from specialist: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5577
  },
  {
    "request_id": "AM-REQ-2026-06084",
    "original_inquiry": "Second opinion requested: Consultation: iPSC-derived neuron with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8968
  },
  {
    "request_id": "AM-REQ-2026-06085",
    "original_inquiry": "海外求诊：Researcher inquiry: cell therapy manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5989
  },
  {
    "request_id": "AM-REQ-2026-06086",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8433
  },
  {
    "request_id": "AM-REQ-2026-06087",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8121
  },
  {
    "request_id": "AM-REQ-2026-06088",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 帕金森 with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.647
  },
  {
    "request_id": "AM-REQ-2026-06089",
    "original_inquiry": "Referral from specialist: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5741
  },
  {
    "request_id": "AM-REQ-2026-06090",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for induced pluripotent stem cell; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8606
  },
  {
    "request_id": "AM-REQ-2026-06091",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5338
  },
  {
    "request_id": "AM-REQ-2026-06092",
    "original_inquiry": "海外求诊：海外求诊：干细胞分化患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8961
  },
  {
    "request_id": "AM-REQ-2026-06093",
    "original_inquiry": "Family seeking information: Researcher inquiry: 帕金森 manufacturing and cardiomyocyte transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6532
  },
  {
    "request_id": "AM-REQ-2026-06094",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-06095",
    "original_inquiry": "患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7767
  },
  {
    "request_id": "AM-REQ-2026-06096",
    "original_inquiry": "研究者咨询：Patient with advanced 心肌修复; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.871
  },
  {
    "request_id": "AM-REQ-2026-06097",
    "original_inquiry": "Referral from specialist: Neurologist: 帕金森 patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6582
  },
  {
    "request_id": "AM-REQ-2026-06098",
    "original_inquiry": "Family seeking information: 海外求诊：帕金森患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-06099",
    "original_inquiry": "Family seeking information: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.815
  },
  {
    "request_id": "AM-REQ-2026-06100",
    "original_inquiry": "Family seeking information: Family seeking 干细胞分化 therapy for Parkinson; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5138
  },
  {
    "request_id": "AM-REQ-2026-06101",
    "original_inquiry": "Second opinion requested: Patient with advanced 心肌修复; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7391
  },
  {
    "request_id": "AM-REQ-2026-06102",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5858
  },
  {
    "request_id": "AM-REQ-2026-06103",
    "original_inquiry": "Urgent: Family seeking clinical trial therapy for iPSC; request centers with organoid programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7272
  },
  {
    "request_id": "AM-REQ-2026-06104",
    "original_inquiry": "研究者咨询：Researcher inquiry: cell therapy manufacturing and induced pluripotent stem cell transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7696
  },
  {
    "request_id": "AM-REQ-2026-06105",
    "original_inquiry": "Second opinion requested: Patient with advanced 干细胞分化; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7226
  },
  {
    "request_id": "AM-REQ-2026-06106",
    "original_inquiry": "Urgent: Cardiologist referral: clinical trial with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-06107",
    "original_inquiry": "海外求诊：海外求诊：iPSC-derived neuron患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5043
  },
  {
    "request_id": "AM-REQ-2026-06108",
    "original_inquiry": "海外求诊：Neurologist: 多能干细胞 patient, exploring spinal cord injury and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5435
  },
  {
    "request_id": "AM-REQ-2026-06109",
    "original_inquiry": "Urgent: 海外求诊：多能干细胞患者，希望评估spinal cord injury或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7086
  },
  {
    "request_id": "AM-REQ-2026-06110",
    "original_inquiry": "海外求诊：Cardiologist referral: 干细胞分化 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6476
  },
  {
    "request_id": "AM-REQ-2026-06111",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6699
  },
  {
    "request_id": "AM-REQ-2026-06112",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7696
  },
  {
    "request_id": "AM-REQ-2026-06113",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.795
  },
  {
    "request_id": "AM-REQ-2026-06114",
    "original_inquiry": "Referral from specialist: Consultation: 类器官移植 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8824
  },
  {
    "request_id": "AM-REQ-2026-06115",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and iPSC transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6956
  },
  {
    "request_id": "AM-REQ-2026-06116",
    "original_inquiry": "Cardiologist referral: cell therapy with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6808
  },
  {
    "request_id": "AM-REQ-2026-06117",
    "original_inquiry": "Second opinion requested: Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.708
  },
  {
    "request_id": "AM-REQ-2026-06118",
    "original_inquiry": "海外求诊：Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5078
  },
  {
    "request_id": "AM-REQ-2026-06119",
    "original_inquiry": "研究者咨询：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8532
  },
  {
    "request_id": "AM-REQ-2026-06120",
    "original_inquiry": "研究者咨询：Neurologist: 类器官移植 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6744
  },
  {
    "request_id": "AM-REQ-2026-06121",
    "original_inquiry": "海外求诊：Consultation: iPSC-derived neuron with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8197
  },
  {
    "request_id": "AM-REQ-2026-06122",
    "original_inquiry": "Urgent: 海外求诊：干细胞分化患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8609
  },
  {
    "request_id": "AM-REQ-2026-06123",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 干细胞分化 manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6212
  },
  {
    "request_id": "AM-REQ-2026-06124",
    "original_inquiry": "海外求诊：clinical trial患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7851
  },
  {
    "request_id": "AM-REQ-2026-06125",
    "original_inquiry": "海外求诊：Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8545
  },
  {
    "request_id": "AM-REQ-2026-06126",
    "original_inquiry": "海外求诊：Family seeking regenerative medicine therapy for spinal cord injury; request centers with iPSC programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7712
  },
  {
    "request_id": "AM-REQ-2026-06127",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5391
  },
  {
    "request_id": "AM-REQ-2026-06128",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7929
  },
  {
    "request_id": "AM-REQ-2026-06129",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5219
  },
  {
    "request_id": "AM-REQ-2026-06130",
    "original_inquiry": "研究者咨询：Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6183
  },
  {
    "request_id": "AM-REQ-2026-06131",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6314
  },
  {
    "request_id": "AM-REQ-2026-06132",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7597
  },
  {
    "request_id": "AM-REQ-2026-06133",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.576
  },
  {
    "request_id": "AM-REQ-2026-06134",
    "original_inquiry": "Referral from specialist: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5499
  },
  {
    "request_id": "AM-REQ-2026-06135",
    "original_inquiry": "Family seeking information: Researcher inquiry: 帕金森 manufacturing and iPSC transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7373
  },
  {
    "request_id": "AM-REQ-2026-06136",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7898
  },
  {
    "request_id": "AM-REQ-2026-06137",
    "original_inquiry": "Cardiologist referral: regenerative medicine with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7144
  },
  {
    "request_id": "AM-REQ-2026-06138",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5199
  },
  {
    "request_id": "AM-REQ-2026-06139",
    "original_inquiry": "Second opinion requested: Family seeking 心肌修复 therapy for heart failure; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5115
  },
  {
    "request_id": "AM-REQ-2026-06140",
    "original_inquiry": "Second opinion requested: Cardiologist referral: regenerative medicine with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7445
  },
  {
    "request_id": "AM-REQ-2026-06141",
    "original_inquiry": "研究者咨询：海外求诊：类器官移植患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6899
  },
  {
    "request_id": "AM-REQ-2026-06142",
    "original_inquiry": "患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7454
  },
  {
    "request_id": "AM-REQ-2026-06143",
    "original_inquiry": "Second opinion requested: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8664
  },
  {
    "request_id": "AM-REQ-2026-06144",
    "original_inquiry": "研究者咨询：Consultation: regenerative medicine with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5427
  },
  {
    "request_id": "AM-REQ-2026-06145",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7176
  },
  {
    "request_id": "AM-REQ-2026-06146",
    "original_inquiry": "海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5694
  },
  {
    "request_id": "AM-REQ-2026-06147",
    "original_inquiry": "研究者咨询：Cardiologist referral: 干细胞分化 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7996
  },
  {
    "request_id": "AM-REQ-2026-06148",
    "original_inquiry": "研究者咨询：Neurologist: 多能干细胞 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5073
  },
  {
    "request_id": "AM-REQ-2026-06149",
    "original_inquiry": "Patient with advanced iPSC-derived neuron; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8854
  },
  {
    "request_id": "AM-REQ-2026-06150",
    "original_inquiry": "Family seeking information: Neurologist: regenerative medicine patient, exploring dopaminergic neuron and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-06151",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7614
  },
  {
    "request_id": "AM-REQ-2026-06152",
    "original_inquiry": "Family seeking information: Patient with advanced 干细胞分化; seeking spinal cord injury or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8878
  },
  {
    "request_id": "AM-REQ-2026-06153",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.67
  },
  {
    "request_id": "AM-REQ-2026-06154",
    "original_inquiry": "Referral from specialist: Patient with advanced regenerative medicine; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-06155",
    "original_inquiry": "Family seeking information: Consultation: 帕金森 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.507
  },
  {
    "request_id": "AM-REQ-2026-06156",
    "original_inquiry": "Cardiologist referral: 帕金森 with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8909
  },
  {
    "request_id": "AM-REQ-2026-06157",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 干细胞分化 manufacturing and organoid transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5081
  },
  {
    "request_id": "AM-REQ-2026-06158",
    "original_inquiry": "Referral from specialist: Researcher inquiry: clinical trial manufacturing and spinal cord injury transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8301
  },
  {
    "request_id": "AM-REQ-2026-06159",
    "original_inquiry": "海外求诊：Researcher inquiry: cell therapy manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-06160",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8989
  },
  {
    "request_id": "AM-REQ-2026-06161",
    "original_inquiry": "Referral from specialist: Family seeking 干细胞分化 therapy for spinal cord injury; request centers with cardiomyocyte programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.872
  },
  {
    "request_id": "AM-REQ-2026-06162",
    "original_inquiry": "Researcher inquiry: clinical trial manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.795
  },
  {
    "request_id": "AM-REQ-2026-06163",
    "original_inquiry": "Second opinion requested: Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.728
  },
  {
    "request_id": "AM-REQ-2026-06164",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-06165",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6493
  },
  {
    "request_id": "AM-REQ-2026-06166",
    "original_inquiry": "Family seeking information: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7839
  },
  {
    "request_id": "AM-REQ-2026-06167",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in Parkinson or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5668
  },
  {
    "request_id": "AM-REQ-2026-06168",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for Parkinson; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6656
  },
  {
    "request_id": "AM-REQ-2026-06169",
    "original_inquiry": "Urgent: Researcher inquiry: cell therapy manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6917
  },
  {
    "request_id": "AM-REQ-2026-06170",
    "original_inquiry": "海外求诊：Neurologist: 帕金森 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8867
  },
  {
    "request_id": "AM-REQ-2026-06171",
    "original_inquiry": "Second opinion requested: Consultation: cell therapy with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6192
  },
  {
    "request_id": "AM-REQ-2026-06172",
    "original_inquiry": "Urgent: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6371
  },
  {
    "request_id": "AM-REQ-2026-06173",
    "original_inquiry": "研究者咨询：Researcher inquiry: clinical trial manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5251
  },
  {
    "request_id": "AM-REQ-2026-06174",
    "original_inquiry": "研究者咨询：Family seeking 干细胞分化 therapy for iPSC; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8115
  },
  {
    "request_id": "AM-REQ-2026-06175",
    "original_inquiry": "海外求诊：Family seeking 干细胞分化 therapy for cell replacement; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5208
  },
  {
    "request_id": "AM-REQ-2026-06176",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.854
  },
  {
    "request_id": "AM-REQ-2026-06177",
    "original_inquiry": "Urgent: Family seeking 类器官移植 therapy for heart failure; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5441
  },
  {
    "request_id": "AM-REQ-2026-06178",
    "original_inquiry": "Urgent: Researcher inquiry: 帕金森 manufacturing and cell replacement transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8148
  },
  {
    "request_id": "AM-REQ-2026-06179",
    "original_inquiry": "Family seeking information: Family seeking 帕金森 therapy for spinal cord injury; request centers with cardiomyocyte programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-06180",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7317
  },
  {
    "request_id": "AM-REQ-2026-06181",
    "original_inquiry": "Family seeking cell therapy therapy for iPSC; request centers with cell replacement programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5899
  },
  {
    "request_id": "AM-REQ-2026-06182",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7409
  },
  {
    "request_id": "AM-REQ-2026-06183",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5408
  },
  {
    "request_id": "AM-REQ-2026-06184",
    "original_inquiry": "海外求诊：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7351
  },
  {
    "request_id": "AM-REQ-2026-06185",
    "original_inquiry": "海外求诊：Family seeking 心肌修复 therapy for iPSC; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5183
  },
  {
    "request_id": "AM-REQ-2026-06186",
    "original_inquiry": "Referral from specialist: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.551
  },
  {
    "request_id": "AM-REQ-2026-06187",
    "original_inquiry": "Referral from specialist: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cell replacement or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8682
  },
  {
    "request_id": "AM-REQ-2026-06188",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5439
  },
  {
    "request_id": "AM-REQ-2026-06189",
    "original_inquiry": "海外求诊：患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6177
  },
  {
    "request_id": "AM-REQ-2026-06190",
    "original_inquiry": "研究者咨询：Neurologist: 干细胞分化 patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5874
  },
  {
    "request_id": "AM-REQ-2026-06191",
    "original_inquiry": "Family seeking information: Researcher inquiry: 心肌修复 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7497
  },
  {
    "request_id": "AM-REQ-2026-06192",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.89
  },
  {
    "request_id": "AM-REQ-2026-06193",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6134
  },
  {
    "request_id": "AM-REQ-2026-06194",
    "original_inquiry": "海外求诊：Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-06195",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5598
  },
  {
    "request_id": "AM-REQ-2026-06196",
    "original_inquiry": "Second opinion requested: Consultation: 类器官移植 with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.561
  },
  {
    "request_id": "AM-REQ-2026-06197",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7878
  },
  {
    "request_id": "AM-REQ-2026-06198",
    "original_inquiry": "Urgent: Family seeking 类器官移植 therapy for induced pluripotent stem cell; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6413
  },
  {
    "request_id": "AM-REQ-2026-06199",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5979
  },
  {
    "request_id": "AM-REQ-2026-06200",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6606
  },
  {
    "request_id": "AM-REQ-2026-06201",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6252
  },
  {
    "request_id": "AM-REQ-2026-06202",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.825
  },
  {
    "request_id": "AM-REQ-2026-06203",
    "original_inquiry": "Family seeking information: 海外求诊：iPSC-derived neuron患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7671
  },
  {
    "request_id": "AM-REQ-2026-06204",
    "original_inquiry": "Family seeking information: Consultation: regenerative medicine with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8343
  },
  {
    "request_id": "AM-REQ-2026-06205",
    "original_inquiry": "Urgent: Cardiologist referral: 干细胞分化 with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5784
  },
  {
    "request_id": "AM-REQ-2026-06206",
    "original_inquiry": "海外求诊：Cardiologist referral: 帕金森 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7925
  },
  {
    "request_id": "AM-REQ-2026-06207",
    "original_inquiry": "Referral from specialist: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8002
  },
  {
    "request_id": "AM-REQ-2026-06208",
    "original_inquiry": "海外求诊：clinical trial患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7686
  },
  {
    "request_id": "AM-REQ-2026-06209",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6018
  },
  {
    "request_id": "AM-REQ-2026-06210",
    "original_inquiry": "Researcher inquiry: 帕金森 manufacturing and induced pluripotent stem cell transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5618
  },
  {
    "request_id": "AM-REQ-2026-06211",
    "original_inquiry": "Neurologist: 心肌修复 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8965
  },
  {
    "request_id": "AM-REQ-2026-06212",
    "original_inquiry": "患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7854
  },
  {
    "request_id": "AM-REQ-2026-06213",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6603
  },
  {
    "request_id": "AM-REQ-2026-06214",
    "original_inquiry": "Referral from specialist: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8452
  },
  {
    "request_id": "AM-REQ-2026-06215",
    "original_inquiry": "Researcher inquiry: 帕金森 manufacturing and organoid transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8947
  },
  {
    "request_id": "AM-REQ-2026-06216",
    "original_inquiry": "Family seeking information: 海外求诊：心肌修复患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5926
  },
  {
    "request_id": "AM-REQ-2026-06217",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估iPSC或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8911
  },
  {
    "request_id": "AM-REQ-2026-06218",
    "original_inquiry": "Urgent: 海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8238
  },
  {
    "request_id": "AM-REQ-2026-06219",
    "original_inquiry": "Urgent: Researcher inquiry: 心肌修复 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5268
  },
  {
    "request_id": "AM-REQ-2026-06220",
    "original_inquiry": "Second opinion requested: Family seeking regenerative medicine therapy for cardiomyocyte; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8544
  },
  {
    "request_id": "AM-REQ-2026-06221",
    "original_inquiry": "Referral from specialist: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7945
  },
  {
    "request_id": "AM-REQ-2026-06222",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6119
  },
  {
    "request_id": "AM-REQ-2026-06223",
    "original_inquiry": "Referral from specialist: Family seeking cell therapy therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6176
  },
  {
    "request_id": "AM-REQ-2026-06224",
    "original_inquiry": "Referral from specialist: Family seeking clinical trial therapy for organoid; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7588
  },
  {
    "request_id": "AM-REQ-2026-06225",
    "original_inquiry": "Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6396
  },
  {
    "request_id": "AM-REQ-2026-06226",
    "original_inquiry": "Urgent: Family seeking 类器官移植 therapy for cell replacement; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6476
  },
  {
    "request_id": "AM-REQ-2026-06227",
    "original_inquiry": "患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5869
  },
  {
    "request_id": "AM-REQ-2026-06228",
    "original_inquiry": "Urgent: Cardiologist referral: clinical trial with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7114
  },
  {
    "request_id": "AM-REQ-2026-06229",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5062
  },
  {
    "request_id": "AM-REQ-2026-06230",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6593
  },
  {
    "request_id": "AM-REQ-2026-06231",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5346
  },
  {
    "request_id": "AM-REQ-2026-06232",
    "original_inquiry": "Second opinion requested: Researcher inquiry: regenerative medicine manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5143
  },
  {
    "request_id": "AM-REQ-2026-06233",
    "original_inquiry": "Cardiologist referral: cell therapy with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7631
  },
  {
    "request_id": "AM-REQ-2026-06234",
    "original_inquiry": "Urgent: Family seeking iPSC-derived neuron therapy for spinal cord injury; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5253
  },
  {
    "request_id": "AM-REQ-2026-06235",
    "original_inquiry": "研究者咨询：Cardiologist referral: 心肌修复 with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5164
  },
  {
    "request_id": "AM-REQ-2026-06236",
    "original_inquiry": "研究者咨询：Neurologist: clinical trial patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.85
  },
  {
    "request_id": "AM-REQ-2026-06237",
    "original_inquiry": "研究者咨询：Researcher inquiry: 多能干细胞 manufacturing and induced pluripotent stem cell transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5697
  },
  {
    "request_id": "AM-REQ-2026-06238",
    "original_inquiry": "Second opinion requested: Family seeking 类器官移植 therapy for spinal cord injury; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7628
  },
  {
    "request_id": "AM-REQ-2026-06239",
    "original_inquiry": "海外求诊：Family seeking iPSC-derived neuron therapy for heart failure; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7616
  },
  {
    "request_id": "AM-REQ-2026-06240",
    "original_inquiry": "研究者咨询：Family seeking cell therapy therapy for cardiomyocyte; request centers with cell replacement programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5268
  },
  {
    "request_id": "AM-REQ-2026-06241",
    "original_inquiry": "Family seeking information: Consultation: cell therapy with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.539
  },
  {
    "request_id": "AM-REQ-2026-06242",
    "original_inquiry": "研究者咨询：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.656
  },
  {
    "request_id": "AM-REQ-2026-06243",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7941
  },
  {
    "request_id": "AM-REQ-2026-06244",
    "original_inquiry": "海外求诊：Researcher inquiry: 多能干细胞 manufacturing and dopaminergic neuron transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8169
  },
  {
    "request_id": "AM-REQ-2026-06245",
    "original_inquiry": "Family seeking information: Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7254
  },
  {
    "request_id": "AM-REQ-2026-06246",
    "original_inquiry": "Second opinion requested: Family seeking iPSC-derived neuron therapy for induced pluripotent stem cell; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5144
  },
  {
    "request_id": "AM-REQ-2026-06247",
    "original_inquiry": "Family seeking 类器官移植 therapy for dopaminergic neuron; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-06248",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5015
  },
  {
    "request_id": "AM-REQ-2026-06249",
    "original_inquiry": "Referral from specialist: Family seeking clinical trial therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5355
  },
  {
    "request_id": "AM-REQ-2026-06250",
    "original_inquiry": "海外求诊：Patient with advanced iPSC-derived neuron; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.745
  },
  {
    "request_id": "AM-REQ-2026-06251",
    "original_inquiry": "研究者咨询：Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6325
  },
  {
    "request_id": "AM-REQ-2026-06252",
    "original_inquiry": "海外求诊：Family seeking clinical trial therapy for Parkinson; request centers with iPSC programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6778
  },
  {
    "request_id": "AM-REQ-2026-06253",
    "original_inquiry": "Urgent: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5257
  },
  {
    "request_id": "AM-REQ-2026-06254",
    "original_inquiry": "海外求诊：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7753
  },
  {
    "request_id": "AM-REQ-2026-06255",
    "original_inquiry": "Second opinion requested: 海外求诊：iPSC-derived neuron患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7462
  },
  {
    "request_id": "AM-REQ-2026-06256",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 心肌修复 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8084
  },
  {
    "request_id": "AM-REQ-2026-06257",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5853
  },
  {
    "request_id": "AM-REQ-2026-06258",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in organoid or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5486
  },
  {
    "request_id": "AM-REQ-2026-06259",
    "original_inquiry": "海外求诊：海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5018
  },
  {
    "request_id": "AM-REQ-2026-06260",
    "original_inquiry": "Urgent: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6203
  },
  {
    "request_id": "AM-REQ-2026-06261",
    "original_inquiry": "Urgent: Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-06262",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring cardiomyocyte and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7893
  },
  {
    "request_id": "AM-REQ-2026-06263",
    "original_inquiry": "研究者咨询：Family seeking 帕金森 therapy for iPSC; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8636
  },
  {
    "request_id": "AM-REQ-2026-06264",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for cell replacement; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8457
  },
  {
    "request_id": "AM-REQ-2026-06265",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8992
  },
  {
    "request_id": "AM-REQ-2026-06266",
    "original_inquiry": "Family seeking information: Family seeking 帕金森 therapy for cell replacement; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8567
  },
  {
    "request_id": "AM-REQ-2026-06267",
    "original_inquiry": "Urgent: Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5259
  },
  {
    "request_id": "AM-REQ-2026-06268",
    "original_inquiry": "Referral from specialist: Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7051
  },
  {
    "request_id": "AM-REQ-2026-06269",
    "original_inquiry": "Referral from specialist: Family seeking 多能干细胞 therapy for iPSC; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8042
  },
  {
    "request_id": "AM-REQ-2026-06270",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-06271",
    "original_inquiry": "Family seeking information: 海外求诊：cell therapy患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-06272",
    "original_inquiry": "Family seeking information: Family seeking 帕金森 therapy for Parkinson; request centers with organoid programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6583
  },
  {
    "request_id": "AM-REQ-2026-06273",
    "original_inquiry": "研究者咨询：海外求诊：regenerative medicine患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5742
  },
  {
    "request_id": "AM-REQ-2026-06274",
    "original_inquiry": "Urgent: Family seeking 多能干细胞 therapy for dopaminergic neuron; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8462
  },
  {
    "request_id": "AM-REQ-2026-06275",
    "original_inquiry": "Urgent: Family seeking 帕金森 therapy for cell replacement; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6177
  },
  {
    "request_id": "AM-REQ-2026-06276",
    "original_inquiry": "海外求诊：干细胞分化患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8504
  },
  {
    "request_id": "AM-REQ-2026-06277",
    "original_inquiry": "研究者咨询：Cardiologist referral: cell therapy with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7712
  },
  {
    "request_id": "AM-REQ-2026-06278",
    "original_inquiry": "研究者咨询：Family seeking 类器官移植 therapy for organoid; request centers with cardiomyocyte programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.504
  },
  {
    "request_id": "AM-REQ-2026-06279",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7516
  },
  {
    "request_id": "AM-REQ-2026-06280",
    "original_inquiry": "Family seeking information: 海外求诊：多能干细胞患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5079
  },
  {
    "request_id": "AM-REQ-2026-06281",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for dopaminergic neuron; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8476
  },
  {
    "request_id": "AM-REQ-2026-06282",
    "original_inquiry": "Urgent: Researcher inquiry: 类器官移植 manufacturing and heart failure transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8918
  },
  {
    "request_id": "AM-REQ-2026-06283",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8964
  },
  {
    "request_id": "AM-REQ-2026-06284",
    "original_inquiry": "海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5569
  },
  {
    "request_id": "AM-REQ-2026-06285",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估iPSC或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8718
  },
  {
    "request_id": "AM-REQ-2026-06286",
    "original_inquiry": "海外求诊：海外求诊：心肌修复患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5159
  },
  {
    "request_id": "AM-REQ-2026-06287",
    "original_inquiry": "海外求诊：iPSC-derived neuron患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.794
  },
  {
    "request_id": "AM-REQ-2026-06288",
    "original_inquiry": "海外求诊：Cardiologist referral: 多能干细胞 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8879
  },
  {
    "request_id": "AM-REQ-2026-06289",
    "original_inquiry": "Family seeking information: Neurologist: 类器官移植 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8101
  },
  {
    "request_id": "AM-REQ-2026-06290",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 帕金森 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8951
  },
  {
    "request_id": "AM-REQ-2026-06291",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.604
  },
  {
    "request_id": "AM-REQ-2026-06292",
    "original_inquiry": "Referral from specialist: 海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5975
  },
  {
    "request_id": "AM-REQ-2026-06293",
    "original_inquiry": "Second opinion requested: Patient with advanced 帕金森; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6404
  },
  {
    "request_id": "AM-REQ-2026-06294",
    "original_inquiry": "Referral from specialist: 海外求诊：多能干细胞患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6174
  },
  {
    "request_id": "AM-REQ-2026-06295",
    "original_inquiry": "研究者咨询：Cardiologist referral: 类器官移植 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7518
  },
  {
    "request_id": "AM-REQ-2026-06296",
    "original_inquiry": "Urgent: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7452
  },
  {
    "request_id": "AM-REQ-2026-06297",
    "original_inquiry": "研究者咨询：Neurologist: clinical trial patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8303
  },
  {
    "request_id": "AM-REQ-2026-06298",
    "original_inquiry": "Second opinion requested: Cardiologist referral: regenerative medicine with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8536
  },
  {
    "request_id": "AM-REQ-2026-06299",
    "original_inquiry": "Patient with advanced clinical trial; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6067
  },
  {
    "request_id": "AM-REQ-2026-06300",
    "original_inquiry": "海外求诊：Neurologist: cell therapy patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5356
  },
  {
    "request_id": "AM-REQ-2026-06301",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5003
  },
  {
    "request_id": "AM-REQ-2026-06302",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5423
  },
  {
    "request_id": "AM-REQ-2026-06303",
    "original_inquiry": "Consultation: 帕金森 with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6175
  },
  {
    "request_id": "AM-REQ-2026-06304",
    "original_inquiry": "Urgent: Researcher inquiry: 干细胞分化 manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5947
  },
  {
    "request_id": "AM-REQ-2026-06305",
    "original_inquiry": "Urgent: Consultation: 多能干细胞 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-06306",
    "original_inquiry": "Patient with advanced 帕金森; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7984
  },
  {
    "request_id": "AM-REQ-2026-06307",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in organoid or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-06308",
    "original_inquiry": "Urgent: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8448
  },
  {
    "request_id": "AM-REQ-2026-06309",
    "original_inquiry": "研究者咨询：Patient with advanced regenerative medicine; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5532
  },
  {
    "request_id": "AM-REQ-2026-06310",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and cell replacement transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5556
  },
  {
    "request_id": "AM-REQ-2026-06311",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.768
  },
  {
    "request_id": "AM-REQ-2026-06312",
    "original_inquiry": "Family seeking information: 海外求诊：iPSC-derived neuron患者，希望评估iPSC或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6455
  },
  {
    "request_id": "AM-REQ-2026-06313",
    "original_inquiry": "Neurologist: clinical trial patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7083
  },
  {
    "request_id": "AM-REQ-2026-06314",
    "original_inquiry": "海外求诊：Patient with advanced iPSC-derived neuron; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6128
  },
  {
    "request_id": "AM-REQ-2026-06315",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8231
  },
  {
    "request_id": "AM-REQ-2026-06316",
    "original_inquiry": "Referral from specialist: Neurologist: iPSC-derived neuron patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5285
  },
  {
    "request_id": "AM-REQ-2026-06317",
    "original_inquiry": "Referral from specialist: Patient with advanced 类器官移植; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-06318",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.744
  },
  {
    "request_id": "AM-REQ-2026-06319",
    "original_inquiry": "海外求诊：海外求诊：干细胞分化患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6217
  },
  {
    "request_id": "AM-REQ-2026-06320",
    "original_inquiry": "患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6741
  },
  {
    "request_id": "AM-REQ-2026-06321",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8415
  },
  {
    "request_id": "AM-REQ-2026-06322",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and dopaminergic neuron transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6827
  },
  {
    "request_id": "AM-REQ-2026-06323",
    "original_inquiry": "Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6641
  },
  {
    "request_id": "AM-REQ-2026-06324",
    "original_inquiry": "Family seeking information: 海外求诊：多能干细胞患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-06325",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.68
  },
  {
    "request_id": "AM-REQ-2026-06326",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring spinal cord injury and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8201
  },
  {
    "request_id": "AM-REQ-2026-06327",
    "original_inquiry": "患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5953
  },
  {
    "request_id": "AM-REQ-2026-06328",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8709
  },
  {
    "request_id": "AM-REQ-2026-06329",
    "original_inquiry": "Patient with advanced cell therapy; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5808
  },
  {
    "request_id": "AM-REQ-2026-06330",
    "original_inquiry": "Family seeking iPSC-derived neuron therapy for Parkinson; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6766
  },
  {
    "request_id": "AM-REQ-2026-06331",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8557
  },
  {
    "request_id": "AM-REQ-2026-06332",
    "original_inquiry": "海外求诊：帕金森患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8859
  },
  {
    "request_id": "AM-REQ-2026-06333",
    "original_inquiry": "研究者咨询：海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-06334",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7234
  },
  {
    "request_id": "AM-REQ-2026-06335",
    "original_inquiry": "海外求诊：Neurologist: regenerative medicine patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7722
  },
  {
    "request_id": "AM-REQ-2026-06336",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8754
  },
  {
    "request_id": "AM-REQ-2026-06337",
    "original_inquiry": "研究者咨询：Cardiologist referral: cell therapy with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5541
  },
  {
    "request_id": "AM-REQ-2026-06338",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for heart failure; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6447
  },
  {
    "request_id": "AM-REQ-2026-06339",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8727
  },
  {
    "request_id": "AM-REQ-2026-06340",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6928
  },
  {
    "request_id": "AM-REQ-2026-06341",
    "original_inquiry": "研究者咨询：Consultation: 心肌修复 with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5566
  },
  {
    "request_id": "AM-REQ-2026-06342",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7782
  },
  {
    "request_id": "AM-REQ-2026-06343",
    "original_inquiry": "Second opinion requested: Patient with advanced iPSC-derived neuron; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5621
  },
  {
    "request_id": "AM-REQ-2026-06344",
    "original_inquiry": "Second opinion requested: Family seeking 心肌修复 therapy for spinal cord injury; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7769
  },
  {
    "request_id": "AM-REQ-2026-06345",
    "original_inquiry": "Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6637
  },
  {
    "request_id": "AM-REQ-2026-06346",
    "original_inquiry": "Referral from specialist: Family seeking 多能干细胞 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7011
  },
  {
    "request_id": "AM-REQ-2026-06347",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5144
  },
  {
    "request_id": "AM-REQ-2026-06348",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8302
  },
  {
    "request_id": "AM-REQ-2026-06349",
    "original_inquiry": "Urgent: Consultation: 多能干细胞 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7624
  },
  {
    "request_id": "AM-REQ-2026-06350",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5699
  },
  {
    "request_id": "AM-REQ-2026-06351",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6117
  },
  {
    "request_id": "AM-REQ-2026-06352",
    "original_inquiry": "海外求诊：Researcher inquiry: 多能干细胞 manufacturing and iPSC transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5909
  },
  {
    "request_id": "AM-REQ-2026-06353",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5056
  },
  {
    "request_id": "AM-REQ-2026-06354",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7045
  },
  {
    "request_id": "AM-REQ-2026-06355",
    "original_inquiry": "Researcher inquiry: iPSC-derived neuron manufacturing and heart failure transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5898
  },
  {
    "request_id": "AM-REQ-2026-06356",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5771
  },
  {
    "request_id": "AM-REQ-2026-06357",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for organoid; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7114
  },
  {
    "request_id": "AM-REQ-2026-06358",
    "original_inquiry": "研究者咨询：Cardiologist referral: 类器官移植 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5759
  },
  {
    "request_id": "AM-REQ-2026-06359",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5602
  },
  {
    "request_id": "AM-REQ-2026-06360",
    "original_inquiry": "Family seeking information: Family seeking clinical trial therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5185
  },
  {
    "request_id": "AM-REQ-2026-06361",
    "original_inquiry": "Referral from specialist: 海外求诊：类器官移植患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7197
  },
  {
    "request_id": "AM-REQ-2026-06362",
    "original_inquiry": "研究者咨询：海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5937
  },
  {
    "request_id": "AM-REQ-2026-06363",
    "original_inquiry": "Urgent: Cardiologist referral: cell therapy with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5992
  },
  {
    "request_id": "AM-REQ-2026-06364",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.714
  },
  {
    "request_id": "AM-REQ-2026-06365",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for heart failure; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5857
  },
  {
    "request_id": "AM-REQ-2026-06366",
    "original_inquiry": "海外求诊：海外求诊：cell therapy患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7067
  },
  {
    "request_id": "AM-REQ-2026-06367",
    "original_inquiry": "Second opinion requested: Family seeking iPSC-derived neuron therapy for cardiomyocyte; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5614
  },
  {
    "request_id": "AM-REQ-2026-06368",
    "original_inquiry": "Family seeking information: Consultation: regenerative medicine with spinal cord injury; interested in heart failure or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5381
  },
  {
    "request_id": "AM-REQ-2026-06369",
    "original_inquiry": "Second opinion requested: Consultation: 类器官移植 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7807
  },
  {
    "request_id": "AM-REQ-2026-06370",
    "original_inquiry": "海外求诊：Cardiologist referral: cell therapy with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.721
  },
  {
    "request_id": "AM-REQ-2026-06371",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8377
  },
  {
    "request_id": "AM-REQ-2026-06372",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 类器官移植 manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7772
  },
  {
    "request_id": "AM-REQ-2026-06373",
    "original_inquiry": "海外求诊：Neurologist: iPSC-derived neuron patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8177
  },
  {
    "request_id": "AM-REQ-2026-06374",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.864
  },
  {
    "request_id": "AM-REQ-2026-06375",
    "original_inquiry": "海外求诊：Consultation: 心肌修复 with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6363
  },
  {
    "request_id": "AM-REQ-2026-06376",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6642
  },
  {
    "request_id": "AM-REQ-2026-06377",
    "original_inquiry": "Consultation: clinical trial with spinal cord injury; interested in spinal cord injury or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6359
  },
  {
    "request_id": "AM-REQ-2026-06378",
    "original_inquiry": "研究者咨询：Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7132
  },
  {
    "request_id": "AM-REQ-2026-06379",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for dopaminergic neuron; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6428
  },
  {
    "request_id": "AM-REQ-2026-06380",
    "original_inquiry": "研究者咨询：Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5028
  },
  {
    "request_id": "AM-REQ-2026-06381",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7212
  },
  {
    "request_id": "AM-REQ-2026-06382",
    "original_inquiry": "Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5559
  },
  {
    "request_id": "AM-REQ-2026-06383",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6613
  },
  {
    "request_id": "AM-REQ-2026-06384",
    "original_inquiry": "Family seeking information: Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8391
  },
  {
    "request_id": "AM-REQ-2026-06385",
    "original_inquiry": "Urgent: Patient with advanced 干细胞分化; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5887
  },
  {
    "request_id": "AM-REQ-2026-06386",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5828
  },
  {
    "request_id": "AM-REQ-2026-06387",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for organoid; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7316
  },
  {
    "request_id": "AM-REQ-2026-06388",
    "original_inquiry": "海外求诊：海外求诊：帕金森患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5061
  },
  {
    "request_id": "AM-REQ-2026-06389",
    "original_inquiry": "Second opinion requested: Neurologist: clinical trial patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6769
  },
  {
    "request_id": "AM-REQ-2026-06390",
    "original_inquiry": "Urgent: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5457
  },
  {
    "request_id": "AM-REQ-2026-06391",
    "original_inquiry": "Referral from specialist: 海外求诊：多能干细胞患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5392
  },
  {
    "request_id": "AM-REQ-2026-06392",
    "original_inquiry": "Referral from specialist: Neurologist: 干细胞分化 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7315
  },
  {
    "request_id": "AM-REQ-2026-06393",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.73
  },
  {
    "request_id": "AM-REQ-2026-06394",
    "original_inquiry": "Family seeking information: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7873
  },
  {
    "request_id": "AM-REQ-2026-06395",
    "original_inquiry": "Family seeking information: Cardiologist referral: 多能干细胞 with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7224
  },
  {
    "request_id": "AM-REQ-2026-06396",
    "original_inquiry": "Referral from specialist: Neurologist: clinical trial patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5511
  },
  {
    "request_id": "AM-REQ-2026-06397",
    "original_inquiry": "海外求诊：Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5605
  },
  {
    "request_id": "AM-REQ-2026-06398",
    "original_inquiry": "Referral from specialist: Family seeking 类器官移植 therapy for organoid; request centers with cardiomyocyte programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5283
  },
  {
    "request_id": "AM-REQ-2026-06399",
    "original_inquiry": "Urgent: Family seeking iPSC-derived neuron therapy for cardiomyocyte; request centers with iPSC programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6661
  },
  {
    "request_id": "AM-REQ-2026-06400",
    "original_inquiry": "Family seeking information: Family seeking clinical trial therapy for iPSC; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.791
  },
  {
    "request_id": "AM-REQ-2026-06401",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for cardiomyocyte; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7188
  },
  {
    "request_id": "AM-REQ-2026-06402",
    "original_inquiry": "Patient with advanced clinical trial; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8691
  },
  {
    "request_id": "AM-REQ-2026-06403",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 心肌修复 manufacturing and heart failure transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-06404",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5046
  },
  {
    "request_id": "AM-REQ-2026-06405",
    "original_inquiry": "海外求诊：海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8473
  },
  {
    "request_id": "AM-REQ-2026-06406",
    "original_inquiry": "海外求诊：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5925
  },
  {
    "request_id": "AM-REQ-2026-06407",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8228
  },
  {
    "request_id": "AM-REQ-2026-06408",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7725
  },
  {
    "request_id": "AM-REQ-2026-06409",
    "original_inquiry": "研究者咨询：Consultation: 多能干细胞 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.84
  },
  {
    "request_id": "AM-REQ-2026-06410",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.603
  },
  {
    "request_id": "AM-REQ-2026-06411",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7138
  },
  {
    "request_id": "AM-REQ-2026-06412",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7158
  },
  {
    "request_id": "AM-REQ-2026-06413",
    "original_inquiry": "Family seeking information: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7374
  },
  {
    "request_id": "AM-REQ-2026-06414",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7966
  },
  {
    "request_id": "AM-REQ-2026-06415",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in heart failure or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7069
  },
  {
    "request_id": "AM-REQ-2026-06416",
    "original_inquiry": "Family seeking 多能干细胞 therapy for heart failure; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7814
  },
  {
    "request_id": "AM-REQ-2026-06417",
    "original_inquiry": "Family seeking information: Researcher inquiry: 帕金森 manufacturing and cell replacement transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5261
  },
  {
    "request_id": "AM-REQ-2026-06418",
    "original_inquiry": "Researcher inquiry: regenerative medicine manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7431
  },
  {
    "request_id": "AM-REQ-2026-06419",
    "original_inquiry": "研究者咨询：Consultation: clinical trial with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6281
  },
  {
    "request_id": "AM-REQ-2026-06420",
    "original_inquiry": "Second opinion requested: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5296
  },
  {
    "request_id": "AM-REQ-2026-06421",
    "original_inquiry": "Urgent: Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.82
  },
  {
    "request_id": "AM-REQ-2026-06422",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6958
  },
  {
    "request_id": "AM-REQ-2026-06423",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5684
  },
  {
    "request_id": "AM-REQ-2026-06424",
    "original_inquiry": "研究者咨询：Researcher inquiry: iPSC-derived neuron manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5118
  },
  {
    "request_id": "AM-REQ-2026-06425",
    "original_inquiry": "Referral from specialist: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6214
  },
  {
    "request_id": "AM-REQ-2026-06426",
    "original_inquiry": "Researcher inquiry: 帕金森 manufacturing and dopaminergic neuron transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8632
  },
  {
    "request_id": "AM-REQ-2026-06427",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7108
  },
  {
    "request_id": "AM-REQ-2026-06428",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8782
  },
  {
    "request_id": "AM-REQ-2026-06429",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5925
  },
  {
    "request_id": "AM-REQ-2026-06430",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8215
  },
  {
    "request_id": "AM-REQ-2026-06431",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and cardiomyocyte transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8541
  },
  {
    "request_id": "AM-REQ-2026-06432",
    "original_inquiry": "海外求诊：Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6988
  },
  {
    "request_id": "AM-REQ-2026-06433",
    "original_inquiry": "研究者咨询：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6902
  },
  {
    "request_id": "AM-REQ-2026-06434",
    "original_inquiry": "Family seeking regenerative medicine therapy for organoid; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8951
  },
  {
    "request_id": "AM-REQ-2026-06435",
    "original_inquiry": "Urgent: Family seeking clinical trial therapy for dopaminergic neuron; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8396
  },
  {
    "request_id": "AM-REQ-2026-06436",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7707
  },
  {
    "request_id": "AM-REQ-2026-06437",
    "original_inquiry": "Neurologist: clinical trial patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8146
  },
  {
    "request_id": "AM-REQ-2026-06438",
    "original_inquiry": "Second opinion requested: Consultation: 多能干细胞 with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7529
  },
  {
    "request_id": "AM-REQ-2026-06439",
    "original_inquiry": "Referral from specialist: Family seeking 心肌修复 therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6102
  },
  {
    "request_id": "AM-REQ-2026-06440",
    "original_inquiry": "海外求诊：Patient with advanced regenerative medicine; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.535
  },
  {
    "request_id": "AM-REQ-2026-06441",
    "original_inquiry": "研究者咨询：Researcher inquiry: iPSC-derived neuron manufacturing and cardiomyocyte transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7042
  },
  {
    "request_id": "AM-REQ-2026-06442",
    "original_inquiry": "Family seeking information: 海外求诊：clinical trial患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6314
  },
  {
    "request_id": "AM-REQ-2026-06443",
    "original_inquiry": "海外求诊：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8882
  },
  {
    "request_id": "AM-REQ-2026-06444",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in cell replacement or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6061
  },
  {
    "request_id": "AM-REQ-2026-06445",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.538
  },
  {
    "request_id": "AM-REQ-2026-06446",
    "original_inquiry": "Family seeking information: Patient with advanced regenerative medicine; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.775
  },
  {
    "request_id": "AM-REQ-2026-06447",
    "original_inquiry": "患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5279
  },
  {
    "request_id": "AM-REQ-2026-06448",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8648
  },
  {
    "request_id": "AM-REQ-2026-06449",
    "original_inquiry": "Family seeking 类器官移植 therapy for iPSC; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6105
  },
  {
    "request_id": "AM-REQ-2026-06450",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 干细胞分化 manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5062
  },
  {
    "request_id": "AM-REQ-2026-06451",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and organoid transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5912
  },
  {
    "request_id": "AM-REQ-2026-06452",
    "original_inquiry": "Second opinion requested: 海外求诊：帕金森患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8752
  },
  {
    "request_id": "AM-REQ-2026-06453",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8904
  },
  {
    "request_id": "AM-REQ-2026-06454",
    "original_inquiry": "Urgent: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.547
  },
  {
    "request_id": "AM-REQ-2026-06455",
    "original_inquiry": "Urgent: Consultation: cell therapy with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8669
  },
  {
    "request_id": "AM-REQ-2026-06456",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5439
  },
  {
    "request_id": "AM-REQ-2026-06457",
    "original_inquiry": "Referral from specialist: Neurologist: 干细胞分化 patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6544
  },
  {
    "request_id": "AM-REQ-2026-06458",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5553
  },
  {
    "request_id": "AM-REQ-2026-06459",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for iPSC; request centers with cell replacement programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7067
  },
  {
    "request_id": "AM-REQ-2026-06460",
    "original_inquiry": "海外求诊：Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-06461",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and cell replacement transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6443
  },
  {
    "request_id": "AM-REQ-2026-06462",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking spinal cord injury or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5591
  },
  {
    "request_id": "AM-REQ-2026-06463",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 心肌修复 manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5383
  },
  {
    "request_id": "AM-REQ-2026-06464",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8064
  },
  {
    "request_id": "AM-REQ-2026-06465",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估spinal cord injury或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8908
  },
  {
    "request_id": "AM-REQ-2026-06466",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6708
  },
  {
    "request_id": "AM-REQ-2026-06467",
    "original_inquiry": "Urgent: Consultation: clinical trial with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6003
  },
  {
    "request_id": "AM-REQ-2026-06468",
    "original_inquiry": "Urgent: Consultation: 多能干细胞 with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5183
  },
  {
    "request_id": "AM-REQ-2026-06469",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6106
  },
  {
    "request_id": "AM-REQ-2026-06470",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8415
  },
  {
    "request_id": "AM-REQ-2026-06471",
    "original_inquiry": "海外求诊：Neurologist: cell therapy patient, exploring cardiomyocyte and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6982
  },
  {
    "request_id": "AM-REQ-2026-06472",
    "original_inquiry": "Urgent: Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6933
  },
  {
    "request_id": "AM-REQ-2026-06473",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7153
  },
  {
    "request_id": "AM-REQ-2026-06474",
    "original_inquiry": "Urgent: Family seeking cell therapy therapy for cardiomyocyte; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5723
  },
  {
    "request_id": "AM-REQ-2026-06475",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6152
  },
  {
    "request_id": "AM-REQ-2026-06476",
    "original_inquiry": "Cardiologist referral: 心肌修复 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5415
  },
  {
    "request_id": "AM-REQ-2026-06477",
    "original_inquiry": "海外求诊：Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5348
  },
  {
    "request_id": "AM-REQ-2026-06478",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7583
  },
  {
    "request_id": "AM-REQ-2026-06479",
    "original_inquiry": "海外求诊：Cardiologist referral: 多能干细胞 with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7056
  },
  {
    "request_id": "AM-REQ-2026-06480",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5593
  },
  {
    "request_id": "AM-REQ-2026-06481",
    "original_inquiry": "Family seeking information: Cardiologist referral: 帕金森 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-06482",
    "original_inquiry": "海外求诊：iPSC-derived neuron患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7017
  },
  {
    "request_id": "AM-REQ-2026-06483",
    "original_inquiry": "Urgent: Consultation: iPSC-derived neuron with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7566
  },
  {
    "request_id": "AM-REQ-2026-06484",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6295
  },
  {
    "request_id": "AM-REQ-2026-06485",
    "original_inquiry": "研究者咨询：Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7952
  },
  {
    "request_id": "AM-REQ-2026-06486",
    "original_inquiry": "Urgent: Neurologist: 类器官移植 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6784
  },
  {
    "request_id": "AM-REQ-2026-06487",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8506
  },
  {
    "request_id": "AM-REQ-2026-06488",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for dopaminergic neuron; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7725
  },
  {
    "request_id": "AM-REQ-2026-06489",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5796
  },
  {
    "request_id": "AM-REQ-2026-06490",
    "original_inquiry": "Urgent: 海外求诊：clinical trial患者，希望评估cell replacement或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7194
  },
  {
    "request_id": "AM-REQ-2026-06491",
    "original_inquiry": "Urgent: Family seeking 干细胞分化 therapy for induced pluripotent stem cell; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8403
  },
  {
    "request_id": "AM-REQ-2026-06492",
    "original_inquiry": "Second opinion requested: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6745
  },
  {
    "request_id": "AM-REQ-2026-06493",
    "original_inquiry": "Referral from specialist: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cell replacement or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.843
  },
  {
    "request_id": "AM-REQ-2026-06494",
    "original_inquiry": "研究者咨询：海外求诊：多能干细胞患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7195
  },
  {
    "request_id": "AM-REQ-2026-06495",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7606
  },
  {
    "request_id": "AM-REQ-2026-06496",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6715
  },
  {
    "request_id": "AM-REQ-2026-06497",
    "original_inquiry": "Second opinion requested: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8337
  },
  {
    "request_id": "AM-REQ-2026-06498",
    "original_inquiry": "Referral from specialist: Neurologist: iPSC-derived neuron patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.505
  },
  {
    "request_id": "AM-REQ-2026-06499",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for Parkinson; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7628
  },
  {
    "request_id": "AM-REQ-2026-06500",
    "original_inquiry": "Family seeking information: Researcher inquiry: 帕金森 manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5579
  },
  {
    "request_id": "AM-REQ-2026-06501",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5775
  },
  {
    "request_id": "AM-REQ-2026-06502",
    "original_inquiry": "Second opinion requested: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5924
  },
  {
    "request_id": "AM-REQ-2026-06503",
    "original_inquiry": "Family seeking information: Family seeking 类器官移植 therapy for iPSC; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7577
  },
  {
    "request_id": "AM-REQ-2026-06504",
    "original_inquiry": "海外求诊：Researcher inquiry: cell therapy manufacturing and spinal cord injury transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.66
  },
  {
    "request_id": "AM-REQ-2026-06505",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8323
  },
  {
    "request_id": "AM-REQ-2026-06506",
    "original_inquiry": "研究者咨询：Consultation: 心肌修复 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7869
  },
  {
    "request_id": "AM-REQ-2026-06507",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.511
  },
  {
    "request_id": "AM-REQ-2026-06508",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.731
  },
  {
    "request_id": "AM-REQ-2026-06509",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6067
  },
  {
    "request_id": "AM-REQ-2026-06510",
    "original_inquiry": "Researcher inquiry: cell therapy manufacturing and heart failure transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8456
  },
  {
    "request_id": "AM-REQ-2026-06511",
    "original_inquiry": "海外求诊：海外求诊：clinical trial患者，希望评估cell replacement或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7364
  },
  {
    "request_id": "AM-REQ-2026-06512",
    "original_inquiry": "Referral from specialist: Neurologist: clinical trial patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7098
  },
  {
    "request_id": "AM-REQ-2026-06513",
    "original_inquiry": "Urgent: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6722
  },
  {
    "request_id": "AM-REQ-2026-06514",
    "original_inquiry": "研究者咨询：Family seeking clinical trial therapy for spinal cord injury; request centers with iPSC programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7252
  },
  {
    "request_id": "AM-REQ-2026-06515",
    "original_inquiry": "Referral from specialist: Patient with advanced 多能干细胞; seeking spinal cord injury or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6688
  },
  {
    "request_id": "AM-REQ-2026-06516",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8286
  },
  {
    "request_id": "AM-REQ-2026-06517",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring heart failure and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8425
  },
  {
    "request_id": "AM-REQ-2026-06518",
    "original_inquiry": "Urgent: Researcher inquiry: 类器官移植 manufacturing and dopaminergic neuron transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-06519",
    "original_inquiry": "Family seeking information: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7188
  },
  {
    "request_id": "AM-REQ-2026-06520",
    "original_inquiry": "Family seeking information: Consultation: cell therapy with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-06521",
    "original_inquiry": "海外求诊：Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7616
  },
  {
    "request_id": "AM-REQ-2026-06522",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8535
  },
  {
    "request_id": "AM-REQ-2026-06523",
    "original_inquiry": "Urgent: Consultation: 多能干细胞 with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6514
  },
  {
    "request_id": "AM-REQ-2026-06524",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5894
  },
  {
    "request_id": "AM-REQ-2026-06525",
    "original_inquiry": "Second opinion requested: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8982
  },
  {
    "request_id": "AM-REQ-2026-06526",
    "original_inquiry": "Patient with advanced 帕金森; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5911
  },
  {
    "request_id": "AM-REQ-2026-06527",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.567
  },
  {
    "request_id": "AM-REQ-2026-06528",
    "original_inquiry": "Urgent: Cardiologist referral: 干细胞分化 with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8091
  },
  {
    "request_id": "AM-REQ-2026-06529",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5423
  },
  {
    "request_id": "AM-REQ-2026-06530",
    "original_inquiry": "研究者咨询：Family seeking 帕金森 therapy for organoid; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7714
  },
  {
    "request_id": "AM-REQ-2026-06531",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7898
  },
  {
    "request_id": "AM-REQ-2026-06532",
    "original_inquiry": "Second opinion requested: Patient with advanced regenerative medicine; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8437
  },
  {
    "request_id": "AM-REQ-2026-06533",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8472
  },
  {
    "request_id": "AM-REQ-2026-06534",
    "original_inquiry": "海外求诊：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8316
  },
  {
    "request_id": "AM-REQ-2026-06535",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5643
  },
  {
    "request_id": "AM-REQ-2026-06536",
    "original_inquiry": "Family seeking information: Consultation: regenerative medicine with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6865
  },
  {
    "request_id": "AM-REQ-2026-06537",
    "original_inquiry": "Urgent: Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7
  },
  {
    "request_id": "AM-REQ-2026-06538",
    "original_inquiry": "Family seeking information: 海外求诊：regenerative medicine患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6344
  },
  {
    "request_id": "AM-REQ-2026-06539",
    "original_inquiry": "Referral from specialist: Patient with advanced clinical trial; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6216
  },
  {
    "request_id": "AM-REQ-2026-06540",
    "original_inquiry": "Second opinion requested: 海外求诊：心肌修复患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6578
  },
  {
    "request_id": "AM-REQ-2026-06541",
    "original_inquiry": "Urgent: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7107
  },
  {
    "request_id": "AM-REQ-2026-06542",
    "original_inquiry": "海外求诊：Researcher inquiry: cell therapy manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8579
  },
  {
    "request_id": "AM-REQ-2026-06543",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7812
  },
  {
    "request_id": "AM-REQ-2026-06544",
    "original_inquiry": "Family seeking 干细胞分化 therapy for organoid; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.521
  },
  {
    "request_id": "AM-REQ-2026-06545",
    "original_inquiry": "Referral from specialist: Consultation: 多能干细胞 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8078
  },
  {
    "request_id": "AM-REQ-2026-06546",
    "original_inquiry": "Referral from specialist: Patient with advanced 类器官移植; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6595
  },
  {
    "request_id": "AM-REQ-2026-06547",
    "original_inquiry": "Family seeking 类器官移植 therapy for cardiomyocyte; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7849
  },
  {
    "request_id": "AM-REQ-2026-06548",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in Parkinson or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5798
  },
  {
    "request_id": "AM-REQ-2026-06549",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8474
  },
  {
    "request_id": "AM-REQ-2026-06550",
    "original_inquiry": "Referral from specialist: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6262
  },
  {
    "request_id": "AM-REQ-2026-06551",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.785
  },
  {
    "request_id": "AM-REQ-2026-06552",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7631
  },
  {
    "request_id": "AM-REQ-2026-06553",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in spinal cord injury or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-06554",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6438
  },
  {
    "request_id": "AM-REQ-2026-06555",
    "original_inquiry": "Family seeking information: Researcher inquiry: 帕金森 manufacturing and cardiomyocyte transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-06556",
    "original_inquiry": "Second opinion requested: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6405
  },
  {
    "request_id": "AM-REQ-2026-06557",
    "original_inquiry": "Urgent: Consultation: 类器官移植 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7662
  },
  {
    "request_id": "AM-REQ-2026-06558",
    "original_inquiry": "Second opinion requested: Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.66
  },
  {
    "request_id": "AM-REQ-2026-06559",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 心肌修复 manufacturing and Parkinson transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7361
  },
  {
    "request_id": "AM-REQ-2026-06560",
    "original_inquiry": "Urgent: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6852
  },
  {
    "request_id": "AM-REQ-2026-06561",
    "original_inquiry": "Urgent: Neurologist: regenerative medicine patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7649
  },
  {
    "request_id": "AM-REQ-2026-06562",
    "original_inquiry": "研究者咨询：Cardiologist referral: cell therapy with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5735
  },
  {
    "request_id": "AM-REQ-2026-06563",
    "original_inquiry": "Second opinion requested: Family seeking cell therapy therapy for dopaminergic neuron; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5215
  },
  {
    "request_id": "AM-REQ-2026-06564",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 帕金森 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6146
  },
  {
    "request_id": "AM-REQ-2026-06565",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8568
  },
  {
    "request_id": "AM-REQ-2026-06566",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking cell replacement or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5047
  },
  {
    "request_id": "AM-REQ-2026-06567",
    "original_inquiry": "海外求诊：海外求诊：心肌修复患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.585
  },
  {
    "request_id": "AM-REQ-2026-06568",
    "original_inquiry": "Patient with advanced cell therapy; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5537
  },
  {
    "request_id": "AM-REQ-2026-06569",
    "original_inquiry": "海外求诊：Researcher inquiry: 多能干细胞 manufacturing and cell replacement transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6569
  },
  {
    "request_id": "AM-REQ-2026-06570",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 多能干细胞 with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5202
  },
  {
    "request_id": "AM-REQ-2026-06571",
    "original_inquiry": "研究者咨询：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5017
  },
  {
    "request_id": "AM-REQ-2026-06572",
    "original_inquiry": "研究者咨询：Consultation: 心肌修复 with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6166
  },
  {
    "request_id": "AM-REQ-2026-06573",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8314
  },
  {
    "request_id": "AM-REQ-2026-06574",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5132
  },
  {
    "request_id": "AM-REQ-2026-06575",
    "original_inquiry": "Urgent: Neurologist: regenerative medicine patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7547
  },
  {
    "request_id": "AM-REQ-2026-06576",
    "original_inquiry": "海外求诊：海外求诊：帕金森患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7912
  },
  {
    "request_id": "AM-REQ-2026-06577",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6932
  },
  {
    "request_id": "AM-REQ-2026-06578",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7241
  },
  {
    "request_id": "AM-REQ-2026-06579",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估cell replacement或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.505
  },
  {
    "request_id": "AM-REQ-2026-06580",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7337
  },
  {
    "request_id": "AM-REQ-2026-06581",
    "original_inquiry": "海外求诊：Patient with advanced 干细胞分化; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7985
  },
  {
    "request_id": "AM-REQ-2026-06582",
    "original_inquiry": "Family seeking information: Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-06583",
    "original_inquiry": "Neurologist: 类器官移植 patient, exploring iPSC and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5313
  },
  {
    "request_id": "AM-REQ-2026-06584",
    "original_inquiry": "海外求诊：Family seeking 干细胞分化 therapy for iPSC; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5177
  },
  {
    "request_id": "AM-REQ-2026-06585",
    "original_inquiry": "Referral from specialist: Neurologist: regenerative medicine patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8097
  },
  {
    "request_id": "AM-REQ-2026-06586",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6336
  },
  {
    "request_id": "AM-REQ-2026-06587",
    "original_inquiry": "Neurologist: cell therapy patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6712
  },
  {
    "request_id": "AM-REQ-2026-06588",
    "original_inquiry": "Family seeking 类器官移植 therapy for Parkinson; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.561
  },
  {
    "request_id": "AM-REQ-2026-06589",
    "original_inquiry": "研究者咨询：Patient with advanced 类器官移植; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8121
  },
  {
    "request_id": "AM-REQ-2026-06590",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8792
  },
  {
    "request_id": "AM-REQ-2026-06591",
    "original_inquiry": "Neurologist: 类器官移植 patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8002
  },
  {
    "request_id": "AM-REQ-2026-06592",
    "original_inquiry": "Family seeking information: Consultation: regenerative medicine with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5101
  },
  {
    "request_id": "AM-REQ-2026-06593",
    "original_inquiry": "Second opinion requested: Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8237
  },
  {
    "request_id": "AM-REQ-2026-06594",
    "original_inquiry": "患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7409
  },
  {
    "request_id": "AM-REQ-2026-06595",
    "original_inquiry": "海外求诊：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7557
  },
  {
    "request_id": "AM-REQ-2026-06596",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5536
  },
  {
    "request_id": "AM-REQ-2026-06597",
    "original_inquiry": "Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-06598",
    "original_inquiry": "Patient with advanced 类器官移植; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5286
  },
  {
    "request_id": "AM-REQ-2026-06599",
    "original_inquiry": "Urgent: Researcher inquiry: 帕金森 manufacturing and iPSC transplantation for organoid; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8949
  },
  {
    "request_id": "AM-REQ-2026-06600",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7761
  },
  {
    "request_id": "AM-REQ-2026-06601",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.611
  },
  {
    "request_id": "AM-REQ-2026-06602",
    "original_inquiry": "Referral from specialist: Family seeking 帕金森 therapy for spinal cord injury; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5829
  },
  {
    "request_id": "AM-REQ-2026-06603",
    "original_inquiry": "Family seeking information: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7054
  },
  {
    "request_id": "AM-REQ-2026-06604",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8082
  },
  {
    "request_id": "AM-REQ-2026-06605",
    "original_inquiry": "海外求诊：患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7056
  },
  {
    "request_id": "AM-REQ-2026-06606",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5555
  },
  {
    "request_id": "AM-REQ-2026-06607",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5596
  },
  {
    "request_id": "AM-REQ-2026-06608",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5671
  },
  {
    "request_id": "AM-REQ-2026-06609",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5609
  },
  {
    "request_id": "AM-REQ-2026-06610",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7886
  },
  {
    "request_id": "AM-REQ-2026-06611",
    "original_inquiry": "海外求诊：Neurologist: 心肌修复 patient, exploring Parkinson and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7991
  },
  {
    "request_id": "AM-REQ-2026-06612",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for cardiomyocyte; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6595
  },
  {
    "request_id": "AM-REQ-2026-06613",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5411
  },
  {
    "request_id": "AM-REQ-2026-06614",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 多能干细胞 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5036
  },
  {
    "request_id": "AM-REQ-2026-06615",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for organoid; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7009
  },
  {
    "request_id": "AM-REQ-2026-06616",
    "original_inquiry": "Second opinion requested: Consultation: 类器官移植 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8069
  },
  {
    "request_id": "AM-REQ-2026-06617",
    "original_inquiry": "海外求诊：Consultation: cell therapy with spinal cord injury; interested in spinal cord injury or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5783
  },
  {
    "request_id": "AM-REQ-2026-06618",
    "original_inquiry": "海外求诊：Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5471
  },
  {
    "request_id": "AM-REQ-2026-06619",
    "original_inquiry": "Family seeking information: 海外求诊：iPSC-derived neuron患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5912
  },
  {
    "request_id": "AM-REQ-2026-06620",
    "original_inquiry": "Consultation: 帕金森 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8453
  },
  {
    "request_id": "AM-REQ-2026-06621",
    "original_inquiry": "Urgent: Patient with advanced regenerative medicine; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7908
  },
  {
    "request_id": "AM-REQ-2026-06622",
    "original_inquiry": "海外求诊：Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6484
  },
  {
    "request_id": "AM-REQ-2026-06623",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7577
  },
  {
    "request_id": "AM-REQ-2026-06624",
    "original_inquiry": "Neurologist: 心肌修复 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6235
  },
  {
    "request_id": "AM-REQ-2026-06625",
    "original_inquiry": "Referral from specialist: Cardiologist referral: regenerative medicine with reduced EF; interested in iPSC or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6694
  },
  {
    "request_id": "AM-REQ-2026-06626",
    "original_inquiry": "Family seeking information: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7496
  },
  {
    "request_id": "AM-REQ-2026-06627",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7661
  },
  {
    "request_id": "AM-REQ-2026-06628",
    "original_inquiry": "海外求诊：Family seeking 类器官移植 therapy for spinal cord injury; request centers with organoid programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8885
  },
  {
    "request_id": "AM-REQ-2026-06629",
    "original_inquiry": "Referral from specialist: 海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6261
  },
  {
    "request_id": "AM-REQ-2026-06630",
    "original_inquiry": "Urgent: Family seeking cell therapy therapy for spinal cord injury; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7631
  },
  {
    "request_id": "AM-REQ-2026-06631",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for cell replacement; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.59
  },
  {
    "request_id": "AM-REQ-2026-06632",
    "original_inquiry": "Family seeking information: Family seeking regenerative medicine therapy for organoid; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7978
  },
  {
    "request_id": "AM-REQ-2026-06633",
    "original_inquiry": "研究者咨询：Consultation: regenerative medicine with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7002
  },
  {
    "request_id": "AM-REQ-2026-06634",
    "original_inquiry": "Neurologist: clinical trial patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6648
  },
  {
    "request_id": "AM-REQ-2026-06635",
    "original_inquiry": "Second opinion requested: Patient with advanced iPSC-derived neuron; seeking spinal cord injury or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6516
  },
  {
    "request_id": "AM-REQ-2026-06636",
    "original_inquiry": "Second opinion requested: 海外求诊：clinical trial患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5829
  },
  {
    "request_id": "AM-REQ-2026-06637",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking spinal cord injury or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5156
  },
  {
    "request_id": "AM-REQ-2026-06638",
    "original_inquiry": "Urgent: 海外求诊：帕金森患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6679
  },
  {
    "request_id": "AM-REQ-2026-06639",
    "original_inquiry": "Family seeking information: Researcher inquiry: 干细胞分化 manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6532
  },
  {
    "request_id": "AM-REQ-2026-06640",
    "original_inquiry": "Referral from specialist: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7407
  },
  {
    "request_id": "AM-REQ-2026-06641",
    "original_inquiry": "Family seeking information: Consultation: iPSC-derived neuron with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8978
  },
  {
    "request_id": "AM-REQ-2026-06642",
    "original_inquiry": "研究者咨询：Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5174
  },
  {
    "request_id": "AM-REQ-2026-06643",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7968
  },
  {
    "request_id": "AM-REQ-2026-06644",
    "original_inquiry": "研究者咨询：Cardiologist referral: regenerative medicine with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.601
  },
  {
    "request_id": "AM-REQ-2026-06645",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.642
  },
  {
    "request_id": "AM-REQ-2026-06646",
    "original_inquiry": "Family seeking information: 海外求诊：多能干细胞患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6626
  },
  {
    "request_id": "AM-REQ-2026-06647",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5651
  },
  {
    "request_id": "AM-REQ-2026-06648",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6012
  },
  {
    "request_id": "AM-REQ-2026-06649",
    "original_inquiry": "研究者咨询：Consultation: 帕金森 with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5942
  },
  {
    "request_id": "AM-REQ-2026-06650",
    "original_inquiry": "Family seeking 干细胞分化 therapy for organoid; request centers with cell replacement programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8962
  },
  {
    "request_id": "AM-REQ-2026-06651",
    "original_inquiry": "Second opinion requested: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7622
  },
  {
    "request_id": "AM-REQ-2026-06652",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 心肌修复 manufacturing and organoid transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8367
  },
  {
    "request_id": "AM-REQ-2026-06653",
    "original_inquiry": "Family seeking information: Consultation: 类器官移植 with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6704
  },
  {
    "request_id": "AM-REQ-2026-06654",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7192
  },
  {
    "request_id": "AM-REQ-2026-06655",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5903
  },
  {
    "request_id": "AM-REQ-2026-06656",
    "original_inquiry": "患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6118
  },
  {
    "request_id": "AM-REQ-2026-06657",
    "original_inquiry": "海外求诊：Cardiologist referral: 多能干细胞 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5269
  },
  {
    "request_id": "AM-REQ-2026-06658",
    "original_inquiry": "海外求诊：Cardiologist referral: 多能干细胞 with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6612
  },
  {
    "request_id": "AM-REQ-2026-06659",
    "original_inquiry": "Family seeking information: Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.836
  },
  {
    "request_id": "AM-REQ-2026-06660",
    "original_inquiry": "海外求诊：患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6235
  },
  {
    "request_id": "AM-REQ-2026-06661",
    "original_inquiry": "研究者咨询：海外求诊：regenerative medicine患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7131
  },
  {
    "request_id": "AM-REQ-2026-06662",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5358
  },
  {
    "request_id": "AM-REQ-2026-06663",
    "original_inquiry": "Referral from specialist: Consultation: 心肌修复 with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6912
  },
  {
    "request_id": "AM-REQ-2026-06664",
    "original_inquiry": "Urgent: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5403
  },
  {
    "request_id": "AM-REQ-2026-06665",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6824
  },
  {
    "request_id": "AM-REQ-2026-06666",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6436
  },
  {
    "request_id": "AM-REQ-2026-06667",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7968
  },
  {
    "request_id": "AM-REQ-2026-06668",
    "original_inquiry": "海外求诊：Consultation: clinical trial with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-06669",
    "original_inquiry": "Referral from specialist: Researcher inquiry: clinical trial manufacturing and dopaminergic neuron transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6027
  },
  {
    "request_id": "AM-REQ-2026-06670",
    "original_inquiry": "Second opinion requested: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7746
  },
  {
    "request_id": "AM-REQ-2026-06671",
    "original_inquiry": "Urgent: Neurologist: iPSC-derived neuron patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5979
  },
  {
    "request_id": "AM-REQ-2026-06672",
    "original_inquiry": "Second opinion requested: Family seeking 类器官移植 therapy for iPSC; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8249
  },
  {
    "request_id": "AM-REQ-2026-06673",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8558
  },
  {
    "request_id": "AM-REQ-2026-06674",
    "original_inquiry": "研究者咨询：Family seeking 多能干细胞 therapy for cell replacement; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6518
  },
  {
    "request_id": "AM-REQ-2026-06675",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.675
  },
  {
    "request_id": "AM-REQ-2026-06676",
    "original_inquiry": "Second opinion requested: Researcher inquiry: iPSC-derived neuron manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.698
  },
  {
    "request_id": "AM-REQ-2026-06677",
    "original_inquiry": "海外求诊：Family seeking regenerative medicine therapy for cell replacement; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7438
  },
  {
    "request_id": "AM-REQ-2026-06678",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7116
  },
  {
    "request_id": "AM-REQ-2026-06679",
    "original_inquiry": "Family seeking information: 海外求诊：帕金森患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7427
  },
  {
    "request_id": "AM-REQ-2026-06680",
    "original_inquiry": "研究者咨询：Patient with advanced iPSC-derived neuron; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6664
  },
  {
    "request_id": "AM-REQ-2026-06681",
    "original_inquiry": "海外求诊：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8428
  },
  {
    "request_id": "AM-REQ-2026-06682",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.571
  },
  {
    "request_id": "AM-REQ-2026-06683",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking iPSC or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.862
  },
  {
    "request_id": "AM-REQ-2026-06684",
    "original_inquiry": "Urgent: Consultation: 类器官移植 with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-06685",
    "original_inquiry": "Referral from specialist: Family seeking iPSC-derived neuron therapy for Parkinson; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6168
  },
  {
    "request_id": "AM-REQ-2026-06686",
    "original_inquiry": "Family seeking information: 海外求诊：clinical trial患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.651
  },
  {
    "request_id": "AM-REQ-2026-06687",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5592
  },
  {
    "request_id": "AM-REQ-2026-06688",
    "original_inquiry": "海外求诊：Neurologist: cell therapy patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8736
  },
  {
    "request_id": "AM-REQ-2026-06689",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-06690",
    "original_inquiry": "Second opinion requested: Consultation: iPSC-derived neuron with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8466
  },
  {
    "request_id": "AM-REQ-2026-06691",
    "original_inquiry": "Family seeking information: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5601
  },
  {
    "request_id": "AM-REQ-2026-06692",
    "original_inquiry": "Second opinion requested: Consultation: clinical trial with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7962
  },
  {
    "request_id": "AM-REQ-2026-06693",
    "original_inquiry": "Second opinion requested: 海外求诊：心肌修复患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6614
  },
  {
    "request_id": "AM-REQ-2026-06694",
    "original_inquiry": "Second opinion requested: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6931
  },
  {
    "request_id": "AM-REQ-2026-06695",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5917
  },
  {
    "request_id": "AM-REQ-2026-06696",
    "original_inquiry": "Referral from specialist: 海外求诊：多能干细胞患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5715
  },
  {
    "request_id": "AM-REQ-2026-06697",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8427
  },
  {
    "request_id": "AM-REQ-2026-06698",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and iPSC transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7919
  },
  {
    "request_id": "AM-REQ-2026-06699",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8758
  },
  {
    "request_id": "AM-REQ-2026-06700",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6781
  },
  {
    "request_id": "AM-REQ-2026-06701",
    "original_inquiry": "Neurologist: clinical trial patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7408
  },
  {
    "request_id": "AM-REQ-2026-06702",
    "original_inquiry": "Second opinion requested: Consultation: regenerative medicine with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8519
  },
  {
    "request_id": "AM-REQ-2026-06703",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5549
  },
  {
    "request_id": "AM-REQ-2026-06704",
    "original_inquiry": "Family seeking information: Neurologist: regenerative medicine patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6217
  },
  {
    "request_id": "AM-REQ-2026-06705",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7396
  },
  {
    "request_id": "AM-REQ-2026-06706",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7944
  },
  {
    "request_id": "AM-REQ-2026-06707",
    "original_inquiry": "Second opinion requested: Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5785
  },
  {
    "request_id": "AM-REQ-2026-06708",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 帕金森 manufacturing and Parkinson transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.698
  },
  {
    "request_id": "AM-REQ-2026-06709",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6857
  },
  {
    "request_id": "AM-REQ-2026-06710",
    "original_inquiry": "Referral from specialist: Consultation: 多能干细胞 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5852
  },
  {
    "request_id": "AM-REQ-2026-06711",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-06712",
    "original_inquiry": "Urgent: Researcher inquiry: 帕金森 manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7975
  },
  {
    "request_id": "AM-REQ-2026-06713",
    "original_inquiry": "海外求诊：Neurologist: cell therapy patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.892
  },
  {
    "request_id": "AM-REQ-2026-06714",
    "original_inquiry": "Family seeking information: Family seeking 帕金森 therapy for cell replacement; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5598
  },
  {
    "request_id": "AM-REQ-2026-06715",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8689
  },
  {
    "request_id": "AM-REQ-2026-06716",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6823
  },
  {
    "request_id": "AM-REQ-2026-06717",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6956
  },
  {
    "request_id": "AM-REQ-2026-06718",
    "original_inquiry": "Referral from specialist: 海外求诊：类器官移植患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6189
  },
  {
    "request_id": "AM-REQ-2026-06719",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5269
  },
  {
    "request_id": "AM-REQ-2026-06720",
    "original_inquiry": "Urgent: Consultation: cell therapy with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8454
  },
  {
    "request_id": "AM-REQ-2026-06721",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for iPSC; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8469
  },
  {
    "request_id": "AM-REQ-2026-06722",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估cell replacement或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6658
  },
  {
    "request_id": "AM-REQ-2026-06723",
    "original_inquiry": "Second opinion requested: Consultation: iPSC-derived neuron with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-06724",
    "original_inquiry": "Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-06725",
    "original_inquiry": "Second opinion requested: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6141
  },
  {
    "request_id": "AM-REQ-2026-06726",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7405
  },
  {
    "request_id": "AM-REQ-2026-06727",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5674
  },
  {
    "request_id": "AM-REQ-2026-06728",
    "original_inquiry": "Referral from specialist: Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-06729",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.548
  },
  {
    "request_id": "AM-REQ-2026-06730",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7979
  },
  {
    "request_id": "AM-REQ-2026-06731",
    "original_inquiry": "海外求诊：多能干细胞患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6622
  },
  {
    "request_id": "AM-REQ-2026-06732",
    "original_inquiry": "Referral from specialist: Neurologist: clinical trial patient, exploring spinal cord injury and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7353
  },
  {
    "request_id": "AM-REQ-2026-06733",
    "original_inquiry": "Second opinion requested: Neurologist: 帕金森 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6808
  },
  {
    "request_id": "AM-REQ-2026-06734",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6438
  },
  {
    "request_id": "AM-REQ-2026-06735",
    "original_inquiry": "Urgent: Family seeking 多能干细胞 therapy for dopaminergic neuron; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6148
  },
  {
    "request_id": "AM-REQ-2026-06736",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5963
  },
  {
    "request_id": "AM-REQ-2026-06737",
    "original_inquiry": "Urgent: Family seeking 类器官移植 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6242
  },
  {
    "request_id": "AM-REQ-2026-06738",
    "original_inquiry": "研究者咨询：Researcher inquiry: cell therapy manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5234
  },
  {
    "request_id": "AM-REQ-2026-06739",
    "original_inquiry": "Referral from specialist: 海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8867
  },
  {
    "request_id": "AM-REQ-2026-06740",
    "original_inquiry": "Urgent: Cardiologist referral: cell therapy with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5999
  },
  {
    "request_id": "AM-REQ-2026-06741",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7087
  },
  {
    "request_id": "AM-REQ-2026-06742",
    "original_inquiry": "Urgent: Consultation: 多能干细胞 with spinal cord injury; interested in organoid or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.614
  },
  {
    "request_id": "AM-REQ-2026-06743",
    "original_inquiry": "研究者咨询：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7585
  },
  {
    "request_id": "AM-REQ-2026-06744",
    "original_inquiry": "Urgent: Cardiologist referral: 干细胞分化 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7366
  },
  {
    "request_id": "AM-REQ-2026-06745",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and induced pluripotent stem cell transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-06746",
    "original_inquiry": "海外求诊：Consultation: clinical trial with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5081
  },
  {
    "request_id": "AM-REQ-2026-06747",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8435
  },
  {
    "request_id": "AM-REQ-2026-06748",
    "original_inquiry": "海外求诊：Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5241
  },
  {
    "request_id": "AM-REQ-2026-06749",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for induced pluripotent stem cell; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8161
  },
  {
    "request_id": "AM-REQ-2026-06750",
    "original_inquiry": "Second opinion requested: Patient with advanced iPSC-derived neuron; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5879
  },
  {
    "request_id": "AM-REQ-2026-06751",
    "original_inquiry": "Second opinion requested: Cardiologist referral: clinical trial with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6387
  },
  {
    "request_id": "AM-REQ-2026-06752",
    "original_inquiry": "Urgent: Family seeking 帕金森 therapy for organoid; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5878
  },
  {
    "request_id": "AM-REQ-2026-06753",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-06754",
    "original_inquiry": "研究者咨询：患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5997
  },
  {
    "request_id": "AM-REQ-2026-06755",
    "original_inquiry": "Second opinion requested: Researcher inquiry: clinical trial manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7885
  },
  {
    "request_id": "AM-REQ-2026-06756",
    "original_inquiry": "海外求诊：Family seeking regenerative medicine therapy for dopaminergic neuron; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6874
  },
  {
    "request_id": "AM-REQ-2026-06757",
    "original_inquiry": "研究者咨询：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7028
  },
  {
    "request_id": "AM-REQ-2026-06758",
    "original_inquiry": "研究者咨询：Researcher inquiry: 帕金森 manufacturing and cell replacement transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6212
  },
  {
    "request_id": "AM-REQ-2026-06759",
    "original_inquiry": "研究者咨询：Researcher inquiry: clinical trial manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.654
  },
  {
    "request_id": "AM-REQ-2026-06760",
    "original_inquiry": "Researcher inquiry: iPSC-derived neuron manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.738
  },
  {
    "request_id": "AM-REQ-2026-06761",
    "original_inquiry": "海外求诊：Researcher inquiry: clinical trial manufacturing and dopaminergic neuron transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.669
  },
  {
    "request_id": "AM-REQ-2026-06762",
    "original_inquiry": "研究者咨询：Family seeking 类器官移植 therapy for induced pluripotent stem cell; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.763
  },
  {
    "request_id": "AM-REQ-2026-06763",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6108
  },
  {
    "request_id": "AM-REQ-2026-06764",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7151
  },
  {
    "request_id": "AM-REQ-2026-06765",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5376
  },
  {
    "request_id": "AM-REQ-2026-06766",
    "original_inquiry": "Referral from specialist: Consultation: 帕金森 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5316
  },
  {
    "request_id": "AM-REQ-2026-06767",
    "original_inquiry": "Second opinion requested: 海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8493
  },
  {
    "request_id": "AM-REQ-2026-06768",
    "original_inquiry": "Urgent: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8165
  },
  {
    "request_id": "AM-REQ-2026-06769",
    "original_inquiry": "Patient with advanced 帕金森; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8001
  },
  {
    "request_id": "AM-REQ-2026-06770",
    "original_inquiry": "Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5623
  },
  {
    "request_id": "AM-REQ-2026-06771",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6041
  },
  {
    "request_id": "AM-REQ-2026-06772",
    "original_inquiry": "Urgent: Patient with advanced 心肌修复; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6429
  },
  {
    "request_id": "AM-REQ-2026-06773",
    "original_inquiry": "研究者咨询：Consultation: 帕金森 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6361
  },
  {
    "request_id": "AM-REQ-2026-06774",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 心肌修复 with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6641
  },
  {
    "request_id": "AM-REQ-2026-06775",
    "original_inquiry": "Urgent: 海外求诊：帕金森患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5165
  },
  {
    "request_id": "AM-REQ-2026-06776",
    "original_inquiry": "Urgent: Family seeking 心肌修复 therapy for spinal cord injury; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8671
  },
  {
    "request_id": "AM-REQ-2026-06777",
    "original_inquiry": "Neurologist: cell therapy patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8601
  },
  {
    "request_id": "AM-REQ-2026-06778",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 心肌修复 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8701
  },
  {
    "request_id": "AM-REQ-2026-06779",
    "original_inquiry": "Second opinion requested: Family seeking cell therapy therapy for induced pluripotent stem cell; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6136
  },
  {
    "request_id": "AM-REQ-2026-06780",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.755
  },
  {
    "request_id": "AM-REQ-2026-06781",
    "original_inquiry": "Second opinion requested: Cardiologist referral: regenerative medicine with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8622
  },
  {
    "request_id": "AM-REQ-2026-06782",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5084
  },
  {
    "request_id": "AM-REQ-2026-06783",
    "original_inquiry": "Referral from specialist: Family seeking 心肌修复 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8273
  },
  {
    "request_id": "AM-REQ-2026-06784",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5627
  },
  {
    "request_id": "AM-REQ-2026-06785",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7143
  },
  {
    "request_id": "AM-REQ-2026-06786",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7929
  },
  {
    "request_id": "AM-REQ-2026-06787",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 心肌修复 with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8764
  },
  {
    "request_id": "AM-REQ-2026-06788",
    "original_inquiry": "研究者咨询：Family seeking clinical trial therapy for dopaminergic neuron; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5498
  },
  {
    "request_id": "AM-REQ-2026-06789",
    "original_inquiry": "Family seeking information: 海外求诊：clinical trial患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8176
  },
  {
    "request_id": "AM-REQ-2026-06790",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6259
  },
  {
    "request_id": "AM-REQ-2026-06791",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8801
  },
  {
    "request_id": "AM-REQ-2026-06792",
    "original_inquiry": "研究者咨询：海外求诊：regenerative medicine患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.653
  },
  {
    "request_id": "AM-REQ-2026-06793",
    "original_inquiry": "Second opinion requested: Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6894
  },
  {
    "request_id": "AM-REQ-2026-06794",
    "original_inquiry": "研究者咨询：Patient with advanced 帕金森; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8744
  },
  {
    "request_id": "AM-REQ-2026-06795",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring organoid and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8247
  },
  {
    "request_id": "AM-REQ-2026-06796",
    "original_inquiry": "Family seeking information: Researcher inquiry: clinical trial manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8722
  },
  {
    "request_id": "AM-REQ-2026-06797",
    "original_inquiry": "Family seeking information: Consultation: cell therapy with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5374
  },
  {
    "request_id": "AM-REQ-2026-06798",
    "original_inquiry": "Referral from specialist: Consultation: 多能干细胞 with spinal cord injury; interested in spinal cord injury or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8003
  },
  {
    "request_id": "AM-REQ-2026-06799",
    "original_inquiry": "研究者咨询：Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6286
  },
  {
    "request_id": "AM-REQ-2026-06800",
    "original_inquiry": "Second opinion requested: Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5492
  },
  {
    "request_id": "AM-REQ-2026-06801",
    "original_inquiry": "海外求诊：干细胞分化患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6623
  },
  {
    "request_id": "AM-REQ-2026-06802",
    "original_inquiry": "Family seeking information: Neurologist: 类器官移植 patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5182
  },
  {
    "request_id": "AM-REQ-2026-06803",
    "original_inquiry": "研究者咨询：Neurologist: 类器官移植 patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7193
  },
  {
    "request_id": "AM-REQ-2026-06804",
    "original_inquiry": "Referral from specialist: Family seeking 干细胞分化 therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6102
  },
  {
    "request_id": "AM-REQ-2026-06805",
    "original_inquiry": "Referral from specialist: Researcher inquiry: regenerative medicine manufacturing and organoid transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8081
  },
  {
    "request_id": "AM-REQ-2026-06806",
    "original_inquiry": "Second opinion requested: Consultation: regenerative medicine with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.683
  },
  {
    "request_id": "AM-REQ-2026-06807",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估spinal cord injury或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6156
  },
  {
    "request_id": "AM-REQ-2026-06808",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8728
  },
  {
    "request_id": "AM-REQ-2026-06809",
    "original_inquiry": "Second opinion requested: Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7305
  },
  {
    "request_id": "AM-REQ-2026-06810",
    "original_inquiry": "Second opinion requested: Family seeking iPSC-derived neuron therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8233
  },
  {
    "request_id": "AM-REQ-2026-06811",
    "original_inquiry": "研究者咨询：Cardiologist referral: clinical trial with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7015
  },
  {
    "request_id": "AM-REQ-2026-06812",
    "original_inquiry": "Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8437
  },
  {
    "request_id": "AM-REQ-2026-06813",
    "original_inquiry": "研究者咨询：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8405
  },
  {
    "request_id": "AM-REQ-2026-06814",
    "original_inquiry": "Second opinion requested: Patient with advanced regenerative medicine; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6986
  },
  {
    "request_id": "AM-REQ-2026-06815",
    "original_inquiry": "Patient with advanced 心肌修复; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6063
  },
  {
    "request_id": "AM-REQ-2026-06816",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 帕金森 manufacturing and heart failure transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5623
  },
  {
    "request_id": "AM-REQ-2026-06817",
    "original_inquiry": "研究者咨询：Researcher inquiry: 类器官移植 manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7138
  },
  {
    "request_id": "AM-REQ-2026-06818",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in iPSC or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6171
  },
  {
    "request_id": "AM-REQ-2026-06819",
    "original_inquiry": "研究者咨询：Consultation: 心肌修复 with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5494
  },
  {
    "request_id": "AM-REQ-2026-06820",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7381
  },
  {
    "request_id": "AM-REQ-2026-06821",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-06822",
    "original_inquiry": "Second opinion requested: Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.552
  },
  {
    "request_id": "AM-REQ-2026-06823",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7399
  },
  {
    "request_id": "AM-REQ-2026-06824",
    "original_inquiry": "Referral from specialist: 海外求诊：干细胞分化患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-06825",
    "original_inquiry": "研究者咨询：Cardiologist referral: 多能干细胞 with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8417
  },
  {
    "request_id": "AM-REQ-2026-06826",
    "original_inquiry": "Cardiologist referral: 多能干细胞 with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6336
  },
  {
    "request_id": "AM-REQ-2026-06827",
    "original_inquiry": "Urgent: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8554
  },
  {
    "request_id": "AM-REQ-2026-06828",
    "original_inquiry": "Family seeking information: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-06829",
    "original_inquiry": "Consultation: 多能干细胞 with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5878
  },
  {
    "request_id": "AM-REQ-2026-06830",
    "original_inquiry": "海外求诊：Cardiologist referral: cell therapy with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5701
  },
  {
    "request_id": "AM-REQ-2026-06831",
    "original_inquiry": "海外求诊：Neurologist: regenerative medicine patient, exploring heart failure and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8203
  },
  {
    "request_id": "AM-REQ-2026-06832",
    "original_inquiry": "Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5595
  },
  {
    "request_id": "AM-REQ-2026-06833",
    "original_inquiry": "研究者咨询：Patient with advanced cell therapy; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.876
  },
  {
    "request_id": "AM-REQ-2026-06834",
    "original_inquiry": "Urgent: 患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7445
  },
  {
    "request_id": "AM-REQ-2026-06835",
    "original_inquiry": "Second opinion requested: 海外求诊：regenerative medicine患者，希望评估organoid或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5753
  },
  {
    "request_id": "AM-REQ-2026-06836",
    "original_inquiry": "Urgent: Family seeking 类器官移植 therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8752
  },
  {
    "request_id": "AM-REQ-2026-06837",
    "original_inquiry": "Referral from specialist: Consultation: 干细胞分化 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5757
  },
  {
    "request_id": "AM-REQ-2026-06838",
    "original_inquiry": "Second opinion requested: Neurologist: 心肌修复 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5915
  },
  {
    "request_id": "AM-REQ-2026-06839",
    "original_inquiry": "Second opinion requested: Cardiologist referral: cell therapy with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6685
  },
  {
    "request_id": "AM-REQ-2026-06840",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7524
  },
  {
    "request_id": "AM-REQ-2026-06841",
    "original_inquiry": "Patient with advanced cell therapy; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6281
  },
  {
    "request_id": "AM-REQ-2026-06842",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6772
  },
  {
    "request_id": "AM-REQ-2026-06843",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7145
  },
  {
    "request_id": "AM-REQ-2026-06844",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5331
  },
  {
    "request_id": "AM-REQ-2026-06845",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6494
  },
  {
    "request_id": "AM-REQ-2026-06846",
    "original_inquiry": "Referral from specialist: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6928
  },
  {
    "request_id": "AM-REQ-2026-06847",
    "original_inquiry": "海外求诊：患者主诉：干细胞分化晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.711
  },
  {
    "request_id": "AM-REQ-2026-06848",
    "original_inquiry": "Family seeking information: Cardiologist referral: 多能干细胞 with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8494
  },
  {
    "request_id": "AM-REQ-2026-06849",
    "original_inquiry": "Second opinion requested: 海外求诊：类器官移植患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8732
  },
  {
    "request_id": "AM-REQ-2026-06850",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5726
  },
  {
    "request_id": "AM-REQ-2026-06851",
    "original_inquiry": "Referral from specialist: Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7992
  },
  {
    "request_id": "AM-REQ-2026-06852",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 干细胞分化 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6364
  },
  {
    "request_id": "AM-REQ-2026-06853",
    "original_inquiry": "Family seeking information: 海外求诊：regenerative medicine患者，希望评估spinal cord injury或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8896
  },
  {
    "request_id": "AM-REQ-2026-06854",
    "original_inquiry": "Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8576
  },
  {
    "request_id": "AM-REQ-2026-06855",
    "original_inquiry": "海外求诊：患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5229
  },
  {
    "request_id": "AM-REQ-2026-06856",
    "original_inquiry": "研究者咨询：Neurologist: clinical trial patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5197
  },
  {
    "request_id": "AM-REQ-2026-06857",
    "original_inquiry": "Family seeking regenerative medicine therapy for induced pluripotent stem cell; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6641
  },
  {
    "request_id": "AM-REQ-2026-06858",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8757
  },
  {
    "request_id": "AM-REQ-2026-06859",
    "original_inquiry": "海外求诊：Consultation: 类器官移植 with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6718
  },
  {
    "request_id": "AM-REQ-2026-06860",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7057
  },
  {
    "request_id": "AM-REQ-2026-06861",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8209
  },
  {
    "request_id": "AM-REQ-2026-06862",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in Parkinson or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8046
  },
  {
    "request_id": "AM-REQ-2026-06863",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5041
  },
  {
    "request_id": "AM-REQ-2026-06864",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6221
  },
  {
    "request_id": "AM-REQ-2026-06865",
    "original_inquiry": "研究者咨询：海外求诊：心肌修复患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8785
  },
  {
    "request_id": "AM-REQ-2026-06866",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and heart failure transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8366
  },
  {
    "request_id": "AM-REQ-2026-06867",
    "original_inquiry": "Family seeking 帕金森 therapy for cell replacement; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7172
  },
  {
    "request_id": "AM-REQ-2026-06868",
    "original_inquiry": "海外求诊：海外求诊：cell therapy患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6783
  },
  {
    "request_id": "AM-REQ-2026-06869",
    "original_inquiry": "Second opinion requested: 海外求诊：类器官移植患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5372
  },
  {
    "request_id": "AM-REQ-2026-06870",
    "original_inquiry": "研究者咨询：海外求诊：iPSC-derived neuron患者，希望评估cell replacement或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8357
  },
  {
    "request_id": "AM-REQ-2026-06871",
    "original_inquiry": "Second opinion requested: 海外求诊：心肌修复患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7458
  },
  {
    "request_id": "AM-REQ-2026-06872",
    "original_inquiry": "患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7628
  },
  {
    "request_id": "AM-REQ-2026-06873",
    "original_inquiry": "海外求诊：Cardiologist referral: clinical trial with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6261
  },
  {
    "request_id": "AM-REQ-2026-06874",
    "original_inquiry": "Family seeking information: Cardiologist referral: regenerative medicine with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8559
  },
  {
    "request_id": "AM-REQ-2026-06875",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and iPSC transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8773
  },
  {
    "request_id": "AM-REQ-2026-06876",
    "original_inquiry": "Family seeking information: Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7971
  },
  {
    "request_id": "AM-REQ-2026-06877",
    "original_inquiry": "Family seeking information: Consultation: 心肌修复 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6534
  },
  {
    "request_id": "AM-REQ-2026-06878",
    "original_inquiry": "Family seeking information: Family seeking 干细胞分化 therapy for cell replacement; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7487
  },
  {
    "request_id": "AM-REQ-2026-06879",
    "original_inquiry": "Referral from specialist: Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7892
  },
  {
    "request_id": "AM-REQ-2026-06880",
    "original_inquiry": "研究者咨询：Patient with advanced iPSC-derived neuron; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7178
  },
  {
    "request_id": "AM-REQ-2026-06881",
    "original_inquiry": "Family seeking information: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7235
  },
  {
    "request_id": "AM-REQ-2026-06882",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.795
  },
  {
    "request_id": "AM-REQ-2026-06883",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7674
  },
  {
    "request_id": "AM-REQ-2026-06884",
    "original_inquiry": "研究者咨询：患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8874
  },
  {
    "request_id": "AM-REQ-2026-06885",
    "original_inquiry": "Family seeking information: Researcher inquiry: 多能干细胞 manufacturing and cardiomyocyte transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5079
  },
  {
    "request_id": "AM-REQ-2026-06886",
    "original_inquiry": "Second opinion requested: Family seeking 心肌修复 therapy for dopaminergic neuron; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7907
  },
  {
    "request_id": "AM-REQ-2026-06887",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8869
  },
  {
    "request_id": "AM-REQ-2026-06888",
    "original_inquiry": "海外求诊：Consultation: iPSC-derived neuron with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8334
  },
  {
    "request_id": "AM-REQ-2026-06889",
    "original_inquiry": "Urgent: 海外求诊：帕金森患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-06890",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for organoid; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7286
  },
  {
    "request_id": "AM-REQ-2026-06891",
    "original_inquiry": "Urgent: Neurologist: clinical trial patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7355
  },
  {
    "request_id": "AM-REQ-2026-06892",
    "original_inquiry": "Urgent: 海外求诊：cell therapy患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8422
  },
  {
    "request_id": "AM-REQ-2026-06893",
    "original_inquiry": "患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7825
  },
  {
    "request_id": "AM-REQ-2026-06894",
    "original_inquiry": "海外求诊：Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8278
  },
  {
    "request_id": "AM-REQ-2026-06895",
    "original_inquiry": "Family seeking information: Family seeking 帕金森 therapy for Parkinson; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5972
  },
  {
    "request_id": "AM-REQ-2026-06896",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6062
  },
  {
    "request_id": "AM-REQ-2026-06897",
    "original_inquiry": "研究者咨询：Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7391
  },
  {
    "request_id": "AM-REQ-2026-06898",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8897
  },
  {
    "request_id": "AM-REQ-2026-06899",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5037
  },
  {
    "request_id": "AM-REQ-2026-06900",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7392
  },
  {
    "request_id": "AM-REQ-2026-06901",
    "original_inquiry": "Urgent: Family seeking clinical trial therapy for spinal cord injury; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8887
  },
  {
    "request_id": "AM-REQ-2026-06902",
    "original_inquiry": "Referral from specialist: Patient with advanced clinical trial; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7514
  },
  {
    "request_id": "AM-REQ-2026-06903",
    "original_inquiry": "Family seeking information: Patient with advanced 心肌修复; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.677
  },
  {
    "request_id": "AM-REQ-2026-06904",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and dopaminergic neuron transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7201
  },
  {
    "request_id": "AM-REQ-2026-06905",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 多能干细胞 manufacturing and organoid transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8535
  },
  {
    "request_id": "AM-REQ-2026-06906",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.553
  },
  {
    "request_id": "AM-REQ-2026-06907",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6142
  },
  {
    "request_id": "AM-REQ-2026-06908",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7361
  },
  {
    "request_id": "AM-REQ-2026-06909",
    "original_inquiry": "Urgent: Patient with advanced regenerative medicine; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.804
  },
  {
    "request_id": "AM-REQ-2026-06910",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6219
  },
  {
    "request_id": "AM-REQ-2026-06911",
    "original_inquiry": "Neurologist: 心肌修复 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-06912",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6228
  },
  {
    "request_id": "AM-REQ-2026-06913",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.766
  },
  {
    "request_id": "AM-REQ-2026-06914",
    "original_inquiry": "Second opinion requested: Consultation: regenerative medicine with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5089
  },
  {
    "request_id": "AM-REQ-2026-06915",
    "original_inquiry": "Urgent: Family seeking clinical trial therapy for heart failure; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8612
  },
  {
    "request_id": "AM-REQ-2026-06916",
    "original_inquiry": "Second opinion requested: Consultation: iPSC-derived neuron with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7469
  },
  {
    "request_id": "AM-REQ-2026-06917",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring cardiomyocyte and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7232
  },
  {
    "request_id": "AM-REQ-2026-06918",
    "original_inquiry": "研究者咨询：海外求诊：类器官移植患者，希望评估iPSC或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6095
  },
  {
    "request_id": "AM-REQ-2026-06919",
    "original_inquiry": "研究者咨询：Cardiologist referral: 帕金森 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8702
  },
  {
    "request_id": "AM-REQ-2026-06920",
    "original_inquiry": "Family seeking information: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5877
  },
  {
    "request_id": "AM-REQ-2026-06921",
    "original_inquiry": "Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8094
  },
  {
    "request_id": "AM-REQ-2026-06922",
    "original_inquiry": "Second opinion requested: 海外求诊：cell therapy患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8166
  },
  {
    "request_id": "AM-REQ-2026-06923",
    "original_inquiry": "Referral from specialist: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5299
  },
  {
    "request_id": "AM-REQ-2026-06924",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7372
  },
  {
    "request_id": "AM-REQ-2026-06925",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7649
  },
  {
    "request_id": "AM-REQ-2026-06926",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8092
  },
  {
    "request_id": "AM-REQ-2026-06927",
    "original_inquiry": "海外求诊：Neurologist: cell therapy patient, exploring Parkinson and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6427
  },
  {
    "request_id": "AM-REQ-2026-06928",
    "original_inquiry": "海外求诊：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7732
  },
  {
    "request_id": "AM-REQ-2026-06929",
    "original_inquiry": "Family seeking regenerative medicine therapy for Parkinson; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8861
  },
  {
    "request_id": "AM-REQ-2026-06930",
    "original_inquiry": "海外求诊：Patient with advanced clinical trial; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7428
  },
  {
    "request_id": "AM-REQ-2026-06931",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5602
  },
  {
    "request_id": "AM-REQ-2026-06932",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-06933",
    "original_inquiry": "Second opinion requested: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5761
  },
  {
    "request_id": "AM-REQ-2026-06934",
    "original_inquiry": "Family seeking information: Cardiologist referral: 帕金森 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5297
  },
  {
    "request_id": "AM-REQ-2026-06935",
    "original_inquiry": "Referral from specialist: Patient with advanced 干细胞分化; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7511
  },
  {
    "request_id": "AM-REQ-2026-06936",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and organoid transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5264
  },
  {
    "request_id": "AM-REQ-2026-06937",
    "original_inquiry": "Family seeking information: Cardiologist referral: clinical trial with reduced EF; interested in Parkinson or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6242
  },
  {
    "request_id": "AM-REQ-2026-06938",
    "original_inquiry": "Second opinion requested: Family seeking clinical trial therapy for organoid; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5981
  },
  {
    "request_id": "AM-REQ-2026-06939",
    "original_inquiry": "Referral from specialist: 海外求诊：clinical trial患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5954
  },
  {
    "request_id": "AM-REQ-2026-06940",
    "original_inquiry": "Researcher inquiry: cell therapy manufacturing and dopaminergic neuron transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5705
  },
  {
    "request_id": "AM-REQ-2026-06941",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6724
  },
  {
    "request_id": "AM-REQ-2026-06942",
    "original_inquiry": "Family seeking information: Consultation: cell therapy with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5506
  },
  {
    "request_id": "AM-REQ-2026-06943",
    "original_inquiry": "Family seeking information: 海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5638
  },
  {
    "request_id": "AM-REQ-2026-06944",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8913
  },
  {
    "request_id": "AM-REQ-2026-06945",
    "original_inquiry": "海外求诊：Family seeking 干细胞分化 therapy for induced pluripotent stem cell; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7483
  },
  {
    "request_id": "AM-REQ-2026-06946",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in cell replacement or neural cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5654
  },
  {
    "request_id": "AM-REQ-2026-06947",
    "original_inquiry": "Referral from specialist: Consultation: cell therapy with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8113
  },
  {
    "request_id": "AM-REQ-2026-06948",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8043
  },
  {
    "request_id": "AM-REQ-2026-06949",
    "original_inquiry": "研究者咨询：Patient with advanced clinical trial; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5127
  },
  {
    "request_id": "AM-REQ-2026-06950",
    "original_inquiry": "研究者咨询：Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for iPSC; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8432
  },
  {
    "request_id": "AM-REQ-2026-06951",
    "original_inquiry": "Second opinion requested: Researcher inquiry: clinical trial manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.786
  },
  {
    "request_id": "AM-REQ-2026-06952",
    "original_inquiry": "海外求诊：Consultation: clinical trial with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5629
  },
  {
    "request_id": "AM-REQ-2026-06953",
    "original_inquiry": "Second opinion requested: Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7139
  },
  {
    "request_id": "AM-REQ-2026-06954",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8596
  },
  {
    "request_id": "AM-REQ-2026-06955",
    "original_inquiry": "海外求诊：患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8682
  },
  {
    "request_id": "AM-REQ-2026-06956",
    "original_inquiry": "研究者咨询：Family seeking 干细胞分化 therapy for cell replacement; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7699
  },
  {
    "request_id": "AM-REQ-2026-06957",
    "original_inquiry": "Urgent: Neurologist: clinical trial patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5417
  },
  {
    "request_id": "AM-REQ-2026-06958",
    "original_inquiry": "Family seeking cell therapy therapy for spinal cord injury; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5974
  },
  {
    "request_id": "AM-REQ-2026-06959",
    "original_inquiry": "Referral from specialist: Consultation: 多能干细胞 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7683
  },
  {
    "request_id": "AM-REQ-2026-06960",
    "original_inquiry": "研究者咨询：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5564
  },
  {
    "request_id": "AM-REQ-2026-06961",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.872
  },
  {
    "request_id": "AM-REQ-2026-06962",
    "original_inquiry": "Urgent: Researcher inquiry: 心肌修复 manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6551
  },
  {
    "request_id": "AM-REQ-2026-06963",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7289
  },
  {
    "request_id": "AM-REQ-2026-06964",
    "original_inquiry": "Family seeking information: 海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6629
  },
  {
    "request_id": "AM-REQ-2026-06965",
    "original_inquiry": "研究者咨询：海外求诊：帕金森患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7568
  },
  {
    "request_id": "AM-REQ-2026-06966",
    "original_inquiry": "Urgent: Family seeking clinical trial therapy for induced pluripotent stem cell; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.617
  },
  {
    "request_id": "AM-REQ-2026-06967",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7186
  },
  {
    "request_id": "AM-REQ-2026-06968",
    "original_inquiry": "Neurologist: cell therapy patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8843
  },
  {
    "request_id": "AM-REQ-2026-06969",
    "original_inquiry": "研究者咨询：海外求诊：多能干细胞患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.766
  },
  {
    "request_id": "AM-REQ-2026-06970",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5477
  },
  {
    "request_id": "AM-REQ-2026-06971",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 心肌修复 manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7378
  },
  {
    "request_id": "AM-REQ-2026-06972",
    "original_inquiry": "Family seeking information: Family seeking 干细胞分化 therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5546
  },
  {
    "request_id": "AM-REQ-2026-06973",
    "original_inquiry": "Family seeking information: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7542
  },
  {
    "request_id": "AM-REQ-2026-06974",
    "original_inquiry": "Family seeking information: Consultation: regenerative medicine with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-06975",
    "original_inquiry": "海外求诊：Neurologist: 类器官移植 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.649
  },
  {
    "request_id": "AM-REQ-2026-06976",
    "original_inquiry": "Second opinion requested: Cardiologist referral: clinical trial with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5016
  },
  {
    "request_id": "AM-REQ-2026-06977",
    "original_inquiry": "Referral from specialist: Researcher inquiry: regenerative medicine manufacturing and Parkinson transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6599
  },
  {
    "request_id": "AM-REQ-2026-06978",
    "original_inquiry": "Family seeking 心肌修复 therapy for organoid; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5834
  },
  {
    "request_id": "AM-REQ-2026-06979",
    "original_inquiry": "Family seeking information: Neurologist: 类器官移植 patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8364
  },
  {
    "request_id": "AM-REQ-2026-06980",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for cardiomyocyte; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8556
  },
  {
    "request_id": "AM-REQ-2026-06981",
    "original_inquiry": "Urgent: Patient with advanced 帕金森; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7405
  },
  {
    "request_id": "AM-REQ-2026-06982",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8634
  },
  {
    "request_id": "AM-REQ-2026-06983",
    "original_inquiry": "Family seeking information: Researcher inquiry: 多能干细胞 manufacturing and heart failure transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6557
  },
  {
    "request_id": "AM-REQ-2026-06984",
    "original_inquiry": "研究者咨询：Consultation: 类器官移植 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.527
  },
  {
    "request_id": "AM-REQ-2026-06985",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6639
  },
  {
    "request_id": "AM-REQ-2026-06986",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8724
  },
  {
    "request_id": "AM-REQ-2026-06987",
    "original_inquiry": "Researcher inquiry: 心肌修复 manufacturing and dopaminergic neuron transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8855
  },
  {
    "request_id": "AM-REQ-2026-06988",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 帕金森 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5536
  },
  {
    "request_id": "AM-REQ-2026-06989",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking spinal cord injury or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5285
  },
  {
    "request_id": "AM-REQ-2026-06990",
    "original_inquiry": "Second opinion requested: 海外求诊：帕金森患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8152
  },
  {
    "request_id": "AM-REQ-2026-06991",
    "original_inquiry": "Second opinion requested: Family seeking iPSC-derived neuron therapy for induced pluripotent stem cell; request centers with cell replacement programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5533
  },
  {
    "request_id": "AM-REQ-2026-06992",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5984
  },
  {
    "request_id": "AM-REQ-2026-06993",
    "original_inquiry": "Urgent: 海外求诊：regenerative medicine患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5589
  },
  {
    "request_id": "AM-REQ-2026-06994",
    "original_inquiry": "Urgent: Cardiologist referral: 类器官移植 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6015
  },
  {
    "request_id": "AM-REQ-2026-06995",
    "original_inquiry": "研究者咨询：Cardiologist referral: clinical trial with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6521
  },
  {
    "request_id": "AM-REQ-2026-06996",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 多能干细胞 manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5494
  },
  {
    "request_id": "AM-REQ-2026-06997",
    "original_inquiry": "Urgent: 海外求诊：多能干细胞患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.794
  },
  {
    "request_id": "AM-REQ-2026-06998",
    "original_inquiry": "Family seeking information: Family seeking clinical trial therapy for cardiomyocyte; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7009
  },
  {
    "request_id": "AM-REQ-2026-06999",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.644
  },
  {
    "request_id": "AM-REQ-2026-07000",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6896
  },
  {
    "request_id": "AM-REQ-2026-07001",
    "original_inquiry": "Urgent: 海外求诊：干细胞分化患者，希望评估spinal cord injury或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8305
  },
  {
    "request_id": "AM-REQ-2026-07002",
    "original_inquiry": "海外求诊：Family seeking clinical trial therapy for dopaminergic neuron; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7011
  },
  {
    "request_id": "AM-REQ-2026-07003",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5304
  },
  {
    "request_id": "AM-REQ-2026-07004",
    "original_inquiry": "Researcher inquiry: cell therapy manufacturing and organoid transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5022
  },
  {
    "request_id": "AM-REQ-2026-07005",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and Parkinson transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8457
  },
  {
    "request_id": "AM-REQ-2026-07006",
    "original_inquiry": "Family seeking information: 海外求诊：cell therapy患者，希望评估organoid或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6344
  },
  {
    "request_id": "AM-REQ-2026-07007",
    "original_inquiry": "海外求诊：iPSC-derived neuron患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5897
  },
  {
    "request_id": "AM-REQ-2026-07008",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5602
  },
  {
    "request_id": "AM-REQ-2026-07009",
    "original_inquiry": "研究者咨询：Cardiologist referral: regenerative medicine with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-07010",
    "original_inquiry": "Referral from specialist: Cardiologist referral: regenerative medicine with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8614
  },
  {
    "request_id": "AM-REQ-2026-07011",
    "original_inquiry": "Second opinion requested: Researcher inquiry: iPSC-derived neuron manufacturing and Parkinson transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5371
  },
  {
    "request_id": "AM-REQ-2026-07012",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.761
  },
  {
    "request_id": "AM-REQ-2026-07013",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8516
  },
  {
    "request_id": "AM-REQ-2026-07014",
    "original_inquiry": "研究者咨询：Consultation: 帕金森 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5935
  },
  {
    "request_id": "AM-REQ-2026-07015",
    "original_inquiry": "Referral from specialist: 海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7341
  },
  {
    "request_id": "AM-REQ-2026-07016",
    "original_inquiry": "Urgent: 海外求诊：帕金森患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6763
  },
  {
    "request_id": "AM-REQ-2026-07017",
    "original_inquiry": "Family seeking information: Patient with advanced clinical trial; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5478
  },
  {
    "request_id": "AM-REQ-2026-07018",
    "original_inquiry": "海外求诊：regenerative medicine患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6981
  },
  {
    "request_id": "AM-REQ-2026-07019",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8988
  },
  {
    "request_id": "AM-REQ-2026-07020",
    "original_inquiry": "Urgent: Neurologist: regenerative medicine patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5227
  },
  {
    "request_id": "AM-REQ-2026-07021",
    "original_inquiry": "Urgent: Neurologist: 类器官移植 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5685
  },
  {
    "request_id": "AM-REQ-2026-07022",
    "original_inquiry": "Second opinion requested: Consultation: clinical trial with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8959
  },
  {
    "request_id": "AM-REQ-2026-07023",
    "original_inquiry": "研究者咨询：Neurologist: cell therapy patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8912
  },
  {
    "request_id": "AM-REQ-2026-07024",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估spinal cord injury或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7604
  },
  {
    "request_id": "AM-REQ-2026-07025",
    "original_inquiry": "Family seeking information: Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8337
  },
  {
    "request_id": "AM-REQ-2026-07026",
    "original_inquiry": "Urgent: Neurologist: iPSC-derived neuron patient, exploring cardiomyocyte and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7899
  },
  {
    "request_id": "AM-REQ-2026-07027",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for organoid; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.811
  },
  {
    "request_id": "AM-REQ-2026-07028",
    "original_inquiry": "海外求诊：海外求诊：clinical trial患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5657
  },
  {
    "request_id": "AM-REQ-2026-07029",
    "original_inquiry": "Researcher inquiry: cell therapy manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.839
  },
  {
    "request_id": "AM-REQ-2026-07030",
    "original_inquiry": "Family seeking 多能干细胞 therapy for Parkinson; request centers with organoid programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7633
  },
  {
    "request_id": "AM-REQ-2026-07031",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5673
  },
  {
    "request_id": "AM-REQ-2026-07032",
    "original_inquiry": "海外求诊：Consultation: iPSC-derived neuron with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6662
  },
  {
    "request_id": "AM-REQ-2026-07033",
    "original_inquiry": "Second opinion requested: Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5839
  },
  {
    "request_id": "AM-REQ-2026-07034",
    "original_inquiry": "研究者咨询：Researcher inquiry: iPSC-derived neuron manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8264
  },
  {
    "request_id": "AM-REQ-2026-07035",
    "original_inquiry": "Referral from specialist: Researcher inquiry: clinical trial manufacturing and cardiomyocyte transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6758
  },
  {
    "request_id": "AM-REQ-2026-07036",
    "original_inquiry": "Urgent: 海外求诊：心肌修复患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5682
  },
  {
    "request_id": "AM-REQ-2026-07037",
    "original_inquiry": "Neurologist: 心肌修复 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8632
  },
  {
    "request_id": "AM-REQ-2026-07038",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for cell replacement; request centers with cardiomyocyte programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7435
  },
  {
    "request_id": "AM-REQ-2026-07039",
    "original_inquiry": "Referral from specialist: Neurologist: 多能干细胞 patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.58
  },
  {
    "request_id": "AM-REQ-2026-07040",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7417
  },
  {
    "request_id": "AM-REQ-2026-07041",
    "original_inquiry": "Referral from specialist: 海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.803
  },
  {
    "request_id": "AM-REQ-2026-07042",
    "original_inquiry": "Second opinion requested: 海外求诊：cell therapy患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.798
  },
  {
    "request_id": "AM-REQ-2026-07043",
    "original_inquiry": "Urgent: Cardiologist referral: 帕金森 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7182
  },
  {
    "request_id": "AM-REQ-2026-07044",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in cardiomyocyte or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6387
  },
  {
    "request_id": "AM-REQ-2026-07045",
    "original_inquiry": "海外求诊：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5422
  },
  {
    "request_id": "AM-REQ-2026-07046",
    "original_inquiry": "Second opinion requested: 海外求诊：iPSC-derived neuron患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.789
  },
  {
    "request_id": "AM-REQ-2026-07047",
    "original_inquiry": "Family seeking information: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6759
  },
  {
    "request_id": "AM-REQ-2026-07048",
    "original_inquiry": "Urgent: Researcher inquiry: 心肌修复 manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5255
  },
  {
    "request_id": "AM-REQ-2026-07049",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6035
  },
  {
    "request_id": "AM-REQ-2026-07050",
    "original_inquiry": "Family seeking information: Family seeking clinical trial therapy for heart failure; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5341
  },
  {
    "request_id": "AM-REQ-2026-07051",
    "original_inquiry": "Second opinion requested: Consultation: cell therapy with spinal cord injury; interested in spinal cord injury or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7928
  },
  {
    "request_id": "AM-REQ-2026-07052",
    "original_inquiry": "Family seeking information: 海外求诊：cell therapy患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5253
  },
  {
    "request_id": "AM-REQ-2026-07053",
    "original_inquiry": "Referral from specialist: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7967
  },
  {
    "request_id": "AM-REQ-2026-07054",
    "original_inquiry": "Consultation: 心肌修复 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8422
  },
  {
    "request_id": "AM-REQ-2026-07055",
    "original_inquiry": "Urgent: Researcher inquiry: 干细胞分化 manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6171
  },
  {
    "request_id": "AM-REQ-2026-07056",
    "original_inquiry": "Second opinion requested: 海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7333
  },
  {
    "request_id": "AM-REQ-2026-07057",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7314
  },
  {
    "request_id": "AM-REQ-2026-07058",
    "original_inquiry": "Urgent: Patient with advanced 类器官移植; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7604
  },
  {
    "request_id": "AM-REQ-2026-07059",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8164
  },
  {
    "request_id": "AM-REQ-2026-07060",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8894
  },
  {
    "request_id": "AM-REQ-2026-07061",
    "original_inquiry": "Second opinion requested: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8683
  },
  {
    "request_id": "AM-REQ-2026-07062",
    "original_inquiry": "研究者咨询：Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8728
  },
  {
    "request_id": "AM-REQ-2026-07063",
    "original_inquiry": "Family seeking information: Cardiologist referral: clinical trial with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7013
  },
  {
    "request_id": "AM-REQ-2026-07064",
    "original_inquiry": "Urgent: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7588
  },
  {
    "request_id": "AM-REQ-2026-07065",
    "original_inquiry": "Referral from specialist: 海外求诊：心肌修复患者，希望评估Parkinson或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8709
  },
  {
    "request_id": "AM-REQ-2026-07066",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5882
  },
  {
    "request_id": "AM-REQ-2026-07067",
    "original_inquiry": "Researcher inquiry: 心肌修复 manufacturing and organoid transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8261
  },
  {
    "request_id": "AM-REQ-2026-07068",
    "original_inquiry": "Family seeking information: 海外求诊：心肌修复患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6984
  },
  {
    "request_id": "AM-REQ-2026-07069",
    "original_inquiry": "海外求诊：Consultation: 类器官移植 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8508
  },
  {
    "request_id": "AM-REQ-2026-07070",
    "original_inquiry": "海外求诊：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.818
  },
  {
    "request_id": "AM-REQ-2026-07071",
    "original_inquiry": "Second opinion requested: Neurologist: 类器官移植 patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8108
  },
  {
    "request_id": "AM-REQ-2026-07072",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8542
  },
  {
    "request_id": "AM-REQ-2026-07073",
    "original_inquiry": "Family seeking information: 海外求诊：类器官移植患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5205
  },
  {
    "request_id": "AM-REQ-2026-07074",
    "original_inquiry": "Second opinion requested: Neurologist: cell therapy patient, exploring heart failure and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6995
  },
  {
    "request_id": "AM-REQ-2026-07075",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7001
  },
  {
    "request_id": "AM-REQ-2026-07076",
    "original_inquiry": "海外求诊：类器官移植患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7058
  },
  {
    "request_id": "AM-REQ-2026-07077",
    "original_inquiry": "Family seeking 类器官移植 therapy for cell replacement; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5262
  },
  {
    "request_id": "AM-REQ-2026-07078",
    "original_inquiry": "Second opinion requested: Consultation: cell therapy with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7079
  },
  {
    "request_id": "AM-REQ-2026-07079",
    "original_inquiry": "Second opinion requested: Neurologist: 干细胞分化 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8802
  },
  {
    "request_id": "AM-REQ-2026-07080",
    "original_inquiry": "Referral from specialist: Neurologist: cell therapy patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8158
  },
  {
    "request_id": "AM-REQ-2026-07081",
    "original_inquiry": "研究者咨询：Family seeking cell therapy therapy for Parkinson; request centers with organoid programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.636
  },
  {
    "request_id": "AM-REQ-2026-07082",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7347
  },
  {
    "request_id": "AM-REQ-2026-07083",
    "original_inquiry": "Patient with advanced clinical trial; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5376
  },
  {
    "request_id": "AM-REQ-2026-07084",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5512
  },
  {
    "request_id": "AM-REQ-2026-07085",
    "original_inquiry": "海外求诊：Neurologist: regenerative medicine patient, exploring cardiomyocyte and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6193
  },
  {
    "request_id": "AM-REQ-2026-07086",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for heart failure; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6603
  },
  {
    "request_id": "AM-REQ-2026-07087",
    "original_inquiry": "Second opinion requested: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8703
  },
  {
    "request_id": "AM-REQ-2026-07088",
    "original_inquiry": "Urgent: Neurologist: iPSC-derived neuron patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7057
  },
  {
    "request_id": "AM-REQ-2026-07089",
    "original_inquiry": "研究者咨询：海外求诊：regenerative medicine患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7504
  },
  {
    "request_id": "AM-REQ-2026-07090",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7569
  },
  {
    "request_id": "AM-REQ-2026-07091",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6123
  },
  {
    "request_id": "AM-REQ-2026-07092",
    "original_inquiry": "海外求诊：Consultation: 干细胞分化 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5815
  },
  {
    "request_id": "AM-REQ-2026-07093",
    "original_inquiry": "Family seeking information: Researcher inquiry: 类器官移植 manufacturing and cell replacement transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8079
  },
  {
    "request_id": "AM-REQ-2026-07094",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for induced pluripotent stem cell; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5108
  },
  {
    "request_id": "AM-REQ-2026-07095",
    "original_inquiry": "Referral from specialist: Consultation: 类器官移植 with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7885
  },
  {
    "request_id": "AM-REQ-2026-07096",
    "original_inquiry": "Urgent: Family seeking 心肌修复 therapy for iPSC; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5626
  },
  {
    "request_id": "AM-REQ-2026-07097",
    "original_inquiry": "Consultation: 类器官移植 with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8658
  },
  {
    "request_id": "AM-REQ-2026-07098",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.885
  },
  {
    "request_id": "AM-REQ-2026-07099",
    "original_inquiry": "研究者咨询：Patient with advanced clinical trial; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7024
  },
  {
    "request_id": "AM-REQ-2026-07100",
    "original_inquiry": "Patient with advanced 心肌修复; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7595
  },
  {
    "request_id": "AM-REQ-2026-07101",
    "original_inquiry": "Family seeking information: Researcher inquiry: regenerative medicine manufacturing and spinal cord injury transplantation for iPSC; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6164
  },
  {
    "request_id": "AM-REQ-2026-07102",
    "original_inquiry": "研究者咨询：Cardiologist referral: 帕金森 with reduced EF; interested in heart failure or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6416
  },
  {
    "request_id": "AM-REQ-2026-07103",
    "original_inquiry": "研究者咨询：Patient with advanced 心肌修复; seeking organoid or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8144
  },
  {
    "request_id": "AM-REQ-2026-07104",
    "original_inquiry": "海外求诊：海外求诊：多能干细胞患者，希望评估dopaminergic neuron或类器官相关临床研究入组。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5582
  },
  {
    "request_id": "AM-REQ-2026-07105",
    "original_inquiry": "Cardiologist referral: 干细胞分化 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6409
  },
  {
    "request_id": "AM-REQ-2026-07106",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6726
  },
  {
    "request_id": "AM-REQ-2026-07107",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in organoid or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-07108",
    "original_inquiry": "Referral from specialist: 海外求诊：cell therapy患者，希望评估spinal cord injury或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8582
  },
  {
    "request_id": "AM-REQ-2026-07109",
    "original_inquiry": "Neurologist: 帕金森 patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5004
  },
  {
    "request_id": "AM-REQ-2026-07110",
    "original_inquiry": "Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6982
  },
  {
    "request_id": "AM-REQ-2026-07111",
    "original_inquiry": "Family seeking information: Patient with advanced cell therapy; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7372
  },
  {
    "request_id": "AM-REQ-2026-07112",
    "original_inquiry": "Urgent: Family seeking 多能干细胞 therapy for spinal cord injury; request centers with induced pluripotent stem cell programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8543
  },
  {
    "request_id": "AM-REQ-2026-07113",
    "original_inquiry": "Consultation: 多能干细胞 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.895
  },
  {
    "request_id": "AM-REQ-2026-07114",
    "original_inquiry": "Referral from specialist: Consultation: 干细胞分化 with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7479
  },
  {
    "request_id": "AM-REQ-2026-07115",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6835
  },
  {
    "request_id": "AM-REQ-2026-07116",
    "original_inquiry": "Referral from specialist: Consultation: 干细胞分化 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-07117",
    "original_inquiry": "Referral from specialist: Cardiologist referral: cell therapy with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8715
  },
  {
    "request_id": "AM-REQ-2026-07118",
    "original_inquiry": "Second opinion requested: Cardiologist referral: regenerative medicine with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6264
  },
  {
    "request_id": "AM-REQ-2026-07119",
    "original_inquiry": "研究者咨询：Cardiologist referral: 心肌修复 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-07120",
    "original_inquiry": "Family seeking information: Cardiologist referral: 多能干细胞 with reduced EF; interested in Parkinson or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7453
  },
  {
    "request_id": "AM-REQ-2026-07121",
    "original_inquiry": "研究者咨询：Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5815
  },
  {
    "request_id": "AM-REQ-2026-07122",
    "original_inquiry": "患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7848
  },
  {
    "request_id": "AM-REQ-2026-07123",
    "original_inquiry": "Family seeking information: 海外求诊：心肌修复患者，希望评估organoid或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6322
  },
  {
    "request_id": "AM-REQ-2026-07124",
    "original_inquiry": "Second opinion requested: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6435
  },
  {
    "request_id": "AM-REQ-2026-07125",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.754
  },
  {
    "request_id": "AM-REQ-2026-07126",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and spinal cord injury transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7436
  },
  {
    "request_id": "AM-REQ-2026-07127",
    "original_inquiry": "Second opinion requested: 海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5985
  },
  {
    "request_id": "AM-REQ-2026-07128",
    "original_inquiry": "Urgent: Researcher inquiry: regenerative medicine manufacturing and cell replacement transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6249
  },
  {
    "request_id": "AM-REQ-2026-07129",
    "original_inquiry": "Family seeking information: 海外求诊：帕金森患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.842
  },
  {
    "request_id": "AM-REQ-2026-07130",
    "original_inquiry": "Urgent: Family seeking 帕金森 therapy for cell replacement; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8744
  },
  {
    "request_id": "AM-REQ-2026-07131",
    "original_inquiry": "Family seeking information: Cardiologist referral: 心肌修复 with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7719
  },
  {
    "request_id": "AM-REQ-2026-07132",
    "original_inquiry": "Referral from specialist: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7285
  },
  {
    "request_id": "AM-REQ-2026-07133",
    "original_inquiry": "Referral from specialist: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6561
  },
  {
    "request_id": "AM-REQ-2026-07134",
    "original_inquiry": "Family seeking information: Consultation: clinical trial with spinal cord injury; interested in heart failure or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8894
  },
  {
    "request_id": "AM-REQ-2026-07135",
    "original_inquiry": "Researcher inquiry: iPSC-derived neuron manufacturing and cell replacement transplantation for iPSC; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.728
  },
  {
    "request_id": "AM-REQ-2026-07136",
    "original_inquiry": "Patient with advanced 多能干细胞; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8961
  },
  {
    "request_id": "AM-REQ-2026-07137",
    "original_inquiry": "Referral from specialist: 海外求诊：regenerative medicine患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7243
  },
  {
    "request_id": "AM-REQ-2026-07138",
    "original_inquiry": "研究者咨询：Consultation: cell therapy with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8008
  },
  {
    "request_id": "AM-REQ-2026-07139",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-07140",
    "original_inquiry": "Second opinion requested: Researcher inquiry: cell therapy manufacturing and dopaminergic neuron transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5137
  },
  {
    "request_id": "AM-REQ-2026-07141",
    "original_inquiry": "Family seeking information: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5823
  },
  {
    "request_id": "AM-REQ-2026-07142",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and spinal cord injury transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5684
  },
  {
    "request_id": "AM-REQ-2026-07143",
    "original_inquiry": "Second opinion requested: Cardiologist referral: regenerative medicine with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8758
  },
  {
    "request_id": "AM-REQ-2026-07144",
    "original_inquiry": "Urgent: Consultation: 类器官移植 with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.704
  },
  {
    "request_id": "AM-REQ-2026-07145",
    "original_inquiry": "Referral from specialist: 海外求诊：帕金森患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.663
  },
  {
    "request_id": "AM-REQ-2026-07146",
    "original_inquiry": "Referral from specialist: Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.885
  },
  {
    "request_id": "AM-REQ-2026-07147",
    "original_inquiry": "Urgent: 海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6243
  },
  {
    "request_id": "AM-REQ-2026-07148",
    "original_inquiry": "Referral from specialist: Neurologist: clinical trial patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-07149",
    "original_inquiry": "Referral from specialist: Family seeking iPSC-derived neuron therapy for organoid; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7155
  },
  {
    "request_id": "AM-REQ-2026-07150",
    "original_inquiry": "研究者咨询：Cardiologist referral: 类器官移植 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8946
  },
  {
    "request_id": "AM-REQ-2026-07151",
    "original_inquiry": "Referral from specialist: 海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7947
  },
  {
    "request_id": "AM-REQ-2026-07152",
    "original_inquiry": "研究者咨询：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in organoid or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7709
  },
  {
    "request_id": "AM-REQ-2026-07153",
    "original_inquiry": "Family seeking information: Neurologist: clinical trial patient, exploring cell replacement and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8865
  },
  {
    "request_id": "AM-REQ-2026-07154",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5803
  },
  {
    "request_id": "AM-REQ-2026-07155",
    "original_inquiry": "海外求诊：Cardiologist referral: 干细胞分化 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6465
  },
  {
    "request_id": "AM-REQ-2026-07156",
    "original_inquiry": "Family seeking information: Researcher inquiry: clinical trial manufacturing and spinal cord injury transplantation for iPSC; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.663
  },
  {
    "request_id": "AM-REQ-2026-07157",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8142
  },
  {
    "request_id": "AM-REQ-2026-07158",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7553
  },
  {
    "request_id": "AM-REQ-2026-07159",
    "original_inquiry": "Urgent: Neurologist: 多能干细胞 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5502
  },
  {
    "request_id": "AM-REQ-2026-07160",
    "original_inquiry": "Second opinion requested: Family seeking 干细胞分化 therapy for dopaminergic neuron; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5151
  },
  {
    "request_id": "AM-REQ-2026-07161",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6372
  },
  {
    "request_id": "AM-REQ-2026-07162",
    "original_inquiry": "Second opinion requested: Neurologist: clinical trial patient, exploring spinal cord injury and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.776
  },
  {
    "request_id": "AM-REQ-2026-07163",
    "original_inquiry": "海外求诊：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8212
  },
  {
    "request_id": "AM-REQ-2026-07164",
    "original_inquiry": "Consultation: cell therapy with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8811
  },
  {
    "request_id": "AM-REQ-2026-07165",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7525
  },
  {
    "request_id": "AM-REQ-2026-07166",
    "original_inquiry": "海外求诊：Cardiologist referral: 帕金森 with reduced EF; interested in heart failure or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6247
  },
  {
    "request_id": "AM-REQ-2026-07167",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6647
  },
  {
    "request_id": "AM-REQ-2026-07168",
    "original_inquiry": "研究者咨询：Researcher inquiry: 多能干细胞 manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8769
  },
  {
    "request_id": "AM-REQ-2026-07169",
    "original_inquiry": "研究者咨询：Cardiologist referral: 干细胞分化 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-07170",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7796
  },
  {
    "request_id": "AM-REQ-2026-07171",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5447
  },
  {
    "request_id": "AM-REQ-2026-07172",
    "original_inquiry": "Family seeking information: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8342
  },
  {
    "request_id": "AM-REQ-2026-07173",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6855
  },
  {
    "request_id": "AM-REQ-2026-07174",
    "original_inquiry": "Patient with advanced cell therapy; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.752
  },
  {
    "request_id": "AM-REQ-2026-07175",
    "original_inquiry": "Cardiologist referral: 类器官移植 with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7911
  },
  {
    "request_id": "AM-REQ-2026-07176",
    "original_inquiry": "Urgent: Patient with advanced regenerative medicine; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.627
  },
  {
    "request_id": "AM-REQ-2026-07177",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8842
  },
  {
    "request_id": "AM-REQ-2026-07178",
    "original_inquiry": "Referral from specialist: Consultation: 类器官移植 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5978
  },
  {
    "request_id": "AM-REQ-2026-07179",
    "original_inquiry": "Second opinion requested: Neurologist: iPSC-derived neuron patient, exploring organoid and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6225
  },
  {
    "request_id": "AM-REQ-2026-07180",
    "original_inquiry": "Urgent: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8607
  },
  {
    "request_id": "AM-REQ-2026-07181",
    "original_inquiry": "Second opinion requested: Patient with advanced clinical trial; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6982
  },
  {
    "request_id": "AM-REQ-2026-07182",
    "original_inquiry": "Urgent: 海外求诊：cell therapy患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6183
  },
  {
    "request_id": "AM-REQ-2026-07183",
    "original_inquiry": "Family seeking information: Family seeking 类器官移植 therapy for organoid; request centers with cardiomyocyte programs.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7538
  },
  {
    "request_id": "AM-REQ-2026-07184",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in cardiomyocyte or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8687
  },
  {
    "request_id": "AM-REQ-2026-07185",
    "original_inquiry": "Family seeking information: 海外求诊：多能干细胞患者，希望评估iPSC或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8874
  },
  {
    "request_id": "AM-REQ-2026-07186",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8395
  },
  {
    "request_id": "AM-REQ-2026-07187",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6617
  },
  {
    "request_id": "AM-REQ-2026-07188",
    "original_inquiry": "Referral from specialist: Patient with advanced 干细胞分化; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7246
  },
  {
    "request_id": "AM-REQ-2026-07189",
    "original_inquiry": "Cardiologist referral: 心肌修复 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6848
  },
  {
    "request_id": "AM-REQ-2026-07190",
    "original_inquiry": "Referral from specialist: 患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6404
  },
  {
    "request_id": "AM-REQ-2026-07191",
    "original_inquiry": "Patient with advanced regenerative medicine; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7716
  },
  {
    "request_id": "AM-REQ-2026-07192",
    "original_inquiry": "研究者咨询：Patient with advanced 多能干细胞; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5725
  },
  {
    "request_id": "AM-REQ-2026-07193",
    "original_inquiry": "研究者咨询：Consultation: 干细胞分化 with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5685
  },
  {
    "request_id": "AM-REQ-2026-07194",
    "original_inquiry": "Urgent: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.61
  },
  {
    "request_id": "AM-REQ-2026-07195",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7023
  },
  {
    "request_id": "AM-REQ-2026-07196",
    "original_inquiry": "Consultation: regenerative medicine with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6753
  },
  {
    "request_id": "AM-REQ-2026-07197",
    "original_inquiry": "海外求诊：Family seeking 干细胞分化 therapy for spinal cord injury; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6002
  },
  {
    "request_id": "AM-REQ-2026-07198",
    "original_inquiry": "海外求诊：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8282
  },
  {
    "request_id": "AM-REQ-2026-07199",
    "original_inquiry": "Second opinion requested: Consultation: 多能干细胞 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-07200",
    "original_inquiry": "Family seeking 心肌修复 therapy for cell replacement; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.837
  },
  {
    "request_id": "AM-REQ-2026-07201",
    "original_inquiry": "Patient with advanced iPSC-derived neuron; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.772
  },
  {
    "request_id": "AM-REQ-2026-07202",
    "original_inquiry": "海外求诊：cell therapy患者，希望评估cell replacement或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5048
  },
  {
    "request_id": "AM-REQ-2026-07203",
    "original_inquiry": "Referral from specialist: Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5399
  },
  {
    "request_id": "AM-REQ-2026-07204",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking Parkinson or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5012
  },
  {
    "request_id": "AM-REQ-2026-07205",
    "original_inquiry": "Second opinion requested: Consultation: regenerative medicine with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5804
  },
  {
    "request_id": "AM-REQ-2026-07206",
    "original_inquiry": "Second opinion requested: Patient with advanced 帕金森; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.77
  },
  {
    "request_id": "AM-REQ-2026-07207",
    "original_inquiry": "Urgent: Cardiologist referral: 干细胞分化 with reduced EF; interested in Parkinson or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7518
  },
  {
    "request_id": "AM-REQ-2026-07208",
    "original_inquiry": "Referral from specialist: Family seeking 干细胞分化 therapy for dopaminergic neuron; request centers with iPSC programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6805
  },
  {
    "request_id": "AM-REQ-2026-07209",
    "original_inquiry": "Family seeking information: Consultation: 类器官移植 with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5596
  },
  {
    "request_id": "AM-REQ-2026-07210",
    "original_inquiry": "研究者咨询：Researcher inquiry: 心肌修复 manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5889
  },
  {
    "request_id": "AM-REQ-2026-07211",
    "original_inquiry": "Researcher inquiry: 类器官移植 manufacturing and heart failure transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8739
  },
  {
    "request_id": "AM-REQ-2026-07212",
    "original_inquiry": "Urgent: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6152
  },
  {
    "request_id": "AM-REQ-2026-07213",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring organoid and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6944
  },
  {
    "request_id": "AM-REQ-2026-07214",
    "original_inquiry": "研究者咨询：Family seeking 多能干细胞 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-07215",
    "original_inquiry": "海外求诊：Researcher inquiry: clinical trial manufacturing and iPSC transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.671
  },
  {
    "request_id": "AM-REQ-2026-07216",
    "original_inquiry": "Second opinion requested: Neurologist: 多能干细胞 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5179
  },
  {
    "request_id": "AM-REQ-2026-07217",
    "original_inquiry": "Family seeking information: Family seeking 心肌修复 therapy for spinal cord injury; request centers with organoid programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7539
  },
  {
    "request_id": "AM-REQ-2026-07218",
    "original_inquiry": "海外求诊：Consultation: 多能干细胞 with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-07219",
    "original_inquiry": "Referral from specialist: Patient with advanced cell therapy; seeking organoid or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7224
  },
  {
    "request_id": "AM-REQ-2026-07220",
    "original_inquiry": "Urgent: Researcher inquiry: 类器官移植 manufacturing and cell replacement transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6675
  },
  {
    "request_id": "AM-REQ-2026-07221",
    "original_inquiry": "Urgent: 海外求诊：多能干细胞患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-07222",
    "original_inquiry": "Second opinion requested: 海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5914
  },
  {
    "request_id": "AM-REQ-2026-07223",
    "original_inquiry": "Family seeking information: Patient with advanced regenerative medicine; seeking heart failure or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-07224",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 多能干细胞 with reduced EF; interested in Parkinson or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6111
  },
  {
    "request_id": "AM-REQ-2026-07225",
    "original_inquiry": "研究者咨询：Cardiologist referral: 帕金森 with reduced EF; interested in Parkinson or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8582
  },
  {
    "request_id": "AM-REQ-2026-07226",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8478
  },
  {
    "request_id": "AM-REQ-2026-07227",
    "original_inquiry": "Urgent: Patient with advanced 心肌修复; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8081
  },
  {
    "request_id": "AM-REQ-2026-07228",
    "original_inquiry": "Family seeking information: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5635
  },
  {
    "request_id": "AM-REQ-2026-07229",
    "original_inquiry": "Family seeking information: Patient with advanced 多能干细胞; seeking Parkinson or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5477
  },
  {
    "request_id": "AM-REQ-2026-07230",
    "original_inquiry": "Patient with advanced 干细胞分化; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.568
  },
  {
    "request_id": "AM-REQ-2026-07231",
    "original_inquiry": "研究者咨询：Cardiologist referral: 帕金森 with reduced EF; interested in iPSC or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.639
  },
  {
    "request_id": "AM-REQ-2026-07232",
    "original_inquiry": "Family seeking information: Neurologist: 类器官移植 patient, exploring dopaminergic neuron and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8786
  },
  {
    "request_id": "AM-REQ-2026-07233",
    "original_inquiry": "Urgent: Consultation: cell therapy with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5193
  },
  {
    "request_id": "AM-REQ-2026-07234",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6834
  },
  {
    "request_id": "AM-REQ-2026-07235",
    "original_inquiry": "Referral from specialist: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7502
  },
  {
    "request_id": "AM-REQ-2026-07236",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for iPSC; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7057
  },
  {
    "request_id": "AM-REQ-2026-07237",
    "original_inquiry": "Urgent: Researcher inquiry: cell therapy manufacturing and spinal cord injury transplantation for iPSC; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6865
  },
  {
    "request_id": "AM-REQ-2026-07238",
    "original_inquiry": "海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6132
  },
  {
    "request_id": "AM-REQ-2026-07239",
    "original_inquiry": "Family seeking information: 海外求诊：心肌修复患者，希望评估organoid或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6553
  },
  {
    "request_id": "AM-REQ-2026-07240",
    "original_inquiry": "海外求诊：Neurologist: cell therapy patient, exploring induced pluripotent stem cell and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-07241",
    "original_inquiry": "Urgent: Neurologist: cell therapy patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6667
  },
  {
    "request_id": "AM-REQ-2026-07242",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 类器官移植 manufacturing and spinal cord injury transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8889
  },
  {
    "request_id": "AM-REQ-2026-07243",
    "original_inquiry": "Urgent: Family seeking cell therapy therapy for heart failure; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.884
  },
  {
    "request_id": "AM-REQ-2026-07244",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8685
  },
  {
    "request_id": "AM-REQ-2026-07245",
    "original_inquiry": "Second opinion requested: Consultation: regenerative medicine with spinal cord injury; interested in heart failure or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7203
  },
  {
    "request_id": "AM-REQ-2026-07246",
    "original_inquiry": "Family seeking information: Cardiologist referral: clinical trial with reduced EF; interested in spinal cord injury or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7495
  },
  {
    "request_id": "AM-REQ-2026-07247",
    "original_inquiry": "研究者咨询：海外求诊：iPSC-derived neuron患者，希望评估cardiomyocyte或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6341
  },
  {
    "request_id": "AM-REQ-2026-07248",
    "original_inquiry": "Family seeking information: Cardiologist referral: 帕金森 with reduced EF; interested in organoid or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7715
  },
  {
    "request_id": "AM-REQ-2026-07249",
    "original_inquiry": "Referral from specialist: Family seeking regenerative medicine therapy for Parkinson; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8644
  },
  {
    "request_id": "AM-REQ-2026-07250",
    "original_inquiry": "海外求诊：Patient with advanced 多能干细胞; seeking cell replacement or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8018
  },
  {
    "request_id": "AM-REQ-2026-07251",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5158
  },
  {
    "request_id": "AM-REQ-2026-07252",
    "original_inquiry": "海外求诊：Consultation: regenerative medicine with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8173
  },
  {
    "request_id": "AM-REQ-2026-07253",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 心肌修复 manufacturing and cardiomyocyte transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7105
  },
  {
    "request_id": "AM-REQ-2026-07254",
    "original_inquiry": "研究者咨询：Researcher inquiry: 心肌修复 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7793
  },
  {
    "request_id": "AM-REQ-2026-07255",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in spinal cord injury or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-07256",
    "original_inquiry": "Second opinion requested: Neurologist: 帕金森 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6403
  },
  {
    "request_id": "AM-REQ-2026-07257",
    "original_inquiry": "Referral from specialist: Patient with advanced 心肌修复; seeking Parkinson or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7404
  },
  {
    "request_id": "AM-REQ-2026-07258",
    "original_inquiry": "研究者咨询：患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7605
  },
  {
    "request_id": "AM-REQ-2026-07259",
    "original_inquiry": "Family seeking information: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.88
  },
  {
    "request_id": "AM-REQ-2026-07260",
    "original_inquiry": "Urgent: Consultation: 心肌修复 with spinal cord injury; interested in Parkinson or neural cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7344
  },
  {
    "request_id": "AM-REQ-2026-07261",
    "original_inquiry": "Referral from specialist: Consultation: clinical trial with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5368
  },
  {
    "request_id": "AM-REQ-2026-07262",
    "original_inquiry": "海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6777
  },
  {
    "request_id": "AM-REQ-2026-07263",
    "original_inquiry": "Referral from specialist: Patient with advanced 帕金森; seeking organoid or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6553
  },
  {
    "request_id": "AM-REQ-2026-07264",
    "original_inquiry": "海外求诊：Family seeking cell therapy therapy for organoid; request centers with cardiomyocyte programs. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7985
  },
  {
    "request_id": "AM-REQ-2026-07265",
    "original_inquiry": "Urgent: Consultation: clinical trial with spinal cord injury; interested in spinal cord injury or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5291
  },
  {
    "request_id": "AM-REQ-2026-07266",
    "original_inquiry": "海外求诊：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8311
  },
  {
    "request_id": "AM-REQ-2026-07267",
    "original_inquiry": "Family seeking information: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5479
  },
  {
    "request_id": "AM-REQ-2026-07268",
    "original_inquiry": "Consultation: iPSC-derived neuron with spinal cord injury; interested in iPSC or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5716
  },
  {
    "request_id": "AM-REQ-2026-07269",
    "original_inquiry": "Second opinion requested: Patient with advanced 多能干细胞; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6465
  },
  {
    "request_id": "AM-REQ-2026-07270",
    "original_inquiry": "海外求诊：患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7419
  },
  {
    "request_id": "AM-REQ-2026-07271",
    "original_inquiry": "研究者咨询：海外求诊：iPSC-derived neuron患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5373
  },
  {
    "request_id": "AM-REQ-2026-07272",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5353
  },
  {
    "request_id": "AM-REQ-2026-07273",
    "original_inquiry": "研究者咨询：患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7101
  },
  {
    "request_id": "AM-REQ-2026-07274",
    "original_inquiry": "海外求诊：海外求诊：iPSC-derived neuron患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8099
  },
  {
    "request_id": "AM-REQ-2026-07275",
    "original_inquiry": "Second opinion requested: 海外求诊：帕金森患者，希望评估heart failure或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6012
  },
  {
    "request_id": "AM-REQ-2026-07276",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8375
  },
  {
    "request_id": "AM-REQ-2026-07277",
    "original_inquiry": "研究者咨询：Consultation: iPSC-derived neuron with spinal cord injury; interested in induced pluripotent stem cell or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-07278",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7185
  },
  {
    "request_id": "AM-REQ-2026-07279",
    "original_inquiry": "Second opinion requested: 海外求诊：干细胞分化患者，希望评估cardiomyocyte或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5732
  },
  {
    "request_id": "AM-REQ-2026-07280",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7328
  },
  {
    "request_id": "AM-REQ-2026-07281",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for cardiomyocyte; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5843
  },
  {
    "request_id": "AM-REQ-2026-07282",
    "original_inquiry": "海外求诊：Neurologist: 干细胞分化 patient, exploring induced pluripotent stem cell and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8343
  },
  {
    "request_id": "AM-REQ-2026-07283",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7133
  },
  {
    "request_id": "AM-REQ-2026-07284",
    "original_inquiry": "Second opinion requested: Neurologist: 干细胞分化 patient, exploring iPSC and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-07285",
    "original_inquiry": "Family seeking information: Cardiologist referral: regenerative medicine with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6616
  },
  {
    "request_id": "AM-REQ-2026-07286",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for cardiomyocyte; request centers with cell replacement programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7775
  },
  {
    "request_id": "AM-REQ-2026-07287",
    "original_inquiry": "Family seeking 多能干细胞 therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8794
  },
  {
    "request_id": "AM-REQ-2026-07288",
    "original_inquiry": "Urgent: Consultation: regenerative medicine with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-07289",
    "original_inquiry": "患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5925
  },
  {
    "request_id": "AM-REQ-2026-07290",
    "original_inquiry": "Neurologist: regenerative medicine patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7614
  },
  {
    "request_id": "AM-REQ-2026-07291",
    "original_inquiry": "Family seeking regenerative medicine therapy for dopaminergic neuron; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7249
  },
  {
    "request_id": "AM-REQ-2026-07292",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for cardiomyocyte; request centers with iPSC programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6253
  },
  {
    "request_id": "AM-REQ-2026-07293",
    "original_inquiry": "Family seeking information: Neurologist: cell therapy patient, exploring Parkinson and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6786
  },
  {
    "request_id": "AM-REQ-2026-07294",
    "original_inquiry": "海外求诊：Researcher inquiry: 心肌修复 manufacturing and dopaminergic neuron transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6859
  },
  {
    "request_id": "AM-REQ-2026-07295",
    "original_inquiry": "Referral from specialist: Neurologist: 干细胞分化 patient, exploring cardiomyocyte and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8779
  },
  {
    "request_id": "AM-REQ-2026-07296",
    "original_inquiry": "Referral from specialist: Neurologist: 类器官移植 patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7388
  },
  {
    "request_id": "AM-REQ-2026-07297",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8916
  },
  {
    "request_id": "AM-REQ-2026-07298",
    "original_inquiry": "研究者咨询：Researcher inquiry: 帕金森 manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.801
  },
  {
    "request_id": "AM-REQ-2026-07299",
    "original_inquiry": "Referral from specialist: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6169
  },
  {
    "request_id": "AM-REQ-2026-07300",
    "original_inquiry": "Family seeking information: Patient with advanced cell therapy; seeking spinal cord injury or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7725
  },
  {
    "request_id": "AM-REQ-2026-07301",
    "original_inquiry": "海外求诊：Family seeking 多能干细胞 therapy for dopaminergic neuron; request centers with induced pluripotent stem cell programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-07302",
    "original_inquiry": "Family seeking information: Researcher inquiry: clinical trial manufacturing and iPSC transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5445
  },
  {
    "request_id": "AM-REQ-2026-07303",
    "original_inquiry": "Consultation: 多能干细胞 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5052
  },
  {
    "request_id": "AM-REQ-2026-07304",
    "original_inquiry": "海外求诊：Neurologist: 多能干细胞 patient, exploring heart failure and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.719
  },
  {
    "request_id": "AM-REQ-2026-07305",
    "original_inquiry": "海外求诊：海外求诊：类器官移植患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.895
  },
  {
    "request_id": "AM-REQ-2026-07306",
    "original_inquiry": "海外求诊：Family seeking iPSC-derived neuron therapy for cardiomyocyte; request centers with iPSC programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6075
  },
  {
    "request_id": "AM-REQ-2026-07307",
    "original_inquiry": "Family seeking information: Family seeking regenerative medicine therapy for iPSC; request centers with cardiomyocyte programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7611
  },
  {
    "request_id": "AM-REQ-2026-07308",
    "original_inquiry": "Family seeking information: 海外求诊：心肌修复患者，希望评估cell replacement或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6645
  },
  {
    "request_id": "AM-REQ-2026-07309",
    "original_inquiry": "Family seeking information: Cardiologist referral: cell therapy with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.662
  },
  {
    "request_id": "AM-REQ-2026-07310",
    "original_inquiry": "研究者咨询：Family seeking iPSC-derived neuron therapy for iPSC; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.536
  },
  {
    "request_id": "AM-REQ-2026-07311",
    "original_inquiry": "海外求诊：Neurologist: iPSC-derived neuron patient, exploring cell replacement and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8285
  },
  {
    "request_id": "AM-REQ-2026-07312",
    "original_inquiry": "Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6061
  },
  {
    "request_id": "AM-REQ-2026-07313",
    "original_inquiry": "患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7776
  },
  {
    "request_id": "AM-REQ-2026-07314",
    "original_inquiry": "Second opinion requested: Family seeking 帕金森 therapy for spinal cord injury; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6802
  },
  {
    "request_id": "AM-REQ-2026-07315",
    "original_inquiry": "Second opinion requested: 海外求诊：帕金森患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5271
  },
  {
    "request_id": "AM-REQ-2026-07316",
    "original_inquiry": "Urgent: Consultation: 干细胞分化 with spinal cord injury; interested in cell replacement or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6153
  },
  {
    "request_id": "AM-REQ-2026-07317",
    "original_inquiry": "Family seeking information: Neurologist: 多能干细胞 patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5393
  },
  {
    "request_id": "AM-REQ-2026-07318",
    "original_inquiry": "Referral from specialist: Neurologist: 心肌修复 patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6072
  },
  {
    "request_id": "AM-REQ-2026-07319",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and Parkinson transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7117
  },
  {
    "request_id": "AM-REQ-2026-07320",
    "original_inquiry": "Second opinion requested: Cardiologist referral: iPSC-derived neuron with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8223
  },
  {
    "request_id": "AM-REQ-2026-07321",
    "original_inquiry": "海外求诊：Family seeking iPSC-derived neuron therapy for spinal cord injury; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7654
  },
  {
    "request_id": "AM-REQ-2026-07322",
    "original_inquiry": "Referral from specialist: Consultation: clinical trial with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6534
  },
  {
    "request_id": "AM-REQ-2026-07323",
    "original_inquiry": "Urgent: Family seeking 干细胞分化 therapy for induced pluripotent stem cell; request centers with iPSC programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8641
  },
  {
    "request_id": "AM-REQ-2026-07324",
    "original_inquiry": "海外求诊：Consultation: 心肌修复 with spinal cord injury; interested in organoid or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5562
  },
  {
    "request_id": "AM-REQ-2026-07325",
    "original_inquiry": "Referral from specialist: Cardiologist referral: clinical trial with reduced EF; interested in cell replacement or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7966
  },
  {
    "request_id": "AM-REQ-2026-07326",
    "original_inquiry": "Urgent: Cardiologist referral: clinical trial with reduced EF; interested in iPSC or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8392
  },
  {
    "request_id": "AM-REQ-2026-07327",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7475
  },
  {
    "request_id": "AM-REQ-2026-07328",
    "original_inquiry": "Referral from specialist: 海外求诊：帕金森患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7122
  },
  {
    "request_id": "AM-REQ-2026-07329",
    "original_inquiry": "Referral from specialist: 患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.681
  },
  {
    "request_id": "AM-REQ-2026-07330",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 帕金森 with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8161
  },
  {
    "request_id": "AM-REQ-2026-07331",
    "original_inquiry": "海外求诊：患者主诉：心肌修复晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8769
  },
  {
    "request_id": "AM-REQ-2026-07332",
    "original_inquiry": "Family seeking information: Family seeking 类器官移植 therapy for heart failure; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6388
  },
  {
    "request_id": "AM-REQ-2026-07333",
    "original_inquiry": "Urgent: Researcher inquiry: clinical trial manufacturing and organoid transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6185
  },
  {
    "request_id": "AM-REQ-2026-07334",
    "original_inquiry": "Family seeking information: Patient with advanced cell therapy; seeking Parkinson or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8698
  },
  {
    "request_id": "AM-REQ-2026-07335",
    "original_inquiry": "Referral from specialist: Researcher inquiry: cell therapy manufacturing and Parkinson transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6377
  },
  {
    "request_id": "AM-REQ-2026-07336",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.894
  },
  {
    "request_id": "AM-REQ-2026-07337",
    "original_inquiry": "Urgent: Neurologist: 多能干细胞 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8174
  },
  {
    "request_id": "AM-REQ-2026-07338",
    "original_inquiry": "Second opinion requested: Researcher inquiry: regenerative medicine manufacturing and dopaminergic neuron transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7614
  },
  {
    "request_id": "AM-REQ-2026-07339",
    "original_inquiry": "Family seeking information: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.852
  },
  {
    "request_id": "AM-REQ-2026-07340",
    "original_inquiry": "Urgent: 海外求诊：clinical trial患者，希望评估heart failure或类器官相关临床研究入组。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.685
  },
  {
    "request_id": "AM-REQ-2026-07341",
    "original_inquiry": "Second opinion requested: Family seeking 多能干细胞 therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5343
  },
  {
    "request_id": "AM-REQ-2026-07342",
    "original_inquiry": "Family seeking cell therapy therapy for iPSC; request centers with cell replacement programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8999
  },
  {
    "request_id": "AM-REQ-2026-07343",
    "original_inquiry": "海外求诊：Researcher inquiry: 干细胞分化 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5903
  },
  {
    "request_id": "AM-REQ-2026-07344",
    "original_inquiry": "海外求诊：Researcher inquiry: regenerative medicine manufacturing and spinal cord injury transplantation for organoid; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6611
  },
  {
    "request_id": "AM-REQ-2026-07345",
    "original_inquiry": "Patient with advanced regenerative medicine; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8273
  },
  {
    "request_id": "AM-REQ-2026-07346",
    "original_inquiry": "海外求诊：海外求诊：类器官移植患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7842
  },
  {
    "request_id": "AM-REQ-2026-07347",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5717
  },
  {
    "request_id": "AM-REQ-2026-07348",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7181
  },
  {
    "request_id": "AM-REQ-2026-07349",
    "original_inquiry": "Family seeking information: Neurologist: iPSC-derived neuron patient, exploring heart failure and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.768
  },
  {
    "request_id": "AM-REQ-2026-07350",
    "original_inquiry": "研究者咨询：患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5176
  },
  {
    "request_id": "AM-REQ-2026-07351",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and heart failure transplantation for induced pluripotent stem cell; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5067
  },
  {
    "request_id": "AM-REQ-2026-07352",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and iPSC transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7856
  },
  {
    "request_id": "AM-REQ-2026-07353",
    "original_inquiry": "Family seeking information: Consultation: 干细胞分化 with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8954
  },
  {
    "request_id": "AM-REQ-2026-07354",
    "original_inquiry": "海外求诊：Patient with advanced 类器官移植; seeking induced pluripotent stem cell or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7929
  },
  {
    "request_id": "AM-REQ-2026-07355",
    "original_inquiry": "Urgent: Family seeking 心肌修复 therapy for cardiomyocyte; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5018
  },
  {
    "request_id": "AM-REQ-2026-07356",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and induced pluripotent stem cell transplantation for cell replacement; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6434
  },
  {
    "request_id": "AM-REQ-2026-07357",
    "original_inquiry": "研究者咨询：Consultation: 类器官移植 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-07358",
    "original_inquiry": "Urgent: Cardiologist referral: 多能干细胞 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8254
  },
  {
    "request_id": "AM-REQ-2026-07359",
    "original_inquiry": "研究者咨询：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6975
  },
  {
    "request_id": "AM-REQ-2026-07360",
    "original_inquiry": "Second opinion requested: 海外求诊：clinical trial患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-07361",
    "original_inquiry": "Family seeking information: Consultation: 心肌修复 with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7005
  },
  {
    "request_id": "AM-REQ-2026-07362",
    "original_inquiry": "海外求诊：多能干细胞患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7857
  },
  {
    "request_id": "AM-REQ-2026-07363",
    "original_inquiry": "Family seeking information: Neurologist: 心肌修复 patient, exploring cell replacement and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8224
  },
  {
    "request_id": "AM-REQ-2026-07364",
    "original_inquiry": "研究者咨询：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5102
  },
  {
    "request_id": "AM-REQ-2026-07365",
    "original_inquiry": "Second opinion requested: 海外求诊：帕金森患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6304
  },
  {
    "request_id": "AM-REQ-2026-07366",
    "original_inquiry": "Family seeking clinical trial therapy for iPSC; request centers with induced pluripotent stem cell programs. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8154
  },
  {
    "request_id": "AM-REQ-2026-07367",
    "original_inquiry": "Family seeking information: Family seeking regenerative medicine therapy for induced pluripotent stem cell; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.883
  },
  {
    "request_id": "AM-REQ-2026-07368",
    "original_inquiry": "Family seeking information: 海外求诊：多能干细胞患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7703
  },
  {
    "request_id": "AM-REQ-2026-07369",
    "original_inquiry": "研究者咨询：Researcher inquiry: 帕金森 manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8108
  },
  {
    "request_id": "AM-REQ-2026-07370",
    "original_inquiry": "研究者咨询：Patient with advanced 类器官移植; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5759
  },
  {
    "request_id": "AM-REQ-2026-07371",
    "original_inquiry": "Second opinion requested: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.796
  },
  {
    "request_id": "AM-REQ-2026-07372",
    "original_inquiry": "Referral from specialist: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5981
  },
  {
    "request_id": "AM-REQ-2026-07373",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-07374",
    "original_inquiry": "Urgent: Cardiologist referral: regenerative medicine with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5335
  },
  {
    "request_id": "AM-REQ-2026-07375",
    "original_inquiry": "Second opinion requested: Patient with advanced 类器官移植; seeking cardiomyocyte or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5302
  },
  {
    "request_id": "AM-REQ-2026-07376",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8477
  },
  {
    "request_id": "AM-REQ-2026-07377",
    "original_inquiry": "Urgent: Patient with advanced clinical trial; seeking organoid or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7625
  },
  {
    "request_id": "AM-REQ-2026-07378",
    "original_inquiry": "研究者咨询：海外求诊：clinical trial患者，希望评估iPSC或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6066
  },
  {
    "request_id": "AM-REQ-2026-07379",
    "original_inquiry": "Referral from specialist: Neurologist: cell therapy patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5443
  },
  {
    "request_id": "AM-REQ-2026-07380",
    "original_inquiry": "Family seeking information: Cardiologist referral: regenerative medicine with reduced EF; interested in iPSC or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5042
  },
  {
    "request_id": "AM-REQ-2026-07381",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5279
  },
  {
    "request_id": "AM-REQ-2026-07382",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 心肌修复 with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7356
  },
  {
    "request_id": "AM-REQ-2026-07383",
    "original_inquiry": "Family seeking information: Family seeking regenerative medicine therapy for dopaminergic neuron; request centers with cardiomyocyte programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5133
  },
  {
    "request_id": "AM-REQ-2026-07384",
    "original_inquiry": "Researcher inquiry: 多能干细胞 manufacturing and organoid transplantation for cell replacement; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-07385",
    "original_inquiry": "海外求诊：海外求诊：regenerative medicine患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5192
  },
  {
    "request_id": "AM-REQ-2026-07386",
    "original_inquiry": "Urgent: 海外求诊：regenerative medicine患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6223
  },
  {
    "request_id": "AM-REQ-2026-07387",
    "original_inquiry": "研究者咨询：Patient with advanced 干细胞分化; seeking cardiomyocyte or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.538
  },
  {
    "request_id": "AM-REQ-2026-07388",
    "original_inquiry": "Family seeking information: Neurologist: 帕金森 patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8058
  },
  {
    "request_id": "AM-REQ-2026-07389",
    "original_inquiry": "Urgent: Patient with advanced 干细胞分化; seeking organoid or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8529
  },
  {
    "request_id": "AM-REQ-2026-07390",
    "original_inquiry": "研究者咨询：Cardiologist referral: 干细胞分化 with reduced EF; interested in Parkinson or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.659
  },
  {
    "request_id": "AM-REQ-2026-07391",
    "original_inquiry": "海外求诊：患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8328
  },
  {
    "request_id": "AM-REQ-2026-07392",
    "original_inquiry": "Second opinion requested: 海外求诊：多能干细胞患者，希望评估Parkinson或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5647
  },
  {
    "request_id": "AM-REQ-2026-07393",
    "original_inquiry": "研究者咨询：Neurologist: 帕金森 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6716
  },
  {
    "request_id": "AM-REQ-2026-07394",
    "original_inquiry": "研究者咨询：Cardiologist referral: 帕金森 with reduced EF; interested in cell replacement or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8981
  },
  {
    "request_id": "AM-REQ-2026-07395",
    "original_inquiry": "Second opinion requested: Researcher inquiry: regenerative medicine manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6618
  },
  {
    "request_id": "AM-REQ-2026-07396",
    "original_inquiry": "Second opinion requested: Family seeking 多能干细胞 therapy for spinal cord injury; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8866
  },
  {
    "request_id": "AM-REQ-2026-07397",
    "original_inquiry": "研究者咨询：Consultation: 类器官移植 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5897
  },
  {
    "request_id": "AM-REQ-2026-07398",
    "original_inquiry": "研究者咨询：Patient with advanced 类器官移植; seeking heart failure or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5589
  },
  {
    "request_id": "AM-REQ-2026-07399",
    "original_inquiry": "研究者咨询：Researcher inquiry: 帕金森 manufacturing and heart failure transplantation for dopaminergic neuron; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7656
  },
  {
    "request_id": "AM-REQ-2026-07400",
    "original_inquiry": "Family seeking information: Family seeking regenerative medicine therapy for iPSC; request centers with cardiomyocyte programs.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6123
  },
  {
    "request_id": "AM-REQ-2026-07401",
    "original_inquiry": "Family seeking information: Cardiologist referral: 多能干细胞 with reduced EF; interested in organoid or cardiac cell therapy.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6563
  },
  {
    "request_id": "AM-REQ-2026-07402",
    "original_inquiry": "海外求诊：Researcher inquiry: 心肌修复 manufacturing and dopaminergic neuron transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6665
  },
  {
    "request_id": "AM-REQ-2026-07403",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5849
  },
  {
    "request_id": "AM-REQ-2026-07404",
    "original_inquiry": "Referral from specialist: Family seeking clinical trial therapy for organoid; request centers with cardiomyocyte programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5303
  },
  {
    "request_id": "AM-REQ-2026-07405",
    "original_inquiry": "海外求诊：Consultation: 帕金森 with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8314
  },
  {
    "request_id": "AM-REQ-2026-07406",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for dopaminergic neuron; request centers with cardiomyocyte programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5509
  },
  {
    "request_id": "AM-REQ-2026-07407",
    "original_inquiry": "Cardiologist referral: 帕金森 with reduced EF; interested in heart failure or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8546
  },
  {
    "request_id": "AM-REQ-2026-07408",
    "original_inquiry": "Neurologist: 干细胞分化 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-07409",
    "original_inquiry": "Family seeking information: Researcher inquiry: clinical trial manufacturing and iPSC transplantation for induced pluripotent stem cell; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5574
  },
  {
    "request_id": "AM-REQ-2026-07410",
    "original_inquiry": "研究者咨询：Patient with advanced iPSC-derived neuron; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7248
  },
  {
    "request_id": "AM-REQ-2026-07411",
    "original_inquiry": "研究者咨询：Cardiologist referral: clinical trial with reduced EF; interested in cardiomyocyte or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7629
  },
  {
    "request_id": "AM-REQ-2026-07412",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6313
  },
  {
    "request_id": "AM-REQ-2026-07413",
    "original_inquiry": "Cardiologist referral: iPSC-derived neuron with reduced EF; interested in iPSC or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7613
  },
  {
    "request_id": "AM-REQ-2026-07414",
    "original_inquiry": "Referral from specialist: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7716
  },
  {
    "request_id": "AM-REQ-2026-07415",
    "original_inquiry": "Referral from specialist: Cardiologist referral: regenerative medicine with reduced EF; interested in spinal cord injury or cardiac cell therapy.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.753
  },
  {
    "request_id": "AM-REQ-2026-07416",
    "original_inquiry": "研究者咨询：Cardiologist referral: iPSC-derived neuron with reduced EF; interested in spinal cord injury or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7951
  },
  {
    "request_id": "AM-REQ-2026-07417",
    "original_inquiry": "Referral from specialist: Neurologist: cell therapy patient, exploring spinal cord injury and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5753
  },
  {
    "request_id": "AM-REQ-2026-07418",
    "original_inquiry": "Urgent: Patient with advanced cell therapy; seeking cell replacement or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6969
  },
  {
    "request_id": "AM-REQ-2026-07419",
    "original_inquiry": "Neurologist: iPSC-derived neuron patient, exploring iPSC and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8219
  },
  {
    "request_id": "AM-REQ-2026-07420",
    "original_inquiry": "Family seeking information: Researcher inquiry: 类器官移植 manufacturing and organoid transplantation for induced pluripotent stem cell; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.522
  },
  {
    "request_id": "AM-REQ-2026-07421",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in cardiomyocyte or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7752
  },
  {
    "request_id": "AM-REQ-2026-07422",
    "original_inquiry": "Urgent: Patient with advanced 多能干细胞; seeking dopaminergic neuron or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5472
  },
  {
    "request_id": "AM-REQ-2026-07423",
    "original_inquiry": "Neurologist: cell therapy patient, exploring dopaminergic neuron and DBS; want frontier trial options.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5178
  },
  {
    "request_id": "AM-REQ-2026-07424",
    "original_inquiry": "海外求诊：Cardiologist referral: regenerative medicine with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.707
  },
  {
    "request_id": "AM-REQ-2026-07425",
    "original_inquiry": "Referral from specialist: Researcher inquiry: iPSC-derived neuron manufacturing and cell replacement transplantation for cardiomyocyte; GMP requirements. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8193
  },
  {
    "request_id": "AM-REQ-2026-07426",
    "original_inquiry": "Second opinion requested: Patient with advanced 心肌修复; seeking spinal cord injury or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-07427",
    "original_inquiry": "Second opinion requested: Researcher inquiry: iPSC-derived neuron manufacturing and Parkinson transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8372
  },
  {
    "request_id": "AM-REQ-2026-07428",
    "original_inquiry": "Family seeking information: Neurologist: 类器官移植 patient, exploring cardiomyocyte and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5545
  },
  {
    "request_id": "AM-REQ-2026-07429",
    "original_inquiry": "Second opinion requested: Family seeking 类器官移植 therapy for dopaminergic neuron; request centers with organoid programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6449
  },
  {
    "request_id": "AM-REQ-2026-07430",
    "original_inquiry": "研究者咨询：Researcher inquiry: cell therapy manufacturing and cell replacement transplantation for dopaminergic neuron; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.768
  },
  {
    "request_id": "AM-REQ-2026-07431",
    "original_inquiry": "海外求诊：Neurologist: clinical trial patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6732
  },
  {
    "request_id": "AM-REQ-2026-07432",
    "original_inquiry": "Urgent: 患者主诉：clinical trial晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6576
  },
  {
    "request_id": "AM-REQ-2026-07433",
    "original_inquiry": "Referral from specialist: 患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8877
  },
  {
    "request_id": "AM-REQ-2026-07434",
    "original_inquiry": "海外求诊：海外求诊：干细胞分化患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-07435",
    "original_inquiry": "Referral from specialist: Family seeking 心肌修复 therapy for spinal cord injury; request centers with dopaminergic neuron programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6586
  },
  {
    "request_id": "AM-REQ-2026-07436",
    "original_inquiry": "Urgent: Neurologist: 心肌修复 patient, exploring cardiomyocyte and DBS; want frontier trial options. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8276
  },
  {
    "request_id": "AM-REQ-2026-07437",
    "original_inquiry": "患者主诉：类器官移植晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7463
  },
  {
    "request_id": "AM-REQ-2026-07438",
    "original_inquiry": "海外求诊：Patient with advanced 类器官移植; seeking iPSC or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6339
  },
  {
    "request_id": "AM-REQ-2026-07439",
    "original_inquiry": "研究者咨询：Neurologist: iPSC-derived neuron patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8913
  },
  {
    "request_id": "AM-REQ-2026-07440",
    "original_inquiry": "研究者咨询：患者主诉：cell therapy晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8799
  },
  {
    "request_id": "AM-REQ-2026-07441",
    "original_inquiry": "Referral from specialist: Consultation: 干细胞分化 with spinal cord injury; interested in dopaminergic neuron or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-07442",
    "original_inquiry": "Urgent: 患者主诉：regenerative medicine晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6269
  },
  {
    "request_id": "AM-REQ-2026-07443",
    "original_inquiry": "Family seeking information: Patient with advanced iPSC-derived neuron; seeking iPSC or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8135
  },
  {
    "request_id": "AM-REQ-2026-07444",
    "original_inquiry": "Family seeking 干细胞分化 therapy for cardiomyocyte; request centers with cell replacement programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7554
  },
  {
    "request_id": "AM-REQ-2026-07445",
    "original_inquiry": "海外求诊：海外求诊：类器官移植患者，希望评估dopaminergic neuron或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6817
  },
  {
    "request_id": "AM-REQ-2026-07446",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 干细胞分化 with reduced EF; interested in cell replacement or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6678
  },
  {
    "request_id": "AM-REQ-2026-07447",
    "original_inquiry": "研究者咨询：患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7524
  },
  {
    "request_id": "AM-REQ-2026-07448",
    "original_inquiry": "Urgent: Neurologist: regenerative medicine patient, exploring heart failure and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7543
  },
  {
    "request_id": "AM-REQ-2026-07449",
    "original_inquiry": "海外求诊：Researcher inquiry: iPSC-derived neuron manufacturing and spinal cord injury transplantation for organoid; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8868
  },
  {
    "request_id": "AM-REQ-2026-07450",
    "original_inquiry": "Second opinion requested: Cardiologist referral: clinical trial with reduced EF; interested in Parkinson or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6768
  },
  {
    "request_id": "AM-REQ-2026-07451",
    "original_inquiry": "Second opinion requested: 患者主诉：多能干细胞晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7984
  },
  {
    "request_id": "AM-REQ-2026-07452",
    "original_inquiry": "Urgent: Researcher inquiry: 多能干细胞 manufacturing and induced pluripotent stem cell transplantation for cardiomyocyte; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8664
  },
  {
    "request_id": "AM-REQ-2026-07453",
    "original_inquiry": "Family seeking information: Neurologist: 干细胞分化 patient, exploring spinal cord injury and DBS; want frontier trial options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6791
  },
  {
    "request_id": "AM-REQ-2026-07454",
    "original_inquiry": "研究者咨询：Researcher inquiry: clinical trial manufacturing and cardiomyocyte transplantation for iPSC; GMP requirements.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.595
  },
  {
    "request_id": "AM-REQ-2026-07455",
    "original_inquiry": "研究者咨询：Patient with advanced clinical trial; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5454
  },
  {
    "request_id": "AM-REQ-2026-07456",
    "original_inquiry": "研究者咨询：Consultation: regenerative medicine with spinal cord injury; interested in cell replacement or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8547
  },
  {
    "request_id": "AM-REQ-2026-07457",
    "original_inquiry": "Consultation: 心肌修复 with spinal cord injury; interested in cardiomyocyte or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7864
  },
  {
    "request_id": "AM-REQ-2026-07458",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 心肌修复 with reduced EF; interested in heart failure or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5306
  },
  {
    "request_id": "AM-REQ-2026-07459",
    "original_inquiry": "海外求诊：Cardiologist referral: 类器官移植 with reduced EF; interested in cell replacement or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8479
  },
  {
    "request_id": "AM-REQ-2026-07460",
    "original_inquiry": "海外求诊：海外求诊：clinical trial患者，希望评估cardiomyocyte或类器官相关临床研究入组。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8489
  },
  {
    "request_id": "AM-REQ-2026-07461",
    "original_inquiry": "研究者咨询：海外求诊：干细胞分化患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6127
  },
  {
    "request_id": "AM-REQ-2026-07462",
    "original_inquiry": "Urgent: Neurologist: 类器官移植 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5377
  },
  {
    "request_id": "AM-REQ-2026-07463",
    "original_inquiry": "研究者咨询：Family seeking 心肌修复 therapy for cell replacement; request centers with induced pluripotent stem cell programs.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.829
  },
  {
    "request_id": "AM-REQ-2026-07464",
    "original_inquiry": "Referral from specialist: 患者主诉：iPSC-derived neuron晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7604
  },
  {
    "request_id": "AM-REQ-2026-07465",
    "original_inquiry": "海外求诊：Patient with advanced 干细胞分化; seeking cardiomyocyte or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8643
  },
  {
    "request_id": "AM-REQ-2026-07466",
    "original_inquiry": "Urgent: 患者主诉：帕金森晚期，寻求iPSC/干细胞治疗方案及国际多中心试验信息。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7529
  },
  {
    "request_id": "AM-REQ-2026-07467",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring cell replacement and DBS; want frontier trial options.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.822
  },
  {
    "request_id": "AM-REQ-2026-07468",
    "original_inquiry": "Referral from specialist: 海外求诊：cell therapy患者，希望评估heart failure或类器官相关临床研究入组。 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8548
  },
  {
    "request_id": "AM-REQ-2026-07469",
    "original_inquiry": "Second opinion requested: Consultation: 多能干细胞 with spinal cord injury; interested in Parkinson or neural cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8328
  },
  {
    "request_id": "AM-REQ-2026-07470",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in iPSC or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8382
  },
  {
    "request_id": "AM-REQ-2026-07471",
    "original_inquiry": "Second opinion requested: Consultation: clinical trial with spinal cord injury; interested in heart failure or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8684
  },
  {
    "request_id": "AM-REQ-2026-07472",
    "original_inquiry": "Second opinion requested: Cardiologist referral: clinical trial with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6107
  },
  {
    "request_id": "AM-REQ-2026-07473",
    "original_inquiry": "Consultation: 心肌修复 with spinal cord injury; interested in Parkinson or neural cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7957
  },
  {
    "request_id": "AM-REQ-2026-07474",
    "original_inquiry": "Urgent: Neurologist: 帕金森 patient, exploring iPSC and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5332
  },
  {
    "request_id": "AM-REQ-2026-07475",
    "original_inquiry": "Urgent: Neurologist: clinical trial patient, exploring Parkinson and DBS; want frontier trial options.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8651
  },
  {
    "request_id": "AM-REQ-2026-07476",
    "original_inquiry": "Referral from specialist: Family seeking clinical trial therapy for Parkinson; request centers with dopaminergic neuron programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7585
  },
  {
    "request_id": "AM-REQ-2026-07477",
    "original_inquiry": "海外求诊：Patient with advanced regenerative medicine; seeking cell replacement or iPSC-derived neuron replacement trials.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8341
  },
  {
    "request_id": "AM-REQ-2026-07478",
    "original_inquiry": "Referral from specialist: Cardiologist referral: 干细胞分化 with reduced EF; interested in dopaminergic neuron or cardiac cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8763
  },
  {
    "request_id": "AM-REQ-2026-07479",
    "original_inquiry": "研究者咨询：Researcher inquiry: 多能干细胞 manufacturing and cell replacement transplantation for iPSC; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8119
  },
  {
    "request_id": "AM-REQ-2026-07480",
    "original_inquiry": "研究者咨询：Family seeking 类器官移植 therapy for cell replacement; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7788
  },
  {
    "request_id": "AM-REQ-2026-07481",
    "original_inquiry": "Referral from specialist: Consultation: regenerative medicine with spinal cord injury; interested in cell replacement or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.788
  },
  {
    "request_id": "AM-REQ-2026-07482",
    "original_inquiry": "海外求诊：Researcher inquiry: 多能干细胞 manufacturing and heart failure transplantation for dopaminergic neuron; GMP requirements. Please advise on next steps.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5133
  },
  {
    "request_id": "AM-REQ-2026-07483",
    "original_inquiry": "海外求诊：Researcher inquiry: 帕金森 manufacturing and organoid transplantation for dopaminergic neuron; GMP requirements.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8577
  },
  {
    "request_id": "AM-REQ-2026-07484",
    "original_inquiry": "Family seeking information: Cardiologist referral: 干细胞分化 with reduced EF; interested in iPSC or cardiac cell therapy. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.846
  },
  {
    "request_id": "AM-REQ-2026-07485",
    "original_inquiry": "Referral from specialist: Consultation: iPSC-derived neuron with spinal cord injury; interested in Parkinson or neural cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-07486",
    "original_inquiry": "Patient with advanced 类器官移植; seeking heart failure or iPSC-derived neuron replacement trials. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.669
  },
  {
    "request_id": "AM-REQ-2026-07487",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 多能干细胞 manufacturing and spinal cord injury transplantation for cardiomyocyte; GMP requirements.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7316
  },
  {
    "request_id": "AM-REQ-2026-07488",
    "original_inquiry": "Urgent: Family seeking regenerative medicine therapy for cardiomyocyte; request centers with organoid programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7976
  },
  {
    "request_id": "AM-REQ-2026-07489",
    "original_inquiry": "海外求诊：多能干细胞患者，希望评估induced pluripotent stem cell或类器官相关临床研究入组。 Please advise on next steps.",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5593
  },
  {
    "request_id": "AM-REQ-2026-07490",
    "original_inquiry": "海外求诊：Patient with advanced 心肌修复; seeking iPSC or iPSC-derived neuron replacement trials. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7034
  },
  {
    "request_id": "AM-REQ-2026-07491",
    "original_inquiry": "海外求诊：Researcher inquiry: 干细胞分化 manufacturing and cardiomyocyte transplantation for cell replacement; GMP requirements. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7514
  },
  {
    "request_id": "AM-REQ-2026-07492",
    "original_inquiry": "Second opinion requested: Cardiologist referral: 类器官移植 with reduced EF; interested in induced pluripotent stem cell or cardiac cell therapy. 希望了解入组标准与中心列表。",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7223
  },
  {
    "request_id": "AM-REQ-2026-07493",
    "original_inquiry": "Second opinion requested: Patient with advanced 类器官移植; seeking spinal cord injury or iPSC-derived neuron replacement trials. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5877
  },
  {
    "request_id": "AM-REQ-2026-07494",
    "original_inquiry": "Urgent: Neurologist: 干细胞分化 patient, exploring dopaminergic neuron and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7634
  },
  {
    "request_id": "AM-REQ-2026-07495",
    "original_inquiry": "研究者咨询：Cardiologist referral: cell therapy with reduced EF; interested in dopaminergic neuron or cardiac cell therapy. Please advise on next steps.",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.8415
  },
  {
    "request_id": "AM-REQ-2026-07496",
    "original_inquiry": "研究者咨询：Researcher inquiry: regenerative medicine manufacturing and dopaminergic neuron transplantation for cardiomyocyte; GMP requirements. 希望了解入组标准与中心列表。",
    "standard_mapping": "Pluripotent stem cell; differentiated cell transplant",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.7835
  },
  {
    "request_id": "AM-REQ-2026-07497",
    "original_inquiry": "Referral from specialist: Consultation: clinical trial with spinal cord injury; interested in iPSC or neural cell therapy.",
    "standard_mapping": "Organoid or cell-based therapy; clinical trial",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.5895
  },
  {
    "request_id": "AM-REQ-2026-07498",
    "original_inquiry": "Second opinion requested: Neurologist: regenerative medicine patient, exploring cardiomyocyte and DBS; want frontier trial options. 希望了解入组标准与中心列表。",
    "standard_mapping": "iPSC-derived cell therapy; Parkinson or cardiac or neural",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6289
  },
  {
    "request_id": "AM-REQ-2026-07499",
    "original_inquiry": "Referral from specialist: 海外求诊：regenerative medicine患者，希望评估heart failure或类器官相关临床研究入组。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Stem cell / regenerative medicine; cell replacement",
    "asset_category": "Stem_Cell",
    "l1_entropy_target": 0.6883
  },
  {
    "request_id": "AM-REQ-2026-07500",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (immune checkpoint); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5117
  },
  {
    "request_id": "AM-REQ-2026-07501",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7394
  },
  {
    "request_id": "AM-REQ-2026-07502",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced KRAS G12C; request ADC and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7882
  },
  {
    "request_id": "AM-REQ-2026-07503",
    "original_inquiry": "Patient with 双特异性抗体 (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7495
  },
  {
    "request_id": "AM-REQ-2026-07504",
    "original_inquiry": "Second opinion requested: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.872
  },
  {
    "request_id": "AM-REQ-2026-07505",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8491
  },
  {
    "request_id": "AM-REQ-2026-07506",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6452
  },
  {
    "request_id": "AM-REQ-2026-07507",
    "original_inquiry": "海外求诊：Consultation: combination immunotherapy with advanced bispecific antibody; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6057
  },
  {
    "request_id": "AM-REQ-2026-07508",
    "original_inquiry": "Urgent: Oncologist referral: ADC联合治疗 positive; interested in CAR-T inhibitors and ADC combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6974
  },
  {
    "request_id": "AM-REQ-2026-07509",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in bispecific antibody inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6178
  },
  {
    "request_id": "AM-REQ-2026-07510",
    "original_inquiry": "Family seeking information: Oncologist referral: melanoma positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6426
  },
  {
    "request_id": "AM-REQ-2026-07511",
    "original_inquiry": "研究者咨询：Oncologist referral: 个体化疫苗 positive; interested in personalized neoantigen inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-07512",
    "original_inquiry": "Family seeking information: Consultation: Phase II/III with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8023
  },
  {
    "request_id": "AM-REQ-2026-07513",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced bispecific antibody; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5689
  },
  {
    "request_id": "AM-REQ-2026-07514",
    "original_inquiry": "Urgent: Researcher inquiry: NSCLC trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6343
  },
  {
    "request_id": "AM-REQ-2026-07515",
    "original_inquiry": "Second opinion requested: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5772
  },
  {
    "request_id": "AM-REQ-2026-07516",
    "original_inquiry": "Family seeking information: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7814
  },
  {
    "request_id": "AM-REQ-2026-07517",
    "original_inquiry": "Family seeking information: Oncologist referral: ADC联合治疗 positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8267
  },
  {
    "request_id": "AM-REQ-2026-07518",
    "original_inquiry": "Second opinion requested: Consultation: Phase II/III with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6388
  },
  {
    "request_id": "AM-REQ-2026-07519",
    "original_inquiry": "研究者咨询：Researcher inquiry: mRNA vaccine trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6591
  },
  {
    "request_id": "AM-REQ-2026-07520",
    "original_inquiry": "海外求药：Phase II/III患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5069
  },
  {
    "request_id": "AM-REQ-2026-07521",
    "original_inquiry": "Second opinion requested: 海外求药：solid tumor患者，希望参加CAR-T或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5962
  },
  {
    "request_id": "AM-REQ-2026-07522",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7925
  },
  {
    "request_id": "AM-REQ-2026-07523",
    "original_inquiry": "Urgent: Urgent: Phase II/III mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5145
  },
  {
    "request_id": "AM-REQ-2026-07524",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7458
  },
  {
    "request_id": "AM-REQ-2026-07525",
    "original_inquiry": "Family seeking information: Researcher inquiry: 个体化疫苗 trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8772
  },
  {
    "request_id": "AM-REQ-2026-07526",
    "original_inquiry": "Urgent: Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7717
  },
  {
    "request_id": "AM-REQ-2026-07527",
    "original_inquiry": "Family seeking information: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6795
  },
  {
    "request_id": "AM-REQ-2026-07528",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5932
  },
  {
    "request_id": "AM-REQ-2026-07529",
    "original_inquiry": "Urgent: Urgent: ADC联合治疗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6567
  },
  {
    "request_id": "AM-REQ-2026-07530",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8919
  },
  {
    "request_id": "AM-REQ-2026-07531",
    "original_inquiry": "Urgent: 海外求药：ADC联合治疗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6583
  },
  {
    "request_id": "AM-REQ-2026-07532",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5074
  },
  {
    "request_id": "AM-REQ-2026-07533",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6592
  },
  {
    "request_id": "AM-REQ-2026-07534",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in KRAS G12C inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.671
  },
  {
    "request_id": "AM-REQ-2026-07535",
    "original_inquiry": "Urgent: 海外求药：melanoma患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8722
  },
  {
    "request_id": "AM-REQ-2026-07536",
    "original_inquiry": "Second opinion requested: Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6592
  },
  {
    "request_id": "AM-REQ-2026-07537",
    "original_inquiry": "研究者咨询：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-07538",
    "original_inquiry": "Urgent: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5097
  },
  {
    "request_id": "AM-REQ-2026-07539",
    "original_inquiry": "海外求诊：Researcher inquiry: NSCLC trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5539
  },
  {
    "request_id": "AM-REQ-2026-07540",
    "original_inquiry": "Urgent: mRNA vaccine mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7737
  },
  {
    "request_id": "AM-REQ-2026-07541",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5496
  },
  {
    "request_id": "AM-REQ-2026-07542",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8727
  },
  {
    "request_id": "AM-REQ-2026-07543",
    "original_inquiry": "Researcher inquiry: mRNA vaccine trial design and personalized neoantigen with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6495
  },
  {
    "request_id": "AM-REQ-2026-07544",
    "original_inquiry": "研究者咨询：患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6703
  },
  {
    "request_id": "AM-REQ-2026-07545",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7722
  },
  {
    "request_id": "AM-REQ-2026-07546",
    "original_inquiry": "Consultation: 个体化疫苗 with advanced immune checkpoint; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6966
  },
  {
    "request_id": "AM-REQ-2026-07547",
    "original_inquiry": "Second opinion requested: 患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5228
  },
  {
    "request_id": "AM-REQ-2026-07548",
    "original_inquiry": "Second opinion requested: Consultation: 个体化疫苗 with advanced bispecific antibody; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5656
  },
  {
    "request_id": "AM-REQ-2026-07549",
    "original_inquiry": "患者家属咨询：ADC联合治疗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5105
  },
  {
    "request_id": "AM-REQ-2026-07550",
    "original_inquiry": "Referral from specialist: Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7616
  },
  {
    "request_id": "AM-REQ-2026-07551",
    "original_inquiry": "Referral from specialist: Oncologist referral: Phase II/III positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7207
  },
  {
    "request_id": "AM-REQ-2026-07552",
    "original_inquiry": "Family seeking information: Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8904
  },
  {
    "request_id": "AM-REQ-2026-07553",
    "original_inquiry": "研究者咨询：Patient with melanoma (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8078
  },
  {
    "request_id": "AM-REQ-2026-07554",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8953
  },
  {
    "request_id": "AM-REQ-2026-07555",
    "original_inquiry": "研究者咨询：Consultation: NSCLC with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5995
  },
  {
    "request_id": "AM-REQ-2026-07556",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5273
  },
  {
    "request_id": "AM-REQ-2026-07557",
    "original_inquiry": "海外求诊：Oncologist referral: Phase II/III positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7266
  },
  {
    "request_id": "AM-REQ-2026-07558",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.734
  },
  {
    "request_id": "AM-REQ-2026-07559",
    "original_inquiry": "Second opinion requested: Consultation: combination immunotherapy with advanced bispecific antibody; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5186
  },
  {
    "request_id": "AM-REQ-2026-07560",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and antibody-drug conjugate with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7671
  },
  {
    "request_id": "AM-REQ-2026-07561",
    "original_inquiry": "海外求诊：Researcher inquiry: Phase II/III trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8574
  },
  {
    "request_id": "AM-REQ-2026-07562",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in bispecific antibody inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7042
  },
  {
    "request_id": "AM-REQ-2026-07563",
    "original_inquiry": "Urgent: 海外求药：Phase II/III患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7368
  },
  {
    "request_id": "AM-REQ-2026-07564",
    "original_inquiry": "Urgent: 双特异性抗体 mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5959
  },
  {
    "request_id": "AM-REQ-2026-07565",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5082
  },
  {
    "request_id": "AM-REQ-2026-07566",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8469
  },
  {
    "request_id": "AM-REQ-2026-07567",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8668
  },
  {
    "request_id": "AM-REQ-2026-07568",
    "original_inquiry": "Urgent: Consultation: combination immunotherapy with advanced mRNA cancer vaccine; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5573
  },
  {
    "request_id": "AM-REQ-2026-07569",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5919
  },
  {
    "request_id": "AM-REQ-2026-07570",
    "original_inquiry": "Referral from specialist: Researcher inquiry: NSCLC trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8704
  },
  {
    "request_id": "AM-REQ-2026-07571",
    "original_inquiry": "Family seeking information: Oncologist referral: ADC联合治疗 positive; interested in antibody-drug conjugate inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5952
  },
  {
    "request_id": "AM-REQ-2026-07572",
    "original_inquiry": "研究者咨询：Patient with solid tumor (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8825
  },
  {
    "request_id": "AM-REQ-2026-07573",
    "original_inquiry": "Family seeking information: Patient with combination immunotherapy (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8772
  },
  {
    "request_id": "AM-REQ-2026-07574",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8057
  },
  {
    "request_id": "AM-REQ-2026-07575",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5702
  },
  {
    "request_id": "AM-REQ-2026-07576",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8716
  },
  {
    "request_id": "AM-REQ-2026-07577",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-07578",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.731
  },
  {
    "request_id": "AM-REQ-2026-07579",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6348
  },
  {
    "request_id": "AM-REQ-2026-07580",
    "original_inquiry": "Urgent: Patient with Phase II/III (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8144
  },
  {
    "request_id": "AM-REQ-2026-07581",
    "original_inquiry": "海外求诊：Researcher inquiry: melanoma trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6099
  },
  {
    "request_id": "AM-REQ-2026-07582",
    "original_inquiry": "Referral from specialist: Patient with Phase II/III (KRAS G12C); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.885
  },
  {
    "request_id": "AM-REQ-2026-07583",
    "original_inquiry": "研究者咨询：Patient with 个体化疫苗 (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7579
  },
  {
    "request_id": "AM-REQ-2026-07584",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7473
  },
  {
    "request_id": "AM-REQ-2026-07585",
    "original_inquiry": "Second opinion requested: 海外求药：NSCLC患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.791
  },
  {
    "request_id": "AM-REQ-2026-07586",
    "original_inquiry": "研究者咨询：Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8214
  },
  {
    "request_id": "AM-REQ-2026-07587",
    "original_inquiry": "Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6474
  },
  {
    "request_id": "AM-REQ-2026-07588",
    "original_inquiry": "Urgent: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8279
  },
  {
    "request_id": "AM-REQ-2026-07589",
    "original_inquiry": "Second opinion requested: 患者家属咨询：ADC联合治疗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8486
  },
  {
    "request_id": "AM-REQ-2026-07590",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8197
  },
  {
    "request_id": "AM-REQ-2026-07591",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7736
  },
  {
    "request_id": "AM-REQ-2026-07592",
    "original_inquiry": "研究者咨询：Consultation: Phase II/III with advanced personalized neoantigen; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5608
  },
  {
    "request_id": "AM-REQ-2026-07593",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.763
  },
  {
    "request_id": "AM-REQ-2026-07594",
    "original_inquiry": "Urgent: Researcher inquiry: Phase II/III trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-07595",
    "original_inquiry": "Referral from specialist: 患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5918
  },
  {
    "request_id": "AM-REQ-2026-07596",
    "original_inquiry": "Urgent: mRNA vaccine mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7097
  },
  {
    "request_id": "AM-REQ-2026-07597",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.821
  },
  {
    "request_id": "AM-REQ-2026-07598",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7382
  },
  {
    "request_id": "AM-REQ-2026-07599",
    "original_inquiry": "Second opinion requested: Consultation: Phase II/III with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8453
  },
  {
    "request_id": "AM-REQ-2026-07600",
    "original_inquiry": "Family seeking information: Researcher inquiry: NSCLC trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7724
  },
  {
    "request_id": "AM-REQ-2026-07601",
    "original_inquiry": "Family seeking information: Consultation: melanoma with advanced KRAS G12C; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5639
  },
  {
    "request_id": "AM-REQ-2026-07602",
    "original_inquiry": "Referral from specialist: 患者家属咨询：个体化疫苗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8309
  },
  {
    "request_id": "AM-REQ-2026-07603",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6237
  },
  {
    "request_id": "AM-REQ-2026-07604",
    "original_inquiry": "Family seeking information: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5523
  },
  {
    "request_id": "AM-REQ-2026-07605",
    "original_inquiry": "Consultation: 双特异性抗体 with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8229
  },
  {
    "request_id": "AM-REQ-2026-07606",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8248
  },
  {
    "request_id": "AM-REQ-2026-07607",
    "original_inquiry": "Urgent: 患者家属咨询：solid tumor晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7501
  },
  {
    "request_id": "AM-REQ-2026-07608",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-07609",
    "original_inquiry": "Referral from specialist: Consultation: melanoma with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8691
  },
  {
    "request_id": "AM-REQ-2026-07610",
    "original_inquiry": "Family seeking information: Researcher inquiry: mRNA vaccine trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7944
  },
  {
    "request_id": "AM-REQ-2026-07611",
    "original_inquiry": "Referral from specialist: Patient with 个体化疫苗 (CAR-T); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7835
  },
  {
    "request_id": "AM-REQ-2026-07612",
    "original_inquiry": "Urgent: Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7505
  },
  {
    "request_id": "AM-REQ-2026-07613",
    "original_inquiry": "海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.84
  },
  {
    "request_id": "AM-REQ-2026-07614",
    "original_inquiry": "Referral from specialist: Oncologist referral: mRNA vaccine positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7541
  },
  {
    "request_id": "AM-REQ-2026-07615",
    "original_inquiry": "研究者咨询：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8585
  },
  {
    "request_id": "AM-REQ-2026-07616",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8634
  },
  {
    "request_id": "AM-REQ-2026-07617",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 双特异性抗体 trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8348
  },
  {
    "request_id": "AM-REQ-2026-07618",
    "original_inquiry": "海外求诊：Consultation: 双特异性抗体 with advanced immune checkpoint; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7135
  },
  {
    "request_id": "AM-REQ-2026-07619",
    "original_inquiry": "Family seeking information: Oncologist referral: ADC联合治疗 positive; interested in ADC inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8979
  },
  {
    "request_id": "AM-REQ-2026-07620",
    "original_inquiry": "Urgent: 患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6675
  },
  {
    "request_id": "AM-REQ-2026-07621",
    "original_inquiry": "Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8389
  },
  {
    "request_id": "AM-REQ-2026-07622",
    "original_inquiry": "Patient with 双特异性抗体 (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6261
  },
  {
    "request_id": "AM-REQ-2026-07623",
    "original_inquiry": "Urgent: 患者家属咨询：Phase II/III晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.532
  },
  {
    "request_id": "AM-REQ-2026-07624",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6998
  },
  {
    "request_id": "AM-REQ-2026-07625",
    "original_inquiry": "Urgent: Urgent: 双特异性抗体 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5686
  },
  {
    "request_id": "AM-REQ-2026-07626",
    "original_inquiry": "Second opinion requested: Oncologist referral: 双特异性抗体 positive; interested in mRNA cancer vaccine inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5204
  },
  {
    "request_id": "AM-REQ-2026-07627",
    "original_inquiry": "Second opinion requested: Patient with NSCLC (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-07628",
    "original_inquiry": "Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6616
  },
  {
    "request_id": "AM-REQ-2026-07629",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6773
  },
  {
    "request_id": "AM-REQ-2026-07630",
    "original_inquiry": "研究者咨询：海外求药：双特异性抗体患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5817
  },
  {
    "request_id": "AM-REQ-2026-07631",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6684
  },
  {
    "request_id": "AM-REQ-2026-07632",
    "original_inquiry": "海外求药：solid tumor患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.874
  },
  {
    "request_id": "AM-REQ-2026-07633",
    "original_inquiry": "海外求诊：Patient with combination immunotherapy (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6453
  },
  {
    "request_id": "AM-REQ-2026-07634",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7446
  },
  {
    "request_id": "AM-REQ-2026-07635",
    "original_inquiry": "Family seeking information: Researcher inquiry: mRNA vaccine trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6158
  },
  {
    "request_id": "AM-REQ-2026-07636",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6193
  },
  {
    "request_id": "AM-REQ-2026-07637",
    "original_inquiry": "Oncologist referral: Phase II/III positive; interested in immune checkpoint inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.583
  },
  {
    "request_id": "AM-REQ-2026-07638",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8649
  },
  {
    "request_id": "AM-REQ-2026-07639",
    "original_inquiry": "Referral from specialist: Consultation: solid tumor with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6598
  },
  {
    "request_id": "AM-REQ-2026-07640",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7477
  },
  {
    "request_id": "AM-REQ-2026-07641",
    "original_inquiry": "Urgent: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8583
  },
  {
    "request_id": "AM-REQ-2026-07642",
    "original_inquiry": "Urgent: 患者家属咨询：Phase II/III晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6989
  },
  {
    "request_id": "AM-REQ-2026-07643",
    "original_inquiry": "Urgent: Urgent: 双特异性抗体 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5503
  },
  {
    "request_id": "AM-REQ-2026-07644",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5535
  },
  {
    "request_id": "AM-REQ-2026-07645",
    "original_inquiry": "Researcher inquiry: mRNA vaccine trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5107
  },
  {
    "request_id": "AM-REQ-2026-07646",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8636
  },
  {
    "request_id": "AM-REQ-2026-07647",
    "original_inquiry": "海外求诊：Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7676
  },
  {
    "request_id": "AM-REQ-2026-07648",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.722
  },
  {
    "request_id": "AM-REQ-2026-07649",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5604
  },
  {
    "request_id": "AM-REQ-2026-07650",
    "original_inquiry": "Referral from specialist: Oncologist referral: solid tumor positive; interested in bispecific antibody inhibitors and ADC combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6526
  },
  {
    "request_id": "AM-REQ-2026-07651",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-07652",
    "original_inquiry": "Second opinion requested: 海外求药：Phase II/III患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6505
  },
  {
    "request_id": "AM-REQ-2026-07653",
    "original_inquiry": "Urgent: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8958
  },
  {
    "request_id": "AM-REQ-2026-07654",
    "original_inquiry": "Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5283
  },
  {
    "request_id": "AM-REQ-2026-07655",
    "original_inquiry": "Family seeking information: Oncologist referral: NSCLC positive; interested in immune checkpoint inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6418
  },
  {
    "request_id": "AM-REQ-2026-07656",
    "original_inquiry": "Family seeking information: Patient with melanoma (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.651
  },
  {
    "request_id": "AM-REQ-2026-07657",
    "original_inquiry": "Urgent: Oncologist referral: 个体化疫苗 positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7777
  },
  {
    "request_id": "AM-REQ-2026-07658",
    "original_inquiry": "海外求诊：Patient with solid tumor (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7057
  },
  {
    "request_id": "AM-REQ-2026-07659",
    "original_inquiry": "研究者咨询：Consultation: NSCLC with advanced antibody-drug conjugate; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6251
  },
  {
    "request_id": "AM-REQ-2026-07660",
    "original_inquiry": "Urgent: 海外求药：个体化疫苗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.582
  },
  {
    "request_id": "AM-REQ-2026-07661",
    "original_inquiry": "Patient with combination immunotherapy (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-07662",
    "original_inquiry": "研究者咨询：Urgent: solid tumor mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6829
  },
  {
    "request_id": "AM-REQ-2026-07663",
    "original_inquiry": "患者家属咨询：NSCLC晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8289
  },
  {
    "request_id": "AM-REQ-2026-07664",
    "original_inquiry": "Second opinion requested: 海外求药：Phase II/III患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8489
  },
  {
    "request_id": "AM-REQ-2026-07665",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8
  },
  {
    "request_id": "AM-REQ-2026-07666",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5043
  },
  {
    "request_id": "AM-REQ-2026-07667",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.648
  },
  {
    "request_id": "AM-REQ-2026-07668",
    "original_inquiry": "Family seeking information: Consultation: solid tumor with advanced ADC; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5758
  },
  {
    "request_id": "AM-REQ-2026-07669",
    "original_inquiry": "Second opinion requested: Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6724
  },
  {
    "request_id": "AM-REQ-2026-07670",
    "original_inquiry": "研究者咨询：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8486
  },
  {
    "request_id": "AM-REQ-2026-07671",
    "original_inquiry": "海外求诊：Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6564
  },
  {
    "request_id": "AM-REQ-2026-07672",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7132
  },
  {
    "request_id": "AM-REQ-2026-07673",
    "original_inquiry": "Referral from specialist: Oncologist referral: combination immunotherapy positive; interested in KRAS G12C inhibitors and CAR-T combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-07674",
    "original_inquiry": "Referral from specialist: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7824
  },
  {
    "request_id": "AM-REQ-2026-07675",
    "original_inquiry": "Patient with combination immunotherapy (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7265
  },
  {
    "request_id": "AM-REQ-2026-07676",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5607
  },
  {
    "request_id": "AM-REQ-2026-07677",
    "original_inquiry": "海外求诊：Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-07678",
    "original_inquiry": "Referral from specialist: Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8932
  },
  {
    "request_id": "AM-REQ-2026-07679",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (personalized neoantigen); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8641
  },
  {
    "request_id": "AM-REQ-2026-07680",
    "original_inquiry": "Referral from specialist: Patient with Phase II/III (CAR-T); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5099
  },
  {
    "request_id": "AM-REQ-2026-07681",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-07682",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6333
  },
  {
    "request_id": "AM-REQ-2026-07683",
    "original_inquiry": "Second opinion requested: Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5112
  },
  {
    "request_id": "AM-REQ-2026-07684",
    "original_inquiry": "Second opinion requested: Consultation: Phase II/III with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8321
  },
  {
    "request_id": "AM-REQ-2026-07685",
    "original_inquiry": "Family seeking information: 患者家属咨询：NSCLC晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8572
  },
  {
    "request_id": "AM-REQ-2026-07686",
    "original_inquiry": "Second opinion requested: Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6375
  },
  {
    "request_id": "AM-REQ-2026-07687",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5065
  },
  {
    "request_id": "AM-REQ-2026-07688",
    "original_inquiry": "Urgent: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and CAR-T combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6584
  },
  {
    "request_id": "AM-REQ-2026-07689",
    "original_inquiry": "海外求诊：Urgent: 个体化疫苗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7302
  },
  {
    "request_id": "AM-REQ-2026-07690",
    "original_inquiry": "Consultation: ADC联合治疗 with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5109
  },
  {
    "request_id": "AM-REQ-2026-07691",
    "original_inquiry": "研究者咨询：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6444
  },
  {
    "request_id": "AM-REQ-2026-07692",
    "original_inquiry": "Family seeking information: Consultation: NSCLC with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7063
  },
  {
    "request_id": "AM-REQ-2026-07693",
    "original_inquiry": "Second opinion requested: 患者家属咨询：NSCLC晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7505
  },
  {
    "request_id": "AM-REQ-2026-07694",
    "original_inquiry": "Urgent: Urgent: mRNA vaccine mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7992
  },
  {
    "request_id": "AM-REQ-2026-07695",
    "original_inquiry": "Referral from specialist: Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7357
  },
  {
    "request_id": "AM-REQ-2026-07696",
    "original_inquiry": "海外求药：solid tumor患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8302
  },
  {
    "request_id": "AM-REQ-2026-07697",
    "original_inquiry": "海外求诊：Researcher inquiry: solid tumor trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8183
  },
  {
    "request_id": "AM-REQ-2026-07698",
    "original_inquiry": "海外求诊：Oncologist referral: Phase II/III positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8949
  },
  {
    "request_id": "AM-REQ-2026-07699",
    "original_inquiry": "Second opinion requested: 患者家属咨询：solid tumor晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-07700",
    "original_inquiry": "海外求诊：Researcher inquiry: Phase II/III trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-07701",
    "original_inquiry": "海外求诊：Oncologist referral: 个体化疫苗 positive; interested in ADC inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6873
  },
  {
    "request_id": "AM-REQ-2026-07702",
    "original_inquiry": "Family seeking information: Urgent: NSCLC mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6263
  },
  {
    "request_id": "AM-REQ-2026-07703",
    "original_inquiry": "海外求诊：Researcher inquiry: NSCLC trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6293
  },
  {
    "request_id": "AM-REQ-2026-07704",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5974
  },
  {
    "request_id": "AM-REQ-2026-07705",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5755
  },
  {
    "request_id": "AM-REQ-2026-07706",
    "original_inquiry": "Family seeking information: Oncologist referral: NSCLC positive; interested in ADC inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6334
  },
  {
    "request_id": "AM-REQ-2026-07707",
    "original_inquiry": "Urgent: 海外求药：Phase II/III患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5174
  },
  {
    "request_id": "AM-REQ-2026-07708",
    "original_inquiry": "Referral from specialist: Consultation: mRNA vaccine with advanced personalized neoantigen; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8449
  },
  {
    "request_id": "AM-REQ-2026-07709",
    "original_inquiry": "Second opinion requested: Researcher inquiry: combination immunotherapy trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8117
  },
  {
    "request_id": "AM-REQ-2026-07710",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8105
  },
  {
    "request_id": "AM-REQ-2026-07711",
    "original_inquiry": "海外求诊：Oncologist referral: NSCLC positive; interested in bispecific antibody inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5174
  },
  {
    "request_id": "AM-REQ-2026-07712",
    "original_inquiry": "Oncologist referral: combination immunotherapy positive; interested in CAR-T inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8838
  },
  {
    "request_id": "AM-REQ-2026-07713",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-07714",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in ADC inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7488
  },
  {
    "request_id": "AM-REQ-2026-07715",
    "original_inquiry": "Second opinion requested: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8924
  },
  {
    "request_id": "AM-REQ-2026-07716",
    "original_inquiry": "Second opinion requested: Urgent: melanoma mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7945
  },
  {
    "request_id": "AM-REQ-2026-07717",
    "original_inquiry": "Second opinion requested: 海外求药：NSCLC患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8203
  },
  {
    "request_id": "AM-REQ-2026-07718",
    "original_inquiry": "Family seeking information: Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-07719",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.799
  },
  {
    "request_id": "AM-REQ-2026-07720",
    "original_inquiry": "海外求诊：Urgent: combination immunotherapy mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6516
  },
  {
    "request_id": "AM-REQ-2026-07721",
    "original_inquiry": "Referral from specialist: 患者家属咨询：双特异性抗体晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7891
  },
  {
    "request_id": "AM-REQ-2026-07722",
    "original_inquiry": "Patient with Phase II/III (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5519
  },
  {
    "request_id": "AM-REQ-2026-07723",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5055
  },
  {
    "request_id": "AM-REQ-2026-07724",
    "original_inquiry": "研究者咨询：Patient with melanoma (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-07725",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5148
  },
  {
    "request_id": "AM-REQ-2026-07726",
    "original_inquiry": "海外求诊：Oncologist referral: Phase II/III positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8906
  },
  {
    "request_id": "AM-REQ-2026-07727",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in KRAS G12C inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5032
  },
  {
    "request_id": "AM-REQ-2026-07728",
    "original_inquiry": "Urgent: 海外求药：个体化疫苗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5694
  },
  {
    "request_id": "AM-REQ-2026-07729",
    "original_inquiry": "研究者咨询：Oncologist referral: ADC联合治疗 positive; interested in personalized neoantigen inhibitors and CAR-T combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.57
  },
  {
    "request_id": "AM-REQ-2026-07730",
    "original_inquiry": "海外求诊：Consultation: 双特异性抗体 with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7964
  },
  {
    "request_id": "AM-REQ-2026-07731",
    "original_inquiry": "Family seeking information: Urgent: solid tumor mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7453
  },
  {
    "request_id": "AM-REQ-2026-07732",
    "original_inquiry": "研究者咨询：Patient with NSCLC (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6437
  },
  {
    "request_id": "AM-REQ-2026-07733",
    "original_inquiry": "Referral from specialist: 患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.648
  },
  {
    "request_id": "AM-REQ-2026-07734",
    "original_inquiry": "Urgent: Urgent: NSCLC mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7852
  },
  {
    "request_id": "AM-REQ-2026-07735",
    "original_inquiry": "Urgent: Patient with solid tumor (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.61
  },
  {
    "request_id": "AM-REQ-2026-07736",
    "original_inquiry": "Urgent: Patient with 个体化疫苗 (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8503
  },
  {
    "request_id": "AM-REQ-2026-07737",
    "original_inquiry": "研究者咨询：海外求药：melanoma患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6311
  },
  {
    "request_id": "AM-REQ-2026-07738",
    "original_inquiry": "Urgent: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7012
  },
  {
    "request_id": "AM-REQ-2026-07739",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5
  },
  {
    "request_id": "AM-REQ-2026-07740",
    "original_inquiry": "Urgent: Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6435
  },
  {
    "request_id": "AM-REQ-2026-07741",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7502
  },
  {
    "request_id": "AM-REQ-2026-07742",
    "original_inquiry": "Urgent: Consultation: 个体化疫苗 with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-07743",
    "original_inquiry": "Second opinion requested: Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-07744",
    "original_inquiry": "Family seeking information: Oncologist referral: NSCLC positive; interested in ADC inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8893
  },
  {
    "request_id": "AM-REQ-2026-07745",
    "original_inquiry": "海外求诊：患者家属咨询：melanoma晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6343
  },
  {
    "request_id": "AM-REQ-2026-07746",
    "original_inquiry": "海外求诊：海外求药：NSCLC患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8094
  },
  {
    "request_id": "AM-REQ-2026-07747",
    "original_inquiry": "患者家属咨询：个体化疫苗晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7656
  },
  {
    "request_id": "AM-REQ-2026-07748",
    "original_inquiry": "研究者咨询：Oncologist referral: mRNA vaccine positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5819
  },
  {
    "request_id": "AM-REQ-2026-07749",
    "original_inquiry": "Second opinion requested: Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7819
  },
  {
    "request_id": "AM-REQ-2026-07750",
    "original_inquiry": "海外求诊：海外求药：ADC联合治疗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7934
  },
  {
    "request_id": "AM-REQ-2026-07751",
    "original_inquiry": "患者家属咨询：ADC联合治疗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8266
  },
  {
    "request_id": "AM-REQ-2026-07752",
    "original_inquiry": "Referral from specialist: 海外求药：ADC联合治疗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6819
  },
  {
    "request_id": "AM-REQ-2026-07753",
    "original_inquiry": "海外求诊：Patient with Phase II/III (KRAS G12C); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7849
  },
  {
    "request_id": "AM-REQ-2026-07754",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7313
  },
  {
    "request_id": "AM-REQ-2026-07755",
    "original_inquiry": "Second opinion requested: Urgent: solid tumor mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5258
  },
  {
    "request_id": "AM-REQ-2026-07756",
    "original_inquiry": "海外求诊：Patient with NSCLC (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7141
  },
  {
    "request_id": "AM-REQ-2026-07757",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5934
  },
  {
    "request_id": "AM-REQ-2026-07758",
    "original_inquiry": "Second opinion requested: Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8574
  },
  {
    "request_id": "AM-REQ-2026-07759",
    "original_inquiry": "海外求诊：患者家属咨询：mRNA vaccine晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.718
  },
  {
    "request_id": "AM-REQ-2026-07760",
    "original_inquiry": "海外求诊：海外求药：solid tumor患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6212
  },
  {
    "request_id": "AM-REQ-2026-07761",
    "original_inquiry": "Researcher inquiry: mRNA vaccine trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8035
  },
  {
    "request_id": "AM-REQ-2026-07762",
    "original_inquiry": "Researcher inquiry: mRNA vaccine trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5478
  },
  {
    "request_id": "AM-REQ-2026-07763",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6678
  },
  {
    "request_id": "AM-REQ-2026-07764",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8459
  },
  {
    "request_id": "AM-REQ-2026-07765",
    "original_inquiry": "Family seeking information: 患者家属咨询：NSCLC晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6179
  },
  {
    "request_id": "AM-REQ-2026-07766",
    "original_inquiry": "Referral from specialist: Consultation: ADC联合治疗 with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.526
  },
  {
    "request_id": "AM-REQ-2026-07767",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.623
  },
  {
    "request_id": "AM-REQ-2026-07768",
    "original_inquiry": "Second opinion requested: 海外求药：mRNA vaccine患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6654
  },
  {
    "request_id": "AM-REQ-2026-07769",
    "original_inquiry": "研究者咨询：Patient with mRNA vaccine (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7249
  },
  {
    "request_id": "AM-REQ-2026-07770",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7899
  },
  {
    "request_id": "AM-REQ-2026-07771",
    "original_inquiry": "Family seeking information: 海外求药：ADC联合治疗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6084
  },
  {
    "request_id": "AM-REQ-2026-07772",
    "original_inquiry": "海外求诊：Researcher inquiry: ADC联合治疗 trial design and personalized neoantigen with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7588
  },
  {
    "request_id": "AM-REQ-2026-07773",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6228
  },
  {
    "request_id": "AM-REQ-2026-07774",
    "original_inquiry": "Urgent: solid tumor mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5508
  },
  {
    "request_id": "AM-REQ-2026-07775",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5884
  },
  {
    "request_id": "AM-REQ-2026-07776",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7294
  },
  {
    "request_id": "AM-REQ-2026-07777",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7842
  },
  {
    "request_id": "AM-REQ-2026-07778",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7481
  },
  {
    "request_id": "AM-REQ-2026-07779",
    "original_inquiry": "Family seeking information: Urgent: solid tumor mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6834
  },
  {
    "request_id": "AM-REQ-2026-07780",
    "original_inquiry": "Family seeking information: Urgent: mRNA vaccine mutation confirmed; seeking CAR-T trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8839
  },
  {
    "request_id": "AM-REQ-2026-07781",
    "original_inquiry": "海外求诊：Consultation: 个体化疫苗 with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5973
  },
  {
    "request_id": "AM-REQ-2026-07782",
    "original_inquiry": "Family seeking information: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.669
  },
  {
    "request_id": "AM-REQ-2026-07783",
    "original_inquiry": "Second opinion requested: 患者家属咨询：solid tumor晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.786
  },
  {
    "request_id": "AM-REQ-2026-07784",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7376
  },
  {
    "request_id": "AM-REQ-2026-07785",
    "original_inquiry": "海外求诊：海外求药：melanoma患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5726
  },
  {
    "request_id": "AM-REQ-2026-07786",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6706
  },
  {
    "request_id": "AM-REQ-2026-07787",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6977
  },
  {
    "request_id": "AM-REQ-2026-07788",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8077
  },
  {
    "request_id": "AM-REQ-2026-07789",
    "original_inquiry": "Urgent: Patient with solid tumor (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5388
  },
  {
    "request_id": "AM-REQ-2026-07790",
    "original_inquiry": "Urgent: 海外求药：ADC联合治疗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5835
  },
  {
    "request_id": "AM-REQ-2026-07791",
    "original_inquiry": "Family seeking information: Oncologist referral: solid tumor positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6058
  },
  {
    "request_id": "AM-REQ-2026-07792",
    "original_inquiry": "研究者咨询：Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8036
  },
  {
    "request_id": "AM-REQ-2026-07793",
    "original_inquiry": "海外求诊：Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.877
  },
  {
    "request_id": "AM-REQ-2026-07794",
    "original_inquiry": "Family seeking information: 患者家属咨询：mRNA vaccine晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5419
  },
  {
    "request_id": "AM-REQ-2026-07795",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5723
  },
  {
    "request_id": "AM-REQ-2026-07796",
    "original_inquiry": "Referral from specialist: 海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6896
  },
  {
    "request_id": "AM-REQ-2026-07797",
    "original_inquiry": "Family seeking information: Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8092
  },
  {
    "request_id": "AM-REQ-2026-07798",
    "original_inquiry": "海外求诊：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5417
  },
  {
    "request_id": "AM-REQ-2026-07799",
    "original_inquiry": "Family seeking information: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6518
  },
  {
    "request_id": "AM-REQ-2026-07800",
    "original_inquiry": "海外求诊：Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7613
  },
  {
    "request_id": "AM-REQ-2026-07801",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6905
  },
  {
    "request_id": "AM-REQ-2026-07802",
    "original_inquiry": "Second opinion requested: 患者家属咨询：mRNA vaccine晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7745
  },
  {
    "request_id": "AM-REQ-2026-07803",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5051
  },
  {
    "request_id": "AM-REQ-2026-07804",
    "original_inquiry": "海外求诊：Consultation: Phase II/III with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.62
  },
  {
    "request_id": "AM-REQ-2026-07805",
    "original_inquiry": "Second opinion requested: 海外求药：combination immunotherapy患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7706
  },
  {
    "request_id": "AM-REQ-2026-07806",
    "original_inquiry": "Second opinion requested: Researcher inquiry: NSCLC trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7396
  },
  {
    "request_id": "AM-REQ-2026-07807",
    "original_inquiry": "海外求诊：Patient with combination immunotherapy (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-07808",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5881
  },
  {
    "request_id": "AM-REQ-2026-07809",
    "original_inquiry": "海外求诊：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6892
  },
  {
    "request_id": "AM-REQ-2026-07810",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.549
  },
  {
    "request_id": "AM-REQ-2026-07811",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5612
  },
  {
    "request_id": "AM-REQ-2026-07812",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-07813",
    "original_inquiry": "Second opinion requested: Oncologist referral: 个体化疫苗 positive; interested in antibody-drug conjugate inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8293
  },
  {
    "request_id": "AM-REQ-2026-07814",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5025
  },
  {
    "request_id": "AM-REQ-2026-07815",
    "original_inquiry": "海外求诊：Patient with melanoma (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8784
  },
  {
    "request_id": "AM-REQ-2026-07816",
    "original_inquiry": "Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6715
  },
  {
    "request_id": "AM-REQ-2026-07817",
    "original_inquiry": "研究者咨询：患者家属咨询：combination immunotherapy晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.593
  },
  {
    "request_id": "AM-REQ-2026-07818",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7316
  },
  {
    "request_id": "AM-REQ-2026-07819",
    "original_inquiry": "Referral from specialist: 患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8113
  },
  {
    "request_id": "AM-REQ-2026-07820",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7286
  },
  {
    "request_id": "AM-REQ-2026-07821",
    "original_inquiry": "海外求诊：Consultation: Phase II/III with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7898
  },
  {
    "request_id": "AM-REQ-2026-07822",
    "original_inquiry": "Researcher inquiry: solid tumor trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6945
  },
  {
    "request_id": "AM-REQ-2026-07823",
    "original_inquiry": "研究者咨询：Patient with ADC联合治疗 (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8073
  },
  {
    "request_id": "AM-REQ-2026-07824",
    "original_inquiry": "Second opinion requested: Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7804
  },
  {
    "request_id": "AM-REQ-2026-07825",
    "original_inquiry": "Family seeking information: Consultation: solid tumor with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7856
  },
  {
    "request_id": "AM-REQ-2026-07826",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (antibody-drug conjugate); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6563
  },
  {
    "request_id": "AM-REQ-2026-07827",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7291
  },
  {
    "request_id": "AM-REQ-2026-07828",
    "original_inquiry": "Urgent: 海外求药：Phase II/III患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6833
  },
  {
    "request_id": "AM-REQ-2026-07829",
    "original_inquiry": "Second opinion requested: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8768
  },
  {
    "request_id": "AM-REQ-2026-07830",
    "original_inquiry": "Family seeking information: 海外求药：solid tumor患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7358
  },
  {
    "request_id": "AM-REQ-2026-07831",
    "original_inquiry": "海外求诊：Consultation: solid tumor with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.574
  },
  {
    "request_id": "AM-REQ-2026-07832",
    "original_inquiry": "研究者咨询：Consultation: Phase II/III with advanced immune checkpoint; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.61
  },
  {
    "request_id": "AM-REQ-2026-07833",
    "original_inquiry": "Urgent: 患者家属咨询：solid tumor晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5676
  },
  {
    "request_id": "AM-REQ-2026-07834",
    "original_inquiry": "海外求诊：海外求药：ADC联合治疗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8509
  },
  {
    "request_id": "AM-REQ-2026-07835",
    "original_inquiry": "Family seeking information: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5728
  },
  {
    "request_id": "AM-REQ-2026-07836",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.559
  },
  {
    "request_id": "AM-REQ-2026-07837",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7201
  },
  {
    "request_id": "AM-REQ-2026-07838",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8938
  },
  {
    "request_id": "AM-REQ-2026-07839",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7875
  },
  {
    "request_id": "AM-REQ-2026-07840",
    "original_inquiry": "Second opinion requested: Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5186
  },
  {
    "request_id": "AM-REQ-2026-07841",
    "original_inquiry": "Referral from specialist: Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8586
  },
  {
    "request_id": "AM-REQ-2026-07842",
    "original_inquiry": "Oncologist referral: combination immunotherapy positive; interested in immune checkpoint inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8058
  },
  {
    "request_id": "AM-REQ-2026-07843",
    "original_inquiry": "研究者咨询：患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6152
  },
  {
    "request_id": "AM-REQ-2026-07844",
    "original_inquiry": "研究者咨询：Urgent: combination immunotherapy mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5687
  },
  {
    "request_id": "AM-REQ-2026-07845",
    "original_inquiry": "Family seeking information: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7548
  },
  {
    "request_id": "AM-REQ-2026-07846",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8177
  },
  {
    "request_id": "AM-REQ-2026-07847",
    "original_inquiry": "Second opinion requested: Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5051
  },
  {
    "request_id": "AM-REQ-2026-07848",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8404
  },
  {
    "request_id": "AM-REQ-2026-07849",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6489
  },
  {
    "request_id": "AM-REQ-2026-07850",
    "original_inquiry": "Second opinion requested: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7594
  },
  {
    "request_id": "AM-REQ-2026-07851",
    "original_inquiry": "Patient with ADC联合治疗 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8589
  },
  {
    "request_id": "AM-REQ-2026-07852",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7967
  },
  {
    "request_id": "AM-REQ-2026-07853",
    "original_inquiry": "研究者咨询：海外求药：个体化疫苗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8817
  },
  {
    "request_id": "AM-REQ-2026-07854",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (immune checkpoint); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-07855",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5276
  },
  {
    "request_id": "AM-REQ-2026-07856",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5389
  },
  {
    "request_id": "AM-REQ-2026-07857",
    "original_inquiry": "Referral from specialist: 患者家属咨询：NSCLC晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8765
  },
  {
    "request_id": "AM-REQ-2026-07858",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-07859",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5265
  },
  {
    "request_id": "AM-REQ-2026-07860",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8319
  },
  {
    "request_id": "AM-REQ-2026-07861",
    "original_inquiry": "海外求诊：患者家属咨询：双特异性抗体晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8655
  },
  {
    "request_id": "AM-REQ-2026-07862",
    "original_inquiry": "Referral from specialist: Consultation: ADC联合治疗 with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5455
  },
  {
    "request_id": "AM-REQ-2026-07863",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5694
  },
  {
    "request_id": "AM-REQ-2026-07864",
    "original_inquiry": "海外求诊：Consultation: combination immunotherapy with advanced immune checkpoint; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6556
  },
  {
    "request_id": "AM-REQ-2026-07865",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in immune checkpoint inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6798
  },
  {
    "request_id": "AM-REQ-2026-07866",
    "original_inquiry": "Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7617
  },
  {
    "request_id": "AM-REQ-2026-07867",
    "original_inquiry": "研究者咨询：Patient with mRNA vaccine (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.717
  },
  {
    "request_id": "AM-REQ-2026-07868",
    "original_inquiry": "Urgent: solid tumor mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8826
  },
  {
    "request_id": "AM-REQ-2026-07869",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5674
  },
  {
    "request_id": "AM-REQ-2026-07870",
    "original_inquiry": "Patient with solid tumor (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6766
  },
  {
    "request_id": "AM-REQ-2026-07871",
    "original_inquiry": "Urgent: 海外求药：Phase II/III患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6471
  },
  {
    "request_id": "AM-REQ-2026-07872",
    "original_inquiry": "海外求诊：Urgent: Phase II/III mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5427
  },
  {
    "request_id": "AM-REQ-2026-07873",
    "original_inquiry": "Second opinion requested: Oncologist referral: solid tumor positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7915
  },
  {
    "request_id": "AM-REQ-2026-07874",
    "original_inquiry": "Referral from specialist: Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5255
  },
  {
    "request_id": "AM-REQ-2026-07875",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced CAR-T; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5166
  },
  {
    "request_id": "AM-REQ-2026-07876",
    "original_inquiry": "Urgent: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5184
  },
  {
    "request_id": "AM-REQ-2026-07877",
    "original_inquiry": "Family seeking information: Consultation: mRNA vaccine with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5193
  },
  {
    "request_id": "AM-REQ-2026-07878",
    "original_inquiry": "Family seeking information: Researcher inquiry: 双特异性抗体 trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6252
  },
  {
    "request_id": "AM-REQ-2026-07879",
    "original_inquiry": "研究者咨询：Urgent: mRNA vaccine mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6697
  },
  {
    "request_id": "AM-REQ-2026-07880",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced immune checkpoint; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7934
  },
  {
    "request_id": "AM-REQ-2026-07881",
    "original_inquiry": "海外求诊：患者家属咨询：双特异性抗体晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7988
  },
  {
    "request_id": "AM-REQ-2026-07882",
    "original_inquiry": "Second opinion requested: Researcher inquiry: combination immunotherapy trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5491
  },
  {
    "request_id": "AM-REQ-2026-07883",
    "original_inquiry": "海外求诊：海外求药：ADC联合治疗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7889
  },
  {
    "request_id": "AM-REQ-2026-07884",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7915
  },
  {
    "request_id": "AM-REQ-2026-07885",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6984
  },
  {
    "request_id": "AM-REQ-2026-07886",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.872
  },
  {
    "request_id": "AM-REQ-2026-07887",
    "original_inquiry": "研究者咨询：Consultation: 双特异性抗体 with advanced immune checkpoint; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.756
  },
  {
    "request_id": "AM-REQ-2026-07888",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5558
  },
  {
    "request_id": "AM-REQ-2026-07889",
    "original_inquiry": "研究者咨询：Oncologist referral: ADC联合治疗 positive; interested in ADC inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7327
  },
  {
    "request_id": "AM-REQ-2026-07890",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8211
  },
  {
    "request_id": "AM-REQ-2026-07891",
    "original_inquiry": "研究者咨询：Patient with NSCLC (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8141
  },
  {
    "request_id": "AM-REQ-2026-07892",
    "original_inquiry": "Family seeking information: Consultation: NSCLC with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8683
  },
  {
    "request_id": "AM-REQ-2026-07893",
    "original_inquiry": "海外求诊：Consultation: 双特异性抗体 with advanced ADC; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8647
  },
  {
    "request_id": "AM-REQ-2026-07894",
    "original_inquiry": "海外求诊：患者家属咨询：NSCLC晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8924
  },
  {
    "request_id": "AM-REQ-2026-07895",
    "original_inquiry": "Second opinion requested: Urgent: 个体化疫苗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5391
  },
  {
    "request_id": "AM-REQ-2026-07896",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7996
  },
  {
    "request_id": "AM-REQ-2026-07897",
    "original_inquiry": "Referral from specialist: 海外求药：melanoma患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5909
  },
  {
    "request_id": "AM-REQ-2026-07898",
    "original_inquiry": "Urgent: Urgent: NSCLC mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7072
  },
  {
    "request_id": "AM-REQ-2026-07899",
    "original_inquiry": "Patient with 个体化疫苗 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.809
  },
  {
    "request_id": "AM-REQ-2026-07900",
    "original_inquiry": "Patient with solid tumor (CAR-T); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-07901",
    "original_inquiry": "Referral from specialist: Urgent: mRNA vaccine mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7053
  },
  {
    "request_id": "AM-REQ-2026-07902",
    "original_inquiry": "Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5805
  },
  {
    "request_id": "AM-REQ-2026-07903",
    "original_inquiry": "Second opinion requested: Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5184
  },
  {
    "request_id": "AM-REQ-2026-07904",
    "original_inquiry": "Oncologist referral: combination immunotherapy positive; interested in CAR-T inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.673
  },
  {
    "request_id": "AM-REQ-2026-07905",
    "original_inquiry": "Family seeking information: 海外求药：个体化疫苗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8573
  },
  {
    "request_id": "AM-REQ-2026-07906",
    "original_inquiry": "Consultation: solid tumor with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8458
  },
  {
    "request_id": "AM-REQ-2026-07907",
    "original_inquiry": "Second opinion requested: Researcher inquiry: NSCLC trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5707
  },
  {
    "request_id": "AM-REQ-2026-07908",
    "original_inquiry": "Family seeking information: Patient with NSCLC (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6148
  },
  {
    "request_id": "AM-REQ-2026-07909",
    "original_inquiry": "Urgent: Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5239
  },
  {
    "request_id": "AM-REQ-2026-07910",
    "original_inquiry": "Second opinion requested: Consultation: combination immunotherapy with advanced mRNA cancer vaccine; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8134
  },
  {
    "request_id": "AM-REQ-2026-07911",
    "original_inquiry": "Urgent: Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.834
  },
  {
    "request_id": "AM-REQ-2026-07912",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.782
  },
  {
    "request_id": "AM-REQ-2026-07913",
    "original_inquiry": "Second opinion requested: Consultation: mRNA vaccine with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6355
  },
  {
    "request_id": "AM-REQ-2026-07914",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5536
  },
  {
    "request_id": "AM-REQ-2026-07915",
    "original_inquiry": "研究者咨询：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7706
  },
  {
    "request_id": "AM-REQ-2026-07916",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6203
  },
  {
    "request_id": "AM-REQ-2026-07917",
    "original_inquiry": "Referral from specialist: Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7105
  },
  {
    "request_id": "AM-REQ-2026-07918",
    "original_inquiry": "海外求诊：海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.65
  },
  {
    "request_id": "AM-REQ-2026-07919",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6609
  },
  {
    "request_id": "AM-REQ-2026-07920",
    "original_inquiry": "研究者咨询：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7707
  },
  {
    "request_id": "AM-REQ-2026-07921",
    "original_inquiry": "海外求诊：Patient with Phase II/III (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6517
  },
  {
    "request_id": "AM-REQ-2026-07922",
    "original_inquiry": "海外求诊：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5675
  },
  {
    "request_id": "AM-REQ-2026-07923",
    "original_inquiry": "Family seeking information: Consultation: combination immunotherapy with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5328
  },
  {
    "request_id": "AM-REQ-2026-07924",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8794
  },
  {
    "request_id": "AM-REQ-2026-07925",
    "original_inquiry": "Consultation: ADC联合治疗 with advanced antibody-drug conjugate; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7277
  },
  {
    "request_id": "AM-REQ-2026-07926",
    "original_inquiry": "Referral from specialist: Patient with 个体化疫苗 (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.526
  },
  {
    "request_id": "AM-REQ-2026-07927",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7114
  },
  {
    "request_id": "AM-REQ-2026-07928",
    "original_inquiry": "研究者咨询：海外求药：combination immunotherapy患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5924
  },
  {
    "request_id": "AM-REQ-2026-07929",
    "original_inquiry": "研究者咨询：Urgent: 双特异性抗体 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7074
  },
  {
    "request_id": "AM-REQ-2026-07930",
    "original_inquiry": "Referral from specialist: Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8385
  },
  {
    "request_id": "AM-REQ-2026-07931",
    "original_inquiry": "Patient with 个体化疫苗 (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7171
  },
  {
    "request_id": "AM-REQ-2026-07932",
    "original_inquiry": "Urgent: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7524
  },
  {
    "request_id": "AM-REQ-2026-07933",
    "original_inquiry": "海外求药：melanoma患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7465
  },
  {
    "request_id": "AM-REQ-2026-07934",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5073
  },
  {
    "request_id": "AM-REQ-2026-07935",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8138
  },
  {
    "request_id": "AM-REQ-2026-07936",
    "original_inquiry": "Second opinion requested: Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8783
  },
  {
    "request_id": "AM-REQ-2026-07937",
    "original_inquiry": "海外求诊：Patient with 个体化疫苗 (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-07938",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8725
  },
  {
    "request_id": "AM-REQ-2026-07939",
    "original_inquiry": "Referral from specialist: Consultation: Phase II/III with advanced ADC; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5635
  },
  {
    "request_id": "AM-REQ-2026-07940",
    "original_inquiry": "研究者咨询：Consultation: NSCLC with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.82
  },
  {
    "request_id": "AM-REQ-2026-07941",
    "original_inquiry": "Urgent: Oncologist referral: mRNA vaccine positive; interested in immune checkpoint inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6925
  },
  {
    "request_id": "AM-REQ-2026-07942",
    "original_inquiry": "Family seeking information: Urgent: solid tumor mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7467
  },
  {
    "request_id": "AM-REQ-2026-07943",
    "original_inquiry": "Second opinion requested: Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7756
  },
  {
    "request_id": "AM-REQ-2026-07944",
    "original_inquiry": "Family seeking information: 海外求药：combination immunotherapy患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5917
  },
  {
    "request_id": "AM-REQ-2026-07945",
    "original_inquiry": "研究者咨询：患者家属咨询：双特异性抗体晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5971
  },
  {
    "request_id": "AM-REQ-2026-07946",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced ADC; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5051
  },
  {
    "request_id": "AM-REQ-2026-07947",
    "original_inquiry": "Urgent: 患者家属咨询：ADC联合治疗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5679
  },
  {
    "request_id": "AM-REQ-2026-07948",
    "original_inquiry": "海外求诊：Patient with Phase II/III (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.578
  },
  {
    "request_id": "AM-REQ-2026-07949",
    "original_inquiry": "Referral from specialist: 患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5775
  },
  {
    "request_id": "AM-REQ-2026-07950",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7023
  },
  {
    "request_id": "AM-REQ-2026-07951",
    "original_inquiry": "Researcher inquiry: 双特异性抗体 trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8954
  },
  {
    "request_id": "AM-REQ-2026-07952",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7169
  },
  {
    "request_id": "AM-REQ-2026-07953",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6278
  },
  {
    "request_id": "AM-REQ-2026-07954",
    "original_inquiry": "Family seeking information: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7024
  },
  {
    "request_id": "AM-REQ-2026-07955",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5252
  },
  {
    "request_id": "AM-REQ-2026-07956",
    "original_inquiry": "Family seeking information: Urgent: solid tumor mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7423
  },
  {
    "request_id": "AM-REQ-2026-07957",
    "original_inquiry": "Second opinion requested: 患者家属咨询：Phase II/III晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6216
  },
  {
    "request_id": "AM-REQ-2026-07958",
    "original_inquiry": "研究者咨询：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5366
  },
  {
    "request_id": "AM-REQ-2026-07959",
    "original_inquiry": "Referral from specialist: Consultation: melanoma with advanced immune checkpoint; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5742
  },
  {
    "request_id": "AM-REQ-2026-07960",
    "original_inquiry": "Second opinion requested: Urgent: mRNA vaccine mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5861
  },
  {
    "request_id": "AM-REQ-2026-07961",
    "original_inquiry": "Referral from specialist: 海外求药：Phase II/III患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5441
  },
  {
    "request_id": "AM-REQ-2026-07962",
    "original_inquiry": "Urgent: Urgent: ADC联合治疗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8148
  },
  {
    "request_id": "AM-REQ-2026-07963",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7766
  },
  {
    "request_id": "AM-REQ-2026-07964",
    "original_inquiry": "Urgent: Urgent: NSCLC mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8127
  },
  {
    "request_id": "AM-REQ-2026-07965",
    "original_inquiry": "Referral from specialist: Urgent: Phase II/III mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5004
  },
  {
    "request_id": "AM-REQ-2026-07966",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6882
  },
  {
    "request_id": "AM-REQ-2026-07967",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8362
  },
  {
    "request_id": "AM-REQ-2026-07968",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6526
  },
  {
    "request_id": "AM-REQ-2026-07969",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7654
  },
  {
    "request_id": "AM-REQ-2026-07970",
    "original_inquiry": "Second opinion requested: Urgent: solid tumor mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7383
  },
  {
    "request_id": "AM-REQ-2026-07971",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and personalized neoantigen with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5013
  },
  {
    "request_id": "AM-REQ-2026-07972",
    "original_inquiry": "研究者咨询：Researcher inquiry: NSCLC trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8731
  },
  {
    "request_id": "AM-REQ-2026-07973",
    "original_inquiry": "Urgent: 海外求药：双特异性抗体患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6888
  },
  {
    "request_id": "AM-REQ-2026-07974",
    "original_inquiry": "海外求诊：Oncologist referral: mRNA vaccine positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6399
  },
  {
    "request_id": "AM-REQ-2026-07975",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5895
  },
  {
    "request_id": "AM-REQ-2026-07976",
    "original_inquiry": "海外求诊：海外求药：solid tumor患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8735
  },
  {
    "request_id": "AM-REQ-2026-07977",
    "original_inquiry": "海外求诊：Urgent: solid tumor mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5148
  },
  {
    "request_id": "AM-REQ-2026-07978",
    "original_inquiry": "海外求诊：Patient with 个体化疫苗 (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7987
  },
  {
    "request_id": "AM-REQ-2026-07979",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6786
  },
  {
    "request_id": "AM-REQ-2026-07980",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6464
  },
  {
    "request_id": "AM-REQ-2026-07981",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (ADC); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7923
  },
  {
    "request_id": "AM-REQ-2026-07982",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5603
  },
  {
    "request_id": "AM-REQ-2026-07983",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.738
  },
  {
    "request_id": "AM-REQ-2026-07984",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5854
  },
  {
    "request_id": "AM-REQ-2026-07985",
    "original_inquiry": "Researcher inquiry: 双特异性抗体 trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7753
  },
  {
    "request_id": "AM-REQ-2026-07986",
    "original_inquiry": "Referral from specialist: 患者家属咨询：melanoma晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6394
  },
  {
    "request_id": "AM-REQ-2026-07987",
    "original_inquiry": "研究者咨询：海外求药：solid tumor患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6967
  },
  {
    "request_id": "AM-REQ-2026-07988",
    "original_inquiry": "Urgent: Urgent: combination immunotherapy mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.833
  },
  {
    "request_id": "AM-REQ-2026-07989",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5322
  },
  {
    "request_id": "AM-REQ-2026-07990",
    "original_inquiry": "海外求诊：Oncologist referral: NSCLC positive; interested in immune checkpoint inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.878
  },
  {
    "request_id": "AM-REQ-2026-07991",
    "original_inquiry": "Referral from specialist: Consultation: mRNA vaccine with advanced CAR-T; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8358
  },
  {
    "request_id": "AM-REQ-2026-07992",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5793
  },
  {
    "request_id": "AM-REQ-2026-07993",
    "original_inquiry": "Referral from specialist: 海外求药：Phase II/III患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7709
  },
  {
    "request_id": "AM-REQ-2026-07994",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7153
  },
  {
    "request_id": "AM-REQ-2026-07995",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (personalized neoantigen); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5059
  },
  {
    "request_id": "AM-REQ-2026-07996",
    "original_inquiry": "Family seeking information: 海外求药：melanoma患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6407
  },
  {
    "request_id": "AM-REQ-2026-07997",
    "original_inquiry": "Researcher inquiry: solid tumor trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8569
  },
  {
    "request_id": "AM-REQ-2026-07998",
    "original_inquiry": "研究者咨询：Oncologist referral: mRNA vaccine positive; interested in bispecific antibody inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6416
  },
  {
    "request_id": "AM-REQ-2026-07999",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7508
  },
  {
    "request_id": "AM-REQ-2026-08000",
    "original_inquiry": "Urgent: 患者家属咨询：solid tumor晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7859
  },
  {
    "request_id": "AM-REQ-2026-08001",
    "original_inquiry": "研究者咨询：海外求药：双特异性抗体患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.557
  },
  {
    "request_id": "AM-REQ-2026-08002",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7529
  },
  {
    "request_id": "AM-REQ-2026-08003",
    "original_inquiry": "研究者咨询：Urgent: ADC联合治疗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8817
  },
  {
    "request_id": "AM-REQ-2026-08004",
    "original_inquiry": "研究者咨询：Consultation: combination immunotherapy with advanced KRAS G12C; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5458
  },
  {
    "request_id": "AM-REQ-2026-08005",
    "original_inquiry": "Referral from specialist: Patient with mRNA vaccine (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8738
  },
  {
    "request_id": "AM-REQ-2026-08006",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8467
  },
  {
    "request_id": "AM-REQ-2026-08007",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8458
  },
  {
    "request_id": "AM-REQ-2026-08008",
    "original_inquiry": "Urgent: 海外求药：双特异性抗体患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5198
  },
  {
    "request_id": "AM-REQ-2026-08009",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-08010",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5187
  },
  {
    "request_id": "AM-REQ-2026-08011",
    "original_inquiry": "Urgent: Oncologist referral: solid tumor positive; interested in ADC inhibitors and CAR-T combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7702
  },
  {
    "request_id": "AM-REQ-2026-08012",
    "original_inquiry": "Consultation: NSCLC with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7772
  },
  {
    "request_id": "AM-REQ-2026-08013",
    "original_inquiry": "研究者咨询：Patient with solid tumor (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6891
  },
  {
    "request_id": "AM-REQ-2026-08014",
    "original_inquiry": "Family seeking information: Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6366
  },
  {
    "request_id": "AM-REQ-2026-08015",
    "original_inquiry": "Urgent: Patient with Phase II/III (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.585
  },
  {
    "request_id": "AM-REQ-2026-08016",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7294
  },
  {
    "request_id": "AM-REQ-2026-08017",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8084
  },
  {
    "request_id": "AM-REQ-2026-08018",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.639
  },
  {
    "request_id": "AM-REQ-2026-08019",
    "original_inquiry": "Referral from specialist: Patient with solid tumor (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7216
  },
  {
    "request_id": "AM-REQ-2026-08020",
    "original_inquiry": "Patient with mRNA vaccine (bispecific antibody); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8083
  },
  {
    "request_id": "AM-REQ-2026-08021",
    "original_inquiry": "Urgent: Researcher inquiry: solid tumor trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-08022",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6582
  },
  {
    "request_id": "AM-REQ-2026-08023",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7395
  },
  {
    "request_id": "AM-REQ-2026-08024",
    "original_inquiry": "研究者咨询：Consultation: combination immunotherapy with advanced immune checkpoint; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8209
  },
  {
    "request_id": "AM-REQ-2026-08025",
    "original_inquiry": "Family seeking information: Researcher inquiry: mRNA vaccine trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8851
  },
  {
    "request_id": "AM-REQ-2026-08026",
    "original_inquiry": "Referral from specialist: Researcher inquiry: combination immunotherapy trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6981
  },
  {
    "request_id": "AM-REQ-2026-08027",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (ADC); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8822
  },
  {
    "request_id": "AM-REQ-2026-08028",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in mRNA cancer vaccine inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8396
  },
  {
    "request_id": "AM-REQ-2026-08029",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5163
  },
  {
    "request_id": "AM-REQ-2026-08030",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8504
  },
  {
    "request_id": "AM-REQ-2026-08031",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5262
  },
  {
    "request_id": "AM-REQ-2026-08032",
    "original_inquiry": "Urgent: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8428
  },
  {
    "request_id": "AM-REQ-2026-08033",
    "original_inquiry": "Urgent: Phase II/III mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6971
  },
  {
    "request_id": "AM-REQ-2026-08034",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5331
  },
  {
    "request_id": "AM-REQ-2026-08035",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8817
  },
  {
    "request_id": "AM-REQ-2026-08036",
    "original_inquiry": "Urgent: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8371
  },
  {
    "request_id": "AM-REQ-2026-08037",
    "original_inquiry": "Urgent: Phase II/III mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7889
  },
  {
    "request_id": "AM-REQ-2026-08038",
    "original_inquiry": "Second opinion requested: 患者家属咨询：NSCLC晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7805
  },
  {
    "request_id": "AM-REQ-2026-08039",
    "original_inquiry": "Consultation: solid tumor with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7678
  },
  {
    "request_id": "AM-REQ-2026-08040",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5229
  },
  {
    "request_id": "AM-REQ-2026-08041",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5634
  },
  {
    "request_id": "AM-REQ-2026-08042",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8159
  },
  {
    "request_id": "AM-REQ-2026-08043",
    "original_inquiry": "研究者咨询：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6535
  },
  {
    "request_id": "AM-REQ-2026-08044",
    "original_inquiry": "Second opinion requested: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.679
  },
  {
    "request_id": "AM-REQ-2026-08045",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6931
  },
  {
    "request_id": "AM-REQ-2026-08046",
    "original_inquiry": "Second opinion requested: Consultation: combination immunotherapy with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5939
  },
  {
    "request_id": "AM-REQ-2026-08047",
    "original_inquiry": "Second opinion requested: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5319
  },
  {
    "request_id": "AM-REQ-2026-08048",
    "original_inquiry": "Family seeking information: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8224
  },
  {
    "request_id": "AM-REQ-2026-08049",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8858
  },
  {
    "request_id": "AM-REQ-2026-08050",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6225
  },
  {
    "request_id": "AM-REQ-2026-08051",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6382
  },
  {
    "request_id": "AM-REQ-2026-08052",
    "original_inquiry": "Family seeking information: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6563
  },
  {
    "request_id": "AM-REQ-2026-08053",
    "original_inquiry": "Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.785
  },
  {
    "request_id": "AM-REQ-2026-08054",
    "original_inquiry": "Second opinion requested: Patient with 个体化疫苗 (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-08055",
    "original_inquiry": "Family seeking information: 患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8369
  },
  {
    "request_id": "AM-REQ-2026-08056",
    "original_inquiry": "海外求诊：Consultation: 个体化疫苗 with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.595
  },
  {
    "request_id": "AM-REQ-2026-08057",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced ADC; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.549
  },
  {
    "request_id": "AM-REQ-2026-08058",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.525
  },
  {
    "request_id": "AM-REQ-2026-08059",
    "original_inquiry": "Referral from specialist: 海外求药：melanoma患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7853
  },
  {
    "request_id": "AM-REQ-2026-08060",
    "original_inquiry": "Urgent: Patient with combination immunotherapy (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8293
  },
  {
    "request_id": "AM-REQ-2026-08061",
    "original_inquiry": "Referral from specialist: Oncologist referral: combination immunotherapy positive; interested in immune checkpoint inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8149
  },
  {
    "request_id": "AM-REQ-2026-08062",
    "original_inquiry": "海外求诊：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7976
  },
  {
    "request_id": "AM-REQ-2026-08063",
    "original_inquiry": "Second opinion requested: Oncologist referral: 个体化疫苗 positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7501
  },
  {
    "request_id": "AM-REQ-2026-08064",
    "original_inquiry": "Oncologist referral: ADC联合治疗 positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8609
  },
  {
    "request_id": "AM-REQ-2026-08065",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in ADC inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8439
  },
  {
    "request_id": "AM-REQ-2026-08066",
    "original_inquiry": "Family seeking information: Patient with mRNA vaccine (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7266
  },
  {
    "request_id": "AM-REQ-2026-08067",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8336
  },
  {
    "request_id": "AM-REQ-2026-08068",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8913
  },
  {
    "request_id": "AM-REQ-2026-08069",
    "original_inquiry": "Consultation: ADC联合治疗 with advanced CAR-T; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5876
  },
  {
    "request_id": "AM-REQ-2026-08070",
    "original_inquiry": "Urgent: Consultation: combination immunotherapy with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.84
  },
  {
    "request_id": "AM-REQ-2026-08071",
    "original_inquiry": "Family seeking information: 患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8298
  },
  {
    "request_id": "AM-REQ-2026-08072",
    "original_inquiry": "研究者咨询：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5026
  },
  {
    "request_id": "AM-REQ-2026-08073",
    "original_inquiry": "Second opinion requested: Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6158
  },
  {
    "request_id": "AM-REQ-2026-08074",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in CAR-T inhibitors and ADC combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5608
  },
  {
    "request_id": "AM-REQ-2026-08075",
    "original_inquiry": "海外求诊：Consultation: NSCLC with advanced CAR-T; request ADC and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7951
  },
  {
    "request_id": "AM-REQ-2026-08076",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5184
  },
  {
    "request_id": "AM-REQ-2026-08077",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6788
  },
  {
    "request_id": "AM-REQ-2026-08078",
    "original_inquiry": "Researcher inquiry: 双特异性抗体 trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7472
  },
  {
    "request_id": "AM-REQ-2026-08079",
    "original_inquiry": "Patient with 双特异性抗体 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7445
  },
  {
    "request_id": "AM-REQ-2026-08080",
    "original_inquiry": "Referral from specialist: Consultation: solid tumor with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6138
  },
  {
    "request_id": "AM-REQ-2026-08081",
    "original_inquiry": "研究者咨询：Patient with solid tumor (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7372
  },
  {
    "request_id": "AM-REQ-2026-08082",
    "original_inquiry": "研究者咨询：Oncologist referral: melanoma positive; interested in bispecific antibody inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8781
  },
  {
    "request_id": "AM-REQ-2026-08083",
    "original_inquiry": "海外求诊：患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5667
  },
  {
    "request_id": "AM-REQ-2026-08084",
    "original_inquiry": "海外求诊：Researcher inquiry: mRNA vaccine trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6985
  },
  {
    "request_id": "AM-REQ-2026-08085",
    "original_inquiry": "Family seeking information: Researcher inquiry: solid tumor trial design and bispecific antibody with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6745
  },
  {
    "request_id": "AM-REQ-2026-08086",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5358
  },
  {
    "request_id": "AM-REQ-2026-08087",
    "original_inquiry": "Referral from specialist: Patient with combination immunotherapy (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6702
  },
  {
    "request_id": "AM-REQ-2026-08088",
    "original_inquiry": "Second opinion requested: Oncologist referral: Phase II/III positive; interested in mRNA cancer vaccine inhibitors and immune checkpoint combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6045
  },
  {
    "request_id": "AM-REQ-2026-08089",
    "original_inquiry": "研究者咨询：Patient with mRNA vaccine (bispecific antibody); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7878
  },
  {
    "request_id": "AM-REQ-2026-08090",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6694
  },
  {
    "request_id": "AM-REQ-2026-08091",
    "original_inquiry": "Family seeking information: Researcher inquiry: 个体化疫苗 trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8588
  },
  {
    "request_id": "AM-REQ-2026-08092",
    "original_inquiry": "Urgent: Oncologist referral: 个体化疫苗 positive; interested in personalized neoantigen inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7389
  },
  {
    "request_id": "AM-REQ-2026-08093",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8696
  },
  {
    "request_id": "AM-REQ-2026-08094",
    "original_inquiry": "研究者咨询：Urgent: 双特异性抗体 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.895
  },
  {
    "request_id": "AM-REQ-2026-08095",
    "original_inquiry": "Urgent: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.621
  },
  {
    "request_id": "AM-REQ-2026-08096",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8892
  },
  {
    "request_id": "AM-REQ-2026-08097",
    "original_inquiry": "Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7468
  },
  {
    "request_id": "AM-REQ-2026-08098",
    "original_inquiry": "Urgent: ADC联合治疗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.891
  },
  {
    "request_id": "AM-REQ-2026-08099",
    "original_inquiry": "Referral from specialist: 海外求药：solid tumor患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7214
  },
  {
    "request_id": "AM-REQ-2026-08100",
    "original_inquiry": "研究者咨询：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7923
  },
  {
    "request_id": "AM-REQ-2026-08101",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6126
  },
  {
    "request_id": "AM-REQ-2026-08102",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in antibody-drug conjugate inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5592
  },
  {
    "request_id": "AM-REQ-2026-08103",
    "original_inquiry": "Researcher inquiry: melanoma trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5666
  },
  {
    "request_id": "AM-REQ-2026-08104",
    "original_inquiry": "Second opinion requested: 患者家属咨询：combination immunotherapy晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6572
  },
  {
    "request_id": "AM-REQ-2026-08105",
    "original_inquiry": "Referral from specialist: Patient with mRNA vaccine (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5511
  },
  {
    "request_id": "AM-REQ-2026-08106",
    "original_inquiry": "Family seeking information: Patient with mRNA vaccine (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5583
  },
  {
    "request_id": "AM-REQ-2026-08107",
    "original_inquiry": "Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7013
  },
  {
    "request_id": "AM-REQ-2026-08108",
    "original_inquiry": "Family seeking information: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7224
  },
  {
    "request_id": "AM-REQ-2026-08109",
    "original_inquiry": "海外求诊：Researcher inquiry: Phase II/III trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6311
  },
  {
    "request_id": "AM-REQ-2026-08110",
    "original_inquiry": "Family seeking information: Patient with solid tumor (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.716
  },
  {
    "request_id": "AM-REQ-2026-08111",
    "original_inquiry": "Urgent: 患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8491
  },
  {
    "request_id": "AM-REQ-2026-08112",
    "original_inquiry": "Referral from specialist: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5429
  },
  {
    "request_id": "AM-REQ-2026-08113",
    "original_inquiry": "研究者咨询：Patient with mRNA vaccine (KRAS G12C); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8436
  },
  {
    "request_id": "AM-REQ-2026-08114",
    "original_inquiry": "Referral from specialist: Patient with ADC联合治疗 (ADC); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8996
  },
  {
    "request_id": "AM-REQ-2026-08115",
    "original_inquiry": "Patient with 个体化疫苗 (antibody-drug conjugate); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6228
  },
  {
    "request_id": "AM-REQ-2026-08116",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.519
  },
  {
    "request_id": "AM-REQ-2026-08117",
    "original_inquiry": "Referral from specialist: Consultation: ADC联合治疗 with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5799
  },
  {
    "request_id": "AM-REQ-2026-08118",
    "original_inquiry": "Second opinion requested: 患者家属咨询：combination immunotherapy晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6746
  },
  {
    "request_id": "AM-REQ-2026-08119",
    "original_inquiry": "海外求药：NSCLC患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.608
  },
  {
    "request_id": "AM-REQ-2026-08120",
    "original_inquiry": "Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.859
  },
  {
    "request_id": "AM-REQ-2026-08121",
    "original_inquiry": "Family seeking information: Consultation: ADC联合治疗 with advanced immune checkpoint; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6643
  },
  {
    "request_id": "AM-REQ-2026-08122",
    "original_inquiry": "Urgent: Oncologist referral: Phase II/III positive; interested in ADC inhibitors and bispecific antibody combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5971
  },
  {
    "request_id": "AM-REQ-2026-08123",
    "original_inquiry": "Family seeking information: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5292
  },
  {
    "request_id": "AM-REQ-2026-08124",
    "original_inquiry": "海外求诊：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7592
  },
  {
    "request_id": "AM-REQ-2026-08125",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5383
  },
  {
    "request_id": "AM-REQ-2026-08126",
    "original_inquiry": "Urgent: Oncologist referral: Phase II/III positive; interested in immune checkpoint inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5805
  },
  {
    "request_id": "AM-REQ-2026-08127",
    "original_inquiry": "Urgent: Oncologist referral: 个体化疫苗 positive; interested in antibody-drug conjugate inhibitors and ADC combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-08128",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6024
  },
  {
    "request_id": "AM-REQ-2026-08129",
    "original_inquiry": "Urgent: Researcher inquiry: mRNA vaccine trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7352
  },
  {
    "request_id": "AM-REQ-2026-08130",
    "original_inquiry": "海外求诊：Consultation: combination immunotherapy with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6428
  },
  {
    "request_id": "AM-REQ-2026-08131",
    "original_inquiry": "Family seeking information: 患者家属咨询：melanoma晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5945
  },
  {
    "request_id": "AM-REQ-2026-08132",
    "original_inquiry": "Family seeking information: Researcher inquiry: 个体化疫苗 trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8888
  },
  {
    "request_id": "AM-REQ-2026-08133",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8529
  },
  {
    "request_id": "AM-REQ-2026-08134",
    "original_inquiry": "Family seeking information: Consultation: mRNA vaccine with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8754
  },
  {
    "request_id": "AM-REQ-2026-08135",
    "original_inquiry": "Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.642
  },
  {
    "request_id": "AM-REQ-2026-08136",
    "original_inquiry": "Family seeking information: Oncologist referral: melanoma positive; interested in immune checkpoint inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6525
  },
  {
    "request_id": "AM-REQ-2026-08137",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6567
  },
  {
    "request_id": "AM-REQ-2026-08138",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.511
  },
  {
    "request_id": "AM-REQ-2026-08139",
    "original_inquiry": "Referral from specialist: Consultation: 双特异性抗体 with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8388
  },
  {
    "request_id": "AM-REQ-2026-08140",
    "original_inquiry": "Second opinion requested: 海外求药：Phase II/III患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5182
  },
  {
    "request_id": "AM-REQ-2026-08141",
    "original_inquiry": "海外求诊：患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5443
  },
  {
    "request_id": "AM-REQ-2026-08142",
    "original_inquiry": "研究者咨询：Oncologist referral: ADC联合治疗 positive; interested in immune checkpoint inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7394
  },
  {
    "request_id": "AM-REQ-2026-08143",
    "original_inquiry": "海外求诊：Urgent: combination immunotherapy mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7572
  },
  {
    "request_id": "AM-REQ-2026-08144",
    "original_inquiry": "Referral from specialist: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8852
  },
  {
    "request_id": "AM-REQ-2026-08145",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in ADC inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5314
  },
  {
    "request_id": "AM-REQ-2026-08146",
    "original_inquiry": "Urgent: 海外求药：mRNA vaccine患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8559
  },
  {
    "request_id": "AM-REQ-2026-08147",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6091
  },
  {
    "request_id": "AM-REQ-2026-08148",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6241
  },
  {
    "request_id": "AM-REQ-2026-08149",
    "original_inquiry": "Family seeking information: Patient with solid tumor (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6093
  },
  {
    "request_id": "AM-REQ-2026-08150",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7849
  },
  {
    "request_id": "AM-REQ-2026-08151",
    "original_inquiry": "研究者咨询：Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6949
  },
  {
    "request_id": "AM-REQ-2026-08152",
    "original_inquiry": "Second opinion requested: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5211
  },
  {
    "request_id": "AM-REQ-2026-08153",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced mRNA cancer vaccine; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8936
  },
  {
    "request_id": "AM-REQ-2026-08154",
    "original_inquiry": "Family seeking information: Patient with NSCLC (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5646
  },
  {
    "request_id": "AM-REQ-2026-08155",
    "original_inquiry": "Second opinion requested: Researcher inquiry: solid tumor trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7784
  },
  {
    "request_id": "AM-REQ-2026-08156",
    "original_inquiry": "Family seeking information: Researcher inquiry: 双特异性抗体 trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8911
  },
  {
    "request_id": "AM-REQ-2026-08157",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6044
  },
  {
    "request_id": "AM-REQ-2026-08158",
    "original_inquiry": "研究者咨询：Consultation: Phase II/III with advanced antibody-drug conjugate; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7831
  },
  {
    "request_id": "AM-REQ-2026-08159",
    "original_inquiry": "海外求诊：Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6642
  },
  {
    "request_id": "AM-REQ-2026-08160",
    "original_inquiry": "Family seeking information: Researcher inquiry: mRNA vaccine trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7162
  },
  {
    "request_id": "AM-REQ-2026-08161",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6232
  },
  {
    "request_id": "AM-REQ-2026-08162",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7938
  },
  {
    "request_id": "AM-REQ-2026-08163",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5068
  },
  {
    "request_id": "AM-REQ-2026-08164",
    "original_inquiry": "研究者咨询：Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and ADC combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6103
  },
  {
    "request_id": "AM-REQ-2026-08165",
    "original_inquiry": "Second opinion requested: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5369
  },
  {
    "request_id": "AM-REQ-2026-08166",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.565
  },
  {
    "request_id": "AM-REQ-2026-08167",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5747
  },
  {
    "request_id": "AM-REQ-2026-08168",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6898
  },
  {
    "request_id": "AM-REQ-2026-08169",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8562
  },
  {
    "request_id": "AM-REQ-2026-08170",
    "original_inquiry": "Consultation: Phase II/III with advanced immune checkpoint; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.867
  },
  {
    "request_id": "AM-REQ-2026-08171",
    "original_inquiry": "海外求药：solid tumor患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.69
  },
  {
    "request_id": "AM-REQ-2026-08172",
    "original_inquiry": "Family seeking information: Consultation: combination immunotherapy with advanced KRAS G12C; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7076
  },
  {
    "request_id": "AM-REQ-2026-08173",
    "original_inquiry": "Family seeking information: 海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5969
  },
  {
    "request_id": "AM-REQ-2026-08174",
    "original_inquiry": "海外求诊：患者家属咨询：solid tumor晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8655
  },
  {
    "request_id": "AM-REQ-2026-08175",
    "original_inquiry": "Family seeking information: Oncologist referral: solid tumor positive; interested in ADC inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6778
  },
  {
    "request_id": "AM-REQ-2026-08176",
    "original_inquiry": "研究者咨询：Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.545
  },
  {
    "request_id": "AM-REQ-2026-08177",
    "original_inquiry": "海外求药：Phase II/III患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7164
  },
  {
    "request_id": "AM-REQ-2026-08178",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7972
  },
  {
    "request_id": "AM-REQ-2026-08179",
    "original_inquiry": "Family seeking information: Consultation: combination immunotherapy with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7321
  },
  {
    "request_id": "AM-REQ-2026-08180",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8745
  },
  {
    "request_id": "AM-REQ-2026-08181",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8367
  },
  {
    "request_id": "AM-REQ-2026-08182",
    "original_inquiry": "Second opinion requested: 海外求药：melanoma患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5387
  },
  {
    "request_id": "AM-REQ-2026-08183",
    "original_inquiry": "Referral from specialist: Patient with melanoma (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8162
  },
  {
    "request_id": "AM-REQ-2026-08184",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6997
  },
  {
    "request_id": "AM-REQ-2026-08185",
    "original_inquiry": "Family seeking information: Researcher inquiry: mRNA vaccine trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6456
  },
  {
    "request_id": "AM-REQ-2026-08186",
    "original_inquiry": "Second opinion requested: 海外求药：NSCLC患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5703
  },
  {
    "request_id": "AM-REQ-2026-08187",
    "original_inquiry": "Urgent: Urgent: 个体化疫苗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6239
  },
  {
    "request_id": "AM-REQ-2026-08188",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7768
  },
  {
    "request_id": "AM-REQ-2026-08189",
    "original_inquiry": "Urgent: Oncologist referral: solid tumor positive; interested in bispecific antibody inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8976
  },
  {
    "request_id": "AM-REQ-2026-08190",
    "original_inquiry": "研究者咨询：患者家属咨询：双特异性抗体晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7788
  },
  {
    "request_id": "AM-REQ-2026-08191",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7594
  },
  {
    "request_id": "AM-REQ-2026-08192",
    "original_inquiry": "研究者咨询：Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6792
  },
  {
    "request_id": "AM-REQ-2026-08193",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-08194",
    "original_inquiry": "Consultation: combination immunotherapy with advanced KRAS G12C; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8483
  },
  {
    "request_id": "AM-REQ-2026-08195",
    "original_inquiry": "Family seeking information: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5041
  },
  {
    "request_id": "AM-REQ-2026-08196",
    "original_inquiry": "Family seeking information: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5081
  },
  {
    "request_id": "AM-REQ-2026-08197",
    "original_inquiry": "Referral from specialist: 患者家属咨询：双特异性抗体晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6816
  },
  {
    "request_id": "AM-REQ-2026-08198",
    "original_inquiry": "Referral from specialist: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.654
  },
  {
    "request_id": "AM-REQ-2026-08199",
    "original_inquiry": "研究者咨询：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6903
  },
  {
    "request_id": "AM-REQ-2026-08200",
    "original_inquiry": "Patient with 个体化疫苗 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.715
  },
  {
    "request_id": "AM-REQ-2026-08201",
    "original_inquiry": "Family seeking information: Consultation: Phase II/III with advanced immune checkpoint; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7733
  },
  {
    "request_id": "AM-REQ-2026-08202",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8796
  },
  {
    "request_id": "AM-REQ-2026-08203",
    "original_inquiry": "海外求诊：Consultation: solid tumor with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7898
  },
  {
    "request_id": "AM-REQ-2026-08204",
    "original_inquiry": "Urgent: Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5636
  },
  {
    "request_id": "AM-REQ-2026-08205",
    "original_inquiry": "海外求药：ADC联合治疗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7863
  },
  {
    "request_id": "AM-REQ-2026-08206",
    "original_inquiry": "Urgent: Patient with melanoma (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8853
  },
  {
    "request_id": "AM-REQ-2026-08207",
    "original_inquiry": "海外求诊：Urgent: combination immunotherapy mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6568
  },
  {
    "request_id": "AM-REQ-2026-08208",
    "original_inquiry": "研究者咨询：Patient with NSCLC (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7707
  },
  {
    "request_id": "AM-REQ-2026-08209",
    "original_inquiry": "Family seeking information: Researcher inquiry: solid tumor trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7745
  },
  {
    "request_id": "AM-REQ-2026-08210",
    "original_inquiry": "研究者咨询：Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.796
  },
  {
    "request_id": "AM-REQ-2026-08211",
    "original_inquiry": "海外求诊：Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5266
  },
  {
    "request_id": "AM-REQ-2026-08212",
    "original_inquiry": "Second opinion requested: Urgent: combination immunotherapy mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7919
  },
  {
    "request_id": "AM-REQ-2026-08213",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8976
  },
  {
    "request_id": "AM-REQ-2026-08214",
    "original_inquiry": "Second opinion requested: Urgent: NSCLC mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5847
  },
  {
    "request_id": "AM-REQ-2026-08215",
    "original_inquiry": "Referral from specialist: Consultation: 双特异性抗体 with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8433
  },
  {
    "request_id": "AM-REQ-2026-08216",
    "original_inquiry": "Urgent: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7599
  },
  {
    "request_id": "AM-REQ-2026-08217",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in ADC inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7292
  },
  {
    "request_id": "AM-REQ-2026-08218",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5773
  },
  {
    "request_id": "AM-REQ-2026-08219",
    "original_inquiry": "Consultation: solid tumor with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7849
  },
  {
    "request_id": "AM-REQ-2026-08220",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced immune checkpoint; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6673
  },
  {
    "request_id": "AM-REQ-2026-08221",
    "original_inquiry": "Referral from specialist: 患者家属咨询：NSCLC晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7087
  },
  {
    "request_id": "AM-REQ-2026-08222",
    "original_inquiry": "Second opinion requested: 海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7978
  },
  {
    "request_id": "AM-REQ-2026-08223",
    "original_inquiry": "Referral from specialist: Researcher inquiry: mRNA vaccine trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6056
  },
  {
    "request_id": "AM-REQ-2026-08224",
    "original_inquiry": "海外求诊：Oncologist referral: NSCLC positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6376
  },
  {
    "request_id": "AM-REQ-2026-08225",
    "original_inquiry": "研究者咨询：海外求药：个体化疫苗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7828
  },
  {
    "request_id": "AM-REQ-2026-08226",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6698
  },
  {
    "request_id": "AM-REQ-2026-08227",
    "original_inquiry": "Referral from specialist: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7501
  },
  {
    "request_id": "AM-REQ-2026-08228",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7068
  },
  {
    "request_id": "AM-REQ-2026-08229",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8974
  },
  {
    "request_id": "AM-REQ-2026-08230",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6481
  },
  {
    "request_id": "AM-REQ-2026-08231",
    "original_inquiry": "研究者咨询：Urgent: 双特异性抗体 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7443
  },
  {
    "request_id": "AM-REQ-2026-08232",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5766
  },
  {
    "request_id": "AM-REQ-2026-08233",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6649
  },
  {
    "request_id": "AM-REQ-2026-08234",
    "original_inquiry": "Second opinion requested: Oncologist referral: Phase II/III positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5112
  },
  {
    "request_id": "AM-REQ-2026-08235",
    "original_inquiry": "Oncologist referral: combination immunotherapy positive; interested in ADC inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8881
  },
  {
    "request_id": "AM-REQ-2026-08236",
    "original_inquiry": "研究者咨询：Patient with solid tumor (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.705
  },
  {
    "request_id": "AM-REQ-2026-08237",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced bispecific antibody; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5649
  },
  {
    "request_id": "AM-REQ-2026-08238",
    "original_inquiry": "Urgent: Researcher inquiry: 双特异性抗体 trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6558
  },
  {
    "request_id": "AM-REQ-2026-08239",
    "original_inquiry": "Urgent: Consultation: ADC联合治疗 with advanced mRNA cancer vaccine; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5136
  },
  {
    "request_id": "AM-REQ-2026-08240",
    "original_inquiry": "Second opinion requested: Oncologist referral: 双特异性抗体 positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8746
  },
  {
    "request_id": "AM-REQ-2026-08241",
    "original_inquiry": "海外求药：solid tumor患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5372
  },
  {
    "request_id": "AM-REQ-2026-08242",
    "original_inquiry": "研究者咨询：Patient with mRNA vaccine (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8698
  },
  {
    "request_id": "AM-REQ-2026-08243",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.868
  },
  {
    "request_id": "AM-REQ-2026-08244",
    "original_inquiry": "海外求药：NSCLC患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6284
  },
  {
    "request_id": "AM-REQ-2026-08245",
    "original_inquiry": "Researcher inquiry: combination immunotherapy trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5388
  },
  {
    "request_id": "AM-REQ-2026-08246",
    "original_inquiry": "Family seeking information: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5323
  },
  {
    "request_id": "AM-REQ-2026-08247",
    "original_inquiry": "研究者咨询：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8666
  },
  {
    "request_id": "AM-REQ-2026-08248",
    "original_inquiry": "研究者咨询：Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7597
  },
  {
    "request_id": "AM-REQ-2026-08249",
    "original_inquiry": "Second opinion requested: Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6577
  },
  {
    "request_id": "AM-REQ-2026-08250",
    "original_inquiry": "Second opinion requested: Consultation: ADC联合治疗 with advanced bispecific antibody; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8637
  },
  {
    "request_id": "AM-REQ-2026-08251",
    "original_inquiry": "海外求诊：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7543
  },
  {
    "request_id": "AM-REQ-2026-08252",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6069
  },
  {
    "request_id": "AM-REQ-2026-08253",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (personalized neoantigen); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8755
  },
  {
    "request_id": "AM-REQ-2026-08254",
    "original_inquiry": "Family seeking information: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5183
  },
  {
    "request_id": "AM-REQ-2026-08255",
    "original_inquiry": "研究者咨询：Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7915
  },
  {
    "request_id": "AM-REQ-2026-08256",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7888
  },
  {
    "request_id": "AM-REQ-2026-08257",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8019
  },
  {
    "request_id": "AM-REQ-2026-08258",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8264
  },
  {
    "request_id": "AM-REQ-2026-08259",
    "original_inquiry": "Urgent: Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8346
  },
  {
    "request_id": "AM-REQ-2026-08260",
    "original_inquiry": "Family seeking information: Urgent: mRNA vaccine mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7589
  },
  {
    "request_id": "AM-REQ-2026-08261",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in ADC inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5224
  },
  {
    "request_id": "AM-REQ-2026-08262",
    "original_inquiry": "Second opinion requested: Researcher inquiry: solid tumor trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8138
  },
  {
    "request_id": "AM-REQ-2026-08263",
    "original_inquiry": "Urgent: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5399
  },
  {
    "request_id": "AM-REQ-2026-08264",
    "original_inquiry": "海外求诊：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7483
  },
  {
    "request_id": "AM-REQ-2026-08265",
    "original_inquiry": "Consultation: Phase II/III with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.584
  },
  {
    "request_id": "AM-REQ-2026-08266",
    "original_inquiry": "Family seeking information: Researcher inquiry: Phase II/III trial design and personalized neoantigen with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7745
  },
  {
    "request_id": "AM-REQ-2026-08267",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8418
  },
  {
    "request_id": "AM-REQ-2026-08268",
    "original_inquiry": "Referral from specialist: 海外求药：melanoma患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5522
  },
  {
    "request_id": "AM-REQ-2026-08269",
    "original_inquiry": "Family seeking information: Researcher inquiry: combination immunotherapy trial design and personalized neoantigen with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5863
  },
  {
    "request_id": "AM-REQ-2026-08270",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5576
  },
  {
    "request_id": "AM-REQ-2026-08271",
    "original_inquiry": "Family seeking information: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6461
  },
  {
    "request_id": "AM-REQ-2026-08272",
    "original_inquiry": "研究者咨询：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7926
  },
  {
    "request_id": "AM-REQ-2026-08273",
    "original_inquiry": "海外求诊：Oncologist referral: 双特异性抗体 positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6229
  },
  {
    "request_id": "AM-REQ-2026-08274",
    "original_inquiry": "海外求诊：海外求药：melanoma患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5685
  },
  {
    "request_id": "AM-REQ-2026-08275",
    "original_inquiry": "海外求诊：Consultation: solid tumor with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7729
  },
  {
    "request_id": "AM-REQ-2026-08276",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in CAR-T inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6547
  },
  {
    "request_id": "AM-REQ-2026-08277",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-08278",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6535
  },
  {
    "request_id": "AM-REQ-2026-08279",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7226
  },
  {
    "request_id": "AM-REQ-2026-08280",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5575
  },
  {
    "request_id": "AM-REQ-2026-08281",
    "original_inquiry": "研究者咨询：Patient with combination immunotherapy (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8043
  },
  {
    "request_id": "AM-REQ-2026-08282",
    "original_inquiry": "Urgent: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8076
  },
  {
    "request_id": "AM-REQ-2026-08283",
    "original_inquiry": "Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5102
  },
  {
    "request_id": "AM-REQ-2026-08284",
    "original_inquiry": "海外求诊：Researcher inquiry: 双特异性抗体 trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7682
  },
  {
    "request_id": "AM-REQ-2026-08285",
    "original_inquiry": "Patient with 个体化疫苗 (CAR-T); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.826
  },
  {
    "request_id": "AM-REQ-2026-08286",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6947
  },
  {
    "request_id": "AM-REQ-2026-08287",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7784
  },
  {
    "request_id": "AM-REQ-2026-08288",
    "original_inquiry": "Oncologist referral: Phase II/III positive; interested in antibody-drug conjugate inhibitors and ADC combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5288
  },
  {
    "request_id": "AM-REQ-2026-08289",
    "original_inquiry": "海外求诊：Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5873
  },
  {
    "request_id": "AM-REQ-2026-08290",
    "original_inquiry": "Family seeking information: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6092
  },
  {
    "request_id": "AM-REQ-2026-08291",
    "original_inquiry": "海外求药：melanoma患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8396
  },
  {
    "request_id": "AM-REQ-2026-08292",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7198
  },
  {
    "request_id": "AM-REQ-2026-08293",
    "original_inquiry": "Family seeking information: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7026
  },
  {
    "request_id": "AM-REQ-2026-08294",
    "original_inquiry": "海外求诊：Patient with Phase II/III (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7297
  },
  {
    "request_id": "AM-REQ-2026-08295",
    "original_inquiry": "Second opinion requested: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5551
  },
  {
    "request_id": "AM-REQ-2026-08296",
    "original_inquiry": "Second opinion requested: 患者家属咨询：Phase II/III晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.635
  },
  {
    "request_id": "AM-REQ-2026-08297",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7636
  },
  {
    "request_id": "AM-REQ-2026-08298",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6856
  },
  {
    "request_id": "AM-REQ-2026-08299",
    "original_inquiry": "海外求诊：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.628
  },
  {
    "request_id": "AM-REQ-2026-08300",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5415
  },
  {
    "request_id": "AM-REQ-2026-08301",
    "original_inquiry": "Second opinion requested: Patient with ADC联合治疗 (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5015
  },
  {
    "request_id": "AM-REQ-2026-08302",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.895
  },
  {
    "request_id": "AM-REQ-2026-08303",
    "original_inquiry": "研究者咨询：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5309
  },
  {
    "request_id": "AM-REQ-2026-08304",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6027
  },
  {
    "request_id": "AM-REQ-2026-08305",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8505
  },
  {
    "request_id": "AM-REQ-2026-08306",
    "original_inquiry": "Urgent: 海外求药：个体化疫苗患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7767
  },
  {
    "request_id": "AM-REQ-2026-08307",
    "original_inquiry": "Researcher inquiry: solid tumor trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6065
  },
  {
    "request_id": "AM-REQ-2026-08308",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7594
  },
  {
    "request_id": "AM-REQ-2026-08309",
    "original_inquiry": "Consultation: NSCLC with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5408
  },
  {
    "request_id": "AM-REQ-2026-08310",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6443
  },
  {
    "request_id": "AM-REQ-2026-08311",
    "original_inquiry": "Urgent: Patient with NSCLC (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6947
  },
  {
    "request_id": "AM-REQ-2026-08312",
    "original_inquiry": "Referral from specialist: Urgent: mRNA vaccine mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6933
  },
  {
    "request_id": "AM-REQ-2026-08313",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.573
  },
  {
    "request_id": "AM-REQ-2026-08314",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8753
  },
  {
    "request_id": "AM-REQ-2026-08315",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8435
  },
  {
    "request_id": "AM-REQ-2026-08316",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.742
  },
  {
    "request_id": "AM-REQ-2026-08317",
    "original_inquiry": "海外求诊：Consultation: mRNA vaccine with advanced antibody-drug conjugate; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5823
  },
  {
    "request_id": "AM-REQ-2026-08318",
    "original_inquiry": "海外求诊：Oncologist referral: Phase II/III positive; interested in bispecific antibody inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5392
  },
  {
    "request_id": "AM-REQ-2026-08319",
    "original_inquiry": "研究者咨询：Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6722
  },
  {
    "request_id": "AM-REQ-2026-08320",
    "original_inquiry": "Referral from specialist: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7656
  },
  {
    "request_id": "AM-REQ-2026-08321",
    "original_inquiry": "研究者咨询：Urgent: ADC联合治疗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6719
  },
  {
    "request_id": "AM-REQ-2026-08322",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6459
  },
  {
    "request_id": "AM-REQ-2026-08323",
    "original_inquiry": "Urgent: Urgent: combination immunotherapy mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6328
  },
  {
    "request_id": "AM-REQ-2026-08324",
    "original_inquiry": "Urgent: Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8531
  },
  {
    "request_id": "AM-REQ-2026-08325",
    "original_inquiry": "研究者咨询：患者家属咨询：solid tumor晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5426
  },
  {
    "request_id": "AM-REQ-2026-08326",
    "original_inquiry": "研究者咨询：Patient with 个体化疫苗 (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5997
  },
  {
    "request_id": "AM-REQ-2026-08327",
    "original_inquiry": "Urgent: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8756
  },
  {
    "request_id": "AM-REQ-2026-08328",
    "original_inquiry": "海外求药：NSCLC患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8035
  },
  {
    "request_id": "AM-REQ-2026-08329",
    "original_inquiry": "研究者咨询：Patient with melanoma (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6244
  },
  {
    "request_id": "AM-REQ-2026-08330",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8605
  },
  {
    "request_id": "AM-REQ-2026-08331",
    "original_inquiry": "Urgent: 海外求药：solid tumor患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6453
  },
  {
    "request_id": "AM-REQ-2026-08332",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6988
  },
  {
    "request_id": "AM-REQ-2026-08333",
    "original_inquiry": "海外求诊：Patient with solid tumor (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8772
  },
  {
    "request_id": "AM-REQ-2026-08334",
    "original_inquiry": "Referral from specialist: Consultation: 双特异性抗体 with advanced CAR-T; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5422
  },
  {
    "request_id": "AM-REQ-2026-08335",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.863
  },
  {
    "request_id": "AM-REQ-2026-08336",
    "original_inquiry": "Family seeking information: Researcher inquiry: 双特异性抗体 trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5431
  },
  {
    "request_id": "AM-REQ-2026-08337",
    "original_inquiry": "Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5399
  },
  {
    "request_id": "AM-REQ-2026-08338",
    "original_inquiry": "Urgent: 患者家属咨询：solid tumor晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5881
  },
  {
    "request_id": "AM-REQ-2026-08339",
    "original_inquiry": "Urgent: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6356
  },
  {
    "request_id": "AM-REQ-2026-08340",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6571
  },
  {
    "request_id": "AM-REQ-2026-08341",
    "original_inquiry": "Urgent: Oncologist referral: ADC联合治疗 positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6533
  },
  {
    "request_id": "AM-REQ-2026-08342",
    "original_inquiry": "Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7451
  },
  {
    "request_id": "AM-REQ-2026-08343",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5721
  },
  {
    "request_id": "AM-REQ-2026-08344",
    "original_inquiry": "Referral from specialist: 海外求药：solid tumor患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5965
  },
  {
    "request_id": "AM-REQ-2026-08345",
    "original_inquiry": "Urgent: 海外求药：NSCLC患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5436
  },
  {
    "request_id": "AM-REQ-2026-08346",
    "original_inquiry": "Family seeking information: 患者家属咨询：melanoma晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5479
  },
  {
    "request_id": "AM-REQ-2026-08347",
    "original_inquiry": "研究者咨询：Patient with 个体化疫苗 (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6692
  },
  {
    "request_id": "AM-REQ-2026-08348",
    "original_inquiry": "海外求诊：患者家属咨询：melanoma晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7263
  },
  {
    "request_id": "AM-REQ-2026-08349",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking ADC trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.845
  },
  {
    "request_id": "AM-REQ-2026-08350",
    "original_inquiry": "Urgent: 双特异性抗体 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6568
  },
  {
    "request_id": "AM-REQ-2026-08351",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6259
  },
  {
    "request_id": "AM-REQ-2026-08352",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in personalized neoantigen inhibitors and CAR-T combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7514
  },
  {
    "request_id": "AM-REQ-2026-08353",
    "original_inquiry": "海外求诊：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6999
  },
  {
    "request_id": "AM-REQ-2026-08354",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7064
  },
  {
    "request_id": "AM-REQ-2026-08355",
    "original_inquiry": "Urgent: Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7905
  },
  {
    "request_id": "AM-REQ-2026-08356",
    "original_inquiry": "Second opinion requested: Consultation: mRNA vaccine with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.769
  },
  {
    "request_id": "AM-REQ-2026-08357",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5639
  },
  {
    "request_id": "AM-REQ-2026-08358",
    "original_inquiry": "Consultation: Phase II/III with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5007
  },
  {
    "request_id": "AM-REQ-2026-08359",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.716
  },
  {
    "request_id": "AM-REQ-2026-08360",
    "original_inquiry": "Consultation: Phase II/III with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6705
  },
  {
    "request_id": "AM-REQ-2026-08361",
    "original_inquiry": "Urgent: Urgent: 双特异性抗体 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7828
  },
  {
    "request_id": "AM-REQ-2026-08362",
    "original_inquiry": "Second opinion requested: Consultation: melanoma with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7169
  },
  {
    "request_id": "AM-REQ-2026-08363",
    "original_inquiry": "Consultation: mRNA vaccine with advanced immune checkpoint; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5936
  },
  {
    "request_id": "AM-REQ-2026-08364",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5872
  },
  {
    "request_id": "AM-REQ-2026-08365",
    "original_inquiry": "海外求诊：Oncologist referral: mRNA vaccine positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.86
  },
  {
    "request_id": "AM-REQ-2026-08366",
    "original_inquiry": "研究者咨询：Consultation: melanoma with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8318
  },
  {
    "request_id": "AM-REQ-2026-08367",
    "original_inquiry": "Urgent: Urgent: melanoma mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6483
  },
  {
    "request_id": "AM-REQ-2026-08368",
    "original_inquiry": "Urgent: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6645
  },
  {
    "request_id": "AM-REQ-2026-08369",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7129
  },
  {
    "request_id": "AM-REQ-2026-08370",
    "original_inquiry": "Family seeking information: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7319
  },
  {
    "request_id": "AM-REQ-2026-08371",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7682
  },
  {
    "request_id": "AM-REQ-2026-08372",
    "original_inquiry": "海外求诊：患者家属咨询：combination immunotherapy晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5634
  },
  {
    "request_id": "AM-REQ-2026-08373",
    "original_inquiry": "海外求诊：Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5779
  },
  {
    "request_id": "AM-REQ-2026-08374",
    "original_inquiry": "Second opinion requested: 患者家属咨询：mRNA vaccine晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6751
  },
  {
    "request_id": "AM-REQ-2026-08375",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in bispecific antibody inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7413
  },
  {
    "request_id": "AM-REQ-2026-08376",
    "original_inquiry": "Second opinion requested: 患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8768
  },
  {
    "request_id": "AM-REQ-2026-08377",
    "original_inquiry": "Family seeking information: Consultation: mRNA vaccine with advanced CAR-T; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5947
  },
  {
    "request_id": "AM-REQ-2026-08378",
    "original_inquiry": "海外求诊：Consultation: 个体化疫苗 with advanced CAR-T; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.518
  },
  {
    "request_id": "AM-REQ-2026-08379",
    "original_inquiry": "研究者咨询：Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6677
  },
  {
    "request_id": "AM-REQ-2026-08380",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8302
  },
  {
    "request_id": "AM-REQ-2026-08381",
    "original_inquiry": "Referral from specialist: Oncologist referral: Phase II/III positive; interested in CAR-T inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8858
  },
  {
    "request_id": "AM-REQ-2026-08382",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6239
  },
  {
    "request_id": "AM-REQ-2026-08383",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5937
  },
  {
    "request_id": "AM-REQ-2026-08384",
    "original_inquiry": "海外求药：mRNA vaccine患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6873
  },
  {
    "request_id": "AM-REQ-2026-08385",
    "original_inquiry": "Second opinion requested: Patient with 个体化疫苗 (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7659
  },
  {
    "request_id": "AM-REQ-2026-08386",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in bispecific antibody inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7777
  },
  {
    "request_id": "AM-REQ-2026-08387",
    "original_inquiry": "研究者咨询：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8639
  },
  {
    "request_id": "AM-REQ-2026-08388",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 双特异性抗体 trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5611
  },
  {
    "request_id": "AM-REQ-2026-08389",
    "original_inquiry": "Family seeking information: Researcher inquiry: 双特异性抗体 trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6678
  },
  {
    "request_id": "AM-REQ-2026-08390",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-08391",
    "original_inquiry": "Urgent: Consultation: Phase II/III with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7259
  },
  {
    "request_id": "AM-REQ-2026-08392",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5028
  },
  {
    "request_id": "AM-REQ-2026-08393",
    "original_inquiry": "Second opinion requested: Researcher inquiry: solid tumor trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6678
  },
  {
    "request_id": "AM-REQ-2026-08394",
    "original_inquiry": "Urgent: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7764
  },
  {
    "request_id": "AM-REQ-2026-08395",
    "original_inquiry": "海外求诊：Patient with Phase II/III (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8295
  },
  {
    "request_id": "AM-REQ-2026-08396",
    "original_inquiry": "Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6106
  },
  {
    "request_id": "AM-REQ-2026-08397",
    "original_inquiry": "Family seeking information: Researcher inquiry: NSCLC trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7952
  },
  {
    "request_id": "AM-REQ-2026-08398",
    "original_inquiry": "研究者咨询：Researcher inquiry: 双特异性抗体 trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6638
  },
  {
    "request_id": "AM-REQ-2026-08399",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6428
  },
  {
    "request_id": "AM-REQ-2026-08400",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8177
  },
  {
    "request_id": "AM-REQ-2026-08401",
    "original_inquiry": "海外求诊：Patient with Phase II/III (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8373
  },
  {
    "request_id": "AM-REQ-2026-08402",
    "original_inquiry": "研究者咨询：海外求药：combination immunotherapy患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8799
  },
  {
    "request_id": "AM-REQ-2026-08403",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8144
  },
  {
    "request_id": "AM-REQ-2026-08404",
    "original_inquiry": "Family seeking information: Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6182
  },
  {
    "request_id": "AM-REQ-2026-08405",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8536
  },
  {
    "request_id": "AM-REQ-2026-08406",
    "original_inquiry": "Urgent: Consultation: ADC联合治疗 with advanced ADC; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.872
  },
  {
    "request_id": "AM-REQ-2026-08407",
    "original_inquiry": "Second opinion requested: Urgent: ADC联合治疗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6568
  },
  {
    "request_id": "AM-REQ-2026-08408",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8476
  },
  {
    "request_id": "AM-REQ-2026-08409",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7111
  },
  {
    "request_id": "AM-REQ-2026-08410",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8234
  },
  {
    "request_id": "AM-REQ-2026-08411",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.732
  },
  {
    "request_id": "AM-REQ-2026-08412",
    "original_inquiry": "海外求诊：患者家属咨询：ADC联合治疗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7772
  },
  {
    "request_id": "AM-REQ-2026-08413",
    "original_inquiry": "Family seeking information: 患者家属咨询：combination immunotherapy晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5581
  },
  {
    "request_id": "AM-REQ-2026-08414",
    "original_inquiry": "Family seeking information: Patient with NSCLC (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5375
  },
  {
    "request_id": "AM-REQ-2026-08415",
    "original_inquiry": "Family seeking information: 海外求药：combination immunotherapy患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7624
  },
  {
    "request_id": "AM-REQ-2026-08416",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5926
  },
  {
    "request_id": "AM-REQ-2026-08417",
    "original_inquiry": "Second opinion requested: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8124
  },
  {
    "request_id": "AM-REQ-2026-08418",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8339
  },
  {
    "request_id": "AM-REQ-2026-08419",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8518
  },
  {
    "request_id": "AM-REQ-2026-08420",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5078
  },
  {
    "request_id": "AM-REQ-2026-08421",
    "original_inquiry": "Urgent: 海外求药：melanoma患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7615
  },
  {
    "request_id": "AM-REQ-2026-08422",
    "original_inquiry": "Referral from specialist: 患者家属咨询：combination immunotherapy晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7776
  },
  {
    "request_id": "AM-REQ-2026-08423",
    "original_inquiry": "Urgent: Oncologist referral: Phase II/III positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5281
  },
  {
    "request_id": "AM-REQ-2026-08424",
    "original_inquiry": "Consultation: melanoma with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7411
  },
  {
    "request_id": "AM-REQ-2026-08425",
    "original_inquiry": "海外求诊：患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5283
  },
  {
    "request_id": "AM-REQ-2026-08426",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8103
  },
  {
    "request_id": "AM-REQ-2026-08427",
    "original_inquiry": "患者家属咨询：个体化疫苗晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6742
  },
  {
    "request_id": "AM-REQ-2026-08428",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7255
  },
  {
    "request_id": "AM-REQ-2026-08429",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5755
  },
  {
    "request_id": "AM-REQ-2026-08430",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7308
  },
  {
    "request_id": "AM-REQ-2026-08431",
    "original_inquiry": "Referral from specialist: Consultation: melanoma with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6009
  },
  {
    "request_id": "AM-REQ-2026-08432",
    "original_inquiry": "Family seeking information: Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and ADC combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7903
  },
  {
    "request_id": "AM-REQ-2026-08433",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in mRNA cancer vaccine inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6406
  },
  {
    "request_id": "AM-REQ-2026-08434",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5804
  },
  {
    "request_id": "AM-REQ-2026-08435",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in antibody-drug conjugate inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5906
  },
  {
    "request_id": "AM-REQ-2026-08436",
    "original_inquiry": "Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8088
  },
  {
    "request_id": "AM-REQ-2026-08437",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7765
  },
  {
    "request_id": "AM-REQ-2026-08438",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7632
  },
  {
    "request_id": "AM-REQ-2026-08439",
    "original_inquiry": "Oncologist referral: solid tumor positive; interested in bispecific antibody inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6349
  },
  {
    "request_id": "AM-REQ-2026-08440",
    "original_inquiry": "Urgent: Researcher inquiry: NSCLC trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5235
  },
  {
    "request_id": "AM-REQ-2026-08441",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.667
  },
  {
    "request_id": "AM-REQ-2026-08442",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6745
  },
  {
    "request_id": "AM-REQ-2026-08443",
    "original_inquiry": "Referral from specialist: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6912
  },
  {
    "request_id": "AM-REQ-2026-08444",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5996
  },
  {
    "request_id": "AM-REQ-2026-08445",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8707
  },
  {
    "request_id": "AM-REQ-2026-08446",
    "original_inquiry": "研究者咨询：患者家属咨询：双特异性抗体晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7642
  },
  {
    "request_id": "AM-REQ-2026-08447",
    "original_inquiry": "Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6994
  },
  {
    "request_id": "AM-REQ-2026-08448",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8232
  },
  {
    "request_id": "AM-REQ-2026-08449",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.892
  },
  {
    "request_id": "AM-REQ-2026-08450",
    "original_inquiry": "海外求诊：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.896
  },
  {
    "request_id": "AM-REQ-2026-08451",
    "original_inquiry": "Urgent: 海外求药：双特异性抗体患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6049
  },
  {
    "request_id": "AM-REQ-2026-08452",
    "original_inquiry": "海外求诊：Researcher inquiry: 双特异性抗体 trial design and antibody-drug conjugate with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.78
  },
  {
    "request_id": "AM-REQ-2026-08453",
    "original_inquiry": "Second opinion requested: Researcher inquiry: mRNA vaccine trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5637
  },
  {
    "request_id": "AM-REQ-2026-08454",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6988
  },
  {
    "request_id": "AM-REQ-2026-08455",
    "original_inquiry": "Urgent: Oncologist referral: solid tumor positive; interested in personalized neoantigen inhibitors and ADC combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-08456",
    "original_inquiry": "Referral from specialist: Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7021
  },
  {
    "request_id": "AM-REQ-2026-08457",
    "original_inquiry": "Family seeking information: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.678
  },
  {
    "request_id": "AM-REQ-2026-08458",
    "original_inquiry": "Referral from specialist: Researcher inquiry: NSCLC trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5581
  },
  {
    "request_id": "AM-REQ-2026-08459",
    "original_inquiry": "患者家属咨询：mRNA vaccine晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6001
  },
  {
    "request_id": "AM-REQ-2026-08460",
    "original_inquiry": "Second opinion requested: Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7169
  },
  {
    "request_id": "AM-REQ-2026-08461",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5857
  },
  {
    "request_id": "AM-REQ-2026-08462",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5869
  },
  {
    "request_id": "AM-REQ-2026-08463",
    "original_inquiry": "海外求诊：海外求药：mRNA vaccine患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7378
  },
  {
    "request_id": "AM-REQ-2026-08464",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced immune checkpoint; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6708
  },
  {
    "request_id": "AM-REQ-2026-08465",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in personalized neoantigen inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-08466",
    "original_inquiry": "Oncologist referral: combination immunotherapy positive; interested in mRNA cancer vaccine inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8418
  },
  {
    "request_id": "AM-REQ-2026-08467",
    "original_inquiry": "Referral from specialist: Consultation: ADC联合治疗 with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8904
  },
  {
    "request_id": "AM-REQ-2026-08468",
    "original_inquiry": "Patient with melanoma (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6855
  },
  {
    "request_id": "AM-REQ-2026-08469",
    "original_inquiry": "患者家属咨询：ADC联合治疗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7941
  },
  {
    "request_id": "AM-REQ-2026-08470",
    "original_inquiry": "海外求诊：Consultation: 个体化疫苗 with advanced bispecific antibody; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6829
  },
  {
    "request_id": "AM-REQ-2026-08471",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8096
  },
  {
    "request_id": "AM-REQ-2026-08472",
    "original_inquiry": "Family seeking information: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8188
  },
  {
    "request_id": "AM-REQ-2026-08473",
    "original_inquiry": "Referral from specialist: Researcher inquiry: solid tumor trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6963
  },
  {
    "request_id": "AM-REQ-2026-08474",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-08475",
    "original_inquiry": "研究者咨询：Patient with ADC联合治疗 (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8956
  },
  {
    "request_id": "AM-REQ-2026-08476",
    "original_inquiry": "海外求诊：Patient with Phase II/III (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8186
  },
  {
    "request_id": "AM-REQ-2026-08477",
    "original_inquiry": "Patient with 个体化疫苗 (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8002
  },
  {
    "request_id": "AM-REQ-2026-08478",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-08479",
    "original_inquiry": "海外求诊：Consultation: ADC联合治疗 with advanced mRNA cancer vaccine; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8617
  },
  {
    "request_id": "AM-REQ-2026-08480",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in ADC inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6313
  },
  {
    "request_id": "AM-REQ-2026-08481",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6609
  },
  {
    "request_id": "AM-REQ-2026-08482",
    "original_inquiry": "Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6488
  },
  {
    "request_id": "AM-REQ-2026-08483",
    "original_inquiry": "Second opinion requested: Patient with 个体化疫苗 (ADC); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8995
  },
  {
    "request_id": "AM-REQ-2026-08484",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 个体化疫苗 trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7154
  },
  {
    "request_id": "AM-REQ-2026-08485",
    "original_inquiry": "研究者咨询：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5841
  },
  {
    "request_id": "AM-REQ-2026-08486",
    "original_inquiry": "海外求药：mRNA vaccine患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.561
  },
  {
    "request_id": "AM-REQ-2026-08487",
    "original_inquiry": "海外求诊：患者家属咨询：Phase II/III晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5359
  },
  {
    "request_id": "AM-REQ-2026-08488",
    "original_inquiry": "Family seeking information: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.768
  },
  {
    "request_id": "AM-REQ-2026-08489",
    "original_inquiry": "Second opinion requested: Researcher inquiry: NSCLC trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.867
  },
  {
    "request_id": "AM-REQ-2026-08490",
    "original_inquiry": "Referral from specialist: 海外求药：melanoma患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6089
  },
  {
    "request_id": "AM-REQ-2026-08491",
    "original_inquiry": "Second opinion requested: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6215
  },
  {
    "request_id": "AM-REQ-2026-08492",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6699
  },
  {
    "request_id": "AM-REQ-2026-08493",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and ADC combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.856
  },
  {
    "request_id": "AM-REQ-2026-08494",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6811
  },
  {
    "request_id": "AM-REQ-2026-08495",
    "original_inquiry": "Family seeking information: Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6525
  },
  {
    "request_id": "AM-REQ-2026-08496",
    "original_inquiry": "Urgent: Patient with mRNA vaccine (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8105
  },
  {
    "request_id": "AM-REQ-2026-08497",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5527
  },
  {
    "request_id": "AM-REQ-2026-08498",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.512
  },
  {
    "request_id": "AM-REQ-2026-08499",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8939
  },
  {
    "request_id": "AM-REQ-2026-08500",
    "original_inquiry": "Urgent: Patient with combination immunotherapy (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8298
  },
  {
    "request_id": "AM-REQ-2026-08501",
    "original_inquiry": "研究者咨询：患者家属咨询：双特异性抗体晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6738
  },
  {
    "request_id": "AM-REQ-2026-08502",
    "original_inquiry": "海外求诊：Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5484
  },
  {
    "request_id": "AM-REQ-2026-08503",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7359
  },
  {
    "request_id": "AM-REQ-2026-08504",
    "original_inquiry": "Family seeking information: Consultation: NSCLC with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5278
  },
  {
    "request_id": "AM-REQ-2026-08505",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6492
  },
  {
    "request_id": "AM-REQ-2026-08506",
    "original_inquiry": "Second opinion requested: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5665
  },
  {
    "request_id": "AM-REQ-2026-08507",
    "original_inquiry": "Second opinion requested: Consultation: melanoma with advanced KRAS G12C; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8616
  },
  {
    "request_id": "AM-REQ-2026-08508",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7499
  },
  {
    "request_id": "AM-REQ-2026-08509",
    "original_inquiry": "海外求诊：Urgent: NSCLC mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5005
  },
  {
    "request_id": "AM-REQ-2026-08510",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8231
  },
  {
    "request_id": "AM-REQ-2026-08511",
    "original_inquiry": "Urgent: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8956
  },
  {
    "request_id": "AM-REQ-2026-08512",
    "original_inquiry": "Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8472
  },
  {
    "request_id": "AM-REQ-2026-08513",
    "original_inquiry": "海外求药：mRNA vaccine患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8034
  },
  {
    "request_id": "AM-REQ-2026-08514",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7865
  },
  {
    "request_id": "AM-REQ-2026-08515",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7854
  },
  {
    "request_id": "AM-REQ-2026-08516",
    "original_inquiry": "Family seeking information: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7559
  },
  {
    "request_id": "AM-REQ-2026-08517",
    "original_inquiry": "Second opinion requested: Consultation: mRNA vaccine with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6887
  },
  {
    "request_id": "AM-REQ-2026-08518",
    "original_inquiry": "Second opinion requested: Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8208
  },
  {
    "request_id": "AM-REQ-2026-08519",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8565
  },
  {
    "request_id": "AM-REQ-2026-08520",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6049
  },
  {
    "request_id": "AM-REQ-2026-08521",
    "original_inquiry": "海外求诊：Researcher inquiry: melanoma trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5633
  },
  {
    "request_id": "AM-REQ-2026-08522",
    "original_inquiry": "研究者咨询：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7503
  },
  {
    "request_id": "AM-REQ-2026-08523",
    "original_inquiry": "Second opinion requested: Consultation: solid tumor with advanced immune checkpoint; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6246
  },
  {
    "request_id": "AM-REQ-2026-08524",
    "original_inquiry": "Family seeking information: Patient with combination immunotherapy (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7344
  },
  {
    "request_id": "AM-REQ-2026-08525",
    "original_inquiry": "Family seeking information: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7063
  },
  {
    "request_id": "AM-REQ-2026-08526",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7255
  },
  {
    "request_id": "AM-REQ-2026-08527",
    "original_inquiry": "Second opinion requested: Consultation: mRNA vaccine with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5723
  },
  {
    "request_id": "AM-REQ-2026-08528",
    "original_inquiry": "Second opinion requested: 海外求药：Phase II/III患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5959
  },
  {
    "request_id": "AM-REQ-2026-08529",
    "original_inquiry": "Urgent: 海外求药：Phase II/III患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8367
  },
  {
    "request_id": "AM-REQ-2026-08530",
    "original_inquiry": "Second opinion requested: Patient with 个体化疫苗 (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7869
  },
  {
    "request_id": "AM-REQ-2026-08531",
    "original_inquiry": "海外求药：NSCLC患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8274
  },
  {
    "request_id": "AM-REQ-2026-08532",
    "original_inquiry": "研究者咨询：Researcher inquiry: NSCLC trial design and bispecific antibody with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8122
  },
  {
    "request_id": "AM-REQ-2026-08533",
    "original_inquiry": "Urgent: melanoma mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6376
  },
  {
    "request_id": "AM-REQ-2026-08534",
    "original_inquiry": "Urgent: Consultation: ADC联合治疗 with advanced personalized neoantigen; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6645
  },
  {
    "request_id": "AM-REQ-2026-08535",
    "original_inquiry": "海外求诊：Researcher inquiry: 双特异性抗体 trial design and personalized neoantigen with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8184
  },
  {
    "request_id": "AM-REQ-2026-08536",
    "original_inquiry": "Referral from specialist: Urgent: ADC联合治疗 mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8505
  },
  {
    "request_id": "AM-REQ-2026-08537",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8393
  },
  {
    "request_id": "AM-REQ-2026-08538",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.882
  },
  {
    "request_id": "AM-REQ-2026-08539",
    "original_inquiry": "Urgent: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7884
  },
  {
    "request_id": "AM-REQ-2026-08540",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.646
  },
  {
    "request_id": "AM-REQ-2026-08541",
    "original_inquiry": "Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8722
  },
  {
    "request_id": "AM-REQ-2026-08542",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.641
  },
  {
    "request_id": "AM-REQ-2026-08543",
    "original_inquiry": "Referral from specialist: Researcher inquiry: mRNA vaccine trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8868
  },
  {
    "request_id": "AM-REQ-2026-08544",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8263
  },
  {
    "request_id": "AM-REQ-2026-08545",
    "original_inquiry": "海外求诊：Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7352
  },
  {
    "request_id": "AM-REQ-2026-08546",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in ADC inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6556
  },
  {
    "request_id": "AM-REQ-2026-08547",
    "original_inquiry": "海外求诊：Oncologist referral: Phase II/III positive; interested in CAR-T inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8004
  },
  {
    "request_id": "AM-REQ-2026-08548",
    "original_inquiry": "Consultation: 个体化疫苗 with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.845
  },
  {
    "request_id": "AM-REQ-2026-08549",
    "original_inquiry": "海外求诊：Consultation: solid tumor with advanced personalized neoantigen; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7173
  },
  {
    "request_id": "AM-REQ-2026-08550",
    "original_inquiry": "Consultation: mRNA vaccine with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6421
  },
  {
    "request_id": "AM-REQ-2026-08551",
    "original_inquiry": "Second opinion requested: 海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5119
  },
  {
    "request_id": "AM-REQ-2026-08552",
    "original_inquiry": "研究者咨询：Consultation: mRNA vaccine with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5493
  },
  {
    "request_id": "AM-REQ-2026-08553",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.716
  },
  {
    "request_id": "AM-REQ-2026-08554",
    "original_inquiry": "海外求诊：Consultation: combination immunotherapy with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8783
  },
  {
    "request_id": "AM-REQ-2026-08555",
    "original_inquiry": "研究者咨询：Consultation: ADC联合治疗 with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7052
  },
  {
    "request_id": "AM-REQ-2026-08556",
    "original_inquiry": "Urgent: Researcher inquiry: Phase II/III trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8863
  },
  {
    "request_id": "AM-REQ-2026-08557",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (personalized neoantigen); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8618
  },
  {
    "request_id": "AM-REQ-2026-08558",
    "original_inquiry": "Urgent: Phase II/III mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8026
  },
  {
    "request_id": "AM-REQ-2026-08559",
    "original_inquiry": "Second opinion requested: Patient with mRNA vaccine (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8404
  },
  {
    "request_id": "AM-REQ-2026-08560",
    "original_inquiry": "Referral from specialist: Patient with combination immunotherapy (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6025
  },
  {
    "request_id": "AM-REQ-2026-08561",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8845
  },
  {
    "request_id": "AM-REQ-2026-08562",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7335
  },
  {
    "request_id": "AM-REQ-2026-08563",
    "original_inquiry": "Urgent: Urgent: melanoma mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8911
  },
  {
    "request_id": "AM-REQ-2026-08564",
    "original_inquiry": "Consultation: NSCLC with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7924
  },
  {
    "request_id": "AM-REQ-2026-08565",
    "original_inquiry": "Family seeking information: Researcher inquiry: combination immunotherapy trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8099
  },
  {
    "request_id": "AM-REQ-2026-08566",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.568
  },
  {
    "request_id": "AM-REQ-2026-08567",
    "original_inquiry": "Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6096
  },
  {
    "request_id": "AM-REQ-2026-08568",
    "original_inquiry": "Family seeking information: 患者家属咨询：melanoma晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6572
  },
  {
    "request_id": "AM-REQ-2026-08569",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6548
  },
  {
    "request_id": "AM-REQ-2026-08570",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 双特异性抗体 trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5451
  },
  {
    "request_id": "AM-REQ-2026-08571",
    "original_inquiry": "Urgent: Patient with 双特异性抗体 (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7619
  },
  {
    "request_id": "AM-REQ-2026-08572",
    "original_inquiry": "海外求诊：海外求药：melanoma患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7605
  },
  {
    "request_id": "AM-REQ-2026-08573",
    "original_inquiry": "Consultation: combination immunotherapy with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6636
  },
  {
    "request_id": "AM-REQ-2026-08574",
    "original_inquiry": "Family seeking information: 患者家属咨询：combination immunotherapy晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7151
  },
  {
    "request_id": "AM-REQ-2026-08575",
    "original_inquiry": "Urgent: Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6607
  },
  {
    "request_id": "AM-REQ-2026-08576",
    "original_inquiry": "Urgent: Oncologist referral: combination immunotherapy positive; interested in ADC inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6611
  },
  {
    "request_id": "AM-REQ-2026-08577",
    "original_inquiry": "Family seeking information: Patient with combination immunotherapy (CAR-T); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6015
  },
  {
    "request_id": "AM-REQ-2026-08578",
    "original_inquiry": "Patient with NSCLC (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-08579",
    "original_inquiry": "海外求诊：Patient with 个体化疫苗 (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6906
  },
  {
    "request_id": "AM-REQ-2026-08580",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7935
  },
  {
    "request_id": "AM-REQ-2026-08581",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in CAR-T inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6939
  },
  {
    "request_id": "AM-REQ-2026-08582",
    "original_inquiry": "Consultation: solid tumor with advanced immune checkpoint; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8739
  },
  {
    "request_id": "AM-REQ-2026-08583",
    "original_inquiry": "Second opinion requested: 患者家属咨询：mRNA vaccine晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-08584",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5209
  },
  {
    "request_id": "AM-REQ-2026-08585",
    "original_inquiry": "海外求诊：海外求药：solid tumor患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8752
  },
  {
    "request_id": "AM-REQ-2026-08586",
    "original_inquiry": "Family seeking information: Consultation: melanoma with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.507
  },
  {
    "request_id": "AM-REQ-2026-08587",
    "original_inquiry": "Referral from specialist: Consultation: melanoma with advanced personalized neoantigen; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8422
  },
  {
    "request_id": "AM-REQ-2026-08588",
    "original_inquiry": "Family seeking information: Researcher inquiry: combination immunotherapy trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5109
  },
  {
    "request_id": "AM-REQ-2026-08589",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7729
  },
  {
    "request_id": "AM-REQ-2026-08590",
    "original_inquiry": "Referral from specialist: Patient with 双特异性抗体 (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7213
  },
  {
    "request_id": "AM-REQ-2026-08591",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced mRNA cancer vaccine; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8255
  },
  {
    "request_id": "AM-REQ-2026-08592",
    "original_inquiry": "Urgent: 患者家属咨询：ADC联合治疗晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5439
  },
  {
    "request_id": "AM-REQ-2026-08593",
    "original_inquiry": "Second opinion requested: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7243
  },
  {
    "request_id": "AM-REQ-2026-08594",
    "original_inquiry": "海外求诊：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6228
  },
  {
    "request_id": "AM-REQ-2026-08595",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-08596",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8171
  },
  {
    "request_id": "AM-REQ-2026-08597",
    "original_inquiry": "Referral from specialist: Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5703
  },
  {
    "request_id": "AM-REQ-2026-08598",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8646
  },
  {
    "request_id": "AM-REQ-2026-08599",
    "original_inquiry": "Urgent: 海外求药：melanoma患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5054
  },
  {
    "request_id": "AM-REQ-2026-08600",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7365
  },
  {
    "request_id": "AM-REQ-2026-08601",
    "original_inquiry": "Referral from specialist: Consultation: mRNA vaccine with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5959
  },
  {
    "request_id": "AM-REQ-2026-08602",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5879
  },
  {
    "request_id": "AM-REQ-2026-08603",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8029
  },
  {
    "request_id": "AM-REQ-2026-08604",
    "original_inquiry": "海外求诊：Consultation: Phase II/III with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.557
  },
  {
    "request_id": "AM-REQ-2026-08605",
    "original_inquiry": "Family seeking information: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6302
  },
  {
    "request_id": "AM-REQ-2026-08606",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6526
  },
  {
    "request_id": "AM-REQ-2026-08607",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8014
  },
  {
    "request_id": "AM-REQ-2026-08608",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8132
  },
  {
    "request_id": "AM-REQ-2026-08609",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7831
  },
  {
    "request_id": "AM-REQ-2026-08610",
    "original_inquiry": "研究者咨询：Patient with combination immunotherapy (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5561
  },
  {
    "request_id": "AM-REQ-2026-08611",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7812
  },
  {
    "request_id": "AM-REQ-2026-08612",
    "original_inquiry": "研究者咨询：海外求药：NSCLC患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5978
  },
  {
    "request_id": "AM-REQ-2026-08613",
    "original_inquiry": "研究者咨询：Urgent: 双特异性抗体 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8655
  },
  {
    "request_id": "AM-REQ-2026-08614",
    "original_inquiry": "海外求诊：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7966
  },
  {
    "request_id": "AM-REQ-2026-08615",
    "original_inquiry": "研究者咨询：Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5981
  },
  {
    "request_id": "AM-REQ-2026-08616",
    "original_inquiry": "Second opinion requested: Urgent: mRNA vaccine mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8165
  },
  {
    "request_id": "AM-REQ-2026-08617",
    "original_inquiry": "Family seeking information: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6572
  },
  {
    "request_id": "AM-REQ-2026-08618",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5446
  },
  {
    "request_id": "AM-REQ-2026-08619",
    "original_inquiry": "Referral from specialist: Oncologist referral: Phase II/III positive; interested in antibody-drug conjugate inhibitors and ADC combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6335
  },
  {
    "request_id": "AM-REQ-2026-08620",
    "original_inquiry": "Urgent: Urgent: mRNA vaccine mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6243
  },
  {
    "request_id": "AM-REQ-2026-08621",
    "original_inquiry": "Urgent: Researcher inquiry: solid tumor trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.758
  },
  {
    "request_id": "AM-REQ-2026-08622",
    "original_inquiry": "Patient with melanoma (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.606
  },
  {
    "request_id": "AM-REQ-2026-08623",
    "original_inquiry": "研究者咨询：Urgent: Phase II/III mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5496
  },
  {
    "request_id": "AM-REQ-2026-08624",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.719
  },
  {
    "request_id": "AM-REQ-2026-08625",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5944
  },
  {
    "request_id": "AM-REQ-2026-08626",
    "original_inquiry": "Researcher inquiry: mRNA vaccine trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7834
  },
  {
    "request_id": "AM-REQ-2026-08627",
    "original_inquiry": "Urgent: Consultation: ADC联合治疗 with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7336
  },
  {
    "request_id": "AM-REQ-2026-08628",
    "original_inquiry": "Referral from specialist: 患者家属咨询：双特异性抗体晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7929
  },
  {
    "request_id": "AM-REQ-2026-08629",
    "original_inquiry": "Second opinion requested: Patient with melanoma (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6946
  },
  {
    "request_id": "AM-REQ-2026-08630",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in immune checkpoint inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7295
  },
  {
    "request_id": "AM-REQ-2026-08631",
    "original_inquiry": "海外求诊：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.658
  },
  {
    "request_id": "AM-REQ-2026-08632",
    "original_inquiry": "研究者咨询：Consultation: ADC联合治疗 with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6102
  },
  {
    "request_id": "AM-REQ-2026-08633",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-08634",
    "original_inquiry": "海外求诊：Patient with NSCLC (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-08635",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8237
  },
  {
    "request_id": "AM-REQ-2026-08636",
    "original_inquiry": "Referral from specialist: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8972
  },
  {
    "request_id": "AM-REQ-2026-08637",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6204
  },
  {
    "request_id": "AM-REQ-2026-08638",
    "original_inquiry": "Referral from specialist: 海外求药：melanoma患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.566
  },
  {
    "request_id": "AM-REQ-2026-08639",
    "original_inquiry": "海外求诊：Researcher inquiry: mRNA vaccine trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5328
  },
  {
    "request_id": "AM-REQ-2026-08640",
    "original_inquiry": "Urgent: Researcher inquiry: melanoma trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.792
  },
  {
    "request_id": "AM-REQ-2026-08641",
    "original_inquiry": "研究者咨询：海外求药：双特异性抗体患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5166
  },
  {
    "request_id": "AM-REQ-2026-08642",
    "original_inquiry": "Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.844
  },
  {
    "request_id": "AM-REQ-2026-08643",
    "original_inquiry": "海外求诊：Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5722
  },
  {
    "request_id": "AM-REQ-2026-08644",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加CAR-T或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8606
  },
  {
    "request_id": "AM-REQ-2026-08645",
    "original_inquiry": "Second opinion requested: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6564
  },
  {
    "request_id": "AM-REQ-2026-08646",
    "original_inquiry": "Second opinion requested: Patient with melanoma (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5374
  },
  {
    "request_id": "AM-REQ-2026-08647",
    "original_inquiry": "海外求诊：Researcher inquiry: 个体化疫苗 trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7655
  },
  {
    "request_id": "AM-REQ-2026-08648",
    "original_inquiry": "Family seeking information: Oncologist referral: mRNA vaccine positive; interested in bispecific antibody inhibitors and ADC combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8721
  },
  {
    "request_id": "AM-REQ-2026-08649",
    "original_inquiry": "研究者咨询：Urgent: ADC联合治疗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.59
  },
  {
    "request_id": "AM-REQ-2026-08650",
    "original_inquiry": "Patient with mRNA vaccine (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8591
  },
  {
    "request_id": "AM-REQ-2026-08651",
    "original_inquiry": "Second opinion requested: Patient with ADC联合治疗 (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5826
  },
  {
    "request_id": "AM-REQ-2026-08652",
    "original_inquiry": "海外求诊：患者家属咨询：双特异性抗体晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7427
  },
  {
    "request_id": "AM-REQ-2026-08653",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in personalized neoantigen inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6033
  },
  {
    "request_id": "AM-REQ-2026-08654",
    "original_inquiry": "Second opinion requested: Consultation: melanoma with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5669
  },
  {
    "request_id": "AM-REQ-2026-08655",
    "original_inquiry": "Family seeking information: Researcher inquiry: 双特异性抗体 trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7667
  },
  {
    "request_id": "AM-REQ-2026-08656",
    "original_inquiry": "海外求诊：患者家属咨询：combination immunotherapy晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5096
  },
  {
    "request_id": "AM-REQ-2026-08657",
    "original_inquiry": "海外求诊：患者家属咨询：ADC联合治疗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6929
  },
  {
    "request_id": "AM-REQ-2026-08658",
    "original_inquiry": "Family seeking information: Researcher inquiry: solid tumor trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8835
  },
  {
    "request_id": "AM-REQ-2026-08659",
    "original_inquiry": "Urgent: Consultation: ADC联合治疗 with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8578
  },
  {
    "request_id": "AM-REQ-2026-08660",
    "original_inquiry": "研究者咨询：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7694
  },
  {
    "request_id": "AM-REQ-2026-08661",
    "original_inquiry": "海外求诊：Consultation: mRNA vaccine with advanced CAR-T; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6968
  },
  {
    "request_id": "AM-REQ-2026-08662",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7505
  },
  {
    "request_id": "AM-REQ-2026-08663",
    "original_inquiry": "研究者咨询：Consultation: combination immunotherapy with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5527
  },
  {
    "request_id": "AM-REQ-2026-08664",
    "original_inquiry": "Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.822
  },
  {
    "request_id": "AM-REQ-2026-08665",
    "original_inquiry": "海外求诊：Oncologist referral: mRNA vaccine positive; interested in antibody-drug conjugate inhibitors and ADC combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.601
  },
  {
    "request_id": "AM-REQ-2026-08666",
    "original_inquiry": "Second opinion requested: Urgent: Phase II/III mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5707
  },
  {
    "request_id": "AM-REQ-2026-08667",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.775
  },
  {
    "request_id": "AM-REQ-2026-08668",
    "original_inquiry": "研究者咨询：Oncologist referral: mRNA vaccine positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7749
  },
  {
    "request_id": "AM-REQ-2026-08669",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7133
  },
  {
    "request_id": "AM-REQ-2026-08670",
    "original_inquiry": "研究者咨询：Urgent: Phase II/III mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5418
  },
  {
    "request_id": "AM-REQ-2026-08671",
    "original_inquiry": "Referral from specialist: 患者家属咨询：个体化疫苗晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5969
  },
  {
    "request_id": "AM-REQ-2026-08672",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7016
  },
  {
    "request_id": "AM-REQ-2026-08673",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8496
  },
  {
    "request_id": "AM-REQ-2026-08674",
    "original_inquiry": "Family seeking information: Oncologist referral: mRNA vaccine positive; interested in antibody-drug conjugate inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5169
  },
  {
    "request_id": "AM-REQ-2026-08675",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7123
  },
  {
    "request_id": "AM-REQ-2026-08676",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (KRAS G12C); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.688
  },
  {
    "request_id": "AM-REQ-2026-08677",
    "original_inquiry": "Consultation: Phase II/III with advanced KRAS G12C; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8761
  },
  {
    "request_id": "AM-REQ-2026-08678",
    "original_inquiry": "海外求诊：患者家属咨询：Phase II/III晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7065
  },
  {
    "request_id": "AM-REQ-2026-08679",
    "original_inquiry": "Second opinion requested: 海外求药：mRNA vaccine患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8612
  },
  {
    "request_id": "AM-REQ-2026-08680",
    "original_inquiry": "Urgent: Urgent: Phase II/III mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8072
  },
  {
    "request_id": "AM-REQ-2026-08681",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in KRAS G12C inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.674
  },
  {
    "request_id": "AM-REQ-2026-08682",
    "original_inquiry": "Oncologist referral: mRNA vaccine positive; interested in CAR-T inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7921
  },
  {
    "request_id": "AM-REQ-2026-08683",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8026
  },
  {
    "request_id": "AM-REQ-2026-08684",
    "original_inquiry": "Urgent: ADC联合治疗 mutation confirmed; seeking ADC trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5272
  },
  {
    "request_id": "AM-REQ-2026-08685",
    "original_inquiry": "Second opinion requested: Urgent: Phase II/III mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7541
  },
  {
    "request_id": "AM-REQ-2026-08686",
    "original_inquiry": "研究者咨询：Researcher inquiry: solid tumor trial design and bispecific antibody with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.624
  },
  {
    "request_id": "AM-REQ-2026-08687",
    "original_inquiry": "Second opinion requested: Consultation: combination immunotherapy with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7536
  },
  {
    "request_id": "AM-REQ-2026-08688",
    "original_inquiry": "海外求诊：海外求药：双特异性抗体患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5092
  },
  {
    "request_id": "AM-REQ-2026-08689",
    "original_inquiry": "海外求诊：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6669
  },
  {
    "request_id": "AM-REQ-2026-08690",
    "original_inquiry": "Urgent: 患者家属咨询：ADC联合治疗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8543
  },
  {
    "request_id": "AM-REQ-2026-08691",
    "original_inquiry": "Second opinion requested: Oncologist referral: 双特异性抗体 positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7803
  },
  {
    "request_id": "AM-REQ-2026-08692",
    "original_inquiry": "Urgent: Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5492
  },
  {
    "request_id": "AM-REQ-2026-08693",
    "original_inquiry": "海外求诊：Consultation: Phase II/III with advanced personalized neoantigen; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6866
  },
  {
    "request_id": "AM-REQ-2026-08694",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5747
  },
  {
    "request_id": "AM-REQ-2026-08695",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5672
  },
  {
    "request_id": "AM-REQ-2026-08696",
    "original_inquiry": "研究者咨询：Patient with NSCLC (ADC); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5417
  },
  {
    "request_id": "AM-REQ-2026-08697",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in mRNA cancer vaccine inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8315
  },
  {
    "request_id": "AM-REQ-2026-08698",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.732
  },
  {
    "request_id": "AM-REQ-2026-08699",
    "original_inquiry": "Referral from specialist: Consultation: solid tumor with advanced KRAS G12C; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5632
  },
  {
    "request_id": "AM-REQ-2026-08700",
    "original_inquiry": "研究者咨询：Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6226
  },
  {
    "request_id": "AM-REQ-2026-08701",
    "original_inquiry": "海外求诊：Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.792
  },
  {
    "request_id": "AM-REQ-2026-08702",
    "original_inquiry": "Family seeking information: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6341
  },
  {
    "request_id": "AM-REQ-2026-08703",
    "original_inquiry": "Family seeking information: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-08704",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8327
  },
  {
    "request_id": "AM-REQ-2026-08705",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8467
  },
  {
    "request_id": "AM-REQ-2026-08706",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8078
  },
  {
    "request_id": "AM-REQ-2026-08707",
    "original_inquiry": "Referral from specialist: Researcher inquiry: mRNA vaccine trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6411
  },
  {
    "request_id": "AM-REQ-2026-08708",
    "original_inquiry": "Consultation: Phase II/III with advanced antibody-drug conjugate; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8045
  },
  {
    "request_id": "AM-REQ-2026-08709",
    "original_inquiry": "海外求诊：Consultation: 双特异性抗体 with advanced personalized neoantigen; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7512
  },
  {
    "request_id": "AM-REQ-2026-08710",
    "original_inquiry": "Referral from specialist: Consultation: solid tumor with advanced immune checkpoint; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7609
  },
  {
    "request_id": "AM-REQ-2026-08711",
    "original_inquiry": "Second opinion requested: Consultation: Phase II/III with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5101
  },
  {
    "request_id": "AM-REQ-2026-08712",
    "original_inquiry": "海外求诊：海外求药：双特异性抗体患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6533
  },
  {
    "request_id": "AM-REQ-2026-08713",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7003
  },
  {
    "request_id": "AM-REQ-2026-08714",
    "original_inquiry": "海外求诊：患者家属咨询：NSCLC晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5202
  },
  {
    "request_id": "AM-REQ-2026-08715",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (KRAS G12C); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6626
  },
  {
    "request_id": "AM-REQ-2026-08716",
    "original_inquiry": "Urgent: Researcher inquiry: ADC联合治疗 trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8352
  },
  {
    "request_id": "AM-REQ-2026-08717",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6383
  },
  {
    "request_id": "AM-REQ-2026-08718",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7772
  },
  {
    "request_id": "AM-REQ-2026-08719",
    "original_inquiry": "研究者咨询：Consultation: Phase II/III with advanced immune checkpoint; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6734
  },
  {
    "request_id": "AM-REQ-2026-08720",
    "original_inquiry": "Family seeking information: 患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6056
  },
  {
    "request_id": "AM-REQ-2026-08721",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in personalized neoantigen inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5304
  },
  {
    "request_id": "AM-REQ-2026-08722",
    "original_inquiry": "Referral from specialist: Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.532
  },
  {
    "request_id": "AM-REQ-2026-08723",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.518
  },
  {
    "request_id": "AM-REQ-2026-08724",
    "original_inquiry": "Referral from specialist: Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8626
  },
  {
    "request_id": "AM-REQ-2026-08725",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7477
  },
  {
    "request_id": "AM-REQ-2026-08726",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6539
  },
  {
    "request_id": "AM-REQ-2026-08727",
    "original_inquiry": "Urgent: melanoma mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6405
  },
  {
    "request_id": "AM-REQ-2026-08728",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5235
  },
  {
    "request_id": "AM-REQ-2026-08729",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7858
  },
  {
    "request_id": "AM-REQ-2026-08730",
    "original_inquiry": "海外求药：mRNA vaccine患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6654
  },
  {
    "request_id": "AM-REQ-2026-08731",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8749
  },
  {
    "request_id": "AM-REQ-2026-08732",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7173
  },
  {
    "request_id": "AM-REQ-2026-08733",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6185
  },
  {
    "request_id": "AM-REQ-2026-08734",
    "original_inquiry": "Second opinion requested: 海外求药：melanoma患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8569
  },
  {
    "request_id": "AM-REQ-2026-08735",
    "original_inquiry": "Urgent: Researcher inquiry: solid tumor trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6538
  },
  {
    "request_id": "AM-REQ-2026-08736",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6588
  },
  {
    "request_id": "AM-REQ-2026-08737",
    "original_inquiry": "Second opinion requested: 患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7632
  },
  {
    "request_id": "AM-REQ-2026-08738",
    "original_inquiry": "Second opinion requested: Patient with NSCLC (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6331
  },
  {
    "request_id": "AM-REQ-2026-08739",
    "original_inquiry": "Urgent: Patient with NSCLC (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8216
  },
  {
    "request_id": "AM-REQ-2026-08740",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6345
  },
  {
    "request_id": "AM-REQ-2026-08741",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7773
  },
  {
    "request_id": "AM-REQ-2026-08742",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8156
  },
  {
    "request_id": "AM-REQ-2026-08743",
    "original_inquiry": "研究者咨询：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7548
  },
  {
    "request_id": "AM-REQ-2026-08744",
    "original_inquiry": "海外求药：双特异性抗体患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7706
  },
  {
    "request_id": "AM-REQ-2026-08745",
    "original_inquiry": "Referral from specialist: Urgent: ADC联合治疗 mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7996
  },
  {
    "request_id": "AM-REQ-2026-08746",
    "original_inquiry": "Second opinion requested: Urgent: 双特异性抗体 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8895
  },
  {
    "request_id": "AM-REQ-2026-08747",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7511
  },
  {
    "request_id": "AM-REQ-2026-08748",
    "original_inquiry": "海外求诊：Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8193
  },
  {
    "request_id": "AM-REQ-2026-08749",
    "original_inquiry": "海外求诊：Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7157
  },
  {
    "request_id": "AM-REQ-2026-08750",
    "original_inquiry": "Family seeking information: 海外求药：solid tumor患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-08751",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in antibody-drug conjugate inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5608
  },
  {
    "request_id": "AM-REQ-2026-08752",
    "original_inquiry": "海外求诊：海外求药：mRNA vaccine患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6657
  },
  {
    "request_id": "AM-REQ-2026-08753",
    "original_inquiry": "研究者咨询：Patient with solid tumor (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7564
  },
  {
    "request_id": "AM-REQ-2026-08754",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.874
  },
  {
    "request_id": "AM-REQ-2026-08755",
    "original_inquiry": "Second opinion requested: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7591
  },
  {
    "request_id": "AM-REQ-2026-08756",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6577
  },
  {
    "request_id": "AM-REQ-2026-08757",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-08758",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6139
  },
  {
    "request_id": "AM-REQ-2026-08759",
    "original_inquiry": "Oncologist referral: combination immunotherapy positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7657
  },
  {
    "request_id": "AM-REQ-2026-08760",
    "original_inquiry": "海外求诊：Consultation: combination immunotherapy with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8381
  },
  {
    "request_id": "AM-REQ-2026-08761",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6339
  },
  {
    "request_id": "AM-REQ-2026-08762",
    "original_inquiry": "Second opinion requested: Researcher inquiry: solid tumor trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5475
  },
  {
    "request_id": "AM-REQ-2026-08763",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (bispecific antibody); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8095
  },
  {
    "request_id": "AM-REQ-2026-08764",
    "original_inquiry": "Urgent: Consultation: 双特异性抗体 with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5715
  },
  {
    "request_id": "AM-REQ-2026-08765",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7433
  },
  {
    "request_id": "AM-REQ-2026-08766",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced bispecific antibody; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8703
  },
  {
    "request_id": "AM-REQ-2026-08767",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6455
  },
  {
    "request_id": "AM-REQ-2026-08768",
    "original_inquiry": "Referral from specialist: 海外求药：solid tumor患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8146
  },
  {
    "request_id": "AM-REQ-2026-08769",
    "original_inquiry": "Referral from specialist: Oncologist referral: mRNA vaccine positive; interested in CAR-T inhibitors and bispecific antibody combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5713
  },
  {
    "request_id": "AM-REQ-2026-08770",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7255
  },
  {
    "request_id": "AM-REQ-2026-08771",
    "original_inquiry": "研究者咨询：Researcher inquiry: 双特异性抗体 trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5091
  },
  {
    "request_id": "AM-REQ-2026-08772",
    "original_inquiry": "Urgent: Urgent: mRNA vaccine mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6054
  },
  {
    "request_id": "AM-REQ-2026-08773",
    "original_inquiry": "Second opinion requested: 患者家属咨询：双特异性抗体晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5573
  },
  {
    "request_id": "AM-REQ-2026-08774",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7673
  },
  {
    "request_id": "AM-REQ-2026-08775",
    "original_inquiry": "Family seeking information: 海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6254
  },
  {
    "request_id": "AM-REQ-2026-08776",
    "original_inquiry": "研究者咨询：Consultation: Phase II/III with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6583
  },
  {
    "request_id": "AM-REQ-2026-08777",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8388
  },
  {
    "request_id": "AM-REQ-2026-08778",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5018
  },
  {
    "request_id": "AM-REQ-2026-08779",
    "original_inquiry": "海外求药：ADC联合治疗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8452
  },
  {
    "request_id": "AM-REQ-2026-08780",
    "original_inquiry": "Second opinion requested: 患者家属咨询：Phase II/III晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6689
  },
  {
    "request_id": "AM-REQ-2026-08781",
    "original_inquiry": "Family seeking information: Oncologist referral: mRNA vaccine positive; interested in immune checkpoint inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6762
  },
  {
    "request_id": "AM-REQ-2026-08782",
    "original_inquiry": "Referral from specialist: Consultation: 个体化疫苗 with advanced ADC; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8105
  },
  {
    "request_id": "AM-REQ-2026-08783",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8741
  },
  {
    "request_id": "AM-REQ-2026-08784",
    "original_inquiry": "患者家属咨询：melanoma晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5796
  },
  {
    "request_id": "AM-REQ-2026-08785",
    "original_inquiry": "海外求诊：Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6423
  },
  {
    "request_id": "AM-REQ-2026-08786",
    "original_inquiry": "研究者咨询：Consultation: melanoma with advanced ADC; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8148
  },
  {
    "request_id": "AM-REQ-2026-08787",
    "original_inquiry": "海外求诊：Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5484
  },
  {
    "request_id": "AM-REQ-2026-08788",
    "original_inquiry": "Referral from specialist: 海外求药：solid tumor患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6294
  },
  {
    "request_id": "AM-REQ-2026-08789",
    "original_inquiry": "Urgent: Patient with combination immunotherapy (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6737
  },
  {
    "request_id": "AM-REQ-2026-08790",
    "original_inquiry": "海外求诊：Consultation: 个体化疫苗 with advanced mRNA cancer vaccine; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7104
  },
  {
    "request_id": "AM-REQ-2026-08791",
    "original_inquiry": "Family seeking information: Oncologist referral: solid tumor positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8507
  },
  {
    "request_id": "AM-REQ-2026-08792",
    "original_inquiry": "海外求诊：Oncologist referral: ADC联合治疗 positive; interested in personalized neoantigen inhibitors and CAR-T combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7433
  },
  {
    "request_id": "AM-REQ-2026-08793",
    "original_inquiry": "Family seeking information: Patient with melanoma (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.674
  },
  {
    "request_id": "AM-REQ-2026-08794",
    "original_inquiry": "Second opinion requested: 海外求药：solid tumor患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5125
  },
  {
    "request_id": "AM-REQ-2026-08795",
    "original_inquiry": "Urgent: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7013
  },
  {
    "request_id": "AM-REQ-2026-08796",
    "original_inquiry": "Referral from specialist: 海外求药：combination immunotherapy患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8556
  },
  {
    "request_id": "AM-REQ-2026-08797",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.821
  },
  {
    "request_id": "AM-REQ-2026-08798",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8651
  },
  {
    "request_id": "AM-REQ-2026-08799",
    "original_inquiry": "海外求诊：Consultation: NSCLC with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.667
  },
  {
    "request_id": "AM-REQ-2026-08800",
    "original_inquiry": "Referral from specialist: Urgent: ADC联合治疗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5172
  },
  {
    "request_id": "AM-REQ-2026-08801",
    "original_inquiry": "Patient with NSCLC (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5579
  },
  {
    "request_id": "AM-REQ-2026-08802",
    "original_inquiry": "海外求诊：Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6316
  },
  {
    "request_id": "AM-REQ-2026-08803",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7595
  },
  {
    "request_id": "AM-REQ-2026-08804",
    "original_inquiry": "海外求诊：Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and bispecific antibody combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8402
  },
  {
    "request_id": "AM-REQ-2026-08805",
    "original_inquiry": "研究者咨询：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5217
  },
  {
    "request_id": "AM-REQ-2026-08806",
    "original_inquiry": "Urgent: Urgent: mRNA vaccine mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7633
  },
  {
    "request_id": "AM-REQ-2026-08807",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5278
  },
  {
    "request_id": "AM-REQ-2026-08808",
    "original_inquiry": "Family seeking information: Consultation: solid tumor with advanced KRAS G12C; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8949
  },
  {
    "request_id": "AM-REQ-2026-08809",
    "original_inquiry": "海外求诊：Patient with combination immunotherapy (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6719
  },
  {
    "request_id": "AM-REQ-2026-08810",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6785
  },
  {
    "request_id": "AM-REQ-2026-08811",
    "original_inquiry": "Urgent: Patient with 个体化疫苗 (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.66
  },
  {
    "request_id": "AM-REQ-2026-08812",
    "original_inquiry": "Urgent: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8345
  },
  {
    "request_id": "AM-REQ-2026-08813",
    "original_inquiry": "海外求诊：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8782
  },
  {
    "request_id": "AM-REQ-2026-08814",
    "original_inquiry": "Urgent: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6938
  },
  {
    "request_id": "AM-REQ-2026-08815",
    "original_inquiry": "Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8611
  },
  {
    "request_id": "AM-REQ-2026-08816",
    "original_inquiry": "Urgent: 患者家属咨询：solid tumor晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6374
  },
  {
    "request_id": "AM-REQ-2026-08817",
    "original_inquiry": "研究者咨询：Patient with NSCLC (ADC); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.555
  },
  {
    "request_id": "AM-REQ-2026-08818",
    "original_inquiry": "研究者咨询：Consultation: melanoma with advanced immune checkpoint; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8504
  },
  {
    "request_id": "AM-REQ-2026-08819",
    "original_inquiry": "海外求诊：Consultation: mRNA vaccine with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8909
  },
  {
    "request_id": "AM-REQ-2026-08820",
    "original_inquiry": "Referral from specialist: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7552
  },
  {
    "request_id": "AM-REQ-2026-08821",
    "original_inquiry": "Family seeking information: 海外求药：个体化疫苗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8848
  },
  {
    "request_id": "AM-REQ-2026-08822",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 双特异性抗体 trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.802
  },
  {
    "request_id": "AM-REQ-2026-08823",
    "original_inquiry": "Second opinion requested: 患者家属咨询：combination immunotherapy晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7222
  },
  {
    "request_id": "AM-REQ-2026-08824",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6854
  },
  {
    "request_id": "AM-REQ-2026-08825",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5552
  },
  {
    "request_id": "AM-REQ-2026-08826",
    "original_inquiry": "Second opinion requested: Patient with 双特异性抗体 (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5019
  },
  {
    "request_id": "AM-REQ-2026-08827",
    "original_inquiry": "研究者咨询：患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5042
  },
  {
    "request_id": "AM-REQ-2026-08828",
    "original_inquiry": "Family seeking information: Researcher inquiry: 个体化疫苗 trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7172
  },
  {
    "request_id": "AM-REQ-2026-08829",
    "original_inquiry": "Oncologist referral: mRNA vaccine positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.741
  },
  {
    "request_id": "AM-REQ-2026-08830",
    "original_inquiry": "Family seeking information: Urgent: NSCLC mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8628
  },
  {
    "request_id": "AM-REQ-2026-08831",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6718
  },
  {
    "request_id": "AM-REQ-2026-08832",
    "original_inquiry": "Family seeking information: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5155
  },
  {
    "request_id": "AM-REQ-2026-08833",
    "original_inquiry": "海外求药：NSCLC患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7942
  },
  {
    "request_id": "AM-REQ-2026-08834",
    "original_inquiry": "Second opinion requested: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6272
  },
  {
    "request_id": "AM-REQ-2026-08835",
    "original_inquiry": "Family seeking information: Urgent: 双特异性抗体 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6681
  },
  {
    "request_id": "AM-REQ-2026-08836",
    "original_inquiry": "Family seeking information: Consultation: melanoma with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5542
  },
  {
    "request_id": "AM-REQ-2026-08837",
    "original_inquiry": "研究者咨询：Patient with NSCLC (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6497
  },
  {
    "request_id": "AM-REQ-2026-08838",
    "original_inquiry": "Second opinion requested: Consultation: solid tumor with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5126
  },
  {
    "request_id": "AM-REQ-2026-08839",
    "original_inquiry": "Referral from specialist: Consultation: melanoma with advanced personalized neoantigen; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-08840",
    "original_inquiry": "Family seeking information: 患者家属咨询：NSCLC晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7315
  },
  {
    "request_id": "AM-REQ-2026-08841",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.765
  },
  {
    "request_id": "AM-REQ-2026-08842",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8648
  },
  {
    "request_id": "AM-REQ-2026-08843",
    "original_inquiry": "海外求诊：Consultation: ADC联合治疗 with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8281
  },
  {
    "request_id": "AM-REQ-2026-08844",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in CAR-T inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7914
  },
  {
    "request_id": "AM-REQ-2026-08845",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6253
  },
  {
    "request_id": "AM-REQ-2026-08846",
    "original_inquiry": "Urgent: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6666
  },
  {
    "request_id": "AM-REQ-2026-08847",
    "original_inquiry": "Patient with solid tumor (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6527
  },
  {
    "request_id": "AM-REQ-2026-08848",
    "original_inquiry": "Consultation: solid tumor with advanced mRNA cancer vaccine; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8587
  },
  {
    "request_id": "AM-REQ-2026-08849",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6791
  },
  {
    "request_id": "AM-REQ-2026-08850",
    "original_inquiry": "Urgent: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.835
  },
  {
    "request_id": "AM-REQ-2026-08851",
    "original_inquiry": "Referral from specialist: 海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6812
  },
  {
    "request_id": "AM-REQ-2026-08852",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced CAR-T; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7328
  },
  {
    "request_id": "AM-REQ-2026-08853",
    "original_inquiry": "Family seeking information: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8098
  },
  {
    "request_id": "AM-REQ-2026-08854",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8666
  },
  {
    "request_id": "AM-REQ-2026-08855",
    "original_inquiry": "研究者咨询：患者家属咨询：solid tumor晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8349
  },
  {
    "request_id": "AM-REQ-2026-08856",
    "original_inquiry": "Family seeking information: Patient with combination immunotherapy (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6415
  },
  {
    "request_id": "AM-REQ-2026-08857",
    "original_inquiry": "Urgent: Researcher inquiry: 双特异性抗体 trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.673
  },
  {
    "request_id": "AM-REQ-2026-08858",
    "original_inquiry": "研究者咨询：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8239
  },
  {
    "request_id": "AM-REQ-2026-08859",
    "original_inquiry": "海外求诊：Patient with solid tumor (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5382
  },
  {
    "request_id": "AM-REQ-2026-08860",
    "original_inquiry": "研究者咨询：Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8623
  },
  {
    "request_id": "AM-REQ-2026-08861",
    "original_inquiry": "海外求诊：Researcher inquiry: melanoma trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7287
  },
  {
    "request_id": "AM-REQ-2026-08862",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5724
  },
  {
    "request_id": "AM-REQ-2026-08863",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6614
  },
  {
    "request_id": "AM-REQ-2026-08864",
    "original_inquiry": "Second opinion requested: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7206
  },
  {
    "request_id": "AM-REQ-2026-08865",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.646
  },
  {
    "request_id": "AM-REQ-2026-08866",
    "original_inquiry": "Referral from specialist: Urgent: solid tumor mutation confirmed; seeking ADC trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6389
  },
  {
    "request_id": "AM-REQ-2026-08867",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.593
  },
  {
    "request_id": "AM-REQ-2026-08868",
    "original_inquiry": "Referral from specialist: Urgent: Phase II/III mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5631
  },
  {
    "request_id": "AM-REQ-2026-08869",
    "original_inquiry": "海外求诊：患者家属咨询：solid tumor晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6844
  },
  {
    "request_id": "AM-REQ-2026-08870",
    "original_inquiry": "海外求诊：Urgent: mRNA vaccine mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7645
  },
  {
    "request_id": "AM-REQ-2026-08871",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6911
  },
  {
    "request_id": "AM-REQ-2026-08872",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7976
  },
  {
    "request_id": "AM-REQ-2026-08873",
    "original_inquiry": "Urgent: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8773
  },
  {
    "request_id": "AM-REQ-2026-08874",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7134
  },
  {
    "request_id": "AM-REQ-2026-08875",
    "original_inquiry": "海外求诊：Oncologist referral: 个体化疫苗 positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7453
  },
  {
    "request_id": "AM-REQ-2026-08876",
    "original_inquiry": "Family seeking information: 海外求药：solid tumor患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5881
  },
  {
    "request_id": "AM-REQ-2026-08877",
    "original_inquiry": "Second opinion requested: 患者家属咨询：solid tumor晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8565
  },
  {
    "request_id": "AM-REQ-2026-08878",
    "original_inquiry": "Referral from specialist: Researcher inquiry: mRNA vaccine trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5261
  },
  {
    "request_id": "AM-REQ-2026-08879",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced ADC; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7721
  },
  {
    "request_id": "AM-REQ-2026-08880",
    "original_inquiry": "Referral from specialist: Patient with combination immunotherapy (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5125
  },
  {
    "request_id": "AM-REQ-2026-08881",
    "original_inquiry": "研究者咨询：Consultation: mRNA vaccine with advanced CAR-T; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8885
  },
  {
    "request_id": "AM-REQ-2026-08882",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced KRAS G12C; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.52
  },
  {
    "request_id": "AM-REQ-2026-08883",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6476
  },
  {
    "request_id": "AM-REQ-2026-08884",
    "original_inquiry": "Second opinion requested: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8851
  },
  {
    "request_id": "AM-REQ-2026-08885",
    "original_inquiry": "Family seeking information: Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8865
  },
  {
    "request_id": "AM-REQ-2026-08886",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8533
  },
  {
    "request_id": "AM-REQ-2026-08887",
    "original_inquiry": "Second opinion requested: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5297
  },
  {
    "request_id": "AM-REQ-2026-08888",
    "original_inquiry": "Second opinion requested: Patient with 双特异性抗体 (personalized neoantigen); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6452
  },
  {
    "request_id": "AM-REQ-2026-08889",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8994
  },
  {
    "request_id": "AM-REQ-2026-08890",
    "original_inquiry": "Family seeking information: Patient with solid tumor (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8564
  },
  {
    "request_id": "AM-REQ-2026-08891",
    "original_inquiry": "海外求诊：Researcher inquiry: 个体化疫苗 trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-08892",
    "original_inquiry": "研究者咨询：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5247
  },
  {
    "request_id": "AM-REQ-2026-08893",
    "original_inquiry": "Second opinion requested: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5433
  },
  {
    "request_id": "AM-REQ-2026-08894",
    "original_inquiry": "Family seeking information: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8232
  },
  {
    "request_id": "AM-REQ-2026-08895",
    "original_inquiry": "研究者咨询：Consultation: combination immunotherapy with advanced immune checkpoint; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6385
  },
  {
    "request_id": "AM-REQ-2026-08896",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7178
  },
  {
    "request_id": "AM-REQ-2026-08897",
    "original_inquiry": "Family seeking information: Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5972
  },
  {
    "request_id": "AM-REQ-2026-08898",
    "original_inquiry": "Urgent: Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7626
  },
  {
    "request_id": "AM-REQ-2026-08899",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7302
  },
  {
    "request_id": "AM-REQ-2026-08900",
    "original_inquiry": "Patient with solid tumor (immune checkpoint); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8266
  },
  {
    "request_id": "AM-REQ-2026-08901",
    "original_inquiry": "Urgent: Consultation: Phase II/III with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6413
  },
  {
    "request_id": "AM-REQ-2026-08902",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5371
  },
  {
    "request_id": "AM-REQ-2026-08903",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5873
  },
  {
    "request_id": "AM-REQ-2026-08904",
    "original_inquiry": "研究者咨询：Patient with solid tumor (bispecific antibody); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5337
  },
  {
    "request_id": "AM-REQ-2026-08905",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8327
  },
  {
    "request_id": "AM-REQ-2026-08906",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7999
  },
  {
    "request_id": "AM-REQ-2026-08907",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced immune checkpoint; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.813
  },
  {
    "request_id": "AM-REQ-2026-08908",
    "original_inquiry": "Consultation: 双特异性抗体 with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8191
  },
  {
    "request_id": "AM-REQ-2026-08909",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7334
  },
  {
    "request_id": "AM-REQ-2026-08910",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5334
  },
  {
    "request_id": "AM-REQ-2026-08911",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8723
  },
  {
    "request_id": "AM-REQ-2026-08912",
    "original_inquiry": "Second opinion requested: 患者家属咨询：NSCLC晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6805
  },
  {
    "request_id": "AM-REQ-2026-08913",
    "original_inquiry": "研究者咨询：Researcher inquiry: Phase II/III trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5285
  },
  {
    "request_id": "AM-REQ-2026-08914",
    "original_inquiry": "Patient with 双特异性抗体 (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.636
  },
  {
    "request_id": "AM-REQ-2026-08915",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6064
  },
  {
    "request_id": "AM-REQ-2026-08916",
    "original_inquiry": "Family seeking information: Researcher inquiry: Phase II/III trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6859
  },
  {
    "request_id": "AM-REQ-2026-08917",
    "original_inquiry": "Family seeking information: Researcher inquiry: NSCLC trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7862
  },
  {
    "request_id": "AM-REQ-2026-08918",
    "original_inquiry": "Referral from specialist: Patient with solid tumor (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6703
  },
  {
    "request_id": "AM-REQ-2026-08919",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7121
  },
  {
    "request_id": "AM-REQ-2026-08920",
    "original_inquiry": "研究者咨询：海外求药：双特异性抗体患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8812
  },
  {
    "request_id": "AM-REQ-2026-08921",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.581
  },
  {
    "request_id": "AM-REQ-2026-08922",
    "original_inquiry": "研究者咨询：Patient with mRNA vaccine (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5315
  },
  {
    "request_id": "AM-REQ-2026-08923",
    "original_inquiry": "研究者咨询：Oncologist referral: 个体化疫苗 positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6023
  },
  {
    "request_id": "AM-REQ-2026-08924",
    "original_inquiry": "Consultation: 个体化疫苗 with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7438
  },
  {
    "request_id": "AM-REQ-2026-08925",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced immune checkpoint; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5792
  },
  {
    "request_id": "AM-REQ-2026-08926",
    "original_inquiry": "Second opinion requested: Urgent: ADC联合治疗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.659
  },
  {
    "request_id": "AM-REQ-2026-08927",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5572
  },
  {
    "request_id": "AM-REQ-2026-08928",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5253
  },
  {
    "request_id": "AM-REQ-2026-08929",
    "original_inquiry": "Urgent: 海外求药：combination immunotherapy患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6498
  },
  {
    "request_id": "AM-REQ-2026-08930",
    "original_inquiry": "Referral from specialist: 患者家属咨询：combination immunotherapy晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-08931",
    "original_inquiry": "Urgent: Oncologist referral: 个体化疫苗 positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7504
  },
  {
    "request_id": "AM-REQ-2026-08932",
    "original_inquiry": "Referral from specialist: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.9
  },
  {
    "request_id": "AM-REQ-2026-08933",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6994
  },
  {
    "request_id": "AM-REQ-2026-08934",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7918
  },
  {
    "request_id": "AM-REQ-2026-08935",
    "original_inquiry": "Family seeking information: 海外求药：个体化疫苗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.806
  },
  {
    "request_id": "AM-REQ-2026-08936",
    "original_inquiry": "Referral from specialist: Patient with 双特异性抗体 (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8256
  },
  {
    "request_id": "AM-REQ-2026-08937",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6281
  },
  {
    "request_id": "AM-REQ-2026-08938",
    "original_inquiry": "Family seeking information: Researcher inquiry: 个体化疫苗 trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.531
  },
  {
    "request_id": "AM-REQ-2026-08939",
    "original_inquiry": "Second opinion requested: Oncologist referral: solid tumor positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7301
  },
  {
    "request_id": "AM-REQ-2026-08940",
    "original_inquiry": "Patient with solid tumor (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6717
  },
  {
    "request_id": "AM-REQ-2026-08941",
    "original_inquiry": "Referral from specialist: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-08942",
    "original_inquiry": "Urgent: Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7842
  },
  {
    "request_id": "AM-REQ-2026-08943",
    "original_inquiry": "Patient with ADC联合治疗 (immune checkpoint); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8434
  },
  {
    "request_id": "AM-REQ-2026-08944",
    "original_inquiry": "患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6431
  },
  {
    "request_id": "AM-REQ-2026-08945",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in ADC inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.727
  },
  {
    "request_id": "AM-REQ-2026-08946",
    "original_inquiry": "Second opinion requested: Urgent: melanoma mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7475
  },
  {
    "request_id": "AM-REQ-2026-08947",
    "original_inquiry": "研究者咨询：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7456
  },
  {
    "request_id": "AM-REQ-2026-08948",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7747
  },
  {
    "request_id": "AM-REQ-2026-08949",
    "original_inquiry": "Second opinion requested: Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8262
  },
  {
    "request_id": "AM-REQ-2026-08950",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6738
  },
  {
    "request_id": "AM-REQ-2026-08951",
    "original_inquiry": "Patient with 个体化疫苗 (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7371
  },
  {
    "request_id": "AM-REQ-2026-08952",
    "original_inquiry": "Referral from specialist: Consultation: ADC联合治疗 with advanced bispecific antibody; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6201
  },
  {
    "request_id": "AM-REQ-2026-08953",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5245
  },
  {
    "request_id": "AM-REQ-2026-08954",
    "original_inquiry": "海外求药：melanoma患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6704
  },
  {
    "request_id": "AM-REQ-2026-08955",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8185
  },
  {
    "request_id": "AM-REQ-2026-08956",
    "original_inquiry": "海外求诊：Urgent: Phase II/III mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8122
  },
  {
    "request_id": "AM-REQ-2026-08957",
    "original_inquiry": "Consultation: solid tumor with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7187
  },
  {
    "request_id": "AM-REQ-2026-08958",
    "original_inquiry": "Patient with mRNA vaccine (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7867
  },
  {
    "request_id": "AM-REQ-2026-08959",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.519
  },
  {
    "request_id": "AM-REQ-2026-08960",
    "original_inquiry": "海外求诊：海外求药：solid tumor患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7431
  },
  {
    "request_id": "AM-REQ-2026-08961",
    "original_inquiry": "海外求诊：Urgent: combination immunotherapy mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5447
  },
  {
    "request_id": "AM-REQ-2026-08962",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8966
  },
  {
    "request_id": "AM-REQ-2026-08963",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-08964",
    "original_inquiry": "Family seeking information: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6967
  },
  {
    "request_id": "AM-REQ-2026-08965",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-08966",
    "original_inquiry": "研究者咨询：Urgent: combination immunotherapy mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5214
  },
  {
    "request_id": "AM-REQ-2026-08967",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in bispecific antibody inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5992
  },
  {
    "request_id": "AM-REQ-2026-08968",
    "original_inquiry": "Urgent: 海外求药：个体化疫苗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5036
  },
  {
    "request_id": "AM-REQ-2026-08969",
    "original_inquiry": "海外求诊：Patient with 双特异性抗体 (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6536
  },
  {
    "request_id": "AM-REQ-2026-08970",
    "original_inquiry": "Researcher inquiry: solid tumor trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7691
  },
  {
    "request_id": "AM-REQ-2026-08971",
    "original_inquiry": "Family seeking information: Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6663
  },
  {
    "request_id": "AM-REQ-2026-08972",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5283
  },
  {
    "request_id": "AM-REQ-2026-08973",
    "original_inquiry": "Second opinion requested: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5013
  },
  {
    "request_id": "AM-REQ-2026-08974",
    "original_inquiry": "Second opinion requested: Urgent: combination immunotherapy mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6886
  },
  {
    "request_id": "AM-REQ-2026-08975",
    "original_inquiry": "Second opinion requested: Patient with mRNA vaccine (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5565
  },
  {
    "request_id": "AM-REQ-2026-08976",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7797
  },
  {
    "request_id": "AM-REQ-2026-08977",
    "original_inquiry": "研究者咨询：患者家属咨询：NSCLC晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6421
  },
  {
    "request_id": "AM-REQ-2026-08978",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.808
  },
  {
    "request_id": "AM-REQ-2026-08979",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8392
  },
  {
    "request_id": "AM-REQ-2026-08980",
    "original_inquiry": "Family seeking information: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6322
  },
  {
    "request_id": "AM-REQ-2026-08981",
    "original_inquiry": "海外求诊：海外求药：mRNA vaccine患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7461
  },
  {
    "request_id": "AM-REQ-2026-08982",
    "original_inquiry": "海外求诊：患者家属咨询：melanoma晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5756
  },
  {
    "request_id": "AM-REQ-2026-08983",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5499
  },
  {
    "request_id": "AM-REQ-2026-08984",
    "original_inquiry": "Urgent: 海外求药：个体化疫苗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5398
  },
  {
    "request_id": "AM-REQ-2026-08985",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (antibody-drug conjugate); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6009
  },
  {
    "request_id": "AM-REQ-2026-08986",
    "original_inquiry": "海外求诊：Consultation: ADC联合治疗 with advanced personalized neoantigen; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.721
  },
  {
    "request_id": "AM-REQ-2026-08987",
    "original_inquiry": "Referral from specialist: Patient with 双特异性抗体 (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5752
  },
  {
    "request_id": "AM-REQ-2026-08988",
    "original_inquiry": "Urgent: Patient with solid tumor (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8792
  },
  {
    "request_id": "AM-REQ-2026-08989",
    "original_inquiry": "Urgent: mRNA vaccine mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8311
  },
  {
    "request_id": "AM-REQ-2026-08990",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8258
  },
  {
    "request_id": "AM-REQ-2026-08991",
    "original_inquiry": "Second opinion requested: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5832
  },
  {
    "request_id": "AM-REQ-2026-08992",
    "original_inquiry": "Referral from specialist: Consultation: ADC联合治疗 with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8777
  },
  {
    "request_id": "AM-REQ-2026-08993",
    "original_inquiry": "Family seeking information: Consultation: Phase II/III with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.623
  },
  {
    "request_id": "AM-REQ-2026-08994",
    "original_inquiry": "Second opinion requested: Patient with NSCLC (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5688
  },
  {
    "request_id": "AM-REQ-2026-08995",
    "original_inquiry": "研究者咨询：Consultation: mRNA vaccine with advanced KRAS G12C; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5294
  },
  {
    "request_id": "AM-REQ-2026-08996",
    "original_inquiry": "Consultation: 个体化疫苗 with advanced ADC; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7095
  },
  {
    "request_id": "AM-REQ-2026-08997",
    "original_inquiry": "Referral from specialist: Consultation: Phase II/III with advanced personalized neoantigen; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7935
  },
  {
    "request_id": "AM-REQ-2026-08998",
    "original_inquiry": "Family seeking information: Researcher inquiry: 双特异性抗体 trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.787
  },
  {
    "request_id": "AM-REQ-2026-08999",
    "original_inquiry": "研究者咨询：Researcher inquiry: solid tumor trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8021
  },
  {
    "request_id": "AM-REQ-2026-09000",
    "original_inquiry": "研究者咨询：Researcher inquiry: mRNA vaccine trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7078
  },
  {
    "request_id": "AM-REQ-2026-09001",
    "original_inquiry": "海外求药：solid tumor患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5316
  },
  {
    "request_id": "AM-REQ-2026-09002",
    "original_inquiry": "海外求诊：患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8688
  },
  {
    "request_id": "AM-REQ-2026-09003",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8529
  },
  {
    "request_id": "AM-REQ-2026-09004",
    "original_inquiry": "Second opinion requested: Oncologist referral: Phase II/III positive; interested in mRNA cancer vaccine inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.531
  },
  {
    "request_id": "AM-REQ-2026-09005",
    "original_inquiry": "海外求药：NSCLC患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6601
  },
  {
    "request_id": "AM-REQ-2026-09006",
    "original_inquiry": "Family seeking information: 患者家属咨询：combination immunotherapy晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5851
  },
  {
    "request_id": "AM-REQ-2026-09007",
    "original_inquiry": "海外求诊：Oncologist referral: Phase II/III positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8106
  },
  {
    "request_id": "AM-REQ-2026-09008",
    "original_inquiry": "海外求诊：Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7746
  },
  {
    "request_id": "AM-REQ-2026-09009",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8206
  },
  {
    "request_id": "AM-REQ-2026-09010",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5763
  },
  {
    "request_id": "AM-REQ-2026-09011",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6632
  },
  {
    "request_id": "AM-REQ-2026-09012",
    "original_inquiry": "研究者咨询：海外求药：melanoma患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6763
  },
  {
    "request_id": "AM-REQ-2026-09013",
    "original_inquiry": "Urgent: 海外求药：NSCLC患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5417
  },
  {
    "request_id": "AM-REQ-2026-09014",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5927
  },
  {
    "request_id": "AM-REQ-2026-09015",
    "original_inquiry": "海外求药：双特异性抗体患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.838
  },
  {
    "request_id": "AM-REQ-2026-09016",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8252
  },
  {
    "request_id": "AM-REQ-2026-09017",
    "original_inquiry": "海外求诊：Researcher inquiry: combination immunotherapy trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5865
  },
  {
    "request_id": "AM-REQ-2026-09018",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6173
  },
  {
    "request_id": "AM-REQ-2026-09019",
    "original_inquiry": "Urgent: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6829
  },
  {
    "request_id": "AM-REQ-2026-09020",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6507
  },
  {
    "request_id": "AM-REQ-2026-09021",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.592
  },
  {
    "request_id": "AM-REQ-2026-09022",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.84
  },
  {
    "request_id": "AM-REQ-2026-09023",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7741
  },
  {
    "request_id": "AM-REQ-2026-09024",
    "original_inquiry": "海外求药：双特异性抗体患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.698
  },
  {
    "request_id": "AM-REQ-2026-09025",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.578
  },
  {
    "request_id": "AM-REQ-2026-09026",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in mRNA cancer vaccine inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5594
  },
  {
    "request_id": "AM-REQ-2026-09027",
    "original_inquiry": "海外求药：双特异性抗体患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6876
  },
  {
    "request_id": "AM-REQ-2026-09028",
    "original_inquiry": "Patient with melanoma (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5612
  },
  {
    "request_id": "AM-REQ-2026-09029",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5566
  },
  {
    "request_id": "AM-REQ-2026-09030",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in mRNA cancer vaccine inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6368
  },
  {
    "request_id": "AM-REQ-2026-09031",
    "original_inquiry": "研究者咨询：Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.821
  },
  {
    "request_id": "AM-REQ-2026-09032",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8677
  },
  {
    "request_id": "AM-REQ-2026-09033",
    "original_inquiry": "Referral from specialist: 海外求药：Phase II/III患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6149
  },
  {
    "request_id": "AM-REQ-2026-09034",
    "original_inquiry": "海外求诊：Researcher inquiry: NSCLC trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6125
  },
  {
    "request_id": "AM-REQ-2026-09035",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7211
  },
  {
    "request_id": "AM-REQ-2026-09036",
    "original_inquiry": "海外求诊：患者家属咨询：mRNA vaccine晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6768
  },
  {
    "request_id": "AM-REQ-2026-09037",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced antibody-drug conjugate; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6889
  },
  {
    "request_id": "AM-REQ-2026-09038",
    "original_inquiry": "Consultation: 个体化疫苗 with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5677
  },
  {
    "request_id": "AM-REQ-2026-09039",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6273
  },
  {
    "request_id": "AM-REQ-2026-09040",
    "original_inquiry": "Family seeking information: Researcher inquiry: 个体化疫苗 trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-09041",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6148
  },
  {
    "request_id": "AM-REQ-2026-09042",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7912
  },
  {
    "request_id": "AM-REQ-2026-09043",
    "original_inquiry": "Urgent: 患者家属咨询：Phase II/III晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.866
  },
  {
    "request_id": "AM-REQ-2026-09044",
    "original_inquiry": "Second opinion requested: Consultation: NSCLC with advanced KRAS G12C; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.59
  },
  {
    "request_id": "AM-REQ-2026-09045",
    "original_inquiry": "Referral from specialist: Urgent: mRNA vaccine mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7618
  },
  {
    "request_id": "AM-REQ-2026-09046",
    "original_inquiry": "Urgent: Urgent: mRNA vaccine mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6013
  },
  {
    "request_id": "AM-REQ-2026-09047",
    "original_inquiry": "Urgent: Patient with NSCLC (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6247
  },
  {
    "request_id": "AM-REQ-2026-09048",
    "original_inquiry": "海外求诊：Consultation: combination immunotherapy with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8016
  },
  {
    "request_id": "AM-REQ-2026-09049",
    "original_inquiry": "研究者咨询：海外求药：Phase II/III患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7934
  },
  {
    "request_id": "AM-REQ-2026-09050",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6755
  },
  {
    "request_id": "AM-REQ-2026-09051",
    "original_inquiry": "Urgent: Oncologist referral: combination immunotherapy positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6466
  },
  {
    "request_id": "AM-REQ-2026-09052",
    "original_inquiry": "研究者咨询：Consultation: mRNA vaccine with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7366
  },
  {
    "request_id": "AM-REQ-2026-09053",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7603
  },
  {
    "request_id": "AM-REQ-2026-09054",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced ADC; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.581
  },
  {
    "request_id": "AM-REQ-2026-09055",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in bispecific antibody inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8074
  },
  {
    "request_id": "AM-REQ-2026-09056",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7495
  },
  {
    "request_id": "AM-REQ-2026-09057",
    "original_inquiry": "Second opinion requested: Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6396
  },
  {
    "request_id": "AM-REQ-2026-09058",
    "original_inquiry": "Family seeking information: Urgent: NSCLC mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5309
  },
  {
    "request_id": "AM-REQ-2026-09059",
    "original_inquiry": "Referral from specialist: Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8014
  },
  {
    "request_id": "AM-REQ-2026-09060",
    "original_inquiry": "Urgent: 患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5889
  },
  {
    "request_id": "AM-REQ-2026-09061",
    "original_inquiry": "Second opinion requested: 海外求药：combination immunotherapy患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7523
  },
  {
    "request_id": "AM-REQ-2026-09062",
    "original_inquiry": "Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7617
  },
  {
    "request_id": "AM-REQ-2026-09063",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and personalized neoantigen with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5381
  },
  {
    "request_id": "AM-REQ-2026-09064",
    "original_inquiry": "研究者咨询：Patient with NSCLC (bispecific antibody); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5176
  },
  {
    "request_id": "AM-REQ-2026-09065",
    "original_inquiry": "Urgent: Consultation: ADC联合治疗 with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.601
  },
  {
    "request_id": "AM-REQ-2026-09066",
    "original_inquiry": "研究者咨询：患者家属咨询：双特异性抗体晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6759
  },
  {
    "request_id": "AM-REQ-2026-09067",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7344
  },
  {
    "request_id": "AM-REQ-2026-09068",
    "original_inquiry": "研究者咨询：Consultation: 双特异性抗体 with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7169
  },
  {
    "request_id": "AM-REQ-2026-09069",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8555
  },
  {
    "request_id": "AM-REQ-2026-09070",
    "original_inquiry": "Urgent: Researcher inquiry: 双特异性抗体 trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.604
  },
  {
    "request_id": "AM-REQ-2026-09071",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5453
  },
  {
    "request_id": "AM-REQ-2026-09072",
    "original_inquiry": "Researcher inquiry: combination immunotherapy trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8314
  },
  {
    "request_id": "AM-REQ-2026-09073",
    "original_inquiry": "Second opinion requested: Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7553
  },
  {
    "request_id": "AM-REQ-2026-09074",
    "original_inquiry": "Second opinion requested: Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8062
  },
  {
    "request_id": "AM-REQ-2026-09075",
    "original_inquiry": "Second opinion requested: 海外求药：个体化疫苗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5992
  },
  {
    "request_id": "AM-REQ-2026-09076",
    "original_inquiry": "患者家属咨询：NSCLC晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5759
  },
  {
    "request_id": "AM-REQ-2026-09077",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8741
  },
  {
    "request_id": "AM-REQ-2026-09078",
    "original_inquiry": "Patient with solid tumor (ADC); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8339
  },
  {
    "request_id": "AM-REQ-2026-09079",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5594
  },
  {
    "request_id": "AM-REQ-2026-09080",
    "original_inquiry": "海外求诊：海外求药：mRNA vaccine患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6821
  },
  {
    "request_id": "AM-REQ-2026-09081",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (KRAS G12C); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6926
  },
  {
    "request_id": "AM-REQ-2026-09082",
    "original_inquiry": "海外求诊：海外求药：solid tumor患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7183
  },
  {
    "request_id": "AM-REQ-2026-09083",
    "original_inquiry": "Referral from specialist: Consultation: Phase II/III with advanced KRAS G12C; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6123
  },
  {
    "request_id": "AM-REQ-2026-09084",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5141
  },
  {
    "request_id": "AM-REQ-2026-09085",
    "original_inquiry": "Family seeking information: 海外求药：melanoma患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8312
  },
  {
    "request_id": "AM-REQ-2026-09086",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7302
  },
  {
    "request_id": "AM-REQ-2026-09087",
    "original_inquiry": "Urgent: Patient with mRNA vaccine (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8879
  },
  {
    "request_id": "AM-REQ-2026-09088",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced KRAS G12C; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5468
  },
  {
    "request_id": "AM-REQ-2026-09089",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8243
  },
  {
    "request_id": "AM-REQ-2026-09090",
    "original_inquiry": "Second opinion requested: Consultation: NSCLC with advanced ADC; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5392
  },
  {
    "request_id": "AM-REQ-2026-09091",
    "original_inquiry": "研究者咨询：Researcher inquiry: Phase II/III trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5167
  },
  {
    "request_id": "AM-REQ-2026-09092",
    "original_inquiry": "Urgent: 海外求药：melanoma患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6249
  },
  {
    "request_id": "AM-REQ-2026-09093",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.749
  },
  {
    "request_id": "AM-REQ-2026-09094",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8205
  },
  {
    "request_id": "AM-REQ-2026-09095",
    "original_inquiry": "Referral from specialist: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7218
  },
  {
    "request_id": "AM-REQ-2026-09096",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6732
  },
  {
    "request_id": "AM-REQ-2026-09097",
    "original_inquiry": "Family seeking information: Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6098
  },
  {
    "request_id": "AM-REQ-2026-09098",
    "original_inquiry": "海外求诊：患者家属咨询：个体化疫苗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5071
  },
  {
    "request_id": "AM-REQ-2026-09099",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in KRAS G12C inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8299
  },
  {
    "request_id": "AM-REQ-2026-09100",
    "original_inquiry": "Urgent: Urgent: melanoma mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.818
  },
  {
    "request_id": "AM-REQ-2026-09101",
    "original_inquiry": "Family seeking information: 患者家属咨询：Phase II/III晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.79
  },
  {
    "request_id": "AM-REQ-2026-09102",
    "original_inquiry": "Family seeking information: 海外求药：个体化疫苗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5095
  },
  {
    "request_id": "AM-REQ-2026-09103",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6395
  },
  {
    "request_id": "AM-REQ-2026-09104",
    "original_inquiry": "研究者咨询：Patient with NSCLC (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7028
  },
  {
    "request_id": "AM-REQ-2026-09105",
    "original_inquiry": "Referral from specialist: 海外求药：双特异性抗体患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.508
  },
  {
    "request_id": "AM-REQ-2026-09106",
    "original_inquiry": "研究者咨询：Researcher inquiry: mRNA vaccine trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8824
  },
  {
    "request_id": "AM-REQ-2026-09107",
    "original_inquiry": "Referral from specialist: Consultation: mRNA vaccine with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6181
  },
  {
    "request_id": "AM-REQ-2026-09108",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in CAR-T inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7418
  },
  {
    "request_id": "AM-REQ-2026-09109",
    "original_inquiry": "海外求诊：Patient with NSCLC (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5634
  },
  {
    "request_id": "AM-REQ-2026-09110",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8622
  },
  {
    "request_id": "AM-REQ-2026-09111",
    "original_inquiry": "Family seeking information: 患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8846
  },
  {
    "request_id": "AM-REQ-2026-09112",
    "original_inquiry": "Second opinion requested: Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5411
  },
  {
    "request_id": "AM-REQ-2026-09113",
    "original_inquiry": "海外求诊：患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7936
  },
  {
    "request_id": "AM-REQ-2026-09114",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5679
  },
  {
    "request_id": "AM-REQ-2026-09115",
    "original_inquiry": "研究者咨询：Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8557
  },
  {
    "request_id": "AM-REQ-2026-09116",
    "original_inquiry": "Referral from specialist: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8933
  },
  {
    "request_id": "AM-REQ-2026-09117",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8471
  },
  {
    "request_id": "AM-REQ-2026-09118",
    "original_inquiry": "海外求诊：Oncologist referral: ADC联合治疗 positive; interested in CAR-T inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7182
  },
  {
    "request_id": "AM-REQ-2026-09119",
    "original_inquiry": "研究者咨询：Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-09120",
    "original_inquiry": "Family seeking information: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8718
  },
  {
    "request_id": "AM-REQ-2026-09121",
    "original_inquiry": "Referral from specialist: Consultation: NSCLC with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6191
  },
  {
    "request_id": "AM-REQ-2026-09122",
    "original_inquiry": "研究者咨询：海外求药：mRNA vaccine患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7683
  },
  {
    "request_id": "AM-REQ-2026-09123",
    "original_inquiry": "Second opinion requested: 海外求药：个体化疫苗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5485
  },
  {
    "request_id": "AM-REQ-2026-09124",
    "original_inquiry": "Referral from specialist: Oncologist referral: mRNA vaccine positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6449
  },
  {
    "request_id": "AM-REQ-2026-09125",
    "original_inquiry": "Family seeking information: Researcher inquiry: NSCLC trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7823
  },
  {
    "request_id": "AM-REQ-2026-09126",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7176
  },
  {
    "request_id": "AM-REQ-2026-09127",
    "original_inquiry": "海外求诊：Urgent: mRNA vaccine mutation confirmed; seeking CAR-T trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8584
  },
  {
    "request_id": "AM-REQ-2026-09128",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7816
  },
  {
    "request_id": "AM-REQ-2026-09129",
    "original_inquiry": "研究者咨询：Urgent: melanoma mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6545
  },
  {
    "request_id": "AM-REQ-2026-09130",
    "original_inquiry": "海外求诊：Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8621
  },
  {
    "request_id": "AM-REQ-2026-09131",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8564
  },
  {
    "request_id": "AM-REQ-2026-09132",
    "original_inquiry": "海外求诊：海外求药：Phase II/III患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8341
  },
  {
    "request_id": "AM-REQ-2026-09133",
    "original_inquiry": "研究者咨询：Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6712
  },
  {
    "request_id": "AM-REQ-2026-09134",
    "original_inquiry": "Urgent: Urgent: solid tumor mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.792
  },
  {
    "request_id": "AM-REQ-2026-09135",
    "original_inquiry": "Second opinion requested: Patient with 双特异性抗体 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6024
  },
  {
    "request_id": "AM-REQ-2026-09136",
    "original_inquiry": "Family seeking information: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6907
  },
  {
    "request_id": "AM-REQ-2026-09137",
    "original_inquiry": "研究者咨询：Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6653
  },
  {
    "request_id": "AM-REQ-2026-09138",
    "original_inquiry": "海外求诊：Consultation: mRNA vaccine with advanced immune checkpoint; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6539
  },
  {
    "request_id": "AM-REQ-2026-09139",
    "original_inquiry": "海外求诊：Patient with NSCLC (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5345
  },
  {
    "request_id": "AM-REQ-2026-09140",
    "original_inquiry": "Second opinion requested: Consultation: solid tumor with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8071
  },
  {
    "request_id": "AM-REQ-2026-09141",
    "original_inquiry": "Urgent: 海外求药：NSCLC患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5624
  },
  {
    "request_id": "AM-REQ-2026-09142",
    "original_inquiry": "Urgent: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8987
  },
  {
    "request_id": "AM-REQ-2026-09143",
    "original_inquiry": "Referral from specialist: Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8968
  },
  {
    "request_id": "AM-REQ-2026-09144",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7455
  },
  {
    "request_id": "AM-REQ-2026-09145",
    "original_inquiry": "Urgent: Consultation: melanoma with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.782
  },
  {
    "request_id": "AM-REQ-2026-09146",
    "original_inquiry": "海外求药：个体化疫苗患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5257
  },
  {
    "request_id": "AM-REQ-2026-09147",
    "original_inquiry": "Second opinion requested: Patient with 个体化疫苗 (mRNA cancer vaccine); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7038
  },
  {
    "request_id": "AM-REQ-2026-09148",
    "original_inquiry": "海外求诊：Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-09149",
    "original_inquiry": "Referral from specialist: Urgent: solid tumor mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8313
  },
  {
    "request_id": "AM-REQ-2026-09150",
    "original_inquiry": "Patient with 个体化疫苗 (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8142
  },
  {
    "request_id": "AM-REQ-2026-09151",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7415
  },
  {
    "request_id": "AM-REQ-2026-09152",
    "original_inquiry": "海外求诊：患者家属咨询：solid tumor晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5974
  },
  {
    "request_id": "AM-REQ-2026-09153",
    "original_inquiry": "研究者咨询：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8715
  },
  {
    "request_id": "AM-REQ-2026-09154",
    "original_inquiry": "海外求诊：Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8666
  },
  {
    "request_id": "AM-REQ-2026-09155",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8486
  },
  {
    "request_id": "AM-REQ-2026-09156",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (immune checkpoint); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6565
  },
  {
    "request_id": "AM-REQ-2026-09157",
    "original_inquiry": "Urgent: Oncologist referral: solid tumor positive; interested in personalized neoantigen inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6795
  },
  {
    "request_id": "AM-REQ-2026-09158",
    "original_inquiry": "Urgent: Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7618
  },
  {
    "request_id": "AM-REQ-2026-09159",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5448
  },
  {
    "request_id": "AM-REQ-2026-09160",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and bispecific antibody with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6122
  },
  {
    "request_id": "AM-REQ-2026-09161",
    "original_inquiry": "海外求诊：Urgent: 个体化疫苗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.801
  },
  {
    "request_id": "AM-REQ-2026-09162",
    "original_inquiry": "研究者咨询：患者家属咨询：solid tumor晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8321
  },
  {
    "request_id": "AM-REQ-2026-09163",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8954
  },
  {
    "request_id": "AM-REQ-2026-09164",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8274
  },
  {
    "request_id": "AM-REQ-2026-09165",
    "original_inquiry": "Patient with solid tumor (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8727
  },
  {
    "request_id": "AM-REQ-2026-09166",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.888
  },
  {
    "request_id": "AM-REQ-2026-09167",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6815
  },
  {
    "request_id": "AM-REQ-2026-09168",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7338
  },
  {
    "request_id": "AM-REQ-2026-09169",
    "original_inquiry": "Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7094
  },
  {
    "request_id": "AM-REQ-2026-09170",
    "original_inquiry": "研究者咨询：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8045
  },
  {
    "request_id": "AM-REQ-2026-09171",
    "original_inquiry": "Second opinion requested: Researcher inquiry: solid tumor trial design and personalized neoantigen with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7585
  },
  {
    "request_id": "AM-REQ-2026-09172",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-09173",
    "original_inquiry": "研究者咨询：患者家属咨询：solid tumor晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8216
  },
  {
    "request_id": "AM-REQ-2026-09174",
    "original_inquiry": "海外求诊：Urgent: Phase II/III mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6169
  },
  {
    "request_id": "AM-REQ-2026-09175",
    "original_inquiry": "研究者咨询：患者家属咨询：solid tumor晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7573
  },
  {
    "request_id": "AM-REQ-2026-09176",
    "original_inquiry": "Urgent: Patient with combination immunotherapy (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6572
  },
  {
    "request_id": "AM-REQ-2026-09177",
    "original_inquiry": "Oncologist referral: NSCLC positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7766
  },
  {
    "request_id": "AM-REQ-2026-09178",
    "original_inquiry": "Second opinion requested: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6022
  },
  {
    "request_id": "AM-REQ-2026-09179",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6583
  },
  {
    "request_id": "AM-REQ-2026-09180",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6961
  },
  {
    "request_id": "AM-REQ-2026-09181",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 双特异性抗体 trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5839
  },
  {
    "request_id": "AM-REQ-2026-09182",
    "original_inquiry": "Consultation: Phase II/III with advanced bispecific antibody; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7226
  },
  {
    "request_id": "AM-REQ-2026-09183",
    "original_inquiry": "Referral from specialist: 海外求药：combination immunotherapy患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8727
  },
  {
    "request_id": "AM-REQ-2026-09184",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7664
  },
  {
    "request_id": "AM-REQ-2026-09185",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 个体化疫苗 trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8723
  },
  {
    "request_id": "AM-REQ-2026-09186",
    "original_inquiry": "患者家属咨询：NSCLC晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8061
  },
  {
    "request_id": "AM-REQ-2026-09187",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7709
  },
  {
    "request_id": "AM-REQ-2026-09188",
    "original_inquiry": "海外求诊：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.735
  },
  {
    "request_id": "AM-REQ-2026-09189",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7874
  },
  {
    "request_id": "AM-REQ-2026-09190",
    "original_inquiry": "研究者咨询：Patient with 个体化疫苗 (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5639
  },
  {
    "request_id": "AM-REQ-2026-09191",
    "original_inquiry": "海外求诊：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6008
  },
  {
    "request_id": "AM-REQ-2026-09192",
    "original_inquiry": "Urgent: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7807
  },
  {
    "request_id": "AM-REQ-2026-09193",
    "original_inquiry": "研究者咨询：海外求药：combination immunotherapy患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5005
  },
  {
    "request_id": "AM-REQ-2026-09194",
    "original_inquiry": "Referral from specialist: 患者家属咨询：combination immunotherapy晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8852
  },
  {
    "request_id": "AM-REQ-2026-09195",
    "original_inquiry": "海外求药：melanoma患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5368
  },
  {
    "request_id": "AM-REQ-2026-09196",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced CAR-T; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7816
  },
  {
    "request_id": "AM-REQ-2026-09197",
    "original_inquiry": "Urgent: Consultation: melanoma with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7639
  },
  {
    "request_id": "AM-REQ-2026-09198",
    "original_inquiry": "Referral from specialist: 海外求药：melanoma患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5516
  },
  {
    "request_id": "AM-REQ-2026-09199",
    "original_inquiry": "研究者咨询：Oncologist referral: Phase II/III positive; interested in immune checkpoint inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8651
  },
  {
    "request_id": "AM-REQ-2026-09200",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5849
  },
  {
    "request_id": "AM-REQ-2026-09201",
    "original_inquiry": "海外求诊：Patient with NSCLC (ADC); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8488
  },
  {
    "request_id": "AM-REQ-2026-09202",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in KRAS G12C inhibitors and ADC combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7217
  },
  {
    "request_id": "AM-REQ-2026-09203",
    "original_inquiry": "Second opinion requested: Patient with Phase II/III (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5503
  },
  {
    "request_id": "AM-REQ-2026-09204",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6431
  },
  {
    "request_id": "AM-REQ-2026-09205",
    "original_inquiry": "研究者咨询：Consultation: 双特异性抗体 with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8034
  },
  {
    "request_id": "AM-REQ-2026-09206",
    "original_inquiry": "Referral from specialist: 海外求药：ADC联合治疗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8699
  },
  {
    "request_id": "AM-REQ-2026-09207",
    "original_inquiry": "海外求诊：Patient with 个体化疫苗 (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5612
  },
  {
    "request_id": "AM-REQ-2026-09208",
    "original_inquiry": "Second opinion requested: 患者家属咨询：NSCLC晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7932
  },
  {
    "request_id": "AM-REQ-2026-09209",
    "original_inquiry": "海外求诊：海外求药：NSCLC患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7426
  },
  {
    "request_id": "AM-REQ-2026-09210",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6281
  },
  {
    "request_id": "AM-REQ-2026-09211",
    "original_inquiry": "患者家属咨询：combination immunotherapy晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7307
  },
  {
    "request_id": "AM-REQ-2026-09212",
    "original_inquiry": "Urgent: Consultation: 双特异性抗体 with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5781
  },
  {
    "request_id": "AM-REQ-2026-09213",
    "original_inquiry": "患者家属咨询：个体化疫苗晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8834
  },
  {
    "request_id": "AM-REQ-2026-09214",
    "original_inquiry": "Family seeking information: Researcher inquiry: solid tumor trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.654
  },
  {
    "request_id": "AM-REQ-2026-09215",
    "original_inquiry": "Referral from specialist: Urgent: 个体化疫苗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5475
  },
  {
    "request_id": "AM-REQ-2026-09216",
    "original_inquiry": "研究者咨询：Urgent: mRNA vaccine mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.684
  },
  {
    "request_id": "AM-REQ-2026-09217",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7946
  },
  {
    "request_id": "AM-REQ-2026-09218",
    "original_inquiry": "Urgent: Patient with NSCLC (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8232
  },
  {
    "request_id": "AM-REQ-2026-09219",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8151
  },
  {
    "request_id": "AM-REQ-2026-09220",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7596
  },
  {
    "request_id": "AM-REQ-2026-09221",
    "original_inquiry": "研究者咨询：Urgent: ADC联合治疗 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7092
  },
  {
    "request_id": "AM-REQ-2026-09222",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7452
  },
  {
    "request_id": "AM-REQ-2026-09223",
    "original_inquiry": "Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8067
  },
  {
    "request_id": "AM-REQ-2026-09224",
    "original_inquiry": "海外求诊：Oncologist referral: melanoma positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7134
  },
  {
    "request_id": "AM-REQ-2026-09225",
    "original_inquiry": "Family seeking information: Oncologist referral: mRNA vaccine positive; interested in antibody-drug conjugate inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6802
  },
  {
    "request_id": "AM-REQ-2026-09226",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加ADC或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.593
  },
  {
    "request_id": "AM-REQ-2026-09227",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8558
  },
  {
    "request_id": "AM-REQ-2026-09228",
    "original_inquiry": "Second opinion requested: Consultation: solid tumor with advanced CAR-T; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6846
  },
  {
    "request_id": "AM-REQ-2026-09229",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and bispecific antibody with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7833
  },
  {
    "request_id": "AM-REQ-2026-09230",
    "original_inquiry": "Second opinion requested: Patient with melanoma (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7113
  },
  {
    "request_id": "AM-REQ-2026-09231",
    "original_inquiry": "研究者咨询：Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6351
  },
  {
    "request_id": "AM-REQ-2026-09232",
    "original_inquiry": "Second opinion requested: Oncologist referral: ADC联合治疗 positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5432
  },
  {
    "request_id": "AM-REQ-2026-09233",
    "original_inquiry": "Urgent: Consultation: 个体化疫苗 with advanced immune checkpoint; request ADC and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6107
  },
  {
    "request_id": "AM-REQ-2026-09234",
    "original_inquiry": "Urgent: Oncologist referral: ADC联合治疗 positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8555
  },
  {
    "request_id": "AM-REQ-2026-09235",
    "original_inquiry": "海外求诊：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7589
  },
  {
    "request_id": "AM-REQ-2026-09236",
    "original_inquiry": "Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5582
  },
  {
    "request_id": "AM-REQ-2026-09237",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8111
  },
  {
    "request_id": "AM-REQ-2026-09238",
    "original_inquiry": "研究者咨询：Patient with solid tumor (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5132
  },
  {
    "request_id": "AM-REQ-2026-09239",
    "original_inquiry": "海外求诊：Researcher inquiry: 双特异性抗体 trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.523
  },
  {
    "request_id": "AM-REQ-2026-09240",
    "original_inquiry": "Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6391
  },
  {
    "request_id": "AM-REQ-2026-09241",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7666
  },
  {
    "request_id": "AM-REQ-2026-09242",
    "original_inquiry": "Referral from specialist: Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6091
  },
  {
    "request_id": "AM-REQ-2026-09243",
    "original_inquiry": "Urgent: Patient with 个体化疫苗 (CAR-T); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5674
  },
  {
    "request_id": "AM-REQ-2026-09244",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7771
  },
  {
    "request_id": "AM-REQ-2026-09245",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6349
  },
  {
    "request_id": "AM-REQ-2026-09246",
    "original_inquiry": "Referral from specialist: Patient with ADC联合治疗 (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7413
  },
  {
    "request_id": "AM-REQ-2026-09247",
    "original_inquiry": "Second opinion requested: Urgent: ADC联合治疗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8496
  },
  {
    "request_id": "AM-REQ-2026-09248",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5179
  },
  {
    "request_id": "AM-REQ-2026-09249",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8834
  },
  {
    "request_id": "AM-REQ-2026-09250",
    "original_inquiry": "Second opinion requested: Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8629
  },
  {
    "request_id": "AM-REQ-2026-09251",
    "original_inquiry": "Urgent: Patient with ADC联合治疗 (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5998
  },
  {
    "request_id": "AM-REQ-2026-09252",
    "original_inquiry": "Referral from specialist: Urgent: Phase II/III mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5839
  },
  {
    "request_id": "AM-REQ-2026-09253",
    "original_inquiry": "Family seeking information: 海外求药：combination immunotherapy患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5265
  },
  {
    "request_id": "AM-REQ-2026-09254",
    "original_inquiry": "Second opinion requested: Urgent: ADC联合治疗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7292
  },
  {
    "request_id": "AM-REQ-2026-09255",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in CAR-T inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8776
  },
  {
    "request_id": "AM-REQ-2026-09256",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8511
  },
  {
    "request_id": "AM-REQ-2026-09257",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6894
  },
  {
    "request_id": "AM-REQ-2026-09258",
    "original_inquiry": "研究者咨询：Urgent: melanoma mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7319
  },
  {
    "request_id": "AM-REQ-2026-09259",
    "original_inquiry": "Family seeking information: 患者家属咨询：NSCLC晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7679
  },
  {
    "request_id": "AM-REQ-2026-09260",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7021
  },
  {
    "request_id": "AM-REQ-2026-09261",
    "original_inquiry": "Referral from specialist: Urgent: Phase II/III mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6308
  },
  {
    "request_id": "AM-REQ-2026-09262",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8294
  },
  {
    "request_id": "AM-REQ-2026-09263",
    "original_inquiry": "Oncologist referral: Phase II/III positive; interested in ADC inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.789
  },
  {
    "request_id": "AM-REQ-2026-09264",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5701
  },
  {
    "request_id": "AM-REQ-2026-09265",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5668
  },
  {
    "request_id": "AM-REQ-2026-09266",
    "original_inquiry": "Family seeking information: Consultation: solid tumor with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7854
  },
  {
    "request_id": "AM-REQ-2026-09267",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6824
  },
  {
    "request_id": "AM-REQ-2026-09268",
    "original_inquiry": "Urgent: Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6653
  },
  {
    "request_id": "AM-REQ-2026-09269",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8805
  },
  {
    "request_id": "AM-REQ-2026-09270",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5544
  },
  {
    "request_id": "AM-REQ-2026-09271",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6157
  },
  {
    "request_id": "AM-REQ-2026-09272",
    "original_inquiry": "Family seeking information: Patient with melanoma (ADC); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7655
  },
  {
    "request_id": "AM-REQ-2026-09273",
    "original_inquiry": "研究者咨询：Oncologist referral: NSCLC positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5495
  },
  {
    "request_id": "AM-REQ-2026-09274",
    "original_inquiry": "Urgent: Urgent: 双特异性抗体 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.639
  },
  {
    "request_id": "AM-REQ-2026-09275",
    "original_inquiry": "研究者咨询：Urgent: 双特异性抗体 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8584
  },
  {
    "request_id": "AM-REQ-2026-09276",
    "original_inquiry": "患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7541
  },
  {
    "request_id": "AM-REQ-2026-09277",
    "original_inquiry": "海外求诊：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5268
  },
  {
    "request_id": "AM-REQ-2026-09278",
    "original_inquiry": "Referral from specialist: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5036
  },
  {
    "request_id": "AM-REQ-2026-09279",
    "original_inquiry": "Patient with melanoma (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5748
  },
  {
    "request_id": "AM-REQ-2026-09280",
    "original_inquiry": "Urgent: 患者家属咨询：melanoma晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8414
  },
  {
    "request_id": "AM-REQ-2026-09281",
    "original_inquiry": "研究者咨询：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7189
  },
  {
    "request_id": "AM-REQ-2026-09282",
    "original_inquiry": "Second opinion requested: Consultation: melanoma with advanced personalized neoantigen; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5573
  },
  {
    "request_id": "AM-REQ-2026-09283",
    "original_inquiry": "Second opinion requested: 患者家属咨询：mRNA vaccine晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8753
  },
  {
    "request_id": "AM-REQ-2026-09284",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in KRAS G12C inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5053
  },
  {
    "request_id": "AM-REQ-2026-09285",
    "original_inquiry": "Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-09286",
    "original_inquiry": "Urgent: Researcher inquiry: solid tumor trial design and personalized neoantigen with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7947
  },
  {
    "request_id": "AM-REQ-2026-09287",
    "original_inquiry": "研究者咨询：Consultation: 双特异性抗体 with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5476
  },
  {
    "request_id": "AM-REQ-2026-09288",
    "original_inquiry": "Second opinion requested: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5183
  },
  {
    "request_id": "AM-REQ-2026-09289",
    "original_inquiry": "Researcher inquiry: 个体化疫苗 trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7422
  },
  {
    "request_id": "AM-REQ-2026-09290",
    "original_inquiry": "Urgent: Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8162
  },
  {
    "request_id": "AM-REQ-2026-09291",
    "original_inquiry": "Second opinion requested: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8821
  },
  {
    "request_id": "AM-REQ-2026-09292",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (ADC); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7977
  },
  {
    "request_id": "AM-REQ-2026-09293",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 个体化疫苗 trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6123
  },
  {
    "request_id": "AM-REQ-2026-09294",
    "original_inquiry": "Family seeking information: Consultation: mRNA vaccine with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.864
  },
  {
    "request_id": "AM-REQ-2026-09295",
    "original_inquiry": "Urgent: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6319
  },
  {
    "request_id": "AM-REQ-2026-09296",
    "original_inquiry": "研究者咨询：海外求药：Phase II/III患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7216
  },
  {
    "request_id": "AM-REQ-2026-09297",
    "original_inquiry": "研究者咨询：Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-09298",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5226
  },
  {
    "request_id": "AM-REQ-2026-09299",
    "original_inquiry": "Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7119
  },
  {
    "request_id": "AM-REQ-2026-09300",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.74
  },
  {
    "request_id": "AM-REQ-2026-09301",
    "original_inquiry": "Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6684
  },
  {
    "request_id": "AM-REQ-2026-09302",
    "original_inquiry": "Consultation: melanoma with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5192
  },
  {
    "request_id": "AM-REQ-2026-09303",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7777
  },
  {
    "request_id": "AM-REQ-2026-09304",
    "original_inquiry": "Second opinion requested: Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.513
  },
  {
    "request_id": "AM-REQ-2026-09305",
    "original_inquiry": "研究者咨询：患者家属咨询：mRNA vaccine晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6733
  },
  {
    "request_id": "AM-REQ-2026-09306",
    "original_inquiry": "Second opinion requested: Consultation: combination immunotherapy with advanced CAR-T; request ADC and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5943
  },
  {
    "request_id": "AM-REQ-2026-09307",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5852
  },
  {
    "request_id": "AM-REQ-2026-09308",
    "original_inquiry": "Second opinion requested: 海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8321
  },
  {
    "request_id": "AM-REQ-2026-09309",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7602
  },
  {
    "request_id": "AM-REQ-2026-09310",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5659
  },
  {
    "request_id": "AM-REQ-2026-09311",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5378
  },
  {
    "request_id": "AM-REQ-2026-09312",
    "original_inquiry": "Family seeking information: 患者家属咨询：mRNA vaccine晚期，寻求ADC、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8753
  },
  {
    "request_id": "AM-REQ-2026-09313",
    "original_inquiry": "Family seeking information: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6048
  },
  {
    "request_id": "AM-REQ-2026-09314",
    "original_inquiry": "Family seeking information: 海外求药：个体化疫苗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6782
  },
  {
    "request_id": "AM-REQ-2026-09315",
    "original_inquiry": "海外求诊：海外求药：solid tumor患者，希望参加CAR-T或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8162
  },
  {
    "request_id": "AM-REQ-2026-09316",
    "original_inquiry": "研究者咨询：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8375
  },
  {
    "request_id": "AM-REQ-2026-09317",
    "original_inquiry": "Family seeking information: Urgent: combination immunotherapy mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6165
  },
  {
    "request_id": "AM-REQ-2026-09318",
    "original_inquiry": "Family seeking information: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8815
  },
  {
    "request_id": "AM-REQ-2026-09319",
    "original_inquiry": "Second opinion requested: 海外求药：mRNA vaccine患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7294
  },
  {
    "request_id": "AM-REQ-2026-09320",
    "original_inquiry": "Urgent: Urgent: melanoma mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6431
  },
  {
    "request_id": "AM-REQ-2026-09321",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.821
  },
  {
    "request_id": "AM-REQ-2026-09322",
    "original_inquiry": "海外求诊：患者家属咨询：ADC联合治疗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5205
  },
  {
    "request_id": "AM-REQ-2026-09323",
    "original_inquiry": "Second opinion requested: Researcher inquiry: NSCLC trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7494
  },
  {
    "request_id": "AM-REQ-2026-09324",
    "original_inquiry": "Urgent: Oncologist referral: 个体化疫苗 positive; interested in immune checkpoint inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7373
  },
  {
    "request_id": "AM-REQ-2026-09325",
    "original_inquiry": "Urgent: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6757
  },
  {
    "request_id": "AM-REQ-2026-09326",
    "original_inquiry": "海外求诊：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8091
  },
  {
    "request_id": "AM-REQ-2026-09327",
    "original_inquiry": "Urgent: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6874
  },
  {
    "request_id": "AM-REQ-2026-09328",
    "original_inquiry": "Urgent: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6838
  },
  {
    "request_id": "AM-REQ-2026-09329",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8866
  },
  {
    "request_id": "AM-REQ-2026-09330",
    "original_inquiry": "Referral from specialist: Urgent: ADC联合治疗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5454
  },
  {
    "request_id": "AM-REQ-2026-09331",
    "original_inquiry": "Second opinion requested: Oncologist referral: Phase II/III positive; interested in bispecific antibody inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6203
  },
  {
    "request_id": "AM-REQ-2026-09332",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8496
  },
  {
    "request_id": "AM-REQ-2026-09333",
    "original_inquiry": "Urgent: Urgent: ADC联合治疗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6487
  },
  {
    "request_id": "AM-REQ-2026-09334",
    "original_inquiry": "Referral from specialist: Consultation: Phase II/III with advanced personalized neoantigen; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5291
  },
  {
    "request_id": "AM-REQ-2026-09335",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8275
  },
  {
    "request_id": "AM-REQ-2026-09336",
    "original_inquiry": "Second opinion requested: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6214
  },
  {
    "request_id": "AM-REQ-2026-09337",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5245
  },
  {
    "request_id": "AM-REQ-2026-09338",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7357
  },
  {
    "request_id": "AM-REQ-2026-09339",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6238
  },
  {
    "request_id": "AM-REQ-2026-09340",
    "original_inquiry": "Second opinion requested: Oncologist referral: Phase II/III positive; interested in mRNA cancer vaccine inhibitors and ADC combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6358
  },
  {
    "request_id": "AM-REQ-2026-09341",
    "original_inquiry": "Urgent: Researcher inquiry: solid tumor trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5261
  },
  {
    "request_id": "AM-REQ-2026-09342",
    "original_inquiry": "Urgent: Oncologist referral: mRNA vaccine positive; interested in KRAS G12C inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6366
  },
  {
    "request_id": "AM-REQ-2026-09343",
    "original_inquiry": "Referral from specialist: 患者家属咨询：ADC联合治疗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8818
  },
  {
    "request_id": "AM-REQ-2026-09344",
    "original_inquiry": "海外求诊：患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5706
  },
  {
    "request_id": "AM-REQ-2026-09345",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6714
  },
  {
    "request_id": "AM-REQ-2026-09346",
    "original_inquiry": "研究者咨询：患者家属咨询：combination immunotherapy晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8377
  },
  {
    "request_id": "AM-REQ-2026-09347",
    "original_inquiry": "Urgent: Patient with 个体化疫苗 (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5798
  },
  {
    "request_id": "AM-REQ-2026-09348",
    "original_inquiry": "研究者咨询：Patient with ADC联合治疗 (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8172
  },
  {
    "request_id": "AM-REQ-2026-09349",
    "original_inquiry": "海外求诊：患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8373
  },
  {
    "request_id": "AM-REQ-2026-09350",
    "original_inquiry": "海外求药：ADC联合治疗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.851
  },
  {
    "request_id": "AM-REQ-2026-09351",
    "original_inquiry": "Second opinion requested: 患者家属咨询：solid tumor晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.576
  },
  {
    "request_id": "AM-REQ-2026-09352",
    "original_inquiry": "Second opinion requested: 患者家属咨询：ADC联合治疗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5543
  },
  {
    "request_id": "AM-REQ-2026-09353",
    "original_inquiry": "Family seeking information: Patient with combination immunotherapy (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5704
  },
  {
    "request_id": "AM-REQ-2026-09354",
    "original_inquiry": "研究者咨询：Urgent: Phase II/III mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8519
  },
  {
    "request_id": "AM-REQ-2026-09355",
    "original_inquiry": "Family seeking information: Patient with mRNA vaccine (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7162
  },
  {
    "request_id": "AM-REQ-2026-09356",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7457
  },
  {
    "request_id": "AM-REQ-2026-09357",
    "original_inquiry": "Referral from specialist: Oncologist referral: melanoma positive; interested in mRNA cancer vaccine inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5578
  },
  {
    "request_id": "AM-REQ-2026-09358",
    "original_inquiry": "Referral from specialist: Consultation: 个体化疫苗 with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5256
  },
  {
    "request_id": "AM-REQ-2026-09359",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in CAR-T inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5741
  },
  {
    "request_id": "AM-REQ-2026-09360",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.735
  },
  {
    "request_id": "AM-REQ-2026-09361",
    "original_inquiry": "海外求诊：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6771
  },
  {
    "request_id": "AM-REQ-2026-09362",
    "original_inquiry": "Researcher inquiry: 双特异性抗体 trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6042
  },
  {
    "request_id": "AM-REQ-2026-09363",
    "original_inquiry": "研究者咨询：Urgent: combination immunotherapy mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.738
  },
  {
    "request_id": "AM-REQ-2026-09364",
    "original_inquiry": "Family seeking information: Urgent: 双特异性抗体 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8662
  },
  {
    "request_id": "AM-REQ-2026-09365",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8271
  },
  {
    "request_id": "AM-REQ-2026-09366",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5711
  },
  {
    "request_id": "AM-REQ-2026-09367",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6761
  },
  {
    "request_id": "AM-REQ-2026-09368",
    "original_inquiry": "海外求诊：Urgent: 个体化疫苗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5715
  },
  {
    "request_id": "AM-REQ-2026-09369",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in bispecific antibody inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7202
  },
  {
    "request_id": "AM-REQ-2026-09370",
    "original_inquiry": "Family seeking information: Patient with ADC联合治疗 (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7029
  },
  {
    "request_id": "AM-REQ-2026-09371",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8562
  },
  {
    "request_id": "AM-REQ-2026-09372",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5761
  },
  {
    "request_id": "AM-REQ-2026-09373",
    "original_inquiry": "海外求诊：Researcher inquiry: mRNA vaccine trial design and CAR-T with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8858
  },
  {
    "request_id": "AM-REQ-2026-09374",
    "original_inquiry": "Referral from specialist: Urgent: melanoma mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5138
  },
  {
    "request_id": "AM-REQ-2026-09375",
    "original_inquiry": "Urgent: 双特异性抗体 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7875
  },
  {
    "request_id": "AM-REQ-2026-09376",
    "original_inquiry": "Family seeking information: Urgent: 双特异性抗体 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7242
  },
  {
    "request_id": "AM-REQ-2026-09377",
    "original_inquiry": "Family seeking information: Oncologist referral: mRNA vaccine positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5079
  },
  {
    "request_id": "AM-REQ-2026-09378",
    "original_inquiry": "海外求诊：Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6729
  },
  {
    "request_id": "AM-REQ-2026-09379",
    "original_inquiry": "Researcher inquiry: combination immunotherapy trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8081
  },
  {
    "request_id": "AM-REQ-2026-09380",
    "original_inquiry": "研究者咨询：Urgent: melanoma mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5367
  },
  {
    "request_id": "AM-REQ-2026-09381",
    "original_inquiry": "Oncologist referral: melanoma positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5958
  },
  {
    "request_id": "AM-REQ-2026-09382",
    "original_inquiry": "海外求诊：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7307
  },
  {
    "request_id": "AM-REQ-2026-09383",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in CAR-T inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8871
  },
  {
    "request_id": "AM-REQ-2026-09384",
    "original_inquiry": "Urgent: Oncologist referral: Phase II/III positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5118
  },
  {
    "request_id": "AM-REQ-2026-09385",
    "original_inquiry": "患者家属咨询：combination immunotherapy晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8672
  },
  {
    "request_id": "AM-REQ-2026-09386",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7473
  },
  {
    "request_id": "AM-REQ-2026-09387",
    "original_inquiry": "Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7864
  },
  {
    "request_id": "AM-REQ-2026-09388",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7175
  },
  {
    "request_id": "AM-REQ-2026-09389",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8403
  },
  {
    "request_id": "AM-REQ-2026-09390",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5337
  },
  {
    "request_id": "AM-REQ-2026-09391",
    "original_inquiry": "Family seeking information: 海外求药：ADC联合治疗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7312
  },
  {
    "request_id": "AM-REQ-2026-09392",
    "original_inquiry": "Second opinion requested: 患者家属咨询：combination immunotherapy晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7817
  },
  {
    "request_id": "AM-REQ-2026-09393",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.526
  },
  {
    "request_id": "AM-REQ-2026-09394",
    "original_inquiry": "Second opinion requested: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8806
  },
  {
    "request_id": "AM-REQ-2026-09395",
    "original_inquiry": "研究者咨询：Consultation: combination immunotherapy with advanced immune checkpoint; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6777
  },
  {
    "request_id": "AM-REQ-2026-09396",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7079
  },
  {
    "request_id": "AM-REQ-2026-09397",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7206
  },
  {
    "request_id": "AM-REQ-2026-09398",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6017
  },
  {
    "request_id": "AM-REQ-2026-09399",
    "original_inquiry": "Referral from specialist: Researcher inquiry: combination immunotherapy trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8182
  },
  {
    "request_id": "AM-REQ-2026-09400",
    "original_inquiry": "研究者咨询：Researcher inquiry: Phase II/III trial design and personalized neoantigen with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5909
  },
  {
    "request_id": "AM-REQ-2026-09401",
    "original_inquiry": "Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5421
  },
  {
    "request_id": "AM-REQ-2026-09402",
    "original_inquiry": "Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7087
  },
  {
    "request_id": "AM-REQ-2026-09403",
    "original_inquiry": "海外求诊：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7663
  },
  {
    "request_id": "AM-REQ-2026-09404",
    "original_inquiry": "Family seeking information: Urgent: mRNA vaccine mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.519
  },
  {
    "request_id": "AM-REQ-2026-09405",
    "original_inquiry": "Urgent: combination immunotherapy mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8173
  },
  {
    "request_id": "AM-REQ-2026-09406",
    "original_inquiry": "海外求诊：Patient with 双特异性抗体 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6968
  },
  {
    "request_id": "AM-REQ-2026-09407",
    "original_inquiry": "研究者咨询：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7119
  },
  {
    "request_id": "AM-REQ-2026-09408",
    "original_inquiry": "患者家属咨询：combination immunotherapy晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6782
  },
  {
    "request_id": "AM-REQ-2026-09409",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.809
  },
  {
    "request_id": "AM-REQ-2026-09410",
    "original_inquiry": "研究者咨询：Researcher inquiry: NSCLC trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8968
  },
  {
    "request_id": "AM-REQ-2026-09411",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in ADC inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6863
  },
  {
    "request_id": "AM-REQ-2026-09412",
    "original_inquiry": "Family seeking information: Consultation: ADC联合治疗 with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8533
  },
  {
    "request_id": "AM-REQ-2026-09413",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7293
  },
  {
    "request_id": "AM-REQ-2026-09414",
    "original_inquiry": "Referral from specialist: Patient with solid tumor (ADC); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7851
  },
  {
    "request_id": "AM-REQ-2026-09415",
    "original_inquiry": "Second opinion requested: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5547
  },
  {
    "request_id": "AM-REQ-2026-09416",
    "original_inquiry": "Referral from specialist: Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6392
  },
  {
    "request_id": "AM-REQ-2026-09417",
    "original_inquiry": "Second opinion requested: Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6244
  },
  {
    "request_id": "AM-REQ-2026-09418",
    "original_inquiry": "海外求诊：Urgent: mRNA vaccine mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6795
  },
  {
    "request_id": "AM-REQ-2026-09419",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8207
  },
  {
    "request_id": "AM-REQ-2026-09420",
    "original_inquiry": "研究者咨询：Urgent: combination immunotherapy mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7959
  },
  {
    "request_id": "AM-REQ-2026-09421",
    "original_inquiry": "Second opinion requested: 海外求药：个体化疫苗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6337
  },
  {
    "request_id": "AM-REQ-2026-09422",
    "original_inquiry": "患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5168
  },
  {
    "request_id": "AM-REQ-2026-09423",
    "original_inquiry": "Referral from specialist: Urgent: ADC联合治疗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.788
  },
  {
    "request_id": "AM-REQ-2026-09424",
    "original_inquiry": "研究者咨询：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6588
  },
  {
    "request_id": "AM-REQ-2026-09425",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5145
  },
  {
    "request_id": "AM-REQ-2026-09426",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5925
  },
  {
    "request_id": "AM-REQ-2026-09427",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in immune checkpoint inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5321
  },
  {
    "request_id": "AM-REQ-2026-09428",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6675
  },
  {
    "request_id": "AM-REQ-2026-09429",
    "original_inquiry": "Family seeking information: 海外求药：个体化疫苗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7031
  },
  {
    "request_id": "AM-REQ-2026-09430",
    "original_inquiry": "Family seeking information: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7566
  },
  {
    "request_id": "AM-REQ-2026-09431",
    "original_inquiry": "研究者咨询：Consultation: ADC联合治疗 with advanced personalized neoantigen; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6525
  },
  {
    "request_id": "AM-REQ-2026-09432",
    "original_inquiry": "Second opinion requested: Urgent: Phase II/III mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.626
  },
  {
    "request_id": "AM-REQ-2026-09433",
    "original_inquiry": "海外求诊：患者家属咨询：mRNA vaccine晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6826
  },
  {
    "request_id": "AM-REQ-2026-09434",
    "original_inquiry": "Urgent: Oncologist referral: ADC联合治疗 positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7696
  },
  {
    "request_id": "AM-REQ-2026-09435",
    "original_inquiry": "Researcher inquiry: 个体化疫苗 trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.695
  },
  {
    "request_id": "AM-REQ-2026-09436",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5866
  },
  {
    "request_id": "AM-REQ-2026-09437",
    "original_inquiry": "海外求诊：Oncologist referral: solid tumor positive; interested in personalized neoantigen inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6232
  },
  {
    "request_id": "AM-REQ-2026-09438",
    "original_inquiry": "Patient with solid tumor (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7872
  },
  {
    "request_id": "AM-REQ-2026-09439",
    "original_inquiry": "Second opinion requested: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8247
  },
  {
    "request_id": "AM-REQ-2026-09440",
    "original_inquiry": "Second opinion requested: 患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5298
  },
  {
    "request_id": "AM-REQ-2026-09441",
    "original_inquiry": "海外求诊：Patient with ADC联合治疗 (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.888
  },
  {
    "request_id": "AM-REQ-2026-09442",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7354
  },
  {
    "request_id": "AM-REQ-2026-09443",
    "original_inquiry": "Patient with Phase II/III (bispecific antibody); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7718
  },
  {
    "request_id": "AM-REQ-2026-09444",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6652
  },
  {
    "request_id": "AM-REQ-2026-09445",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in ADC inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5286
  },
  {
    "request_id": "AM-REQ-2026-09446",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5317
  },
  {
    "request_id": "AM-REQ-2026-09447",
    "original_inquiry": "研究者咨询：Patient with solid tumor (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7434
  },
  {
    "request_id": "AM-REQ-2026-09448",
    "original_inquiry": "Urgent: Researcher inquiry: mRNA vaccine trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8342
  },
  {
    "request_id": "AM-REQ-2026-09449",
    "original_inquiry": "Patient with 个体化疫苗 (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8787
  },
  {
    "request_id": "AM-REQ-2026-09450",
    "original_inquiry": "海外求诊：Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6823
  },
  {
    "request_id": "AM-REQ-2026-09451",
    "original_inquiry": "Urgent: 患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7189
  },
  {
    "request_id": "AM-REQ-2026-09452",
    "original_inquiry": "研究者咨询：患者家属咨询：Phase II/III晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5817
  },
  {
    "request_id": "AM-REQ-2026-09453",
    "original_inquiry": "Second opinion requested: Consultation: 个体化疫苗 with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7938
  },
  {
    "request_id": "AM-REQ-2026-09454",
    "original_inquiry": "Family seeking information: Urgent: ADC联合治疗 mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6461
  },
  {
    "request_id": "AM-REQ-2026-09455",
    "original_inquiry": "研究者咨询：Researcher inquiry: solid tumor trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.543
  },
  {
    "request_id": "AM-REQ-2026-09456",
    "original_inquiry": "Family seeking information: Consultation: combination immunotherapy with advanced antibody-drug conjugate; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5486
  },
  {
    "request_id": "AM-REQ-2026-09457",
    "original_inquiry": "Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6368
  },
  {
    "request_id": "AM-REQ-2026-09458",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5138
  },
  {
    "request_id": "AM-REQ-2026-09459",
    "original_inquiry": "Urgent: Oncologist referral: mRNA vaccine positive; interested in CAR-T inhibitors and immune checkpoint combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6149
  },
  {
    "request_id": "AM-REQ-2026-09460",
    "original_inquiry": "海外求诊：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6884
  },
  {
    "request_id": "AM-REQ-2026-09461",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in personalized neoantigen inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5378
  },
  {
    "request_id": "AM-REQ-2026-09462",
    "original_inquiry": "海外求药：双特异性抗体患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7444
  },
  {
    "request_id": "AM-REQ-2026-09463",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5404
  },
  {
    "request_id": "AM-REQ-2026-09464",
    "original_inquiry": "Referral from specialist: Oncologist referral: Phase II/III positive; interested in personalized neoantigen inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.559
  },
  {
    "request_id": "AM-REQ-2026-09465",
    "original_inquiry": "研究者咨询：Consultation: NSCLC with advanced personalized neoantigen; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6218
  },
  {
    "request_id": "AM-REQ-2026-09466",
    "original_inquiry": "Second opinion requested: Urgent: 双特异性抗体 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7218
  },
  {
    "request_id": "AM-REQ-2026-09467",
    "original_inquiry": "Urgent: Oncologist referral: Phase II/III positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7518
  },
  {
    "request_id": "AM-REQ-2026-09468",
    "original_inquiry": "Second opinion requested: Oncologist referral: solid tumor positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.771
  },
  {
    "request_id": "AM-REQ-2026-09469",
    "original_inquiry": "Urgent: Consultation: Phase II/III with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.819
  },
  {
    "request_id": "AM-REQ-2026-09470",
    "original_inquiry": "Family seeking information: Oncologist referral: melanoma positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7274
  },
  {
    "request_id": "AM-REQ-2026-09471",
    "original_inquiry": "海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6269
  },
  {
    "request_id": "AM-REQ-2026-09472",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced ADC; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8757
  },
  {
    "request_id": "AM-REQ-2026-09473",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced immune checkpoint; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6352
  },
  {
    "request_id": "AM-REQ-2026-09474",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6807
  },
  {
    "request_id": "AM-REQ-2026-09475",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7829
  },
  {
    "request_id": "AM-REQ-2026-09476",
    "original_inquiry": "Second opinion requested: Patient with NSCLC (ADC); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6101
  },
  {
    "request_id": "AM-REQ-2026-09477",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.723
  },
  {
    "request_id": "AM-REQ-2026-09478",
    "original_inquiry": "Second opinion requested: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6127
  },
  {
    "request_id": "AM-REQ-2026-09479",
    "original_inquiry": "Second opinion requested: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5513
  },
  {
    "request_id": "AM-REQ-2026-09480",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6621
  },
  {
    "request_id": "AM-REQ-2026-09481",
    "original_inquiry": "海外求诊：Oncologist referral: combination immunotherapy positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5868
  },
  {
    "request_id": "AM-REQ-2026-09482",
    "original_inquiry": "Urgent: Consultation: 个体化疫苗 with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7502
  },
  {
    "request_id": "AM-REQ-2026-09483",
    "original_inquiry": "Second opinion requested: Researcher inquiry: mRNA vaccine trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.812
  },
  {
    "request_id": "AM-REQ-2026-09484",
    "original_inquiry": "Second opinion requested: 海外求药：melanoma患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6588
  },
  {
    "request_id": "AM-REQ-2026-09485",
    "original_inquiry": "Referral from specialist: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7832
  },
  {
    "request_id": "AM-REQ-2026-09486",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5317
  },
  {
    "request_id": "AM-REQ-2026-09487",
    "original_inquiry": "Referral from specialist: Consultation: solid tumor with advanced ADC; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8066
  },
  {
    "request_id": "AM-REQ-2026-09488",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5028
  },
  {
    "request_id": "AM-REQ-2026-09489",
    "original_inquiry": "Second opinion requested: Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7034
  },
  {
    "request_id": "AM-REQ-2026-09490",
    "original_inquiry": "Referral from specialist: 患者家属咨询：Phase II/III晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7173
  },
  {
    "request_id": "AM-REQ-2026-09491",
    "original_inquiry": "Second opinion requested: Urgent: NSCLC mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8859
  },
  {
    "request_id": "AM-REQ-2026-09492",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (ADC); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8887
  },
  {
    "request_id": "AM-REQ-2026-09493",
    "original_inquiry": "研究者咨询：患者家属咨询：combination immunotherapy晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.713
  },
  {
    "request_id": "AM-REQ-2026-09494",
    "original_inquiry": "Researcher inquiry: combination immunotherapy trial design and antibody-drug conjugate with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8584
  },
  {
    "request_id": "AM-REQ-2026-09495",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5287
  },
  {
    "request_id": "AM-REQ-2026-09496",
    "original_inquiry": "研究者咨询：Consultation: ADC联合治疗 with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7548
  },
  {
    "request_id": "AM-REQ-2026-09497",
    "original_inquiry": "Urgent: Patient with combination immunotherapy (ADC); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6488
  },
  {
    "request_id": "AM-REQ-2026-09498",
    "original_inquiry": "Family seeking information: Patient with 双特异性抗体 (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7982
  },
  {
    "request_id": "AM-REQ-2026-09499",
    "original_inquiry": "研究者咨询：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8438
  },
  {
    "request_id": "AM-REQ-2026-09500",
    "original_inquiry": "Urgent: Researcher inquiry: mRNA vaccine trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.628
  },
  {
    "request_id": "AM-REQ-2026-09501",
    "original_inquiry": "海外求诊：海外求药：melanoma患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5212
  },
  {
    "request_id": "AM-REQ-2026-09502",
    "original_inquiry": "Family seeking information: Oncologist referral: 双特异性抗体 positive; interested in bispecific antibody inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8432
  },
  {
    "request_id": "AM-REQ-2026-09503",
    "original_inquiry": "Family seeking information: 海外求药：combination immunotherapy患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8158
  },
  {
    "request_id": "AM-REQ-2026-09504",
    "original_inquiry": "研究者咨询：Urgent: ADC联合治疗 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8342
  },
  {
    "request_id": "AM-REQ-2026-09505",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6852
  },
  {
    "request_id": "AM-REQ-2026-09506",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6855
  },
  {
    "request_id": "AM-REQ-2026-09507",
    "original_inquiry": "海外求诊：患者家属咨询：Phase II/III晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7535
  },
  {
    "request_id": "AM-REQ-2026-09508",
    "original_inquiry": "海外求诊：Urgent: ADC联合治疗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8967
  },
  {
    "request_id": "AM-REQ-2026-09509",
    "original_inquiry": "研究者咨询：Consultation: mRNA vaccine with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5671
  },
  {
    "request_id": "AM-REQ-2026-09510",
    "original_inquiry": "海外求诊：Consultation: solid tumor with advanced KRAS G12C; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8397
  },
  {
    "request_id": "AM-REQ-2026-09511",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8468
  },
  {
    "request_id": "AM-REQ-2026-09512",
    "original_inquiry": "Urgent: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8054
  },
  {
    "request_id": "AM-REQ-2026-09513",
    "original_inquiry": "Second opinion requested: Researcher inquiry: solid tumor trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8751
  },
  {
    "request_id": "AM-REQ-2026-09514",
    "original_inquiry": "研究者咨询：Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.698
  },
  {
    "request_id": "AM-REQ-2026-09515",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6302
  },
  {
    "request_id": "AM-REQ-2026-09516",
    "original_inquiry": "海外求诊：患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6077
  },
  {
    "request_id": "AM-REQ-2026-09517",
    "original_inquiry": "Family seeking information: Oncologist referral: combination immunotherapy positive; interested in mRNA cancer vaccine inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8592
  },
  {
    "request_id": "AM-REQ-2026-09518",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8247
  },
  {
    "request_id": "AM-REQ-2026-09519",
    "original_inquiry": "Referral from specialist: 患者家属咨询：combination immunotherapy晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5397
  },
  {
    "request_id": "AM-REQ-2026-09520",
    "original_inquiry": "Referral from specialist: 患者家属咨询：个体化疫苗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7521
  },
  {
    "request_id": "AM-REQ-2026-09521",
    "original_inquiry": "Patient with 个体化疫苗 (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5163
  },
  {
    "request_id": "AM-REQ-2026-09522",
    "original_inquiry": "Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5688
  },
  {
    "request_id": "AM-REQ-2026-09523",
    "original_inquiry": "Second opinion requested: 海外求药：solid tumor患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6484
  },
  {
    "request_id": "AM-REQ-2026-09524",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8858
  },
  {
    "request_id": "AM-REQ-2026-09525",
    "original_inquiry": "Second opinion requested: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7062
  },
  {
    "request_id": "AM-REQ-2026-09526",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6013
  },
  {
    "request_id": "AM-REQ-2026-09527",
    "original_inquiry": "Researcher inquiry: solid tumor trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8518
  },
  {
    "request_id": "AM-REQ-2026-09528",
    "original_inquiry": "Second opinion requested: Patient with 双特异性抗体 (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7644
  },
  {
    "request_id": "AM-REQ-2026-09529",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5794
  },
  {
    "request_id": "AM-REQ-2026-09530",
    "original_inquiry": "Urgent: Researcher inquiry: melanoma trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8048
  },
  {
    "request_id": "AM-REQ-2026-09531",
    "original_inquiry": "Referral from specialist: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8976
  },
  {
    "request_id": "AM-REQ-2026-09532",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced CAR-T; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8201
  },
  {
    "request_id": "AM-REQ-2026-09533",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5494
  },
  {
    "request_id": "AM-REQ-2026-09534",
    "original_inquiry": "Patient with mRNA vaccine (ADC); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5478
  },
  {
    "request_id": "AM-REQ-2026-09535",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7851
  },
  {
    "request_id": "AM-REQ-2026-09536",
    "original_inquiry": "Urgent: 患者家属咨询：双特异性抗体晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8821
  },
  {
    "request_id": "AM-REQ-2026-09537",
    "original_inquiry": "海外求诊：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7066
  },
  {
    "request_id": "AM-REQ-2026-09538",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced personalized neoantigen; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-09539",
    "original_inquiry": "Family seeking information: Oncologist referral: Phase II/III positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7221
  },
  {
    "request_id": "AM-REQ-2026-09540",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in ADC inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5938
  },
  {
    "request_id": "AM-REQ-2026-09541",
    "original_inquiry": "Referral from specialist: Oncologist referral: combination immunotherapy positive; interested in immune checkpoint inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8355
  },
  {
    "request_id": "AM-REQ-2026-09542",
    "original_inquiry": "Referral from specialist: Urgent: NSCLC mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6721
  },
  {
    "request_id": "AM-REQ-2026-09543",
    "original_inquiry": "Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7247
  },
  {
    "request_id": "AM-REQ-2026-09544",
    "original_inquiry": "Referral from specialist: Oncologist referral: solid tumor positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6918
  },
  {
    "request_id": "AM-REQ-2026-09545",
    "original_inquiry": "Urgent: Urgent: 个体化疫苗 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8745
  },
  {
    "request_id": "AM-REQ-2026-09546",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5956
  },
  {
    "request_id": "AM-REQ-2026-09547",
    "original_inquiry": "Family seeking information: Urgent: melanoma mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6568
  },
  {
    "request_id": "AM-REQ-2026-09548",
    "original_inquiry": "研究者咨询：Patient with combination immunotherapy (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8046
  },
  {
    "request_id": "AM-REQ-2026-09549",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5732
  },
  {
    "request_id": "AM-REQ-2026-09550",
    "original_inquiry": "海外求药：combination immunotherapy患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5252
  },
  {
    "request_id": "AM-REQ-2026-09551",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7494
  },
  {
    "request_id": "AM-REQ-2026-09552",
    "original_inquiry": "Second opinion requested: Researcher inquiry: mRNA vaccine trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7066
  },
  {
    "request_id": "AM-REQ-2026-09553",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6054
  },
  {
    "request_id": "AM-REQ-2026-09554",
    "original_inquiry": "Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7481
  },
  {
    "request_id": "AM-REQ-2026-09555",
    "original_inquiry": "海外求诊：Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5031
  },
  {
    "request_id": "AM-REQ-2026-09556",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.541
  },
  {
    "request_id": "AM-REQ-2026-09557",
    "original_inquiry": "Referral from specialist: Urgent: ADC联合治疗 mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7381
  },
  {
    "request_id": "AM-REQ-2026-09558",
    "original_inquiry": "海外求诊：Consultation: 双特异性抗体 with advanced mRNA cancer vaccine; request CAR-T and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5501
  },
  {
    "request_id": "AM-REQ-2026-09559",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.754
  },
  {
    "request_id": "AM-REQ-2026-09560",
    "original_inquiry": "研究者咨询：海外求药：双特异性抗体患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5145
  },
  {
    "request_id": "AM-REQ-2026-09561",
    "original_inquiry": "Second opinion requested: Oncologist referral: Phase II/III positive; interested in mRNA cancer vaccine inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8171
  },
  {
    "request_id": "AM-REQ-2026-09562",
    "original_inquiry": "海外求药：solid tumor患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6977
  },
  {
    "request_id": "AM-REQ-2026-09563",
    "original_inquiry": "Referral from specialist: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7733
  },
  {
    "request_id": "AM-REQ-2026-09564",
    "original_inquiry": "研究者咨询：Consultation: solid tumor with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8291
  },
  {
    "request_id": "AM-REQ-2026-09565",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7897
  },
  {
    "request_id": "AM-REQ-2026-09566",
    "original_inquiry": "患者家属咨询：melanoma晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5024
  },
  {
    "request_id": "AM-REQ-2026-09567",
    "original_inquiry": "海外求诊：Researcher inquiry: Phase II/III trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.887
  },
  {
    "request_id": "AM-REQ-2026-09568",
    "original_inquiry": "Second opinion requested: Consultation: ADC联合治疗 with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6447
  },
  {
    "request_id": "AM-REQ-2026-09569",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7494
  },
  {
    "request_id": "AM-REQ-2026-09570",
    "original_inquiry": "Referral from specialist: 海外求药：ADC联合治疗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7036
  },
  {
    "request_id": "AM-REQ-2026-09571",
    "original_inquiry": "研究者咨询：Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5392
  },
  {
    "request_id": "AM-REQ-2026-09572",
    "original_inquiry": "研究者咨询：海外求药：Phase II/III患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6058
  },
  {
    "request_id": "AM-REQ-2026-09573",
    "original_inquiry": "Urgent: Patient with Phase II/III (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6734
  },
  {
    "request_id": "AM-REQ-2026-09574",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8797
  },
  {
    "request_id": "AM-REQ-2026-09575",
    "original_inquiry": "患者家属咨询：solid tumor晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7956
  },
  {
    "request_id": "AM-REQ-2026-09576",
    "original_inquiry": "Urgent: Researcher inquiry: Phase II/III trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5189
  },
  {
    "request_id": "AM-REQ-2026-09577",
    "original_inquiry": "研究者咨询：海外求药：combination immunotherapy患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7795
  },
  {
    "request_id": "AM-REQ-2026-09578",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5997
  },
  {
    "request_id": "AM-REQ-2026-09579",
    "original_inquiry": "海外求诊：海外求药：NSCLC患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7261
  },
  {
    "request_id": "AM-REQ-2026-09580",
    "original_inquiry": "Urgent: 患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6388
  },
  {
    "request_id": "AM-REQ-2026-09581",
    "original_inquiry": "Urgent: Patient with combination immunotherapy (immune checkpoint); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6681
  },
  {
    "request_id": "AM-REQ-2026-09582",
    "original_inquiry": "Urgent: 海外求药：双特异性抗体患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5408
  },
  {
    "request_id": "AM-REQ-2026-09583",
    "original_inquiry": "Urgent: ADC联合治疗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5842
  },
  {
    "request_id": "AM-REQ-2026-09584",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8516
  },
  {
    "request_id": "AM-REQ-2026-09585",
    "original_inquiry": "Oncologist referral: solid tumor positive; interested in KRAS G12C inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7835
  },
  {
    "request_id": "AM-REQ-2026-09586",
    "original_inquiry": "海外求诊：患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5361
  },
  {
    "request_id": "AM-REQ-2026-09587",
    "original_inquiry": "研究者咨询：海外求药：mRNA vaccine患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5304
  },
  {
    "request_id": "AM-REQ-2026-09588",
    "original_inquiry": "Family seeking information: 海外求药：solid tumor患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8621
  },
  {
    "request_id": "AM-REQ-2026-09589",
    "original_inquiry": "Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8704
  },
  {
    "request_id": "AM-REQ-2026-09590",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8239
  },
  {
    "request_id": "AM-REQ-2026-09591",
    "original_inquiry": "Patient with ADC联合治疗 (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6768
  },
  {
    "request_id": "AM-REQ-2026-09592",
    "original_inquiry": "海外求诊：海外求药：双特异性抗体患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.543
  },
  {
    "request_id": "AM-REQ-2026-09593",
    "original_inquiry": "海外求诊：Patient with 双特异性抗体 (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6314
  },
  {
    "request_id": "AM-REQ-2026-09594",
    "original_inquiry": "Referral from specialist: 患者家属咨询：双特异性抗体晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5613
  },
  {
    "request_id": "AM-REQ-2026-09595",
    "original_inquiry": "海外求诊：患者家属咨询：Phase II/III晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7704
  },
  {
    "request_id": "AM-REQ-2026-09596",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6816
  },
  {
    "request_id": "AM-REQ-2026-09597",
    "original_inquiry": "海外求诊：Researcher inquiry: mRNA vaccine trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7699
  },
  {
    "request_id": "AM-REQ-2026-09598",
    "original_inquiry": "Family seeking information: Urgent: mRNA vaccine mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8308
  },
  {
    "request_id": "AM-REQ-2026-09599",
    "original_inquiry": "Patient with NSCLC (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7158
  },
  {
    "request_id": "AM-REQ-2026-09600",
    "original_inquiry": "研究者咨询：Urgent: combination immunotherapy mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7015
  },
  {
    "request_id": "AM-REQ-2026-09601",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5141
  },
  {
    "request_id": "AM-REQ-2026-09602",
    "original_inquiry": "研究者咨询：Consultation: 双特异性抗体 with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6965
  },
  {
    "request_id": "AM-REQ-2026-09603",
    "original_inquiry": "Urgent: Patient with solid tumor (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8586
  },
  {
    "request_id": "AM-REQ-2026-09604",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5331
  },
  {
    "request_id": "AM-REQ-2026-09605",
    "original_inquiry": "Patient with 个体化疫苗 (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8482
  },
  {
    "request_id": "AM-REQ-2026-09606",
    "original_inquiry": "Referral from specialist: 海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6038
  },
  {
    "request_id": "AM-REQ-2026-09607",
    "original_inquiry": "Referral from specialist: Researcher inquiry: NSCLC trial design and ADC with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5423
  },
  {
    "request_id": "AM-REQ-2026-09608",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and CAR-T with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8359
  },
  {
    "request_id": "AM-REQ-2026-09609",
    "original_inquiry": "Family seeking information: Patient with 个体化疫苗 (ADC); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5862
  },
  {
    "request_id": "AM-REQ-2026-09610",
    "original_inquiry": "Consultation: solid tumor with advanced immune checkpoint; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7205
  },
  {
    "request_id": "AM-REQ-2026-09611",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5008
  },
  {
    "request_id": "AM-REQ-2026-09612",
    "original_inquiry": "Family seeking information: Oncologist referral: 个体化疫苗 positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8588
  },
  {
    "request_id": "AM-REQ-2026-09613",
    "original_inquiry": "海外求诊：Researcher inquiry: combination immunotherapy trial design and bispecific antibody with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5912
  },
  {
    "request_id": "AM-REQ-2026-09614",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5125
  },
  {
    "request_id": "AM-REQ-2026-09615",
    "original_inquiry": "Second opinion requested: Consultation: combination immunotherapy with advanced personalized neoantigen; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.838
  },
  {
    "request_id": "AM-REQ-2026-09616",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8901
  },
  {
    "request_id": "AM-REQ-2026-09617",
    "original_inquiry": "Urgent: Patient with 个体化疫苗 (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.599
  },
  {
    "request_id": "AM-REQ-2026-09618",
    "original_inquiry": "Family seeking information: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6684
  },
  {
    "request_id": "AM-REQ-2026-09619",
    "original_inquiry": "海外求诊：Urgent: NSCLC mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5151
  },
  {
    "request_id": "AM-REQ-2026-09620",
    "original_inquiry": "Referral from specialist: Consultation: solid tumor with advanced KRAS G12C; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6785
  },
  {
    "request_id": "AM-REQ-2026-09621",
    "original_inquiry": "海外求诊：Oncologist referral: 个体化疫苗 positive; interested in immune checkpoint inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6694
  },
  {
    "request_id": "AM-REQ-2026-09622",
    "original_inquiry": "Researcher inquiry: melanoma trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5602
  },
  {
    "request_id": "AM-REQ-2026-09623",
    "original_inquiry": "海外求诊：Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8751
  },
  {
    "request_id": "AM-REQ-2026-09624",
    "original_inquiry": "研究者咨询：Patient with combination immunotherapy (personalized neoantigen); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6552
  },
  {
    "request_id": "AM-REQ-2026-09625",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7726
  },
  {
    "request_id": "AM-REQ-2026-09626",
    "original_inquiry": "Second opinion requested: 海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7209
  },
  {
    "request_id": "AM-REQ-2026-09627",
    "original_inquiry": "Urgent: 海外求药：个体化疫苗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8196
  },
  {
    "request_id": "AM-REQ-2026-09628",
    "original_inquiry": "Referral from specialist: Oncologist referral: 双特异性抗体 positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8269
  },
  {
    "request_id": "AM-REQ-2026-09629",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5415
  },
  {
    "request_id": "AM-REQ-2026-09630",
    "original_inquiry": "Referral from specialist: Oncologist referral: 个体化疫苗 positive; interested in immune checkpoint inhibitors and ADC combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6787
  },
  {
    "request_id": "AM-REQ-2026-09631",
    "original_inquiry": "Referral from specialist: Researcher inquiry: solid tumor trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8732
  },
  {
    "request_id": "AM-REQ-2026-09632",
    "original_inquiry": "Family seeking information: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7723
  },
  {
    "request_id": "AM-REQ-2026-09633",
    "original_inquiry": "患者家属咨询：melanoma晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8129
  },
  {
    "request_id": "AM-REQ-2026-09634",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5297
  },
  {
    "request_id": "AM-REQ-2026-09635",
    "original_inquiry": "Consultation: 双特异性抗体 with advanced ADC; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6976
  },
  {
    "request_id": "AM-REQ-2026-09636",
    "original_inquiry": "Referral from specialist: 海外求药：个体化疫苗患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6103
  },
  {
    "request_id": "AM-REQ-2026-09637",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.779
  },
  {
    "request_id": "AM-REQ-2026-09638",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8389
  },
  {
    "request_id": "AM-REQ-2026-09639",
    "original_inquiry": "Second opinion requested: Consultation: Phase II/III with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5688
  },
  {
    "request_id": "AM-REQ-2026-09640",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6945
  },
  {
    "request_id": "AM-REQ-2026-09641",
    "original_inquiry": "海外求诊：Patient with NSCLC (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7706
  },
  {
    "request_id": "AM-REQ-2026-09642",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in bispecific antibody inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8944
  },
  {
    "request_id": "AM-REQ-2026-09643",
    "original_inquiry": "Urgent: Researcher inquiry: 双特异性抗体 trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8984
  },
  {
    "request_id": "AM-REQ-2026-09644",
    "original_inquiry": "海外求诊：Oncologist referral: melanoma positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6421
  },
  {
    "request_id": "AM-REQ-2026-09645",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6688
  },
  {
    "request_id": "AM-REQ-2026-09646",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (mRNA cancer vaccine); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8726
  },
  {
    "request_id": "AM-REQ-2026-09647",
    "original_inquiry": "Family seeking information: Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.597
  },
  {
    "request_id": "AM-REQ-2026-09648",
    "original_inquiry": "研究者咨询：患者家属咨询：melanoma晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6837
  },
  {
    "request_id": "AM-REQ-2026-09649",
    "original_inquiry": "Consultation: combination immunotherapy with advanced CAR-T; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7726
  },
  {
    "request_id": "AM-REQ-2026-09650",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced CAR-T; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8576
  },
  {
    "request_id": "AM-REQ-2026-09651",
    "original_inquiry": "Second opinion requested: Consultation: melanoma with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.899
  },
  {
    "request_id": "AM-REQ-2026-09652",
    "original_inquiry": "研究者咨询：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5363
  },
  {
    "request_id": "AM-REQ-2026-09653",
    "original_inquiry": "Referral from specialist: Oncologist referral: 双特异性抗体 positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8082
  },
  {
    "request_id": "AM-REQ-2026-09654",
    "original_inquiry": "Family seeking information: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7086
  },
  {
    "request_id": "AM-REQ-2026-09655",
    "original_inquiry": "Urgent: Oncologist referral: combination immunotherapy positive; interested in antibody-drug conjugate inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5787
  },
  {
    "request_id": "AM-REQ-2026-09656",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8477
  },
  {
    "request_id": "AM-REQ-2026-09657",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5573
  },
  {
    "request_id": "AM-REQ-2026-09658",
    "original_inquiry": "Researcher inquiry: 双特异性抗体 trial design and ADC with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6853
  },
  {
    "request_id": "AM-REQ-2026-09659",
    "original_inquiry": "Urgent: Urgent: 双特异性抗体 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7516
  },
  {
    "request_id": "AM-REQ-2026-09660",
    "original_inquiry": "Family seeking information: Patient with mRNA vaccine (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5517
  },
  {
    "request_id": "AM-REQ-2026-09661",
    "original_inquiry": "Urgent: 患者家属咨询：个体化疫苗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8533
  },
  {
    "request_id": "AM-REQ-2026-09662",
    "original_inquiry": "Patient with solid tumor (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5171
  },
  {
    "request_id": "AM-REQ-2026-09663",
    "original_inquiry": "研究者咨询：Researcher inquiry: 个体化疫苗 trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.597
  },
  {
    "request_id": "AM-REQ-2026-09664",
    "original_inquiry": "研究者咨询：海外求药：个体化疫苗患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7242
  },
  {
    "request_id": "AM-REQ-2026-09665",
    "original_inquiry": "研究者咨询：Consultation: ADC联合治疗 with advanced CAR-T; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7741
  },
  {
    "request_id": "AM-REQ-2026-09666",
    "original_inquiry": "Family seeking information: Consultation: solid tumor with advanced immune checkpoint; request ADC and ADC immunotherapy options.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6939
  },
  {
    "request_id": "AM-REQ-2026-09667",
    "original_inquiry": "Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7942
  },
  {
    "request_id": "AM-REQ-2026-09668",
    "original_inquiry": "海外求诊：Patient with 个体化疫苗 (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5373
  },
  {
    "request_id": "AM-REQ-2026-09669",
    "original_inquiry": "Consultation: ADC联合治疗 with advanced immune checkpoint; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5941
  },
  {
    "request_id": "AM-REQ-2026-09670",
    "original_inquiry": "患者家属咨询：melanoma晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5781
  },
  {
    "request_id": "AM-REQ-2026-09671",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (bispecific antibody); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5627
  },
  {
    "request_id": "AM-REQ-2026-09672",
    "original_inquiry": "海外求诊：Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8425
  },
  {
    "request_id": "AM-REQ-2026-09673",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in personalized neoantigen inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5477
  },
  {
    "request_id": "AM-REQ-2026-09674",
    "original_inquiry": "Patient with mRNA vaccine (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7303
  },
  {
    "request_id": "AM-REQ-2026-09675",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7608
  },
  {
    "request_id": "AM-REQ-2026-09676",
    "original_inquiry": "Urgent: 海外求药：NSCLC患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5977
  },
  {
    "request_id": "AM-REQ-2026-09677",
    "original_inquiry": "Oncologist referral: Phase II/III positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7035
  },
  {
    "request_id": "AM-REQ-2026-09678",
    "original_inquiry": "Second opinion requested: Patient with mRNA vaccine (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7488
  },
  {
    "request_id": "AM-REQ-2026-09679",
    "original_inquiry": "研究者咨询：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7795
  },
  {
    "request_id": "AM-REQ-2026-09680",
    "original_inquiry": "研究者咨询：海外求药：melanoma患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6837
  },
  {
    "request_id": "AM-REQ-2026-09681",
    "original_inquiry": "Family seeking information: Oncologist referral: solid tumor positive; interested in KRAS G12C inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8572
  },
  {
    "request_id": "AM-REQ-2026-09682",
    "original_inquiry": "Family seeking information: Patient with combination immunotherapy (mRNA cancer vaccine); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7793
  },
  {
    "request_id": "AM-REQ-2026-09683",
    "original_inquiry": "研究者咨询：Researcher inquiry: combination immunotherapy trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8956
  },
  {
    "request_id": "AM-REQ-2026-09684",
    "original_inquiry": "海外求诊：Researcher inquiry: melanoma trial design and immune checkpoint with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7483
  },
  {
    "request_id": "AM-REQ-2026-09685",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8322
  },
  {
    "request_id": "AM-REQ-2026-09686",
    "original_inquiry": "Referral from specialist: Urgent: melanoma mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5355
  },
  {
    "request_id": "AM-REQ-2026-09687",
    "original_inquiry": "Family seeking information: 患者家属咨询：combination immunotherapy晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6323
  },
  {
    "request_id": "AM-REQ-2026-09688",
    "original_inquiry": "Consultation: melanoma with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5619
  },
  {
    "request_id": "AM-REQ-2026-09689",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5594
  },
  {
    "request_id": "AM-REQ-2026-09690",
    "original_inquiry": "Consultation: ADC联合治疗 with advanced CAR-T; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6715
  },
  {
    "request_id": "AM-REQ-2026-09691",
    "original_inquiry": "Urgent: Phase II/III mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5034
  },
  {
    "request_id": "AM-REQ-2026-09692",
    "original_inquiry": "Oncologist referral: ADC联合治疗 positive; interested in CAR-T inhibitors and mRNA cancer vaccine combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.677
  },
  {
    "request_id": "AM-REQ-2026-09693",
    "original_inquiry": "Patient with 个体化疫苗 (antibody-drug conjugate); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5137
  },
  {
    "request_id": "AM-REQ-2026-09694",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5187
  },
  {
    "request_id": "AM-REQ-2026-09695",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5099
  },
  {
    "request_id": "AM-REQ-2026-09696",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8703
  },
  {
    "request_id": "AM-REQ-2026-09697",
    "original_inquiry": "患者家属咨询：mRNA vaccine晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7558
  },
  {
    "request_id": "AM-REQ-2026-09698",
    "original_inquiry": "研究者咨询：Oncologist referral: combination immunotherapy positive; interested in KRAS G12C inhibitors and CAR-T combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7863
  },
  {
    "request_id": "AM-REQ-2026-09699",
    "original_inquiry": "Second opinion requested: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5055
  },
  {
    "request_id": "AM-REQ-2026-09700",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8388
  },
  {
    "request_id": "AM-REQ-2026-09701",
    "original_inquiry": "Urgent: 海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7183
  },
  {
    "request_id": "AM-REQ-2026-09702",
    "original_inquiry": "Second opinion requested: Patient with combination immunotherapy (antibody-drug conjugate); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6683
  },
  {
    "request_id": "AM-REQ-2026-09703",
    "original_inquiry": "Urgent: 患者家属咨询：mRNA vaccine晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6725
  },
  {
    "request_id": "AM-REQ-2026-09704",
    "original_inquiry": "Referral from specialist: Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7664
  },
  {
    "request_id": "AM-REQ-2026-09705",
    "original_inquiry": "Second opinion requested: Researcher inquiry: 个体化疫苗 trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5887
  },
  {
    "request_id": "AM-REQ-2026-09706",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and personalized neoantigen with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6885
  },
  {
    "request_id": "AM-REQ-2026-09707",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in KRAS G12C inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8431
  },
  {
    "request_id": "AM-REQ-2026-09708",
    "original_inquiry": "Urgent: Urgent: Phase II/III mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6407
  },
  {
    "request_id": "AM-REQ-2026-09709",
    "original_inquiry": "研究者咨询：患者家属咨询：个体化疫苗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.669
  },
  {
    "request_id": "AM-REQ-2026-09710",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5488
  },
  {
    "request_id": "AM-REQ-2026-09711",
    "original_inquiry": "Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5788
  },
  {
    "request_id": "AM-REQ-2026-09712",
    "original_inquiry": "研究者咨询：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7899
  },
  {
    "request_id": "AM-REQ-2026-09713",
    "original_inquiry": "海外求诊：海外求药：个体化疫苗患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5942
  },
  {
    "request_id": "AM-REQ-2026-09714",
    "original_inquiry": "Urgent: Patient with solid tumor (KRAS G12C); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.591
  },
  {
    "request_id": "AM-REQ-2026-09715",
    "original_inquiry": "Urgent: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.811
  },
  {
    "request_id": "AM-REQ-2026-09716",
    "original_inquiry": "海外求诊：患者家属咨询：combination immunotherapy晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6093
  },
  {
    "request_id": "AM-REQ-2026-09717",
    "original_inquiry": "海外求药：Phase II/III患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8287
  },
  {
    "request_id": "AM-REQ-2026-09718",
    "original_inquiry": "Second opinion requested: Urgent: NSCLC mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7801
  },
  {
    "request_id": "AM-REQ-2026-09719",
    "original_inquiry": "Second opinion requested: Patient with 双特异性抗体 (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.727
  },
  {
    "request_id": "AM-REQ-2026-09720",
    "original_inquiry": "Referral from specialist: Researcher inquiry: solid tumor trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7084
  },
  {
    "request_id": "AM-REQ-2026-09721",
    "original_inquiry": "Referral from specialist: Patient with combination immunotherapy (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5993
  },
  {
    "request_id": "AM-REQ-2026-09722",
    "original_inquiry": "患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6766
  },
  {
    "request_id": "AM-REQ-2026-09723",
    "original_inquiry": "Referral from specialist: 患者家属咨询：ADC联合治疗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5739
  },
  {
    "request_id": "AM-REQ-2026-09724",
    "original_inquiry": "Second opinion requested: Patient with melanoma (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6892
  },
  {
    "request_id": "AM-REQ-2026-09725",
    "original_inquiry": "Family seeking information: 海外求药：mRNA vaccine患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6435
  },
  {
    "request_id": "AM-REQ-2026-09726",
    "original_inquiry": "Researcher inquiry: NSCLC trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6473
  },
  {
    "request_id": "AM-REQ-2026-09727",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5423
  },
  {
    "request_id": "AM-REQ-2026-09728",
    "original_inquiry": "Referral from specialist: 海外求药：双特异性抗体患者，希望参加ADC或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8119
  },
  {
    "request_id": "AM-REQ-2026-09729",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8208
  },
  {
    "request_id": "AM-REQ-2026-09730",
    "original_inquiry": "Referral from specialist: Urgent: mRNA vaccine mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8539
  },
  {
    "request_id": "AM-REQ-2026-09731",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5689
  },
  {
    "request_id": "AM-REQ-2026-09732",
    "original_inquiry": "患者家属咨询：NSCLC晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6638
  },
  {
    "request_id": "AM-REQ-2026-09733",
    "original_inquiry": "Referral from specialist: Consultation: NSCLC with advanced bispecific antibody; request mRNA cancer vaccine and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7358
  },
  {
    "request_id": "AM-REQ-2026-09734",
    "original_inquiry": "Urgent: Oncologist referral: NSCLC positive; interested in immune checkpoint inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7601
  },
  {
    "request_id": "AM-REQ-2026-09735",
    "original_inquiry": "海外求诊：Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6365
  },
  {
    "request_id": "AM-REQ-2026-09736",
    "original_inquiry": "研究者咨询：Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6933
  },
  {
    "request_id": "AM-REQ-2026-09737",
    "original_inquiry": "Family seeking information: 患者家属咨询：ADC联合治疗晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5256
  },
  {
    "request_id": "AM-REQ-2026-09738",
    "original_inquiry": "研究者咨询：Consultation: melanoma with advanced immune checkpoint; request ADC and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6065
  },
  {
    "request_id": "AM-REQ-2026-09739",
    "original_inquiry": "海外求诊：海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7121
  },
  {
    "request_id": "AM-REQ-2026-09740",
    "original_inquiry": "Second opinion requested: 海外求药：Phase II/III患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5267
  },
  {
    "request_id": "AM-REQ-2026-09741",
    "original_inquiry": "患者家属咨询：combination immunotherapy晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-09742",
    "original_inquiry": "海外求诊：Urgent: mRNA vaccine mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8484
  },
  {
    "request_id": "AM-REQ-2026-09743",
    "original_inquiry": "Urgent: Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6836
  },
  {
    "request_id": "AM-REQ-2026-09744",
    "original_inquiry": "Urgent: solid tumor mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7457
  },
  {
    "request_id": "AM-REQ-2026-09745",
    "original_inquiry": "Consultation: melanoma with advanced antibody-drug conjugate; request mRNA cancer vaccine and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.755
  },
  {
    "request_id": "AM-REQ-2026-09746",
    "original_inquiry": "Family seeking information: 患者家属咨询：个体化疫苗晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6351
  },
  {
    "request_id": "AM-REQ-2026-09747",
    "original_inquiry": "海外求诊：Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6762
  },
  {
    "request_id": "AM-REQ-2026-09748",
    "original_inquiry": "Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and immune checkpoint combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5381
  },
  {
    "request_id": "AM-REQ-2026-09749",
    "original_inquiry": "Second opinion requested: Patient with mRNA vaccine (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5175
  },
  {
    "request_id": "AM-REQ-2026-09750",
    "original_inquiry": "Family seeking information: Consultation: 双特异性抗体 with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5662
  },
  {
    "request_id": "AM-REQ-2026-09751",
    "original_inquiry": "Urgent: Oncologist referral: mRNA vaccine positive; interested in ADC inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7712
  },
  {
    "request_id": "AM-REQ-2026-09752",
    "original_inquiry": "研究者咨询：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7516
  },
  {
    "request_id": "AM-REQ-2026-09753",
    "original_inquiry": "Urgent: Patient with melanoma (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5437
  },
  {
    "request_id": "AM-REQ-2026-09754",
    "original_inquiry": "Family seeking information: 海外求药：melanoma患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6375
  },
  {
    "request_id": "AM-REQ-2026-09755",
    "original_inquiry": "Urgent: Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8505
  },
  {
    "request_id": "AM-REQ-2026-09756",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5163
  },
  {
    "request_id": "AM-REQ-2026-09757",
    "original_inquiry": "患者家属咨询：NSCLC晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6144
  },
  {
    "request_id": "AM-REQ-2026-09758",
    "original_inquiry": "Oncologist referral: NSCLC positive; interested in ADC inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7215
  },
  {
    "request_id": "AM-REQ-2026-09759",
    "original_inquiry": "Consultation: 双特异性抗体 with advanced bispecific antibody; request ADC and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8831
  },
  {
    "request_id": "AM-REQ-2026-09760",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced bispecific antibody; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8793
  },
  {
    "request_id": "AM-REQ-2026-09761",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in antibody-drug conjugate inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5026
  },
  {
    "request_id": "AM-REQ-2026-09762",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8557
  },
  {
    "request_id": "AM-REQ-2026-09763",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.65
  },
  {
    "request_id": "AM-REQ-2026-09764",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6378
  },
  {
    "request_id": "AM-REQ-2026-09765",
    "original_inquiry": "Urgent: Consultation: NSCLC with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6172
  },
  {
    "request_id": "AM-REQ-2026-09766",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced KRAS G12C; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7334
  },
  {
    "request_id": "AM-REQ-2026-09767",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8203
  },
  {
    "request_id": "AM-REQ-2026-09768",
    "original_inquiry": "Second opinion requested: Patient with NSCLC (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5692
  },
  {
    "request_id": "AM-REQ-2026-09769",
    "original_inquiry": "Family seeking information: Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5525
  },
  {
    "request_id": "AM-REQ-2026-09770",
    "original_inquiry": "Urgent: Researcher inquiry: solid tumor trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5595
  },
  {
    "request_id": "AM-REQ-2026-09771",
    "original_inquiry": "Family seeking information: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.661
  },
  {
    "request_id": "AM-REQ-2026-09772",
    "original_inquiry": "Second opinion requested: 海外求药：combination immunotherapy患者，希望参加CAR-T或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8563
  },
  {
    "request_id": "AM-REQ-2026-09773",
    "original_inquiry": "研究者咨询：患者家属咨询：NSCLC晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7961
  },
  {
    "request_id": "AM-REQ-2026-09774",
    "original_inquiry": "海外求诊：Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6681
  },
  {
    "request_id": "AM-REQ-2026-09775",
    "original_inquiry": "Second opinion requested: 患者家属咨询：个体化疫苗晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8209
  },
  {
    "request_id": "AM-REQ-2026-09776",
    "original_inquiry": "Urgent: Phase II/III mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8257
  },
  {
    "request_id": "AM-REQ-2026-09777",
    "original_inquiry": "Referral from specialist: Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5473
  },
  {
    "request_id": "AM-REQ-2026-09778",
    "original_inquiry": "研究者咨询：Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6578
  },
  {
    "request_id": "AM-REQ-2026-09779",
    "original_inquiry": "Referral from specialist: Oncologist referral: 个体化疫苗 positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5838
  },
  {
    "request_id": "AM-REQ-2026-09780",
    "original_inquiry": "Urgent: Urgent: mRNA vaccine mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5957
  },
  {
    "request_id": "AM-REQ-2026-09781",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5002
  },
  {
    "request_id": "AM-REQ-2026-09782",
    "original_inquiry": "研究者咨询：Patient with Phase II/III (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8598
  },
  {
    "request_id": "AM-REQ-2026-09783",
    "original_inquiry": "Family seeking information: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8028
  },
  {
    "request_id": "AM-REQ-2026-09784",
    "original_inquiry": "Referral from specialist: Consultation: combination immunotherapy with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6365
  },
  {
    "request_id": "AM-REQ-2026-09785",
    "original_inquiry": "Referral from specialist: 海外求药：Phase II/III患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5517
  },
  {
    "request_id": "AM-REQ-2026-09786",
    "original_inquiry": "研究者咨询：Researcher inquiry: melanoma trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5206
  },
  {
    "request_id": "AM-REQ-2026-09787",
    "original_inquiry": "Urgent: Consultation: Phase II/III with advanced CAR-T; request ADC and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7809
  },
  {
    "request_id": "AM-REQ-2026-09788",
    "original_inquiry": "Oncologist referral: solid tumor positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5773
  },
  {
    "request_id": "AM-REQ-2026-09789",
    "original_inquiry": "海外求诊：海外求药：combination immunotherapy患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7869
  },
  {
    "request_id": "AM-REQ-2026-09790",
    "original_inquiry": "研究者咨询：Researcher inquiry: solid tumor trial design and CAR-T with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5926
  },
  {
    "request_id": "AM-REQ-2026-09791",
    "original_inquiry": "研究者咨询：Consultation: NSCLC with advanced mRNA cancer vaccine; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7829
  },
  {
    "request_id": "AM-REQ-2026-09792",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6784
  },
  {
    "request_id": "AM-REQ-2026-09793",
    "original_inquiry": "Second opinion requested: 海外求药：双特异性抗体患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5307
  },
  {
    "request_id": "AM-REQ-2026-09794",
    "original_inquiry": "Referral from specialist: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.758
  },
  {
    "request_id": "AM-REQ-2026-09795",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7894
  },
  {
    "request_id": "AM-REQ-2026-09796",
    "original_inquiry": "研究者咨询：患者家属咨询：NSCLC晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5506
  },
  {
    "request_id": "AM-REQ-2026-09797",
    "original_inquiry": "Referral from specialist: Patient with combination immunotherapy (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7861
  },
  {
    "request_id": "AM-REQ-2026-09798",
    "original_inquiry": "Urgent: Oncologist referral: Phase II/III positive; interested in mRNA cancer vaccine inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7579
  },
  {
    "request_id": "AM-REQ-2026-09799",
    "original_inquiry": "Urgent: Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.793
  },
  {
    "request_id": "AM-REQ-2026-09800",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5871
  },
  {
    "request_id": "AM-REQ-2026-09801",
    "original_inquiry": "研究者咨询：海外求药：mRNA vaccine患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8101
  },
  {
    "request_id": "AM-REQ-2026-09802",
    "original_inquiry": "Urgent: Consultation: combination immunotherapy with advanced KRAS G12C; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6002
  },
  {
    "request_id": "AM-REQ-2026-09803",
    "original_inquiry": "Urgent: 患者家属咨询：combination immunotherapy晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6851
  },
  {
    "request_id": "AM-REQ-2026-09804",
    "original_inquiry": "Second opinion requested: Oncologist referral: melanoma positive; interested in bispecific antibody inhibitors and CAR-T combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8339
  },
  {
    "request_id": "AM-REQ-2026-09805",
    "original_inquiry": "Second opinion requested: 海外求药：melanoma患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6017
  },
  {
    "request_id": "AM-REQ-2026-09806",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求ADC、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6594
  },
  {
    "request_id": "AM-REQ-2026-09807",
    "original_inquiry": "Referral from specialist: Researcher inquiry: melanoma trial design and bispecific antibody with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6617
  },
  {
    "request_id": "AM-REQ-2026-09808",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7469
  },
  {
    "request_id": "AM-REQ-2026-09809",
    "original_inquiry": "研究者咨询：Patient with combination immunotherapy (immune checkpoint); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8926
  },
  {
    "request_id": "AM-REQ-2026-09810",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (mRNA cancer vaccine); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8762
  },
  {
    "request_id": "AM-REQ-2026-09811",
    "original_inquiry": "海外求诊：Urgent: 双特异性抗体 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7864
  },
  {
    "request_id": "AM-REQ-2026-09812",
    "original_inquiry": "Urgent: Consultation: solid tumor with advanced bispecific antibody; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7167
  },
  {
    "request_id": "AM-REQ-2026-09813",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.763
  },
  {
    "request_id": "AM-REQ-2026-09814",
    "original_inquiry": "患者家属咨询：NSCLC晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6939
  },
  {
    "request_id": "AM-REQ-2026-09815",
    "original_inquiry": "Urgent: Request for second opinion: mRNA vaccine; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8939
  },
  {
    "request_id": "AM-REQ-2026-09816",
    "original_inquiry": "Patient with combination immunotherapy (KRAS G12C); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8577
  },
  {
    "request_id": "AM-REQ-2026-09817",
    "original_inquiry": "研究者咨询：Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6325
  },
  {
    "request_id": "AM-REQ-2026-09818",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8461
  },
  {
    "request_id": "AM-REQ-2026-09819",
    "original_inquiry": "Second opinion requested: 患者家属咨询：solid tumor晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5463
  },
  {
    "request_id": "AM-REQ-2026-09820",
    "original_inquiry": "Family seeking information: Consultation: melanoma with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7897
  },
  {
    "request_id": "AM-REQ-2026-09821",
    "original_inquiry": "Urgent: Researcher inquiry: 个体化疫苗 trial design and bispecific antibody with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5936
  },
  {
    "request_id": "AM-REQ-2026-09822",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5639
  },
  {
    "request_id": "AM-REQ-2026-09823",
    "original_inquiry": "Urgent: 双特异性抗体 mutation confirmed; seeking ADC trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8717
  },
  {
    "request_id": "AM-REQ-2026-09824",
    "original_inquiry": "海外求诊：Researcher inquiry: combination immunotherapy trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8783
  },
  {
    "request_id": "AM-REQ-2026-09825",
    "original_inquiry": "Family seeking information: Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7035
  },
  {
    "request_id": "AM-REQ-2026-09826",
    "original_inquiry": "Referral from specialist: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8124
  },
  {
    "request_id": "AM-REQ-2026-09827",
    "original_inquiry": "研究者咨询：Urgent: melanoma mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5856
  },
  {
    "request_id": "AM-REQ-2026-09828",
    "original_inquiry": "Referral from specialist: Consultation: NSCLC with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6537
  },
  {
    "request_id": "AM-REQ-2026-09829",
    "original_inquiry": "海外求诊：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6182
  },
  {
    "request_id": "AM-REQ-2026-09830",
    "original_inquiry": "研究者咨询：Consultation: mRNA vaccine with advanced bispecific antibody; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.875
  },
  {
    "request_id": "AM-REQ-2026-09831",
    "original_inquiry": "海外求诊：Patient with 双特异性抗体 (CAR-T); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6382
  },
  {
    "request_id": "AM-REQ-2026-09832",
    "original_inquiry": "Urgent: 海外求药：mRNA vaccine患者，希望参加ADC或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5938
  },
  {
    "request_id": "AM-REQ-2026-09833",
    "original_inquiry": "海外求诊：Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7723
  },
  {
    "request_id": "AM-REQ-2026-09834",
    "original_inquiry": "Urgent: Patient with Phase II/III (antibody-drug conjugate); seeking ADC or ADC clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5045
  },
  {
    "request_id": "AM-REQ-2026-09835",
    "original_inquiry": "Referral from specialist: Urgent: 双特异性抗体 mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7159
  },
  {
    "request_id": "AM-REQ-2026-09836",
    "original_inquiry": "Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8412
  },
  {
    "request_id": "AM-REQ-2026-09837",
    "original_inquiry": "Family seeking information: 海外求药：双特异性抗体患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6079
  },
  {
    "request_id": "AM-REQ-2026-09838",
    "original_inquiry": "海外求诊：海外求药：NSCLC患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7913
  },
  {
    "request_id": "AM-REQ-2026-09839",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and KRAS G12C with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7885
  },
  {
    "request_id": "AM-REQ-2026-09840",
    "original_inquiry": "Family seeking information: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8701
  },
  {
    "request_id": "AM-REQ-2026-09841",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 个体化疫苗 trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6862
  },
  {
    "request_id": "AM-REQ-2026-09842",
    "original_inquiry": "海外求药：solid tumor患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7751
  },
  {
    "request_id": "AM-REQ-2026-09843",
    "original_inquiry": "海外求诊：Consultation: NSCLC with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8385
  },
  {
    "request_id": "AM-REQ-2026-09844",
    "original_inquiry": "Urgent: 患者家属咨询：NSCLC晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6877
  },
  {
    "request_id": "AM-REQ-2026-09845",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6175
  },
  {
    "request_id": "AM-REQ-2026-09846",
    "original_inquiry": "Family seeking information: Consultation: 个体化疫苗 with advanced CAR-T; request immune checkpoint and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8441
  },
  {
    "request_id": "AM-REQ-2026-09847",
    "original_inquiry": "Family seeking information: 患者家属咨询：双特异性抗体晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6112
  },
  {
    "request_id": "AM-REQ-2026-09848",
    "original_inquiry": "Second opinion requested: Urgent: Phase II/III mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5166
  },
  {
    "request_id": "AM-REQ-2026-09849",
    "original_inquiry": "研究者咨询：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6553
  },
  {
    "request_id": "AM-REQ-2026-09850",
    "original_inquiry": "研究者咨询：Oncologist referral: solid tumor positive; interested in personalized neoantigen inhibitors and antibody-drug conjugate combinations.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7855
  },
  {
    "request_id": "AM-REQ-2026-09851",
    "original_inquiry": "Second opinion requested: 海外求药：个体化疫苗患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8807
  },
  {
    "request_id": "AM-REQ-2026-09852",
    "original_inquiry": "研究者咨询：海外求药：solid tumor患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6632
  },
  {
    "request_id": "AM-REQ-2026-09853",
    "original_inquiry": "Family seeking information: Patient with melanoma (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5435
  },
  {
    "request_id": "AM-REQ-2026-09854",
    "original_inquiry": "研究者咨询：Oncologist referral: melanoma positive; interested in KRAS G12C inhibitors and mRNA cancer vaccine combinations.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6744
  },
  {
    "request_id": "AM-REQ-2026-09855",
    "original_inquiry": "Referral from specialist: Urgent: combination immunotherapy mutation confirmed; seeking CAR-T trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.776
  },
  {
    "request_id": "AM-REQ-2026-09856",
    "original_inquiry": "Second opinion requested: Researcher inquiry: Phase II/III trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8653
  },
  {
    "request_id": "AM-REQ-2026-09857",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6598
  },
  {
    "request_id": "AM-REQ-2026-09858",
    "original_inquiry": "Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6955
  },
  {
    "request_id": "AM-REQ-2026-09859",
    "original_inquiry": "研究者咨询：患者家属咨询：ADC联合治疗晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6604
  },
  {
    "request_id": "AM-REQ-2026-09860",
    "original_inquiry": "Family seeking information: Patient with mRNA vaccine (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8161
  },
  {
    "request_id": "AM-REQ-2026-09861",
    "original_inquiry": "海外求诊：Urgent: solid tumor mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8565
  },
  {
    "request_id": "AM-REQ-2026-09862",
    "original_inquiry": "Patient with mRNA vaccine (ADC); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6632
  },
  {
    "request_id": "AM-REQ-2026-09863",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced immune checkpoint; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6005
  },
  {
    "request_id": "AM-REQ-2026-09864",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6617
  },
  {
    "request_id": "AM-REQ-2026-09865",
    "original_inquiry": "Urgent: 个体化疫苗 mutation confirmed; seeking ADC trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5813
  },
  {
    "request_id": "AM-REQ-2026-09866",
    "original_inquiry": "研究者咨询：Consultation: 个体化疫苗 with advanced bispecific antibody; request CAR-T and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.779
  },
  {
    "request_id": "AM-REQ-2026-09867",
    "original_inquiry": "Second opinion requested: 海外求药：Phase II/III患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5887
  },
  {
    "request_id": "AM-REQ-2026-09868",
    "original_inquiry": "Second opinion requested: Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8452
  },
  {
    "request_id": "AM-REQ-2026-09869",
    "original_inquiry": "海外求诊：Consultation: melanoma with advanced antibody-drug conjugate; request immune checkpoint and ADC immunotherapy options.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.563
  },
  {
    "request_id": "AM-REQ-2026-09870",
    "original_inquiry": "Urgent: Patient with 双特异性抗体 (CAR-T); seeking ADC or ADC clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7439
  },
  {
    "request_id": "AM-REQ-2026-09871",
    "original_inquiry": "Urgent: 患者家属咨询：solid tumor晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6754
  },
  {
    "request_id": "AM-REQ-2026-09872",
    "original_inquiry": "海外求诊：Consultation: ADC联合治疗 with advanced mRNA cancer vaccine; request bispecific antibody and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.613
  },
  {
    "request_id": "AM-REQ-2026-09873",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6535
  },
  {
    "request_id": "AM-REQ-2026-09874",
    "original_inquiry": "Referral from specialist: Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5257
  },
  {
    "request_id": "AM-REQ-2026-09875",
    "original_inquiry": "Family seeking information: 患者家属咨询：mRNA vaccine晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5353
  },
  {
    "request_id": "AM-REQ-2026-09876",
    "original_inquiry": "Urgent: 海外求药：Phase II/III患者，希望参加ADC或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6288
  },
  {
    "request_id": "AM-REQ-2026-09877",
    "original_inquiry": "Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and mRNA cancer vaccine combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5795
  },
  {
    "request_id": "AM-REQ-2026-09878",
    "original_inquiry": "Second opinion requested: Researcher inquiry: ADC联合治疗 trial design and immune checkpoint with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7226
  },
  {
    "request_id": "AM-REQ-2026-09879",
    "original_inquiry": "研究者咨询：Oncologist referral: NSCLC positive; interested in bispecific antibody inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6266
  },
  {
    "request_id": "AM-REQ-2026-09880",
    "original_inquiry": "Patient with melanoma (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6293
  },
  {
    "request_id": "AM-REQ-2026-09881",
    "original_inquiry": "Urgent: combination immunotherapy mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6893
  },
  {
    "request_id": "AM-REQ-2026-09882",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking personalized neoantigen trials and bispecific antibody programs.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8292
  },
  {
    "request_id": "AM-REQ-2026-09883",
    "original_inquiry": "研究者咨询：Urgent: NSCLC mutation confirmed; seeking bispecific antibody trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8159
  },
  {
    "request_id": "AM-REQ-2026-09884",
    "original_inquiry": "海外求诊：Urgent: 个体化疫苗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6601
  },
  {
    "request_id": "AM-REQ-2026-09885",
    "original_inquiry": "Second opinion requested: Consultation: ADC联合治疗 with advanced antibody-drug conjugate; request bispecific antibody and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7944
  },
  {
    "request_id": "AM-REQ-2026-09886",
    "original_inquiry": "Family seeking information: 患者家属咨询：melanoma晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7912
  },
  {
    "request_id": "AM-REQ-2026-09887",
    "original_inquiry": "Second opinion requested: 海外求药：ADC联合治疗患者，希望参加KRAS G12C或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6472
  },
  {
    "request_id": "AM-REQ-2026-09888",
    "original_inquiry": "Referral from specialist: Urgent: 个体化疫苗 mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6301
  },
  {
    "request_id": "AM-REQ-2026-09889",
    "original_inquiry": "研究者咨询：Patient with combination immunotherapy (KRAS G12C); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7176
  },
  {
    "request_id": "AM-REQ-2026-09890",
    "original_inquiry": "Oncologist referral: Phase II/III positive; interested in antibody-drug conjugate inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.873
  },
  {
    "request_id": "AM-REQ-2026-09891",
    "original_inquiry": "海外求诊：Researcher inquiry: NSCLC trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7907
  },
  {
    "request_id": "AM-REQ-2026-09892",
    "original_inquiry": "研究者咨询：Oncologist referral: Phase II/III positive; interested in mRNA cancer vaccine inhibitors and immune checkpoint combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.655
  },
  {
    "request_id": "AM-REQ-2026-09893",
    "original_inquiry": "海外求诊：Urgent: mRNA vaccine mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5196
  },
  {
    "request_id": "AM-REQ-2026-09894",
    "original_inquiry": "Urgent: Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7371
  },
  {
    "request_id": "AM-REQ-2026-09895",
    "original_inquiry": "Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8576
  },
  {
    "request_id": "AM-REQ-2026-09896",
    "original_inquiry": "研究者咨询：海外求药：Phase II/III患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8119
  },
  {
    "request_id": "AM-REQ-2026-09897",
    "original_inquiry": "研究者咨询：海外求药：mRNA vaccine患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5803
  },
  {
    "request_id": "AM-REQ-2026-09898",
    "original_inquiry": "Consultation: melanoma with advanced ADC; request immune checkpoint and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5442
  },
  {
    "request_id": "AM-REQ-2026-09899",
    "original_inquiry": "研究者咨询：Patient with 双特异性抗体 (bispecific antibody); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7838
  },
  {
    "request_id": "AM-REQ-2026-09900",
    "original_inquiry": "Family seeking information: 海外求药：Phase II/III患者，希望参加immune checkpoint或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8363
  },
  {
    "request_id": "AM-REQ-2026-09901",
    "original_inquiry": "Family seeking information: Researcher inquiry: ADC联合治疗 trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5162
  },
  {
    "request_id": "AM-REQ-2026-09902",
    "original_inquiry": "Request for second opinion: Phase II/III; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.795
  },
  {
    "request_id": "AM-REQ-2026-09903",
    "original_inquiry": "Urgent: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6188
  },
  {
    "request_id": "AM-REQ-2026-09904",
    "original_inquiry": "Referral from specialist: Oncologist referral: NSCLC positive; interested in immune checkpoint inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.705
  },
  {
    "request_id": "AM-REQ-2026-09905",
    "original_inquiry": "海外求诊：Patient with 个体化疫苗 (mRNA cancer vaccine); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8867
  },
  {
    "request_id": "AM-REQ-2026-09906",
    "original_inquiry": "Referral from specialist: Researcher inquiry: 个体化疫苗 trial design and mRNA cancer vaccine with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7314
  },
  {
    "request_id": "AM-REQ-2026-09907",
    "original_inquiry": "Referral from specialist: Oncologist referral: ADC联合治疗 positive; interested in bispecific antibody inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.579
  },
  {
    "request_id": "AM-REQ-2026-09908",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求bispecific antibody、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.771
  },
  {
    "request_id": "AM-REQ-2026-09909",
    "original_inquiry": "海外求诊：Patient with 双特异性抗体 (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8744
  },
  {
    "request_id": "AM-REQ-2026-09910",
    "original_inquiry": "Family seeking information: Patient with Phase II/III (ADC); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5819
  },
  {
    "request_id": "AM-REQ-2026-09911",
    "original_inquiry": "研究者咨询：海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8263
  },
  {
    "request_id": "AM-REQ-2026-09912",
    "original_inquiry": "Referral from specialist: 患者家属咨询：NSCLC晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6409
  },
  {
    "request_id": "AM-REQ-2026-09913",
    "original_inquiry": "Referral from specialist: 患者家属咨询：combination immunotherapy晚期，寻求KRAS G12C、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.886
  },
  {
    "request_id": "AM-REQ-2026-09914",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8826
  },
  {
    "request_id": "AM-REQ-2026-09915",
    "original_inquiry": "海外求诊：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6987
  },
  {
    "request_id": "AM-REQ-2026-09916",
    "original_inquiry": "Family seeking information: Urgent: Phase II/III mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7521
  },
  {
    "request_id": "AM-REQ-2026-09917",
    "original_inquiry": "海外求诊：Researcher inquiry: NSCLC trial design and antibody-drug conjugate with checkpoint inhibition.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7529
  },
  {
    "request_id": "AM-REQ-2026-09918",
    "original_inquiry": "Consultation: NSCLC with advanced KRAS G12C; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5066
  },
  {
    "request_id": "AM-REQ-2026-09919",
    "original_inquiry": "Second opinion requested: Researcher inquiry: Phase II/III trial design and mRNA cancer vaccine with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.586
  },
  {
    "request_id": "AM-REQ-2026-09920",
    "original_inquiry": "Urgent: Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5403
  },
  {
    "request_id": "AM-REQ-2026-09921",
    "original_inquiry": "Second opinion requested: Consultation: mRNA vaccine with advanced mRNA cancer vaccine; request antibody-drug conjugate and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5796
  },
  {
    "request_id": "AM-REQ-2026-09922",
    "original_inquiry": "Urgent: Request for second opinion: 双特异性抗体; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5108
  },
  {
    "request_id": "AM-REQ-2026-09923",
    "original_inquiry": "Family seeking information: 海外求药：NSCLC患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6488
  },
  {
    "request_id": "AM-REQ-2026-09924",
    "original_inquiry": "海外求诊：Researcher inquiry: mRNA vaccine trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6363
  },
  {
    "request_id": "AM-REQ-2026-09925",
    "original_inquiry": "Family seeking information: 海外求药：ADC联合治疗患者，希望参加bispecific antibody或mRNA癌症疫苗相关试验。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8921
  },
  {
    "request_id": "AM-REQ-2026-09926",
    "original_inquiry": "Family seeking information: Urgent: NSCLC mutation confirmed; seeking antibody-drug conjugate trials and bispecific antibody programs.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7917
  },
  {
    "request_id": "AM-REQ-2026-09927",
    "original_inquiry": "Urgent: Oncologist referral: melanoma positive; interested in mRNA cancer vaccine inhibitors and CAR-T combinations. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8001
  },
  {
    "request_id": "AM-REQ-2026-09928",
    "original_inquiry": "Urgent: Researcher inquiry: combination immunotherapy trial design and KRAS G12C with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.89
  },
  {
    "request_id": "AM-REQ-2026-09929",
    "original_inquiry": "Patient with mRNA vaccine (bispecific antibody); seeking ADC or ADC clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6235
  },
  {
    "request_id": "AM-REQ-2026-09930",
    "original_inquiry": "海外求诊：海外求药：mRNA vaccine患者，希望参加CAR-T或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8397
  },
  {
    "request_id": "AM-REQ-2026-09931",
    "original_inquiry": "Second opinion requested: Oncologist referral: mRNA vaccine positive; interested in CAR-T inhibitors and antibody-drug conjugate combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6045
  },
  {
    "request_id": "AM-REQ-2026-09932",
    "original_inquiry": "Patient with combination immunotherapy (immune checkpoint); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.63
  },
  {
    "request_id": "AM-REQ-2026-09933",
    "original_inquiry": "研究者咨询：Patient with melanoma (antibody-drug conjugate); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8413
  },
  {
    "request_id": "AM-REQ-2026-09934",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加mRNA cancer vaccine或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7527
  },
  {
    "request_id": "AM-REQ-2026-09935",
    "original_inquiry": "Second opinion requested: 患者家属咨询：combination immunotherapy晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7291
  },
  {
    "request_id": "AM-REQ-2026-09936",
    "original_inquiry": "Second opinion requested: Oncologist referral: 个体化疫苗 positive; interested in bispecific antibody inhibitors and ADC combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8739
  },
  {
    "request_id": "AM-REQ-2026-09937",
    "original_inquiry": "Urgent: Oncologist referral: mRNA vaccine positive; interested in antibody-drug conjugate inhibitors and CAR-T combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7236
  },
  {
    "request_id": "AM-REQ-2026-09938",
    "original_inquiry": "Referral from specialist: 患者家属咨询：solid tumor晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5713
  },
  {
    "request_id": "AM-REQ-2026-09939",
    "original_inquiry": "Referral from specialist: Consultation: 个体化疫苗 with advanced antibody-drug conjugate; request mRNA cancer vaccine and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6523
  },
  {
    "request_id": "AM-REQ-2026-09940",
    "original_inquiry": "Patient with Phase II/III (CAR-T); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7566
  },
  {
    "request_id": "AM-REQ-2026-09941",
    "original_inquiry": "Referral from specialist: Patient with melanoma (KRAS G12C); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.759
  },
  {
    "request_id": "AM-REQ-2026-09942",
    "original_inquiry": "Family seeking information: 患者家属咨询：solid tumor晚期，寻求mRNA cancer vaccine、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7806
  },
  {
    "request_id": "AM-REQ-2026-09943",
    "original_inquiry": "海外求诊：Patient with melanoma (immune checkpoint); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6785
  },
  {
    "request_id": "AM-REQ-2026-09944",
    "original_inquiry": "研究者咨询：Request for second opinion: combination immunotherapy; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7902
  },
  {
    "request_id": "AM-REQ-2026-09945",
    "original_inquiry": "Family seeking information: Consultation: mRNA vaccine with advanced personalized neoantigen; request antibody-drug conjugate and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8487
  },
  {
    "request_id": "AM-REQ-2026-09946",
    "original_inquiry": "研究者咨询：Oncologist referral: 双特异性抗体 positive; interested in immune checkpoint inhibitors and mRNA cancer vaccine combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.615
  },
  {
    "request_id": "AM-REQ-2026-09947",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7829
  },
  {
    "request_id": "AM-REQ-2026-09948",
    "original_inquiry": "Consultation: Phase II/III with advanced personalized neoantigen; request bispecific antibody and ADC immunotherapy options.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5999
  },
  {
    "request_id": "AM-REQ-2026-09949",
    "original_inquiry": "Second opinion requested: Patient with melanoma (antibody-drug conjugate); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6047
  },
  {
    "request_id": "AM-REQ-2026-09950",
    "original_inquiry": "研究者咨询：Oncologist referral: 双特异性抗体 positive; interested in CAR-T inhibitors and ADC combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6592
  },
  {
    "request_id": "AM-REQ-2026-09951",
    "original_inquiry": "Referral from specialist: Researcher inquiry: mRNA vaccine trial design and CAR-T with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6064
  },
  {
    "request_id": "AM-REQ-2026-09952",
    "original_inquiry": "Patient with solid tumor (bispecific antibody); seeking immune checkpoint or immune checkpoint clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7804
  },
  {
    "request_id": "AM-REQ-2026-09953",
    "original_inquiry": "研究者咨询：Urgent: ADC联合治疗 mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6187
  },
  {
    "request_id": "AM-REQ-2026-09954",
    "original_inquiry": "海外求诊：Researcher inquiry: 双特异性抗体 trial design and antibody-drug conjugate with checkpoint inhibition. 希望了解入组标准与中心列表。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7675
  },
  {
    "request_id": "AM-REQ-2026-09955",
    "original_inquiry": "Second opinion requested: Request for second opinion: melanoma; interest in personalized neoantigen vaccine and CAR-T. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8538
  },
  {
    "request_id": "AM-REQ-2026-09956",
    "original_inquiry": "Family seeking information: 患者家属咨询：mRNA vaccine晚期，寻求antibody-drug conjugate、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8089
  },
  {
    "request_id": "AM-REQ-2026-09957",
    "original_inquiry": "研究者咨询：Researcher inquiry: solid tumor trial design and immune checkpoint with checkpoint inhibition.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8704
  },
  {
    "request_id": "AM-REQ-2026-09958",
    "original_inquiry": "Family seeking information: Urgent: 个体化疫苗 mutation confirmed; seeking KRAS G12C trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6741
  },
  {
    "request_id": "AM-REQ-2026-09959",
    "original_inquiry": "Referral from specialist: 海外求药：mRNA vaccine患者，希望参加CAR-T或mRNA癌症疫苗相关试验。 Please advise on next steps.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7955
  },
  {
    "request_id": "AM-REQ-2026-09960",
    "original_inquiry": "Second opinion requested: Urgent: combination immunotherapy mutation confirmed; seeking ADC trials and bispecific antibody programs. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6721
  },
  {
    "request_id": "AM-REQ-2026-09961",
    "original_inquiry": "Urgent: 患者家属咨询：mRNA vaccine晚期，寻求ADC、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8003
  },
  {
    "request_id": "AM-REQ-2026-09962",
    "original_inquiry": "研究者咨询：Consultation: NSCLC with advanced personalized neoantigen; request mRNA cancer vaccine and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7169
  },
  {
    "request_id": "AM-REQ-2026-09963",
    "original_inquiry": "Referral from specialist: 患者家属咨询：mRNA vaccine晚期，寻求immune checkpoint、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6552
  },
  {
    "request_id": "AM-REQ-2026-09964",
    "original_inquiry": "Referral from specialist: Consultation: Phase II/III with advanced bispecific antibody; request antibody-drug conjugate and ADC immunotherapy options.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8555
  },
  {
    "request_id": "AM-REQ-2026-09965",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8833
  },
  {
    "request_id": "AM-REQ-2026-09966",
    "original_inquiry": "Referral from specialist: Oncologist referral: solid tumor positive; interested in personalized neoantigen inhibitors and bispecific antibody combinations. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6583
  },
  {
    "request_id": "AM-REQ-2026-09967",
    "original_inquiry": "海外求诊：Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6904
  },
  {
    "request_id": "AM-REQ-2026-09968",
    "original_inquiry": "Oncologist referral: 双特异性抗体 positive; interested in personalized neoantigen inhibitors and ADC combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8006
  },
  {
    "request_id": "AM-REQ-2026-09969",
    "original_inquiry": "患者家属咨询：Phase II/III晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7284
  },
  {
    "request_id": "AM-REQ-2026-09970",
    "original_inquiry": "Referral from specialist: 海外求药：NSCLC患者，希望参加antibody-drug conjugate或mRNA癌症疫苗相关试验。 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6843
  },
  {
    "request_id": "AM-REQ-2026-09971",
    "original_inquiry": "Second opinion requested: Consultation: 双特异性抗体 with advanced personalized neoantigen; request CAR-T and ADC immunotherapy options. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7967
  },
  {
    "request_id": "AM-REQ-2026-09972",
    "original_inquiry": "Family seeking information: Urgent: 双特异性抗体 mutation confirmed; seeking immune checkpoint trials and bispecific antibody programs.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7184
  },
  {
    "request_id": "AM-REQ-2026-09973",
    "original_inquiry": "研究者咨询：Researcher inquiry: mRNA vaccine trial design and mRNA cancer vaccine with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5715
  },
  {
    "request_id": "AM-REQ-2026-09974",
    "original_inquiry": "Oncologist referral: NSCLC positive; interested in personalized neoantigen inhibitors and CAR-T combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7808
  },
  {
    "request_id": "AM-REQ-2026-09975",
    "original_inquiry": "Second opinion requested: Oncologist referral: ADC联合治疗 positive; interested in immune checkpoint inhibitors and CAR-T combinations.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7911
  },
  {
    "request_id": "AM-REQ-2026-09976",
    "original_inquiry": "患者家属咨询：双特异性抗体晚期，寻求personalized neoantigen、双抗或ADC联合方案及入组条件。 Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5219
  },
  {
    "request_id": "AM-REQ-2026-09977",
    "original_inquiry": "Second opinion requested: Patient with melanoma (KRAS G12C); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7364
  },
  {
    "request_id": "AM-REQ-2026-09978",
    "original_inquiry": "Urgent: solid tumor mutation confirmed; seeking mRNA cancer vaccine trials and bispecific antibody programs.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5246
  },
  {
    "request_id": "AM-REQ-2026-09979",
    "original_inquiry": "Second opinion requested: Patient with solid tumor (personalized neoantigen); seeking bispecific antibody or bispecific antibody clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8678
  },
  {
    "request_id": "AM-REQ-2026-09980",
    "original_inquiry": "Second opinion requested: Request for second opinion: solid tumor; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8608
  },
  {
    "request_id": "AM-REQ-2026-09981",
    "original_inquiry": "Researcher inquiry: Phase II/III trial design and KRAS G12C with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.8382
  },
  {
    "request_id": "AM-REQ-2026-09982",
    "original_inquiry": "Request for second opinion: NSCLC; interest in personalized neoantigen vaccine and CAR-T.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6508
  },
  {
    "request_id": "AM-REQ-2026-09983",
    "original_inquiry": "Urgent: Request for second opinion: ADC联合治疗; interest in personalized neoantigen vaccine and CAR-T. Please advise on next steps.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5656
  },
  {
    "request_id": "AM-REQ-2026-09984",
    "original_inquiry": "Family seeking information: 海外求药：solid tumor患者，希望参加personalized neoantigen或mRNA癌症疫苗相关试验。",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6231
  },
  {
    "request_id": "AM-REQ-2026-09985",
    "original_inquiry": "Family seeking information: Researcher inquiry: melanoma trial design and antibody-drug conjugate with checkpoint inhibition. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7926
  },
  {
    "request_id": "AM-REQ-2026-09986",
    "original_inquiry": "Urgent: Oncologist referral: solid tumor positive; interested in mRNA cancer vaccine inhibitors and bispecific antibody combinations.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5606
  },
  {
    "request_id": "AM-REQ-2026-09987",
    "original_inquiry": "Patient with mRNA vaccine (immune checkpoint); seeking mRNA cancer vaccine or mRNA cancer vaccine clinical trials, preferably Phase II/III. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.786
  },
  {
    "request_id": "AM-REQ-2026-09988",
    "original_inquiry": "Researcher inquiry: solid tumor trial design and personalized neoantigen with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7139
  },
  {
    "request_id": "AM-REQ-2026-09989",
    "original_inquiry": "Referral from specialist: Patient with Phase II/III (personalized neoantigen); seeking CAR-T or CAR-T clinical trials, preferably Phase II/III. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7756
  },
  {
    "request_id": "AM-REQ-2026-09990",
    "original_inquiry": "Second opinion requested: Urgent: NSCLC mutation confirmed; seeking CAR-T trials and bispecific antibody programs. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6745
  },
  {
    "request_id": "AM-REQ-2026-09991",
    "original_inquiry": "Second opinion requested: Researcher inquiry: melanoma trial design and ADC with checkpoint inhibition. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7269
  },
  {
    "request_id": "AM-REQ-2026-09992",
    "original_inquiry": "Second opinion requested: Patient with 双特异性抗体 (CAR-T); seeking antibody-drug conjugate or antibody-drug conjugate clinical trials, preferably Phase II/III.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5305
  },
  {
    "request_id": "AM-REQ-2026-09993",
    "original_inquiry": "Urgent: Consultation: Phase II/III with advanced mRNA cancer vaccine; request ADC and ADC immunotherapy options. 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6871
  },
  {
    "request_id": "AM-REQ-2026-09994",
    "original_inquiry": "Request for second opinion: 个体化疫苗; interest in personalized neoantigen vaccine and CAR-T. 希望了解入组标准与中心列表。",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6992
  },
  {
    "request_id": "AM-REQ-2026-09995",
    "original_inquiry": "Urgent: Oncologist referral: 双特异性抗体 positive; interested in ADC inhibitors and immune checkpoint combinations. 希望了解入组标准与中心列表。",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.5393
  },
  {
    "request_id": "AM-REQ-2026-09996",
    "original_inquiry": "海外求诊：Oncologist referral: ADC联合治疗 positive; interested in ADC inhibitors and antibody-drug conjugate combinations. Would like to discuss eligibility and timeline.",
    "standard_mapping": "High-end clinical trial; mRNA vaccine / bispecific / ADC / immunotherapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6802
  },
  {
    "request_id": "AM-REQ-2026-09997",
    "original_inquiry": "Referral from specialist: Patient with NSCLC (personalized neoantigen); seeking ADC or ADC clinical trials, preferably Phase II/III. Please advise on next steps.",
    "standard_mapping": "Oncology clinical research; targeted or immune therapy",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.897
  },
  {
    "request_id": "AM-REQ-2026-09998",
    "original_inquiry": "Referral from specialist: Consultation: 双特异性抗体 with advanced mRNA cancer vaccine; request CAR-T and ADC immunotherapy options. Would like to discuss eligibility and timeline.",
    "standard_mapping": "Phase II/III trial; solid tumor or hematologic",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.7037
  },
  {
    "request_id": "AM-REQ-2026-09999",
    "original_inquiry": "Second opinion requested: 患者家属咨询：mRNA vaccine晚期，寻求CAR-T、双抗或ADC联合方案及入组条件。 希望了解入组标准与中心列表。",
    "standard_mapping": "Combination immunotherapy; biomarker-driven",
    "asset_category": "Clinical_Trial",
    "l1_entropy_target": 0.6704
  }
]